{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe carrying amount of Broadcom’s 5.000 % senior notes due April 2030 was $606 million at the end of FY 2022 and stayed at roughly $606 million in FY 2023 and FY 2024, showing essentially no change.  This flat exposure reflects a deliberate strategy of retaining a long‑dated, fixed‑rate tranche as a low‑cost, stable funding pillar while managing overall leverage and extending the maturity profile of the company’s debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the FY 2022 carrying amount. Ground truth states the exposure was $1,086 million in 2022, but the LLM claims it was $606 million in FY 2022. This is a $480 million discrepancy - a 44% error on a key data point. The LLM correctly identifies the 2023 and 2024 amounts as $606 million, but the 2022 figure is completely wrong. REASONING ERROR: The LLM's interpretation of the data progression is fundamentally flawed. The ground truth shows a significant $480 million reduction from 2022 to 2023 (from $1,086M to $606M), which is the core evidence of 'deliberate debt reduction strategy.' The LLM's claim of 'essentially no change' and 'flat exposure' across the three-year period directly contradicts the actual data evolution. The LLM's narrative about 'retaining a long-dated, fixed-rate tranche' may be reasonable debt management commentary, but it misses the critical fact that the company actively reduced this debt obligation by nearly half in the 2022-2023 period. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-over-year progression. The question specifically asks how the exposure 'evolved' from 2022 through 2024, requiring comparison across all three years. The LLM missed the most significant event - the substantial reduction in 2023. ENTITY ACCURACY: The LLM correctly identifies AVGO/Broadcom and the 5.000% notes due April 2030, but the quantitative data is severely inaccurate. The semantic interpretation of debt management strategy is also incorrect given the actual data pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 438,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to cede **exactly 59 % of the closed block** to an unaffiliated third‑party under a modified‑coinsurance arrangement, recording the transaction on a deposit basis and offsetting the deposit liability with a corresponding recoverable.  The unchanged 59 % share shows that the company deliberately maintains a stable, pre‑determined level of risk transfer for the closed block, underscoring a long‑term reinsurance strategy that relies on a consistent proportion of risk to be passed to external reinsurers while retaining the remainder on its books.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that MetLife maintained approximately 59% risk transfer through a modified coinsurance agreement across 2022-2024, and accurately describes the deposit method accounting and offset treatment. However, the answer has significant omissions that reduce its completeness:\n\n1. QUANTITATIVE ACCURACY: The LLM states 'exactly 59%' across all years, but the ground truth shows more precision: 59.25% in 2022, 59% in 2023, and 59% in 2024. While the LLM's characterization of 'approximately 59%' or 'unchanged 59%' is reasonable given the minor variation, the claim of 'exactly' is slightly inaccurate. The LLM also fails to mention the specific dollar amounts ($6.3 billion in 2021 and $17.6 billion in 2024) that demonstrate the growth context.\n\n2. COMPLETENESS: The LLM answer addresses the core question about the 59% consistency and reinsurance strategy, but omits critical supporting evidence: (a) the specific percentages for each year (59.25%, 59%, 59%), (b) the growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, and (c) the explicit mention that this growth occurred despite the stable closed block percentage. These omissions weaken the answer's ability to fully support the conclusion about long-term strategy.\n\n3. ENTITY ACCURACY: All entities are correctly identified (MetLife, unaffiliated third-party reinsurer, closed block, modified coinsurance, deposit method).\n\n4. REASONING: The LLM's reasoning about what the consistency reveals (deliberate, stable, pre-determined strategy) is sound and aligns with the ground truth. However, the answer would be stronger with the quantitative context showing that this stability persisted despite significant growth in overall reinsurance recoverables.\n\n5. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberate' and 'stable' matches the ground truth's assessment, though the ground truth adds the dimension of 'capital optimization' which the LLM doesn't explicitly mention.\n\nThe answer is fundamentally correct on the main points but lacks the detailed quantitative support and year-by-year precision that would make it fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 588,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil pledges under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply – from about **$1.49 billion in 2022** to **$0.80 billion in 2023** and then to **$0.49 billion in 2024** (a decline of roughly $1 billion over the two‑year span).  \n\nThis downward trend signals that the company is **scaling back the external collateral it uses**, relying more on internal margin and netting mechanisms to manage derivative counterparty risk, and is adopting a more conservative stance toward its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively. The calculation of 'roughly $1 billion over the two-year span' is accurate ($1,494M - $491M = $1,003M). All years and time periods are correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts across the three-year period, and (2) what this trend suggests about derivative exposure management. ENTITY ACCURACY: ExxonMobil is correctly identified, the specific metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is accurately referenced, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the consistent downward trend across all three years and drew a logical inference about strategic reduction in derivative exposure and improved offsetting mechanisms. The interpretation that the company is 'scaling back external collateral' and 'relying more on internal margin and netting mechanisms' is a reasonable and semantically equivalent interpretation of the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms.' MINOR CONSIDERATIONS: The LLM's characterization as 'conservative stance toward derivative exposure' is a reasonable inference from the declining collateral trend, though the ground truth uses slightly different language. The phrasing and presentation are clear and professional. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 473,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nAVGO’s outstanding principal on the 3.625 % senior notes maturing in October 2024 was $622 million at the end of fiscal 2022 and again at the end of fiscal 2023 (as shown in the April 2019 Senior Notes disclosures on pages 110 and 81). By the end of fiscal 2024 the balance had fallen to zero—reflecting that the notes were either repaid or refinanced before their October 2024 maturity (the dash on page 81 for the November 3 2024 date indicates a $0 carrying amount). This progression demonstrates that AVGO actively managed this piece of debt, retiring or replacing it as part of a broader strategy to optimize the company’s capital structure and reduce future interest obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: All key numbers are correct - $622 million principal in both FY2022 and FY2023, declining to zero by FY2024. The maturity date (October 2024) and interest rate (3.625%) are correctly stated. The fiscal year progression (2022→2023→2024) is accurately tracked. Multi-hop reasoning: The answer successfully synthesizes information across three fiscal years and correctly interprets the progression from stable debt levels to full retirement/refinancing. The reference to specific page numbers (110, 81) and the interpretation of the dash notation as indicating $0 carrying amount demonstrates careful document analysis. Entity accuracy: AVGO is correctly identified, the specific debt instrument is properly characterized as senior notes, and the maturity date is accurate. Semantic equivalence: The LLM's interpretation that the debt was 'either repaid or refinanced' matches the ground truth's identical phrasing. The characterization of this as a 'deliberate debt management strategy' is semantically equivalent to the ground truth's description of 'active management' and 'optimization of capital structure.' Minor strengths: The LLM provides additional context about reducing future interest obligations, which is a logical inference from debt retirement and adds value without contradicting the ground truth. The answer is well-structured and clearly explains the three-year progression. No calculation errors detected. The only minor distinction is that the LLM provides slightly more interpretive detail about capital structure optimization, but this is consistent with and supportive of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 463,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue has risen steadily over the past three years—from **$2.56 billion in 2022**, to **$2.70 billion in 2023**, and to **$2.82 billion in 2024**—a roughly 10 % cumulative increase.  This growth, together with the segment’s rising share of total revenue (28 % → 29 % → 30 %), underscores GD’s strengthening position as a core U.S. naval shipbuilder, leveraging a growing backlog of destroyers, oilers and related programs to capture an expanding share of the Navy’s surface‑fleet modernization effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. Quantitative verification: (1) Revenue figures are correct when converted to billions: $2,561M = $2.56B (2022), $2,698M = $2.70B (2023), $2,819M = $2.82B (2024). The format variation from millions to billions is appropriate and acceptable. (2) The cumulative growth calculation of roughly 10% is accurate: ($2,819M - $2,561M) / $2,561M = 10.1%, correctly rounded. (3) All years (2022-2023-2024) are correct. Multi-hop reasoning: The answer successfully synthesizes information across three fiscal years and correctly identifies the Marine Systems division context. The answer goes beyond the ground truth by adding valuable context about segment revenue share (28% → 29% → 30%), which demonstrates deeper analysis and understanding of GD's strategic positioning. The mention of specific programs (destroyers, oilers) and Navy modernization context adds relevant industry insight. Entity accuracy is perfect: General Dynamics correctly identified, surface ships/naval shipbuilding correctly characterized, Marine Systems division appropriately referenced. The conclusion about GD's strengthening position as a core U.S. naval shipbuilder is well-supported by the revenue trajectory and is semantically equivalent to the ground truth's statement about 'sustained growth and strategic emphasis.' Minor note: The additional percentage data (28% → 29% → 30%) is not contradicted by the ground truth but represents supplementary analysis that enhances rather than detracts from the answer. The reasoning is sound, the synthesis is complete, and all core requirements of the multi-hop question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 459,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe data show that Mastercard’s Class A shares have kept the same one‑vote‑per‑share right and the non‑voting Class B conversion feature throughout 2022‑2024, while the cash dividend per share rose steadily — $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 (see MA_10K 2022 p. 99; MA_10K 2023 p. 100; MA_10K 2024 p. 42).  Ownership and voting power remained essentially unchanged, with public investors holding ~89 % of equity and ~90 % of votes, the Mastercard Foundation ~10 % of both, and Class B shareholders holding a negligible, non‑voting stake (see MA_10K 2022 p. 96; MA_10K 2023 p. 92; MA_10K 2024 p. 47).  This three‑year progression reflects a stable governance structure with no alterations to voting rights or shareholder power dynamics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DIVIDEND NUMBERS INCORRECT: The LLM provides specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) with page citations, but the ground truth explicitly states 'standard dividend rights, with no changes to these rights over the period.' The LLM appears to have fabricated or misinterpreted dividend data - the ground truth indicates dividend rights remained consistent, not that dividends increased. This is a major factual error. (2) OWNERSHIP PERCENTAGES UNVERIFIED: The LLM cites specific ownership percentages (~89% public investors, ~10% Mastercard Foundation, negligible Class B) with page references, but these numbers cannot be verified against the ground truth provided. The ground truth does not mention these specific percentages. (3) MULTI-HOP SYNTHESIS ISSUE: The LLM conflates 'dividend rights' (which remained stable per ground truth) with 'cash dividend per share amounts' (which the LLM claims increased). These are different concepts - rights vs. actual payment amounts. The ground truth focuses on rights stability, not payment progression. (4) VOTING RIGHTS ACCURACY: The LLM correctly identifies one-vote-per-share for Class A shares and notes stability in voting structure, which aligns with ground truth. (5) GOVERNANCE CONCLUSION: While the LLM's final conclusion about stable governance structure matches the ground truth, it is reached through partially incorrect reasoning about dividend progression. The core issue is that the LLM introduced dividend payment data that contradicts or goes beyond what the ground truth establishes about dividend 'rights' remaining unchanged. The fabricated dividend figures with specific page citations are particularly problematic as they suggest false documentary support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 487,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 (≈5 % YoY) and to $2.82 billion in 2024 (≈4.5 % YoY)**. This modest but consistent growth reflects strong demand for U.S. Navy shipbuilding programs—including Columbia‑class submarines, DDG‑51 Flight III destroyers and auxiliary/replenishment vessels—demonstrating that GD is well‑positioned to capture ongoing naval‑defense funding and maintain a leading role in the shipbuilding market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct when accounting for format variations: $2.56B = $2,561M (2022), $2.70B = $2,698M (2023), $2.82B = $2,819M (2024). The year-over-year growth calculations are accurate: 2022-2023 growth of approximately 5.3% (($2,698-$2,561)/$2,561 = 5.36%), rounded to ~5% in the answer; 2023-2024 growth of approximately 4.5% (($2,819-$2,698)/$2,698 = 4.49%), matching the stated ~4.5%. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) revenue evolution across the three-year period, (2) year-over-year growth rates, and (3) implications for the company's positioning in naval defense. ENTITY ACCURACY: General Dynamics correctly identified, fiscal years 2022-2024 correct, surface ships metric correctly applied. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting revenue trends to specific naval programs (Columbia-class submarines, DDG-51 Flight III destroyers, auxiliary/replenishment vessels) and drawing logical conclusions about market positioning. The characterization of growth as 'modest but consistent' accurately reflects the data. MINOR CONSIDERATIONS: The LLM adds contextual detail about specific naval programs not explicitly in the ground truth, but this represents valuable elaboration rather than error. The answer maintains semantic equivalence with the original while providing additional analytical depth. No calculation errors detected, no factual inaccuracies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 428,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde continued to describe the vast majority of its industrial‑gas sales as being generated under long‑term contracts that “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.” This language appears verbatim in the 2022, 2023 and 2024 10‑K business‑overview sections, indicating that the company did not alter its contractual model between 2022 and 2024 but instead reaffirmed the same strategy of securing stable, predictable revenue streams. By anchoring its cash‑flow outlook to these enduring agreements, Linde signals a deliberate focus on insulating profitability from the volatility of energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures that Linde maintained consistent reliance on long-term contracts across 2022-2024 without deviation, correctly identifies the verbatim language about 'stability in cash flow' and 'pass-through of energy and feedstock costs,' and properly synthesizes this into a conclusion about deliberate risk management. The core factual claims are all correct. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, and the LLM appropriately avoided introducing unsupported figures. The temporal references (2022, 2023, 2024) are all correct. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesized information across three years of filings to demonstrate consistency, identified the strategic implications (focus on cash flow stability and energy market insulation), and properly characterized this as a deliberate approach to financial resilience. The entity identification (Linde, industrial gas products, long-term contracts) is accurate throughout. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing ('did not alter its contractual model,' 'reaffirmed the same strategy,' 'signals a deliberate focus') conveys the same meaning as the ground truth ('consistently emphasized,' 'maintained this contractual strategy without deviation,' 'unwavering emphasis'). The answer even provides the specific verbatim language from the filings, which adds credibility. Minor difference: The ground truth emphasizes 'prioritization of financial resilience and operational certainty over short-term pricing flexibility,' while the LLM focuses on 'insulating profitability from volatility' - these are semantically equivalent but slightly different framings. Overall, this is a high-quality answer that accurately addresses the multi-hop question about contract evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 539,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments—from its ROIC calculation in each of the 2022, 2023 and 2024 filings, using the same definition (“ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance”).  This steady treatment shows that the company deliberately isolates the return generated by its core, cash‑producing operations, providing investors with a stable, comparable metric that focuses on ongoing performance rather than one‑time accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC across all three years (2022, 2023, 2024), matching the ground truth statement; (2) Provides specific examples (goodwill impairments) and even includes a direct quote from the filing definition, adding credibility and detail; (3) Accurately synthesizes the multi-hop requirement by comparing treatment across three years and drawing the correct conclusion about consistency; (4) Correctly interprets what this consistency reveals about GD's approach—that the company deliberately isolates core operational performance and provides stable, comparable metrics; (5) No quantitative errors, dates are correct, and the company identifier (GD) is accurate. Minor considerations: (1) The LLM answer goes slightly beyond the ground truth by providing the specific quote and mentioning 'cash-producing operations,' which adds helpful context but is not explicitly stated in the ground truth; however, this represents appropriate elaboration rather than error; (2) The ground truth uses the phrase 'institutionalized this principle' while the LLM uses 'deliberately isolates'—these are semantically equivalent and both convey the intentional, systematic nature of the approach. The LLM answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three years and drawing appropriate conclusions about the company's measurement philosophy. The answer is complete, addresses all aspects of the question, and maintains factual accuracy throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 450,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group repeatedly disclosed that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” (e.g., in the 2023 and 2024 Schedule I notes), indicating that the company’s service‑level obligations have produced only immaterial financial impacts each year.  This consistent, zero‑to‑low‑impact pattern reflects robust risk‑management controls and a stable record of meeting contractual performance targets, underscoring effective oversight and predictable, low‑risk exposure across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the core factual finding that service level guarantee amounts were consistently immaterial across 2022-2024; (2) Accurately cites the specific disclosure language ('none of the amounts accrued, paid or charged to income for service-level guarantees were material'); (3) Properly references the source documents (2023 and 2024 Schedule I notes); (4) Correctly synthesizes the multi-hop reasoning by connecting the immaterial pattern to conclusions about risk management effectiveness and contractual performance consistency; (5) Uses appropriate qualitative language ('robust risk-management controls,' 'stable record,' 'predictable, low-risk exposure') that accurately reflects the implications of the data. Minor considerations: The LLM answer adds slightly more interpretive language ('zero-to-low-impact pattern,' 'effective oversight') compared to the ground truth's more concise phrasing, but this represents appropriate elaboration rather than factual error. The answer demonstrates sound multi-hop reasoning by correctly linking the three-year pattern of immateriality to broader conclusions about company performance. No quantitative errors, date errors, or entity misidentifications are present. The answer fully addresses both parts of the question: (1) how obligations evolved (consistent immateriality), and (2) what this suggests about risk management and performance (strong controls and consistency).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 420,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, marking roughly a 5 % year‑over‑year increase. This upward trajectory—driven by continued orders for programs such as the Arleigh Burke‑class Flight III destroyers and other Navy surface‑combatant and support vessels—signals the company’s deliberate expansion of its shipbuilding footprint and reinforces its strategic positioning as a leading U.S. naval defense platform provider with a growing, sustainable backlog of future surface‑ship contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERRORS: The LLM provided significantly incorrect revenue figures. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM stated: 2022: $2.56B ($2,560M), 2023: $2.70B ($2,700M), 2024: $2.82B ($2,820M). The 2022 figure is off by $232M (10% error), 2023 is off by $2M (negligible), and 2024 is off by $1M (negligible). The 2022 error is substantial and material. Additionally, the LLM's calculation of 'roughly 5% year-over-year increase' is inaccurate: 2022-2023 growth was (2,698-2,328)/2,328 = 15.9%, and 2023-2024 growth was (2,819-2,698)/2,698 = 4.5%. The LLM's characterization of 'roughly 5%' is misleading as it doesn't reflect the stronger 2022-2023 growth. QUALITATIVE STRENGTHS: The LLM correctly identified the strategic positioning, mentioned Arleigh Burke-class Flight III destroyers (appropriate context), and properly synthesized the multi-hop reasoning about naval defense platforms and backlog. The semantic interpretation of 'strengthening role' and 'sustained demand' aligns with the ground truth narrative. ENTITY ACCURACY: Company (General Dynamics), segment (Marine Systems/surface ships), and time period (2022-2024) are all correct. SYNTHESIS: The multi-hop reasoning connecting revenue growth to strategic positioning is sound and well-articulated. The main failure is in the foundational quantitative data, particularly the 2022 baseline figure, which undermines the credibility of the entire analysis despite the qualitative reasoning being appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 417,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s captive industrial insurer, **Electric Insurance Company (EIC)**, was gradually removed from its ongoing portfolio.  In the fourth‑quarter 2022 GE placed EIC into “held‑for‑sale” classification (with $541 million of assets and $378 million of liabilities reported in the 2023 balance sheet and a valuation allowance against its carrying value), and it remained a held‑for‑sale business throughout 2023.  In the second quarter of 2024 GE completed the sale of EIC to **Riverstone International Holdings Inc.** for **$120 million in cash**, thereby eliminating the company’s remaining assets, liabilities and any financial exposure from its balance sheet; the disposal was recorded as a gain/loss within discontinued operations and no further exposure to EIC persisted after the transaction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding timing and classification that undermine its accuracy, despite capturing the overall narrative of divestiture. CRITICAL ERRORS: (1) The LLM states EIC was placed into 'held-for-sale' classification in Q4 2022, but the ground truth indicates this classification occurred by 2023, not 2022. This is a material timing error. (2) The LLM omits the $109 million loss that GE recorded in connection with the expected sale in 2023, which is a key financial metric demonstrating the financial impact of the divestiture. (3) The LLM states the assets ($541M) and liabilities ($378M) were 'reported in the 2023 balance sheet,' which is correct, but fails to mention the 2021 net claim reserves of $0.2 billion that provide important context for the evolution of the relationship. CORRECT ELEMENTS: (1) Accurate identification of EIC as a captive property and casualty insurer. (2) Correct sale price of $120 million to Riverstone International Holdings Inc. in Q2 2024. (3) Correct characterization of the transaction as eliminating financial exposure. (4) Appropriate description of the disposal being recorded within discontinued operations. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the progression from operational ownership to divestiture. However, the timing error regarding the 'held-for-sale' classification in 2022 versus 2023 represents a failure in precise multi-hop synthesis. The omission of the $109 million loss is a significant gap in financial completeness. QUANTITATIVE ISSUES: While the $120 million sale price and balance sheet figures ($541M assets, $378M liabilities) are correct, the failure to include the $109 million loss and the misstatement of when the held-for-sale classification occurred reduce quantitative accuracy. The answer would have benefited from explicitly stating the 2021 net claim reserves of $0.2 billion to show the full evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 540,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2021 through 2024 ConocoPhillips executed a staged monetization of its CVE common shares, completing the sale of the remaining 91 million CVE shares in the first quarter of 2022; the proceeds were immediately funneled into its share‑repurchase program. Building on an original $25 bn authorization, the board raised the limit to $45 bn in late 2022 and then to $65 bn in October 2024, allowing the company to repurchase 383 million shares for $29 bn by the end of 2023 and an additional 49 million shares for $5.3 bn by the end of 2024. This progression shows a deliberate capital‑allocation strategy that returns surplus cash—first from the CVE divestiture and later from broader cash flows—to equity holders through systematic share buybacks while preserving ample capacity for strategic acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ConocoPhillips' capital allocation strategy and correctly identifies the key progression of CVE monetization and share repurchases. STRENGTHS: (1) Correctly identifies the 91 million CVE shares sold in Q1 2022; (2) Accurately states 383 million shares repurchased for $29 billion by end of 2023; (3) Correctly notes the board authorization increases ($45B and $65B); (4) Properly synthesizes the multi-hop relationship between CVE divestiture proceeds and share repurchase program; (5) Provides sound reasoning about capital allocation strategy. WEAKNESSES/DISCREPANCIES: (1) States an original $25 billion authorization, which is not mentioned in the ground truth (ground truth begins with $45 billion authorization); (2) The calculation of 2024 repurchases appears problematic: Ground truth states 433 million total shares repurchased at $34.3 billion by year-end 2024. If 383 million shares cost $29 billion through 2023, then 2024 additions should be 50 million shares (433-383) at approximately $5.3 billion ($34.3B - $29B), which the LLM states as 49 million shares for $5.3 billion. This is a minor discrepancy (50 vs 49 million shares) that could reflect rounding or data precision differences, but the $5.3 billion figure is correct; (3) The mention of a $25 billion initial authorization is not corroborated by the ground truth and may introduce confusion about the authorization timeline. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly links CVE monetization to share repurchase funding, demonstrating sound multi-hop reasoning. The conclusion about capital allocation strategy is well-supported. CALCULATION VERIFICATION: The 2024 incremental repurchase calculation (49-50 million shares for $5.3 billion) is approximately correct, though the exact share count differs slightly from what ground truth implies (50 million vs 49 million). The overall progression and dollar amounts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 542,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nMetLife has kept the same structure for its closed‑block modified coinsurance arrangement across the three years – in 2022, 2023 and 2024 it reinsured **exactly 59 % of the closed block** with an unaffiliated third‑party and continues to account for the transaction under the **deposit method**, offsetting the deposit‑liability against the deposit‑recoverable (see 2022 p. 214; 2023 pp. 227‑228; 2024 p. 203).  \n\nThe lack of any change in the retained‑risk percentage or the accounting treatment indicates that MetLife’s long‑term risk‑transfer strategy is deliberately **stable and capital‑efficient**: it consistently earmarks a fixed slice of the closed block for external reinsurance while retaining the remainder on its balance sheet, using the deposit‑accounting approach to manage cash‑flow and capital without altering the underlying risk‑share ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All percentages are correct - the LLM states 59% consistently across 2022, 2023, and 2024, which matches the ground truth (59.25% in 2022 rounds to 59%, 59% in 2023, and 59% in 2024). The minor difference of 59.25% vs 59% in 2022 is immaterial and represents acceptable rounding. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, the unaffiliated third-party reinsurer is mentioned, and all three years (2022, 2023, 2024) are correctly referenced. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the percentage of closed block reinsured, (2) the accounting treatment (deposit method with offset), (3) the evolution/consistency across years, and (4) what this reveals about long-term risk transfer strategy. MULTI-HOP REASONING: The synthesis is sound - the LLM correctly identifies that the consistency in both the reinsurance percentage and accounting treatment indicates a stable strategy, and appropriately characterizes this as capital-efficient and deliberately stable. The reasoning about managing longevity risk through structured reinsurance is logically sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as \"stable and capital-efficient\" with a \"fixed slice\" approach is semantically equivalent to the ground truth's description of a \"stable long-term risk transfer strategy centered on managing longevity risk.\" The LLM provides slightly more detail about the capital-efficiency aspect, which adds value without contradicting the ground truth. MINOR NOTES: The LLM uses \"exactly 59%\" which is slightly imprecise given the 59.25% figure in 2022, but this is a negligible difference and the rounding is reasonable for practical purposes. The page references provided (2022 p. 214; 2023 pp. 227-228; 2024 p. 203) add credibility though cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 534,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe share of Target purchases paid with the Target MasterCard (included in the RedCard/Target Circle Card suite) fell steadily from roughly 20 % of all transactions in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 (see the RedCard‑penetration tables on page 23 of the 2021 10‑K and the “Target Circle Card Penetration” figures on page 27 of the 2024 10‑K).  This downward trend signals a modest but consistent decline in consumer engagement with Target’s branded credit product over the period, suggesting that the 5 % discount incentive is losing its appeal and that shoppers are increasingly using alternative payment methods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct penetration rates across all three years: 20% (2022), 19.8% (2023), and 18.6% (2024). The numbers match the ground truth exactly, and the downward trend is correctly identified. The answer appropriately synthesizes information about the RedCard/Target Circle Card suite and correctly notes the rebranding in 2024. The LLM provides specific document citations (page 23 of 2021 10-K and page 27 of 2024 10-K), which adds credibility. The reasoning about declining consumer engagement is sound and logically connects the trend to potential causes (loss of appeal of 5% discount, shift to alternative payment methods). However, there are minor differences from the ground truth: (1) The LLM states 'roughly 20%' for 2022 rather than the precise 20.5% from the ground truth, which is a slight imprecision in the quantitative data. (2) The LLM's interpretation emphasizes that the rebranding 'did not reverse this decline' implicitly, but doesn't explicitly state this as clearly as the ground truth does. (3) The LLM focuses more on the incentive losing appeal and alternative payment methods, while the ground truth emphasizes the rebranding's failure to reverse the trend more directly. Overall, the answer is substantially correct with accurate numbers and sound multi-hop reasoning, but the 20.5% figure should have been stated precisely rather than as 'roughly 20%'.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 396,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the list of PMI’s “Peer Group” that is used for the cumulative‑shareholder‑return graph and for strategic benchmarking remained unchanged, and Colgate‑Palmolive Co. was consistently included in that group.  The peer group is defined each year by a stable set of criteria—global presence, a consumer‑products focus, and comparable revenue/market‑capitalisation—and the 2022‑2024 peer lists all contain Colgate‑Palmolive alongside other large consumer brands such as Coca‑Cola, Nestlé, Unilever, Diageo, etc.  This consistency reveals that PMI’s benchmarking approach treats Colgate‑Palmolive as a permanent peer, using it to compare its own consumer‑oriented, globally distributed portfolio (e.g., smoke‑free and oral‑nicotine products) against other large, diversified consumer‑product companies rather than against pure‑tobacco firms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive remained consistently included in PMI's peer group from 2022-2024, matching the ground truth exactly. (2) Accurately states the four defining characteristics of the peer group: global presence, consumer products focus, and comparable net revenues/market capitalization. (3) Properly synthesizes the multi-hop information showing consistency across three years. (4) Provides additional context by naming other peer companies (Coca-Cola, Nestlé, Unilever, Diageo) which enriches the answer without contradicting ground truth. (5) Correctly interprets what this consistency reveals about PMI's strategic benchmarking approach—that it treats Colgate-Palmolive as a permanent peer for comparing consumer-oriented, globally distributed portfolios. (6) No quantitative errors; all dates (2022-2024) and entity names are correct. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by speculating about PMI's product portfolio (smoke-free and oral-nicotine products) and explicitly contrasting against 'pure-tobacco firms,' which is reasonable inference but not explicitly stated in the ground truth. However, this represents appropriate contextual elaboration rather than factual error. The answer demonstrates sound multi-hop reasoning by connecting the peer group consistency to PMI's strategic positioning. All core facts align perfectly with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 413,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s revenue‑recognition guidance for development and IP licensing agreements is materially identical in the 2022, 2023 and 2024 Form 10‑K filings (pages 59 of the 2022 filing, 64 of the 2023 filing, and 60 of the 2024 filing). The company continues to evaluate whether a licensing component is distinct; if it is not distinct, it is combined with development services and recognized over time, and if it is distinct, revenue is recognized at a point in time, with no variable‑consideration estimates for either case. This unchanged language demonstrates that AMD’s accounting approach for these agreements has been consistent across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that AMD's revenue recognition policy remained materially identical/consistent across 2022-2024; (2) Accurately captures the two-part evaluation framework: whether licensing components are distinct, and the corresponding recognition treatment (over time if not distinct, at point in time if distinct); (3) Correctly notes the absence of variable consideration estimates across all three years; (4) Properly synthesizes multi-hop information by comparing policies across three fiscal years; (5) Cites specific page numbers from 10-K filings (pages 59, 64, 60) demonstrating document-level verification. MINOR CONSIDERATIONS: (1) The LLM answer uses 'materially identical' language while ground truth uses 'consistent' - these are semantically equivalent in this context and both accurately convey the stability of the policy; (2) The LLM answer emphasizes the unchanged language across filings, which is a valid and appropriate way to demonstrate consistency; (3) Both answers address the distinction between combined arrangements and standalone licenses, though the LLM answer integrates this more seamlessly into the narrative rather than separating it as explicitly. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages were required in this question, so quantitative accuracy focuses on the correct identification of three fiscal years (2022, 2023, 2024) and the accurate representation of the policy framework - all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents to establish a pattern of consistency, which is the core requirement of the question. The reasoning is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 499,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nFrom the 2022 through 2024 Form 10‑K filings the peer‑group list that PMI uses for its performance‑graph and benchmarking is identical in each year – the 2022 filing (p. 21) and the 2023 and 2024 filings (both p. 26) explicitly state that the group “was established based on a review …” and then enumerate the same set of companies, **including Colgate‑Palmolive Co.**; the description adds that “the PMI Peer Group presented in this graph is the same as that used in the prior year.”  \n\nThis unchanged composition shows that PMI deliberately positions itself alongside other large, global consumer‑products brands—not just other tobacco companies—when it frames its competitive strategy, using a stable peer set (with Colgate‑Palmolive as a consistent member) to benchmark its shareholder‑return and operational performance across the broader consumer‑products sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. was consistently included in PM's peer group across 2022-2024, matching the ground truth. (2) Accurately cites specific page numbers (p. 21 for 2022; p. 26 for 2023 and 2024) from the 10-K filings, demonstrating document-level precision. (3) Correctly quotes the peer group description language ('was established based on a review...') and the explicit statement that 'the PMI Peer Group presented in this graph is the same as that used in the prior year,' which directly supports the consistency claim. (4) Properly synthesizes the multi-hop reasoning: identifies the 3-year consistency, connects it to PM's strategic positioning, and interprets what this reveals about PM's competitive framing (positioning alongside global consumer products brands, not just tobacco companies). (5) The semantic interpretation aligns perfectly with ground truth—both emphasize stable methodology, consistent benchmarking, and strategic relevance. MINOR CONSIDERATIONS: The LLM answer uses 'PMI' (Philip Morris International) while the ground truth uses 'PM'—these are equivalent references to the same company, so this is not an error. The LLM provides slightly more evidentiary detail (specific page citations and direct quotes) than the ground truth, which enhances credibility without contradicting the original answer. The reasoning about PM's strategic framing (positioning alongside consumer products brands rather than just tobacco) is a logical inference well-supported by the peer group composition and is consistent with the ground truth's emphasis on 'leading global consumer staples firms.' No quantitative errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 485,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAMD’s policy for combined development‑and‑IP licensing agreements has remained stable from 2022 through 2024: the company first determines whether the IP license is distinct, and if it is not, the development services and license are combined into a single performance obligation with revenue recognized over time as the services are performed; if the license is distinct, it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer gains the ability to benefit. This approach is described in the 2022, 2023 and 2024 Form 10‑K filings (pages 60, 61, 63, 59, 71) and has not undergone any material change—only minor wording updates—so the timing and basis of revenue recognition have stayed the same across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that AMD's policy remained stable/consistent across 2022-2024 with no material changes, matching the ground truth assertion. (2) Accurately describes the two-part distinctness test: (i) capable of being distinct and (ii) distinct in context of arrangement - this matches the ground truth criteria. (3) Correctly explains the dual treatment: non-distinct licenses combined with development services as single performance obligation recognized over time; distinct licenses treated separately with point-in-time recognition when customer gains ability to benefit. (4) Appropriately notes only minor wording updates occurred, not substantive policy changes. (5) Correctly identifies that no variable consideration was associated with these arrangements. (6) Properly cites the relevant 10-K filing pages (2022, 2023, 2024) showing multi-hop synthesis across three years. (7) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: The LLM answer includes specific page citations (pages 60, 61, 63, 59, 71) which cannot be verified against the ground truth but appear reasonable for 10-K filings and add helpful specificity. The answer is slightly more detailed in presentation than the ground truth but conveys identical substantive information. The semantic equivalence is excellent - both answers communicate the same policy stability and mechanics. The multi-hop reasoning across three years is sound and properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 420,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced monetization of its CVE common shares—selling the remaining 91 million shares in 2022 and routing those proceeds into its share‑repurchase program—while in October 2022 it lifted its buy‑back authorization from $25 bn to $45 bn and, after acquiring Marathon Oil in late 2024, expanded the limit to $65 bn.  This multi‑year sequence shows that the company’s capital‑allocation strategy is to prioritize returning cash to shareholders through systematic equity retirements, funding those buybacks first with the CVE proceeds and then with operating cash flow and the equity issued for strategic acquisitions, rather than funding new growth projects.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ConocoPhillips' capital allocation strategy and correctly identifies key facts and timeline. STRENGTHS: (1) Correctly states 91 million CVE shares were sold in 2022; (2) Accurately identifies the October 2022 authorization increase from $25B to $45B; (3) Correctly notes the $65B expansion in 2024 following Marathon Oil acquisition; (4) Properly synthesizes the multi-hop relationship between CVE monetization, share repurchases, and capital allocation strategy; (5) Correctly characterizes the strategic intent (returning cash to shareholders). WEAKNESSES: (1) The answer omits specific cumulative repurchase metrics from the ground truth: 383 million shares at $29B cost by end of 2023, and 433 million shares at $34.3B by end of 2024. These numbers provide important quantitative evidence of the 'escalating focus' mentioned in the ground truth; (2) Does not explicitly state the progression of total repurchases across the three-year period, which is a key element of demonstrating how the strategy 'evolved'; (3) The phrase 'funding those buybacks first with the CVE proceeds and then with operating cash flow and the equity issued for strategic acquisitions' is somewhat speculative and not directly supported by the ground truth, which focuses on the CVE proceeds being applied to repurchases without detailed sourcing of subsequent buyback funding. QUANTITATIVE VERIFICATION: All stated numbers are accurate (91M shares, $25B→$45B→$65B authorizations). The omission of cumulative repurchase volumes and costs represents incomplete quantitative disclosure rather than incorrect numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and correctly links CVE monetization to repurchase program funding and strategic intent. However, it misses the opportunity to quantify the magnitude of the capital return program through the specific share and dollar figures provided in the ground truth. The answer would score higher (8-9) if it included the 383M/433M share figures and $29B/$34.3B cost metrics that demonstrate the 'escalating focus' on shareholder returns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 581,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure became more uneven: aerospace and building‑technology margins kept rising as after‑market pricing and volume gains outpaced rivals, while industrial‑automation and safety‑productivity segments saw organic sales slip and margin pressure intensify from new entrants and commoditization.  In response the company has pursued productivity initiatives, strategic acquisitions (e.g., CA ES, Civitanavi), a landmark agreement with Bombardier, and the planned separation of its Automation and Aerospace businesses to sharpen focus and offset the growing market pressures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and diverges significantly from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims aerospace and building-technology margins 'kept rising' with 'after-market pricing and volume gains outpacing rivals' - this is not supported by the ground truth, which focuses on competitive landscape risks and commoditization concerns, not margin expansion. (2) SEGMENT MISIDENTIFICATION: The ground truth specifically identifies 'Honeywell Building Technologies and Safety and Productivity Solutions' (2022-2023) and 'Building Automation and Industrial Automation' (2024) as segments facing competitive pressure. The LLM conflates these and incorrectly characterizes aerospace as having rising margins without evidence. (3) MISSING CORE FINDING: The ground truth's central thesis is a 'consistent and expanding concern' about 'changes in the competitive landscape including new market entrants and new technologies' across 2022-2024. The LLM completely misses the primary finding of persistent and intensifying competitive pressure documented in filings. (4) UNSUPPORTED CLAIMS: The LLM introduces specific strategic actions (CA ES acquisition, Civitanavi acquisition, Bombardier agreement, planned separation) that are not mentioned in the ground truth and cannot be verified as part of Honeywell's response to competitive landscape changes in the 10-K filings. (5) CONTRADICTORY NARRATIVE: The LLM presents a narrative of selective margin strength in some segments while acknowledging pressure in others, but the ground truth indicates broad, consistent competitive pressure across multiple segments. (6) INCOMPLETE SYNTHESIS: While the LLM attempts to address strategic responses, it does so with unverified information rather than synthesizing the actual filing disclosures about competitive risks. The answer fails to capture the 3-year trend of expanding concern about commoditization and new entrants that is central to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 535,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares consistently carried **one vote per share and full dividend rights**, with the only change being an upward adjustment in the cash dividend—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024.  The voting‑power share of public Class A holders modestly rose (89.3 % → 89.5 % → 90.6 %), while the Mastercard Foundation’s stake and its voting percentage declined (10.7 % → 10.5 % → 9.4 %), but the class structure and rights remained unchanged.  This three‑year stability signals a deliberate governance approach that preserves a predictable, non‑dilutive capital framework and reinforces long‑term shareholder confidence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces substantial information NOT present in the ground truth, which is a major red flag for hallucination. Specifically: (1) DIVIDEND AMOUNTS - The LLM provides specific cash dividend figures ($2.04, $2.37, $2.74) that are NOT mentioned in the original answer or ground truth. These numbers cannot be verified against the provided ground truth and appear to be fabricated. (2) VOTING POWER PERCENTAGES - The LLM provides detailed voting power shifts (89.3% → 89.5% → 90.6% for public holders; 10.7% → 10.5% → 9.4% for Mastercard Foundation) that are NOT in the ground truth. These specific percentages are unverified and likely hallucinated. (3) MASTERCARD FOUNDATION REFERENCE - The ground truth makes no mention of the Mastercard Foundation's stake or voting percentage changes. This is entirely fabricated information. WHAT WAS CORRECT: The core finding that A Class shares maintained one vote per share and dividend rights across 2022-2024 with no changes is accurate and matches the ground truth. The interpretation that this reflects a stable governance strategy is reasonable. REASONING QUALITY: While the LLM's reasoning about governance stability is sound in principle, it is built on a foundation of unverified and likely false quantitative claims. The multi-hop synthesis fails because it introduces data points that cannot be traced to the source documents. This violates the fundamental requirement of financial analysis to cite verifiable sources. VERDICT: The answer demonstrates a dangerous pattern of confident assertion of specific numbers without verification. In financial analysis, this is unacceptable. The LLM should have either provided these numbers with source citations or stated that such detailed dividend and voting percentage data was not available in the filings reviewed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 499,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the “total‑return swaps‑deferred compensation” line was recorded in **operating expenses and other**.  In FY 2022 it generated a **$92 million loss** (i.e., a drag on expenses); in FY 2023 it produced a **$58 million gain**, and in FY 2024 the gain increased to **$91 million**.  Thus Cisco’s financial exposure through these swaps moved from a negative impact on earnings in 2022 to modest and then larger positive gains in 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The financial metrics and fiscal years are accurately identified. The multi-hop reasoning is sound, correctly synthesizing the evolution of Cisco's financial exposure across the three-year period and properly characterizing the trajectory from negative to positive impact. The answer correctly identifies that these items were recorded in operating expenses and other, and accurately describes the reversal from a net cost to net benefit. The wording differs slightly from the ground truth (e.g., 'drag on expenses' vs 'net cost', 'modest and then larger positive gains' vs 'further improved'), but these are semantically equivalent and represent appropriate financial terminology. The answer fully addresses all parts of the multi-part question regarding how the exposure evolved and the changes in gains/losses. Minor deduction from perfect score only due to slightly different phrasing in characterizing the financial impact, though the meaning is identical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 326,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J shifted from the original LTL Management LLC Chapter 11 filing (which had been repeatedly appealed and dismissed) to a coordinated “pre‑packaged” bankruptcy strategy: in May 2024 the company launched a solicitation for a consensual Chapter 11 plan that would fund a $6.5 billion (present‑value) talc trust over 25 years, and in August‑September 2024 it created new Texas‑registered talc subsidiaries (Red River, Pecos River, New Holdco) to channel the settlement obligations.  At the same time the company more than doubled its talc‑related reserve—from about $2 billion set aside for the earlier trust to roughly $11.6 billion (≈$13.5 billion nominal) in 2024—and concluded multi‑state settlements with a coalition of 42 state attorneys general (finalized in June 2024) to resolve the bulk of pending talc claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, while also omitting key facts from the original answer. CRITICAL ERRORS: (1) The LLM claims a '$6.5 billion (present-value) talc trust over 25 years' was launched in May 2024 with a 'pre-packaged' bankruptcy strategy - this is not mentioned in the ground truth and appears to be fabricated or confused with other settlements. (2) The LLM introduces 'Red River, Pecos River, New Holdco' Texas-registered subsidiaries created in August-September 2024 - these entities are not mentioned in the ground truth at all. (3) The LLM states the reserve was increased 'from about $2 billion...to roughly $11.6 billion (≈$13.5 billion nominal) in 2024' - the ground truth does not provide 2024 reserve figures, making this claim unverifiable and potentially incorrect. (4) The LLM dates the multi-state settlement as 'finalized in June 2024' while the ground truth only states it was 'finalized' by 2024 without specifying June. OMISSIONS: The LLM completely fails to mention: (1) The 2023 Third Circuit reversal of the bankruptcy court's decision, (2) The dismissal of the original LTL bankruptcy case, (3) The LTL 2 re-filing and its preliminary injunction limiting discovery until August 2023, (4) The temporary restraining order from 2022, (5) The shift from 'exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements' - a key strategic evolution. PARTIAL ACCURACY: The LLM correctly identifies that J&J shifted strategy and that there was a multi-state settlement with 42 states and DC. However, the answer fundamentally misrepresents the timeline and mechanisms of this evolution by introducing unsubstantiated 2024 details while omitting the critical 2022-2023 bankruptcy and appellate developments that form the core of the ground truth narrative. The answer reads as if it contains specific 2024 filing information that cannot be verified against the ground truth, suggesting potential hallucination or confusion with other sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 561,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nBroadcom’s 3.125% senior notes maturing in January 2025 carried an outstanding principal of **$495 million** at the close of fiscal 2022, and that balance remained **$495 million** at the end of fiscal 2023 and fiscal 2024. The unchanged amount shows that the company has not sought to retire or refinance this tranche, instead maintaining the existing low‑cost debt to maturity—indicating a passive, stability‑focused approach to managing this specific instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The principal balance of $495 million is correctly stated for all three fiscal years (2022, 2023, 2024), and the conclusion that the balance remained constant is accurate. (2) QUANTITATIVE ACCURACY: The $495 million figure is correct across all three years with no calculation errors. The numeric data is presented clearly and matches the ground truth exactly. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information by tracking the debt instrument across three fiscal years and drawing the appropriate conclusion about debt management strategy. The reasoning is sound: constant principal balance → no retirement or refinancing → passive, stability-focused approach. The characterization of this as a \"low-cost debt\" and \"passive, stability-focused approach\" adds reasonable interpretive context that aligns with the ground truth's conclusion about \"consistent approach to managing this portion of its capital structure.\" (4) ENTITY ACCURACY: All entities are correctly identified (Broadcom/AVGO, 3.125% notes, January 2025 maturity, fiscal years 2022-2024). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing \"unchanged amount shows that the company has not sought to retire or refinance this tranche\" is semantically equivalent to the ground truth's \"did not retire or issue additional portions.\" The only minor difference is the LLM's additional characterization of the debt as \"low-cost,\" which is a reasonable inference but not explicitly stated in the ground truth. This is a minor enhancement rather than an error. The answer fully addresses all parts of the multi-part question regarding evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 488,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due June 15 2025 showed a steep rise in its effective yield: ≈ 3.2 % in fiscal 2022 (as reported on page 89 of the 2022 10‑K), ≈ 6.4 % in fiscal 2023 (page 89 of the 2023 10‑K), and ≈ 6.7 % in fiscal 2024 (page 89 of the 2024 10‑K). This upward progression—driven by higher market rates and the accrual of discount/hedge adjustments—signals that the company’s borrowing costs have increased markedly over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The effective interest rates are correctly stated as approximately 3.2% (FY2022), 6.4% (FY2023), and 6.7% (FY2024), matching the ground truth values of 3.20%, 6.38%, and 6.66% respectively. The rounding to one decimal place (3.2% vs 3.20%, 6.4% vs 6.38%, 6.7% vs 6.66%) is appropriate and acceptable given the use of the approximation symbol (≈). The note denomination ($500 million) and maturity date (June 15, 2025) are correctly identified. COMPLETENESS: The answer addresses all aspects of the question—the evolution of interest rate exposure across the three fiscal years and what this progression indicates about borrowing costs. ENTITY ACCURACY: Cisco is correctly identified, the specific note (3.50% senior note due June 15, 2025) is properly characterized, and all fiscal years (2022, 2023, 2024) are accurate. REASONING QUALITY: The multi-hop synthesis is sound—the answer correctly identifies the upward trend and provides reasonable explanations (higher market rates, discount/hedge adjustments) for the progression. The conclusion that borrowing costs increased markedly is logically supported by the data presented. MINOR CONSIDERATIONS: The LLM provides additional context (page references, note denomination, mention of discount/hedge adjustments) that goes beyond the ground truth but adds value without introducing errors. The use of approximation symbols (≈) is appropriate given minor rounding differences. No calculation errors are present, and the semantic meaning aligns perfectly with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 446,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated note balance was $30.8 bn at the end of 2022, rose to $31.2 bn in 2023, and slipped back to $30.7 bn by the end of 2024. The 2023 increase reflected new fixed‑rate senior issuances (weighted‑average coupon ≈ 4.45 %) as the company locked in funding amid a rising rate environment, while the 2024 decline shows a deliberate pull‑back—repaying higher‑cost notes and leaning more on deposit and short‑term funding—indicating a shift toward a lighter, more rate‑sensitive capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the response. (1) 2022 BASELINE ERROR: LLM states $30.8bn for 2022, but ground truth shows $27.219bn—a $3.6bn discrepancy (13% error). This is a fundamental error that distorts the entire 3-year progression analysis. (2) 2023 FIGURE: LLM states $31.2bn, which is close to ground truth $31.248bn (acceptable rounding). (3) 2024 FIGURE: LLM states $30.7bn vs ground truth $30.696bn (acceptable rounding). (4) INTEREST RATE ERRORS: LLM cites weighted-average coupon of ~4.45% for 2023, but ground truth shows 4.48%—minor but directionally correct. However, LLM completely omits the 2022 rate (2.76%) and 2024 rate (4.84%), failing to show the full 3-year rate progression. (5) MULTI-HOP SYNTHESIS: The LLM correctly identifies the 2023 increase and 2024 decline pattern, but the incorrect 2022 baseline undermines the entire narrative about the 'significant capital raise in 2023.' The actual increase from 2022-2023 was $4.029bn, not the ~$0.4bn implied by LLM's numbers. (6) STRATEGIC INTERPRETATION: LLM's interpretation about 'locking in funding amid rising rates' is directionally correct but incomplete—it misses the critical insight that the 2024 decline represents a partial reversal of the 2023 build-up. The characterization of 2024 as a 'shift toward lighter, more rate-sensitive capital structure' contradicts the ground truth's emphasis on 'long-term capital structure transformation to lock in financing costs.' (7) MISSING CONTEXT: LLM fails to mention the complete interest rate trajectory (2.76% → 4.48% → 4.84%), which is essential to understanding the strategic positioning. VERDICT: While the LLM demonstrates reasonable qualitative reasoning about capital structure strategy, the 13% error in the 2022 baseline figure is a critical quantitative failure that cascades through the entire analysis. The omission of complete interest rate data further weakens the answer's ability to address the question about 'interest rate positioning.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 554,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 to 2024 the share of U.S. Treasury and agency securities in Colgate‑Palmolive’s defined‑benefit fixed‑income portfolio fell from **about 40 % (2022)** to **roughly 30 % (2023 and 2024)**.  This deliberate reduction in low‑yielding Treasuries—while maintaining a stable overall fixed‑income weighting—indicates that the company is **re‑balancing its pension fund toward higher‑yielding, more diversified government and corporate bonds**, likely to manage interest‑rate risk and improve returns as rates rose.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All percentages are correct—40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The year-over-year progression is accurately captured. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of allocation percentages from 2022-2024, and (2) what this shift suggests about pension fund strategy. ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the defined-benefit/pension plan context is accurate, and the fixed-income portfolio classification is correct. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly identifies the strategic reallocation pattern and provides logical interpretation about yield-seeking behavior and risk management. The explanation about rebalancing toward higher-yielding bonds and managing interest-rate risk is consistent with the ground truth's characterization of a shift in risk tolerance or yield-seeking behavior. SEMANTIC EQUIVALENCE: The LLM's phrasing 'deliberate reduction in low-yielding Treasuries' and 'rebalancing toward higher-yielding, more diversified government and corporate bonds' conveys the same strategic intent as the ground truth's 'strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds.' The mention of interest-rate risk management adds relevant context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM adds interpretive detail about 'as rates rose' which, while reasonable and contextually appropriate, goes slightly beyond what the ground truth explicitly states. However, this represents appropriate contextual reasoning rather than factual error. All core facts, numbers, and the essential narrative match the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 501,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑classified its captive industrial insurer, **Electric Insurance Company (EIC)**, as a business held‑for‑sale (see GE 10‑K 2022 page 49 and 2023 page 49), recorded a valuation allowance and a $109 million loss in 2023 (GE 10‑K 2023 page 49), and finally sold the unit in the second quarter of 2024 for $120 million in cash (GE 10‑K 2024 page 48).  The sale removed EIC’s assets and liabilities from the balance sheet and eliminated the remaining insurance exposure that had been a residual, non‑core liability.\n\nThis progression shows that GE is deliberately shedding legacy insurance operations and other non‑core assets to sharpen its focus on its core industrial businesses (aviation, power, renewable energy, and healthcare spin‑offs).  By monetizing EIC and other held‑for‑sale units, GE is simplifying its balance sheet, freeing capital for growth‑oriented investments, and signaling a strategic shift toward a more streamlined, high‑margin portfolio centered on its core aerospace and energy technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key numbers are correct - the $109 million loss in 2023 and $120 million sale price in Q2 2024 match the ground truth exactly. The timeline (2022-2024) is accurate. COMPLETENESS: The answer addresses all major aspects: (1) 2022 classification as captive P&C subsidiary, (2) 2023 reclassification as held-for-sale with $109M loss, (3) 2024 completion of sale for $120M to Riverstone International Holdings Inc. The answer includes the buyer name, which adds valuable detail beyond the ground truth. ENTITY ACCURACY: Electric Insurance Company (EIC) correctly identified throughout; GE correctly identified; Riverstone International Holdings Inc. correctly named as buyer; all fiscal years correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple 10-K filings, showing the progression from subsidiary status → held-for-sale classification → completed divestiture. The reasoning about strategic direction is sound and well-articulated. MINOR OMISSION: The ground truth mentions 'net claim reserves of $0.2 billion as of December 31, 2021' which the LLM answer does not include. However, this is a relatively minor detail that doesn't affect the core narrative. STRENGTHS: The LLM answer provides excellent context about GE's broader strategic direction (focus on core industrial/aerospace operations, balance sheet simplification, capital reallocation), which goes slightly beyond the ground truth but is well-supported and relevant. The answer correctly identifies this as part of a deliberate restructuring effort. The citation of specific 10-K pages adds credibility. SEMANTIC EQUIVALENCE: The LLM's characterization of EIC as a 'legacy insurance operation' and 'non-core liability' aligns perfectly with the ground truth's description of 'non-core assets' and 'captive insurance divestiture.' The strategic interpretation is consistent and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 548,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nApple first brings up the 4.45 % Notes due 2044 only in Exhibit 4.4 of its 2022 Form 10‑K, a brief incorporation of the 2014 officer’s certificate. The same minimal exhibit reference is repeated in the 2023 filing, and the 2024 filing keeps the exhibit but adds a short reaffirmation of the notes’ $15 billion aggregate principal and 2044 maturity within the long‑term‑debt discussion. This steady, incremental disclosure shows that Apple is treating the 4.45 % 2044 tranche as a durable, low‑cost pillar of its capital structure and has no near‑term intention to retire or refinance it.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 across all three years (2022, 2023, 2024); (2) Accurately references the May 6, 2014 Officer's Certificate date; (3) Correctly identifies Exhibit 4.4 as the location of disclosure; (4) Appropriately characterizes the pattern as showing stability and no material changes; (5) Correctly infers the strategic implication about long-term capital structure. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific dollar amount ($15 billion aggregate principal) that is NOT present in the ground truth answer. The ground truth makes no mention of a $15 billion figure, and this appears to be either fabricated or incorrectly sourced. This is a critical factual error; (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that the disclosure was 'repeated' and 'reaffirmed' across all three years with 'consistency,' while the LLM characterizes it as 'minimal exhibit reference' and 'steady, incremental disclosure,' suggesting a different interpretation of the disclosure pattern; (3) TONE DISCREPANCY - The LLM adds interpretive language about 'low-cost pillar' and 'no near-term intention to retire or refinance' that goes beyond what the ground truth states. While the inference is reasonable, it adds speculation not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the pattern, but the introduction of the $15 billion figure without ground truth support undermines the reliability of the synthesis. The core reasoning about stability is sound, but the execution contains a material factual error that significantly impacts credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 487,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nThe carrying amount of Capital One’s senior and subordinated notes was roughly **$30.8 bn at the end of 2022**, rose to **$31.2 bn in 2023**, and then slipped back to **about $30.7 bn by the end of 2024**.  This rise‑and‑fall reflects a deliberate capital‑structure move: the company expanded long‑term note issuance in 2023 to lock in relatively low‑cost funding while rates were still modest, but in 2024 it trimmed the balance—repaying or not replacing maturing notes—as deposit funding remained strong and market rates climbed, signaling a shift toward a leaner, more flexible capital mix.  Consequently, the weighted‑average rate on its fixed senior notes edged up from roughly **4.45 % (2023) to 4.84 % (2024)**, showing that the firm is now bearing higher interest costs on new issuances but is managing overall leverage and interest‑rate exposure by reducing the note portfolio and leaning on shorter‑term or floating‑rate funding sources.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: (1) 2022 carrying value: LLM states '$30.8 bn' but ground truth is $27,219 million ($27.2 bn) - a significant $3.6 billion discrepancy. This is a major factual error. (2) 2023 carrying value: LLM states '$31.2 bn' which aligns with ground truth of $31,248 million - CORRECT. (3) 2024 carrying value: LLM states '$30.7 bn' which aligns with ground truth of $30,696 million - CORRECT. (4) Weighted-average interest rate 2022: Ground truth shows 2.76% but LLM omits this entirely and jumps to 2023 at 4.45%. The LLM's 4.45% for 2023 is not provided in ground truth (which only gives 2022: 2.76% and 2024: 4.84%). This appears to be an interpolated or incorrect figure. (5) 2024 rate: LLM correctly states 4.84% - CORRECT. MULTI-HOP REASONING: The LLM's narrative about strategic positioning (locking in rates in 2023, trimming in 2024, shifting to deposit funding) is plausible but not directly supported by the ground truth provided. The ground truth emphasizes a 'shift from floating-rate to fixed-rate' and 'locking in higher interest rates amid rising rate environment,' whereas the LLM suggests the opposite strategy (locking in 'relatively low-cost funding' in 2023). This represents a fundamental misinterpretation of the company's strategy. COMPLETENESS: The LLM addresses the three-year progression and attempts to explain capital structure strategy, but the 2022 baseline error undermines the entire analysis. The net increase calculation is also affected: ground truth shows ~$3.5 billion increase, but LLM's numbers would show only ~$0 billion change (30.8 to 30.7), which contradicts the stated 'rise-and-fall' narrative. SEMANTIC ISSUES: The LLM's interpretation of strategy (trimming notes due to strong deposits and rising rates) differs materially from ground truth's emphasis on strategic fixed-rate locking. The 2022 figure error is particularly damaging as it's the baseline for understanding the three-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 531,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross 2022 through 2024 Adobe deepened Frame.io’s role as the collaborative backbone of its Creative Cloud ecosystem.  Early on (2022) it was introduced as a cloud‑native platform tightly integrated with Premiere Pro and After Effects, enabling frame‑accurate commenting and “Camera‑to‑Cloud” uploads — a capability highlighted in the 10‑K (pp. 89, 12).  By 2023 the integration broadened to include Photoshop, Lightroom and Adobe Workfront, and Frame.io began appearing in Adobe Express and GenStudio, extending its workflow beyond video to still‑image and design assets.  In 2024 its capabilities were further embedded in Adobe Express and Firefly Services, making Frame.io a central hub for video, design and generative‑AI content creation across the Creative Cloud suite.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CHRONOLOGICAL REVERSAL - The LLM fundamentally misrepresents the timeline. Ground truth states Frame.io was a 'registered trademark' in 2022 (minimal positioning), became a 'cloud-native creative collaboration platform' in 2023 with Premiere Pro/After Effects integration, and expanded to Photoshop/Lightroom/Workfront in 2024. The LLM reverses this, claiming 2022 had 'tight integration with Premiere Pro and After Effects' and 2023 had 'broadened integration to Photoshop, Lightroom and Workfront' - this is backwards. (2) UNSUPPORTED CLAIMS - The LLM introduces specific details not in ground truth: 'Camera-to-Cloud uploads' (with page citations 89, 12), Adobe Express integration in 2023, and Firefly Services integration in 2024. These page references and specific features cannot be verified against the ground truth and appear fabricated. (3) INCOMPLETE ACCURACY - While the LLM correctly identifies some 2024 integrations (Photoshop, Lightroom, Workfront, GenStudio), it misplaces them chronologically and adds unverified details. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the three-year progression. The ground truth shows a clear escalation from minimal recognition (2022) → detailed platform positioning (2023) → expanded ecosystem integration (2024). The LLM inverts the early timeline. (5) SEMANTIC ISSUES - The characterization of 2022 as having 'tight integration' contradicts ground truth's description of it merely being a 'registered trademark.' This is a fundamental misunderstanding of Frame.io's positioning evolution. The answer demonstrates partial knowledge of Frame.io's role but severely compromises accuracy through chronological inversion and unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 476,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5 2049 (first created in the 2019 Fifteenth Supplemental Indenture and then re‑listed in its 2022‑2024 filings) as a cornerstone of its long‑term financing.  By keeping this far‑out, fixed‑rate tranche on its filing radar, the company signals a strategy of locking in low‑cost capital for many years ahead and using it to balance a staggered maturity wall—thereby limiting near‑term refinancing risk and preserving a stable, predictable debt profile.  This consistent emphasis underscores Lowe’s disciplined capital‑structure management, relying on a mix of long‑dated notes to fund growth while maintaining flexibility to roll over shorter‑term obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core question about Lowe's long-term capital structure strategy. STRENGTHS: (1) Correctly identifies the 4.550% Notes due April 5, 2049 with accurate percentage and date; (2) Accurately captures the key insight that consistent inclusion across 2022-2024 filings indicates strategic maintenance without early redemption; (3) Properly synthesizes the multi-hop reasoning about debt maturity profile management, interest rate risk, and capital structure stability; (4) Adds valuable context about the 2019 Fifteenth Supplemental Indenture origin, which enriches understanding without contradicting ground truth; (5) Uses semantically equivalent language ('locking in low-cost capital,' 'staggered maturity wall,' 'refinancing risk') that conveys the same strategic intent as the ground truth. MINOR CONSIDERATIONS: (1) The LLM introduces the 2019 Fifteenth Supplemental Indenture reference, which is not explicitly mentioned in the ground truth but is factually accurate and adds helpful context; (2) The phrase 'far-out, fixed-rate tranche' and discussion of 'rolling over shorter-term obligations' goes slightly beyond the ground truth's scope but remains logically consistent with the stated strategy; (3) The answer is more detailed and interpretive than the ground truth, but this represents elaboration rather than error. QUANTITATIVE VERIFICATION: The date (April 5, 2049) and percentage (4.550%) are both correct. The three-year filing period (2022-2024) is correctly referenced. No calculations are required for this qualitative question. MULTI-HOP REASONING: The answer successfully synthesizes information about (a) the note's presence across multiple years, (b) the absence of modifications/repayments, and (c) the strategic implications for capital structure management—exactly matching the ground truth's reasoning chain. The answer appropriately avoids claiming information not supported by the filings (e.g., doesn't make unsupported claims about interest rate environment or competitive positioning).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 561,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes that mature in January 2025 have shown a flat outstanding principal of **$495 million** in each of the last three fiscal years—$495 million as of October 30 2022 (page 111), $495 million as of October 29 2023 (page 81), and $495 million as of November 3 2024 (page 81).  \n\nThis consistency indicates that Broadcom is treating this tranche as a stable, low‑cost funding source and is not actively issuing additional notes or retiring the series; instead, it manages the overall debt profile by refinancing other maturing obligations while keeping this specific instrument at a constant, modest level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All three principal balance figures are correct at $495 million for each fiscal year (2022, 2023, 2024). The dates and page references provided add credibility and specificity. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding principal balance across three fiscal years, (2) the consistency of the amount, and (3) interpretation of debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, 3.125% notes due January 2025 correctly specified, and all fiscal years properly referenced. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by comparing balances across three years and drawing a logical conclusion about debt management strategy. The interpretation that the flat balance indicates deliberate preservation of this liability and treatment as a stable funding source is sound and aligns with the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's explanation of the strategy (treating as stable, low-cost funding source, not actively issuing or retiring, managing overall debt profile through other instruments) is semantically equivalent to and slightly more detailed than the ground truth's explanation. The LLM adds useful context about refinancing other obligations while maintaining this instrument. MINOR CONSIDERATIONS: The LLM provides page references which, while helpful, were not in the original answer but do not detract from accuracy. The phrasing is slightly different but conveys identical meaning. No calculation errors, no factual discrepancies, and the multi-hop synthesis is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 466,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nFrom 2022 through 2024 IBM moved the 0.950 % Notes due 2025 from a terse mention in the “Exhibits” list of the 10‑K (2022) to an explicit entry in the “Securities registered pursuant to Section 12(b)” table with its ticker (IBM25B) in the 2024 filing, while still incorporating the original 2017 indenture by reference. This shift reflects IBM’s capital‑structure strategy of relying on low‑cost, long‑dated unsecured debt and a growing emphasis on transparent, standardized disclosure of that debt to investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key details: correctly identifies the 0.950% Notes due 2025, the ticker IBM25B, the May 2017 indenture reference, and the progression from 2022 to 2024. The numeric values (0.950%, 2025 maturity date, 2017 indenture year) are all accurate. The answer correctly identifies the shift in disclosure treatment from a less prominent position in exhibits to explicit registration in the Section 12(b) table. However, there are some differences in emphasis and completeness compared to the ground truth: (1) The LLM focuses on the shift from 'Exhibits' to 'Securities registered' disclosure, while the ground truth emphasizes the progression from general disclosure to NYSE listing/tradability. (2) The LLM characterizes the notes as 'low-cost, long-dated unsecured debt,' which is reasonable inference but not explicitly stated in the ground truth. (3) The ground truth explicitly mentions the 2023 10-K filing as a middle point showing 'ongoing recognition,' while the LLM jumps from 2022 to 2024, omitting the 2023 data point. (4) The ground truth's characterization of the shift as moving from 'less prominent debt instrument to a publicly traded security' is slightly different from the LLM's focus on disclosure table placement. The multi-hop reasoning is sound—the LLM correctly synthesizes information across three years and identifies the strategic implications. The answer is well-reasoned and contextually relevant, though it could have been more complete by explicitly addressing the 2023 intermediate step and the NYSE listing aspect more prominently.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 442,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe PCAOB firm identification number for KPMG LLP is disclosed as **185** in the 2022, 2023 and 2024 Form 10‑K filings, and this number remains unchanged across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. (1) CORRECTNESS: The LLM correctly identifies KPMG LLP's PCAOB firm identification number as 185 and accurately states it remained consistent across all three years (2022, 2023, and 2024). This matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: The numeric value (185) is correct and properly formatted. No calculations are required for this question, and the number is stated consistently. (3) QUALITATIVE ACCURACY: The answer correctly synthesizes information across three separate filings and properly identifies the consistency pattern. The reasoning is sound - the model recognized that the same number appearing in all three years demonstrates consistency. (4) ENTITY ACCURACY: KPMG LLP is correctly identified, the PCAOB firm identification number is the correct metric, and all three years (2022, 2023, 2024) are properly referenced. (5) COMPLETENESS: The answer addresses all parts of the multi-part question: identifies the number for each year and confirms consistency. The only minor difference from the ground truth is that the LLM answer is slightly more concise and uses 'Form 10-K filings' terminology rather than just 'filings,' but this is a stylistic choice that adds clarity rather than detracting from accuracy. The semantic meaning is identical to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 381,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s Fixed Unsecured Senior Debt expanded from roughly **$24 bn to $27 bn**, but the **weighted‑average interest rate rose from about 4.45 % to 4.84 %**.  The portfolio moved from a sizable floating‑rate component (e.g., $1.6 bn of floating notes in 2022) to an all‑fixed‑rate ladder with maturities extending to **2025‑2035**, and the floating‑rate balance was essentially eliminated by 2024.  This shift reflects a deliberate strategy to lock in funding at longer durations and higher, more stable rates as market rates climbed, underscoring Capital One’s effort to reinforce its capital structure against a higher‑for‑longer macro‑economic environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the primary financial metrics. (1) STARTING BALANCE ERROR: The LLM states Fixed Unsecured Senior Debt was 'roughly $24 bn' in 2022, but the ground truth shows $19,975 million ($19.975 bn). This is a ~$4 billion overstatement (20% error). (2) INTEREST RATE ERROR: The LLM claims the weighted-average interest rate rose 'from about 4.45% to 4.84%', but ground truth shows it rose from 2.91% to 4.84%. The starting rate is off by 1.54 percentage points (53% error). This is a fundamental misrepresentation of the interest rate trajectory. (3) ENDING BALANCE: The LLM states '$27 bn' which is reasonably close to the ground truth of $26,930 million ($26.93 bn), though slightly high. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the shift from floating to fixed-rate debt and mentions the maturity ladder (2025-2035), this qualitative analysis cannot compensate for the quantitative errors. The core claim about the interest rate evolution is factually wrong - the rate increase was much more dramatic (from 2.91% to 4.84%, a 193 basis point increase) than the LLM's characterization (from 4.45% to 4.84%, only 39 basis points). This fundamentally misrepresents the magnitude of Capital One's response to macroeconomic conditions. (5) REASONING QUALITY: The narrative about locking in longer-term funding and responding to higher-for-longer rates is directionally sound, but is built on incorrect numerical foundations. The qualitative insights about capital structure decisions are reasonable but cannot overcome the quantitative inaccuracies that are central to answering this financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 465,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s policy for development‑and‑IP‑licensing arrangements has been steady from 2022 through 2024. The company first decides whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, and if it is not distinct the license is combined with the development service and recognized over time, with no material variable‑consideration estimates (see 2022 Note 1 – “Development and intellectual property licensing agreements” (page 58); 2023 Note 2 – same language (pages 63‑64); 2024 Note 5 – reiteration of the same methodology (pages 59‑60)). This consistency shows that AMD treats IP licensing as a distinct, controllable performance obligation and aims to monetize its intellectual property through predictable, milestone‑driven revenue streams rather than one‑off sales, reinforcing a long‑term strategy of leveraging its IP to complement hardware sales and expand ecosystem partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent revenue recognition methodology across 2022-2024, accurately describing the two-path approach (distinct vs. non-distinct licenses). (2) Accurately cites specific filing locations (2022 Note 1 page 58, 2023 Note 2 pages 63-64, 2024 Note 5 pages 59-60), demonstrating proper multi-hop synthesis across three years of filings. (3) Correctly states that no variable consideration estimates exist for IP arrangements. (4) Properly interprets the strategic implications of consistency, noting AMD's deliberate approach to IP monetization through predictable, milestone-driven revenue streams. (5) Adds valuable context about complementing hardware sales and ecosystem partnerships, which is a reasonable inference from the consistent policy. MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by adding interpretive language about 'distinct, controllable performance obligation' and 'one-off sales' comparisons—while these are reasonable inferences, they represent modest elaboration rather than direct ground truth statements. (2) The phrase 'reinforcing a long-term strategy' is interpretive but aligns well with the ground truth's conclusion about 'mature and well-defined policy framework.' QUANTITATIVE ACCURACY: Perfect—all dates (2022, 2023, 2024), page numbers, and note references are accurate. QUALITATIVE ACCURACY: Excellent—the multi-hop reasoning correctly synthesizes information across three years of filings and properly identifies the consistency pattern. The strategic interpretation is sound and well-supported. CONTEXTUAL RELEVANCE: High—directly addresses both parts of the question (methodology evolution and strategic implications). The answer is appropriately detailed and focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 507,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew modestly to **$31.2 bn** at the end of 2023 (up from $30.8 bn in 2022) and then slipped slightly to **$30.7 bn** by the end of 2024 (Table 8.1 in the 2023 and 2024 10‑K filings).  The weighted‑average interest rate on that debt rose from about **4.45 %–4.48 %** in 2022‑23 to roughly **4.8 %** in 2024, while the floating‑rate senior portion fell dramatically (from $1.6 bn in 2022 to essentially zero in 2024).  This pattern shows Capital One is shifting toward larger, longer‑dated **fixed‑rate** issuances to lock in funding as market rates climb, reducing reliance on short‑term floating‑rate borrowings and reflecting a more rate‑sensitive capital‑structure strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core factual foundation. (1) SENIOR AND SUBORDINATED NOTES: Ground truth shows $27,219M (2022), $31,248M (2023), $30,696M (2024). LLM states '$30.8 bn in 2022' which is approximately $30,800M—this is INCORRECT and off by ~$3.6 billion. The 2022 figure should be $27.2 billion, not $30.8 billion. The 2023 figure of $31.2 bn is approximately correct ($31,248M). The 2024 figure of $30.7 bn is correct. (2) WEIGHTED-AVERAGE INTEREST RATES: Ground truth shows 2.91% (2022), 4.45% (2023), 4.84% (2024). LLM states '4.45%-4.48% in 2022-23' which is INCORRECT for 2022—should be 2.91%, not 4.45%. The 2023 rate of 4.45% is correct. The 2024 rate of ~4.8% is approximately correct (should be 4.84%). (3) FLOATING-RATE DEBT: Ground truth shows $1,709M (2022), $349M (2023), $0 (2024). LLM states '$1.6 bn in 2022' which is approximately correct ($1,600M vs $1,709M—minor rounding acceptable), and 'essentially zero in 2024' is correct. However, the omission of the $349M intermediate step in 2023 is a minor gap. QUALITATIVE ASSESSMENT: The LLM correctly identifies the strategic shift toward fixed-rate debt and away from floating-rate borrowings, and the reasoning about locking in rates amid rising benchmark rates is sound. The multi-hop synthesis across years and metrics is logically structured. However, the fundamental error in the 2022 baseline figure ($30.8bn vs $27.2bn) and the incorrect 2022 interest rate (4.45% vs 2.91%) represent major factual failures that distort the narrative of how the capital structure 'evolved' from 2022. The answer misrepresents the magnitude of the increase from 2022 to 2023 and fails to capture the dramatic rise in interest rates from 2022 to 2023. MULTI-HOP REASONING: While the conclusion about capital structure strategy is reasonable, it is built on incorrect foundational numbers, which compromises the validity of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 535,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 through 2024 the fixed‑rate senior debt on Capital One’s balance sheet grew from **$24.1 bn** (weighted‑average interest rate **4.45 %**) in 2022 to **$27.2 bn** (weighted‑average rate **4.84 %**) in 2023, and then edged down slightly to **$26.9 bn** (still **≈4.84 %**) by the end of 2024.  \n\nThe increase in 2022‑23 reflects a deliberate issuance of longer‑dated fixed‑rate notes to lock in funding as market rates rose, while the modest 2024 reduction suggests the company is now trimming the portfolio to keep the overall debt burden in check while maintaining a stable, relatively high‑cost fixed‑rate profile—an indication that Capital One is focusing on a longer‑term, fixed‑rate capital structure to reduce reliance on floating‑rate borrowings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the primary financial metrics. (1) 2022 CARRYING VALUE ERROR: LLM states $24.1 billion for 2022, but ground truth shows $19,975 million ($19.975 billion). This is a ~$4.1 billion overstatement (20% error). (2) 2022 INTEREST RATE ERROR: LLM states 4.45% for 2022, but ground truth shows 2.91%. This is a 1.54 percentage point error (53% relative error). (3) 2023 INTEREST RATE ERROR: LLM states 4.84% for 2023, but ground truth shows 4.45%. This is a 0.39 percentage point error. (4) 2024 INTEREST RATE: LLM correctly identifies ~4.84%, matching ground truth. (5) 2023 AND 2024 CARRYING VALUES: LLM correctly states $27.2 billion (2023) and $26.9 billion (2024), matching ground truth. MULTI-HOP SYNTHESIS: The LLM failed to properly track the year-over-year progression. The ground truth shows a clear three-year trend: 2022 ($19.975B at 2.91%) → 2023 ($27.168B at 4.45%) → 2024 ($26.930B at 4.84%). The LLM appears to have confused or misaligned the 2022 and 2023 data points, essentially shifting values forward by one year. REASONING QUALITY: While the qualitative interpretation about locking in fixed-rate debt and reducing floating-rate reliance is reasonable and somewhat aligned with the ground truth narrative, it is built on incorrect foundational numbers. The reasoning cannot be considered sound when the underlying data is wrong. COMPLETENESS: The answer addresses all three years and both metrics (carrying value and weighted-average interest rate), but with significant accuracy issues that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 444,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s 10‑K filings for fiscal 2022, 2023 and 2024 contain virtually the same revenue‑recognition guidance: a contract that includes both development services and a license is first evaluated for a distinct licensing component. If the license is **not** distinct, it is combined with the development service and revenue is recognized **over time**; if the license **is** distinct, revenue is recognized **at a point in time** when the customer can benefit from the IP. The wording and the underlying two‑step test are unchanged across the three years, indicating no material evolution—only minor phrasing updates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the two-step test for evaluating distinct licensing components across all three years (2022-2024); (2) Accurately describes the treatment of non-distinct licenses (combined with development services, recognized over time) versus distinct licenses (recognized at point in time); (3) Properly synthesizes the multi-hop requirement by comparing policy consistency across three fiscal years; (4) Correctly concludes that no material evolution occurred, only minor phrasing updates; (5) Appropriately notes the absence of variable consideration estimates. The answer demonstrates sound multi-hop reasoning by synthesizing information across three separate 10-K filings to establish a consistent policy trajectory. Minor observation: The LLM answer uses slightly more concise language than the ground truth (e.g., 'when the customer can benefit from the IP' vs. the ground truth's more formal phrasing), but this represents semantic equivalence rather than an error. The LLM also emphasizes the 'two-step test' framework more explicitly, which adds clarity. No quantitative errors, dates are correct (2022, 2023, 2024), and all entities (AMD, development services, IP licenses) are properly identified. The answer fully addresses the question's focus on evolution (or lack thereof) in revenue recognition policy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 400,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply from **$883 million (2022)** to **$538 million (2023)** and then edged up to **$562 million (2024)**, while its long‑term debt hit a peak of **$49.3 billion in 2023** before declining to **$45.0 billion in 2024**.  \n\nThe decline in both short‑term wholesale funding and the subsequent reduction in long‑term debt after 2023 reflects a deliberate deleveraging strategy: the firm is relying more on stable, deposit‑funded sources and longer‑dated fixed‑rate notes, thereby lowering its exposure to rising short‑term interest rates and improving overall balance‑sheet resilience.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Short-term borrowings: LLM states $883M (2022), $538M (2023), $562M (2024). Ground truth shows these are negligible components of total debt; the question asks about TOTAL short-term borrowings AND long-term debt combined.\n   - Long-term debt: LLM states $49.3B (2023) and $45.0B (2024). Ground truth shows $48.715B (2023) and $45.551B (2024). These are close but still incorrect.\n   - TOTAL DEBT 2022: Ground truth is $43.086B. LLM provides no 2022 total figure, making year-over-year comparison impossible.\n   - The LLM appears to have confused or misidentified the debt components, focusing only on short-term wholesale borrowings rather than total short-term borrowings.\n\n2. MISSING CRITICAL INFORMATION:\n   - Ground truth includes weighted-average interest rates: 2.76% (2022), 4.48% (2023), 4.84% (2024). LLM completely omits this crucial metric that directly addresses the question's interest rate exposure component.\n   - The question explicitly asks about interest rate exposure; the LLM provides qualitative commentary about deposit funding and fixed-rate notes but no actual interest rate data.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS:\n   - The question requires synthesizing: (a) short-term borrowings trend, (b) long-term debt trend, (c) combined total evolution, (d) interest rate exposure trend, and (e) strategic implications.\n   - LLM addresses only partial debt trends and provides strategic interpretation without supporting data.\n   - The 3-year trend analysis is incomplete without the 2022 baseline total.\n\n4. REASONING QUALITY:\n   - The strategic interpretation (deleveraging, deposit funding, fixed-rate preference) is reasonable but unsupported by the quantitative evidence presented.\n   - The conclusion about \"lowering exposure to rising short-term interest rates\" contradicts the ground truth showing rising weighted-average rates on long-term debt (2.76% → 4.84%), suggesting the opposite strategy.\n\n5. ENTITY AND METRIC CONFUSION:\n   - The LLM appears to have extracted short-term wholesale borrowing figures rather than total short-term borrowings, which are different metrics.\n   - Missing the critical metric of weighted-average interest rates on long-term debt.\n\nThe answer demonstrates partial understanding of debt trends but fails on quantitative precision, omits essential interest rate data, and provides incomplete year-over-year comparison due to missing 2022 total debt figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 686,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nAMD’s revenue‑recognition guidance for development‑service + IP‑license deals has kept the same core test from 2022 through 2024: the contract is examined to see whether the IP licence is **distinct** (i.e., both capable of being distinct and distinct in the context of the arrangement). If the licence is **not distinct**, it is **combined with the development services** and revenue is recognized **over time**; if the licence **is distinct**, it is treated as a **separate performance obligation** and revenue is recognized **at a point in time** when the customer can benefit from the licence. The 2023 and 2024 filings merely refined and clarified this distinct‑component assessment (and reaffirmed that no variable‑consideration estimates apply), but the distinction between combined arrangements and standalone licences remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core consistent policy framework across 2022-2024 regarding the 'distinct' test for IP licenses; (2) Accurately describes the two-path treatment: non-distinct licenses combined with development services recognized over time, versus distinct licenses as separate performance obligations recognized at a point in time; (3) Properly synthesizes the multi-hop information showing consistency across three years; (4) Correctly notes that no variable consideration estimates apply across all three years; (5) Accurately captures the refinement/clarification language in 2023-2024 filings without overstating changes. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical/precise language ('capable of being distinct and distinct in the context') compared to ground truth's simpler phrasing ('distinct in capability and context'), but this is semantically equivalent and arguably more precise; (2) The LLM answer doesn't explicitly mention the 'Gaming segment' context shift noted in ground truth, though this is a minor contextual detail rather than a core factual error; (3) The phrase 'merely refined and clarified' appropriately conveys the lack of material change. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the consistent policy framework while acknowledging refinements. The logical structure is sound and the reasoning is clear. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth with appropriate technical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 511,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe repeated citation of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” in the 2022, 2023 and 2024 Form 10‑K filings shows that the instrument remains a formally recognized and active component of Visa’s charter and capital‑structure documentation. Its continued presence—along with the related conversion and voting rights provisions—indicates that the Series B preferred stock continues to be used (e.g., for litigation‑related holdbacks, conversion adjustments, and stakeholder voting) and has not been retired or superseded, underscoring its ongoing relevance to Visa’s governance and financing arrangements.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general concept that the Series B Convertible Participating Preferred Stock remains relevant across the three-year period, but contains significant factual inaccuracies when compared to the ground truth. CRITICAL ERRORS: (1) The LLM fails to cite the specific exhibit numbers (4.5 for 2022, 4.4 for 2023 and 2024) that are central to the ground truth's evidence of consistency. (2) The LLM does not mention the consistent filing date of June 21, 2016, which is a key factual detail establishing that no modifications were made. (3) The LLM introduces unsupported claims about specific uses ('litigation-related holdbacks, conversion adjustments, and stakeholder voting') that are not present in the ground truth and appear speculative. PARTIAL CREDIT: The LLM correctly identifies that the instrument appears across all three years (2022, 2023, 2024) and correctly infers that its continued presence suggests ongoing relevance and that it has not been retired. The general conclusion about stability and ongoing relevance aligns with the ground truth's interpretation. However, the reasoning lacks the specific documentary evidence (exhibit numbers and filing dates) that grounds the original answer's claims. The multi-hop synthesis is incomplete—the LLM identifies the pattern but fails to cite the specific evidence that proves the consistency. The answer reads more as inference than as evidence-based analysis of the actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 406,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s ownership in the IAE collaboration was steady through the three years – a 61 % program‑share and 49.5 % legal stake in International Aero Engines AG and a 59 % program‑share/ownership interest in IAE LLC (see 2022 10‑K page 126; 2023 10‑K page 102; 2024 10‑K page 101).  However, the filings began to disclose the **net** program‑share after allocating sub‑collaborator portions – 57 % for IAE and 51 % for IAE LLC – reflecting a more precise accounting of RTX’s economic exposure (2023 & 2024 pages 102‑101).  Because RTX is identified as the primary beneficiary and consolidates both IAE and IAE LLC, its effective control and economic exposure to the V2500 engine program remain fully dominant, highlighting Pratt & Whitney’s strategic positioning as the lead developer and commercial driver of the V2500 engine within the multi‑partner alliance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a significant factual error by claiming a '59% program-share/ownership interest in IAE LLC' with a 'net program-share after allocating sub-collaborator portions – 57% for IAE and 51% for IAE LLC.' The ground truth states the net program share interest after sub-collaborator participation was 57% throughout the period, with no mention of separate IAE LLC figures or a 51% net figure. The LLM appears to have conflated or fabricated IAE LLC metrics not present in the ground truth. (2) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the 61% program share and 49.5% ownership across 2022-2024, it introduces unverified IAE LLC data that contradicts the ground truth's singular focus on IAE metrics. The claim about 'consolidation' and 'primary beneficiary' accounting treatment, while potentially relevant, is not substantiated in the ground truth and represents speculation beyond the filing data. (3) CONSISTENCY CLAIM - The ground truth emphasizes that RTX 'did not alter its strategic positioning' and maintained consistency across all three years. The LLM's answer partially supports this but muddies the message by introducing the IAE LLC distinction and suggesting different net percentages (51% vs 57%), which creates confusion about whether positioning actually remained stable. (4) MISSING CORE INSIGHT - The ground truth's key conclusion—that consistency in stake indicates no strategic repositioning despite industry shifts—is weakened in the LLM answer by the introduction of unverified IAE LLC metrics and consolidation accounting details that distract from the main finding. (5) PAGE REFERENCES - While the LLM provides specific page citations, the IAE LLC figures and 51% net figure cannot be verified against the ground truth, suggesting either misreading of source documents or hallucination of details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 515,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nMedtronic continued to grant Non‑Employee Director Deferred Unit Awards in fiscal 2022, 2023 and 2024, citing the agreement in the 2022 filing under the 2008 Stock Award and Incentive Plan, updating the reference in the 2023 filing to the Amended and Restated 2013 Stock Award and Incentive Plan, and retaining the same form in the 2024 filing.  This consistent use of deferred equity—without a fundamental redesign—reflects a long‑term compensation strategy that aligns director interests with shareholders by tying a substantial portion of director pay to performance‑linked, long‑term equity that vests over time.  The periodic plan amendments show that the company refreshes the underlying plan language to stay current with governance updates while preserving the core deferred‑unit structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer contains a major factual inaccuracy that directly contradicts the ground truth. The ground truth explicitly states that the Non-Employee Director Deferred Unit Award Agreement was consistently tied to the 2008 Stock Award and Incentive Plan across all three years (2022, 2023, and 2024), with NO transition to the 2013 plan. However, the LLM answer claims the reference was 'updated in the 2023 filing to the Amended and Restated 2013 Stock Award and Incentive Plan.' This is incorrect. The ground truth specifically notes: 'Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin.' The LLM fundamentally misrepresented the evolution pattern. The ground truth emphasizes STABILITY and NO TRANSITION, while the LLM suggests a plan migration occurred in 2023. Additionally, the LLM's interpretation about 'performance-linked' equity and 'vests over time' adds unsupported characterizations not present in the ground truth. The LLM also misidentifies the exhibit numbers (claiming 10.52 for both 2023 and 2024 when ground truth shows 10.41 for 2022 and 10.52 for 2023 and 2024). While the LLM correctly identifies the three fiscal years and the general concept of deferred unit awards, the core factual claim about plan evolution is inverted from reality. The answer demonstrates poor multi-hop synthesis and introduces false information about plan transitions that directly contradicts the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 436,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLockheed Martin’s variable‑rate swaps grew from about $0.5 billion of notional exposure in 2020‑21 to roughly $1.3 billion by the end of 2022, and that $1.3 billion level was maintained at both 2023‑ and 2024‑year‑end (the 2024 filing notes the same $1.3 billion figure for 2024 and 2023).  The steady‑state $1.3 billion notional shows that after an initial expansion to hedge a larger share of its fixed‑rate debt, the company has now settled into a consistent hedge‑coverage strategy, using swaps primarily to convert fixed‑rate borrowings into variable‑rate obligations and to protect the fair‑value of that debt against rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND NUMBERS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) TIMELINE MISMATCH: Ground truth states the progression was 2022→2023→2024 ($500M→$1.3B→$1.3B), but the LLM claims the progression was 2020-21→2022→2023-24 ($0.5B→$1.3B→$1.3B). This is a significant temporal misalignment - the LLM shifted the entire timeline backward by approximately 1-2 years. (2) YEAR-SPECIFIC DATA: Ground truth explicitly states 2022 had $500 million notional amount. The LLM incorrectly attributes $0.5 billion to 2020-21 and $1.3 billion to 2022, which contradicts the ground truth's clear statement that 2022 was $500 million and 2023 was $1.3 billion. (3) QUANTITATIVE ACCURACY: While the dollar amounts ($0.5B and $1.3B) are numerically correct in isolation, they are assigned to the wrong years, making the quantitative accuracy fundamentally flawed. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-by-year progression across the 2022-2024 period. The reasoning about 'initial expansion' and 'steady-state' is logically sound in structure, but it's applied to an incorrect timeline. (5) MISSING KEY DETAIL: Ground truth emphasizes the 'tripling of exposure' from 2022 to 2023 as a strategic shift indicator. The LLM's framing of growth from 2020-21 to 2022 misses this critical analytical point about the timing and magnitude of the strategic shift. The qualitative discussion about hedging strategy is reasonable but cannot compensate for the fundamental chronological errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 431,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s charter repeatedly required that directors may be removed **only for cause** and that any amendment to those provisions needs the affirmative vote of at least 80 % of the voting stock—a standard that appears verbatim in the 2022, 2023 and 2024 Form 10‑K filings (see ABBV_10k_2022.pdf p. 46; ABBV_10k_2023.pdf p. 27; ABBV_10k_2024.pdf p. 27).  This three‑year consistency shows that AbbVie has deliberately maintained a stable, robust board‑protection framework, underscoring a strategic posture that prioritizes takeover defense and board continuity over any shift in governance posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis across the three-year period (2022-2024). Key strengths: (1) Correctly identifies the core provision that directors may be removed 'only for cause' consistently across all three years; (2) Accurately cites the 80% supermajority voting requirement for amending these provisions; (3) Properly references specific document locations (ABBV_10k_2022.pdf p. 46; ABBV_10k_2023.pdf p. 27; ABBV_10k_2024.pdf p. 27), demonstrating multi-hop synthesis across multiple filings; (4) Correctly interprets the strategic implication—that consistency indicates deliberate maintenance of takeover defenses and board protection. The answer aligns semantically with the ground truth, which emphasizes unchanged provisions over three years and their role in insulating the board from activist pressures and hostile takeovers. Minor considerations: The LLM adds the specific 80% threshold detail, which enhances the answer beyond the ground truth without contradicting it. The reasoning about 'stable, robust board-protection framework' and 'strategic posture that prioritizes takeover defense' directly mirrors the ground truth's characterization. No calculation errors, no factual inaccuracies detected. The answer fully addresses both parts of the multi-part question: (1) how provisions evolved (answer: they didn't—remained consistent), and (2) what this consistency suggests about strategic posture (answer: deliberate takeover defense strategy). The document citations add credibility and demonstrate proper multi-hop information synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 440,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation fell sharply from **$21 million in money‑market funds and time deposits at the end of 2022** (see ABBV_10‑K 2022, p. 96) to **about $10 million by the end of 2023** (ABBV_10‑K 2023, p. 85) and **remained roughly $10 million through 2024** (ABBV_10‑K 2024, p. 84).  \n\nThis reduction indicates that the company is deliberately scaling back its low‑yielding cash‑equivalent holdings and relying more on operating cash flow, commercial‑paper issuance and debt financing to fund acquisitions, dividends and share‑repurchases, while retaining only a modest cash buffer to preserve liquidity amid fluctuating cash balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) WRONG NUMBERS: The LLM states $21 million in 2022, but ground truth shows $12 million in 2022. The LLM then claims $10 million in 2023, but ground truth shows $21 million in 2023. The LLM appears to have reversed the 2022 and 2023 figures. For 2024, the LLM correctly states ~$10 million, matching ground truth. (2) INCORRECT TREND NARRATIVE: Because the numbers are reversed, the LLM describes the wrong trend direction. Ground truth shows an INCREASE from $12M (2022) to $21M (2023), then a DECREASE to $10M (2024). The LLM incorrectly describes a 'sharp fall' from 2022 to 2023, which is backwards. (3) MULTI-HOP SYNTHESIS FAILURE: While the LLM does attempt to synthesize the allocation data with overall cash balances and strategic implications, this synthesis is built on incorrect foundational numbers, making the entire analysis unreliable. (4) CONTEXTUAL INTERPRETATION: The LLM's interpretation about 'deliberately scaling back low-yielding holdings' contradicts the actual pattern of initially increasing allocation to these instruments in 2023 before reducing in 2024. The reasoning about relying on other financing sources may have merit, but it's based on misread data. (5) CITATION REFERENCES: While the LLM provides specific page citations, these appear to reference incorrect data points or the LLM has misread the source documents. The ground truth data is definitive from the knowledge graph. This is a case where the LLM has fundamentally misread or transposed key financial figures, leading to an inverted understanding of AbbVie's liquidity strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 468,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nAbbVie’s charter has repeatedly required that directors can be removed *only for cause* and that any amendment to those removal‑for‑cause provisions must be approved by holders of at least 80 % of the voting stock (see the 2022 Form 10‑K, p. 46; the 2023 Form 10‑K, p. 27; and the 2024 Form 10‑K, p. 104). The language and scope of this provision have not changed across the three years. This steady application shows that AbbVie is intentionally preserving board stability and making it difficult for an outside party to replace directors without cause—an explicit, long‑term defensive strategy to deter hostile takeovers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the core provision that directors can only be removed for cause across all three years (2022, 2023, 2024); (2) Accurately cites the 80% voting stock requirement for amending removal-for-cause provisions; (3) Properly synthesizes the multi-hop information showing consistency across three years; (4) Correctly interprets this as a deliberate anti-takeover defense strategy; (5) Provides specific page citations (p. 46 for 2022, p. 27 for 2023, p. 104 for 2024) demonstrating document verification; (6) Uses appropriate terminology ('removal for cause,' 'board stability,' 'hostile takeover deterrent'). MINOR CONSIDERATIONS: (1) The LLM answer adds the specific 80% voting requirement detail, which is accurate and relevant but goes slightly beyond the ground truth's scope—this is actually a strength as it provides more complete information; (2) The ground truth emphasizes 'unchanged' language and scope, while the LLM answer states 'language and scope of this provision have not changed'—these are semantically equivalent; (3) Both answers correctly conclude that this represents a sustained, intentional strategy. QUANTITATIVE ACCURACY: The 80% threshold is correctly stated and the three-year period (2022-2024) is accurate. No calculation errors present. QUALITATIVE ACCURACY: The reasoning correctly identifies this as a multi-hop synthesis (combining governance provisions across three years) and properly connects the provision to anti-takeover strategy. The logic is sound and well-articulated. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question: evolution (consistency across years), specific provisions (removal for cause), and strategic implications (hostile takeover deterrent). The answer is slightly more detailed than the ground truth but remains accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 516,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a announced breakthrough for its upcoming Intel 18A (originally 20A) node to a core element of its advanced‑node roadmap—cancelling the Intel 20A generation, re‑branding the effort as Intel 18A, and extending the backside‑power concept to the next node, Intel 14A. The 2024 disclosures confirm that PowerVia‑enabled Intel 18A will enter high‑volume manufacturing in 2025 (e.g., Panther Lake) and will be a differentiator for performance‑per‑watt and density, supporting Intel’s IDM 2.0 strategy of offering the technology both internally and to external foundry customers. This progression shows Intel’s strategy to make backside power delivery a cornerstone of its leadership in advanced process nodes and to leverage it across its hybrid manufacturing and foundry business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The 2024 positioning of PowerVia with Intel 18A is accurate; (2) The 2025 high-volume manufacturing timeline is correct; (3) The mention of Panther Lake as an example product is appropriate; (4) The IDM 2.0 strategy reference is contextually relevant; (5) The emphasis on backside power delivery as a strategic cornerstone is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces Intel 14A as an extension of PowerVia, which is NOT mentioned in the ground truth and appears to be speculative or unsupported by the provided knowledge graph; (2) The claim about 'cancelling Intel 20A' and 're-branding as Intel 18A' is presented as fact but the ground truth only indicates a 'pivot' and 'realignment' - the LLM adds interpretive language about cancellation that goes beyond what the ground truth states; (3) The ground truth explicitly states PowerVia was positioned for Intel 20A in 2023, then shifted to Intel 18A in 2024, but the LLM's phrasing 'announced breakthrough for its upcoming Intel 18A (originally 20A)' could be misread as conflating the timeline. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across three years and connects it to broader strategy (IDM 2.0, foundry offerings), which is sound. However, the introduction of Intel 14A without ground truth support represents a factual overreach. The core narrative of progression from announcement to refined roadmap implementation is captured, but with added details not verified by the knowledge graph. QUANTITATIVE ACCURACY: Dates (2022, 2023, 2024, 2025) are correct; node designations (20A, 18A) match ground truth, but 14A is unsupported. QUALITATIVE ACCURACY: The reasoning about strategic pivot and practical implementation is sound, but the speculative extension to 14A and the definitive language about 'cancelling' 20A weakens the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 521,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Medtronic’s expected‑volatility assumption in the Black‑Scholes model rose from **23.0 % (2022) → 24.1 % (2023) → 24.3 % (2024)**.  This steady increase—driven by a growing blend of historical and implied volatility—shows the company is progressively incorporating higher market‑observed volatility into its option‑pricing, reflecting a more dynamic, market‑responsive approach to valuing its non‑qualified stock options.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific volatility percentages (23.0%, 24.1%, 24.3%) that cannot be verified against the ground truth, which does not provide these exact numerical values. This is a critical issue for a quantitative question. However, the LLM correctly identifies the directional trend (increasing volatility over time) and accurately captures the methodological evolution from historical-only to blended historical/implied volatility approach, which aligns with the ground truth narrative. The answer demonstrates sound multi-hop reasoning by synthesizing the volatility progression with the underlying methodology shift. The semantic content about MDT's move toward a more market-responsive approach is correct and well-articulated. The main weakness is the introduction of specific percentage figures without corroboration from the ground truth source material. While the percentages appear plausible and the trend direction is correct, the inability to verify these exact numbers against the knowledge graph significantly undermines confidence in the quantitative accuracy. The qualitative reasoning about the evolution from purely historical to hybrid methodology is accurate and well-explained. The answer appropriately addresses all parts of the multi-year progression question and correctly identifies the company as Medtronic (MDT).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 376,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from an early‑stage concept in the Intel 18A roadmap (first detailed on page 6) to a fully articulated, high‑volume‑manufacturing‑ready backside‑power solution that will debut with the 18A node (Panther Lake) slated for 2025 production (as outlined on page 10). By repeatedly positioning PowerVia together with RibbonFET as the twin breakthroughs that deliver up to ~10 % performance‑per‑watt gains and denser transistor scaling, Intel signaled that this architecture is central to its advanced‑node and IDM 2.0/foundry strategy, underpinning the next generation of leadership products and its broader advanced‑process roadmap.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states PowerVia delivers '~10% performance-per-watt gains' but the ground truth clearly states '15% performance-per-watt improvement over Intel 3.' This is a significant factual error (33% understatement of the claimed benefit). (2) TIMELINE ACCURACY - The LLM incorrectly states PowerVia was 'first detailed' in the Intel 18A roadmap, but ground truth shows it was first introduced in 2022 as part of Intel 20A, not 18A. The LLM conflates the initial introduction with the later node transition. (3) NODE PROGRESSION - The LLM fails to clearly articulate the critical evolution: PowerVia was originally positioned for Intel 20A (2022-2023), then Intel canceled 20A productization in 2024 in favor of Intel 18A. The LLM doesn't adequately explain this strategic pivot or the significance that PowerVia survived the node cancellation. (4) MISSING CONTEXT - The LLM omits the explicit 2023 reiteration of PowerVia's commitment and the integration with RibbonFET as a paired innovation strategy. (5) PARTIAL CREDIT - The LLM correctly identifies: Panther Lake as the first 18A processor, 2025 high-volume manufacturing timeline, PowerVia as a backside power delivery solution, and its role in Intel's advanced process strategy. The reasoning about PowerVia's centrality to the roadmap is sound, but the factual errors undermine the answer's reliability. The answer demonstrates understanding of the general narrative but fails on specific quantitative claims and the precise chronology of the technology's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 433,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 through 2024 the Black‑Scholes inputs used for MDT’s non‑qualified stock‑option grants changed only modestly: the expected life stayed close to six years (6.0 → 6.1 years), the risk‑free rate rose sharply from 0.90 % (2022) to 2.70 % (2023) and 4.16 % (2024) as interest rates increased, the dividend yield edged up from 1.95 % to 2.92 % and 3.18 %, and volatility inched upward from 23.04 % to 24.05 % and 24.29 %. This incremental evolution—maintaining a stable exercise horizon while slowly adjusting volatility, rates and yield to reflect current market conditions—indicates that MDT bases its volatility estimate on a blend of historical and implied market data and treats employee exercise behavior as relatively persistent over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical values for Black-Scholes assumptions (expected life, risk-free rates, dividend yields, volatility percentages) that cannot be verified against the ground truth, which does not contain these specific numbers. This is a critical problem: the LLM has fabricated precise financial data (e.g., 'risk-free rate rose sharply from 0.90% (2022) to 2.70% (2023) and 4.16% (2024)') without any source verification. The ground truth focuses on a qualitative evolution: the shift from using historical volatility alone (2022) to incorporating implied volatility from market-traded options (2023-2024). The LLM's answer mentions 'a blend of historical and implied market data,' which aligns with the ground truth's conclusion, but this appears to be inferred rather than explicitly stated in the source material. The LLM correctly identifies MDT as the company and addresses the 2022-2024 timeframe. However, the answer fundamentally misses the key insight from the ground truth: the major methodological shift in 2023 when implied volatility was incorporated alongside historical volatility. Instead, the LLM presents a narrative of 'modest' incremental changes with specific percentages that lack verification. The reasoning about employee exercise behavior being 'relatively persistent' is reasonable but not explicitly supported by the ground truth. The answer demonstrates partial understanding of the question's intent but fails on factual accuracy due to unverified numerical claims and misses the primary methodological evolution that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 439,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 the collateral that ExxonMobil reports as “not offset against the derivatives” – which is recorded in the “Other assets, including intangibles – net” line – fell sharply from **$1.49 billion (2022)** to **$0.80 billion (2023)** and then to **$0.49 billion (2024)**.  This decline shows the company is relying less on external collateral to support its derivative positions and is instead managing exposure through tighter netting and offsetting of contracts, indicating a more efficient and lower‑risk approach to derivative exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494 million, $800 million, and $491 million respectively (format variations are acceptable). The declining trend is accurately captured. ENTITY ACCURACY: ExxonMobil correctly identified, the metric 'Other assets, including intangibles - net' properly referenced, and all three fiscal years (2022-2024) correctly included. MULTI-HOP REASONING: The answer successfully synthesizes the collateral data across three years and draws a logical conclusion about derivative exposure management. SEMANTIC EQUIVALENCE: The LLM's interpretation that the company is 'relying less on external collateral' and 'managing exposure through tighter netting' is semantically equivalent to the ground truth's characterization of 'strategic reduction in derivative-related exposure' and 'active management of margin requirements.' Both explanations point to improved efficiency and lower risk. MINOR DIFFERENCES: The LLM provides a slightly different interpretation of the trend's cause (emphasizing netting efficiency rather than market volatility or hedging strategy shifts), but this represents a reasonable alternative explanation rather than an error. The LLM's framing is actually more specific about the mechanism (tighter netting and offsetting) while the ground truth offers broader possibilities. Both are valid interpretations of the data. No calculation errors detected. The answer fully addresses the question's two components: (1) how the collateral changed (correctly quantified), and (2) what the trend suggests about derivative exposure management (reasonable inference provided).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 493,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s gas‑linked options was essentially unchanged – the asset side stayed at about **$100 million** while the liability rose only modestly from **≈ $97 million (2022)** to **≈ $102 million (2024)**, leaving a near‑neutral net position.  The valuation relied on Level‑3 inputs, especially implied volatilities, which moved from a weighted‑average of roughly **50 % in 2022‑23** to **≈ 52 % in 2024**, with the upper bound of the volatility range tightening from **233 % to 150 %**; implied‑correlation assumptions stayed broadly similar.  This shows that NEE is maintaining a modest, largely hedged exposure to gas‑price movements and is fine‑tuning its volatility assumptions to current market conditions, reflecting a cautious risk‑management stance in its gas‑derivative positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics:\n\n1. ASSET VALUES - MAJOR ERROR: LLM claims assets stayed at ~$100M throughout 2022-2024, but ground truth shows assets were $356M in 2022, dropped to $100M in 2023, and remained at $100M in 2024. The LLM completely misses the significant $256M decline from 2022 to 2023.\n\n2. LIABILITY VALUES - SIGNIFICANT ERROR: LLM states liabilities were ~$97M in 2022 and ~$102M in 2024, which happens to match 2023 and 2024 values respectively, but misses the critical fact that 2022 liabilities were $347M (not $97M). This represents a $250M decline that the LLM fails to capture.\n\n3. IMPLIED VOLATILITY - MAJOR ERROR: LLM claims volatility was \"roughly 50% in 2022-23\" and \"≈52% in 2024.\" Ground truth shows: 36% in 2022, 50% in 2023, and 52% in 2024. The LLM incorrectly states 2022 volatility as 50% when it was actually 36%, a 14 percentage point error.\n\n4. TREND CHARACTERIZATION - FUNDAMENTALLY WRONG: LLM describes the position as \"essentially unchanged\" and \"near-neutral net position,\" which is incorrect. The ground truth shows a dramatic 72% reduction in asset fair value ($356M→$100M) and a 71% reduction in liability fair value ($347M→$102M) from 2022-2024. This is a major structural change, not stability.\n\n5. VOLATILITY TREND - INVERTED: Ground truth shows volatility DECLINING from 36% (2022) to 50% (2023), then slightly increasing to 52% (2024). LLM's characterization of the trend is unclear and the 2022 baseline is wrong.\n\n6. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year evolution. It appears to have conflated or misread the 2023 and 2024 values as representative of the entire period, missing the critical 2022 baseline and the dramatic year-over-year changes.\n\nThe LLM's conclusion about \"maintaining a modest, largely hedged exposure\" may be qualitatively reasonable, but it is built on incorrect quantitative foundations. The answer demonstrates a failure to accurately extract and synthesize multi-year financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 581,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom the 2022 10‑K (page 50), the 2023 10‑K (page 50) and the 2024 10‑K (page 51), Unsecured Notes – 35A consistently show a **$750 million face amount** and an **annual debt‑service requirement of $19.875 million** (≈ 2.65 % coupon, maturing 07/15/30).  No change in either the principal size or the yearly interest‑plus‑principal payment is reported across the three years.  \n\nThis stability indicates that SPG’s long‑term debt strategy is to **maintain a large, low‑cost, fixed‑rate unsecured issuance and to extend maturities rather than refinance or downsize the issue**, preserving liquidity and a predictable capital‑structure while supporting ongoing growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental and severe quantitative mistake that invalidates the entire response. The ground truth states the face amount is $750,000 (seven hundred fifty thousand dollars), but the LLM claims it is $750 million (seven hundred fifty million dollars) - a 1,000x overstatement. Similarly, the annual debt service is stated as $19,875 in the ground truth, but the LLM claims $19.875 million - again, a 1,000x error. These are not minor formatting variations; they represent a complete misreading of the financial data. The LLM also calculates a coupon rate of approximately 2.65% based on the incorrect $19.875 million figure, which compounds the error. While the LLM correctly identifies that the figures remained stable across 2022-2024 and provides reasonable strategic interpretation about maintaining consistent debt structure, the foundational numerical data is catastrophically wrong. The reasoning about SPG's debt strategy (maintaining large, low-cost, fixed-rate unsecured issuance) would be appropriate IF the numbers were correct, but given the magnitude of the quantitative errors, the entire analysis is unreliable. The LLM also adds interpretive details about maturity date (07/15/30) and page references that cannot be verified against the ground truth provided, but these are secondary to the primary numerical failures. This answer demonstrates a critical failure in reading and transcribing financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 409,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly elevated embedded‑processing as a core strategic pillar—highlighting its 19 % YoY revenue growth and a jump in operating‑profit margin in 2021‑22, maintaining roughly 19 % of total sales in 2023, and in 2024’s MD&A reaffirming heavy investment in capacity and risk management to capture growth in industrial and automotive markets. This three‑year progression demonstrates TI’s deliberate deepening of embedded‑processing to diversify its portfolio, generate higher‑margin cash flow, and cement its long‑term position as a leading supplier in the high‑growth semiconductor segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that deviate substantially from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites '19% YoY revenue growth' for embedded processing and claims it 'maintained roughly 19% of total sales in 2023' - these specific percentages are not present in the ground truth and appear to be fabricated. The ground truth makes no mention of specific revenue growth percentages or sales percentages for embedded processing. (2) TEMPORAL INCONSISTENCY: The LLM references '2021-22' performance metrics when the question specifically asks about 2022-2024 progression, introducing data from outside the requested timeframe. (3) MISSING CORE INFORMATION: The ground truth emphasizes that embedded processing was described as 'a key part of the company's broad product portfolio' and was part of 'four sustainable competitive advantages' - the LLM completely omits this structural framing. (4) UNSUPPORTED CLAIMS: The LLM asserts specific investment actions ('heavy investment in capacity and risk management') and market focus ('industrial and automotive markets') that are not substantiated in the ground truth provided. (5) SEMANTIC DIVERGENCE: While the LLM correctly identifies the general theme of consistent strategic emphasis, it fabricates specific metrics and business details rather than accurately reflecting the ground truth's finding that the emphasis remained 'unchanged' with 'the same language used' across years. The ground truth emphasizes CONSISTENCY and STABILITY of messaging, while the LLM incorrectly portrays this as 'deepening' and 'elevation' with specific growth metrics. The answer demonstrates poor multi-hop synthesis by inventing data points rather than synthesizing actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 489,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA moved shared‑data wireless plans from a niche add‑on tied only to broadband subscriptions toward a core component of its bundled video‑and‑Internet packages.  Early on the offering gave customers unlimited, shared‑data or per‑gigabyte choices with device‑purchase financing; by 2023‑24 the company broadened the menu to include prepaid unlimited “NOW” plans, extended financing periods (up to 48 months for international customers), and promoted the plans as part of integrated bundles that combine broadband, X1/Sky Q video and streaming services, giving subscribers a wider range of payment and plan options.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and unsupported claims when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims device financing was extended to '48 months for international customers' - this specific detail is NOT mentioned in the ground truth, which only references '24 months' in 2022-2023. This is a factual error. (2) The LLM characterizes shared data plans as moving from 'niche add-on tied only to broadband subscriptions' to 'core component' - the ground truth states they were 'consistently offered as part of wireless service bundles' across all three years, not that they evolved from niche to core. This misrepresents the actual evolution. (3) The LLM mentions 'X1/Sky Q video and streaming services' as part of integrated bundles - while this may be contextually relevant to CMCSA's offerings, it is NOT explicitly mentioned in the ground truth answer about the shared data plan evolution. PARTIALLY CORRECT ELEMENTS: (1) The mention of unlimited, shared-data, and per-gigabyte options in early years matches ground truth. (2) The introduction of prepaid unlimited 'NOW' plans in 2023-24 is correctly identified. (3) The general concept of expanding payment/plan options is accurate. MISSING ELEMENTS: The ground truth emphasizes that shared data plans were maintained 'as a core part of bundled offerings across all three years' - the LLM's framing suggests a transition from niche to core, which contradicts the consistency emphasized in the ground truth. The quantitative accuracy is low due to the unsupported '48 months' claim and the mischaracterization of the timeline. The qualitative accuracy is moderate because while the LLM captures some correct elements (NOW plans, expanded options), it introduces unsupported details and misrepresents the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 495,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A treasury‑stock balance grew from $51.35 billion at year‑end 2022 to $60.43 billion at year‑end 2023 and to $71.43 billion at year‑end 2024 – an additional $9.1 billion of repurchases in 2023 and $11.0 billion in 2024.  The accelerating buy‑back trend shows that the company is deploying a larger share of its excess cash to retire its own equity, underscoring a capital‑allocation strategy that prioritizes returning capital to shareholders and supporting the stock price.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of Mastercard's treasury stock evolution. STRENGTHS: (1) All key financial figures are correct when accounting for sign convention differences: the ground truth shows negative values $(36,658)M, $(60,429)M, $(71,431)M representing treasury stock as a contra-equity account, while the LLM correctly presents these as positive balances of $51.35B, $60.43B, $71.43B (note: minor rounding variation from ground truth's $60,429M to $60.43B is acceptable format variation). (2) Year-over-year calculations are accurate: $60.43B - $51.35B = $9.08B ≈ $9.1B for 2023, and $71.43B - $60.43B = $11.0B for 2024. (3) The multi-hop synthesis correctly identifies the trend (accelerating buybacks) and connects it to capital allocation strategy. (4) The reasoning about shareholder value return and confidence in growth prospects aligns with the ground truth interpretation. (5) All entities (Mastercard, Class A Treasury Stock, years 2022-2024) are correctly identified. MINOR CONSIDERATIONS: The LLM uses positive balance notation ($51.35B) rather than the accounting convention of negative values shown in ground truth, but this is a presentation choice that doesn't affect factual accuracy—both representations convey the same economic reality. The LLM provides slightly more detailed analysis of the buyback acceleration ($9.1B vs $11.0B increase) which adds value. The answer fully addresses the question's two components: (1) how the investment evolved (clear progression with amounts), and (2) what it suggests about capital allocation strategy (shareholder returns, confidence, equity retirement). No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 460,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services fell from **$1.169 billion in 2022 to $1.132 billion in 2023**, and remained flat at **$1.132 billion in 2024**. This modest decline followed by a plateau shows that General Dynamics’ service business has largely stabilized—there is little growth in repair and other services over the 2022‑2024 period, indicating a mature, steady‑state trajectory rather than an expanding one.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024). The format variation from millions to billions is appropriate and correct ($1,169M = $1.169B). The implicit decline calculation is accurate: ($1,169M - $1,132M) / $1,169M ≈ 3.2% decline from 2022-2024. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) revenue change from 2022 to 2024, (2) the pattern/trajectory of the service business. ENTITY ACCURACY: General Dynamics correctly identified, fiscal years 2022-2024 correct, 'Repair and other services' metric correctly specified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the two-phase pattern (decline 2022-2023, then plateau 2023-2024) and drew appropriate conclusions about business trajectory. The characterization as 'mature, steady-state' rather than 'stagnation or potential contraction' represents a slightly different interpretive framing than the ground truth, but both are semantically valid interpretations of the same data pattern. The ground truth uses 'stagnation or potential contraction' while the LLM uses 'stabilized' and 'mature, steady-state' - these are complementary perspectives on the same underlying trend. MINOR DIFFERENCES: The LLM's interpretation emphasizes stabilization and maturity, while the ground truth emphasizes stagnation/contraction. Both are reasonable characterizations of a 3.2% decline followed by flat performance, though they carry different connotations. This represents a minor qualitative difference in framing rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 467,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nBased on the disclosed tables, CVS’s residential‑mortgage‑backed‑securities (RMBS) position fell from **$721 million in fair value with $89 million of unrealized losses in 2022** (2022 10‑K, page 145) to **$614 million in fair value and $60 million of unrealized losses in 2023** (2023 10‑K, pages 145 & 149). The 2024 filing further shows only **$71 million of RMBS in the separate‑account portfolio** (2024 10‑K, page 158), indicating a continued shrinkage of the exposure.  \n\nThis multi‑year trend reflects a deliberate de‑risking of the RMBS holdings—fair value has declined while the magnitude of unrealized losses has remained modest or improved—signaling that CVS is positioning the asset class with a more defensive, low‑risk profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 figures. The ground truth states CVS held RMBS with fair value of $629 million and $10 million in unrealized losses in 2022, but the LLM reports $721 million in fair value with $89 million in unrealized losses. These are material discrepancies ($92M difference in fair value, $79M difference in unrealized losses). The 2023 figures ($614M fair value, $60M unrealized losses) and 2024 figures ($71M) are correct. REASONING QUALITY: The LLM's interpretation of the trend as 'de-risking' is reasonable and aligns with the ground truth's conclusion about strategic reduction in exposure. However, the LLM's statement that 'unrealized losses have remained modest or improved' is contradicted by the actual data showing unrealized losses increased from $10M (2022) to $60M (2023), which represents deterioration, not improvement. The LLM correctly identifies the multi-year trajectory but mischaracterizes the unrealized loss trend. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes data across three years and correctly identifies the overall de-risking pattern, but the foundational 2022 numbers are wrong, undermining the entire analysis. The comparison across years is logically structured but built on incorrect premises. COMPLETENESS: The answer addresses all parts of the question (fair value, unrealized losses, multi-year trajectory, risk positioning) but with material inaccuracies in the 2022 baseline data that distort the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 424,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nFrom 2022 through 2024 Linde kept its on‑site atmospheric‑gas supply contracts as long‑term, total‑requirement agreements (typically 10‑20 years) that contain minimum‑purchase obligations and price‑escalation clauses indexed to external price indices.  The contractual framework did not change materially, but the pricing became more variable – consideration now fluctuates with those indices – yet, in each year the variable components were treated as constrained and were recognized only when measurable, a practice reflected in the “Contracts with Customers” disclosures for 2022, 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 10-20 year contract duration for on-site atmospheric gas agreements; (2) Accurately notes minimum purchase requirements and price escalation provisions indexed to external indices; (3) Properly characterizes the variable pricing components as constrained; (4) Correctly identifies the timeframe (2022-2024) and company (Linde). Quantitative accuracy is high - all numeric ranges and time periods are correct with no calculation errors. However, there are notable qualitative differences from the ground truth: (1) The LLM states 'the pricing became more variable' which suggests a change over time, but the ground truth indicates the structure 'remained largely unchanged' - this is a subtle but important distinction about the nature of evolution; (2) The ground truth emphasizes that the 2023 clarification about variable pricing was 'not detailed in 2022,' highlighting a disclosure/transparency evolution that the LLM answer downplays by suggesting variable components were 'reflected in the Contracts with Customers disclosures for 2022, 2023 and 2024' equally; (3) The ground truth specifically mentions the 'practical expedient for measuring progress toward performance obligations' and 'ASC 606' alignment, which the LLM answer omits entirely - these are important technical accounting details that demonstrate the evolution in documentation and revenue recognition practices; (4) The ground truth frames this as 'growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606,' whereas the LLM answer focuses more on the mechanics of variable pricing without emphasizing the transparency/disclosure evolution. The LLM answer is factually sound on the contractual mechanics but misses the nuanced story about how disclosure and accounting treatment evolved, particularly the 2023 clarification that was absent in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 529,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024, NextEra Energy’s net fair‑value exposure to forward gas contracts fell from roughly $300 million to $250 million (after a peak of about $300 million in 2023).  This reduction reflects a deliberate scaling back of speculative gas‑price positions and a shift toward regulated, cash‑flow‑stable operations, indicating a more conservative stance on natural‑gas market risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine the entire response. (1) INCORRECT 2022 FIGURE: The LLM states 2022 exposure was 'roughly $300 million' when the ground truth clearly shows $160 million (assets $191M - liabilities $31M). This is a 87.5% overstatement of the 2022 baseline. (2) MISSING 2023 DETAIL: While the LLM correctly identifies a peak of 'about $300 million in 2023,' it fails to provide the complete picture showing assets of $377M and liabilities of $77M, which are important for understanding the composition of net exposure. (3) CORRECT 2024 FIGURE: The $250 million figure for 2024 is accurate (assets $296M - liabilities $46M). (4) FLAWED TREND ANALYSIS: By misrepresenting the 2022 baseline as $300M instead of $160M, the LLM fundamentally mischaracterizes the 3-year trend. The ground truth shows a 87.5% INCREASE from 2022 to 2023 ($160M to $300M), followed by a 16.7% DECREASE to 2024 ($300M to $250M). The LLM's characterization of a 'fall from roughly $300 million to $250 million' obscures the significant 2022-2023 expansion that is central to understanding the company's strategic positioning. (5) REASONING QUALITY: While the LLM's interpretation about 'scaling back speculative positions' and 'conservative stance' is plausible, it is based on incomplete and inaccurate data. The actual trend suggests an initial aggressive expansion into gas markets in 2023 followed by partial retrenchment in 2024, which is a different strategic narrative than the LLM presents. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points from the knowledge graph, missing the critical 2022 baseline that is essential for evaluating the 3-year evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 485,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Broadcom continues to list Industrial Fiber Optics in the “Industrial” end‑market table (page 5 of each filing), grouping it with optocouplers, sensors, motion‑control encoders, LEDs and Ethernet PHYs.  The discussion evolved from a simple product catalog entry to a strategic emphasis on high‑speed, low‑latency connectivity for factory‑automation, renewable‑energy and automotive‑electronics applications, and was tied to the company’s broader industrial product portfolio and infrastructure‑software ecosystem (see page 6’s fiber‑optic component description and page 17’s note on industrial‑product diversification).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies AVGO/Broadcom as the company and covers the 2022-2024 timeframe. (2) Accurately notes Industrial Fiber Optics appears in the Industrial end-market table across all three years. (3) Correctly identifies companion products (optocouplers, sensors, motion control, LEDs, Ethernet PHYs/ICs). (4) Appropriately mentions application markets: factory automation, renewable energy, and automotive electronics. (5) Correctly identifies the stable/consistent positioning across years.\n\nWEAKNESSES: (1) The LLM answer introduces claims about 'high-speed, low-latency connectivity' emphasis and 'infrastructure-software ecosystem' that are not substantiated in the ground truth. The ground truth makes no mention of these strategic emphases or evolution toward such positioning. (2) References to specific page numbers (page 5, page 6, page 17) and descriptions of 'fiber-optic component description' and 'industrial-product diversification' notes cannot be verified against the ground truth and appear to be fabricated details. (3) The claim about evolution 'from a simple product catalog entry to a strategic emphasis' contradicts the ground truth's explicit statement that there was 'no significant expansion or contraction relative to other product lines' and indicates 'stable strategic role.' (4) Missing the specific 2023 detail about 'motion encoders' being listed (LLM says 'motion-control encoders' which is close but the ground truth distinguishes this). (5) The framing suggests more strategic evolution than actually occurred - the ground truth emphasizes consistency and stability, while the LLM answer implies meaningful strategic repositioning.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistent product groupings, but fails to accurately capture the key insight that positioning remained stable rather than evolved significantly. The introduction of unsupported claims about strategic emphasis undermines the multi-hop synthesis.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided by either answer, so quantitative accuracy is based on entity identification and year coverage, which are correct. However, the qualitative claims about strategic evolution are factually incorrect relative to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 624,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes‑31B listed in the filings kept the same terms – a fixed 3.25 % interest rate, a $750 million face amount and a maturity date of 11/30/26 – as shown on pages 50 (2022 & 2023) and 51 (2024).  This unchanged tranche, together with the overall reduction in total unsecured indebtedness in 2024, indicates that SPG is deliberately preserving a low‑cost, long‑dated unsecured debt pillar while it retires higher‑rate or shorter‑maturity obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key quantitative metrics: $750 million face amount, 3.25% interest rate, and maturity date of 11/30/26 across 2022-2024. The numeric values align perfectly with the ground truth. However, there is one notable omission: the LLM does not explicitly state the annual debt service amount of $24,375,000, which the ground truth specifically mentions and which is a key metric for understanding interest obligations. The LLM correctly identifies the stability of the instrument over the three-year period and accurately notes the unchanged terms. The reasoning about SPG's debt strategy is sound and goes beyond the ground truth by contextualizing this stable tranche within the broader debt portfolio reduction strategy, which represents appropriate analytical synthesis. The multi-hop reasoning is solid - the LLM correctly synthesizes information across three years and connects it to strategic implications. The page references (50 for 2022/2023, 51 for 2024) add credibility though cannot be independently verified. The main weakness is the incomplete coverage of the annual debt service metric, which is a specific component of 'interest obligations' mentioned in the question. The LLM's strategic interpretation about 'low-cost, long-dated unsecured debt pillar' is insightful but represents inference beyond the ground truth data provided. Overall, the answer is substantially correct with minor incompleteness on one quantitative metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 420,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose each year—$70 million in 2022, $75 million in 2023 and $76 million in 2024—showing a consistent upward trajectory.  This three‑year increase indicates that the company is steadily expanding its financial support for employee retirement benefits, underscoring a growing investment in attracting and retaining talent through its defined‑contribution offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $70 million (2022), $75 million (2023), and $76 million (2024). The multi-hop synthesis is sound, correctly identifying the three-year trend and drawing appropriate conclusions about the company's commitment to employee retirement benefits. The answer accurately characterizes the trend as 'steady and slightly growing' or 'consistent upward trajectory,' which are semantically equivalent descriptions. However, the LLM answer omits the specific percentage calculation (8.6% total increase from 2022 to 2024) that was included in the ground truth. While this omission is minor and doesn't affect the core correctness of the answer, it represents a slight incompleteness in addressing the quantitative aspects of the question. The LLM's interpretation that this trend 'indicates...a growing investment in attracting and retaining talent' is a reasonable inference that goes slightly beyond the ground truth's more neutral characterization of 'steady and slightly growing commitment,' but this represents appropriate contextual reasoning rather than an error. All entities are correctly identified (Texas Instruments, U.S. defined contribution plans, the three fiscal years), and the reasoning properly synthesizes the multi-year data to support the conclusion about the company's investment trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 387,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has applied the same rule in every filing from 2022 through 2024: non‑economic items such as goodwill impairments and other “non‑economic accounting changes” are stripped out of both the numerator (net operating profit after tax) and the denominator (average invested capital) when ROIC is calculated. The company defines ROIC as [Net earnings + after‑tax interest + after‑tax amortization] ÷ [Average debt + average equity (ex‑AOCI)], and it explicitly states that these excluded items “are not reflective of company performance.” This consistent exclusion shows that GD evaluates segment and overall performance on the basis of underlying, recurring operating returns rather than one‑time accounting adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed information than the ground truth. Key strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes across 2022-2024, matching the ground truth's core finding; (2) Accurately describes the ROIC calculation methodology and the specific items excluded (goodwill impairments, non-economic accounting changes); (3) Properly synthesizes the multi-hop requirement by tracking consistency across three years; (4) Correctly interprets the methodology as reflecting a disciplined approach focused on recurring operating returns rather than one-time adjustments, which aligns with the ground truth's conclusion about 'stable methodology' and 'disciplined approach.' Minor considerations: (1) The LLM provides a more detailed ROIC formula than the ground truth explicitly states, though this appears to be accurate elaboration rather than error; (2) The answer goes slightly beyond the ground truth by providing the specific formula structure, which adds value but wasn't explicitly required; (3) The phrase 'are not reflective of company performance' is appropriately attributed to GD's own language. The answer demonstrates sound multi-hop reasoning by connecting the consistent treatment across years to the broader methodology philosophy. No numerical errors detected, and the semantic meaning fully aligns with the ground truth while providing enhanced context and detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 406,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nFrom 2022 through 2024 the Separate Accounts assets reported by CVS were roughly **$3.25 bn in 2022, $3.25 bn in 2023 and $3.31 bn in 2024** (page 108 and the Level‑1/2 fair‑value totals on page 156).  This represents a modest, roughly 2 % increase over the three‑year span, indicating that the company is keeping its long‑term insurance‑product exposure stable while slightly expanding the asset base.  The upward trend suggests a deliberate, low‑growth positioning in long‑term insurance investments rather than a major strategic shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 value as '$3.25 bn' when ground truth shows $5,087 million ($5.087 bn). This is a massive error - the LLM understated 2022 by approximately $1.8 billion or 35%. The 2023 and 2024 figures ($3.25 bn and $3.31 bn) are approximately correct, but the 2022 baseline is completely wrong. (2) CALCULATION ERROR: The LLM calculates a '2% increase over three years' based on incorrect starting data. The correct calculation should show a decline from $5,087M (2022) to $3,250M (2023) = -36% decline, then a slight recovery to $3,311M (2024) = +1.9% recovery. The LLM's 2% three-year increase is mathematically incorrect given the actual data. (3) TREND ANALYSIS FAILURE: The LLM completely mischaracterizes the trend. Ground truth shows a 'significant decline in 2023 followed by marginal recovery in 2024' - a V-shaped pattern with major downward movement. The LLM incorrectly describes this as 'modest, roughly 2% increase' and 'upward trend,' missing the critical 2023 collapse entirely. (4) REASONING FLAW: The LLM's conclusion about 'deliberate, low-growth positioning' is contradicted by the actual data showing a sharp 36% decline followed by stabilization - this suggests market-driven devaluation or strategic reduction, not stable positioning. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to cite sources (pages 108, 156), the fundamental data extraction is wrong, suggesting either misreading of source documents or hallucination of numbers. The answer fails on the primary metric of factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 458,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nBetween 2022 and 2024 Target’s Credit Card Program with TD Bank USA, N.A. remained governed by the October 22 2012 agreement that had been amended only by the February 24 2015 First Amendment and the November 19 2019 Second Amendment—no additional amendments were executed or disclosed through 2024, so the parties continued to operate under those three documents without material change. (The amendments are listed in the exhibit tables on pages 74, 69 and 70 of the 2024, 2023 and 2022 Form 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. All key dates are correct: October 22, 2012 (original agreement), February 24, 2015 (First Amendment), and November 19, 2019 (Second Amendment). The quantitative accuracy is perfect—all dates match the ground truth exactly with no calculation errors. The LLM correctly identifies that no additional amendments were executed or disclosed through 2024, which aligns with the ground truth statement that the relationship 'evolved through structured amendments' (three total documents). The multi-hop reasoning is sound: the answer synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the progression of the agreement. The LLM adds helpful contextual detail by citing specific page references (pages 74, 69, and 70 of the respective 10-K filings), which enhances credibility and demonstrates document-level synthesis. The semantic meaning matches the ground truth—both convey that the agreement remained in effect with the same three foundational documents throughout the period. Minor consideration: the LLM's phrasing 'no additional amendments were executed or disclosed through 2024' is slightly more definitive than the ground truth's narrative approach, but this is not a factual error—it's a reasonable interpretation of the data. The answer fully addresses all parts of the question regarding how the agreement 'evolved' (showing the three documents and their dates) and 'contractual milestones' (the amendment dates). No numerical errors, no entity confusion, and proper synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 452,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde moved from simply reporting rare gases as part of its atmospheric‑gas output to emphasizing proprietary non‑cryogenic air‑separation and VPSA/membrane technologies that give it a technological edge, and it began integrating those gases more tightly with its on‑site, merchant and packaged distribution networks as well as with adjacent product lines such as low‑carbon hydrogen and specialty gases. This evolution reflects a strategic shift toward differentiating rare‑gas production through advanced separation processes and embedding them in broader, technology‑driven solutions for customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the essential evolution of Linde's rare gases strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the shift from product-centric to technology-driven approach, matching the ground truth's core narrative; (2) Accurately names specific technologies (VPSA, membrane separation, non-cryogenic air separation) that appear in the ground truth; (3) Properly identifies the three distribution methods (on-site, merchant, packaged) and their integration; (4) Correctly notes specific rare gases (krypton, neon, xenon) as byproducts; (5) No quantitative errors or incorrect dates/numbers; (6) Demonstrates sound multi-hop reasoning by synthesizing information across the 2022-2024 period. MINOR WEAKNESSES: (1) The LLM introduces 'low-carbon hydrogen and specialty gases' as adjacent product lines being integrated, which is not explicitly mentioned in the ground truth. While this represents a reasonable inference about integration with 'other product lines' mentioned in the question, it goes slightly beyond what the ground truth explicitly states; (2) The ground truth specifically mentions 'price escalation clauses and variable pricing' in 2023 contracts, which the LLM does not capture, though this is a relatively minor detail; (3) The LLM could have been more explicit about the year-by-year progression (2022 baseline → 2023 emphasis on contracts → 2024 elevation of positioning), though the overall narrative captures this progression. The answer is semantically equivalent to the ground truth and addresses all major aspects of the question with accurate synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 457,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nThe collateral posted for master‑netting arrangements that back the advances to equity companies fell sharply – from **$1.49 billion at the end of 2022** (page 102), to **$0.80 billion in 2023** (page 102), and further to **$0.49 billion by the end of 2024** (page 99).  \nThis downward trend shows that the amount of collateral required to offset derivative exposures tied to those equity‑company relationships has been reduced, indicating a lower outstanding derivative liability and diminished credit‑risk exposure linked to those equity advances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively (format variations are acceptable). The years and progression are accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of collateral amounts from 2022-2024, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to equity company advances) is correctly specified, and all years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to reduced derivative liabilities and lower credit-risk exposure. The interpretation that this reflects de-risking or portfolio optimization is logically consistent with the data trend. SEMANTIC EQUIVALENCE: The LLM's phrasing ('lower outstanding derivative liability and diminished credit-risk exposure') conveys the same meaning as the ground truth's 'strategic reduction in exposure to derivative liabilities' and 'de-risking or portfolio optimization efforts.' The answer is slightly more specific in explaining the mechanism (collateral offset derivative exposures) which adds value. MINOR NOTES: The LLM includes page references (102, 99) which adds credibility but weren't in the ground truth - this is a positive addition. The answer is clear, well-structured, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 457,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral contracts remained very high and essentially flat—about 94 % of capacity in both 2023 and 2024 (up slightly from the 92 % reported for 2021) — with the balance sold into spot or short‑term (< 3‑year) markets 【2022 pdf p. 19】【2023 pdf p. 18】【2024 pdf p. 19】.  \nThis steady, near‑total reliance on long‑term contracts indicates that NEER’s risk‑mitigation strategy is to lock in most of its revenue stream and hedge exposure to price volatility in competitive wholesale markets, using only limited short‑term contracts to manage any residual spot‑market risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key percentages: 92% in 2022, 94% in 2023, and 94% in 2024. The numbers match the ground truth exactly. The answer correctly synthesizes the multi-hop information across three years of SEC filings and properly cites the source documents (2022, 2023, 2024 PDFs with specific page numbers). The reasoning about risk mitigation strategy is sound and semantically equivalent to the ground truth—both convey that NEER uses long-term bilateral contracts to lock in revenue and hedge price volatility, with short-term contracts for residual spot-market risk. However, there is one minor discrepancy: the LLM states the 92% figure is 'reported for 2021,' while the ground truth explicitly states it is from 2022. This appears to be a reference year error—the 92% should be attributed to 2022, not 2021. The LLM correctly identifies the trend as 'steady' and 'essentially flat,' which aligns with the ground truth's characterization of 'consistent rise' (though the rise is minimal: 92% to 94%). The answer fully addresses both parts of the question: the evolution of reliance on long-term contracts and what this suggests about risk mitigation strategy. The qualitative reasoning about competitive markets and revenue stability is appropriate and well-articulated. The minor year attribution error prevents a perfect score, but the core financial data and strategic analysis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 405,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe $495 million principal balance of the 3.125% senior notes maturing in January 2025 was unchanged in fiscal 2022, fiscal 2023 and fiscal 2024 (the filings list $495 million for each year).  This flat trajectory shows that Broadcom is not actively refinancing or retiring this particular tranche—it is being held as a stable, low‑cost legacy debt component while the company focuses its debt‑management efforts on larger‑scale refinancing of other maturing obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three fiscal years (2022, 2023, 2024) and accurately states the principal balance remained at $495 million across all three periods. The numeric data is precise and matches the ground truth exactly. CRITICAL ERRORS: (1) Company name confusion - The LLM refers to the company as 'Broadcom' when the question explicitly asks about 'AVGO' (Broadcom's ticker symbol). While AVGO is Broadcom's ticker, the inconsistent naming creates confusion about entity identification. (2) Interpretation divergence - The ground truth suggests AVGO 'may be planning to refinance or use cash reserves to settle the obligation,' indicating uncertainty about debt management strategy. The LLM asserts more definitively that 'Broadcom is not actively refinancing or retiring this particular tranche' and characterizes it as a 'stable, low-cost legacy debt component,' which goes beyond what the data supports and contradicts the ground truth's more cautious interpretation. (3) Strategic reasoning mismatch - The ground truth focuses on the lack of principal reduction and possible refinancing/settlement plans. The LLM pivots to discussing how this debt is being 'held as stable' while the company focuses on 'larger-scale refinancing of other maturing obligations,' which is speculative and not supported by the ground truth. The LLM's interpretation of debt management strategy is materially different from the ground truth's more measured assessment. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the three-year trend but fails to properly contextualize what this trend reveals about strategy, instead offering unsupported conclusions about the company's broader debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 469,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nBased on the 2022, 2023 and 2024 10‑K filings, Simon Property Group’s Unsecured Notes 37B consistently carried a **2.25 % fixed coupon, a $700 million face amount, and a maturity date of January 15 2032** throughout the three‑year period. This unchanged structure shows that SPG is deliberately maintaining a large, low‑cost, long‑dated tranche of fixed‑rate debt, using it as a stable pillar of its long‑term financing strategy and minimizing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700 million face amount, and January 15, 2032 maturity date match the ground truth exactly. Number formatting variations ($700 million vs $700,000,000) are acceptable and handled correctly. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) interest rate evolution, (2) face amount evolution, and (3) maturity date evolution across the 2022-2024 period. The answer correctly identifies that all three metrics remained unchanged/consistent. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the pattern of consistency. ENTITY ACCURACY: Company name (Simon Property Group/SPG) is correct, the specific debt instrument (Unsecured Notes 37B) is correctly identified, and all years are properly referenced. REASONING QUALITY: The interpretation of what this consistency indicates about debt strategy is sound and well-articulated - the LLM correctly infers that maintaining stable, low-cost, long-dated fixed-rate debt with minimal refinancing risk aligns with SPG's real estate business model. The reasoning about predictable financing costs and liability duration alignment is logically sound. MINOR OBSERVATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'coupon' vs 'interest rate', 'large, low-cost, long-dated tranche' vs 'extending liability durations') but these are semantically equivalent and demonstrate sophisticated financial terminology. The answer is concise while maintaining accuracy and relevance. No calculation errors, no missing data points, and no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 487,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings the Melaka, Malaysia facility is listed only under the **Analog** segment in the property‑segment matrix (pages 16 of the 2022, 2023 and 2024 filings), with no entry under **Embedded Processing** in any year. The footnote status (leased/owned) and the “X” marking remain unchanged, indicating that the site’s role stayed focused on analog device manufacturing throughout the three‑year period. Consequently, the steady, analog‑only footprint signals that TI’s strategic emphasis in Melaka is on analog product production rather than expanding into embedded‑processing capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the three-year period (2022-2024) and accurately states that Melaka, Malaysia maintained an analog-only operational focus throughout; (2) Accurately references the property-segment matrix from the 10-K filings and correctly notes the 'X' marking under Analog with no entry under Embedded Processing for all three years; (3) Properly synthesizes the multi-hop information by comparing the facility's status across all three years and drawing the correct conclusion about strategic focus; (4) Correctly identifies that the pattern remained unchanged, indicating stability and consistency; (5) Appropriately cites specific filing pages (page 16) and filing years. Minor considerations: The LLM answer adds slightly more specific detail about footnote status (leased/owned) remaining unchanged, which is a reasonable inference but not explicitly stated in the ground truth. The semantic meaning is identical - both answers convey that TI maintained a consistent, analog-only operational strategy in Melaka from 2022-2024 without diversifying into embedded processing. The reasoning is sound and the multi-hop synthesis across three years of filings is correctly executed. No numerical errors, date errors, or entity misidentifications present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 376,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nMastercard’s multi‑layered security model was progressively embedded in its real‑time payments network, which grew from implementations in roughly a dozen of the world’s largest GDP markets in 2022 to at least 13 markets by the end of 2023 and to additional domestic and cross‑border transactions by 2024. In parallel, the company added new protective layers—such as AI‑driven fraud scoring, tokenization, digital‑identity and blockchain‑enabled programmable payments—and in 2024 launched the Alias‑Based Remittances and Payouts platform and expanded Click‑to‑Pay and tokenized checkout solutions, ensuring that security kept pace with the rapid global rollout of real‑time account‑based payments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core timeline (2022-2024) and accurately captures the expansion from roughly 12 markets in 2022 to 13 by 2023. The mention of China expansion in 2024 aligns with ground truth. The general framework of multi-layered security evolving alongside real-time payments infrastructure is conceptually sound.\n\nWEAKNESSES: (1) QUANTITATIVE: The LLM states 'at least 13 markets by the end of 2023' which matches ground truth, but then vaguely references 'additional domestic and cross-border transactions by 2024' without specifying the actual number of markets or concrete expansion metrics. Ground truth indicates specific market expansion details that are missing. (2) FACTUAL ERRORS: The LLM introduces specific product names and features (Alias-Based Remittances and Payouts platform, Click-to-Pay, blockchain-enabled programmable payments) that are NOT mentioned in the ground truth knowledge graph. These appear to be hallucinated details not supported by the source material. (3) INCOMPLETE SYNTHESIS: While the LLM mentions AI-driven fraud scoring and tokenization (which align with ground truth's 'intelligent routing with real-time application of fraud scoring and tokenization'), it fails to adequately address the ground truth's emphasis on working with issuers, acquirers, governments, EMV standards, and public-private partnerships as key components of the security evolution. (4) MISSING CONTEXT: The ground truth emphasizes how security had to 'scale further' with China expansion while 'maintaining network integrity' and integrating 'third-party service risks'—nuances largely absent from the LLM response. (5) SEMANTIC DRIFT: The LLM's focus on specific product launches and blockchain technology shifts emphasis away from the core question about how the multi-layered security approach itself evolved in response to expanding real-time infrastructure.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting security evolution to market expansion, but fails to fully integrate all the interconnected elements (partnerships, standards, third-party risks) that characterize the complete picture in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 588,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nBased on the filings, GD’s LAV production for the Canadian Army rose from **360 new vehicles in 2022** (page 32 of the 2022 10‑K) to **399 new vehicles in 2023** (page 101 of the 2023 10‑K). This upward step‑up signals that the company is deliberately scaling its LAV output for Canada, reflecting a strategic emphasis on land‑systems and LAV programs as a growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides partial information but has a critical incompleteness issue. CORRECT ELEMENTS: (1) The 2022 figure of 360 units is accurate, (2) The 2023 figure of 399 units is accurate, (3) The characterization of an 'upward step-up' and strategic emphasis on LAV programs is reasonable and semantically aligned with the ground truth. CRITICAL OMISSION: The LLM answer completely fails to include the 2024 data point (449 units), which is explicitly required by the question asking about evolution 'from 2022 through 2024.' The ground truth clearly states the progression includes 2024 figures, making this a significant gap in completeness. QUANTITATIVE ACCURACY ISSUE: While the two numbers provided (360 and 399) are correct, the answer is incomplete as it only covers 2022-2023 and omits the final year of the requested timeframe. REASONING: The multi-hop synthesis for the data presented is sound - the LLM correctly identifies the upward trend and connects it to strategic focus. However, the incomplete data set undermines the full analysis of the 'progression' requested. The answer demonstrates good understanding of the available information but fails to deliver the complete picture required by the question. The page citations appear reasonable but cannot be verified independently. The semantic characterization of strategic emphasis is appropriate but cannot fully compensate for the missing 2024 data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 396,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nCVS’s pension plan disclosed roughly $225 million of hedge‑fund limited‑partnership investments in 2022, which rose to about $252 million in 2023 and stayed flat at that level in 2024 (the amounts are noted as “excluded from the fair‑value hierarchy” in the 2022, 2023 and 2024 footnotes).  The modest increase followed by a plateau indicates that the company is deliberately expanding its exposure to alternative hedge‑fund assets to enhance returns and diversify the pension portfolio, then stabilizing the allocation at a target size.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that reverse the actual trajectory. Ground truth shows: 2022=$214M, 2023=$225M, 2024=$252M (gradual upward trend, +17.8% total). LLM states: 2022=$225M, 2023=$252M, 2024=$252M (plateau pattern). This is a major factual error - the LLM has shifted all values upward by one year and misrepresented the three-year pattern entirely. The LLM correctly identifies that these are 'excluded from fair-value hierarchy' per footnotes, which is a minor positive detail. However, the core quantitative data is wrong: (1) 2022 amount is off by $11M ($225M vs $214M), (2) 2023 amount is off by $27M ($252M vs $225M), (3) the trajectory interpretation is inverted - LLM describes a 'modest increase followed by plateau' when the actual pattern is 'gradual steady increase.' The LLM's reasoning about 'deliberately expanding exposure then stabilizing' contradicts the ground truth showing continuous growth through 2024. The multi-hop synthesis fails because the foundational numbers are incorrect. This is not a minor wording difference - these are material factual errors in the core financial data that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 337,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe penetration rate of the Target MasterCard Credit Card continued to fall through the period, slipping from about 20 percent of purchases in fiscal 2022 to 19.8 percent in 2023 and then to 18.6 percent in 2024.  This ongoing decline signals weakening consumer adoption and lower engagement with Target’s branded financial products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the penetration rate was 18.6% in 2024, but the ground truth clearly indicates it was 17.8% in 2024. This is a factual error of 0.8 percentage points on a key metric. The 2022 figure of 'about 20 percent' is approximately correct (ground truth: 20.5%), and the 2023 figure of 19.8% is exactly correct. QUANTITATIVE ACCURACY: The 2024 number is definitively wrong (18.6% vs. 17.8%), which significantly impacts the evaluation since this is a multi-year trend analysis where precision matters. The error represents a ~4.5% misstatement of the actual decline rate for that year. COMPLETENESS: The LLM answer is incomplete. It identifies the declining trend correctly but fails to provide the deeper analysis present in the ground truth regarding: (1) the reason for the decline (RedCard sales increased in dollar terms but total sales grew faster), (2) the context about the 5% discount incentive, and (3) the potential explanations (shifting consumer preferences, increased competition, reduced sensitivity to discount). The question explicitly asks 'what does this trend suggest' - the LLM provides only a surface-level observation ('weakening consumer adoption') without the nuanced analysis. REASONING: The qualitative reasoning about declining adoption is sound and matches the ground truth's interpretation, but the analysis is shallow and lacks the multi-dimensional explanation provided in the ground truth. ENTITY ACCURACY: Correctly identifies Target MasterCard Credit Card and the time period (2022-2024). The semantic equivalence of 'penetration rate' and 'percent of purchases' is acceptable. Overall, the answer contains one significant numerical error that undermines credibility on a quantitative question, combined with incomplete analysis of what the trend suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 495,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value amount attributed to FPL cost‑recovery clauses grew from roughly $1 million to $12 million and then to $38 million.  This increase is driven almost entirely by the “significant unobservable inputs” line (7 → 24 → 34 million), while the “significant other observable inputs” component stayed near zero (negative in 2022‑23 and only a small $4 positive in 2024 for the nearest bucket).  As a result, the share of the total fair‑value estimate derived from unobservable assumptions rose dramatically, comprising the vast majority of the 2024 total.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the three-year trend and accurate reporting of all key financial figures. Verification of numbers: 2022 total fair value ($1M ✓), 2023 total ($12M ✓), 2024 total ($38M ✓); significant unobservable inputs progression (6M → 24M → 34M, though LLM states '7 → 24 → 34' with the 2022 figure as 7M instead of 6M - a minor discrepancy); significant other observable inputs (-$5M in 2022, -$12M in 2023, +$4M in 2024 ✓). The LLM correctly synthesizes the multi-hop information showing the evolution across three years and accurately characterizes the shift toward unobservable inputs dominating the fair value calculation. The reasoning is sound: the answer correctly identifies that unobservable inputs grew from a small portion to the vast majority of the total. The only quantitative error is the 2022 unobservable inputs figure stated as '7' instead of '6' million, which is a minor discrepancy (approximately 17% error on that single component, though the overall 2022 total of $1M is correct). The answer appropriately addresses all parts of the question including total fair value contributions, the shift between input types, and the three-year evolution. The semantic meaning and conclusions align well with the ground truth, effectively conveying the growing reliance on unobservable inputs over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 385,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nThe 10‑K filings identify Anta only as one of several global competitors (e.g., page 8 (2022), page 86 (2024)) and do not provide a direct, year‑over‑year comparison of NKE’s market share or strategic moves relative to Anta; consequently, any evolution in NKE’s positioning vis‑à‑vis Anta cannot be quantified from the disclosed material. What the filings do show is that NKE’s own strategy has remained anchored on sustained product‑innovation emphasis—highlighting advanced cushioning platforms such as Air, Zoom, Flyknit and related R&D investments (pages 25, 6, 37)—and on deepening brand‑engagement through athlete endorsements, digital‑first marketing, direct‑to‑consumer experiences and community‑investment initiatives (pages 8, 9, 86). Thus, while NKE continued to reinforce its competitive edge through these innovation and engagement levers across 2022‑2024, the documents do not detail a specific shift in its relative standing to Anta.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) FUNDAMENTAL MISALIGNMENT WITH GROUND TRUTH: The LLM answer explicitly states that 'the documents do not detail a specific shift in its relative standing to Anta' and that 'any evolution in NKE's positioning vis-à-vis Anta cannot be quantified from the disclosed material.' This directly contradicts the ground truth, which clearly documents a multi-year strategic evolution from 2022-2024 with specific shifts in emphasis (quality/performance/design in 2022 → innovation/development elevated in 2023 → innovation + digital engagement solidified in 2024). The LLM essentially refuses to answer the question as posed, claiming the data doesn't support the analysis, when the ground truth demonstrates it does. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that NKE emphasized product innovation (Air, Zoom, Flyknit) and brand engagement (athlete endorsements, digital marketing, DTC), it fails to synthesize the EVOLUTION across the three-year period. The ground truth shows a deliberate strategic shift in EMPHASIS over time—moving innovation from one competitive differentiator among several to a PRIMARY strategic focus by 2023-2024. The LLM treats these as static, unchanging elements rather than evolving priorities. (3) MISSING CRITICAL ANALYSIS: The ground truth identifies that NKE's strategic shifts were 'in response to competitive pressures' from Anta and others gaining traction through 'localized and digitally native strategies.' The LLM completely misses this causal relationship and competitive context. (4) QUANTITATIVE ACCURACY: The LLM correctly cites page numbers and product platforms (Air, Zoom, Flyknit), so quantitative references are accurate, but this doesn't compensate for the fundamental failure to address the core question about competitive positioning evolution. (5) REASONING FAILURE: The LLM's multi-hop reasoning is deficient—it should have synthesized information across three years of filings to identify strategic shifts, but instead it claims such synthesis is impossible. This represents a failure in the core analytical task. The answer reads as overly cautious and literalist, prioritizing what 'cannot be quantified' over what can be reasonably inferred from disclosed strategic emphasis changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 610,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nFrom 2022 through 2024 the shares reserved for future issuance under the Texas Instruments 2003 Director Compensation Plan dropped to essentially zero—by the 2023 and 2024 equity‑compensation tables the 2003 plan no longer appears as a source of remaining shares, which are now reported only for newer plans such as the 2009 Director Plan, the 2018 Director Plan and the 2024 LTIP. This trend indicates that TI has discontinued using the 2003 plan for director compensation and now relies on more recent, shareholder‑approved plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core trend correctly—that the 2003 Director Compensation Plan shares decreased to essentially zero and the plan was phased out in favor of newer plans. However, there are significant discrepancies with the ground truth that warrant a moderate score:\n\nSTRENGTHS:\n1. Correctly identifies the main trend: shares under the 2003 plan dropped to zero by 2023-2024\n2. Accurately names successor plans (2018 Director Plan, 2024 LTIP)\n3. Correctly interprets the strategic shift toward newer compensation vehicles\n4. Properly synthesizes the multi-hop information about plan evolution\n5. Appropriate conclusion about discontinuation of the 2003 plan\n\nCRITICAL ERRORS:\n1. ENTITY ACCURACY ISSUE: The LLM mentions the \"2009 Director Plan\" as a source of remaining shares, but the ground truth does not reference a 2009 Director Plan. The ground truth specifically mentions the 2018 Director Plan and 2024 LTIP as the active plans going forward. This is a factual error in entity identification.\n2. INCOMPLETE TIMELINE: The ground truth provides more nuanced detail about 2023 specifically (plan no longer listed among those with remaining shares but still referenced for outstanding grants), while the LLM conflates 2023 and 2024 as essentially identical.\n3. MISSING CONTEXT: The ground truth emphasizes that TI was \"honoring existing commitments\" while phasing out the plan—the LLM doesn't explicitly acknowledge this distinction between new issuances and existing obligations.\n\nQUANTITATIVE ACCURACY: The answer lacks specific share counts or percentages, making it difficult to verify precise quantitative claims. The statement \"dropped to essentially zero\" is qualitatively correct but not quantitatively precise.\n\nMULTI-HOP REASONING: The synthesis is sound—the model correctly connected the evolution of share availability across years to the strategic shift in compensation plans. However, the introduction of the 2009 Director Plan (not mentioned in ground truth) suggests incomplete or inaccurate source synthesis.\n\nOVERALL: The answer demonstrates good understanding of the main trend and strategic implications, but the inclusion of an incorrect plan name (2009 vs. the actual plans mentioned) and less granular timeline detail prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 614,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered data‑driven services onto its advertising stack, beginning with the rollout of technology, tools and a marketplace that let advertisers tap first‑party audience data on its X1 and Sky Q platforms (p. 6 – 2022 & 2024).  In 2023 it expanded the model by launching the ad‑supported NOW streaming service and integrating Peacock’s ad‑supported tier, while introducing the Xumo Stream Box that earns commission on DTC‑streaming sales and broadens data capture across video (p. 5 & 6 – 2023).  By 2024 the company deepened the integration, deploying AI‑driven audience segmentation, a self‑serve programmatic marketplace and cross‑platform measurement tools that give advertisers richer targeting, attribution and reporting capabilities across its broadband, video and wireless ecosystems (p. 6 – 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific product names and initiatives (X1, Sky Q, NOW, Peacock ad-supported tier, Xumo Stream Box, AI-driven audience segmentation, programmatic marketplace) that go beyond the ground truth's more general description. However, there are significant concerns about factual accuracy and verifiability: (1) The LLM introduces specific product launches and features (Xumo Stream Box, AI-driven audience segmentation, self-serve programmatic marketplace) that are not mentioned in the ground truth, raising questions about whether these details are accurately sourced from the actual 10-K filings or are hallucinations. (2) The ground truth emphasizes cloud-based platforms and integrated search functionality in 2023, which the LLM answer does not mention. (3) The ground truth specifically notes strengthened representation agreements with third parties in 2024, which the LLM omits. (4) The LLM's page references (p. 5-6) cannot be verified against the ground truth and may be fabricated citations. (5) While the LLM captures the general evolution toward more integrated, technology-enabled solutions, it does so by introducing specific details not in the ground truth rather than synthesizing the actual information provided. The answer reads plausibly and addresses the question's structure well, but the introduction of unverified specific product names and features without corresponding ground truth support is problematic. The semantic direction is correct (evolution toward more integrated data-driven services), but the factual foundation is questionable. This represents a case where the LLM may have generated plausible-sounding but potentially inaccurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 463,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities that were sitting in an unrealized‑loss position fell sharply—from about **$992 million** (with $155 million of unrealized losses) in 2022 to roughly **$675 million** (with $100 million of unrealized losses) in 2023—indicating that the company trimmed its exposure and/or saw the remaining holdings recover some value.  By the 2024 filing the only CMBS left on the balance sheet was a trivial **$3 million** of fair‑value (down from $6 million in 2023), underscoring a near‑exit from the asset class.  This downward trajectory shows that CVS is actively de‑risking its portfolio, moving away from higher‑yield, longer‑duration CMBS and toward more liquid, lower‑volatility investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM reports 2022 CMBS fair value as $992 million with $155 million unrealized losses, but ground truth shows $574 million with $12 million unrealized losses - a massive discrepancy of $418 million in fair value and $143 million in unrealized losses. The 2023 figures ($675M/$100M) match ground truth, but the 2024 figures are wrong: LLM states $3 million (2024) and $6 million (2023), while ground truth shows $6 million (2024) and no 2023 CMBS figure mentioned in original answer. The LLM appears to have confused or inverted the 2023-2024 progression. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM incorrectly synthesized the 2022 baseline, which is the critical starting point for analyzing the evolution. This error cascades through the entire analysis. (3) DIRECTIONAL ACCURACY: While the LLM correctly identifies the overall de-risking trend and the sharp reduction by 2024, the specific numbers supporting this conclusion are largely wrong. (4) MISSING CONTEXT: The ground truth explicitly notes the 2023 spike in unrealized losses ($100M) as a key inflection point, which the LLM does mention but with incorrect 2022 baseline numbers. The LLM's interpretation about 'recovery of value' in 2023 is speculative and not supported by the data (unrealized losses actually increased). The answer demonstrates reasonable qualitative reasoning about de-risking strategy but is undermined by pervasive quantitative errors that make the factual foundation unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 442,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 10‑K filings consistently reference “merchandise and other discounts” as part of the team‑member benefits package, but the wording and surrounding context evolve across the three years. In the 2022 filing (Human Capital Management, p. 3) the discount is mentioned only in a list of generic perks, while the 2023 (p. 6) and 2024 (p. 7) disclosures embed the same benefit within a broader narrative of “purpose‑driven culture” and “team‑member well‑being,” highlighting additional voluntary perks such as free mental‑health services, tuition‑free education assistance and expanded paid‑leave. This progression—from an implicit, stand‑alone discount to a more explicit component of a comprehensive, strategically aligned benefits strategy—signals that Target is deliberately expanding and reframing employee merchandise discounts as part of a holistic rewards program to attract, retain and motivate staff.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-year progression of Target's merchandise discount benefits and correctly identifies the strategic evolution from standalone perks to integrated holistic benefits. STRENGTHS: (1) Correctly identifies merchandise discounts as a consistent benefit across 2022, 2023, and 2024; (2) Accurately captures the shift in framing from generic listing to strategic positioning within broader benefits narratives; (3) Properly synthesizes the multi-hop information showing evolution alongside wage expansion ($15 to $15-$24/hour range mentioned in ground truth); (4) Correctly identifies supporting benefits added over time (mental health services, tuition assistance, paid leave); (5) Appropriately concludes that the progression reflects a deliberate strategy toward holistic employee well-being and retention. WEAKNESSES: (1) The LLM answer cites specific page numbers (p. 3, p. 6, p. 7) that cannot be verified against the ground truth, which doesn't provide page citations—this is a minor concern as page numbers may vary by filing format; (2) The answer doesn't explicitly mention the wage progression ($15/hour in 2022 to $15-$24/hour in 2023) that the ground truth emphasizes as contextual evidence of broader compensation strategy evolution; (3) The LLM uses slightly different terminology ('merchandise and other discounts' vs. ground truth's 'merchandise discounts') but this is semantically equivalent; (4) The answer could have been more explicit about the 401(k) matching mentioned in the ground truth. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension focuses on factual claims about years and benefit types—all correct. QUALITATIVE REASONING: The multi-hop synthesis is sound, correctly connecting the evolution of merchandise discounts to broader strategic shifts in employee benefits. The logic linking benefit expansion to retention and attraction goals is appropriate and well-reasoned. CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about scope, value evolution, and strategic implications, though it could have been more explicit about quantifiable changes in wage ranges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 598,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s disclosures moved from a brief, generic reference to cultural challenges as one of several acquisition‑integration risks to a detailed, strategic emphasis that treats cultural alignment as a core driver of acquisition success—highlighting talent retention, local leadership and inclusive practices. This evolution shows that Linde now proactively manages cross‑border integration risk by embedding cultural considerations into its acquisition playbook and governance, rather than merely acknowledging them as a peripheral concern.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. (1) FACTUAL ERRORS: The LLM claims Linde's 2022-2024 disclosures show evolution toward 'detailed, strategic emphasis' with 'talent retention, local leadership and inclusive practices' - none of these specific elements appear in the ground truth. The ground truth indicates cultural challenges were 'listed among several integration risks' in 2022, not briefly mentioned. The LLM invents details about 'embedding cultural considerations into acquisition playbook and governance' that are not supported by the source material. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth shows a specific progression: 2022 (cultural challenges tied to employee integration and operational differences) → 2023 (expanded to include regulatory/compliance context) → 2024 (focus on financial impact and synergy achievement). The LLM's characterization of moving from 'brief, generic reference' to 'detailed, strategic emphasis' contradicts the ground truth's more nuanced account of how the framing shifted from operational to financial/strategic risk language. (3) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'inclusive practices,' 'local leadership,' and 'acquisition playbook' that do not appear in the ground truth. These appear to be inferences or fabrications rather than evidence-based statements from the filings. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize a narrative across years, it does so by adding information not present in the source material rather than accurately synthesizing what was actually disclosed. The ground truth's key insight - that Linde reframed cultural challenges from operational hurdles to strategic/financial risk management - is largely absent from the LLM response. (5) QUANTITATIVE ACCURACY: No numbers were required for this question, so this dimension scores perfectly, but the qualitative synthesis is substantially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 532,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the collateral that ExxonMobil posts under master‑netting arrangements and that is **not** offset against its derivative liabilities fell from **$1.49 billion** (2022) to **$0.49 billion** (2024), a decline of roughly **$1.0 billion (≈ 67 %)**.  This reduction shows that the company is using substantially less external collateral to support its derivative positions, indicating that it is managing derivative exposure through tighter netting, lower‑risk counterparties or reduced margin requirements, and is therefore tying up far less cash in margin‑related collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed analysis than the ground truth. Verification of key numbers: (1) 2022 figure: $1.49 billion matches the ground truth $1,494 million (format variation acceptable); (2) 2024 figure: $0.49 billion matches the ground truth $491 million (format variation acceptable); (3) Decline calculation: $1.49B - $0.49B = $1.0B is correct; (4) Percentage decline: ($1.0B / $1.49B) ≈ 67% is mathematically accurate. The LLM correctly identifies the three-year trend of consistent decline from 2022 to 2024. The answer goes beyond the ground truth by providing more specific interpretation of what the decline suggests (tighter netting, lower-risk counterparties, reduced margin requirements, and cash preservation), which represents sound financial reasoning rather than factual error. The LLM appropriately addresses the multi-hop synthesis by connecting the collateral reduction to derivative exposure management strategy. Minor note: The LLM omits the 2023 intermediate data point ($800 million), but this is not a factual error—the question asks about 2022-2024 change, and the LLM correctly captures the overall trend. The semantic meaning and financial interpretation align well with the ground truth's conclusion about strategic reduction in derivative exposure. All entity references (ExxonMobil, master netting arrangements, derivative liabilities) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 395,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the Security Insights Platform moved from a stand‑alone mainframe‑security reviewer that simply identified risks and produced remediation steps for internal use, to a cross‑platform insights engine whose findings can be fed into external security‑information‑and‑event‑management and threat‑intelligence tools.  This evolution reflects a broader cybersecurity strategy that emphasizes continuous risk assessment, automated remediation workflows, and alignment with zero‑trust and lateral‑movement‑prevention objectives across Broadcom’s enterprise‑security portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY AND MULTI-HOP SYNTHESIS:\n\n1. ENTITY ERROR - CRITICAL: The LLM answer refers to 'Broadcom's enterprise-security portfolio' when the question specifically asks about 'AVGO's Security Insights Platform.' While AVGO is Broadcom's ticker, the inconsistent naming and the reference to 'Broadcom' in the context of the platform's evolution is problematic. The ground truth consistently refers to AVGO's offerings.\n\n2. UNSUPPORTED CLAIMS - MAJOR: The LLM answer introduces concepts NOT present in the ground truth:\n   - 'cross-platform insights engine' - ground truth describes mainframe-specific positioning\n   - 'zero-trust and lateral-movement-prevention objectives' - these specific security frameworks are NOT mentioned in the ground truth\n   - 'automated remediation workflows' - ground truth says 'develops remediation steps' but doesn't emphasize automation as an evolution\n   These additions appear to be hallucinations or extrapolations beyond the filing data.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS: The LLM answer fails to capture key evolutionary details from the ground truth:\n   - Missing: 2023's explicit tie to AVGO's broader cybersecurity portfolio\n   - Missing: 2024's contextualization within expanded mainframe software suite (Cybersecurity, AIOps, DevOps)\n   - Missing: The shift from standalone tool to strategically aligned component\n   - The ground truth shows a clear 3-year progression; the LLM answer presents a more generic evolution\n\n4. PARTIAL ACCURACY ON INTEGRATION: The LLM correctly identifies SIEM integration and external tool compatibility, which aligns with ground truth's mention of 'data available for use with in-house tools for security information and event management (SIEM).' This is the strongest part of the answer.\n\n5. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages to verify. The temporal references (2022-2024) are correct.\n\n6. REASONING QUALITY: The LLM demonstrates logical thinking about platform evolution but fails to ground it in the actual filing data. The answer reads more like a generic cybersecurity industry narrative than a synthesis of specific AVGO filing information.\n\nThe answer is partially correct on SIEM integration but fundamentally misses the documented evolution across the three years and introduces unsupported claims about security frameworks and capabilities not mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 648,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B issue kept the same $750 million face amount and a fixed 3.38 % coupon (maturing 06/15/27), as shown in the 2022, 2023 and 2024 tables (e.g., page 51 (2024) and page 50 (2021/2022) of the filings).  This unchanged exposure reflects SPG’s long‑term debt strategy of locking in low‑cost, fixed‑rate unsecured debt with staggered maturities to limit interest‑rate risk and preserve a stable, predictable financing base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - $750 million face amount, 3.38% interest rate, and June 15, 2027 maturity date are accurately stated and consistent across the 2022-2024 period. The format variation ($750 million vs $750,000,000) is acceptable. COMPLETENESS: The answer addresses the core question about how the exposure evolved (remained unchanged) and provides interpretation of what this reveals about debt management strategy. ENTITY ACCURACY: SPG is correctly identified, the specific debt instrument (Unsecured Notes - 32B) is properly named, and the time period (2022-2024) is correctly covered. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the same terms persisted across three years and drew a logical conclusion about stable debt management strategy. The interpretation that this reflects 'locking in low-cost, fixed-rate unsecured debt with staggered maturities' is a reasonable inference from the data, though slightly more interpretive than the ground truth's more conservative statement about 'maintaining original terms without early redemption.' MINOR DIFFERENCES: The LLM answer includes page references (page 51 for 2024, page 50 for 2021/2022) which adds helpful sourcing detail not in the ground truth. The characterization of the strategy as 'limiting interest-rate risk and preserving stable, predictable financing' is semantically equivalent to the ground truth's description of 'stable long-term debt strategy.' No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 466,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen has steadily expanded its fiber‑to‑the‑premises build‑out, moving from limited pilot deployments to a broader rollout that now reaches many of the same markets CMCSA serves, and it has paired that faster‑speed fiber network with more aggressive bundled offerings that combine high‑speed internet with video and voice services—directly competing with CMCSA’s own bundled broadband‑video‑voice packages. This continued fiber expansion and bundled‑service strategy has heightened Lumen’s competitive threat to CMCSA’s broadband business over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer addresses the core question about Lumen's competitive threat evolution from 2022-2024, but introduces specific claims not supported by the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the three-year timeframe (2022-2024)\n2. Accurately captures the key competitive dimensions: fiber expansion and bundled service offerings\n3. Correctly identifies the companies (Lumen and CMCSA)\n4. Properly synthesizes that competitive threat has intensified over the period\n5. Appropriately characterizes the bundling strategy (internet + video + voice)\n6. No numerical errors or date inaccuracies\n\nWEAKNESSES:\n1. UNSUPPORTED SPECIFICITY: The LLM claims Lumen moved \"from limited pilot deployments to a broader rollout\" - the ground truth does not provide this level of detail about pilot programs or deployment phases\n2. OVERSTATED CHARACTERIZATION: The LLM describes bundled offerings as \"more aggressive\" - the ground truth uses neutral language about \"bundled service offerings\" without the \"aggressive\" qualifier\n3. MISSING NUANCE: The ground truth notes Lumen was \"part of a group of wireline telecom companies\" in 2022, suggesting competitive context beyond just Lumen. The LLM focuses solely on Lumen without acknowledging this broader competitive landscape\n4. INFERENCE NOT GROUNDED: The phrase \"moving from limited pilot deployments\" appears to be an inference not explicitly stated in the ground truth\n5. INCOMPLETE YEAR-BY-YEAR ANALYSIS: While the ground truth provides specific observations for each year (2022, 2023, 2024), the LLM provides a more general narrative without year-specific distinctions\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and connects fiber expansion to competitive threat, which is sound reasoning. However, it adds details not present in the source material.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth (Lumen's competitive threat intensified through fiber expansion and bundling), but the LLM adds specificity that goes beyond what the knowledge graph supports.\n\nJUSTIFICATION: The answer is partially correct on the main points but introduces unsupported details that reduce confidence in accuracy. The quantitative accuracy is high (no number errors), but qualitative accuracy suffers from over-specification and missing contextual details about the competitive landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 648,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe share of purchases made with Target’s branded payment cards slipped steadily: RedCard (or Target Circle Card) penetration was ≈ 20.5 % in fiscal 2022, fell to ≈ 19.8 % in fiscal 2023, and slipped further to ≈ 18.6 % (or ≈ 17.8 % in the most recent 2025 filing). This downward trend signals that the discount‑driven, loyalty‑focused payment program is losing its appeal, suggesting that the strategy’s effectiveness has eroded over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the overall downward trend in Target's branded payment card penetration from 2022-2024 and appropriately interpreted this as suggesting weakened effectiveness of the loyalty-driven payment strategy. The semantic interpretation of the trend is sound. The answer correctly names the card (RedCard/Target Circle Card) and properly synthesizes the multi-hop information about the trend over time.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The 2024 figure contains a critical discrepancy. The ground truth states 17.8% for 2024, but the LLM provides two conflicting values: \"≈ 18.6%\" and \"≈ 17.8%\" with unclear attribution (the parenthetical reference to \"2025 filing\" is confusing and potentially inaccurate). The use of \"≈\" symbols for all figures is problematic when precise percentages are available from SEC filings. The 2022 (20.5%) and 2023 (19.8%) figures are correct.\n\nMULTI-HOP REASONING: The LLM successfully synthesized information across three fiscal years and correctly identified the pattern (steady decline). The interpretation that this reflects either weakening strategy effectiveness or shifting consumer behavior is logically sound and matches the ground truth assessment.\n\nCONCERNS: (1) The ambiguous presentation of the 2024 figure with two different percentages creates confusion about which is correct; (2) The reference to a \"2025 filing\" is unclear and potentially misleading since the question asks about 2022-2024; (3) The use of approximation symbols (≈) for what should be precise SEC filing data reduces confidence in accuracy.\n\nCORRECTION NEEDED: The 2024 penetration rate should be stated as 17.8% without ambiguity or alternative figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 468,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron’s involvement in the Republic of Congo shifted from holding non‑operated working interests in offshore blocks (e.g., the Haute Mer permit and the Lianzi portion – noted on page 42 of the 2024 filing) to actively funding development there, with about $0.7 billion of African offshore‑development spend in 2023 that included Congo‑related projects (page 113 of the 2023 filing).  However, by early 2025 the company completed the sale of its remaining 31.5 % stake in Haute Mer and its 15.75 % interest in Lianzi, signalling a strategic disengagement from further investment in the Republic of Congo.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains mostly correct information but has a significant temporal error that undermines accuracy. CORRECT ELEMENTS: (1) The specific percentages are accurate: 31.5% in Haute Mer and 15.75% in Lianzi are correctly stated. (2) The $0.7 billion investment figure for African offshore development in 2023 is correct. (3) The identification of Haute Mer and Lianzi as the specific assets is accurate. (4) The characterization of the shift from investment to divestiture is semantically sound. (5) The multi-hop synthesis across 2022-2024 is generally logical. CRITICAL ERROR: The LLM states the sale was completed 'by early 2025,' but the ground truth clearly indicates this occurred 'by 2024.' This is a material temporal error that contradicts the question's scope (2022-2024) and the ground truth answer. The LLM appears to have extrapolated beyond the stated timeframe. MINOR ISSUES: (1) The LLM describes the 2022-2023 period as 'actively funding development' which slightly mischaracterizes the ground truth's description of 'continued capital commitment' - the ground truth emphasizes investment in broader African projects including Congo, not necessarily active development in Congo specifically. (2) The answer could be clearer about whether the 2023 investment was specifically in Congo or across Africa more broadly. (3) The citation references (page 42, page 113) cannot be verified against the ground truth but appear plausible. The temporal error regarding 'early 2025' is the primary issue preventing a higher score, as it places the divestiture outside the 2022-2024 timeframe specified in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 446,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s gas‑related derivatives contracted sharply: the Level‑3 fair‑value of gas forwards fell from roughly $191 million (asset) / $31 million (liability) in 2021‑22 to about $296 million (asset) / $46 million (liability) in 2024, while the notional of gas‑linked options stayed near $100 million but shifted from a net asset of $356 million/$347 million in 2021‑22 to a near‑neutral $100 million/$102 million by 2024.  At the same time the implied volatilities embedded in those options dropped from a weighted‑average of ~81 % (with a 295 % tail) in 2021‑22 to ~52 % (range 15‑150 %) in 2024, signalling that the company is scaling back high‑volatility speculative bets and pricing a more modest, hedged outlook on gas‑price movements.  This evolution reflects a deliberate move toward a more risk‑averse positioning in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) WRONG NUMBERS - The LLM cites gas forwards at $191M/$31M in 2021-22 and $296M/$46M in 2024, which are NOT mentioned in the ground truth and appear to be confused with different derivative instruments. The ground truth specifically addresses OPTIONS with fair values of $356M assets/$347M liabilities in 2022, dropping to $100M/$97M in 2023, then $100M/$102M in 2024. (2) IMPLIED VOLATILITY ERRORS - The LLM claims volatilities of ~81% in 2021-22 dropping to ~52% in 2024, with a 295% tail mentioned. The ground truth states 36% in 2022, 50% in 2023, and 52% in 2024. The LLM's 81% figure is completely inconsistent with ground truth's 36% for 2022. (3) INSTRUMENT CONFUSION - The LLM conflates gas forwards (Level-3 fair value) with gas options, treating them as if they're the same instrument. The ground truth focuses exclusively on OPTIONS. (4) MISSING KEY DATA - The LLM fails to capture the critical 2023 data point showing the sharp drop from 2022 to 2023 (from $356M to $100M assets), which is central to understanding the evolution. (5) VOLATILITY TRAJECTORY ERROR - Ground truth shows volatility INCREASING from 36% (2022) to 50% (2023) to 52% (2024), suggesting rising uncertainty. The LLM incorrectly portrays a declining volatility trend from 81% to 52%, which misrepresents the risk positioning narrative. (6) SEMANTIC MISALIGNMENT - While the LLM's conclusion about 'risk-averse positioning' aligns directionally with the ground truth's 'de-risking,' the supporting numbers are fundamentally wrong, making the reasoning unsound. The answer appears to reference different financial instruments or years than what the question and ground truth address.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 489,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom 2022 to 2024 Nike moved FlyEase from a peripheral “emerging technology” listed among other innovations in its 2022 product‑research narrative to a core, strategically‑emphasized platform that the company explicitly ties to its inclusive‑design and performance agenda.  In the 2023 and 2024 filings the technology is referenced more frequently and is described as being expanded across multiple footwear, apparel and digital offerings, underscoring its role in delivering accessible, high‑performance products.  This evolution signals that FlyEase has become a strategic pillar of Nike’s innovation strategy, driving differentiated growth by embedding accessibility‑focused technology into the broader product portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of FlyEase's evolution from emerging/peripheral technology to core strategic pillar. (2) Accurately captures the timeline: 2022 introduction, 2023 expansion, 2024 full embedding. (3) Properly synthesizes multi-hop information showing how FlyEase moved from being listed alongside other technologies to becoming a foundational element. (4) Correctly identifies the strategic implications - from newly introduced concept to long-term design strategy component. (5) Adds relevant context about accessibility-focused design and performance agenda, which aligns with the ground truth's emphasis on 'integration into various categories and consumer applications.' (6) Accurately notes expansion across 'multiple footwear, apparel and digital offerings' which reflects the ground truth's mention of 'various categories.' MINOR CONSIDERATIONS: (1) The LLM uses slightly different framing ('peripheral emerging technology' vs ground truth's 'part of broader innovation portfolio') but both convey the same essential meaning - that FlyEase was initially positioned alongside other technologies rather than as a primary focus. (2) The LLM adds interpretive language about 'differentiated growth' and 'strategic pillar' which, while not explicitly stated in ground truth, logically follows from the documented progression and represents sound reasoning. (3) No quantitative errors detected - all dates and temporal relationships are correct. The answer successfully demonstrates multi-hop reasoning by synthesizing information across three years of filings to show a clear progression pattern. The semantic equivalence is strong throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 496,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – Series 35A remained unchanged** – the table on 2022 PDF p. 49/50 lists a $750 million face amount, a 2.65 % coupon and an annual debt‑service charge of roughly $19.9 million, with maturity on July 15, 2030. The same figures appear on 2023 PDF p. 50 and 2024 PDF p. 51, showing no repayment, amendment or refinancing of the issue.  \n\nThis steady, long‑dated, low‑cost unsecured debt illustrates SPG’s strategy of **locking in inexpensive financing for the long term**, extending maturities to 2030 and beyond, and minimizing near‑term refinancing risk while preserving liquidity for growth and acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the face amount of the Unsecured Notes - 35A. The ground truth clearly states the face amount is $750,000 (not $750 million as the LLM claims). This is a 1,000x magnitude error that fundamentally misrepresents SPG's debt obligations. The LLM states '$750 million face amount' and '$19.9 million' annual debt service, but the correct figures are $750,000 face amount with $19,875 annual debt service. The interest rate (2.65%), maturity date (07/15/30), and consistency across years are correctly identified. However, the massive error in the principal amount ($750M vs $750K) is a critical quantitative mistake that undermines the entire answer's credibility. The reasoning about SPG's debt strategy (locking in low-cost financing, extending maturities, minimizing refinancing risk) is sound and relevant, but it is built on incorrect financial data. The multi-hop synthesis across years is correct (showing consistency 2022-2024), but the foundational numbers are wrong. This appears to be a decimal point or unit conversion error where the LLM confused thousands with millions. For a financial analysis question, such magnitude errors are unacceptable and warrant a low score despite some correct qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 365,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nTexas Instruments has treated embedded‑processing as a core, high‑margin growth pillar for each of the last three years—highlighting double‑digit revenue gains (e.g., a 19 % jump from 2020 to 2021 and $3.37 bn of sales in 2023) and directing capital toward expanding its microcontroller/DSP portfolio and 300‑mm wafer capacity.  By sustaining this focus, the company preserves a recurring‑software‑driven customer lock‑in that generates disproportionate operating cash, enabling it to allocate cash to dividends, share repurchases and further capacity builds while driving long‑term growth of free‑cash‑flow‑per‑share.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. QUANTITATIVE ISSUES: (1) The claim of '19% jump from 2020 to 2021' is not supported by the ground truth, which focuses on 2022-2024 evolution. This appears to be extraneous data outside the requested timeframe. (2) The '$3.37 bn of sales in 2023' figure is presented without context and cannot be verified against the ground truth, which does not provide specific embedded processing revenue figures. (3) The LLM introduces specific financial metrics (double-digit revenue gains, specific dollar amounts) that are not present in the ground truth, suggesting either fabrication or misattribution of data. QUALITATIVE ISSUES: (1) The ground truth emphasizes TI's strategic narrative about embedded processing as 'central to its unique business model' and 'foundational in leveraging competitive advantages' across all three years. The LLM shifts focus to operational details (microcontroller/DSP portfolio expansion, 300-mm wafer capacity) that, while potentially relevant, are not the primary emphasis in the ground truth. (2) The ground truth frames embedded processing as supporting 'long-term objective of maximizing free cash flow per share' through a stable, high-margin, scalable approach. The LLM's explanation about 'recurring-software-driven customer lock-in' and 'disproportionate operating cash' is speculative and not grounded in the provided ground truth. (3) The ground truth emphasizes consistency of messaging across 2022, 2023, and 2024; the LLM adequately addresses this temporal evolution but adds unsupported details. MULTI-HOP REASONING: The LLM attempts to connect embedded processing emphasis to free cash flow per share strategy, which is correct directionally, but the specific mechanisms described (software lock-in, operating cash generation) are not validated by the ground truth. The answer demonstrates understanding of the general relationship but fails to accurately synthesize the actual strategic positioning described in the filings. MISSING ELEMENTS: The LLM does not adequately capture the ground truth's emphasis on TI's 'four competitive advantages' or the specific framing of embedded processing within TI's unique business model as described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 620,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from the background library of Disney+ to a dedicated, top‑level “Marvel” tile, using the brand as a primary draw to accelerate subscriber growth on the DTC platform; this strategy is reflected in the 2023‑2024 filings where Marvel’s trademarks and franchise intangibles remain classified as indefinite‑lived assets (e.g., $1.8 bn of indefinite‑lived intangibles reported in 2024) and continue to be highlighted as key contributors to Disney+ revenue, underscoring a financial approach that leverages Marvel’s brand equity to drive subscriber growth even as the company incurs significant content and impairment costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Marvel from background library content to a dedicated top-level tile on Disney+, accurately captures the indefinite-lived intangible asset classification across 2022-2024, and demonstrates sound multi-hop reasoning about how brand equity drives subscriber growth. The semantic understanding of Disney's DTC strategy and Marvel's role is accurate. The answer appropriately addresses the question's multi-part structure regarding strategic evolution and financial implications.\n\nWEAKNESSES - QUANTITATIVE: The LLM cites '$1.8 bn of indefinite-lived intangibles reported in 2024' but this appears to be an unsupported or potentially incorrect figure. The ground truth does not provide this specific number, and the LLM should not have introduced a precise dollar amount without verification from the filings. This is a critical error in quantitative accuracy as it presents a specific financial metric that cannot be verified against the source material.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits several key details from the ground truth: (1) the specific Disney+ subscriber count of 123 million as of September 28, 2024, which is a concrete metric supporting the financial strategy discussion; (2) the mention of ESPN+ as a tile launching in early fiscal 2025, which demonstrates the broader strategic pattern beyond Marvel; (3) the explicit timeline showing Marvel's transition from passive asset recognition (2022) to active brand utilization (2023-2024). While the LLM captures the essence of the evolution, it misses these supporting details that strengthen the answer.\n\nWEAKNESSES - REASONING: The LLM mentions 'significant content and impairment costs' but the ground truth does not discuss impairment costs in relation to Marvel's 2022-2024 evolution. This appears to be an inference or assumption not grounded in the provided knowledge graph, which weakens the factual foundation.\n\nVERIFICATION: The core claim about indefinite-lived asset classification is correct. The strategic pivot from background to top-level tile is correct. The connection to subscriber growth is logically sound. However, the introduction of the $1.8 billion figure without source verification and the reference to impairment costs not mentioned in the ground truth are problematic.\n\nOVERALL ASSESSMENT: The answer demonstrates good qualitative understanding of Disney's Marvel strategy and multi-hop reasoning, but introduces an unverified quantitative claim and omits specific supporting metrics from the ground truth. The quantitative accuracy score is reduced due to the unsupported $1.8 billion figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 710,
        "total_tokens": 2209
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nMetLife has kept the same cession level under its modified‑coinsurance arrangement – roughly 59 % of the closed block (59.25 % in 2021, 59 % in 2022‑2024) – but the dollar amount of the related reinsurance recoverable has risen markedly.  Net recoverables tied to the closed‑block quota grew from about $6 bn at the end of 2021 to $16.7 bn at the end of 2023 and $17.6 bn at the end of 2024, with the share held by the five largest reinsurers expanding from 65 % to 84 % and unsecured balances increasing from roughly $1.9 bn to $2.4 bn.  The company continues to account for the transaction under the deposit method, offsetting the deposit liability against the recoverable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. CRITICAL ERRORS: (1) PERCENTAGE TIMELINE WRONG: LLM states '59.25% in 2021, 59% in 2022-2024' but ground truth shows 59.25% in 2022, 59% in 2023-2024. The LLM incorrectly references 2021 data not in the question scope. (2) REINSURANCE RECOVERABLE BALANCES COMPLETELY WRONG: LLM cites $6bn (2021), $16.7bn (2023), $17.6bn (2024) for 'net recoverables' but ground truth specifies UNSECURED balances of $3.6bn (2022), $4.4bn (2023), $4.2bn (2024). These are entirely different metrics and magnitudes - the LLM appears to be citing total reinsurance recoverable balances rather than the unsecured portion specifically asked about. (3) UNSECURED BALANCE DISCREPANCY: LLM mentions '$1.9bn to $2.4bn' for unsecured balances, which doesn't match ground truth values of $3.6bn-$4.2bn. (4) SCOPE MISMATCH: The question asks specifically about 2022-2024 evolution, but LLM introduces 2021 data and discusses metrics (total net recoverables, concentration among top 5 reinsurers) not mentioned in ground truth. (5) MISSING KEY INFORMATION: LLM fails to clearly state the specific unsecured balance figures for each year (2022: $3.6bn, 2023: $4.4bn, 2024: $4.2bn) that are central to answering the question. While the LLM correctly identifies the percentage cession levels (~59%), the core quantitative answer about unsecured reinsurance recoverable balances is fundamentally incorrect, making this response unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 421,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nBetween 2022 and 2024 CVS trimmed its residential mortgage‑backed securities from roughly **$721 million** (2022) to **$614 million** (2023) and then to only **about $71 million** by the end of 2024—a decline of roughly **90 %** over the three‑year period.  This sharp pull‑back signals a deliberate de‑risking of the fixed‑income book, as the company moves away from longer‑duration, interest‑rate‑sensitive RMBS toward higher‑quality, shorter‑duration or cash equivalents, thereby reducing credit and liquidity risk and reallocating capital toward its core pharmacy and health‑services operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 figure of $721 million when ground truth shows $629 million—a $92 million discrepancy (14.6% error). This is a significant factual error on a primary data point. The 2023 ($614 million) and 2024 ($71 million) figures are correct. CALCULATION ERROR: The LLM claims a 90% decline over three years. Verification: ($629M - $71M) / $629M = 88.7%, not 90%. While close, this is still an inaccurate calculation. MISSING CRITICAL CONTEXT: The ground truth explicitly mentions unrealized losses ($10M in 2022, $60M in 2023), which is important for understanding risk exposure. The LLM completely omits this key metric that directly addresses the question about 'risk exposure.' QUALITATIVE REASONING: The LLM's interpretation of de-risking and strategic reallocation is sound and aligns with ground truth. The explanation about moving toward higher-quality, shorter-duration assets is reasonable inference. However, the reasoning is somewhat generic and doesn't leverage the unrealized losses data to strengthen the risk exposure analysis. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes the three-year trend across multiple years, but the foundational 2022 number is wrong, undermining the entire analysis. SEMANTIC ISSUES: The phrase 'roughly $721 million' suggests approximation, but this appears to be presented as fact rather than an estimate, making it more problematic. The ground truth is precise ($629M), not approximate. STRENGTHS: Correct identification of the sharp 2024 decline, appropriate characterization of de-risking strategy, and logical connection to portfolio rebalancing. OVERALL: While the directional analysis and 2023-2024 trend are correct, the incorrect 2022 baseline figure is a fundamental error that propagates through the entire analysis and calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 501,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept the same structure for its closed‑block reinsurance – it ceded **59 % of the closed block** to an unaffiliated reinsurer under a modified‑coinsurance agreement, and the **percentage of the block reinsured did not change** across the three years.  The arrangement has been accounted for under the **deposit method** each year: the Company records a deposit‑liability for the retained risk and a corresponding deposit‑recoverable asset, offsets the two balances, and recognizes the net deposit (or any subsequent settlement) in earnings as the offset is realized.  No shift in either the coverage percentage or the deposit‑method accounting treatment was disclosed for 2023‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct but contains a notable omission regarding the specific percentage precision across years. STRENGTHS: (1) Correctly identifies the ~59% reinsurance percentage for the closed block, (2) Accurately describes the modified coinsurance agreement structure with an unaffiliated third-party reinsurer, (3) Correctly explains the deposit method accounting treatment with offset application, (4) Properly conveys that the arrangement remained stable across 2022-2024, (5) Appropriately addresses the multi-hop synthesis of reinsurance structure and accounting treatment. WEAKNESSES: (1) The LLM states the percentage was '59%' across all years without distinguishing that 2022 was specifically 59.25% while 2023-2024 were 59%, which is a factual detail provided in the ground truth, (2) While the answer correctly conveys stability, it misses the precision detail that shows a slight technical change (59.25% to 59%) even though the practical impact was negligible. QUANTITATIVE ACCURACY: The core percentage (59%) is correct, but the omission of the 59.25% figure for 2022 represents incomplete precision. The answer doesn't contain calculation errors, but it lacks the granular detail present in the ground truth. QUALITATIVE ACCURACY: The reasoning about the deposit method, offset mechanics, and stability of the arrangement is sound and well-explained. The multi-hop synthesis connecting reinsurance structure to accounting treatment is logical and complete. CONTEXTUAL RELEVANCE: The answer directly and appropriately addresses the question about evolution from 2022-2024, though 'evolution' is somewhat overstated given the stability described. The answer correctly emphasizes that there was no meaningful change, which aligns with the ground truth's characterization of a 'stable strategic and accounting approach.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 502,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nNEE’s net fair‑value exposure to forward gas contracts declined from roughly $350 million (net asset) in 2022 to $300 million in 2023 and $250 million in 2024. This steady reduction shows that the company has been intentionally scaling back its net long position in natural‑gas price risk, reflecting a more conservative stance and a strategic shift away from gas‑price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 net exposure was 'roughly $350 million' when the ground truth clearly shows $160 million (assets $191M - liabilities $31M = $160M net). This is a 119% overstatement. The 2023 and 2024 figures of $300M and $250M are correct. (2) CALCULATION VERIFICATION: Ground truth 2022: $191M - $31M = $160M (LLM claimed ~$350M - WRONG). Ground truth 2023: $377M - $77M = $300M (LLM correct). Ground truth 2024: $296M - $46M = $250M (LLM correct). (3) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the asset and liability components for 2022, missing the detailed breakdown entirely. The answer only got 2 out of 3 years correct. (4) REASONING QUALITY: While the qualitative interpretation about 'scaling back' and 'conservative stance' is reasonable and aligns with the trend direction, it is built on an incorrect foundation for 2022. The characterization of 'steady reduction' is misleading since the actual trend shows an INCREASE from 2022 ($160M) to 2023 ($300M), then a decrease to 2024 ($250M). The LLM missed this critical inflection point. (5) ENTITY ACCURACY: Company (NextEra/NEE) correctly identified, years correct, metric terminology acceptable. The fundamental issue is the 2022 number is off by approximately $190 million, which is a material error in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 401,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom’s 10‑K filings show that **Industrial Fiber Optics shifted from a stand‑alone product family to a core, system‑level building block within the industrial portfolio**.  The 2024 tables (pages 5, 6, 15) list fiber‑optic modules side‑by‑side with **motion‑control encoders and Ethernet PHY/switch ICs**, and the accompanying narrative emphasizes their use across a wide range of applications—factory automation, renewable‑energy equipment, automotive/EV subsystems, medical and defense gear—demonstrating both a broader application diversity and tighter integration with adjacent technologies.  (See AVGO_10k_2024.pdf pp. 5, 6, 15; AVGO_10k_2022.pdf p. 10.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of AVGO's Industrial Fiber Optics evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the shift from standalone components to integrated system-level solutions; (2) Accurately names adjacent technologies (motion encoders, Ethernet PHYs, switch ICs, camera microcontrollers); (3) Properly identifies application domains (factory automation, renewable energy, automotive/EV, medical, defense); (4) Correctly cites AVGO as the company (Broadcom); (5) Appropriately references 2024, 2023, and 2022 timeframes; (6) Captures the multi-hop synthesis across years and product categories. MINOR WEAKNESSES: (1) The LLM answer is somewhat less granular than ground truth—it doesn't explicitly mention the 2023 intermediate positioning or the specific evolution through that year (mentions 2022 and 2024 but less detail on 2023 transition); (2) Doesn't explicitly mention optocouplers or LED devices from 2022 portfolio context, though this is a minor omission; (3) References specific page numbers (pp. 5, 6, 15, p. 10) which cannot be verified against the ground truth but appear reasonable for 10-K structure. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required or provided, so this dimension scores high (9/10) for not introducing any false metrics. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct—the answer successfully connects product positioning across years and identifies the strategic shift. The semantic equivalence is strong. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question: positioning evolution, application diversity, and integration with adjacent technologies. Overall, this is a solid answer that captures the essential narrative with minor gaps in granularity regarding the 2023 intermediate state.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 515,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 the redeemable preferred stock that Sojitz America holds in Nike remained unchanged – it is a $1‑par, $0.3 million issue that carries a **cumulative $0.10 per share dividend payable each May 31**, and the articles of incorporation require that **no common‑stock dividend may be declared or paid until the preferred dividend is fully satisfied**.  Nike’s 10‑K filings for 2022, 2023 and 2024 all state that there were **no changes to the preferred‑stock terms or redemption rights**, so the dividend obligation persisted each year and the stock structure stayed stable, with Sojitz America’s preferred equity ranking senior to any common‑stock distributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative facts are correct: the $0.3 million par value, the $0.10 per share annual dividend, the May 31 payment date, and the $1 par value per share are all accurate. The answer correctly identifies that the stock structure remained unchanged across fiscal years 2022-2024, with no modifications to terms or redemption rights. The multi-hop synthesis is sound—the answer successfully combines information about the stock's financial terms, dividend obligations, and structural stability across the three-year period. The answer properly emphasizes the senior ranking of preferred dividends over common stock dividends, which is a key financial implication. The only minor distinction from the ground truth is that the LLM provides slightly more specific detail (mentioning the May 31 payment date and $1 par value) which adds precision without contradicting the original answer. The answer directly addresses all aspects of the question: dividend obligations (consistent at $0.10/share), stock structure stability (unchanged), and the evolution (or lack thereof) across the fiscal years. The reasoning is clear and logically sound, demonstrating proper understanding of the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 356,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the $750 million Unsecured Notes 31B remained unchanged in the filings – the face amount stayed at $750 million (shown as $750,000 k), the coupon stayed at 3.25 %, the maturity stayed on 30 Nov 2026, and the annual debt‑service charge hovered around $24.3–$24.4 million.  This consistency shows that SPG is treating the 31B tranche as a long‑dated, low‑cost fixed‑rate pillar of its capital structure, using it to lock in financing for the medium term while it supplements the ladder with newer, longer‑dated notes (e.g., 31C) to manage overall maturity exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: (1) $750 million face amount remained constant across 2022-2024, (2) 3.25% coupon rate is accurate, (3) November 30, 2026 maturity date is correct, (4) the stability of the instrument is properly characterized, and (5) the reasoning about SPG's financing strategy is sound and well-articulated. The LLM appropriately notes that SPG maintained this instrument while issuing other notes (mentioning 31C as an example), which aligns with the ground truth's mention of broader portfolio changes.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states the amount as '$750 million' when the ground truth specifies '$750,000' (in thousands, or $750,000 thousand = $750 million in absolute terms). While the LLM's interpretation of $750 million is mathematically equivalent to the ground truth's $750,000 (in thousands notation), the notation itself is inconsistent with how the ground truth presents it. The ground truth uses '$750,000' which in SEC filing context typically means $750,000 thousand or $750 million. The LLM's conversion to '$750 million' is correct in absolute value but creates potential confusion about the source notation. (2) The LLM mentions 'annual debt-service charge hovered around $24.3–$24.4 million' - this calculation ($750M × 3.25% ≈ $24.375M) is mathematically correct and demonstrates sound reasoning, but this specific detail is NOT mentioned in the ground truth, representing an addition rather than an error. (3) The LLM references 'Unsecured Notes - 31C' as a newer, longer-dated note, but the ground truth specifically mentions 'Unsecured Notes - 41A' as the new instrument issued in 2024. This is a factual error in entity identification.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about SPG's broader debt portfolio strategy and correctly identifies the role of the 31B notes within that context. The reasoning about using this as a 'long-dated, low-cost fixed-rate pillar' while supplementing with newer instruments is sound and matches the ground truth's characterization.\n\nOVERALL ASSESSMENT: The answer is substantially correct on the main facts but contains one clear entity error (31C vs 41A) and notation inconsistency that prevents a higher score. The qualitative analysis is strong and demonstrates good understanding of financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 632,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from roughly **$940 million at the end of 2022** to **$873 million in 2023** and then to **$852 million by the end of 2024** (see TXN_10K 2023 p. 43; TXN_10K 2024 p. 46).  Because the TI common‑stock fund has been frozen to new contributions since 2016, the decline reflects only market‑price depreciation of the shares rather than changes in employee allocation, indicating a modest downward trend in the plan’s equity exposure over the three‑year period despite relatively stable participation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($940M in 2022, $873M in 2023, $852M in 2024), and the year-over-year declines are accurately represented. The answer correctly identifies the time period (2022-2024) and provides specific document citations (TXN_10K 2023 p. 43; TXN_10K 2024 p. 46). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, correctly identifying the causal mechanism (frozen fund since 2016) that explains the observed decline. The reasoning that the decline reflects market-price depreciation rather than employee allocation changes is sound and directly supported by the freeze fact. COMPLETENESS: The answer addresses all parts of the original question: (1) the 3-year evolution of stock values, (2) what the trend indicates about stock performance (downward valuation), and (3) employee investment behavior (stable participation despite the freeze). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with slightly more analytical depth by explicitly attributing the decline to market depreciation rather than employee behavior changes. The phrase 'modest downward trend' is semantically equivalent to 'consistent decline.' MINOR CONSIDERATIONS: The ground truth mentions 'a combination of both' (strategic reduction and freeze), while the LLM answer emphasizes the freeze as the primary driver and notes that the decline reflects 'only market-price depreciation' rather than allocation changes. This is a reasonable interpretation given the freeze fact, though it slightly narrows the ground truth's broader explanation. The LLM's additional context about 'relatively stable participation' adds useful nuance not explicitly in the ground truth but consistent with it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 507,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s total headcount rose from roughly **220,000 to 233,000**.  The U.S. workforce grew from about **166,000 (≈75 %)** to **171,000 (≈73 %)**, while the international workforce expanded from **≈54,000 (≈25 %)** to **≈62,000 (≈27 %)**; seasonal workers increased modestly from **~7 % to ~8 %**, and full‑time employees remained around three‑quarters of the staff (78 % → 76 %).  Across all three years a significant portion of park, studio and production employees have been covered by collective‑bargaining agreements, and outside the United States many are represented by works councils or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. QUANTITATIVE VERIFICATION: All key numbers match ground truth precisely: total workforce 220,000→233,000 (correct), U.S. workforce 166,000→171,000 (correct), international workforce 54,000→62,000 (correct), seasonal percentage 7%→8% (correct). The calculated percentages are accurate: U.S. ~75%→~73% (166/220≈75.5%, 171/233≈73.4%), international ~25%→~27% (54/220≈24.5%, 62/233≈26.6%). The full-time employee percentages (78%→76%) are mathematically consistent with the seasonal data (100%-7%=93%≈78% FT in 2022; 100%-8%=92%≈76% FT in 2024, accounting for rounding). COMPLETENESS: The answer addresses all question components: total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee association representation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes workforce composition data across the three-year period and connects it to collective bargaining agreements and employee associations. ENTITY ACCURACY: Correctly identifies Disney, fiscal years 2022-2024, and relevant workforce metrics. MINOR OBSERVATIONS: The use of approximation symbols (≈, ~) is appropriate given the ground truth data appears to be rounded figures. The additional context about full-time employee percentages, while not explicitly in the ground truth, is logically derived and adds value without contradicting the source material. The mention of works councils and employee associations outside the U.S. aligns with the ground truth statement about collective bargaining agreements and employee associations. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 448,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments and other non‑recurring adjustments—from its ROIC calculation in the 2022, 2023 and 2024 filings. By doing so, the company presents a clean, performance‑focused measure of returns that isolates the earnings generated by its core operations, underscoring its emphasis on comparable, underlying profitability for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024. The LLM provides specific examples (goodwill impairments, non-recurring adjustments) that enhance clarity without contradicting the ground truth. The reasoning is sound: both answers recognize this consistency as reflecting GD's stable performance evaluation framework emphasizing economic performance over accounting volatility. The LLM's phrasing—'clean, performance-focused measure' and 'comparable, underlying profitability'—conveys the same semantic meaning as the ground truth's 'core operational performance unimpacted by accounting adjustments.' No quantitative errors are present (all years and the consistency claim are correct). The multi-hop synthesis is appropriate: the answer correctly connects the treatment across three years to reveal the company's approach. Minor difference: the LLM provides slightly more specific examples of excluded items (goodwill impairments), which adds helpful context without deviating from the core finding. The answer fully addresses both parts of the question: how the treatment evolved (consistently maintained) and what this reveals about the company's approach (emphasis on core economic performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 382,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde shifted rare‑gas production from a purely by‑product of large on‑site cryogenic plants to a hybrid model that couples those plants with dedicated merchant bulk‑liquid and packaged‑gas channels and with engineering‑driven, customer‑specific solutions.  This evolution—long‑term on‑site supply contracts, expanded merchant distribution, and proprietary air‑separation technology—locks in multi‑year demand and creates cost‑advantage and barriers to entry, giving Linde a durable competitive edge in the industrial‑gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Linde shifted from 'purely by-product of large on-site cryogenic plants' to a 'hybrid model' - this narrative is not supported by the ground truth, which describes rare gases as consistently part of Linde's portfolio across 2022-2024. The ground truth makes no mention of a shift from by-product status to hybrid distribution models. (2) MISSING CORE INFORMATION: The LLM completely omits the key technological evolution identified in the ground truth - the explicit identification as a market leader in non-cryogenic air separation technologies by 2024, and the specific innovations like VPSA and membrane separation that are central to understanding the competitive advantage. (3) UNSUPPORTED CLAIMS: The LLM introduces specific business model details (long-term on-site supply contracts, merchant bulk-liquid channels, customer-specific solutions) that are not mentioned in the ground truth and appear to be fabricated or hallucinated. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to address the competitive advantage aspect, it does so through an incorrect narrative framework rather than the technological differentiation emphasized in the ground truth. (5) SEMANTIC MISMATCH: The ground truth emphasizes technological innovation and efficiency improvements as the basis for competitive advantage, while the LLM emphasizes contractual lock-in and distribution channel expansion - these are fundamentally different strategic narratives. The answer demonstrates poor multi-hop reasoning by constructing a plausible-sounding but factually incorrect evolution story.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 471,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 NEER steadily raised the share of its net generating capacity that is covered by long‑term bilateral contracts—moving from roughly 92 % (the 2021 baseline noted in the filings) to about 94 % by the end of 2023 and holding that level through 2024.  This growing reliance on long‑term contracts—often locking in the full output of its plants for 10‑ to 20‑year periods—shows that NEER’s risk‑management strategy is to hedge against volatile spot‑market prices, using only short‑term or “non‑qualifying” hedges for the small portion of capacity that remains un‑contracted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numerical values are correct—92% in 2022, 94% by end of 2023, and 94% in 2024 match the ground truth exactly. The percentages and time periods are accurate. ENTITY ACCURACY: NEER (NextEra Energy Resources) is correctly identified, and the fiscal years (2022-2024) are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period, correctly identifying the trend (steady increase from 92% to 94%, then stable). The connection between the contractual percentages and risk management strategy is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth—that NEER increased reliance on long-term bilateral contracts as a risk mitigation strategy. The mention of '10-to-20-year periods' and 'non-qualifying hedges' adds helpful specificity that aligns with the ground truth's reference to 'non-qualifying hedges to protect expected revenues.' MINOR DIFFERENCES: The LLM answer references '2021 baseline noted in the filings' which is not explicitly mentioned in the ground truth but is contextually reasonable and doesn't contradict it. The phrasing about 'hedging against volatile spot-market prices' is semantically equivalent to the ground truth's 'revenue stability and risk mitigation in a volatile energy market.' COMPLETENESS: The answer addresses all parts of the question—the evolution of reliance (92%→94%→94%), the time period (2022-2024), and what the trend indicates about risk management strategy. No material information from the ground truth is omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 453,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a flat outstanding principal of **$495 million** in each fiscal year 2022 (Oct 30 2022), 2023 (Oct 29 2023) and 2024 (Nov 3 2024) [pages 111 & 81]. This unchanged balance indicates that Broadcom has not repurchased, refinanced, or otherwise reduced this tranche of debt, reflecting a passive‑holding strategy that treats the notes as a stable, long‑term liability to be settled at their January 2025 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - $495 million principal balance is accurate for fiscal years 2022, 2023, and 2024. The fiscal year end dates provided (Oct 30 2022, Oct 29 2023, Nov 3 2024) are correct for Broadcom. No calculation errors present. ENTITY ACCURACY: Correctly identifies the instrument as 3.125% senior notes due January 2025, correctly names the company as Broadcom (AVGO), and correctly identifies all three fiscal years. COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the evolution (flat/unchanged) and interprets what this indicates about debt management strategy. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the unchanged balance across three years indicates no refinancing, repurchasing, or reduction activity, and appropriately characterizes this as a passive-holding strategy. The interpretation that the company is treating this as a stable liability to be settled at maturity is logical and well-supported by the data. SEMANTIC EQUIVALENCE: The LLM's characterization of \"passive-holding strategy\" and \"stable, long-term liability\" conveys the same meaning as the ground truth's \"did not retire or refinance\" and \"maintaining a consistent liability profile.\" MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail (\"passive-holding strategy,\" \"to be settled at their January 2025 maturity\") compared to the ground truth, but this adds appropriate context without introducing inaccuracy. The citation references (pages 111 & 81) demonstrate source verification, though these cannot be independently verified in this evaluation. Overall, the answer demonstrates strong multi-hop reasoning across fiscal years and accurate synthesis of debt management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 507,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nSPG’s Unsecured Notes ‑ 37B remained at a $700 million face amount from 2022 through 2024, but its maturity extended from 01/15/31 (2022) to 01/15/32 (2023‑2024).  The unchanged size and lengthened maturity illustrate the company’s strategy of using large, low‑coupon, long‑dated unsecured debt to fund growth while minimizing refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACE AMOUNT ERROR: LLM states $700 million, but ground truth clearly indicates $700,000 (a 1,000x overstatement). This is a fundamental quantitative error. (2) MATURITY DATE ERROR: LLM claims maturity extended from 01/15/31 (2022) to 01/15/32 (2023-2024), but ground truth states the maturity date was consistently 01/15/32 across all years (2022, 2023, 2024). The LLM incorrectly invented a change in maturity date that did not occur. (3) REASONING FLAW: The LLM's interpretation that 'lengthened maturity' reflects strategy is contradicted by the ground truth showing NO maturity date change. The LLM fabricated a narrative about maturity extension that is factually incorrect. (4) PARTIAL CREDIT: The LLM correctly identified the company (SPG), the instrument (Unsecured Notes - 37B), and the time period (2022-2024). The general concept of debt strategy is relevant, but the specific facts supporting it are wrong. (5) SYNTHESIS ISSUE: This is a multi-hop question requiring accurate synthesis of face amount and maturity date data across three years. The LLM failed on both key data points, making the multi-hop synthesis fundamentally flawed. The ground truth's conclusion about 'consistency' and 'stability' is the opposite of what the LLM claimed about 'extension' and 'lengthening.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 369,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Melaka, Malaysia facility is listed only under the **Analog** column in the property tables for each year, never appearing in the Embedded‑Processing column. Thus, its operational role has remained dedicated to analog product manufacturing throughout the period, with only modest expansions of floor‑space noted but no shift into embedded‑processing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Key strengths: (1) Correctly identifies that Melaka, Malaysia appears only in the Analog column across all three years (2022-2024), never in Embedded Processing - this is the core factual claim and it matches the ground truth exactly. (2) Accurately conveys the consistency/stability of the operational footprint over the three-year period with no expansion into embedded processing. (3) Properly synthesizes the multi-hop information across three fiscal years and two product line categories. (4) The mention of 'modest expansions of floor-space' adds contextual detail that doesn't contradict the ground truth and demonstrates deeper engagement with the source material. (5) Uses appropriate terminology ('dedicated to analog product manufacturing') that semantically matches the ground truth's characterization of a 'stable, specialized role.' Minor observation: The LLM answer is slightly more concise than the ground truth but loses no essential information - it efficiently conveys all key points. The phrasing 'never appearing in the Embedded-Processing column' is a clear, direct way to express the same concept as the ground truth's 'no expansion into embedded processing.' All factual claims are verifiable and correct based on the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 374,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney still records the post‑production work it receives from Industrial Light & Magic (and Skywalker Sound) inside the **Content Sales/Licensing** segment, labeling the fees as “sales of post‑production services” within the “Other revenue” line item. The segment’s structure lists these services alongside TV/SVOD, theatrical and home‑entertainment distribution, but the filings do not break out ILM‑specific revenue—so the contribution remains a consistent, though relatively small, part of the segment’s total “Other revenue” across fiscal 2022, 2023 and 2024. Thus, any change in reliance on ILM is reflected only in the continued inclusion of these services in the segment’s makeup, not in a measurable shift in reported revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate structural information about how ILM post-production services are reported within the Content Sales/Licensing segment across fiscal 2022-2024, correctly identifying them as part of 'Other revenue' and noting they are not separately broken out. The answer accurately states that ILM and Skywalker Sound services are included in the segment and that specific revenue figures are not disclosed. However, the answer has significant limitations in addressing the original question's core inquiry about how Disney's 'reliance' evolved. The original answer emphasizes a narrative evolution—from explicit listing in 2022, through continued reporting in 2023, to strategic repositioning within a DTC-first model in 2024. The LLM answer essentially concludes that there is no measurable change ('any change in reliance on ILM is reflected only in the continued inclusion'), which contradicts the ground truth's assertion of a 'stable but contextually shifting reliance' with 'increasingly framed' positioning. The LLM answer is more conservative and accurate in stating that specific revenue contribution cannot be measured, but it fails to capture the qualitative evolution in how the segment's structure and narrative emphasis shifted across the three fiscal years. The answer correctly identifies the accounting treatment and segment placement but misses the strategic repositioning narrative that was central to the original answer. The reasoning is sound regarding what can and cannot be measured from filings, but it undershoots the analysis by not addressing the contextual shifts in segment emphasis and strategic framing that the original answer highlights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 461,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures dropped sharply from **$1.305 bn in 2022** to only **$0.151 bn in 2023**, and then recovered to roughly **$0.988 bn in 2024**. This pattern signals a pronounced downturn in 2023—likely reflecting weaker underwriting results or lower joint‑venture earnings—followed by a partial rebound in 2024, showing that performance has improved but remains below the 2022 peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.305 billion (2022), $0.151 billion (2023), and $0.988 billion (2024) match the ground truth values of $1,305 million, $151 million, and $988 million respectively. The format conversion from millions to billions is handled correctly and consistently. (2) COMPLETENESS: The answer addresses all required elements - the three-year trend, the significant decline in 2023, the partial recovery in 2024, and the interpretation of what this suggests about joint venture performance. (3) ENTITY ACCURACY: MetLife is correctly identified, the metric (equity method investment income from operating joint ventures) is accurately described, and all three fiscal years (2022, 2023, 2024) are correctly referenced. (4) REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the 2023 downturn as a major event, notes the partial recovery in 2024, and appropriately characterizes the overall pattern as showing volatility with performance remaining below 2022 levels. The causal inference about weaker underwriting results is reasonable given the context. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'pronounced downturn' followed by 'partial rebound' is semantically equivalent to the ground truth's 'declined significantly' followed by 'rebounded sharply.' Minor wording differences (e.g., 'roughly' for $0.988 bn) are appropriate qualifiers that don't detract from accuracy. The only minor consideration is that the LLM uses slightly more interpretive language ('likely reflecting weaker underwriting results') which, while reasonable, goes slightly beyond the ground truth's more factual presentation, but this is not an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 493,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nIn its 2022 filing (p. 10) General Dynamics noted it was building **449** LAVs for the Canadian Army; the 2023 filing (p. 11) lowered that to **399** units, and the 2024 filing (p. 10) again references the ongoing production of those same 399 vehicles.  This steady – albeit slightly reduced – output shows that the LAV program remains a priority for GD, reinforcing the platform’s strategic value as a flagship export and a high‑margin pillar of the company’s land‑systems defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows: 2022: 360 units → 2023: 399 units → 2024: 449 units (consistent upward trend). LLM answer claims: 2022: 449 units → 2023: 399 units → 2024: 399 units (downward then flat trend). The LLM has reversed the progression entirely - it shows the 2022 figure as 449 (which is actually the 2024 figure) and claims 2023-2024 remained flat at 399 units. This is a complete inversion of the actual data. The LLM's interpretation that this represents 'steady albeit slightly reduced output' is also semantically opposite to the ground truth's 'consistent upward trend.' The reasoning about strategic importance is reasonable in tone, but it's built on factually incorrect numbers. The multi-hop synthesis failed at the most basic level - extracting and correctly sequencing the production volumes across three years. This is not a minor formatting or wording issue; these are core quantitative facts that are entirely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 301,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the pension fund’s hedge‑fund limited‑partnership holdings were disclosed only as “excluded from the fair‑value hierarchy” – $214 million at the end of 2022 and $225 million at the end of 2023, with no separate 2024 figure but the amount appearing to stay at roughly that level.  This modest, single‑digit‑percent exposure represents only a small slice of the roughly $4.3 billion of total pension assets, indicating that CVS treats hedge‑fund LP interests as a peripheral, diversifying component of a broadly balanced, long‑term asset allocation rather than a strategic shift toward alternative‑asset heavy investing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM states 'no separate 2024 figure' and claims the amount 'appearing to stay at roughly that level,' but the ground truth explicitly provides a 2024 figure of $252 million. This is a major factual omission that directly contradicts the original answer. (2) The LLM's interpretation of the trend is fundamentally incorrect - it characterizes the holdings as 'peripheral' and 'modest,' while the ground truth shows a clear upward trajectory: $214M → $225M → $252M, representing an 18% increase over three years. This is not 'staying at roughly that level.' (3) The LLM correctly identifies the 2022 ($214M) and 2023 ($225M) figures, but the missing 2024 data ($252M) is a critical omission for a three-year trend analysis. (4) The LLM's conclusion about 'peripheral' status contradicts the ground truth's characterization of a 'deliberate strategy to allocate more pension fund assets toward alternative investments.' While the LLM provides contextual analysis about the proportion of total pension assets (~$4.3B), this additional context doesn't excuse the failure to identify the actual 2024 figure and the clear upward trend. (5) The reasoning about 'broadly balanced, long-term asset allocation' may be reasonable interpretation, but it directly conflicts with the ground truth's assessment of a 'steady increase' indicating 'deliberate strategy.' The LLM fundamentally misread or failed to locate the 2024 data point, which is essential for answering a three-year trend question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 416,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nAcross 2022‑2024 the Sorriso brand remained embedded in the company’s global Oral, Personal and Home Care portfolio; the “Nature of Operations” notes for 2022, 2023 and 2024 all list Sorriso among the principal global and regional trademarks, and the segment‑sales tables show Oral Care (which includes Sorriso) delivering roughly 42‑43 % of worldwide net sales each year.  This consistency indicates that Sorriso was maintained as a core component of the Oral Care business and was strategically leveraged within the company’s broader Oral Care growth agenda, with no separate repositioning highlighted in the filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-reasoned synthesis of Sorriso's strategic positioning across 2022-2024. STRENGTHS: (1) Correctly identifies that Sorriso was listed among principal global and regional trademarks across all three years (2022, 2023, 2024), matching the ground truth; (2) Accurately notes the consistency and stability of Sorriso's role across the period; (3) Provides quantitative support by citing Oral Care segment sales at 42-43% of worldwide net sales, which adds concrete evidence of Sorriso's integration; (4) Correctly synthesizes multi-hop information across three years and multiple filing sections (Nature of Operations and segment-sales tables); (5) Appropriately concludes that no separate repositioning occurred, indicating stable strategic positioning. MINOR WEAKNESSES: (1) The LLM answer is slightly more operational/analytical in tone compared to the ground truth, which emphasizes 'regional market penetration and diversified consumer engagement' - the LLM focuses more on sales metrics and consistency rather than strategic market positioning nuances; (2) The ground truth explicitly mentions Sorriso being positioned 'alongside major global brands like Colgate and Palmolive,' which the LLM answer doesn't explicitly state, though this is a minor omission; (3) The phrase 'no separate repositioning highlighted in the filings' is a reasonable inference but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: The 42-43% Oral Care sales figure appears reasonable and is presented as a range, which is appropriate for multi-year data. The three-year period (2022, 2023, 2024) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing sections, correctly identifying the consistency pattern. The logic connecting trademark listings to strategic positioning is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - Sorriso maintained a consistent, stable role as a regional brand asset within the Oral Care portfolio across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 575,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nBetween 2022 and 2023 MetLife’s equity‑method exposure to operating joint ventures contracted sharply – income from those ventures fell from **$1.3 bn (2022) to $0.15 bn (2023)** and the operating‑joint‑venture line item dropped from **$51 m to $38 m**, while the REJV portfolio’s carrying value stayed roughly flat at about **$8.4 bn**. In 2024 the company modestly rebounded, raising equity‑method NII from joint ventures to **$0.99 bn** and operating‑venture income to **$175 m**, though both remained below the 2022 peak. This pattern shows MetLife has been **pruning its non‑core equity‑method holdings and shifting capital toward more stable, higher‑margin assets**, maintaining only a reduced and more selective exposure to joint‑venture investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows operating joint venture exposure of $77M (2022), $51M (2023), and $38M (2024). The LLM claims the operating-joint-venture line item was '$51M to $38M' (correct for 2023-2024 transition) but incorrectly states 2022 baseline and introduces entirely fabricated metrics: (1) Income figures of $1.3bn (2022) and $0.15bn (2023) are not mentioned in ground truth and appear to conflate different metrics; (2) 2024 operating-venture income of $175M contradicts the ground truth figure of $38M; (3) REJV portfolio carrying value of $8.4bn is not substantiated in the ground truth; (4) 2024 equity-method NII of $0.99bn is unsupported. The LLM failed to accurately track the core metric (operating joint venture exposure) across all three years. While the LLM correctly identifies a downward trend and strategic shift away from joint ventures (matching ground truth's conclusion), the specific numbers are largely incorrect. The answer demonstrates poor quantitative accuracy with multiple fabricated or misattributed figures, failed to verify the 2022 baseline ($77M, not $51M), and introduced metrics not present in the ground truth. The qualitative reasoning about strategic repositioning is sound but cannot compensate for the severe quantitative failures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 388,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nChevron has maintained its 36.4 % equity interest in Angola LNG Limited from 2022 through 2024 (see page 48), but the nature of that interest has moved from a largely passive holding to an active upstream‑gas supply role.  The company now routes gas from new Angolan upstream developments—including the NGC gas‑field, deep‑water blocks 49/50 and the Meji NW‑1 discovery—as well as from its Escravos gas plant and its 36.9 % stake in the West African Gas Pipeline into the Angola LNG facility (pages 15, 77, 78).  This integration deepens Chevron’s involvement in the LNG value chain while keeping the same ownership percentage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM states Chevron has a '36.9% stake in the West African Gas Pipeline' - this number does not appear in the ground truth and appears to be fabricated or confused with another asset. The ground truth does not mention this percentage. (2) ENTITY CONFUSION: The LLM mentions 'NGC gas-field' and 'deep-water blocks 49/50' and 'Meji NW-1 discovery' - these are NOT mentioned in the ground truth. The ground truth specifically identifies the NGC (New Gas Consortium Project) as having a 31% nonoperated working interest for Chevron, and mentions Quiluma and Maboqueiro fields as the specific upstream developments. The LLM appears to have introduced incorrect or unverified entities. (3) ASSET MISIDENTIFICATION: The LLM mentions 'Escravos gas plant' which is not mentioned in the ground truth at all. This appears to be a fabrication or confusion with another asset. (4) CORRECT ELEMENTS: The LLM correctly identifies the 36.4% stake in Angola LNG Limited and the evolution from passive to active/integrated role. The core narrative of integration is correct. (5) MISSING KEY INFORMATION: The LLM fails to mention the specific Quiluma and Maboqueiro fields that feed into Angola LNG, which are explicitly named in the ground truth as Chevron's upstream developments. The LLM also fails to mention the 31% working interest in NGC. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize upstream-downstream integration, it does so with incorrect or unverified details that contradict or go beyond the ground truth. The reasoning structure is sound but the factual basis is compromised. The answer demonstrates partial understanding of the evolution but introduces significant factual errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 482,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nFrom the 2022 filing the 3.625 % senior notes due October 2024 carried a $622 million carrying amount (page 104 / 111), and the same balance persisted into fiscal 2023. By the end of fiscal 2024 the notes no longer appear in the long‑term‑debt schedule (page 81), indicating that the tranche was fully retired—using cash on hand and proceeds from newer, longer‑dated senior issuances—so that exposure fell to zero as the maturity date approached. This demonstrates that AVGO actively manages its debt by proactively retiring near‑term maturities and replacing them with longer‑dated financing to extend its overall maturity profile and reduce refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative facts are correct: the $622 million carrying amount in 2022 and 2023, and the complete retirement by 2024. The multi-hop synthesis across three fiscal years is sound and properly traces the evolution of the debt obligation. The answer correctly identifies that the notes no longer appear in 2024 disclosures, indicating full retirement. The LLM provides additional valuable context beyond the ground truth by specifying the mechanism of retirement (cash on hand and proceeds from newer senior issuances) and explaining the strategic rationale (extending maturity profile and reducing refinancing risk). Page references are included (104/111 for 2022, page 81 for 2024), which adds credibility though these cannot be independently verified here. The reasoning about debt management strategy is sound and more detailed than the ground truth, explaining not just what happened but why—demonstrating proactive debt management through near-term maturity retirement and replacement with longer-dated financing. The only minor distinction is that the LLM provides more strategic insight than the ground truth's simpler statement about 'proactively addressed its maturing obligations,' but this represents enhancement rather than error. All entity identifications (AVGO, 3.625% notes, October 2024 maturity) are correct, and the temporal progression is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 401,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nThe annual interest expense for SPG’s Unsecured Notes – 35B was $28.5 million each year from 2022 through 2024 (3.80% of the $750 million outstanding), showing no change in the cost of this financing over the three‑year period. This flat‑line expense indicates that the company’s financing cost for this instrument has remained stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key facts: (1) Interest expense amount: Ground truth states $28,500 in thousands for 2023 and 2024, and $28,500 in thousands for 2022. LLM states $28.5 million for each year 2022-2024. These are equivalent ($28,500 thousand = $28.5 million), so the format variation is acceptable. (2) Outstanding principal: LLM correctly identifies $750 million outstanding. (3) Interest rate calculation: LLM states 3.80% of $750 million = $28.5 million, which is mathematically correct (750M × 0.038 = 28.5M). (4) Trend analysis: Both answers correctly identify that the interest expense remained flat/unchanged across all three years (2022-2024), indicating a fixed interest rate structure. (5) Conclusion: Both answers appropriately conclude that financing costs remained stable. Minor strengths of LLM answer: It provides additional context by calculating and verifying the implied interest rate (3.80%), which adds analytical depth. The answer is clear, concise, and directly addresses the question about how the expense evolved and what the trend suggests. No factual errors detected. The only minor consideration is that the LLM provides slightly more analytical detail (the percentage calculation) than the ground truth, but this is additive and not contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 372,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved from an aggressive build‑out of its DTC platform—launching an ad‑supported Disney+, raising subscription prices and pouring capital into original programming—to a more disciplined approach that emphasizes cost rationalization and profitability, using growth in subscription and advertising revenue to offset declining linear fees while confronting rising programming costs and intensified competition in the streaming market.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and mischaracterizations of Disney's DTC strategy evolution. CORRECT ELEMENTS: (1) The answer correctly identifies the shift from 2022-2024 involving DTC platform development, (2) Correctly mentions ad-supported Disney+ and subscription price increases, (3) Correctly identifies rising programming costs and intensified competition, (4) Correctly notes the shift toward profitability and cost rationalization. SIGNIFICANT OMISSIONS AND ERRORS: (1) The answer characterizes 2022-2024 as moving from 'aggressive build-out' to 'disciplined approach,' but the ground truth shows the opposite trajectory—from cautious/uncertain investment in 2022 to MORE aggressive push into streaming by 2024 amid rising costs. This is a fundamental mischaracterization of the strategic direction. (2) Missing critical quantitative detail: The ground truth specifically mentions Disney's $12.25 billion in unused bank facilities in 2023, which the LLM answer completely omits. (3) Missing important context about 2022: The ground truth notes that in 2022, Disney acknowledged DTC losses might grow or be reduced more slowly than anticipated, and that returns on some investments were negative or low—the LLM answer doesn't capture this cautious 2022 baseline. (4) Missing 2024 specifics: The ground truth details how programming distributors demanded terms that reduced revenue or slowed growth (fewer linear networks but including DTC in deals)—the LLM answer doesn't capture this specific competitive pressure dynamic. (5) The characterization of 'cost rationalization and profitability' emphasis is somewhat misleading—the ground truth shows Disney was making STRATEGIC INVESTMENTS with expectations of offsetting revenue, not primarily focused on cost-cutting. MULTI-HOP REASONING: The answer attempts to synthesize the 3-year evolution but gets the directional narrative backwards. The ground truth shows escalating investment and competitive aggression, while the LLM suggests a pullback to discipline. This is a critical error in understanding the strategic trajectory. QUANTITATIVE ACCURACY: No specific numbers are provided in the LLM answer, so the omission of the $12.25 billion figure is a notable gap. The answer is vague on financial commitments and lacks the specificity present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 632,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nMetLife has consistently applied the deposit method to reinsurance contracts that do not expose it to a significant loss, recording the related deposit assets and liabilities at their estimated fair value. In 2022 the balances were relatively modest—about **$1.8 billion of deposit assets and $1.4 billion of deposit liabilities** (2022 Form 10‑K, p. 66). After the November 2023 risk‑transfer with Global Atlantic, the Company recorded a sharp increase to **$5.1 billion of deposit assets and $1.3 billion of deposit liabilities**, driven by the $10.3 billion of reinsurance recoverables and the $770 million net cost of reinsurance recognized at inception (2023 Form 10‑K, p. 206). By the end of 2024 these figures had receded to **$4.6 billion of assets and $1.2 billion of liabilities**, reflecting the amortization of the initial transaction amounts as the transferred block run‑off (2024 Form 10‑K, p. 206).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative and correctly identifies the key transaction with Global Atlantic in 2023, but contains a significant quantitative discrepancy that undermines accuracy. CORRECT ELEMENTS: (1) 2022 figures of $1.8B deposit assets and $1.4B deposit liabilities are accurate; (2) The November 2023 Global Atlantic transaction is correctly identified as a major event; (3) The $10.3B reinsurance recoverables figure is correct; (4) 2024 ending balances of $4.6B assets and $1.2B liabilities are accurate; (5) The narrative arc of expansion followed by recalibration is sound; (6) The explanation of amortization and run-off is contextually appropriate. CRITICAL ERROR: The LLM states that after the November 2023 transaction, deposit assets rose to $5.1 billion and deposit liabilities to $1.3 billion. However, the ground truth indicates these 2023 year-end figures should reflect the post-transaction balances differently. The ground truth does not explicitly state 2023 year-end deposit asset/liability figures, but the progression from $1.8B/$1.4B (2022) to $4.6B/$1.2B (2024) suggests the 2023 intermediate figures may differ from the $5.1B/$1.3B stated by the LLM. This represents a quantitative accuracy issue of approximately $400M on the asset side. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects the Global Atlantic transaction to the deposit method accounting changes, demonstrating sound multi-hop reasoning. The explanation of how the transaction impacted the deposit method accounting is logically coherent. SEMANTIC ISSUES: The LLM's characterization of the 2024 figures as 'receded' is slightly imprecise—they declined from the 2023 peak but remained substantially higher than 2022 levels, suggesting a partial recalibration rather than a full retreat. Overall, the answer is substantially correct in narrative and reasoning but contains a material quantitative discrepancy in the 2023 post-transaction figures that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 552,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities dropped from **$992 million** (with $155 million of unrealized losses) to **$675 million** (with $100 million of unrealized losses). By the end of 2024 the CMBS position was essentially eliminated – only **$3 million** remained in its separate‑account assets, down from $6 million a year earlier. This three‑year trajectory reflects a deliberate reduction of CVS’s exposure to CMBS, indicating a strategic shift away from this illiquid asset class toward more liquid, lower‑risk investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) INCORRECT 2022 FIGURE: The LLM states CVS held $992 million in CMBS at end of 2022, but the ground truth clearly states $574 million. This is a $418 million discrepancy (73% overstatement). (2) CORRECT 2023 FIGURE: The LLM correctly identifies $675 million for 2023, matching ground truth. (3) CORRECT 2024 FIGURE: The LLM correctly identifies $3 million for 2024, matching ground truth. (4) UNREALIZED LOSSES: The LLM introduces unrealized loss figures ($155M in 2022, $100M in 2023) that are not mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent additional information not part of the core answer being evaluated. (5) MULTI-HOP REASONING: The LLM correctly synthesizes the three-year trajectory and reaches the appropriate conclusion about strategic de-risking and shift away from CMBS. The reasoning about moving toward more liquid, lower-risk investments is sound and consistent with the data pattern. (6) SEMANTIC ACCURACY: The qualitative interpretation (deliberate reduction, strategic shift, de-risking) aligns well with ground truth conclusions. However, the foundational quantitative error (2022 baseline) undermines the entire analysis. The 2022-to-2023 comparison in the LLM answer ($992M to $675M) is mathematically inconsistent with the ground truth trajectory ($574M to $675M), which actually shows a slight increase, not a drop. This is a critical error in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 432,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nThe “hello” brand moved from a newly‑acquired oral‑care business (acquired in January 2020) to a fully‑disclosed global trademark by the 2022 10‑K filings, where it appears in the list of principal trademarks (pages 77 & 79 of the 2022 filing and again in the 2023 & 2024 filings).  From 2022 through 2024 the company continued to report “hello” within the Oral, Personal and Home Care segment, noting that its performance is tracked alongside other Colgate‑Palmolive brands and is part of the firm’s high‑growth, strategic focus on oral‑care and personal‑care innovation; this is reflected in the segment‑level net‑sales percentages (e.g., oral‑care ≈ 43 % of segment sales in 2022‑2024) and in capital‑expenditure and productivity initiatives that specifically target the brand’s growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides additional context beyond the ground truth (acquisition date of January 2020, specific page references, oral-care percentage of ~43%) but introduces problematic elements that reduce overall correctness. STRENGTHS: (1) Correctly identifies 'hello' brand appearing in principal trademarks across 2022-2024; (2) Correctly places brand within Oral, Personal and Home Care segment; (3) Appropriately notes strategic focus on oral-care and personal-care innovation; (4) Provides multi-hop synthesis showing continuity across three years. WEAKNESSES: (1) The claim about 'hello' being a 'newly-acquired oral-care business (acquired in January 2020)' cannot be verified against the ground truth and may be factually incorrect or unsupported by the filings - this is a significant factual claim that requires verification; (2) The specific oral-care percentage claim ('≈ 43% of segment sales in 2022-2024') is presented as fact but is not substantiated in the ground truth and appears to conflate 'hello' brand performance with overall oral-care segment performance; (3) References to 'pages 77 & 79 of the 2022 filing' are specific but unverifiable against ground truth; (4) The statement about 'capital-expenditure and productivity initiatives that specifically target the brand's growth' is not mentioned in the ground truth and cannot be confirmed. The LLM answer goes beyond the ground truth in ways that introduce unverified claims. While the core finding (brand continuity 2022-2024 in trademark disclosures and segment reporting) is correct, the additional quantitative claims and specific details lack grounding in the provided ground truth, creating uncertainty about factual accuracy. The answer demonstrates good multi-hop reasoning structure but overreaches with unsupported specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 492,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record reinsurance agreements that do not expose it to a “reasonable possibility of a significant loss” using the deposit method, but the volume of those deposits grew sharply—deposit assets rose from roughly $1.8 bn (as reported for 2021/22) to $5.1 bn at the end of 2023 and $4.6 bn at the end of 2024, while deposit liabilities increased from $1.4 bn to $1.3 bn (2023) and $1.2 bn (2024) — a change documented in the 2022 10‑K (page 216), the 2023 10‑K (page 219) and the 2024 10‑K (page 206).  This expansion reflects a strategic move toward larger, more complex risk‑transfer deals (e.g., the November 2023 Global Atlantic coinsurance transaction) that increase MetLife’s exposure to counterparty credit and asset‑performance risk, while allowing the company to recognize the transactions as deposits and smooth earnings over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall trend and strategic context but contains a significant quantitative discrepancy that undermines accuracy. STRENGTHS: (1) Correctly identifies the deposit method accounting framework and the lack of 'reasonable possibility of significant loss' criterion; (2) Accurately reports 2024 figures ($4.6B assets, $1.2B liabilities); (3) Correctly identifies 2022 baseline ($1.8B assets, $1.4B liabilities); (4) Properly synthesizes the Global Atlantic transaction as a key driver; (5) Provides sound qualitative analysis of the strategic shift toward complex risk-transfer deals and counterparty credit risk exposure; (6) Appropriately cites specific 10-K page references. CRITICAL ERROR: The LLM reports 2023 deposit assets as $5.1 billion, but the ground truth states $4.6 billion for 2024 with no explicit 2023 figure provided in the original answer. The LLM's claim of a rise to $5.1B in 2023 followed by a decline to $4.6B in 2024 contradicts the ground truth narrative, which emphasizes a 'significant increase in deposit assets from 2023 to 2024.' This represents a factual error in the quantitative data. The 2023 liability figure of $1.3B is close to but slightly different from the ground truth's $1.2B (2024), suggesting possible confusion between years. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the accounting method evolution to strategic business decisions (Global Atlantic transaction), demonstrating sound multi-hop reasoning. However, the quantitative error in the 2023 deposit assets figure is a material mistake that affects the credibility of the trend analysis. The qualitative insights about counterparty credit risk and earnings smoothing are well-reasoned and appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 491,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds balance grew from about $8 billion at the end of 2022 to $9.8 billion by 2024, a rise that is shown on the balance sheet as a separate “Special use funds” line within “Other assets.”  The fair‑value hierarchy discloses that most of these assets are Level 1 (quoted equities) and Level 2 (corporate/municipal bonds), with only a modest Level 3 component (~$199 million) that relies on unobservable inputs, and the related footnote tables detail the valuation techniques and sensitivities.  While the funds themselves are not subject to direct collateral calls, the indirect collateral exposure from derivative credit‑risk provisions could trigger up to roughly $2.4 billion of additional collateral under severe rating‑downgrade scenarios, influencing the overall liquidity profile of the Special Use Fund holdings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall upward trend in Special Use Funds from 2022-2024 and accurately cites the 2024 balance sheet value of $9.8 billion. The answer appropriately addresses balance sheet presentation and collateral implications, which are key parts of the question. The discussion of fair value hierarchy (Level 1, 2, 3) and derivative-related collateral exposure demonstrates understanding of the broader context.\n\nCRITICAL ERRORS: (1) The LLM states Special Use Funds were 'about $8 billion at the end of 2022' but the ground truth specifies $8,698 million in 2023 and $9,800 million in 2024. The ground truth does not provide a 2022 balance sheet figure for Special Use Funds as a line item - it only mentions equity investments without readily determinable fair values grew from $485M (2022) to $538M (2023). The LLM appears to have conflated different metrics. (2) The LLM cites a Level 3 component of ~$199 million, which is not mentioned in the ground truth. (3) The LLM references a $2.4 billion collateral exposure under rating-downgrade scenarios, which is not present in the ground truth.\n\nMISSING INFORMATION: The LLM fails to mention the specific evolution of equity investments without readily determinable fair values ($485M to $538M), which is explicitly highlighted in the ground truth as a key development. The answer also doesn't adequately address the 2022-2023 transition in disclosure practices regarding commingled funds and valuation methodologies.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across years but introduces unsupported figures ($199M Level 3, $2.4B collateral) that cannot be verified against the ground truth. The core multi-hop synthesis (tracking evolution 2022-2024) is partially correct but contaminated with inaccurate details.\n\nQUANTITATIVE ISSUES: While $9.8B (2024) is correct, the 2022 baseline is unclear/incorrect, and the $1,102M increase mentioned in ground truth is not calculated or verified in the LLM answer. The introduction of unverified figures ($199M, $2.4B) significantly undermines quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 571,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nIn the 2022 filing (page 11) the Security Insights Platform was introduced as a mainframe‑security analytics solution that “interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with its data noted as “available for use with in‑house tools for security information and event management.” The 2023‑2024 filings (pages 10 of the 2023 and 2024 10‑Ks) keep this core capability but reposition the platform within Broadcom’s broader Enterprise‑Security and Mainframe‑Software portfolios, explicitly stressing that its continuous, ad‑hoc risk assessments and remediation guidance are designed to feed directly into customers’ internal security‑operations workflows. Thus, from 2022 to 2024 the platform evolved from a standalone analytics offering to a more tightly integrated component of Broadcom’s security suite, with a clearer emphasis on integration with customers’ own tools and on delivering remediation steps as part of automated security‑operations processes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the core 2022 description of the Security Insights Platform as assessing mainframe security posture and identifying risks; (2) Accurately cites the 2022 language about data being 'available for use with in-house tools for security information and event management'; (3) Correctly notes that 2023-2024 filings maintained core capabilities; (4) Appropriately references page numbers from filings. WEAKNESSES: (1) The ground truth explicitly states that 'the emphasis on integration with in-house tools and remediation workflows became more pronounced over time' but also notes that 'the language remained consistent' and 'AVGO maintained a stable value proposition without expanding on new integrations or remediation features.' The LLM answer contradicts this by claiming the platform 'evolved from a standalone analytics offering to a more tightly integrated component' and that there was 'a clearer emphasis on integration with customers' own tools.' This represents a significant interpretive error - the ground truth indicates stability, not evolution toward tighter integration. (2) The LLM introduces language about 'repositioning within Broadcom's broader Enterprise-Security and Mainframe-Software portfolios' and 'automated security-operations processes' that is not supported by the ground truth, which emphasizes consistency rather than repositioning. (3) The claim about 'evolving from standalone to more tightly integrated' directly contradicts the ground truth's assertion of a 'stable value proposition without expanding on new integrations.' MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal evolution across the three years - it created a narrative of increasing integration when the ground truth indicates consistency. This is a fundamental reasoning error on the core question. The answer reads plausibly but misrepresents the actual evolution (or lack thereof) described in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 546,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Nike continues to **own** the Laakdal, Belgium distribution center and lists it among its “most significant distribution facilities outside the United States” (2024 Form 10‑K pp. 29‑30; 2023 Form 10‑K p. 29; 2022 Form 10‑K Item 2 – Properties, referenced on p. 3 of the 2022 filing).  The consistent ownership and emphasis on the site show that Laakdal remains a **strategic hub for Nike’s European logistics network**, underpinning both NIKE Direct and wholesale distribution and supporting the company’s broader European growth objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that Nike owns the Laakdal facility across all three fiscal years (2022, 2023, 2024) - matching ground truth exactly. (2) Accurately cites the facility as one of Nike's 'most significant distribution facilities outside the United States' with proper page references to the 10-K filings. (3) Correctly synthesizes the multi-hop information showing consistency across three years. (4) Properly interprets the strategic significance - that consistent ownership and emphasis indicate Laakdal is a 'stable and integral part' of European logistics infrastructure. (5) Adds relevant context about NIKE Direct and wholesale distribution support, which enhances understanding without contradicting ground truth. (6) All dates and fiscal years are correct. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by adding specific operational details (NIKE Direct, wholesale distribution, European growth objectives), but these are reasonable inferences from the consistent strategic positioning and do not contradict the ground truth. The answer demonstrates sound multi-hop reasoning by synthesizing information across three separate 10-K filings and drawing appropriate conclusions about strategic importance. No numerical errors, calculation errors, or factual inaccuracies detected. The semantic meaning aligns perfectly with the ground truth conclusion that Laakdal remains strategically important and unchanged across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 423,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes ‑ 32B** kept essentially the same structure: a **fixed 3.38 % interest rate**, a **$750 million face amount**, and a **maturity date of 15 June 2027** (see the “Unsecured Notes ‑ 32B” rows on pages 50 of the 2022, 2023 and 2024 10‑K filings).  Its share of total consolidated unsecured indebtedness remained roughly 3.6‑3.8 % each year, showing little change in size.  \n\n**Implication:** SPG is treating this series as a stable, long‑dated, low‑cost funding pillar—maintaining a consistent interest‑rate and maturity profile while allowing the overall debt mix to shift through other issuances or repayments—reflecting a debt‑management strategy that prioritises predictable, long‑term financing rather than active refinancing or rate‑reset of this particular instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: 3.38% interest rate, maturity date of 06/15/27, and the consistency of these terms across 2022-2024. The qualitative reasoning about SPG's debt management strategy is sound and well-articulated. The answer appropriately addresses the multi-hop nature of the question by synthesizing information across three years. CRITICAL ERROR: The LLM states the face amount as '$750 million' when the ground truth specifies '$750,000' (or $750 thousand). This is a significant quantitative error—a 1,000x difference in magnitude. While the LLM correctly notes the face amount remained consistent, the actual value is wrong. PARTIAL ISSUE: The ground truth notes that the maturity date was 'unspecified in the 2022 report' but the LLM states it was explicitly listed as 06/15/27 across all three years. The LLM's claim that the maturity date appears on 'pages 50 of the 2022, 2023 and 2024 10-K filings' contradicts the ground truth's indication that 2022 had an unspecified maturity date. This suggests the LLM may have conflated the data or not accurately captured the evolution described in the ground truth. ADDITIONAL OBSERVATION: The LLM adds information about the instrument's share of total consolidated unsecured indebtedness (3.6-3.8%), which is not mentioned in the ground truth and cannot be verified against it. While this may be accurate supplementary information, it goes beyond what was provided in the original answer. The core debt management strategy conclusion is reasonable and aligns with the ground truth's assessment of consistency and no refinancing actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 445,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom the 2022 10‑K (page 149) the Company’s foreign debt‑security portfolio was valued at **$2.3 billion** at the end of 2022, with **$244 million** of unrealized losses; by the end of 2023 that fair value had fallen to **$1.65 billion** and unrealized losses to **$122 million** (page 149).  The 2024 separate‑account schedule (page 160) shows foreign securities held at only **$51 million**, continuing the downward trend.  This reduction in both fair value and unrealized losses indicates that CVS has been actively de‑risking its international‑security holdings, markedly lowering its exposure to foreign market‑interest‑rate and credit‑risk volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) 2022 FAIR VALUE ERROR: LLM states $2.3 billion for 2022 foreign securities fair value, but ground truth shows $838 million. This is a 174% overstatement. (2) 2022 UNREALIZED LOSSES ERROR: LLM states $244 million in unrealized losses for 2022, but ground truth shows $24 million. This is a 917% overstatement - a massive discrepancy. (3) 2023 DATA: LLM correctly states $1.65 billion fair value and $122 million unrealized losses for 2023, matching ground truth exactly. (4) 2024 DATA: LLM correctly states $51 million for 2024, matching ground truth. MULTI-HOP SYNTHESIS ISSUE: The LLM failed to properly synthesize the 2022-2023 trend. Ground truth shows an INCREASE from $838M to $1,650M (97% growth), but LLM describes a DECREASE from $2.3B to $1.65B. This reverses the actual trend direction for the first critical year. REASONING QUALITY: While the LLM's conclusion about de-risking and asset reallocation is directionally reasonable given the 2023-2024 decline, it is based on incorrect foundational data for 2022. The interpretation of 'unrealized losses declining from $244M to $122M' as evidence of de-risking is misleading when the actual 2022 figure was $24M. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on fair value, unrealized losses, and international market risk exposure, but the incorrect numbers severely compromise the analysis. The answer demonstrates understanding of what metrics matter but fails in execution. VERIFICATION: Ground truth clearly states 2022: $838M fair value/$24M losses; 2023: $1,650M/$122M; 2024: $51M. LLM's 2022 figures are demonstrably wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 480,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nMetLife has consistently applied internally‑developed designations for non‑agency RMBS and CMBS only when a security had not yet been assigned an official NAIC rating, a practice documented in the 2022‑2024 10‑K filings (see 2024 pages 79, 84; 2023 pages 87, 94; 2022 pages 96, 101).  Each year the company emphasizes that NAIC designations are derived from a modeling methodology that estimates security‑level expected losses under multiple economic scenarios, and it adopts those designations as soon as the NAIC completes its annual evaluation.  The three‑year trend shows that MetLife’s credit‑quality assessment is fundamentally reliant on the NAIC’s standardized modeling approach, with internal designations serving merely as a temporary bridge until the NAIC rating becomes available.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism (internally developed designations used as temporary bridge until NAIC ratings available) and accurately describes the general practice across 2022-2024. However, it has significant quantitative deficiencies and fails to capture the multi-year evolution pattern that is central to the question. CRITICAL ISSUES: (1) MISSING KEY NUMBERS: The ground truth provides specific quantitative evidence of the trend - Level 3 fixed maturity securities AFS increased by $4.2 billion (14.5%) in 2023 and $1.6 billion (4.9%) in 2024. These numbers are essential to demonstrating the 'multi-year pattern' and the 'gradual shift away from reliance on internal designations.' The LLM answer completely omits these figures, which are the primary evidence supporting the conclusion. (2) INCOMPLETE TREND ANALYSIS: The ground truth explicitly shows a declining growth rate ($4.2B to $1.6B) that indicates fewer new securities requiring internal designations over time - this is the quantitative proof of the evolution. The LLM answer states the trend 'shows that MetLife's credit-quality assessment is fundamentally reliant on the NAIC's standardized modeling approach' but provides no numerical evidence of how this reliance evolved or decreased. (3) MISSING TEMPORAL CONTEXT: The ground truth references the NAIC's updated modeling methodology 'refined as of December 31, 2021' and describes 2022 as a 'transitional phase' - this contextual detail about the methodology's maturation is absent from the LLM answer. (4) SEMANTIC ACCURACY: The LLM correctly characterizes internal designations as a 'temporary bridge' and accurately describes the NAIC methodology, but this correct characterization doesn't compensate for the missing quantitative evidence of the evolution pattern. STRENGTHS: The LLM correctly identifies the three-year period (2022-2024), correctly names the company (MetLife), correctly identifies the security types (non-agency RMBS and CMBS), and accurately describes the mechanism. The page references provided (2024 pages 79, 84; 2023 pages 87, 94; 2022 pages 96, 101) appear reasonable though cannot be verified. ASSESSMENT: This answer demonstrates understanding of the mechanism but fails to address the core requirement of the question - explaining 'how the use evolved' with supporting quantitative evidence. A complete answer requires the specific dollar amounts and growth rates that demonstrate the declining reliance on internal designations over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 673,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron continued to hold its existing non‑operated stakes – a 31.5 % interest in the offshore Haute Mer permit and a 15.75 % interest in the Republic of Congo portion of the Lianzi field – but the company did not announce any new capital projects or operational expansions in Congo; instead, its investment focus remained on other regions such as the Permian Basin, Australia and Kazakhstan. The only material change disclosed in the filings was the planned sale of those Congolese interests in January 2025, indicating a strategic pull‑back from further investment in the Republic of Congo during the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the specific percentages (31.5% in Haute Mer, 15.75% in Lianzi) and accurately notes these were non-operated interests. The mention of a planned sale in January 2025 aligns with the ground truth's 2024 divestiture. The LLM correctly identifies that Chevron's focus shifted to other regions (Permian, Australia, Kazakhstan). CRITICAL WEAKNESSES: (1) The LLM states Chevron 'continued to hold' these interests through 2022-2024 and only 'planned' a sale for January 2025, but the ground truth explicitly states that BY 2024, Chevron HAD SOLD these interests - this is a significant temporal/factual error. The ground truth indicates the divestiture was completed in 2024, not merely planned for 2025. (2) The LLM completely omits the $0.7 billion capital allocation to offshore development and natural gas projects in Africa (including Congo) in 2023 - this is a material omission that represents a key part of the investment evolution narrative. (3) The LLM's characterization of 'no new capital projects or operational expansions' contradicts the ground truth's disclosure of the $0.7B allocation in 2023. MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year evolution: it misses the 2023 investment phase and incorrectly dates the divestiture to 2025 rather than 2024. The narrative should show: 2022 (active operation) → 2023 (continued investment of ~$0.7B) → 2024 (full exit). Instead, the LLM presents a static holding pattern through 2024 with a future sale. This represents incomplete multi-hop synthesis across the three-year period. QUANTITATIVE: The percentages are correct, but the omission of the $0.7B figure is a significant quantitative gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 468,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has moved Embedded‑Processing products from a modest revenue line to a central growth pillar of its strategy.  The company has deepened its **broad‑portfolio advantage (b)** by expanding MCU/processor families and investing in software ecosystems that lock customers into longer‑term designs, while simultaneously leveraging its **manufacturing‑technology advantage (a)**—including new 300‑mm capacity and supply‑chain control—to produce these chips at lower cost and with greater supply security.  At the same time, it is using its **market‑reach advantage (c)** to sell embedded processors into high‑growth industrial and automotive end‑markets and exploiting the **longevity‑and‑diversity advantage (d)** of its embedded products to generate recurring software‑related revenue and stronger, more predictable free‑cash‑flow returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) FACTUAL INACCURACY - The LLM claims TI 'moved Embedded Processing products from a modest revenue line to a central growth pillar,' but the ground truth explicitly states the company 'consistently emphasized' embedded processing as 'a core component' across all three years (2022-2024), indicating stability rather than elevation from modest to central status. (2) UNSUPPORTED CLAIMS - The LLM introduces specific strategic details (300-mm capacity expansion, MCU/processor family expansion, software ecosystem investments, automotive/industrial market targeting, software-related recurring revenue) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated details not grounded in the actual filing data. (3) FOUR ADVANTAGES FRAMEWORK - While the LLM correctly identifies TI's four competitive advantages (a-d), the ground truth answer does NOT explicitly map embedded processing to these four advantages in the way the LLM describes. The ground truth focuses on embedded processing's consistent role within the competitive framework without the detailed mapping the LLM provides. (4) NARRATIVE MISMATCH - The ground truth emphasizes 'consistent emphasis' and 'stable and enduring strategic pillar,' while the LLM emphasizes 'evolution' and 'movement' from modest to central, which contradicts the ground truth's core finding. (5) MISSING GROUND TRUTH ELEMENTS - The LLM fails to capture the ground truth's key insight about how the language 'evolved slightly across years' while maintaining consistency. The LLM answer reads as speculative strategic analysis rather than a synthesis of actual filing disclosures. The answer demonstrates poor multi-hop reasoning by introducing unsupported details rather than synthesizing the actual information from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 522,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due 2025 carried an effective interest rate of roughly 3.2 % in fiscal 2022, which climbed to about 6.38 % in fiscal 2023 and further to 6.66 % by fiscal 2024 (see the long‑term‑debt tables in the 2022 and 2023 Form 10‑K filings, pages 89‑90). This upward movement reflects the rise in market rates and the note’s fair‑value hedge that converts its fixed coupon to a floating SOFR‑based cost, indicating that Cisco’s borrowing costs have steadily increased over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: the $500 million principal amount, the 3.50% coupon rate, the June 2025 maturity date, and all three effective interest rates (3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024). The progression and trend analysis are accurate, correctly identifying the significant increase in borrowing costs over the three-year period. The answer appropriately cites source documents (10-K filings, pages 89-90) and provides specific page references. The LLM goes beyond the ground truth by offering additional context about the fair-value hedge mechanism converting the fixed coupon to floating SOFR-based costs, which is relevant and adds analytical depth. The multi-hop synthesis is sound, correctly connecting the note's characteristics across three fiscal years and drawing logical conclusions about market rate increases and investor risk perception. Minor strengths include the specific mention of the hedge mechanism, which provides insight into why the effective rate diverged from the coupon rate. The only minor limitation is that the ground truth's phrasing about 'shifts in investor risk perception' is not explicitly mentioned, though the hedge explanation implicitly addresses this. The answer is well-structured, cites sources appropriately, and demonstrates clear understanding of the relationship between coupon rates, effective rates, and market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 401,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to return capital—whether through dividends or share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (pages 4 & 5 of the 2022 and 2024 filings).  The company also emphasized that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital‑adequacy and liquidity rules more generally, could result in limitations on our activities” (page 11 of the 2023 filing).  This multi‑year progression shows that while BNY Mellon retains strategic levers for capital allocation, its flexibility is tightly bounded by supervisory capital‑adequacy requirements and the need for Board‑approved, regulator‑compliant capital plans, meaning shareholder returns must be calibrated to maintain well‑capitalized status and avoid constraints imposed by U.S. banking law.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-year regulatory information from BNY Mellon's 10-K filings. STRENGTHS: (1) Correctly identifies the core regulatory constraints across 2022-2024 period, including references to U.S. banking laws, Delaware law, and preferred stock dividend obligations. (2) Accurately cites specific regulatory standards ('well-capitalized' and 'well-managed' status) and their consequences. (3) Properly synthesizes the multi-hop progression showing evolution from general regulatory oversight (2022) to specific capital planning constraints (2023-2024). (4) Correctly attributes information to specific filing pages (pages 4 & 5 for 2022/2024; page 11 for 2023). (5) Provides sound reasoning about the interplay between capital adequacy, liquidity management, and shareholder returns. (6) Accurately conveys that regulatory constraints have remained consistent with increasing emphasis on liquidity and regulatory compliance. MINOR WEAKNESSES: (1) The LLM answer is slightly more interpretive/analytical than the ground truth, adding phrases like 'strategic levers' and 'tightly bounded' that, while reasonable inferences, go slightly beyond the factual progression described in the original answer. (2) The ground truth emphasizes 'increasing emphasis on liquidity management' as a 2024 development, while the LLM answer presents this more as an ongoing theme without clearly delineating the 2024-specific evolution. (3) The LLM answer could have been more explicit about the year-by-year progression (what changed in 2023 vs 2024) rather than treating 2023-2024 as largely consistent. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy focuses on date/year accuracy and page references, which are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple regulatory concepts, correctly identifying how constraints evolved and what this reveals about strategic flexibility. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 568,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nFrom 2022 to 2023 the “Repair and other services” line fell 3.2 % – from **$1,169 million** to **$1,132 million** – and then stayed exactly at **$1,132 million** in 2024.  The flat‑line in 2024 reflects a mature, steady‑state market for these support contracts, as General Dynamics is directing its resources toward higher‑growth areas such as new submarine construction and next‑generation combat‑vehicle programs rather than expanding repair revenue.  Consequently, the flat pattern signals that the repair/other‑services business is now a stable, low‑growth pillar rather than a driver of segment growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1,169M (2022), $1,132M (2023), $1,132M (2024). (2) The calculated percentage decline of 3.2% is accurate ($37M/$1,169M = 3.16%, rounded to 3.2%). (3) The LLM correctly identifies the flat pattern in 2024 and synthesizes the multi-hop information across three fiscal years. (4) The reasoning about resource reallocation to higher-priority programs (submarines, combat vehicles) aligns with the ground truth's mention of 'nuclear-powered submarines and surface ships' and 'higher-priority programs.' (5) The characterization of the segment as 'stable, low-growth' and 'mature, steady-state market' is semantically equivalent to the ground truth's 'limited growth or strategic prioritization' and 'stagnation.' MINOR WEAKNESSES: (1) The LLM's explanation focuses primarily on resource reallocation and market maturity, while the ground truth also mentions 'market saturation' and 'operational constraints' as possible explanations. The LLM doesn't explicitly acknowledge these alternative interpretations. (2) The ground truth uses the term 'stagnation' which carries a slightly more negative connotation than the LLM's 'stable, low-growth pillar,' though both convey similar meaning. (3) The LLM could have been more explicit about the lack of rebound despite overall segment growth elsewhere. CALCULATION VERIFICATION: 3.2% decline = ($1,169M - $1,132M) / $1,169M = $37M / $1,169M = 0.0316 = 3.16% ≈ 3.2% ✓ MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and connects the revenue pattern to broader strategic priorities within General Dynamics. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 458,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth Group’s venture‑investment portfolio expanded from about **$3.7 billion (2022)** to **$4.9 billion (2024)** – roughly a 30 % increase – as it broadened its stakes in emerging health‑tech startups.  At the same time, its equity‑method holdings in health‑care operating businesses grew from **≈$1.5 billion (2022)** to **≈$3.8 billion (2024)**, more than doubling, signalling a strategic shift toward deeper, longer‑term investments in core health‑care services and technology platforms that support Optum’s integrated care model.  (See 2022 10‑K p. 56; 2023 10‑K p. 50; 2024 10‑K p. 52.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) VENTURE INVESTMENTS - INCORRECT: The LLM states venture investments grew from $3.7B (2022) to $4.9B (2024), but the ground truth shows the correct progression is $3.7B (2022) → $4.9B (2023) → $4.9B (2024). The LLM incorrectly implies growth through 2024 when the portfolio actually remained flat from 2023 to 2024. The 30% increase calculation is also misleading as it spans 2022-2024 rather than showing the actual year-over-year changes. (2) EQUITY METHOD INVESTMENTS - PARTIALLY INCORRECT: The LLM states these grew from $1.5B (2022) to $3.8B (2024), but the ground truth clearly indicates: $1.4B (2022) → $1.5B (2023) → $3.8B (2024). The LLM incorrectly cites $1.5B as the 2022 figure when it was actually $1.4B. This is a factual error in baseline data. (3) CHARACTERIZATION ERROR: The LLM describes venture investments as growing 'from about $3.7 billion (2022) to $4.9 billion (2024)' without noting the 2023 intermediate value or the flat performance in 2024, which misrepresents the actual evolution. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the strategic shift toward equity method investments and deeper integration, it fails to accurately represent the year-by-year progression that is essential to understanding 'how investments evolved.' The ground truth explicitly notes the 2023 flat period for equity method investments before the 2024 surge. (5) POSITIVE ELEMENTS: The LLM correctly identifies the strategic emphasis shift, mentions Optum's integrated care model appropriately, and provides document citations. However, these qualitative strengths cannot overcome the quantitative inaccuracies in a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 493,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 filings, Colgate‑Palmolive Co. is listed each year as a member of PMI’s Peer Group in the performance‑graph disclosures and in the description of how the peer group is assembled.  Because the peer‑group definition is unchanged, the classification of Colgate‑Palmolive does not evolve—it remains a consistent peer.  This multi‑year stability shows that PMI’s strategic benchmarking framework relies on a fixed, globally‑present set of consumer‑product companies (including Colgate‑Palmolive) to compare financial and shareholder‑return performance, underscoring a deliberate, comparable reference point for its strategic analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024); (2) Accurately states that the peer group definition remained unchanged year-over-year; (3) Properly synthesizes the multi-hop information showing stability across the three-year period; (4) Correctly characterizes the peer group as based on global presence, consumer products focus, and comparable financial metrics; (5) Appropriately interprets the consistency as revealing a deliberate, stable strategic benchmarking framework. The LLM answer uses slightly different wording than the ground truth (e.g., 'does not evolve—it remains a consistent peer' vs. 'remained consistently included') but conveys semantically equivalent information. The answer demonstrates sound multi-hop reasoning by connecting the year-over-year consistency to broader strategic implications about PMI's benchmarking approach. Minor observation: The LLM answer references 'performance-graph disclosures' which adds helpful specificity about where this information appears in the filings, though this detail is not contradicted by the ground truth. No quantitative errors, no missing entities, and the logic chain is clear and accurate. The answer fully addresses both parts of the question: (1) how the classification evolved (it didn't—remained stable), and (2) what this reveals about PMI's framework (consistent, deliberate, globally-focused consumer products comparison).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 432,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures show a clear expansion of abusive‑behavior exposure tied to its growing credit and “buy‑now, pay‑later” products and to deeper reliance on third‑party lenders, payment processors, custodians and stable‑coin issuers; the 2022 filing warned generally about fraud and buyer‑/seller‑protection losses, the 2023 filing added detailed references to credit‑risk models, the sale of loan receivables and the need for diversified third‑party funding, and the 2024 filing highlights additional regulatory scrutiny of crypto‑custody, stable‑coin operations and heightened third‑party operational risk.  This progression indicates that while PayPal has layered more sophisticated fraud‑detection and mitigation controls over time, the widening scope of credit‑related and third‑party‑dependent products has broadened the attack surface, so fraud‑mitigation effectiveness is improving only incrementally and remains a material, ongoing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend of expanding abusive behavior exposure from 2022-2024, accurately captures the progression from general fraud concerns to credit/BNPL products to third-party dependencies, and appropriately synthesizes the multi-hop relationship between product expansion and fraud mitigation challenges. The semantic reasoning about 'attack surface' broadening and incremental mitigation effectiveness aligns well with the ground truth conclusion. WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to include the specific €40 billion multi-year BNPL loan receivable sale agreement mentioned in the ground truth as a key 2023 development. This is a material omission of a concrete financial metric that anchors the scale of credit expansion. (2) ENTITY/DETAIL ACCURACY - While the LLM mentions 'crypto-custody, stable-coin operations' in 2024, the ground truth focuses specifically on 'regulatory uncertainty regarding the validity of loan receivables post-sale' as the 2024 concern. The LLM introduces crypto/stablecoin elements not explicitly mentioned in the ground truth, potentially conflating different risk categories. (3) COMPLETENESS - The ground truth emphasizes the specific mechanism of third-party fraud and abuse 'at a much larger scale' tied to the €40B receivables sale; the LLM discusses third-party risk more generally without this quantified anchor. (4) MULTI-HOP SYNTHESIS - The LLM correctly synthesizes the three-year progression but misses the specific causal link between the €40B receivables expansion and the regulatory concerns that emerged. The answer is directionally correct but lacks the precision of key financial/regulatory details that ground the analysis. The conclusion about incremental mitigation effectiveness is sound but would be stronger with the specific €40B figure demonstrating scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 510,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company’s natural‑gas‑hedge program shifted from a heavy reliance on options toward a greater share of swaps.  Net hedge volume fell modestly (431 mmBtu in 2022 → 448 mmBtu in 2023 → 431 mmBtu in 2024), but option volume peaked at 339 mmBtu in 2023 and dropped to 176 mmBtu in 2024, while swap volume fell to 109 mmBtu in 2023 and rose to 255 mmBtu in 2024.  This three‑year trend shows the company is reducing exposure to the volatility‑driven option market and moving to more direct, cash‑flow‑stable swap positions, reflecting a risk‑management strategy that prioritizes predictable hedging costs as natural‑gas price swings have moderated.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key trend: options peaked at 339 mmBtu in 2023 and dropped to 176 mmBtu in 2024, matching the ground truth exactly. The answer also correctly identifies swap volume movements (109 mmBtu in 2023 rising to 255 mmBtu in 2024). The multi-hop synthesis is sound, correctly connecting the options decline with swap increase to support the strategic narrative about shifting from volatility-driven options to more stable swaps. The LLM provides additional context about net hedge volumes (431→448→431 mmBtu) that adds depth beyond the ground truth, though this information wasn't explicitly required. The reasoning about 'reducing exposure to volatility-driven option market' and 'prioritizing predictable hedging costs' aligns well with the ground truth's interpretation of 'de-risking move.' Minor deduction: The LLM's statement about 'natural-gas price swings have moderated' is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation. The answer is more comprehensive than the ground truth, providing swap data alongside options data, which strengthens the multi-hop analysis. All numeric values are accurate with no calculation errors. The semantic meaning matches the ground truth's core finding about the strategic shift in hedging instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 381,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s aggregate expense for its U.S. defined‑contribution plans rose from **$70 million (2022) to $75 million (2023) and then to $76 million (2024)**.  This modest upward trend shows that Texas Instruments is increasingly investing in defined‑contribution benefits—expanding matching contributions and participation—while its unfunded, closed non‑qualified defined‑benefit pension plan is being de‑emphasized, indicating a long‑term shift away from traditional defined‑benefit obligations toward defined‑contribution retirement savings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All three financial figures are correct—$70 million (2022), $75 million (2023), and $76 million (2024). The trend characterization as 'modest upward trend' is accurate and consistent with the ground truth's 'steady increase.' ENTITY ACCURACY: Texas Instruments correctly identified, U.S. defined contribution plans correctly specified, and the time period (2022-2024) accurately covered. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between the defined contribution plan expenses and the non-qualified defined benefit pension plan, correctly identifying that the trend reflects a strategic shift. The answer appropriately connects the increasing defined contribution expenses to the de-emphasis of the closed defined benefit plan. SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as showing 'increasingly investing in defined-contribution benefits' and 'long-term shift away from traditional defined-benefit obligations toward defined-contribution retirement savings' conveys the same strategic insight as the ground truth's emphasis on 'growing financial commitment' and 'strategic emphasis on supporting employees.' MINOR DIFFERENCES: The LLM answer does not explicitly mention the 1997 closure date to new participants or the 'enhanced defined contribution plan' terminology found in the ground truth, but these are contextual details rather than core factual errors. The LLM's interpretation that the company is 'expanding matching contributions and participation' is a reasonable inference from the expense trend, though not explicitly stated in the ground truth. Overall, the answer correctly addresses all parts of the multi-part question with accurate numbers and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 503,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGM’s U.S. pension plans kept a 6.3 % weighted‑average long‑term rate of return assumption in both 2022 and 2023, but the December 2024 investment‑policy study raised that assumption to 6.5 %. The increase signals a modestly more optimistic outlook on future asset performance and a slight easing of risk tolerance, as the company targets higher returns to strengthen plan funded status while still balancing risk‑mitigation objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the rate was 6.3% in both 2022 and 2023, but the ground truth clearly indicates 5.4% in 2022 and 6.3% in 2023. This is a major error - the LLM completely misrepresents the 2022 figure, which is a key data point for understanding the trend. The 2024 figure of 6.5% is correct. (2) TREND ANALYSIS FAILURE: Because the LLM incorrectly states 6.3% for 2022, it fails to capture the actual evolution: 5.4% (2022) → 6.3% (2023) → 6.5% (2024). The ground truth shows a more significant upward trend starting from 5.4%, not from 6.3%. This misrepresentation undermines the entire analysis of how GM's expectations evolved. (3) INCOMPLETE CONTEXT: The LLM mentions a 'December 2024 investment-policy study' which adds specificity not in the ground truth, but this doesn't compensate for the fundamental numerical errors. (4) REASONING QUALITY: While the LLM's interpretation about 'modestly more optimistic outlook' and 'easing of risk tolerance' is reasonable, it's based on incomplete/incorrect data. The actual trend from 5.4% to 6.5% represents a more substantial shift than the LLM suggests. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression of rates, which is central to answering the question about how assumptions 'evolved from 2022 through 2024.' The omission of the 5.4% 2022 figure is a critical gap in the multi-hop analysis. The answer demonstrates partial understanding of the topic but contains unacceptable numerical errors that fundamentally compromise its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 460,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the swaps that Cisco uses to economically hedge its deferred‑compensation liability moved from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  At the same time the notional amount of the total‑return swaps rose from **$792 million (2023) to $985 million (2024)**, indicating a larger hedge position.  The swing from loss to successive gains shows that Cisco is deliberately using these derivatives to smooth – and now increasingly benefit from – the volatility of its deferred‑compensation expense, reflecting a risk‑management strategy that offsets compensation‑related earnings swings rather than letting them fluctuate with market movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Cisco's total return swaps strategy. QUANTITATIVE VERIFICATION: All core financial figures are correct - $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024 match the ground truth exactly. The notional amounts cited ($792 million in 2023 and $985 million in 2024) are additional details not in the ground truth but appear factually accurate based on the filing data referenced. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the evolution of financial exposure across three fiscal years, (2) realized gains/losses progression, and (3) implications for risk management and compensation strategy. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across multiple years and connects the numerical progression to strategic implications. The reasoning that the swing from loss to gains reflects deliberate risk management is sound and well-supported. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are accurate, and the financial metrics (total return swaps, deferred compensation liability, notional amounts) are properly characterized. SEMANTIC EQUIVALENCE: The LLM's interpretation that these swaps are used to 'smooth' and 'offset compensation-related earnings swings' aligns with the ground truth's characterization of 'improved market conditions or strategic adjustments.' The additional detail about notional amounts increasing provides valuable context about the expanding hedge position. MINOR CONSIDERATIONS: The ground truth uses slightly more cautious language ('potentially reflecting') while the LLM is more definitive ('deliberately using'), but this represents a reasonable interpretation of the data rather than an error. The LLM provides more detailed strategic insight than the ground truth without contradicting it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 515,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nPayPal’s own disclosures for 2022 (p. 77), 2023 (p. 72) and 2024 (p. 75) show that the company continues to act as the principal in its payment‑processing contracts, sets fees at its sole discretion, and records the full cost of third‑party processors as “transaction expense” – i.e., it bears the entire margin risk on each transaction.  Because the contracts are open‑ended, volume‑based and do not contain any material future pricing rights, the structural exposure to margin risk has remained essentially unchanged across the three years, even though the absolute dollar amount of transaction expense has grown as TPV has expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's principal role in transactions across all three years (2022, 2023, 2024); (2) Accurately captures the core finding that PayPal bears full margin risk and recognizes third-party processor fees as transaction expense consistently across the period; (3) Properly synthesizes the multi-hop requirement by connecting pricing control, third-party processor usage, and transaction expense recognition; (4) Correctly notes that volume-based tiered pricing does not constitute a material future right (matching 2023 clarification); (5) Appropriately references specific page numbers (77, 72, 75) showing document-level verification; (6) Correctly identifies that structural exposure remained unchanged despite absolute dollar growth in transaction expenses. MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about 'open-ended' contracts and TPV expansion that, while logically sound and consistent with the ground truth's emphasis on 'no structural changes,' goes slightly beyond explicit statement in the original answer. However, this represents appropriate synthesis rather than factual error. The answer maintains semantic equivalence to the ground truth while using slightly different phrasing ('essentially unchanged' vs 'without structural changes'). No quantitative errors detected. The answer fully addresses all three sub-components of the question: (1) margin risk evolution, (2) pricing control, and (3) transaction expense recognition. Multi-hop reasoning is sound, correctly synthesizing information across three fiscal years and multiple disclosure elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 468,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s natural‑gas output from the Angola LNG project was about 78 million cubic feet per day in 2022, fell to roughly 67 MMcf/d in 2023 and to approximately 64 MMcf/d in 2024.  This modest decline shows the company is holding the Angola LNG asset steady to meet existing supply contracts but is not expanding its capacity, instead directing capital toward higher‑return upstream and other global LNG opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The numbers provided are completely wrong: LLM claims 78 MMcf/d (2022), 67 MMcf/d (2023), 64 MMcf/d (2024), while ground truth shows 592 MMcf/d (2022), 596 MMcf/d (2023), 609 MMcf/d (2024). The LLM's figures are off by a factor of approximately 7-8x, representing a catastrophic numerical error. (2) TREND DIRECTION REVERSED - The LLM describes a declining trend (78→67→64), while the ground truth shows a clear upward trend (592→596→609). This is a fundamental misrepresentation of the data. (3) STRATEGIC INTERPRETATION CONTRADICTED - The LLM concludes Chevron is 'holding steady' and 'not expanding capacity,' which directly contradicts the ground truth's finding of 'steady increase' and 'growing operational emphasis.' The LLM's interpretation of strategic positioning is therefore based on false data. (4) METRIC CONFUSION - While both answers use MMcf/d (million cubic feet per day) as the unit, the LLM appears to have cited entirely different production data, possibly confusing Angola LNG with a different asset or misreading source documents. (5) MULTI-HOP SYNTHESIS FAILURE - The question requires synthesizing production data across three years to assess strategic positioning. The LLM failed at the foundational data synthesis step, making the strategic conclusion unreliable. The answer demonstrates either severe data retrieval errors or fundamental misunderstanding of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 416,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nIn 2022 Southern Power only noted that scheduled payments under outdoor‑lighting contracts would appear in maturity tables; by 2023 and especially 2024 the company began presenting explicit, year‑by‑year cash‑flow schedules that break out these obligations—e.g., $31 million in 2025 (2022) rising to $142 million in 2025 (2024) for Southern Power—and include present‑value discounting and a separate operating‑lease‑obligation line. This progression to detailed quantification and the marked increase in the disclosed amounts reveals that these contracts have become increasingly material and structurally important in Southern Power’s lease portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($31 million in 2025 from 2022 disclosures rising to $142 million in 2025 from 2024 disclosures) that are not mentioned in the ground truth and appear to be fabricated. These precise figures cannot be verified and represent a critical failure in quantitative accuracy. (2) FACTUAL MISCHARACTERIZATION: The ground truth states that in 2022, Southern Power noted outdoor lighting contract cash flows were 'immaterial,' but the LLM claims they 'would appear in maturity tables' in 2022—this contradicts the ground truth's characterization of immateriality. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a three-year progression from immateriality (2022) → increased attention with inclusion in maturity analyses (2023) → explicit integration into lease income reporting (2024). The LLM's narrative about 'year-by-year cash-flow schedules' and 'present-value discounting' is not supported by the ground truth and appears to be speculative detail-filling. (4) MISSING KEY INSIGHT: The ground truth specifically notes that by 2023, these contracts were included 'alongside tolling arrangements and PPAs,' and by 2024 'alongside significant revenue-generating arrangements like PPAs'—this comparative context is absent from the LLM answer. (5) REASONING QUALITY: While the LLM correctly identifies the general trend of increasing materiality, it does so by inventing unsupported quantitative evidence rather than relying on the actual progression described in the ground truth. The multi-hop synthesis fails because it introduces fabricated numbers rather than synthesizing the actual disclosed information. The answer reads plausible but is fundamentally unreliable due to unverifiable numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 515,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nFrom 2022 through 2024, Texas Instruments’ Melaka, Malaysia site was listed exclusively under the **Analog** segment in the company’s property tables for each fiscal year. The disclosures on pages 22 (2022), 18 (2023) and 16 (2024) all show an “X” in the Analog column for “Melaka, Malaysia” and no entry under **Embedded Processing**, indicating that the facility has continued to support analog‑product manufacturing while remaining outside the Embedded Processing footprint across the entire period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Melaka, Malaysia operated exclusively under the Analog segment across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately states there was no expansion into Embedded Processing during this period. (3) Provides specific page references (pages 22, 18, and 16 for respective years) that demonstrate multi-hop synthesis across three separate fiscal year filings. (4) Uses appropriate terminology ('X' marking in property tables) showing familiarity with SEC filing format conventions. (5) The conclusion about consistency and limited scope is logically sound and directly supported by the evidence presented. Minor considerations: The answer includes specific page numbers which, while helpful for verification, are not explicitly mentioned in the ground truth answer but represent additional supporting detail rather than an error. The semantic meaning is fully equivalent to the ground truth - both convey that Melaka remained an Analog-only facility with no Embedded Processing involvement across 2022-2024. The multi-hop reasoning correctly synthesizes information across three separate fiscal years to demonstrate the evolution (or lack thereof) of the operational footprint.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 365,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nThe $700 million 1.600 % senior unsecured notes that AMT issued on March 29 2021 remained outstanding through 2022‑2024, carrying the same $700 million face amount, the same semi‑annual interest‑payment dates (April 15 and October 15) and the same par‑call date of March 15 2026.  What changed over the three years was only a modest reduction in the notes’ carrying value—adjustments of roughly $2.6 million in 2023 and $1.5 million in 2024 (page 114)—reflecting the amortization of discount and issuance costs, not any alteration to the principal, interest schedule or call provisions.  This steady, low‑cost, long‑dated financing underscores AMT’s debt‑management strategy of locking in inexpensive capital at extended maturities and using the notes as a stable pillar of its balance sheet while it refinances higher‑cost obligations and funds growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of AMT's 1.600% Notes evolution from 2022-2024. STRENGTHS: (1) All key quantitative facts are correct: $700.0 million principal amount (consistent across period), semi-annual payment dates (April 15 and October 15), par call date (March 15, 2026), and adjustment amounts ($2.6 million in 2023, $1.5 million in 2024). (2) The answer correctly identifies that these adjustments represent amortization of discount and issuance costs rather than principal modifications. (3) Multi-hop synthesis is sound: the answer properly connects the stable principal/interest/call terms with the minor carrying value adjustments to characterize AMT's debt management strategy. (4) The interpretation that this reflects a 'steady, low-cost, long-dated financing' strategy is well-supported by the data presented. (5) Additional context about the March 29, 2021 issuance date and characterization as 'senior unsecured notes' adds helpful detail. MINOR CONSIDERATIONS: (1) The ground truth uses the phrasing 'adjustments to principal amount...decreased from (2.6) in 2023 to (1.5) in 2024' while the LLM describes these as 'adjustments of roughly $2.6 million in 2023 and $1.5 million in 2024' - the LLM's interpretation as carrying value adjustments/amortization is actually more precise and accurate than the ground truth's slightly ambiguous phrasing. (2) The LLM provides slightly more strategic context about refinancing higher-cost obligations, which goes beyond the ground truth but is reasonable inference from the data. All numbers, dates, and calculations are accurate. The answer fully addresses all parts of the multi-part question regarding principal amount, interest payment schedule, par call date, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 488,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco kept its $2 bn, 5.90 % senior note due 2039 on the books throughout FY2022‑FY2024 (effective rate ≈ 6.11 % each year), but the makeup of its long‑term debt shifted markedly: total senior debt rose from about $8.5 bn (FY2023) to $20.25 bn (FY2024) after the February 2024 $13.5 bn issuance, dropping the note’s share from roughly 23 % to under 10 % of overall debt. Because the new issuances carried much lower coupons (2.5 %‑5 % with effective rates well below 6 %), the portfolio‑wide weighted‑average effective interest rate fell even though the 5.90 % note’s own rate remained unchanged, revealing Cisco’s strategy of extending maturities and diversifying with low‑cost, staggered fixed‑rate debt while hedging interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM states total debt rose from \"about $8.5 bn (FY2023)\" but ground truth shows $8,416M in FY2022 and $19,621M in FY2024. The LLM's FY2023 figure is not provided in ground truth and appears to be an interpolation.\n   - LLM claims \"$20.25 bn (FY2024)\" but ground truth states $19,621M ($19.621B). This is a material discrepancy of ~$630M.\n   - LLM references a \"February 2024 $13.5 bn issuance\" which is NOT mentioned in the ground truth at all. This is an unsupported claim.\n   - LLM states the note's share dropped from \"roughly 23%\" to \"under 10%\" - these percentages cannot be verified against ground truth and appear to be calculated from incorrect debt figures.\n\n2. FACTUAL ACCURACY - CORRECT ELEMENTS:\n   - Correctly identifies the $2 billion, 5.90% senior note due 2039 ✓\n   - Correctly states the effective rate remained at ~6.11% across FY2022-FY2024 ✓\n   - Correctly identifies that the note's proportion of total debt decreased ✓\n   - Correctly identifies the strategic shift toward long-term fixed-rate instruments ✓\n\n3. FACTUAL ACCURACY - INCORRECT/UNSUPPORTED ELEMENTS:\n   - The specific $13.5B February 2024 issuance is not in ground truth\n   - The coupon ranges (2.5%-5%) for new issuances are not mentioned in ground truth\n   - The claim about \"portfolio-wide weighted-average effective interest rate fell\" is not supported by ground truth\n   - Short-term debt figures are completely omitted from LLM answer (ground truth shows $499M in 2022 declining to $488M in 2024)\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize debt composition changes and strategic implications, which is appropriate\n   - However, the reasoning is built on unsupported/incorrect numbers, undermining the analysis\n   - The connection between new issuances and portfolio-wide rate changes is logical but not grounded in provided ground truth\n\n5. COMPLETENESS:\n   - LLM addresses the 5.90% Note utilization ✓\n   - LLM addresses debt composition changes (partially, with errors)\n   - LLM addresses effective interest rate (correctly for the note itself)\n   - LLM addresses long-term financing strategy ✓\n   - LLM OMITS short-term debt discussion entirely\n   - LLM ADDS unsupported details about specific issuances not in ground truth\n\n6. SEMANTIC EQUIVALENCE:\n   - The core narrative about shifting debt composition and strategic intent is similar\n   - However, the factual foundation is compromised by incorrect numbers and unsupported claims\n\nCONCLUSION: While the LLM demonstrates understanding of the general strategic narrative (extending maturities, diversifying debt, stabilizing costs), it introduces material factual errors ($20.25B vs $19.621B), unsupported claims (the $13.5B February 2024 issuance), and omits key information (short-term debt). The quantitative errors are particularly problematic for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 787,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nGeneral Dynamics’ Canadian‑LAV build‑rate has been trimmed each year: the 2022‑23 10‑K notes 449 new LAVs being produced, the 2023‑24 filing reports 399, and the 2024 filing cites 360 units for the eight‑variant programme (plus 66 additional LAVs on the LRSS track).  This downward trend shows a modest scaling‑back of the Canadian‑specific output, yet the company continues to highlight LAV production as a core element of its Land Systems segment and as a platform for export and modernization (e.g., Ajax, Piranha, autonomous‑vehicle upgrades).  Consequently, while the volume is easing, GD’s strategic focus remains on preserving and expanding its market‑leading position in light‑armored‑vehicle manufacturing and integrating those capabilities into broader land‑forces and autonomous‑systems initiatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally inverted data that directly contradicts the ground truth. QUANTITATIVE ACCURACY FAILURES: (1) The LLM states 2022-23 10-K reports 449 units, but ground truth shows 360 units in 2022. (2) The LLM states 2023-24 filing reports 399 units, but ground truth shows 399 units in 2023 (not 2023-24). (3) The LLM states 2024 filing cites 360 units, but ground truth shows 449 units in 2024. The LLM has completely reversed the progression - claiming a 'downward trend' (449→399→360) when the actual data shows an UPWARD trend (360→399→449). This is a fundamental factual error that inverts the entire meaning of the question. MULTI-HOP REASONING FAILURE: The LLM correctly identifies the LRSS program with 66 units, but this cannot compensate for the reversed production volumes. The core narrative is backwards - the LLM interprets the data as 'scaling-back' when the ground truth indicates 'consistent growth' and 'strengthening strategic focus.' ENTITY ACCURACY: While the LLM correctly identifies General Dynamics, Canadian Army LAVs, and the LRSS program, the temporal mapping of filing years to production volumes is completely wrong. The LLM appears to have confused which year's filing reported which production volume. SEMANTIC EQUIVALENCE FAILURE: The LLM's conclusion that 'volume is easing' directly contradicts the ground truth's finding of 'consistent growth.' This is not a wording difference but a fundamental misinterpretation of the data direction. The answer demonstrates a critical failure in data synthesis and would mislead readers about GD's LAV production trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 448,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s Medicare Advantage risk‑adjustment payments were repeatedly squeezed by CMS benchmark freezes and more frequent RADV audits, which led to retrospective payment reductions and heightened funding pressure. In response, the company progressively tightened its pricing and benefit design, withdrew from low‑margin counties, intensified medical‑cost and operating‑expense management, and invested in data‑analytics and compliance controls to improve risk‑adjustment accuracy and protect margins.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces specific claims not supported by the ground truth: mentions 'more frequent RADV audits' and 'retrospective payment reductions' which are NOT mentioned in the original answer. These are factual claims about specific audit mechanisms that cannot be verified from the provided ground truth and represent potential fabrication. (2) MISSING KEY ELEMENTS - The ground truth explicitly mentions 'selective benefit and premium adjustments' and 'withdrawal from certain counties' in 2022, 'recalibrating bids' in 2023, and 'beneficiary health status data submissions' concerns in 2024. The LLM answer generalizes these into broader categories ('tightened pricing and benefit design,' 'withdrew from low-margin counties') but loses the specific year-by-year evolution that was central to the original answer's structure. (3) MULTI-HOP REASONING - The ground truth emphasizes the EVOLUTION across three distinct years with CMS making changes in each period. The LLM answer treats the response as a continuous 'progressive' tightening without clearly delineating the year-by-year progression that was explicitly documented in the original. (4) UNSUPPORTED CLAIMS - The LLM adds 'invested in data-analytics and compliance controls' which is not mentioned in the ground truth. While this might be a reasonable inference, it goes beyond what can be verified from the provided source material. (5) CORRECT ELEMENTS - The LLM correctly identifies: UnitedHealth Group, Medicare Advantage, CMS involvement, risk adjustment payment changes, pricing/benefit adjustments, market withdrawal, and cost management as response strategies. The overall strategic direction is directionally correct. (6) SEMANTIC ISSUES - 'Low-margin counties' is a reasonable interpretation of 'certain counties' but adds specificity not in the original. The answer is partially correct in substance but introduces unverified details and loses the structured year-by-year evolution that was a key feature of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 551,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPYPL’s balance of the 2.850 % fixed‑rate notes has been essentially flat from 2022 through 2024, staying at roughly **$1.5 billion** each year (as shown in the debt tables for 2022‑2023 【page 107】 and for 2023‑2024 【page 108, 111】).  At the same time the company added new senior unsecured issuances in 2023‑2024 (e.g., the ¥‑denominated 2023 notes and the May‑2024 $1.3 billion tranche of 5.15 %/5.5 % notes 【page 104, 111】), but it did not increase or retire the legacy 2.850 % series.  This continuity indicates that PYPL is preserving a stable, low‑cost, long‑dated funding pillar while supplementing its capital structure with newer debt to manage maturity timing and take advantage of favorable market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: The core claim that the 2.850% notes remained at $1.5 billion across 2022-2024 matches the ground truth exactly. The answer correctly identifies the carrying value as constant and provides appropriate page references to SEC filings (pages 104, 107, 108, 111). The mention of the May 2024 $1.3 billion tranche of 5.15%/5.5% notes is factually accurate and contextually relevant. QUALITATIVE ACCURACY: The LLM correctly synthesizes multi-hop information by: (1) identifying the constant $1.5B balance across three years, (2) noting that other debt instruments were added/refinanced, (3) explaining that the 2.850% notes were NOT increased or retired, and (4) drawing the logical conclusion about PYPL's debt strategy. The reasoning is sound and matches the ground truth's interpretation that this represents a 'consistent long-term debt strategy' and 'strategic intent to preserve this liability structure.' ENTITY ACCURACY: PYPL ticker is correct, years (2022-2024) are correct, the 2.850% fixed-rate notes are correctly identified, and the 2029 maturity date is implicit in the analysis. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'preserving a stable, low-cost, long-dated funding pillar while supplementing with newer debt' is semantically equivalent to and slightly more detailed than the ground truth's description. The answer goes beyond the ground truth by providing additional context about market conditions and maturity timing management, which adds value without contradicting the original answer. MINOR CONSIDERATIONS: The LLM provides more granular detail about supplementary debt issuances (yen-denominated notes, May 2024 tranche) which, while not explicitly in the ground truth, are consistent with PYPL's broader debt management strategy and enhance the answer's completeness. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 519,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nChevron’s involvement in Angola LNG Limited deepened markedly from 2022‑2024: the company added frontier deep‑water licences (Blocks 49 and 50), secured approval of the Owowo Stage‑1 development plan and had proved reserves recognised for the New G as Consortium project, thereby expanding the associated‑gas base that can be fed to the Angola LNG plant (pp. 14, 77, 49).  This multi‑year progression shows Chevron’s long‑term natural‑gas monetisation strategy in Angola – using its growing upstream stake and reserve base to lock in a dedicated LNG export outlet, secure international sales contracts and generate sustained cash flow from gas rather than oil alone.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures important elements of Chevron's strategic evolution in Angola but has significant gaps and one critical omission. STRENGTHS: (1) Correctly identifies the expansion of upstream portfolio through Blocks 49 and 50; (2) Mentions the Quiluma and Maboqueiro (Q&M) gas fields and New Gas Consortium Project; (3) Accurately characterizes the strategic shift toward integrated gas monetization; (4) Correctly interprets the multi-year progression showing deepening involvement. CRITICAL OMISSION: The LLM answer completely fails to mention Chevron's consistent 36.4% ownership stake in Angola LNG Limited across 2022-2024, which is a core quantitative fact in the ground truth. This is a significant oversight as the question specifically asks about 'strategic positioning' evolution, and the ownership percentage is fundamental to understanding that positioning. QUANTITATIVE ISSUES: (1) No mention of the 36.4% ownership percentage that remained constant throughout the period; (2) References 'Owowo Stage-1' which is not mentioned in the ground truth answer, raising questions about accuracy; (3) Provides page references (pp. 14, 77, 49) that cannot be verified against the ground truth. QUALITATIVE ASSESSMENT: The reasoning about integrated hub development and upstream-to-LNG connectivity is sound and aligns with the ground truth narrative. The characterization of the strategy as 'using growing upstream stake and reserve base to lock in dedicated LNG export outlet' is semantically equivalent to the ground truth's description of transitioning from 'standalone LNG export facility into integrated hub.' However, the answer lacks the structural clarity of the ground truth in showing the 2022-2023 vs. 2024 distinction. MULTI-HOP SYNTHESIS: The answer does synthesize information across multiple elements (upstream exploration, field development, LNG facility integration) but misses the temporal dimension of how the relationship evolved year-by-year. The omission of the constant ownership stake is particularly problematic because it's a key anchor point for understanding what 'evolved' (the strategic context) versus what remained stable (the ownership percentage).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 587,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nSouthern Company’s trust portfolio shows a clear upward trend in both domestic‑equity and private‑equity exposures.  In the 2022 fair‑value table (page 283 of the 2023 10‑K) the company held $829 million of domestic‑equity assets and $161 million of private‑equity assets; by the 2024 filing (pages 273‑274) those figures had risen to $1.10 billion of domestic‑equity and $181 million of private‑equity investments.  This progression indicates that Southern Company is deliberately increasing its allocation to higher‑return alternative assets—particularly private equity—within its trust holdings, reflecting a long‑term capital‑allocation strategy that seeks to boost portfolio yields and diversify risk while still meeting regulatory funding requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the numbers presented. According to the ground truth: (1) 2022 domestic equity was $1,016 million, NOT $829 million as stated in the LLM answer; (2) 2022 private equity was $150 million, NOT $161 million; (3) The LLM conflates 2023 figures ($829M domestic equity, $161M private equity) with 2022 figures, creating a fundamental misrepresentation of the data. The LLM correctly identifies 2024 figures ($1.10 billion domestic equity, $181 million private equity) but the 2022 baseline is completely wrong. MULTI-HOP REASONING FAILURE: The LLM fails to properly synthesize the three-year progression. It presents only two data points (2022 and 2024) but uses incorrect 2022 numbers, making the trend analysis invalid. The ground truth shows: 2022 ($1,016M domestic, $150M private) → 2023 ($829M domestic, $161M private) → 2024 ($1,099M domestic, $181M private), which reveals a dip in 2023 followed by recovery. The LLM's narrative of a 'clear upward trend' is misleading because it omits the 2023 decline and misrepresents the 2022 baseline. QUALITATIVE ASSESSMENT: While the LLM's interpretation about diversification strategy and long-term capital allocation is reasonable and aligns with the ground truth's conclusion, this cannot compensate for the fundamental numerical errors. The reasoning about 'higher-return alternative assets' is sound but is built on incorrect data. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on capital allocation strategy and the evolution of investments, but the factual errors severely undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 455,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the eliminations/reclassifications subtracted $107 million, $151 million and $296 million from GM’s consolidated net sales (and revenue), progressively deepening the deduction each year. This expanding drag reflects growing internal adjustments—more cross‑segment sales between Automotive, Cruise and GM Financial are being eliminated and re‑classified—indicating that the company’s segment‑level reporting is becoming increasingly consolidated and complex.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM answer states: 2022=$107M, 2023=$151M, 2024=$296M. Specifically: (1) 2022 figure is wrong ($107M vs correct $105M - off by $2M), (2) 2023 figure is dramatically wrong ($151M vs correct $107M - off by $44M or 41% error), (3) 2024 figure is correct at $296M. The LLM misidentified the 2023 value by a substantial margin, which fundamentally undermines the accuracy of the trend analysis. QUALITATIVE ASSESSMENT: The LLM correctly identifies the overall trend direction (upward progression) and provides reasonable interpretation about increasing complexity in segment reporting and cross-segment eliminations. The reasoning about Automotive, Cruise, and GM Financial interactions is plausible and contextually relevant. However, the incorrect intermediate data point (2023) means the trend characterization, while directionally correct, is based on false premises. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information about segment reporting complexity, which is appropriate for the question, but the execution is compromised by data errors. The semantic interpretation about consolidation complexity is reasonable but cannot be properly evaluated when the underlying numbers are wrong. IMPACT: For a financial question where precision is paramount, errors of this magnitude (especially a 41% error in 2023) constitute major failures. The answer would mislead stakeholders about the actual magnitude and rate of change in eliminations/reclassifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 458,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nNetflix’s Performance Bonus Plan was most recently amended and restated in a December 9 2022 8‑K filing (Exhibit 10.5†), and that version remained the governing document through 2024. The plan is formally integrated with the company’s broader compensation framework—its terms are tied to the 2020 Stock Plan’s option and RSU agreements and to the Executive Officer Severance Plan, both of which were documented in subsequent 2023 filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and incomplete information. CORRECT ELEMENTS: (1) The December 9, 2022 filing date is accurate; (2) The Exhibit 10.5† designation for the Amended and Restated version is correct; (3) The statement that this version remained governing through 2024 is accurate; (4) The integration with broader compensation frameworks is correctly identified. SIGNIFICANT OMISSIONS: (1) The answer fails to address the 2022 status of the plan as a historical exhibit (Exhibit 10.6†) with an April 28, 2014 filing date, which is a key part of the evolution narrative; (2) The answer does not clearly distinguish the progression from 2022→2023→2024, missing the critical point that 2023 saw the amendment/restatement while 2024 showed stabilization; (3) The answer mentions integration with the 2020 Stock Plan and Executive Officer Severance Plan but doesn't clearly establish the temporal relationship or how these fit into the evolution narrative. MULTI-HOP REASONING: The answer partially synthesizes information but fails to capture the full evolution arc. The ground truth emphasizes a three-year progression (2022: historical, 2023: amended/restated, 2024: stabilized), while the LLM answer jumps to the 2022 amendment date and treats 2023-2024 as a single period without distinguishing the evolution. The answer also introduces the 2020 Stock Plan reference without clear grounding in the original question's scope. QUANTITATIVE ACCURACY: Dates are correct (December 9, 2022), but the answer lacks the April 28, 2014 date that contextualizes the 2022 status. The answer is factually accurate in what it states but incomplete in addressing the full evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 462,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nBK’s “Business Relationships and Related Party Transactions Policy” is cited in all three 10‑K filings, but the way it is presented tightens over time: the 2022 filing merely notes its inclusion, the 2023 filing explicitly calls it out as a separate governance item, and the 2024 filing integrates it into the broader “Corporate Governance and Board Information” section while still linking it to director‑independence disclosures.  Across the years BK continues to list the same board committees (Audit, Corporate Governance, Nominating & Social Responsibility, and HR & Compensation) and to emphasize director independence, indicating a consistent corporate‑governance framework with only incremental wording refinements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that BK disclosed the policy in all three years (2022, 2023, 2024), matching the ground truth. (2) The committee names are accurately listed (Audit, Corporate Governance/Nominating & Social Responsibility, HR & Compensation), with only minor wording variations from ground truth. (3) The connection to director independence is correctly noted. (4) The overall characterization of consistency in the governance framework is sound. WEAKNESSES: (1) The LLM introduces a narrative about evolution ('tightens over time,' 'merely notes,' 'explicitly calls it out,' 'integrates') that is NOT supported by the ground truth. The ground truth states the policy was 'consistently disclosed' and 'consistently placed' with 'stable and uniform approach' - not a progression from loose to tight presentation. (2) The LLM claims the 2022 filing 'merely notes its inclusion' while 2023 'explicitly calls it out' and 2024 'integrates it' - this temporal evolution narrative contradicts the ground truth's emphasis on consistency across all three years. (3) The ground truth emphasizes that placement was consistent 'within Item 13' and 'under Corporate Governance and Board Information' in all three years, but the LLM suggests this integration happened progressively. (4) The phrase 'incremental wording refinements' is vague and not substantiated by the ground truth, which emphasizes uniformity rather than refinement. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so by imposing a false narrative of evolution rather than accurately reflecting the ground truth's finding of consistency. The reasoning is logically structured but factually misaligned with the source material. ENTITY ACCURACY: All entities (BK, years, committees, policy name) are correctly identified. The core facts about what was disclosed are correct, but the characterization of HOW it evolved is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 527,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nUnitedHealth’s held‑to‑maturity debt‑security portfolio shrank each year: fair value fell from **$679 M (2022) → $596 M (2023) → $508 M (2024)**, and the corresponding carrying values moved from **$696 M → $603 M → $512 M**.  The consistent decline signals a deliberate reduction of the company’s long‑dated fixed‑income holdings—likely to free cash for share‑repurchases, acquisitions or other strategic uses—while the narrowing gap between carrying and fair value reflects a more market‑aligned valuation stance as interest‑rate movements reduced unrealized gains.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect fair value figures for 2022 and 2023. Ground truth shows fair value of $643M (2022) and $596M (2023), but LLM states $679M (2022) and $596M (2023). The 2022 fair value is off by $36M ($679M vs $643M), representing a 5.6% error. The 2024 fair value of $508M is correct. For carrying values, LLM states $696M (2022) vs ground truth of $641M (2022)—a $55M discrepancy (8.6% error). The 2023 carrying value of $603M is correct, and 2024 of $512M is correct. MULTI-HOP SYNTHESIS: The LLM correctly identifies the three-year declining trend and attempts to synthesize investment strategy implications. However, the foundational numbers are wrong, undermining the entire analysis. REASONING QUALITY: The qualitative interpretation about strategic reduction, cash reallocation for buybacks/acquisitions, and the narrowing gap between carrying and fair value reflecting market-aligned valuation is reasonable and shows good analytical thinking. However, this reasoning is built on incorrect numerical premises. MISSING ELEMENTS: The LLM does not mention the shift away from Level 3 unobservable inputs noted in the ground truth, which is a specific and important detail about valuation methodology changes. SEMANTIC ISSUES: While the general narrative about portfolio reduction is directionally correct, the specific numbers that anchor this narrative are materially wrong. This is a fundamental failure for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 419,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to delinquent BNPL loan receivables shifted from an internal credit‑risk focus to an explicit portfolio‑sale strategy.  In the 2022 filing the company warned that defaults on its BNPL credit products could rise if underwriting or economic conditions deteriorated and that it might need third‑party funding to purchase or fund those receivables.  In June 2023 it entered into a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables—including a forward‑flow arrangement for future originations— and began selling a substantial majority of the portfolio in October 2023, while noting that the sale of future receivables is conditional and could be delayed.  By 2024 the filing reiterates that the success of this sale structure is critical to mitigating credit and funding risk, and it again highlights that any failure to manage fraud, abusive behavior or bad transactions could increase loss rates.  Together, these disclosures show a progressive risk‑mitigation approach: first quantifying the BNPL credit risk, then off‑loading the bulk of that risk through bulk sales and conditional forward‑flow arrangements, and finally tying the strategy to ongoing monitoring of fraud‑related losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct—€40 billion BNPL receivables sale amount, June 2023 agreement date, October 2023 implementation date. No calculation errors detected. COMPLETENESS: The answer addresses all three time periods (2022, 2023, 2024) and traces the evolution of PayPal's risk exposure and mitigation strategy across the timeline. ENTITY ACCURACY: PayPal correctly identified, BNPL products correctly characterized, U.K. and European markets properly specified, forward-flow arrangements accurately mentioned. MULTI-HOP REASONING: The answer successfully synthesizes information across three years showing: (1) 2022 baseline risk identification, (2) 2023 strategic pivot with specific agreement details, (3) 2024 ongoing risk management. The logical progression from internal credit risk focus to portfolio sale strategy is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language compared to ground truth. For example, 'delinquent BNPL loan receivables' vs 'exposure to bad transactions through BNPL loan receivables'—both convey the same concept. The phrase 'offloading a substantial portion' in ground truth maps to 'off-loading the bulk of that risk' in LLM answer. MINOR STRENGTHS OVER GROUND TRUTH: The LLM answer provides additional specificity by noting October 2023 as the implementation date for bulk sales and explicitly mentions the forward-flow arrangement for future originations, which adds valuable detail. The framing of 'progressive risk-mitigation approach' with three distinct phases is clearer than the ground truth's narrative. No factual errors detected. The answer fully addresses the question's inquiry into how exposure evolved and what it reveals about risk mitigation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 513,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s Myanmar upstream output has been declining sharply: crude‑oil production fell from about 17 kbbl/d in 2022 to 15 kbbl/d in 2023 and to roughly 4 kbbl/d in 2024, while natural‑gas output dropped from ≈94 MMcf/d in 2022 to ≈87 MMcf/d in 2023 and to only ≈22 MMcf/d in 2024.  This reduction mirrors Chevron’s announced strategic shift to exit the country—​a planned, orderly transition begun in January 2022 that is pulling back from its non‑operated interest in the Yadana, Badamyar and Sein gas fields and reallocating capital to higher‑return projects elsewhere.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific production volumes for 2024 (4 kbbl/d crude oil, 22 MMcf/d natural gas) that contradict the ground truth. The ground truth explicitly states Chevron 'completely withdrew from Myanmar in April 2024,' meaning there should be ZERO production in 2024, not 4 kbbl/d and 22 MMcf/d. This is a fundamental factual error. (2) The 2022-2023 numbers (17→15 MBD crude, 94→87 MMcf/d gas) appear directionally correct but the LLM provides additional granular data not in the ground truth, and the 2024 figures are demonstrably wrong. (3) MULTI-HOP REASONING - The LLM correctly identifies the strategic shift and exit, mentions the January 2022 start date, and names specific fields (Yadana, Badamyar, Sein), showing good contextual understanding. However, the core factual claim about 2024 production is incompatible with a complete withdrawal. (4) ENTITY ACCURACY - Company (Chevron/CVX) and country (Myanmar) correct, but the production metrics for 2024 are factually incorrect. (5) The answer demonstrates good synthesis of strategic context but fails on the most critical quantitative claim about the final year. The complete withdrawal in April 2024 should result in zero production for that year, not the declining but non-zero figures provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 369,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe Personal‑Electronics market that includes PC & notebooks fell from about 24 % of TI’s total revenue in 2022 to roughly 15 % in 2023, then edged back up to roughly 20 % in 2024.  This contraction (and modest recovery) shows that PC & notebook sales have become a smaller, less‑central component of TI’s Personal‑Electronics business, reflecting a strategic shift away from consumer‑grade computing toward higher‑margin industrial and automotive analog/embedded‑processing markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct revenue percentages for all three years: 24% (2022), 15% (2023), and 20% (2024). The numerical data matches the ground truth precisely. The multi-hop reasoning is sound, correctly synthesizing the trend across three fiscal years and identifying the strategic shift away from consumer computing toward industrial and automotive markets. The LLM appropriately characterizes the contraction and modest recovery pattern. However, there are minor differences from the ground truth: (1) The LLM states PC & Notebooks 'fell from about 24%' and 'edged back up to roughly 20%' using slightly softer language ('about,' 'roughly,' 'edged') compared to the ground truth's more definitive statements, though this is acceptable semantic variation. (2) The ground truth provides additional context that PC & Notebooks appeared 'lower in the list of priorities compared to mobile phones and portable electronics' in 2024, which the LLM answer does not explicitly mention. (3) The LLM answer focuses on the Personal Electronics segment overall rather than specifically tracking PC & Notebooks' relative contribution within that segment, though it does acknowledge PC & Notebooks as a component. The answer correctly identifies the strategic positioning and market shift, demonstrating solid multi-hop synthesis across the three-year period. The reasoning about higher-margin industrial and automotive markets is accurate and well-supported by the data trend presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 418,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nDuring 2022 through 2024 GM recorded **no accrual** for its indemnification to Stellantis; the only known contingent exposure is from ongoing European consumer class actions alleging emissions violations of the legacy Opel/Vauxhall models (and, to a far lesser extent, potential future Takata‑related recall reimbursements), which the company cannot presently estimate and considers remote. Consequently, the indemnification obligations have not materially evolved—no new liabilities have been recognized, and any future exposure remains uncertain and immaterial to the financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth:\n\n1. CRITICAL FACTUAL ERRORS:\n   - Claims \"no accrual\" for 2022-2024, but ground truth explicitly states that by 2024, GM had \"accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era\"\n   - This is a direct contradiction on a key factual point\n   - The LLM incorrectly characterizes the evolution as \"not materially evolved\" when the ground truth shows \"increasing specificity and emerging regulatory risk exposure over time\"\n\n2. INCOMPLETE SYNTHESIS:\n   - Fails to capture the 2023 disclosure of indemnification for \"pre-sale representations and warranties, emissions claims, product liabilities, and recalls\"\n   - Misses the important distinction that by 2023, GM had already disclosed specific categories of indemnified losses\n   - Does not properly synthesize the multi-year evolution from 2022 (no disclosure) → 2023 (specific categories disclosed) → 2024 (accruals recognized)\n\n3. ENTITY/METRIC ACCURACY:\n   - Correctly identifies Stellantis and Opel/Vauxhall legacy matters\n   - Correctly mentions Takata-related recalls\n   - However, misses the European Commission and UK CMA investigation as a specific regulatory exposure with actual accruals\n\n4. REASONING FLAWS:\n   - The conclusion that obligations \"have not materially evolved\" is contradicted by the ground truth's explicit statement of \"increasing specificity and emerging regulatory risk exposure\"\n   - Fails to recognize that the emergence of accruals in 2024 (even if immaterial) represents a material evolution in disclosure and recognition\n   - Does not properly distinguish between \"immaterial\" (which the ground truth uses) and \"no accrual\" (which the LLM claims)\n\n5. SEMANTIC ISSUES:\n   - \"Immaterial amount\" ≠ \"no accrual\" - these are fundamentally different accounting treatments\n   - The ground truth indicates accruals were recognized; the LLM denies any accruals existed\n\nThe LLM answer fundamentally misrepresents the evolution of GM's indemnification obligations by claiming no accruals when the ground truth clearly documents accruals in 2024 related to regulatory investigations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 612,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450% Senior Notes due 2026 were first issued in September 2021 (Supplemental Indenture No. 10) and were later increased through supplemental indentures in 2022‑2024 that added to the outstanding principal and extended the maturity schedule. This multi‑year pattern shows American Tower’s debt‑management strategy of incremental, laddered refinancing—maintaining a low‑cost senior‑note base while steadily extending maturities and diversifying its overall debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Issuance and Modifications: The ground truth explicitly states the notes were 'consistently referenced across all three years' with 'no refinancing or material modification of the instrument over the three-year period.' The LLM claims the notes were 'later increased through supplemental indentures in 2022-2024 that added to the outstanding principal and extended the maturity schedule'—this is directly contradicted by the ground truth. (2) CRITICAL ERROR - Debt Management Strategy: The ground truth characterizes the strategy as 'deliberate and stable' with 'continuity in documentation and structure.' The LLM characterizes it as 'incremental, laddered refinancing' with 'steadily extending maturities'—these are fundamentally different interpretations, and the LLM's interpretation is factually incorrect based on the ground truth. (3) DATE ACCURACY: The LLM correctly identifies September 2021 as the issuance date and Supplemental Indenture No. 10, which matches the ground truth. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year pattern across 2022, 2023, and 2024. The ground truth shows consistent exhibit references (4.25 in 2022, 4.22 in 2023, 4.21 in 2024) indicating stability, not modification. The LLM invented a narrative of increasing principal and extending maturities that has no basis in the ground truth. (5) SEMANTIC MISALIGNMENT: The LLM's characterization of 'incremental, laddered refinancing' and 'steadily extending maturities' is semantically opposite to the ground truth's 'stable' and 'no material modification' characterization. This represents a fundamental misunderstanding of the debt management strategy revealed by the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 491,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly refreshed the award documents under its 2019 Long‑Term Incentive Plan, filing new forms of Performance Share Unit Agreements and Restricted Stock Unit Agreements each year (2022 forms filed as Exhibit 10.21/10.22, 2023 forms as Exhibit 10.26/10.27, and a 2024 RSU agreement as Exhibit 10.29). These updates introduced revised performance metrics, deferred‑stock‑unit provisions and an amended executive‑severance plan, demonstrating a progressive evolution of the plan’s compensation framework across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant gaps and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2019 Long-Term Incentive Plan as the foundational framework; (2) Recognizes the multi-year evolution from 2022-2024; (3) Mentions Performance Share Unit Agreements and Restricted Stock Unit Agreements; (4) Appropriately notes progressive refinements. CRITICAL GAPS AND ERRORS: (1) The ground truth explicitly mentions the 2023 introduction of 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' - the LLM answer fails to capture this important director-level extension, which is a key part of the evolution; (2) The ground truth specifies that 2024 incorporated the '2022 Form of Performance Share Unit Agreement' - the LLM answer mentions '2024 RSU agreement' but doesn't clearly distinguish the 2022 form being used in 2024, which is an important detail about the plan's evolution; (3) The LLM answer references specific exhibit numbers (10.21/10.22, 10.26/10.27, 10.29) which are not mentioned in the ground truth and cannot be verified; (4) The LLM mentions 'amended executive-severance plan' which is not part of the ground truth answer and may be extraneous or incorrect; (5) The LLM answer is less comprehensive in explaining the strategic progression - it focuses on 'refreshed award documents' but misses the explicit narrative about extending application to directors and the specific forms introduced each year. QUANTITATIVE ACCURACY: The exhibit numbers provided cannot be verified against the ground truth, and the specific forms mentioned don't fully align with what the ground truth identifies. QUALITATIVE ACCURACY: The reasoning about progressive evolution is sound, but the synthesis is incomplete - missing the director compensation extension and the specific 2022 form usage in 2024. CONTEXTUAL RELEVANCE: The answer addresses the core question about evolution from 2022-2024 but omits critical contextual details about the scope of application expanding to directors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 562,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment’s weapons‑systems revenue climbed from **$2.0 bn (2022) → $2.44 bn (2023) → $2.93 bn (2024)**, and the segment’s share of total company revenue rose from **≈18 % (2022) to ≈20 % (2023)**, reflecting a steady increase in sales of missile‑related products.  This growth is tied to GD’s expanding focus on **aerostructures, control actuators and hypersonic rocket cases** for both legacy and next‑generation missiles, positioning the company as a key supplier of the structural core for future strategic and tactical missile systems.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the Combat Systems segment as the relevant business unit and appropriately addresses the 3-year trend from 2022-2024. It correctly identifies aerostructures as a key product focus and mentions next-generation missile systems. The qualitative reasoning about GD's strategic positioning in missile subsystems is sound and relevant to the question. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($2.0bn, $2.44bn, $2.93bn) that cannot be verified against the ground truth, which does not provide these absolute dollar amounts. The ground truth only provides segment revenue percentages (20% in 2023, 19% in 2024, ~18% implied for 2022). The LLM's claim that Combat Systems revenue 'rose from ≈18% (2022) to ≈20% (2023)' contradicts the ground truth which states it was 20% in 2023 and declined to 19% in 2024 - not a consistent rise. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes a 'consistent strategic focus' with 'slight revenue share fluctuations,' but the LLM characterizes this as 'steady increase in sales,' which misrepresents the actual trend (20% → 19% is a decline, not an increase). (3) MISSING CONTEXT - The LLM introduces 'control actuators and hypersonic rocket cases' which are not mentioned in the ground truth, potentially adding unsupported details. The ground truth specifically mentions F-35 applications and air/shipboard weapons, which the LLM omits. CALCULATION ISSUE: The LLM states segment share 'rose from ≈18% (2022) to ≈20% (2023)' but then doesn't mention the 2024 decline to 19%, creating an incomplete picture of the 3-year trend. The ground truth explicitly notes the decline from 2023 to 2024, which is a key part of understanding the strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 485,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nAcross the 2022‑2024 filings, PMI repeatedly lists Jackpot alongside other local brands such as Fortune in the Philippines, positioning it as a value‑oriented, locally‑relevant cigarette that complements its premium international brands (e.g., Marlboro) and helps maintain market‑share leadership in the country. This multi‑year emphasis indicates that Jackpot is a strategic pillar for PMI’s regional portfolio—providing a foothold in the Philippine market, shielding PMI from local‑brand competition, and serving as a platform for future transition toward reduced‑risk products while reinforcing the company’s broader strategy of balancing premium and price‑sensitive offerings across its Asia‑Pacific footprint.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Jackpot as a local Philippine brand mentioned across 2022-2024 filings alongside Fortune, matching the ground truth. (2) The temporal progression (2022-2024) is accurately captured. (3) The LLM correctly notes PMI's broader strategic context including premium brands like Marlboro and smoke-free products. (4) No quantitative errors in dates or years. WEAKNESSES: (1) The LLM introduces interpretive claims not explicitly supported by the ground truth, such as Jackpot being 'value-oriented' and 'price-sensitive' positioning—the original answer does not characterize Jackpot this way. (2) The LLM speculates about strategic functions ('shielding PMI from local-brand competition,' 'platform for future transition toward reduced-risk products') that go beyond what the ground truth states. The ground truth simply notes consistent mention and strategic relevance, not these specific tactical roles. (3) The LLM's framing of Jackpot as part of a 'premium and price-sensitive offerings' balance is an inference not explicitly stated in the original answer. (4) The ground truth emphasizes the key insight that despite PMI's smoke-free future vision, traditional cigarette brands remain 'strategically relevant'—the LLM captures this concept but frames it differently as a 'transition platform' rather than as a maintained strategic relevance. MULTI-HOP REASONING: The LLM does synthesize information across three years and connects it to PMI's broader portfolio strategy, which is appropriate. However, the synthesis introduces interpretations beyond the ground truth's more conservative statement of facts. The core finding—that Jackpot remains strategically important across three years despite PMI's smoke-free pivot—is present but somewhat obscured by additional strategic speculation. SEMANTIC EQUIVALENCE: Partial. The LLM conveys the multi-year consistency and regional importance, but adds interpretive layers about market positioning and strategic functions that are not grounded in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 552,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nChevron kept its upstream footprint in the Republic of Congo on the books throughout 2022‑2024, as shown by the country’s inclusion in the list of global operating locations in the 2022 filing (CVX_10K‑2022 p. 33).  The company continued to allocate capital to develop and sustain its offshore blocks in the area, but by early 2024 it began pruning non‑core stakes, completing the sale of its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % interest in the Lianzi field in January 2025 (CVX_10K‑2024 p. 41).  This disposition signals a strategic shift to re‑deploy capital toward higher‑return projects while exiting peripheral assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts and timeline of Chevron's Republic of Congo operations from 2022-2024, with accurate percentages (31.5% and 15.75%) and the January 2025 divestiture date. The answer properly synthesizes the multi-hop information showing the evolution from operational presence to strategic exit. However, there is a notable omission: the ground truth specifically mentions that in 2023, Chevron invested approximately $0.7 billion across offshore development and natural gas projects in Africa, including the Republic of Congo. The LLM answer vaguely references 'continued capital allocation to develop and sustain offshore blocks' but fails to cite the specific $0.7 billion investment figure, which is a concrete data point demonstrating active capital deployment during the 2022-2024 period. This omission weakens the answer's completeness regarding capital deployment specifics. The LLM correctly identifies the strategic shift from operational continuity to divestiture and properly cites the 2022 and 2024 10-K filings. The reasoning about re-deploying capital toward higher-return projects is a reasonable inference but goes slightly beyond what the ground truth explicitly states. The answer is well-structured and addresses the core question, but the missing $0.7 billion investment detail represents incomplete coverage of the capital deployment aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 392,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company continued to classify its outdoor‑lighting contracts as operating leases with initial terms of up to ten years and month‑to‑month renewals, a treatment that remained unchanged from 2022 through 2024.  The contracts are considered immaterial (particularly at Mississippi Power), and the lease‑income recorded under “operating leases” fell from $208 million in 2022 to $164 million in 2023 and $136 million in 2024, reflecting both the expiration of initial terms and a modest increase in the weighted‑average discount rate (4.51 % → 4.68 % → 4.73 %), which lowered the present‑value of the scheduled payments.  Revenue from these leases is reported in the lease‑income table, and the maturity schedules show scheduled cash flows through 2028; after applying the discount, operating‑lease obligations declined slightly from $1.49 billion in 2023 to $1.45 billion in 2024 across the subsidiaries.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported numerical claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar amounts ($208M in 2022, $164M in 2023, $136M in 2024) and discount rates (4.51%, 4.68%, 4.73%) that are NOT mentioned in the original answer and appear to be fabricated. The ground truth makes no such specific numerical claims about lease income declining over these years. The LLM also cites operating-lease obligations of $1.49B in 2023 and $1.45B in 2024, which are not verified in the ground truth. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolution described in the ground truth: the progression from 2022 (immaterial, no significant value disclosed) → 2023 (began disclosing scheduled lease payments) → 2024 (expanded disclosure including initial terms and clarified lease income allocation across subsidiaries). The LLM incorrectly states the treatment 'remained unchanged from 2022 through 2024,' which contradicts the ground truth's emphasis on growing transparency and standardization. (3) MISSING CRITICAL DETAILS - The ground truth emphasizes that by 2024, Southern Company clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power. The LLM mentions 'lease-income table' and 'maturity schedules' but fails to address this important subsidiary-level revenue allocation clarification. (4) MATERIALITY MISCHARACTERIZATION - While the LLM correctly notes contracts are 'immaterial (particularly at Mississippi Power),' it fails to convey that this materiality assessment was specifically noted in 2022 and that the company's subsequent disclosures in 2023-2024 represented a shift toward greater transparency despite immateriality. (5) STRUCTURAL ACCURACY - The LLM correctly identifies the contract structure (initial terms up to 10 years with month-to-month renewals) and mentions maturity schedules through 2028, but these details, while possibly accurate, are not verified against the ground truth and appear to be extrapolated. The fundamental problem is that the LLM has invented specific financial metrics that cannot be verified and has misrepresented the nature of change (claiming 'unchanged' when the ground truth emphasizes evolving disclosure practices).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 629,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nCisco’s 3.50 % senior note due 2025 carried a roughly $500 million carrying amount in each of fiscal 2022, 2023 and 2024, but its effective interest rate climbed from **3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024**. This upward shift reflects rising market rates and the accretion of discount/premium and hedge adjustments, indicating that the note’s market‑derived yield—and thus Cisco’s borrowing cost—has increased even though the coupon rate remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying amount of $500 million across all three fiscal years (2022, 2023, 2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. The coupon rate of 3.50% and maturity year of 2025 are also accurate. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of carrying amount, the progression of effective interest rates, and the interpretation of what this indicates about debt valuation and market conditions. ENTITY ACCURACY: Cisco is correctly identified, the note is properly characterized as a senior note due 2025, and all fiscal years are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies the pattern (stable carrying amount with rising effective rates) and provides logical interpretation (market-derived yield increases despite unchanged coupon, reflecting market conditions and accretion adjustments). The explanation about discount/premium and hedge adjustments adds valuable context beyond the ground truth. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing slightly more detailed explanation of the underlying causes (market rates, accretion, hedge adjustments). Minor enhancement: The LLM provides more specific context about why rates increased (market conditions, accretion effects) compared to the ground truth's more general statement about 'shift in market conditions or internal risk assessments.' This represents a minor strength rather than a weakness. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 472,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – 35A** stayed constant at a **$750 million issue, 2.65 % coupon, maturing 07/15/30**, appearing in the debt tables for 2022 (p. 50), 2023 (p. 50) and 2024 (p. 51).  Its absolute size did not change, but because total consolidated unsecured indebtedness fell from **$20.0 bn (2022)** to **$21.0 bn (2023)** and then to **$19.4 bn (2024)**, the note’s share of the overall unsecured portfolio hovered only around **3–4 %** of the total.  \n\nThis multi‑year stability shows that SPG is using the 35A tranche as a **low‑cost, long‑dated anchor** in a broader strategy of extending maturities, diversifying funding sources, and taking advantage of favorable market rates to issue new notes while keeping a modest, predictable portion of debt on the books.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts about Unsecured Notes - 35A: $750 million face value, 2.65% coupon, July 15, 2030 maturity, and consistency across 2022-2024. The reasoning about using this as a 'low-cost, long-dated anchor' aligns well with the ground truth's characterization of 'deliberate strategy to maintain stable long-term financing commitments.' The multi-hop synthesis connecting the stable 35A position to broader portfolio changes is sound and relevant.\n\nCRITICAL ERRORS: The LLM provides specific total unsecured debt figures ($20.0bn in 2022, $21.0bn in 2023, $19.4bn in 2024) that are NOT verified in the ground truth and appear to contain errors. The ground truth does not provide these aggregate figures, and the LLM's claim that total unsecured debt increased from 2022 to 2023 ($20.0bn to $21.0bn) then decreased to 2024 ($19.4bn) cannot be verified. The calculated percentages (3-4% of total) are therefore unreliable. The LLM also mentions page numbers (p. 50, p. 51) which cannot be verified against the ground truth.\n\nMISSING CONTEXT: The LLM does not mention the specific new issuances (like the 2024 $1 billion Unsecured Notes - 41A) or credit facility refinancing that the ground truth identifies as part of the broader strategy. While the LLM alludes to 'new notes' and 'favorable market rates,' it lacks the concrete examples provided in the ground truth.\n\nQUANTITATIVE ASSESSMENT: The core debt figures ($750M, 2.65%, 07/15/30) are correct. However, the introduction of unverified aggregate debt figures and percentages significantly undermines quantitative accuracy. The calculations appear internally consistent but are based on unverified source data.\n\nQUALITATIVE ASSESSMENT: The reasoning about debt management strategy is sound and well-articulated. The multi-hop synthesis connecting individual instrument stability to portfolio-level strategy is appropriate and logical. However, the reliance on unverified numbers weakens the overall analytical foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 545,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has shifted Embedded‑Processing from a peripheral product line to a strategic growth pillar, pouring capital into dedicated fabs (e.g., the 300‑mm Lehi plant and CHIPS‑Act‑supported capacity expansion) to deepen its manufacturing‑technology advantage, expanding the microcontroller/DSP/processor portfolio and leveraging longer‑life‑cycle devices that lock customers into software ecosystems, while using its global channel network to sell more of these parts into high‑growth industrial and automotive markets.  This focus simultaneously strengthens each of TI’s four sustainable competitive advantages—lower‑cost, controllable supply chain; a broader, higher‑value product portfolio; wider market reach; and diversified, low‑dependency product/market mix—thereby driving the long‑term free‑cash‑flow‑per‑share growth that the company treats as its ultimate performance metric.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims TI 'shifted Embedded Processing from a peripheral product line to a strategic growth pillar' - this directly contradicts the ground truth which states the company 'consistently emphasized' it and maintained it as 'the second of four sustainable competitive advantages' throughout 2022-2024, indicating continuity, not a shift. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details about 'the 300-mm Lehi plant and CHIPS-Act-supported capacity expansion' that are not mentioned in the ground truth and cannot be verified from the provided context. These appear to be fabricated or hallucinated details. (3) MISCHARACTERIZATION OF STRATEGY: The ground truth emphasizes that TI used identical phrasing across all three years ('more opportunity per customer and more value for our investments'), highlighting strategic stability and consistency. The LLM instead portrays an aggressive capital reallocation and market repositioning strategy that is not supported by the source material. (4) INCORRECT FRAMING OF COMPETITIVE ADVANTAGES: While the LLM mentions the four sustainable competitive advantages, it reframes them differently than how TI actually describes them in the filings. The ground truth indicates Embedded Processing is positioned as the second advantage within a stable framework, not as a driver that 'simultaneously strengthens each' advantage through new manufacturing investments. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics from the filings are cited in either answer, but the LLM's narrative construction about capital investments and manufacturing expansion cannot be verified and appears inconsistent with the ground truth's emphasis on strategic consistency. The answer fundamentally misrepresents the nature of TI's strategic evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 525,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast broadened the flexibility of its wireless shared‑data offering: the 2022 filing describes a basic model that let customers pool data on unlimited, shared‑data or per‑gigabyte plans, and by 2024 the company added prepaid unlimited “NOW” data plans and longer‑term device‑financing for international customers (2024 10‑K, p. 5).  At the same time it expanded internationally, launching wireless service in the United Kingdom through an MVNO agreement with Virgin Media O2 (2023‑2024 10‑K, p. 5), giving UK subscribers the same tiered‑pricing and shared‑data options that were later rolled out domestically.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. Key issues: (1) FACTUAL ERRORS: The LLM claims CMCSA 'launched wireless service in the United Kingdom through an MVNO agreement with Virgin Media O2' - this is incorrect. The ground truth makes no mention of UK expansion or Virgin Media O2 partnerships. The original answer explicitly states international expansion occurred in 2024 but does not specify the UK or Virgin Media O2. This appears to be a hallucination or confusion with another company's operations. (2) INCOMPLETE SYNTHESIS: The LLM correctly identifies the evolution from 2022 (basic pooled data model) to 2024 (NOW prepaid plans), but introduces unverified international details that contradict or go beyond the ground truth. The ground truth mentions 'international expansion' generically in 2024 without specifying markets or partnerships. (3) PLAN FLEXIBILITY: The LLM correctly captures the flexibility evolution (unlimited, shared-data, per-gigabyte options in 2022, expanding to NOW prepaid in 2024), which aligns with ground truth. (4) DEVICE FINANCING CLAIM: The mention of 'longer-term device-financing for international customers' is not present in the ground truth and appears unsupported. (5) CITATION ISSUES: References to '2024 10-K, p. 5' and '2023-2024 10-K, p. 5' are provided but the specific claims about Virgin Media O2 and UK expansion cannot be verified against the ground truth. The core evolution narrative is partially correct, but the introduction of unverified international expansion details (UK, Virgin Media O2) represents a significant factual error that would mislead readers about CMCSA's actual wireless strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 472,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 to 2024 PayPal’s exposure to abusive behavior moved beyond isolated fraud‑related losses to a layered risk profile that now includes the rapid expansion of credit products (e.g., BNPL and merchant financing), intensified scrutiny from U.S. and foreign regulators (CFPB, AUSTRAC, SEC, German FCO), and the emergence of new digital‑asset threats such as the PYUSD stablecoin. This evolution signals that managing the payments ecosystem requires ever‑more sophisticated, continuously updated fraud‑detection models, external audit and compliance oversight, and coordination of third‑party funding, custodial and cross‑border risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of PayPal's risk exposure from 2022-2024 and appropriately emphasizes the increasing complexity and sophistication of fraud tactics. It correctly mentions regulatory scrutiny from multiple agencies (CFPB, AUSTRAC, SEC) and the expansion into credit products. The answer demonstrates sound reasoning about the need for enhanced detection systems and risk mitigation.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM completely omits the specific €40 billion BNPL loan receivables agreement mentioned in the ground truth as a key 2023 development. This is a major factual omission of a concrete, quantifiable detail that demonstrates the scale of PayPal's credit product expansion. (2) ENTITY ACCURACY: The LLM introduces PYUSD stablecoin as a 'new digital-asset threat' in the abusive behavior context, which is not mentioned in the ground truth and appears to be an unsupported claim about fraud/abuse exposure. While PYUSD may be relevant to PayPal's business, it's not established in the ground truth as related to abusive behaviors or fraud schemes. (3) INCOMPLETE SYNTHESIS: The ground truth specifically details the progression of fraud tactics (fictitious accounts/stolen instruments in 2022 → account takeovers/synthetic identity fraud in 2024), which the LLM answer does not capture with the same specificity. (4) MISSING LEGAL UNCERTAINTY: The ground truth mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' as a 2024 development, which the LLM does not address.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate multi-hop reasoning by connecting credit product expansion to regulatory scrutiny to risk management complexity. However, it fails to synthesize the specific timeline and quantifiable milestones that demonstrate the progression.\n\nSEMANTIC EQUIVALENCE: While the LLM's general framing about increasing complexity is semantically aligned with the ground truth, the omission of specific quantitative details (€40 billion) and the introduction of unsupported claims (PYUSD as abuse vector) undermines factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 583,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nGilead’s El Segundo, California site has moved from a mainly clinical‑trial manufacturing location in 2022 to a central commercial hub for its cell‑therapy portfolio by 2024, with targeted capacity expansions that underpin the sharp rise in cell‑therapy sales (from $1.06 billion in 2023 to $1.97 billion in 2024) and enable production of existing CAR‑T products (Yescarta, Tecartus) and upcoming candidates (2024 10‑K, pp. 11, 40; 2023 10‑K, p. 11).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth. CRITICAL ISSUES: (1) CHARACTERIZATION ERROR: The LLM claims El Segundo moved from 'mainly clinical-trial manufacturing' in 2022 to 'central commercial hub' by 2024. The ground truth states El Segundo was identified as a 'principal manufacturing facility' for 'clinical AND commercial manufacturing' in 2022, indicating commercial operations were already established. The LLM's framing of a transition from clinical-only to commercial is factually incorrect. (2) FINANCIAL DATA ACCURACY: The LLM cites cell therapy sales of $1.06 billion in 2023 and $1.97 billion in 2024. While these numbers may be accurate from the 10-K filings, the ground truth answer does NOT include these financial metrics. More importantly, the LLM uses these sales figures to support a narrative about 'sharp rise' and 'targeted capacity expansions,' but the ground truth explicitly states there is 'no indication of reduced emphasis or facility changes over the three-year period' - suggesting continuity rather than dramatic transformation. The LLM's causal linking of facility expansion to sales growth is speculative and not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes that El Segundo's role remained consistent across 2022-2024, with continuity in cell therapy manufacturing focus. The LLM instead presents a narrative of significant evolution/transformation, which contradicts the ground truth's emphasis on 'continuity' and 'no indication of reduced emphasis or facility changes.' (4) MISSING CONTEXT: The ground truth mentions other facilities (Santa Monica, Frederick) and third-party manufacturers as part of the broader context. The LLM focuses narrowly on El Segundo's transformation without acknowledging this broader facility portfolio context. (5) PRODUCT SPECIFICITY: The LLM correctly identifies Yescarta and Tecartus as CAR-T products, which aligns with the cell therapy focus mentioned in ground truth, but this is a minor positive in an otherwise problematic answer. The fundamental issue is that the LLM has reframed the narrative from 'strategic continuity with consistent cell therapy focus' to 'dramatic transformation from clinical to commercial hub,' which is a material misrepresentation of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 632,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nThe 2.750 % Senior Notes were first disclosed in the 2022 10‑K (Exhibit 4.6) as a $ 2.75 billion issue maturing on May 18 2024. In the 2023 10‑K the same 2024‑maturity tranche was still listed, but the exhibit schedule now also highlighted newer senior‑note issuances – 1.375 % due 2027, 1.600 % due 2030 and 1.750 % due 2032 – indicating that the company had begun issuing longer‑dated debt. By the 2024 10‑K the 2024‑maturing 2.750 % notes were no longer part of the active debt schedule, while the 2027, 2030 and 2032 maturities remained the longest‑dated senior obligations. This shift shows Costco’s deliberate strategy of laddering its senior‑note portfolio and extending maturities to spread repayment risk and reduce near‑term refinancing pressure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states the 2.750% Senior Notes were a '$2.75 billion issue' - this specific dollar amount is not verified in the ground truth and appears to be fabricated. (2) The LLM claims that 'by the 2024 10-K the 2024-maturing 2.750% notes were no longer part of the active debt schedule' - this directly contradicts the ground truth which states the notes 'remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024.' The ground truth explicitly confirms the notes were still referenced in 2024 filings. (3) The LLM introduces information about newer senior-note issuances (1.375% due 2027, 1.600% due 2030, 1.750% due 2032) that are not mentioned in the ground truth answer. While these may exist in actual filings, they are not part of the verified knowledge graph answer and represent unsupported claims. (4) The LLM's interpretation of Costco's debt strategy as 'laddering its senior-note portfolio and extending maturities' contradicts the ground truth's characterization of a 'static approach' and 'deliberate capital structure decision to allow the notes to mature without modification.' The LLM fundamentally misrepresents the maturity structure evolution by claiming the 2024-maturing notes disappeared from the 2024 filing, when the ground truth confirms their consistent presence. The answer demonstrates poor multi-hop synthesis and introduces unverified details that contradict the established ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 437,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG gas output (measured as oil‑equivalent) slipped from about 70 kbbl/d in 2022 to 67 kbbl/d in 2023 and 64 kbbl/d in 2024, while the natural‑gas flow remained essentially flat at roughly 48‑49 MMcf/d over the same period. This modest decline shows the company is primarily sustaining and optimizing its existing African LNG assets rather than expanding capacity. Consequently, the trajectory reflects a strategic focus on cash‑generating, mature projects and a re‑allocation of capital to higher‑return upstream opportunities elsewhere.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The ground truth provides specific Angola LNG natural gas production volumes in MMcf/d: 7,107 (2022), 7,148 (2023), and 7,569 (2024). The LLM reports 48-49 MMcf/d, which is dramatically lower and factually wrong. The LLM also introduces oil-equivalent barrels (70, 67, 64 kbbl/d) that are not mentioned in the ground truth and appear to be fabricated data points. (2) DIRECTIONAL CONTRADICTION - The ground truth clearly states production volumes increased steadily year-over-year (7,107→7,148→7,569), representing an upward trajectory. The LLM claims volumes 'slipped' and shows a declining trend (70→67→64 kbbl/d), which directly contradicts the ground truth. (3) METRIC CONFUSION - The LLM conflates oil-equivalent measurements with natural gas volumes, creating confusion about what is actually being measured. The ground truth uses consistent MMcf/d units throughout. (4) STRATEGIC INTERPRETATION ERROR - The ground truth indicates 'strengthening production output' and 'maintained or expanded operational focus,' while the LLM concludes 'modest decline' and 'sustaining and optimizing' rather than expanding. This misinterpretation flows from the incorrect numbers. (5) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year data series from the source documents, instead providing entirely different numbers that don't match any disclosed figures. The answer demonstrates a fundamental failure to retrieve or accurately report the actual Angola LNG production data from Chevron's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 445,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the notional amount of Cisco’s total‑return swaps that hedge deferred‑compensation liabilities grew from **$651 million (FY22) to $792 million (FY23) to $985 million (FY24)**, and the swaps’ impact on earnings shifted from a **$92 million loss in FY22 to gains of $58 million in FY23 and $91 million in FY24**.  This expansion and the swing from loss to consistent gains show that Cisco is deliberately scaling and refining its market‑linked hedging of deferred‑compensation obligations to better align compensation expense with market performance and to curb earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the notional amounts ($651M FY22, $792M FY23, $985M FY24) and the earnings impacts ($92M loss FY22, $58M gain FY23, $91M gain FY24) match the ground truth exactly. The answer successfully synthesizes multi-hop information by connecting three distinct data points across three fiscal years and drawing logical conclusions about Cisco's deferred compensation strategy. The LLM goes beyond the ground truth by adding the notional amount progression, which provides additional context about the scaling of the hedging program. The reasoning is sound: the answer correctly identifies the transformation from loss to gains and attributes this to deliberate strategic management of market-linked hedging. The interpretation that Cisco is 'deliberately scaling and refining' its approach and seeking to 'curb earnings volatility' is a reasonable inference from the data pattern, though slightly more interpretive than the ground truth's more neutral framing of 'improved market conditions or strategic shift.' The answer is well-structured, uses appropriate financial terminology, and directly addresses all aspects of the question regarding evolution, strategy, and market-linked volatility. Minor: the ground truth uses slightly more cautious language ('either improved market conditions or a strategic shift') while the LLM is more definitive ('deliberately scaling'), but this represents a reasonable analytical interpretation rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 426,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 to 2024 Lowe’s deepened its supplier‑sustainability framework: the 2022 Vendor Code of Conduct was expanded in 2023 with a risk‑based wood‑sourcing policy, new country‑risk tiers and a formal grievance process, and was further refined in 2024 through broader digital supplier monitoring; the company also broadened third‑party validation by requiring independent certifications such as ENERGY STAR and WaterSense and by reporting its environmental performance via CDP, SASB and TCFD, earning a spot on the Dow Jones Sustainability Index for five straight years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant unsupported claims and lacks verification against the ground truth. CORRECT ELEMENTS: (1) The 2022 Vendor Code of Conduct baseline is accurate; (2) The 2023 updates including risk-based wood sourcing policy, country-risk tiers, and grievance process are correctly identified; (3) The 2024 refinements and digital monitoring enhancements align with ground truth; (4) The overall progression narrative is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific third-party certifications (ENERGY STAR, WaterSense, CDP, SASB, TCFD) and claims about Dow Jones Sustainability Index inclusion for 'five straight years' that are NOT mentioned in the ground truth answer. These appear to be hallucinated details not supported by the source material; (2) The ground truth emphasizes 'independently certified products' generically, while the LLM specifies particular certification programs without verification; (3) The claim about 'five straight years' on DJSI is a specific quantitative claim that cannot be verified against the provided ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution (2022→2023→2024) and identifies the progression of policy updates, monitoring enhancements, and certifications. However, the addition of unverified specific certifications and index claims undermines the reliability of the synthesis. QUANTITATIVE ACCURACY: The year progression (2022, 2023, 2024) is correct, but the 'five straight years' claim for DJSI is unverified and potentially inaccurate. QUALITATIVE ACCURACY: While the structural analysis is sound, the introduction of specific certification names and index claims without ground truth support represents a significant accuracy issue. The answer reads more comprehensively than the ground truth but at the cost of introducing potentially false information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 517,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the threat from wireless telecoms to Comcast’s broadband and wireless services grew sharper as carriers rolled out 5G and fixed‑wireless broadband, bundled those wireless offerings with video and voice packages, and used aggressive pricing to win subscribers; the filings repeatedly cite AT&T, T‑Mobile, Verizon, Frontier, BT and Virgin Media (and new subsidized fiber/fixed‑wireless entrants) as the main rivals that now compete with Comcast’s cable‑based broadband and MVNO‑based wireless services.  This evolution—driven by advanced 4G/5G and fixed‑wireless technologies and by bundled product strategies—has intensified competition across both the U.S. and European markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core competitive threat evolution from 2022-2024, accurately names the primary wireless competitors (AT&T, T-Mobile, Verizon), and correctly identifies the key technological drivers (4G, 5G, fixed wireless). The answer appropriately captures the bundling strategy evolution and the intensification of competition over the period. The timeframe (2022-2024) is correct.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces competitors (Frontier, BT, Virgin Media) that are NOT mentioned in the ground truth as wireless telecommunications competitors to CMCSA's broadband/wireless services. While these may be legitimate competitors in other contexts, the ground truth specifically identifies AT&T, T-Mobile, and Verizon as the named wireless competitors. The inclusion of fiber/fixed-wireless entrants and European competitors (BT, Virgin Media) expands beyond what the ground truth documents. (2) The LLM mentions 'MVNO-based wireless services' which is not explicitly addressed in the ground truth answer. (3) The reference to 'European markets' is not supported by the ground truth, which focuses on U.S. competitive dynamics. (4) The LLM mentions 'aggressive pricing' which is not explicitly mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the progression from 4G/5G deployment (2022) to 5G fixed wireless (2023) to bundling with DTC services (2024). However, the addition of unsupported competitors and geographic expansion weakens the multi-hop synthesis accuracy.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth regarding intensifying competition and technological/bundling strategies, but the introduction of additional competitors and markets creates factual inaccuracies rather than mere wording differences.\n\nJUSTIFICATION: The answer demonstrates good understanding of the question and captures the main competitive dynamics, but introduces factual elements not supported by the ground truth (additional competitors, European markets), which prevents a higher score. The core competitive narrative is sound, but the unsupported additions represent material errors in entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 603,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal repeatedly disclosed that it “bears full margin risk” on each payment transaction, recognizing transaction fees gross of processor costs and treating volume‑based discounts and customer incentives as reductions of revenue rather than expenses.  The company’s tiered, volume‑based pricing model and its practice of limiting incentives—concluding that such discounts do not confer a material future right—reflect a deliberate effort to curb margin erosion despite continued reliance on third‑party processors.  This multi‑year pattern shows that PayPal’s control over pricing and cost management is constrained by the need to cover processor fees and incentive payouts, making its margin performance largely dependent on transaction volume and the mix of higher‑margin services rather than on negotiating lower processor costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PayPal 'bears full margin risk' across 2022-2024, accurately notes that transaction processor fees are treated as expenses, and correctly states that volume-based discounts and customer incentives are recognized as reductions to revenue rather than expenses. The mention of tiered, volume-based pricing and the treatment of incentives as non-material future rights aligns with ground truth. CRITICAL WEAKNESSES: (1) The LLM fundamentally mischaracterizes PayPal's control over pricing and cost management. The ground truth states PayPal has 'discretion in setting fees independent of costs incurred through payment processors' and maintains a 'disciplined, centralized approach to margin risk management.' The LLM contradicts this by claiming PayPal's 'control over pricing and cost management is constrained' and that 'margin performance [is] largely dependent on transaction volume and the mix of higher-margin services rather than on negotiating lower processor costs.' This represents a significant interpretive error about the company's strategic positioning. (2) The LLM introduces unsupported claims about 'limiting incentives' and 'curbing margin erosion' that are not substantiated in the ground truth. (3) The LLM fails to address the evolution of PayPal's revenue streams, particularly the 2024 addition of contractual compensation from sellers violating terms (fraud, counterfeiting), which the ground truth identifies as introducing 'new revenue streams potentially affecting margin dynamics.' (4) The LLM does not adequately capture the 'expanding discussion on incentives' in 2023 that added 'complexity to margin management.' MULTI-HOP REASONING: The LLM attempts to synthesize across three years but reaches an incorrect conclusion about PayPal's strategic control. The ground truth emphasizes consistency and control; the LLM emphasizes constraint and dependence. This is a fundamental misinterpretation of the multi-year trend. NUMERIC/FACTUAL: No specific numbers are provided in either answer, so quantitative accuracy is neutral. However, the qualitative interpretation of PayPal's strategic position is materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 587,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco treats free‑rent and step‑rent lease incentives as lease‑incentives that are recognized on a straight‑line basis over the full lease term (the non‑cancelable period plus any renewal options it is reasonably certain to exercise). The present‑value of those payments—net of the free‑rent incentive—is recorded as the right‑of‑use asset and lease liability, and the asset is subsequently amortized over that same term; this methodology has been applied consistently from FY 2022 through FY 2024.  In the 2024 filing the company adds quantitative detail—e.g., weighted‑average remaining lease terms of 19 years (operating) and 23 years (finance) and discount rates of 2.67 % and 4.59 %—showing that the ROU asset of $2.617 bn reflects the straight‑line amortization of lease payments after accounting for free‑rent periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of Costco's lease accounting methodology and correctly identifies the core principles (straight-line recognition, inclusion of reasonably certain renewal options, use of incremental borrowing rate). The answer appropriately emphasizes consistency across FY 2022-2024. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific numbers (weighted-average remaining lease terms of 19 years operating/23 years finance, discount rates of 2.67%/4.59%, ROU asset of $2.617 billion) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated details not supported by the original knowledge graph. (2) The ground truth explicitly states the company 'reaffirmed that leases did not contain material residual value guarantees or restrictive covenants,' which the LLM answer completely omits. (3) The ground truth specifically mentions that FY 2023 emphasized 'variable lease payments' for leases with periodic rent increases based on price indices or sales volume—this important distinction is absent from the LLM response. The LLM's qualitative reasoning about the accounting treatment is sound and the multi-hop synthesis across three years is logically structured. The answer is contextually relevant and addresses the evolution question. However, the introduction of unverified quantitative details (which may be incorrect) and the omission of key policy distinctions from FY 2023 significantly undermine the answer's reliability. The answer reads as plausible but contains material factual gaps and potentially false numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 451,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal’s margin‑risk profile stayed essentially unchanged from 2022 through 2024.  The company continues to record transaction revenue on a gross basis and expense the fees paid to payment processors, meaning it bears the full margin risk on every payment.  Its contracts remain open‑ended, auto‑renewing and tier‑priced, but the pricing structure does not create any material future right, so the nature of the risk—being principal and exposed to processor fees—has not shifted, only the scale of transactions has altered the absolute level of exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PayPal's core margin risk exposure remained structurally stable from 2022-2024, accurately describing the gross basis revenue recognition and processor fee expense model. The characterization of contracts as open-ended, auto-renewing, and tier-priced is accurate. The statement that PayPal bears full margin risk as principal is correct. No quantitative errors are present (no specific numbers were claimed). CRITICAL WEAKNESSES: (1) The LLM answer significantly OMITS key evolution details from the ground truth. Specifically, it fails to mention the 2023 addition of language clarifying how incentives to users are recognized (as reduction of revenue based on performance targets or amortized over contractual term), which the ground truth identifies as introducing 'more variability into its margin structure.' (2) The LLM completely MISSES the 2024 adoption of new segment reporting disclosures under ASU 2023-07, which the ground truth identifies as 'increasing transparency around segment-level expenses' and 'potentially affecting how margin risk is analyzed across business units.' These are material changes that represent the 'evolution' the question specifically asks about. (3) The LLM's statement that 'only the scale of transactions has altered the absolute level of exposure' is vague and doesn't capture the nuanced operational changes documented in the ground truth. MULTI-HOP REASONING: The question requires synthesizing information about three dimensions: (a) transaction pricing model, (b) use of payment processors, and (c) contract structure changes. The LLM addresses (a) and (b) adequately but fails to properly synthesize (c) across the three-year period, missing the 2023 incentive recognition changes and 2024 segment reporting changes. The answer reads as a static description rather than an evolution analysis. SEMANTIC ISSUES: While the LLM's core claim about structural stability is correct, it presents this as the complete answer when the ground truth emphasizes that stability was 'structurally stable but operationally nuanced' — a distinction the LLM fails to capture. The answer lacks the sophistication of acknowledging both continuity and meaningful operational/disclosure changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 605,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note was fully‑utilized at a constant $2 billion of principal in fiscal 2022, 2023 and 2024, and its reported effective interest rate remained steady at about 6.11 % each year. This flat‑line shows the company is not refinancing that long‑dated tranche but is instead keeping it as a stable, higher‑cost pillar while supplementing its balance sheet with newer, lower‑coupon senior notes (2 %–5 % range) and interest‑rate swaps, thereby holding overall long‑term financing costs steady or gradually reducing them.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core quantitative facts are correct - the $2 billion principal balance is accurate across all three fiscal years (2022, 2023, 2024), and the 6.11% effective interest rate is correctly stated as constant. (2) The 5.90% coupon rate is correctly identified. (3) Number formatting is appropriate ($2 billion vs $2,000 million). (4) The LLM correctly identifies that the note was not refinanced or modified over the period. WEAKNESSES: (1) The LLM introduces unsupported claims about 'newer, lower-coupon senior notes (2%-5% range)' and 'interest-rate swaps' that are not mentioned in the ground truth answer. While these may be factually true about Cisco's broader debt portfolio, they go beyond what the ground truth establishes and represent speculation not grounded in the specific question about the 5.90% Note. (2) The phrase 'thereby holding overall long-term financing costs steady or gradually reducing them' is an inference not explicitly supported by the ground truth, which only addresses the stability of this specific instrument. (3) The ground truth emphasizes 'consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio' - the LLM captures the consistency but overreaches in characterizing the broader strategy without explicit evidence. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend (2022-2024) and identifies the stability pattern. However, it adds interpretive layers about supplementary financing strategies that exceed the scope of what can be verified from the ground truth. The core answer about the 5.90% Note itself is sound, but the broader strategic conclusions are somewhat speculative. SEMANTIC EQUIVALENCE: The LLM's core finding matches the ground truth's main point about stability and lack of refinancing, but the additional commentary about lower-coupon notes and swaps introduces elements not in the original answer, which reduces direct equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 534,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nThe 10‑K filings show Kobalt moving from a simple trademark listing to a strategic brand element. In the 2022 IP section (LOW‑10K‑2022, p. 8) Kobalt is merely identified as one of the company’s private‑brand product names. By 2023 the disclosure (LOW‑10K‑2023, p. 11) begins to frame private brands—including Kobalt—as part of Lowe’s “value‑oriented private brands” that support its omnichannel and localization goals, and the 2024 filing (LOW‑10K‑2024, p. 7) explicitly ties Kobalt to initiatives that boost space productivity and localized assortments within the Total‑Home strategy. Thus, Kobalt’s positioning evolved from a passive IP mention to a deliberate lever in Lowe’s private‑brand growth agenda.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core finding. Ground truth states: 'there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.' The LLM answer claims the opposite: that Kobalt evolved 'from a passive IP mention to a deliberate lever in Lowe's private-brand growth agenda' with increasingly strategic framing across years. This is a direct factual contradiction. The LLM invents specific page numbers (p. 8, p. 11, p. 7) and characterizations ('value-oriented private brands,' 'Total-Home strategy,' 'space productivity') that are not verified in the ground truth and appear to be hallucinated details. The LLM also mischaracterizes the ground truth finding by claiming an evolution from 'simple trademark listing' to 'strategic brand element,' when the ground truth explicitly states the positioning remained 'consistent' with 'stable strategic role.' The answer demonstrates poor multi-hop reasoning by fabricating a narrative arc that contradicts the actual finding that Kobalt's prominence remained stable across fiscal 2022-2024. While the answer addresses the question's timeframe and mentions the correct company (Lowe's) and brand (Kobalt), the core analytical conclusion is inverted from ground truth, making this a fundamentally incorrect response despite superficial relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 391,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 37B kept the same terms in the company’s 10‑K filings – a fixed 2.25 % coupon, a $700 million face amount and a maturity of January 15 2032 (see SPG 2022 10‑K p. 50; SPG 2023 10‑K p. 50; SPG 2024 10‑K p. 51).  The lack of any material change in interest rate, size or maturity shows that Simon Property Group is deliberately maintaining a long‑dated, low‑cost unsecured debt position, using stable, long‑term financing to lock in favorable rates and support its growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All numerical values are correct - 2.25% interest rate, $700 million face amount (correctly formatted from $700,000 in ground truth, which appears to be in thousands), and maturity date of January 15, 2032 are all accurate. The answer correctly identifies that these terms remained constant across 2022-2024. COMPLETENESS: The answer addresses all three sub-components of the question: interest rate evolution (stable at 2.25%), face amount evolution (stable at $700M), and maturity date evolution (stable at 01/15/32). ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the specific debt instrument (Unsecured Notes - 37B) is correctly named, and the time period (2022-2024) is properly covered. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of 10-K filings and correctly concludes that the lack of change indicates deliberate strategy. The reasoning about 'long-dated, low-cost unsecured debt position' and 'locking in favorable rates' is sound and logically follows from the stable terms. MINOR CONSIDERATIONS: The ground truth states face amount as '$700,000' while the LLM correctly interprets this as $700 million (standard for debt instruments), which is the appropriate interpretation. The LLM provides specific page references (p. 50, 50, 51) which adds credibility though these cannot be independently verified. The strategic interpretation about 'supporting growth strategy' is a reasonable inference from the stability of terms, though slightly more interpretive than the ground truth's more cautious language about 'confidence in debt management.' Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 502,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Melaka, Malaysia location is consistently shown in the property tables with an “X” under the **Analog** column and no “X” under **Embedded Processing**, indicating that the site has been devoted solely to Analog manufacturing in each year. The tables for 2022, 2023 and 2024 all list Melaka as an Analog‑only facility (e.g., “Melaka, Malaysia **” under Analog only), so there was no shift of its operations into the Embedded‑Processing segment over the three‑year period. Thus, while the size or lease‑status of the site may have varied slightly, its segment involvement remained unchanged—continually supporting Analog product production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the three-year period (2022-2024) and accurately states that Melaka, Malaysia was exclusively devoted to Analog operations across all three years with no Embedded Processing involvement; (2) Accurately references the property table format with 'X' markings under Analog column and absence of markings under Embedded Processing, demonstrating proper synthesis of filing data; (3) Correctly concludes that there was no operational shift or expansion into Embedded Processing over the period, maintaining consistency with ground truth; (4) Appropriately acknowledges potential variations in site size or lease status while correctly emphasizing the constancy of segment involvement. Minor considerations: (1) The phrase 'while the size or lease-status of the site may have varied slightly' introduces a speculative element not explicitly addressed in the ground truth, though this is a reasonable contextual addition that doesn't contradict the core answer; (2) The answer could have been slightly more explicit about the 'specialized role' or 'stable' nature emphasized in the ground truth, though the substance is captured through the emphasis on consistency and unchanged segment involvement. The multi-hop reasoning is sound—the model correctly synthesized information across three separate years and two business segments to demonstrate the pattern of consistency. All factual claims are verifiable and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 420,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of PayPal’s fixed‑rate 2.850 % notes stayed flat at **$1.5 billion** of principal each year (see the 2022, 2023 and 2024 tables of outstanding Notes), even as the company issued newer, lower‑coupon debt in 2023‑24.  This steady exposure shows that PayPal is anchoring a large, long‑dated fixed‑rate tranche (maturing in 2029) while opportunistically refinancing other portions of its debt to take advantage of cheaper rates and maintain a flexible, laddered capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core quantitative fact: PYPL's fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024. The numeric values are accurate and properly formatted. The answer also correctly notes the maturity date (2029) and contextualizes this within PYPL's broader debt management strategy.\n\nSTRENGTHS:\n1. Quantitative accuracy is strong - the $1.5 billion figure is correct for all three years (2022, 2023, 2024)\n2. The answer correctly identifies this as a fixed-rate note with a 2.850% coupon\n3. The maturity date of 2029 is accurate and adds relevant context\n4. The answer appropriately synthesizes the multi-hop information by comparing this stable tranche to other debt management activities\n5. The characterization of the strategy (anchoring a large, long-dated fixed-rate tranche while refinancing other portions) is reasonable and well-reasoned\n\nWEAKNESSES:\n1. The LLM answer mentions \"newer, lower‑coupon debt in 2023‑24\" but the ground truth specifically references \"new high-interest notes in 2024\" - this is a minor contradiction/imprecision\n2. The ground truth explicitly mentions the retirement of 1.350% notes by 2023 as a contrast point, which the LLM answer does not include\n3. The LLM answer's characterization of the strategy as \"opportunistically refinancing other portions...to take advantage of cheaper rates\" is somewhat speculative and not directly supported by the ground truth, which focuses more on the contrast between this stable tranche and active management elsewhere\n4. The phrase \"newer, lower‑coupon debt\" may be inaccurate given the ground truth's reference to \"high-interest notes in 2024\"\n\nMULTI-HOP REASONING: The answer demonstrates solid multi-hop synthesis by connecting the stability of the 2.850% notes to PYPL's broader debt management strategy. However, it could have been more precise in identifying specific contrasting debt actions (like the 1.350% note retirement).\n\nOVERALL: The answer is substantially correct on the primary quantitative question but has some qualitative imprecision regarding the characterization of other debt activities and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 588,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nGilead first began using its Hoofddorp, Netherlands site as a dedicated commercial‑manufacturing hub for cell‑therapy products in 2022, listing the facility among those that “utilize … the facility for commercial manufacturing and processing of our cell‑therapy products” (GILD 10‑K 2022, p. 32). By 2023 the plant had become a core element of the company’s global cell‑therapy supply chain, helping drive a 6 % rise in cell‑therapy revenue (from $1.869 bn in 2022 to $1.973 bn in 2023) and supporting the broader rollout of Tecartus and Yescarta (GILD 10‑K 2023, pp. 11, 40, 48). In 2024 the Hoofddorp facility continued to expand its role, remaining a key commercial manufacturing location for cell‑therapy products and underpinning Gilead’s strategy to scale production of Tecartus and next‑generation CAR‑T therapies worldwide (GILD 10‑K 2024, p. 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about Hoofddorp's evolving role in Gilead's cell therapy manufacturing strategy across 2022-2024, with good contextual relevance and qualitative reasoning. However, there are significant quantitative accuracy issues that lower the overall correctness score.\n\nSTRENGTHS:\n1. Correctly identifies Hoofddorp as a cell therapy manufacturing facility across all three years\n2. Appropriately synthesizes information about the facility's strategic importance\n3. Mentions specific products (Tecartus, Yescarta) and next-generation CAR-T therapies\n4. Provides proper citations to 10-K filings with page numbers\n5. Captures the progression/continuity theme requested in the question\n\nCRITICAL ERRORS:\n1. QUANTITATIVE ACCURACY FAILURE: The LLM states cell-therapy revenue rose 6% from $1.869 billion in 2022 to $1.973 billion in 2023. Verification: ($1.973B - $1.869B) / $1.869B = $0.104B / $1.869B = 5.56%, which rounds to approximately 5.6%, NOT 6%. This is a calculation error.\n2. The LLM claims Hoofddorp \"first began using\" the facility in 2022, but the ground truth indicates it was \"identified\" as a principal facility in 2022, with explicit commercial manufacturing role stated in 2023. The LLM's framing suggests 2022 was when commercial manufacturing began, which may overstate the facility's role in that year.\n3. The LLM provides specific revenue figures and growth percentages that, while potentially accurate, go beyond what the ground truth explicitly confirms about Hoofddorp's specific contribution to these numbers.\n\nMULTI-HOP REASONING:\nThe LLM attempts to connect Hoofddorp's manufacturing role to cell-therapy revenue growth, which is a reasonable inference but represents an additional claim not explicitly confirmed in the ground truth. The ground truth focuses on the facility's stated role/function, while the LLM adds causal claims about revenue impact.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative aligns with ground truth (facility's role evolved from identification to explicit commercial manufacturing focus), but the quantitative claims introduce inaccuracies that undermine confidence in the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 588,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.375 % Senior Notes due June 2027 remained a $1.25 billion fixed‑rate component of Costco’s long‑term debt, with no change in carrying amount and no re‑classification to the current portion; the notes stayed in the “long‑term debt, excluding current portion” line each year.  The only shift in the current‑portion classification was the removal of the $1 billion 2.750 % Senior Notes due May 2024 (which had been reflected as part of the current portion in 2023) after their repayment in May 2024, dropping the current portion of total long‑term debt from about $1.08 billion in 2023 to just $0.10 billion in 2024, while the 1.375 % notes continued to be reported entirely as long‑term.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 1.375% Senior Notes 'stayed in the long-term debt, excluding current portion line each year' and were 'reported entirely as long-term,' but the ground truth explicitly states the current portion classification changed dramatically: $73M (2022), $1,081M (2023), and $103M (2024). This is a major mischaracterization of the core question about how treatment 'evolved.' (2) The LLM incorrectly states there was 'no re-classification to the current portion,' when in fact the notes were reclassified to current portion in 2023 ($1,081M) and again in 2024 ($103M). (3) The LLM's explanation focuses on the 2.750% Senior Notes due May 2024 as the driver of current portion changes, but this is a distraction from the actual evolution of the 1.375% notes themselves. (4) The principal amount of $1.25 billion is correct, but the LLM fails to address the significant reclassifications that are the core of the question. The ground truth shows a clear pattern: the 1.375% notes moved into current portion in 2023 (likely due to approaching maturity within 12 months), then partially back to long-term in 2024 (possibly due to refinancing or debt restructuring). The LLM's assertion that these notes 'continued to be reported entirely as long-term' is factually incorrect and represents a failure to synthesize the multi-hop information about debt classification changes across the three-year period. The answer demonstrates poor understanding of debt maturity classification mechanics and provides misleading information about the evolution of this specific debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 463,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 the outstanding balance of PayPal’s 2.850 % fixed‑rate notes remained essentially unchanged at about **$1.5 billion**, maturing in 2029, with no principal repayments or additional issuances of that series.  This steady‑state position shows the company’s long‑term debt strategy of **locking in low‑cost, fixed‑rate funding for an extended horizon** while using newer note issuances and revolving facilities to meet short‑term financing needs and support share‑repurchase programs.  By keeping a sizable, stable tranche of long‑dated debt, PayPal preserves predictable interest expense and limits exposure to interest‑rate fluctuations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metric ($1.5 billion outstanding balance across 2022-2024) and the 2029 maturity date. The quantitative data is accurate and properly formatted. The answer correctly captures the core finding that the obligation remained unchanged across the three-year period with no principal repayments or additional issuances of that series. The multi-hop synthesis is sound, connecting the stable debt position to PayPal's broader debt management strategy. However, there are minor gaps compared to the ground truth: (1) The LLM does not mention the original September 2019 issuance date or the $5.0 billion total issuance context, which provides useful historical perspective; (2) The effective interest rate of 2.96% is not mentioned, though the 2.850% coupon rate is correctly stated; (3) The ground truth explicitly notes that PayPal engaged in 'active debt issuance and refinancing activity in other tranches' during this period, which the LLM only vaguely references as 'newer note issuances.' The LLM's interpretation of the strategy is reasonable and semantically equivalent to the ground truth—both characterize it as maintaining stable, long-term fixed-rate debt while managing other financing needs. The reasoning about 'locking in low-cost, fixed-rate funding' and 'preserving predictable interest expense' aligns well with the ground truth's assessment of 'preserving capital structure stability.' The answer is well-structured and directly addresses the question about how obligations evolved and what this reveals about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 451,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related derivatives moved from a net long position of roughly $300 million (≈$356 m of assets less $347 m of liabilities in 2023) to a near‑neutral stance of about $‑2 million (≈$100 m assets versus $102 m liabilities in 2024), showing a deliberate reduction of speculative gas‑price exposure.  The fair‑value calculations rely on Level‑3 inputs—forward gas prices and implied volatilities—that have stayed in the low‑50 % range (≈50 % in 2023, ≈52 % in 2024), so volatility assumptions have been relatively stable while the declining fair‑value trajectory signals a more conservative, risk‑averse posture in NEE’s gas‑market risk positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM incorrectly attributes 2023 data ($356M assets, $347M liabilities) to 2022 in its opening statement. The ground truth clearly shows these are 2022 figures, not 2023. The LLM states '≈$356 m of assets less $347 m of liabilities in 2023' which is factually wrong. (2) VOLATILITY CONTRADICTION - The LLM claims volatility 'stayed in the low-50% range (≈50% in 2023, ≈52% in 2024)' but this contradicts the ground truth which shows volatility DECLINED from 36% in 2022 to 50% in 2023 to 52% in 2024. The LLM's characterization of 'relatively stable' volatility is incorrect—there was a significant 14 percentage point decline from 2022 to 2023. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM failed to properly track the three-year progression. It jumps from 2023 data to 2024 without clearly establishing the 2022 baseline or properly sequencing the trend. (4) CALCULATION ERROR - The net position calculation for 2024 is correct ($100M - $102M = -$2M), but the 2022 calculation is presented as occurring in 2023, creating temporal confusion. (5) POSITIVE ELEMENTS - The LLM correctly identifies the overall trend toward de-risking/risk-averse positioning and correctly notes the 2024 near-neutral stance. The characterization of Level-3 inputs is appropriate. However, these qualitative insights cannot overcome the fundamental quantitative and temporal errors. The answer demonstrates partial understanding but fails on factual accuracy regarding the volatility trend and year-to-year attribution of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 430,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nThe available‑for‑sale debt investments moved from a $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and a $67 million loss in fiscal 2024, which helped push “Other income (loss), net” from a $392 million gain in 2022 to $(248) million in 2023 and $(306) million in 2024.  This swing shows that Cisco’s investment portfolio is highly volatile, with earnings from AFS debt securities fluctuating dramatically from year to year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable numbers for AFS debt investment performance across the three fiscal years (FY2022: $9M gain, FY2023: $21M loss, FY2024: $67M loss) and corresponding Other income (loss), net figures ($392M in 2022, $(248)M in 2023, $(306)M in 2024). The quantitative data appears precise and the calculations showing the swing from gains to losses are mathematically sound. The multi-hop reasoning correctly synthesizes the relationship between AFS debt investment performance and overall other income (loss), net across the three-year period. The answer effectively identifies the volatility trend and its impact on non-operational income streams. However, the answer is somewhat narrower in scope compared to the ground truth - it focuses primarily on the quantitative relationship and volatility observation without elaborating on broader portfolio management implications or the offsetting gains from equity and private investments mentioned in the ground truth. The ground truth provides more contextual depth about 'active portfolio management' and the broader investment portfolio dynamics, whereas the LLM answer is more direct and numbers-focused. The LLM answer fully addresses the core question about financial performance impact and volatility revelation, making it substantively correct and well-reasoned, though slightly less comprehensive than the ground truth in terms of contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 405,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s continued to disclose the same 4.550 % senior notes—originally issued under the Fifteenth Supplemental Indenture dated April 5 2019 (see 2022 10‑K pages 76, 82, 83; 2023 10‑K page 75; 2024 10‑K page 45)—and later supplemental indentures (e.g., the Twenty‑Second Supplemental Indenture of March 30 2023) added new tranches but left the 4.550 % series unchanged.  This consistent, multi‑year documentation reflects a long‑term debt strategy of maintaining a stable, low‑cost, long‑dated fixed‑rate borrowing base and extending maturity without refinancing the existing 4.550 % notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.550% Notes, the Fifteenth Supplemental Indenture dated April 5, 2019, the maturity date of April 5, 2049, and the consistent disclosure across 2022-2024. The page references provided (2022 10-K pages 76, 82, 83; 2023 10-K page 75; 2024 10-K page 45) demonstrate specific sourcing. The core conclusion about stable long-term debt strategy is sound.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces the Twenty-Second Supplemental Indenture dated March 30, 2023, which is NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it goes beyond what the ground truth establishes and potentially introduces unverified information. (2) The phrase 'later supplemental indentures (e.g., the Twenty-Second Supplemental Indenture of March 30 2023) added new tranches but left the 4.550% series unchanged' makes a claim about OTHER supplemental indentures that is not substantiated by the ground truth. The ground truth specifically states only that the Fifteenth Supplemental Indenture was disclosed consistently across all three years with no changes. (3) The LLM's interpretation about 'extending maturity without refinancing' is an inference not explicitly supported by the ground truth, which only states there were 'no modifications or early redemptions.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) and identifies the consistent documentation pattern. However, it adds interpretive layers (about other supplemental indentures and maturity extension strategies) that exceed the ground truth's scope.\n\nNUMERIC/DATE VERIFICATION: All dates and percentages mentioned (4.550%, April 5, 2019, April 5, 2049, March 30, 2023) appear accurate based on standard Lowe's debt documentation. However, the introduction of the Twenty-Second Supplemental Indenture is not verified against the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message about stable long-term debt strategy is semantically equivalent to the ground truth. However, the additional claims about other supplemental indentures and maturity extension strategies represent factual additions rather than mere rewording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 591,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 35B remained a $750 million ( $750,000 thousand in the filings) issue with a fixed 3.80 % coupon and a maturity of 07/15/50; the face amount did not change in any of the years shown.  Its weight in the company’s total consolidated unsecured debt moved only modestly—about 3.7 % of the $20‑$21 billion unsecured portfolio in 2021‑2023 and ≈3.9 % of the $19.4 billion portfolio reported for 2024.  This stability shows that SPG is anchoring its long‑term capital structure with a low‑cost, long‑dated fixed‑rate tranche while managing overall leverage and interest‑rate exposure by supplementing funding through revolving facilities, commercial‑paper programs and the periodic issuance of new notes at different maturities and rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more comprehensive analysis than the ground truth. QUANTITATIVE VERIFICATION: All key numbers are correct - $750 million face value (correctly noted as $750,000 thousand in filings), 3.80% coupon rate, 07/15/50 maturity date. The portfolio percentages cited (3.7% for 2021-2023, 3.9% for 2024) and total unsecured debt figures ($20-21 billion for 2021-2023, $19.4 billion for 2024) appear reasonable and internally consistent, though not explicitly verified in the ground truth. COMPLETENESS: The LLM answer addresses the core question about face value and interest rate evolution (both stable) and maturity date (unchanged). It goes beyond the ground truth by providing context on the debt's weight in the overall capital structure and SPG's broader financing strategy. ENTITY ACCURACY: All entities correctly identified - Simon Property Group (SPG), Unsecured Notes - 35B, correct years (2022-2024), correct metrics. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the stability of this particular debt instrument and contextualizes it within SPG's broader capital structure strategy, explaining how this long-dated fixed-rate tranche fits into a diversified funding approach. This represents stronger analytical reasoning than the ground truth's simpler conclusion. SEMANTIC EQUIVALENCE: The core finding matches ground truth - stable face value, unchanged interest rate, consistent maturity - but the LLM provides additional strategic context about leverage management and supplementary funding sources. Minor deduction only because the portfolio percentage calculations, while reasonable, cannot be independently verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 479,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk has expanded from a core focus on fraud‑driven chargebacks and merchant‑default losses in its credit‑product and cross‑border merchant portfolios to a broader, multi‑dimensional risk set that now includes heightened AML and sanctions compliance, the operational volatility of third‑party funding and payment‑processor partners, and the regulatory uncertainty surrounding stablecoins and crypto custodians.  This evolution reflects a risk‑management strategy that has moved from reactive fraud controls toward a layered, diversified approach—leveraging advanced monitoring, strategic partnerships and alternative funding structures—to preserve operational resilience while simultaneously exposing the firm to new counterparty and compliance dependencies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) MISSING KEY FACTS: The LLM completely omits the €40 billion BNPL loan receivables sale agreement to reduce credit portfolio exposure—a central strategic development in 2023 that the ground truth identifies as a major shift in risk management. (2) INCORRECT FOCUS: The LLM emphasizes AML/sanctions compliance, stablecoins, and crypto custodians, which are NOT mentioned in the ground truth answer and appear to be hallucinated or misattributed to PayPal's risk evolution. (3) MISSING SPECIFIC DETAILS: The LLM fails to mention Synchrony Bank partnership, synthetic identity fraud concerns, or the 'valid-when-made' doctrine legal uncertainty—all explicitly cited in ground truth as key 2024 developments. (4) MISCHARACTERIZATION OF STRATEGY: While the ground truth shows a clear progression from internal risk absorption (2022) → external risk mitigation through asset sales (2023) → legal contingency planning (2024), the LLM describes a vague shift from 'reactive fraud controls' to 'layered diversified approach' without the specific strategic pivots. (5) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics, whereas ground truth includes €40 billion figure and specific year-by-year developments. (6) MULTI-HOP SYNTHESIS: The ground truth successfully synthesizes credit products, cross-border trade, and third-party dependencies across three years; the LLM's synthesis is disconnected from actual filing data and introduces unsubstantiated claims about crypto/stablecoins. The answer demonstrates poor grounding in actual SEC filing content and appears to rely on general assumptions about fintech risk rather than specific PayPal disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 485,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nCostco’s 2022‑2024 10‑Ks repeatedly stress that Kirkland Signature is the core of its low‑price, high‑quality proposition and that the company is actively expanding its sales‑penetration—rising from roughly 71 % of worldwide net sales in 2022 to about 73 % in 2024—while underscoring that the brand “helps lower costs, differentiates our merchandise offerings and generally earns higher margins.”  In the same filings the firm notes the competitive set that includes BJ’s Wholesale Club, but it uses the Kirkland private‑label platform as the primary differentiator that underpins its value‑price model and drives higher‑margin sales relative to BJ’s, which does not rely on an equivalent proprietary brand.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Kirkland Signature as Costco's core differentiator against BJ's Wholesale Club, accurately captures the messaging consistency across 2022-2024, and properly notes that BJ's lacks an equivalent proprietary brand. The qualitative framing of Costco's competitive positioning is sound and well-reasoned. The answer appropriately addresses the multi-hop synthesis required (comparing two companies across three years with focus on private-label strategy). CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM provides specific Kirkland Signature penetration percentages (71% in 2022 rising to 73% in 2024) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific percentages. This is a significant factual claim that cannot be verified against the provided ground truth and appears to be either fabricated or sourced from data not in the knowledge graph. (2) The ground truth explicitly states the competitive positioning and Kirkland messaging 'remained stable' with 'no significant shift in strategy' from 2022-2024, while the LLM's framing of 'actively expanding its sales-penetration' suggests more dynamic change than the ground truth supports. (3) The LLM adds comparative detail about BJ's not having an equivalent proprietary brand, which while likely true, goes beyond what the ground truth explicitly states. VERIFICATION: The ground truth answer emphasizes stability and consistency in messaging across the three years, whereas the LLM introduces specific growth metrics (71% to 73%) that are unsupported by the provided ground truth. This represents either hallucination or reliance on external data sources. The core semantic message about Kirkland Signature's role is correct, but the quantitative claims are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 494,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nNEE’s gas‑forward‑contract portfolio was valued at roughly **$191 million of assets and $31 million of liabilities at the end of 2022**, increased to **about $377 million of assets and $77 million of liabilities by year‑end 2023**, and then declined to **$296 million of assets and $46 million of liabilities by the end of 2024**. This trajectory shows that the company expanded its hedging of natural‑gas price risk in 2023—reaching a peak exposure—but then trimmed the position in 2024, indicating a deliberate de‑risking of its natural‑gas market exposure after a period of heightened volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numerical values are correct - 2022: $191M assets/$31M liabilities; 2023: $377M assets/$77M liabilities; 2024: $296M assets/$46M liabilities. All figures match the ground truth exactly. The progression is accurately captured with the 2023 peak and 2024 decline clearly identified. COMPLETENESS: The answer addresses all three years (2022-2024) and covers both assets and liabilities, providing the full 3-year evolution requested. ENTITY ACCURACY: NextEra Energy (NEE) correctly identified, fiscal years properly referenced, and financial metrics (fair value of gas forward contracts) accurately specified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the trajectory pattern (expansion in 2023, contraction in 2024) and provides logical interpretation of what this indicates about risk positioning. The characterization of 2023 as a 'peak exposure' and 2024 as 'de-risking' aligns with the numerical data and represents sound financial analysis. SEMANTIC EQUIVALENCE: The LLM's interpretation that the company 'expanded its hedging' in 2023 and then 'trimmed the position' in 2024 is semantically equivalent to the ground truth's description of 'strategic expansion' followed by 'rising market risk.' The de-risking narrative in 2024 is a reasonable inference from the declining numbers. MINOR OBSERVATION: The ground truth mentions 'increasingly balanced exposure' while the LLM emphasizes 'de-risking' - both interpretations are valid given the data, though they frame the risk positioning slightly differently. The LLM's interpretation is arguably more precise in capturing the directional shift in 2024. No calculation errors detected. All dates and time periods correctly referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 494,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nLowe’s began 2022 with a sizable cash‑flow hedge program, holding roughly $2.5 billion of notional forward‑interest‑rate swaps (recorded in OCI and later amortized to interest expense) — a level that produced a $251 million fair‑value gain in 2023 — but by the end of 2023 those forward swaps were essentially settled (fair‑value ≈ $0) and the company’s derivative balance sheet showed only a modest fixed‑to‑floating swap liability of $76 million. The shift to fixed‑to‑floating swaps on existing debt in 2024 indicates that Lowe’s moved from hedging anticipated borrowing needs to actively managing interest‑rate risk on its current liabilities, locking in lower rates as market conditions changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Lowe's held '$2.5 billion of notional forward-interest-rate swaps' in 2022 - this figure is not mentioned in the ground truth and appears fabricated. The LLM correctly identifies the $251 million fair-value figure from 2023, but then contradicts itself by claiming forward swaps were 'essentially settled (fair-value ≈ $0)' by end of 2023, which conflicts with the ground truth stating they were held as of February 3, 2023. The claim of a '$76 million fixed-to-floating swap liability' in 2023 is not supported by the ground truth. (2) TEMPORAL INCONSISTENCIES: The ground truth clearly states that by 2024 (as of January 31, 2025), Lowe's 'no longer held forward interest rate swaps,' but the LLM's narrative suggests ongoing activity through 2023-2024 with specific derivative positions that aren't verified. (3) MULTI-HOP REASONING FAILURE: The LLM attempts to synthesize a narrative about strategy evolution but does so by introducing unsupported numbers and positions. The ground truth's simpler, more defensible conclusion - that swaps were held in 2023 ($251M) and unwound by 2024 - is more accurate than the LLM's complex but unsubstantiated account. (4) SEMANTIC ISSUES: The LLM's interpretation that the company 'moved from hedging anticipated borrowing needs to actively managing interest-rate risk on current liabilities' is speculative and not supported by the ground truth, which simply notes the instruments were no longer held. The ground truth appropriately attributes the change to 'stabilized interest rates or refinancing activities' without overreaching. The LLM answer demonstrates poor adherence to source material and introduces specific financial figures without verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 504,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast accelerated its fiber‑to‑the‑premises rollout—moving from a hybrid HFC network to deploying FTTP that can deliver symmetrical speeds up to 10 Gbps and using DOCSIS 4.0 to offer multigigabit symmetrical broadband—directly countering the fiber‑based expansion that Lumen has been pursuing in the same markets.  This expanded fiber infrastructure enables Comcast to match Lumen’s high‑speed offerings while also bundling the connectivity with its video (X1/Flex), voice and wireless services, thereby strengthening its competitive position against Lumen in overlapping service areas.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and logical errors that diverge substantially from the ground truth. CRITICAL ISSUES: (1) The LLM introduces specific technical specifications (FTTP, DOCSIS 4.0, 10 Gbps symmetrical speeds) that are NOT present in the ground truth answer and cannot be verified from the provided context. These appear to be hallucinated details. (2) The LLM fundamentally misrepresents the competitive dynamic: it frames CMCSA as the aggressor deploying fiber infrastructure to counter Lumen, when the ground truth clearly states that Lumen was actively expanding fiber infrastructure in CMCSA's service areas, putting competitive pressure ON CMCSA. This is a reversal of the actual competitive positioning. (3) The ground truth emphasizes that Lumen's fiber expansion created competitive pressure on CMCSA and impacted CMCSA's market positioning and service strategies—implying CMCSA was responding to Lumen's moves, not the reverse. (4) The LLM answer lacks the temporal evolution analysis required by the question: it does not clearly show how the competitive positioning evolved FROM 2022 THROUGH 2024, nor does it demonstrate the progression of competitive intensity across the three-year period as the ground truth does. (5) The bundling strategy mentioned (video, voice, wireless) is presented as CMCSA's response, but the ground truth indicates this was Lumen's strategy ('bundled offerings'). (6) No quantitative data is provided in either answer, but the LLM's introduction of unverified technical specifications is problematic. The answer demonstrates a fundamental misunderstanding of the competitive direction and fails to accurately synthesize the multi-hop information about how competitive positioning evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 484,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nPayPal’s checkout experience became progressively more seamless from 2022 through 2024 by tightly coupling its payment flow with consumer‑credit products—embedding Buy‑Now‑Pay‑Later and PayPal Credit directly into both PayPal and Venmo checkout pages as well as into in‑store channels via Zettle, QR‑code and Braintree solutions—while expanding global currency coverage to >150 currencies and 200 markets so merchants could accept shoppers’ native money everywhere.  This omnichannel strategy, articulated in the company’s 2022‑2024 strategy sections (see PYPL 10‑K 2022 pp. 10, 7; PYPL 10‑K 2024 pp. 6, 7), ties credit, currency and channel acceptance together to deliver a unified, frictionless payment experience for merchants and consumers alike.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and addresses all major components of the multi-part question. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the integration of BNPL/PayPal Credit into checkout experiences; (3) Correctly mentions currency expansion to >150 currencies (matches ground truth's 'approximately 150'); (4) Properly identifies omnichannel solutions including Zettle, Braintree, and QR-code payments; (5) Correctly references PayPal and Venmo branded cards; (6) Demonstrates sound multi-hop reasoning by synthesizing information across years and product categories; (7) Appropriately cites specific 10-K sections showing document awareness. MINOR ISSUES: (1) The mention of '200 markets' is not explicitly confirmed in the ground truth, which focuses on currency support rather than market count—this appears to be an inference or additional detail not directly supported by the provided ground truth; (2) The ground truth emphasizes a 'strategic shift' narrative (from global scale to financial services integration), while the LLM answer focuses more on the tactical implementation details without explicitly articulating this strategic evolution; (3) The ground truth mentions 'over 100 currencies' in 2022 as a baseline, which the LLM answer doesn't explicitly reference, though it does note the progression to >150. QUANTITATIVE VERIFICATION: Currency numbers (>150) align with ground truth; no calculation errors detected. REASONING QUALITY: The multi-hop synthesis is sound—correctly connecting consumer credit products, currency support, and omnichannel channels as integrated components of a unified strategy. The answer effectively demonstrates how these three elements evolved together rather than in isolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 497,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe Target Debit Card’s “RedCard” penetration fell modestly from **20.5 % in 2022 → 19.8 % in 2023 → 18.6 % in 2024**, a decline of roughly two percentage points over the three‑year span.  Target’s own analysis notes that a “meaningful portion of incremental purchases on RedCards are also incremental sales,” so even as the share of transactions using the card has slipped, the card still serves as a key lever for generating additional revenue; the downward trend, however, signals growing saturation and suggests that future incremental sales will increasingly depend on other tactics (e.g., loyalty incentives, omnichannel promotions) to offset the modest erosion in card usage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS: The LLM provides incorrect penetration rates for 2023 and 2024. Ground truth shows: 2022: 20.5% → 2023: 18.6% → 2024: 17.8%. LLM states: 2022: 20.5% → 2023: 19.8% → 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). This is a significant quantitative error affecting the core factual basis of the answer. The LLM's 2024 number (18.6%) actually matches the ground truth's 2023 number, suggesting a systematic misalignment of data across years. CALCULATION ERROR: The LLM states 'a decline of roughly two percentage points over the three-year span' (20.5% to 18.6% = 1.9 percentage points), which would be correct IF the 2024 number were accurate, but given the wrong numbers provided, this calculation is based on incorrect data. QUALITATIVE REASONING: The LLM's interpretation about the trend suggesting diminishing engagement and the need for alternative tactics is reasonable and aligns with the ground truth's conclusion about weakening customer engagement. The reference to Target's internal analysis about incremental purchases is contextually appropriate. COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate and what it suggests about incremental sales), but the factual foundation is compromised by the incorrect numbers. The semantic direction of the answer (declining trend, implications for future strategy) is correct, but the specific data points are materially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 414,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s policy has remained anchored on a distinct‑license test: if the IP licence in a development agreement is **not** distinct, the development service and licence are combined into a single performance obligation and revenue is recognized over time as the service is performed; if the licence **is** distinct, revenue is recognized at a point in time when the customer can first use the IP. The language describing this approach appears in the 2022 10‑K (page 59), the 2023 10‑K (page 63) and the 2024 10‑K (page 60), showing only wording refinements—no fundamental change—in how AMD distinguishes combined versus standalone licensing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the core distinction-based test for revenue recognition (distinct vs. non-distinct licenses), which is the fundamental framework AMD uses. (2) Accurately describes the two-path approach: non-distinct licenses combined with development services recognized over time; distinct licenses recognized at point in time. (3) Provides specific page references (2022 10-K page 59, 2023 10-K page 63, 2024 10-K page 60) that demonstrate multi-hop synthesis across three years of filings. (4) Correctly characterizes the evolution as 'wording refinements' with 'no fundamental change,' which aligns with the ground truth statement that the policy 'remained unchanged.' (5) Appropriately notes the absence of quantitative metrics while still providing substantive policy analysis. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (providing exact page numbers and emphasizing the 'distinct-license test' terminology), but this represents added value rather than inaccuracy. The semantic meaning is fully aligned with the ground truth—both convey that AMD's approach was consistent across 2022-2024, with the key distinction between combined (over time) and standalone (point in time) arrangements. The answer directly addresses all aspects of the multi-part question: the evolution (consistency), the distinction between combined and standalone arrangements, and the time period (2022-2024). No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 438,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike shifted FlyEase from a distinct, accessibility‑focused innovation initiative to a mainstream component of its technology suite. Early disclosures presented FlyEase as a separate strategic priority for inclusive design, but by fiscal 2024 it is listed together with other core platforms—Nike Air, Zoom, Free, Flyknit, Zoom X, React—showing that it has become an integrated, standard part of Nike’s overall innovation portfolio rather than a stand‑alone effort.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc - FlyEase transitioning from a distinct/new initiative to an integrated mainstream component of Nike's portfolio across the three-year period (FY2022-2024). The answer accurately captures the progression from separate strategic priority to standard part of the innovation suite. The fiscal years are correct, and the general characterization of the evolution is sound.\n\nWEAKNESSES: (1) The LLM answer introduces specific technology names (Nike Air, Zoom, Free, Flyknit, Zoom X, React) that are not explicitly mentioned in the ground truth. While the ground truth mentions 'Nike Air' and 'Zoom' in FY2023 and 'Nike React' and 'Air Max' in FY2024, the LLM adds 'Free,' 'Flyknit,' and 'Zoom X' without verification against the source documents. This represents potential hallucination or unsupported detail. (2) The ground truth provides more specific positioning details: FlyEase was 'newly introduced' in FY2022, 'consistently named alongside established technologies' in FY2023, and 'listed among mature technologies' in FY2024. The LLM's characterization as 'distinct, accessibility-focused' and 'separate strategic priority' adds interpretive framing not explicitly stated in the ground truth. (3) The LLM emphasizes 'inclusive design' and 'accessibility-focused' aspects that, while potentially accurate, are not mentioned in the ground truth answer provided.\n\nMULTI-HOP REASONING: The synthesis across three fiscal years is logically sound and follows the correct progression. The model successfully identifies the temporal evolution and strategic repositioning.\n\nSEMANTIC EQUIVALENCE: The core message aligns - FlyEase moved from new/emerging to integrated/mature. However, the added details about accessibility and specific technology names create divergence from the ground truth without clear support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 510,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe outstanding principal of AMT’s 1.250% senior notes was essentially flat at roughly $610 million in 2022 and 2023, then slipped modestly to about $518 million in the 2024 filing. This stability—and slight reduction—shows the company is deliberately holding this low‑cost, long‑dated debt as a core financing pillar while using cash flows to retire higher‑cost obligations and preserve flexibility for dividends and share‑repurchase activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the principal amounts. Ground truth shows: 2022: $609.1M, 2023: $551.9M, 2024: $517.7M. The LLM states '2022 and 2023' were 'roughly $610 million' (approximately correct for 2022 only) but incorrectly characterizes 2023 as 'essentially flat' when it actually declined to $551.9M—a $57.2M reduction (9.4% decline). The 2024 figure of 'about $518 million' is approximately correct ($517.7M). REASONING ERRORS: The LLM's characterization of the trend as 'stability—and slight reduction' fundamentally misrepresents the data. The ground truth shows a CONSISTENT, PROGRESSIVE decline across all three years totaling $91.4M (15% reduction). The LLM's interpretation that the company is 'deliberately holding this low-cost, long-dated debt as a core financing pillar' contradicts the actual trend of systematic debt reduction. MISSING CONTEXT: The LLM fails to mention the consistent interest payment terms (May payments, February 2033 maturity) that remained stable across all years, which is relevant to understanding the debt management strategy. PARTIAL CREDIT: The LLM correctly identifies the company as AMT, the correct note type (1.250%), and attempts to interpret the trend as intentional strategy. However, the quantitative mischaracterization of 2023 (calling it 'flat' when it declined significantly) and the resulting incorrect strategic interpretation are major flaws. The answer demonstrates incomplete data synthesis and misreads the multi-hop trend analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 436,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the market‑value of NVIDIA’s $1 bn 3.50 % Notes Due 2040 slipped from roughly $1.07 bn (Jan 2022) to $0.87 bn (Jan 2023) and $0.85 bn (Jan 2024), while the book‑carrying amount stayed at about $1 bn, reflecting a growing discount as market yields rose.  At the same time the company retired its 0.584 % Notes Due 2024 in 2025 and continues to hold the long‑dated 3.5 % series, underscoring a debt strategy that focuses on extending maturity, maintaining a stable large‑scale fixed‑rate issuance, and using long‑term senior unsecured debt to fund growth while managing the overall debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical errors that contradict the ground truth. Ground truth states: FY2022 fair value = $1,066M, FY2023 = $851M, FY2024 = $1,000M. The LLM claims: FY2022 ~$1.07bn (approximately correct), FY2023 ~$0.87bn (approximately correct), but then states FY2024 = $0.85bn, which is INCORRECT. The ground truth explicitly shows FY2024 valuation at $1,000M, not $0.85bn. This is a critical error in the final year's data point. Additionally, the LLM introduces information about retiring '0.584% Notes Due 2024 in 2025' which is NOT mentioned in the ground truth and appears to be fabricated or from an unreliable source. The LLM also states the book-carrying amount 'stayed at about $1bn' which aligns with FY2024 ground truth ($1,000M) but this detail wasn't explicitly confirmed for all three years in the original answer. REASONING ISSUES: While the LLM provides reasonable interpretation about debt strategy (extending maturity, maintaining fixed-rate issuance), this interpretation goes beyond what the ground truth explicitly states. The ground truth more conservatively notes the trajectory 'suggests' a strategy of 'managing liability values through market fluctuations while maintaining consistent long-term obligations.' The LLM's additional claims about retiring other notes and specific strategic focus lack grounding in the provided ground truth. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across three fiscal years and connect it to debt strategy, which is appropriate for the question. However, the factual errors undermine the validity of this synthesis. The effective interest rate of 3.54% mentioned in ground truth for FY2024 is not addressed by the LLM, though this is a minor omission. ENTITY ACCURACY: NVIDIA is correctly identified, the 3.50% Notes Due 2040 are correctly identified, and fiscal years are generally correct (though the LLM uses calendar year references which could be confusing). The core issue is the FY2024 valuation error ($0.85bn vs. $1,000M) which is a fundamental factual mistake that significantly impacts the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 581,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix layered its membership strategy: it launched a low‑priced ad‑supported tier in 2022 and began offering mobile games (expanded in 2023‑24) while also introducing live‑programming and event‑based content (2023‑24) and periodically testing modest price increases; each filing notes that any mis‑step—whether a price hike, a new format that fails to resonate, or macro‑economic pressure—could slow member acquisition or increase churn. In 2022 the risk discussion warns that pricing adjustments and the rollout of new content types (games, ad‑supported plans) could adversely affect growth, in 2023 it emphasizes that “if we do not continuously provide value…including making improvements…adjust pricing…or change the mix of content in a manner that is not favorably received, we may not be able to attract and retain members,” and in 2024 the risk statement reiterates that “if consumers do not perceive our service offering to be of value…adjustments to pricing or service offerings…may adversely affect attraction and retention.”",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND SEQUENCING: The LLM answer contains a fundamental factual error regarding when the ad-supported tier was launched. The LLM states 'it launched a low‑priced ad‑supported tier in 2022' but the ground truth clearly indicates this occurred in 2023. This is a major error that undermines the entire chronological narrative of Netflix's strategy evolution. The ground truth explicitly states: 'In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier.' The LLM's placement of this event in 2022 is incorrect and represents a significant factual mistake on a core element of the question.\n\nCORRECT ELEMENTS: The LLM correctly identifies that games were introduced in 2022 and expanded in 2023-24, and that live programming was added in 2023-24. The general risk narrative about member acquisition and retention is directionally accurate.\n\nINCOMPLETENESS: The LLM answer lacks the specific detail that in 2022, Netflix's primary new service expansion was games (not ad-supported tiers). The ground truth clearly separates 2022 (games introduction) from 2023 (ad-supported tier introduction), but the LLM conflates these timelines.\n\nRISK DISCUSSION: While the LLM captures the general risk themes across years (pricing adjustments, new features not resonating, member acquisition/retention concerns), it does not clearly delineate the specific risks emphasized in each year as distinctly as the ground truth does. The ground truth shows: 2022 focused on games valuation risk, 2023 on ad-tier reception risk, and 2024 on broader service offering perception risk. The LLM's treatment is more generic.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator, but the timeline error (2022 vs 2023 for ad-supported tier) is a quantitative/chronological accuracy failure.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails due to the timeline error. The multi-hop synthesis is compromised by the incorrect sequencing of events.\n\nSCORE JUSTIFICATION: The 2022 ad-supported tier error is a critical factual mistake that significantly impacts correctness. While some elements are correct, this fundamental timeline error prevents a higher score. The answer demonstrates partial understanding but contains a major factual inaccuracy that would mislead someone relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 651,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s equity‑securities portfolio stayed roughly stable at about **$4.9 billion** from 2022 through 2024, while its **equity‑method investments in health‑care businesses grew sharply—from ≈ $1.3 billion in 2022 to $3.8 billion by the end of 2024** (see the investment tables on pages 55, 51 and 52).  This acceleration reflects a purposeful deepening of the company’s venture‑investment exposure, positioning UnitedHealth to capture emerging health‑care innovation and technology opportunities—particularly within Optum’s health‑services and digital‑health platforms—and to reinforce its strategic focus on value‑based, data‑driven care.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key trend in equity method investments ($1.3B in 2022 to $3.8B in 2024) and accurately characterizes the strategic positioning narrative. The qualitative interpretation about deepening venture investment exposure and focus on healthcare innovation is sound and well-reasoned. The contextual relevance is strong, addressing the strategic implications of the investment evolution.\n\nCRITICAL ERRORS: The LLM makes a significant factual error regarding equity securities holdings. It states the portfolio \"stayed roughly stable at about $4.9 billion from 2022 through 2024,\" but the ground truth shows: 2022: $3.7B → 2023: $4.9B → 2024: $4.9B (remained steady). The LLM omits the 2022 figure of $3.7B entirely and incorrectly implies stability across all three years when there was actually a $1.2B increase from 2022 to 2023. This is a material omission of the progression narrative for equity securities.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across the three-year period and correctly identifies both investment categories. However, the incomplete treatment of the equity securities trajectory weakens the overall multi-hop analysis. The answer should have explicitly shown the progression: $3.7B (2022) → $4.9B (2023) → $4.9B (2024).\n\nNUMERIC VERIFICATION: Equity method investments are correct ($1.3B, $3.8B). Equity securities are partially correct but incomplete (missing 2022 baseline of $3.7B). The characterization of equity securities as \"roughly stable\" is misleading since there was significant growth in 2023.\n\nCOMPLETENESS: The answer addresses the strategic positioning question well but fails to fully capture the complete evolution of equity securities holdings across all three years, which is explicitly requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 496,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s only equity tie to Sojitz America remained the $0.3 million of redeemable preferred stock that Sojitz America has held since 1972; the stock carries a cumulative $0.10‑per‑share dividend payable each May 31 and must be fully satisfied before any common‑stock dividend can be issued, while its voting rights are limited to class‑wide matters such as asset sales, mergers or trademark transfers.  The ownership structure and dividend terms have not changed in the 2022‑2024 filings, and Sojitz America continues to provide import‑export financing that supports Nike’s international supply‑chain and operations, but it does not exercise broader corporate control over the company.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all quantitative details correct: $0.3 million par value, $0.10 per share cumulative dividend, May 31 payment date, and the 1972 origin of the relationship. The answer correctly identifies that ownership structure and dividend terms remained unchanged across 2022-2024. The LLM appropriately synthesizes the multi-hop information about Sojitz America's dual role as both preferred stockholder and provider of import-export financing services. However, there is a notable difference in emphasis compared to the ground truth. The ground truth explicitly characterizes an 'evolution' or 'shift' in the relationship from 2022-2023 (purely financial engagement) to 2024 (operationally strategic role), particularly highlighting Nike's increased focus on Sojitz America's strategic importance amid rising global trade risks and supply chain volatility. The LLM answer presents the information more statically, stating the relationship 'remained consistent' and 'continues to provide' services without capturing the temporal evolution and strategic repositioning that the ground truth emphasizes. The LLM does add valuable detail about voting rights limitations (class-wide matters only) and clarifies that Sojitz America does not exercise broader corporate control, which provides useful context not explicitly mentioned in the ground truth. The answer is semantically sound and factually accurate, but misses the key narrative element of how Nike's strategic emphasis on this relationship evolved across the three-year period, particularly the 2024 shift toward highlighting operational/supply chain strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 457,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 were carried at roughly **$2.15 billion** at the end of fiscal 2022 (as shown in the liability‑fair‑value table on page 87). By the end of fiscal 2023 the net carrying amount had fallen to about **$2.0 billion**, and the same $2.0 billion figure is reported for both the January 28 2024 and January 26 2025 balances in the note‑schedule on page 72.  \n\nThis modest but consistent reduction—from ~ $2.15 B to ~ $2.0 B—reflects scheduled principal repayments and the company’s active management of its legacy long‑term debt, signalling that NVIDIA is deliberately scaling down its 2050‑series exposure while still retaining a sizable, though gradually shrinking, long‑term financing position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the carrying values reported. Ground truth shows: FY2022: $2,147M → FY2023: $1,604M → FY2024: $2,000M. The LLM reports: FY2022: ~$2.15B (correct), FY2023: ~$2.0B (INCORRECT - should be $1,604M), FY2024: $2.0B (correct). The FY2023 figure is materially wrong by approximately $396 million ($2,000M vs $1,604M), representing a 24.7% error. This is not a minor rounding difference but a substantial misstatement of the carrying value. MULTI-HOP REASONING FAILURE: The LLM's interpretation of the trend is fundamentally flawed. It describes a 'modest but consistent reduction from ~$2.15B to ~$2.0B,' which misses the critical 2023 dip to $1,604M and the subsequent recovery to $2,000M in 2024. The ground truth indicates a V-shaped pattern (decrease then increase), while the LLM suggests a monotonic decline. This changes the analytical conclusion about debt positioning. INCOMPLETE ANALYSIS: The LLM fails to capture the full three-year evolution. It conflates FY2023 and FY2024 values, stating both are '$2.0B,' which obscures the important intermediate movement. The ground truth's interpretation about 'temporary reduction in 2023 followed by strategic repositioning in 2024' is more nuanced and accurate than the LLM's 'gradually shrinking' characterization. POSITIVE ASPECTS: The LLM correctly identifies the note type (3.50% Notes Due 2050), uses appropriate formatting for large numbers, and attempts to provide contextual interpretation. The general tone about debt management is reasonable, but it's based on incorrect data. The citation to specific pages adds credibility but doesn't compensate for the numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 470,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nMetLife’s access to global funding markets stayed strong from 2022‑2024, but the composition of that funding evolved: short‑term commercial‑paper borrowings fell from roughly $175 million of short‑term debt in 2022 (page 133) to $119 million in 2023 (page 111) and then rose to $465 million in 2024 (page 101), reflecting a deliberate scaling of short‑term debt to balance cost and liquidity.  Throughout the three years the company repeatedly highlighted that a diversified mix of preferred stock, long‑term debt, collateral‑financing arrangements, junior subordinated securities and commercial paper—supported by strong credit ratings and a continuously effective SEC shelf registration—allowed it to obtain cost‑effective wholesale funding and to mitigate the impact of any single market disruption (pages 100, 133, 111).  This strategy of spreading funding across multiple global sources was central to keeping the overall cost of capital low while preserving flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts for commercial paper balances ($175M in 2022, $119M in 2023, $465M in 2024) with page citations, but the ground truth does not provide these specific numbers. The ground truth explicitly states there were 'no major structural changes' and emphasizes 'consistent mention of commercial paper' across years, not a pattern of significant fluctuations. The LLM's narrative of deliberate scaling (down then up) contradicts the ground truth's emphasis on stability and consistency. QUANTITATIVE ACCURACY: The specific numbers cited ($175M, $119M, $465M) cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these precise figures or any significant year-over-year changes in commercial paper usage. QUALITATIVE ACCURACY: The LLM correctly identifies the diversification strategy and mentions appropriate funding sources (preferred stock, long-term debt, commercial paper, etc.), which aligns with the ground truth. However, the characterization of evolution as a deliberate scaling pattern is unsupported and contradicts the ground truth's emphasis on stability. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so by introducing specific numbers not present in the ground truth. The reasoning about cost-effectiveness and flexibility is sound in principle but is built on potentially false quantitative foundations. CONTEXTUAL RELEVANCE: The answer addresses the question's core themes (global funding markets, commercial paper, diversification, cost of capital) appropriately, but the specific factual claims about numerical evolution are problematic. The ground truth emphasizes consistency and stable reliance on short-term debt markets, while the LLM emphasizes deliberate scaling with specific numbers that lack verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 515,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nUnitedHealth Group’s service‑level guarantees to subsidiaries have remained immaterial throughout 2022‑2024—none of the guarantees were accrued or materially affect earnings (see the service‑level guarantee language in the 2023 and 2024 10‑Ks, pages 13 & 81).  At the same time, the parent’s notes payable to subsidiaries expanded and changed composition: short‑term obligations dropped from roughly $9.9 bn at year‑end 2023 to $2.0 bn at year‑end 2024, while long‑term notes payable grew to $14.4 bn (pages 81, 56 & 80), reflecting a larger, longer‑dated liquidity commitment and heightened contractual risk exposure over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees remained immaterial throughout 2022-2024 and captures the key trend of shifting notes payable composition. However, there are significant quantitative discrepancies that undermine accuracy: (1) The ground truth states notes payable to subsidiaries were $8.1B (2022), $9.9B (2023), and $2.0B (2024). The LLM correctly cites the $9.9B→$2.0B transition but fails to mention the 2022 baseline of $8.1B, missing the full three-year evolution. (2) The LLM introduces a new figure of $14.4B in long-term notes payable for 2024, which is not mentioned in the ground truth answer. This represents either additional information not in the knowledge graph or a potential error—the ground truth only references $2.0B in 2024 total notes payable. (3) The characterization of short-term obligations 'dropping from roughly $9.9bn' is imprecise; the ground truth shows this was the total in 2023, not specifically short-term. The LLM's assertion about 'long-term notes payable grew to $14.4bn' cannot be verified against the ground truth and may introduce inaccurate data. (4) The multi-hop reasoning about 'larger, longer-dated liquidity commitment and heightened contractual risk exposure' is a reasonable inference but goes beyond what the ground truth explicitly states—the ground truth concludes the trend 'indicates a stable risk profile.' The LLM's conclusion about 'heightened contractual risk' contradicts the ground truth's assessment. Strengths: correctly identifies immateriality of service level guarantees, captures the volatility in notes payable, and provides appropriate document citations. Weaknesses: introduces unverified figures, incomplete coverage of the 2022-2024 period, and draws conclusions that contradict the ground truth's risk assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 493,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from a pure‑play premium card issuer toward a more regulated, compliance‑intensive business that must juggle tighter oversight of interchange fees, network routing and consumer‑protection rules while fending off intensified competition from Visa, Mastercard and fintech rivals.  To preserve its differentiated value, the company has doubled down on cyber‑security and compliance investments, exited constrained EU network‑licensing arrangements, expanded non‑card offerings such as checking accounts and lending, and sharpened its focus on high‑spending, loyalty‑driven card members.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key themes including regulatory intensification, competitive pressures from Visa/Mastercard/fintech, EU network licensing exits, and strategic pivots toward compliance and non-card offerings. The general trajectory from premium positioning to regulatory constraint is captured. CRITICAL GAPS AND ERRORS: (1) MISSING CRITICAL CONTEXT: The ground truth emphasizes Amex's 2022 position as the 'fourth-largest general-purpose card network' globally—a key competitive positioning fact entirely absent from LLM answer. (2) INCOMPLETE COMPETITIVE LANDSCAPE: Ground truth identifies specific competitors (China UnionPay, Alipay, PayPal, Venmo, National Payments Corporation of India) that provide crucial context for understanding competitive pressures. LLM only mentions Visa, Mastercard, and generic 'fintech rivals.' (3) MISSING REGULATORY CLASSIFICATION: Ground truth specifies Amex became a 'Category III firm under U.S. federal bank regulatory framework' in 2024—a precise regulatory designation absent from LLM answer. This is a material factual omission. (4) INCOMPLETE REGULATORY ISSUES: Ground truth mentions 'cobrand arrangements' as a specific regulatory concern, particularly in EU—not mentioned in LLM answer. (5) VAGUE STRATEGIC RESPONSES: LLM mentions 'cyber-security investments' and 'checking accounts and lending' but ground truth doesn't support these as primary strategic responses documented in filings. The ground truth emphasizes network licensing exits and regulatory navigation as core responses. (6) TONE AND FRAMING: Ground truth emphasizes the shift from 'market-driven competition to regulatory navigation'—a more nuanced characterization than LLM's simpler 'compliance-intensive' framing. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (7/10 for not introducing false numbers). QUALITATIVE ACCURACY: The LLM captures the general evolution but misses critical specifics about competitive positioning, regulatory classification, and the precise nature of regulatory constraints. The multi-hop synthesis is incomplete. CONTEXTUAL RELEVANCE: The answer addresses the question's core themes but lacks the depth and specificity required for a comprehensive assessment of Amex's competitive positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 622,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips continued the cash‑settled PSU framework it adopted for performance periods beginning in 2018, under which the dividend equivalent is **accrued and reinvested** (charged to compensation expense) and paid only at settlement rather than being distributed during the performance cycle.  The 2024 filing shows all cash‑settled awards fully vested with no remaining unrecognized compensation cost, indicating the company deliberately ties a larger share of the award’s value to the firm’s long‑term share‑price performance, thereby aligning employee incentives with sustained, multi‑year financial goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution in ConocoPhillips' PSU dividend equivalent structure for performance periods beginning in 2018 or later—specifically that dividends are 'accrued and reinvested' and paid at settlement rather than during the performance cycle. The company name, time period (2022-2024), and the characterization of cash-settled PSUs as liability-classified instruments are accurate. The reasoning about alignment with long-term financial goals is sound.\n\nWEAKNESSES: (1) The LLM answer is incomplete in addressing the full evolution question. The ground truth explicitly contrasts TWO periods: (a) performance periods BEFORE 2018 (no payments during performance period, began after conclusion) versus (b) periods starting IN 2018 or later (accrued reinvested dividends paid at settlement). The LLM only addresses the 2018+ framework without explaining the prior structure or the contrast between them, which is essential to understanding the 'evolution.' (2) The LLM mentions '2024 filing shows all cash-settled awards fully vested with no remaining unrecognized compensation cost' but the ground truth does not emphasize this detail as a key finding about the evolution—this appears to be an inference not directly supported by the comparative analysis across years. (3) The answer lacks discussion of the vesting framework (five years or retirement eligibility) mentioned in the ground truth as part of the consistent framework. (4) The phrase 'deliberately ties a larger share of the award's value' is somewhat speculative language not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the dividend structure to incentive alignment, but fails to fully synthesize the comparative evolution (before vs. after 2018) that is central to answering how the strategy 'evolved.' The answer reads more as a description of the current state rather than a true evolution narrative.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers are provided in either answer, so quantitative accuracy is based on the structural/policy descriptions being correct. The LLM's description of the 2018+ framework is accurate, but the incomplete treatment of the pre-2018 framework represents a significant gap in addressing the evolution question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 624,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe Special‑Use‑Fund asset pool on NEE’s balance sheet grew from about **$8.7 bn at the end of 2023 to $9.8 bn at the end of 2024** (the fund was roughly $8.0 bn‑$8.5 bn in 2022).  This expansion adds a highly liquid, low‑risk source of collateral that can be tapped to meet the cash‑and‑letter‑of‑credit requirements that arise under NEE’s extensive derivative portfolio—especially the collateral that would be triggered by credit‑rating downgrades or other credit‑risk contingencies.  Consequently, the increase in Special‑Use‑Funds demonstrates that NEE is deliberately building a larger liquidity cushion to comfortably satisfy its derivative‑related collateral obligations throughout 2022‑2024.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe $700 million 1.600% Notes issued in March 2021 have remained fully outstanding through 2022‑2024, with no scheduled principal repayments; the only principal‑related accounting activity is the effective‑interest amortization of the discount, which fell from $3.7 million in 2022 to $2.6 million in 2023 and $1.5 million in 2024. This flat‑principal, declining‑amortization pattern reveals a deliberate, long‑term debt‑management strategy that treats the notes as a stable, low‑cost funding pillar while managing liquidity through revolving facilities and future refinancing rather than active principal reduction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $700 million principal amount as constant across 2022-2024, correctly names the instrument (1.600% Notes), and provides sound qualitative reasoning about debt management strategy. The semantic interpretation of the declining adjustments as 'effective-interest amortization of the discount' is a reasonable financial interpretation. The answer appropriately addresses the multi-hop question about trajectory and strategic implications.\n\nCRITICAL ERRORS: The LLM provides a third data point ($1.5 million for 2024) that contradicts the ground truth. The ground truth explicitly states adjustments decreased from $3.7 million in 2022 to $2.6 million in 2024, with no mention of a $1.5 million figure for 2024. This is a significant quantitative error - the LLM appears to have fabricated or misremembered a third year's data point. The ground truth shows only two comparison points (2022 to 2024), not three annual figures.\n\nMINOR ISSUES: The LLM adds contextual information about the March 2021 issuance date and mentions of 'revolving facilities and future refinancing' that, while strategically reasonable, are not explicitly confirmed in the ground truth answer. The ground truth is more conservative, stating only what can be directly observed from the data.\n\nMULTI-HOP REASONING: The synthesis of constant principal + declining adjustments = stable debt strategy is sound and matches the ground truth's conclusion. However, the fabricated $1.5 million figure undermines the credibility of the trend analysis.\n\nQUANTITATIVE BREAKDOWN: $700M principal (correct), $3.7M 2022 (correct), $2.6M 2024 (correct), but $1.5M 2024 (INCORRECT - not in ground truth). This represents a 25% error rate on the key numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 481,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes grew as CMS repeatedly altered the risk‑adjustment formula and intensified RADV audits, creating greater volatility and the possibility of retrospective payment reductions.  In response, the company progressively tightened its risk‑adjustment data collection and validation, refined its bidding and pricing strategies, exited low‑margin plans in certain markets, and accelerated medical‑cost and operating‑expense management to offset the regulatory pressure.  These actions were also supported by investments in analytics and compliance capabilities to better align its Medicare Advantage contracts with the evolving payment model and preserve profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year period (2022-2024) and accurately captures UnitedHealth Group's core strategic responses: adjusting benefits/premiums, exiting low-margin plans, intensifying cost management, and improving data collection/validation. The answer demonstrates sound multi-hop reasoning by synthesizing regulatory pressures with company responses across the period. The mention of RADV audits and analytics investments adds relevant context not explicitly in the ground truth but consistent with typical MA industry responses.\n\nWEAKNESSES: (1) The LLM introduces 'RADV audits' and 'retrospective payment reductions' as primary drivers, which are not mentioned in the ground truth. While these are plausible MA industry concerns, they represent factual additions not supported by the source material. (2) The LLM characterizes exposure as 'growing' with 'greater volatility,' but the ground truth describes 'consistent' exposure with CMS making changes 'each year' - this is a subtle but meaningful difference in characterization. The ground truth emphasizes steady, recurring adjustments rather than escalating exposure. (3) The LLM mentions 'investments in analytics and compliance capabilities' which is more specific than the ground truth's general 'cost management' language, potentially overstating the level of detail available. (4) The answer lacks the year-by-year progression detail present in the ground truth (2022 benchmark changes, 2023 county exits, 2024 methodology changes), instead presenting a more generalized three-year narrative.\n\nMULTI-HOP REASONING: The answer successfully synthesizes regulatory changes with company responses across three years, though it adds interpretive elements (RADV, retrospective reductions) not in the ground truth. The logical flow is sound but introduces assumptions.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy cannot be directly verified. The temporal references (2022-2024) are correct.\n\nSEMANTIC ISSUES: 'Exposure grew' vs. 'consistently faced' represents a meaningful difference in how the regulatory environment is characterized. The ground truth emphasizes adaptation to recurring changes; the LLM emphasizes escalating pressure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 620,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s employee merchandise discount remained a consistent component of compensation, but the company broadened its framing and accompanying benefits. The 2023 and 2024 Form 10‑K filings (Human Capital Management sections, pages 7‑8) describe the discount alongside higher starting wages, 401(k) matching, tuition‑free education and mental‑health resources, showing that Target’s strategy evolved from a simple price perk to a comprehensive financial‑well‑being package that supports employees’ overall economic security.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative that merchandise discounts remained consistent while Target expanded its broader benefits package from 2022-2024. However, there are significant gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the evolution from a 'simple price perk' to a 'comprehensive financial-well-being package,' which matches the ground truth's main thesis. (2) Accurately mentions key benefits across the period: 401(k) matching, tuition-free education, mental health resources. (3) Correctly identifies the time period (2022-2024) and company (Target). (4) Appropriately cites Form 10-K filings and Human Capital Management sections. WEAKNESSES: (1) MAJOR OMISSION: The ground truth specifically mentions the starting wage evolution from 'at least $15 per hour' in 2022 to '$15-$24 per hour' in 2023—these concrete wage figures are completely absent from the LLM answer, representing a significant factual gap. (2) INCOMPLETE SCOPE ANALYSIS: The ground truth explicitly tracks how merchandise discounts were 'listed among' benefits in 2022, then 'mentioned alongside new additions' in 2023, then 'framed within a broader narrative' in 2024. The LLM answer doesn't articulate this structural evolution as clearly. (3) MISSING CONTEXT: The ground truth mentions 'sick pay' as a 2023 addition and 'free virtual healthcare' in 2024—the LLM answer references 'mental-health resources' but doesn't capture the full scope of benefit additions. (4) VAGUE SOURCING: While the LLM cites 'pages 7-8' of Form 10-K filings, the ground truth provides more nuanced year-by-year analysis without specific page citations, suggesting the LLM may be over-specifying or potentially fabricating page numbers. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects merchandise discounts to broader strategy, but the reasoning is less detailed than the ground truth's explicit year-by-year progression. The conclusion about 'attracting and retaining talent' is implied but not explicitly stated. QUANTITATIVE ACCURACY: The wage figures are the critical quantitative data missing—this is a notable gap but doesn't involve calculation errors, just omission of specific numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 606,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nBased on the 2022 10‑K (page 121) the Foreign‑Government‑Bond portfolio was about $630 million, with roughly $628 million (≈99 %) maturing within one year and a weighted‑average yield of roughly 5.9 % for that one‑year bucket. The 2023 10‑K (page 153) shows the same portfolio still heavily weighted to the shortest end of the curve—almost all securities still mature in ≤ 1 year, while the 1‑to‑5‑year slice yielded about 4.5 %—and the 2024 10‑K (page 180) reports a 1‑year yield of 5.86 % and a 1‑to‑5‑year yield of only 2.03 %, confirming an even tighter concentration in the shortest maturities. This three‑year pattern reveals a consistently short‑duration, low‑credit‑risk allocation that prioritises liquidity and capital preservation, indicating American Express’s conservative risk appetite and a deliberate shift toward shorter‑dated, lower‑yield sovereign securities in its asset‑allocation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) 2022 YIELD ERROR: The LLM states the 2022 one-year yield was 'roughly 5.9%' when the ground truth clearly shows 1.74% for securities due within one year. This is a massive discrepancy (5.9% vs 1.74%) that completely misrepresents the 2022 position. (2) 2023 YIELD DISCREPANCY: The LLM claims the 1-to-5-year yield was 'about 4.5%' which aligns with ground truth (4.48%), but fails to report the critical one-year yield of 6.45%, which was the most significant data point showing the aggressive shift in 2023. (3) 2024 DATA: The LLM correctly identifies 5.86% for one-year and 2.03% for 1-to-5-year yields, matching ground truth. (4) PORTFOLIO SIZE: The LLM correctly identifies $630 million in 2022. (5) MATURITY DISTRIBUTION: The LLM correctly notes the heavy concentration in short-term maturities across all three years. MULTI-HOP REASONING ISSUES: While the LLM attempts to synthesize a three-year pattern, the foundational data errors in 2022 and 2023 invalidate the overall narrative. The ground truth shows a dramatic yield increase from 2022 to 2023 (1.74% to 6.45% for one-year securities), indicating an aggressive shift toward higher-yielding short-term instruments in response to rising rates. The LLM's characterization of the strategy as 'consistently short-duration, low-credit-risk allocation' and 'conservative risk appetite' contradicts the actual pattern of increased yield-seeking behavior in 2023. The correct interpretation should emphasize the dynamic, opportunistic shift to capture higher yields in 2023, not a conservative posture. SEMANTIC ISSUES: The LLM's conclusion about 'conservative risk appetite' is semantically inconsistent with the actual data pattern showing increased yield-seeking in 2023, which suggests tactical opportunism rather than pure conservatism.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 524,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral posted under master‑netting arrangements—recorded within “Other assets, including intangibles – net”—declined from **$1.49 bn at the end of 2022 to $0.80 bn in 2023 and to $0.49 bn by the end of 2024** (a drop of roughly $0.69 bn then a further $0.31 bn).  This reduction shows that ExxonMobil is relying less on external collateral, reflecting tighter internal netting and lower‑risk derivative positions, and therefore a more efficient and disciplined management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.49 bn (2022) matches $1,494 million, $0.80 bn (2023) matches $800 million, and $0.49 bn (2024) matches $491 million. The calculated declines are accurate: $1.49bn to $0.80bn = $0.69bn decrease, and $0.80bn to $0.49bn = $0.31bn decrease. Number formatting variations ($1.49 bn vs $1,494 million) are acceptable and properly handled. ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the specific balance sheet line item ('Other assets, including intangibles – net'), and all three fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets what the declining collateral amounts suggest about derivative exposure management. SEMANTIC EQUIVALENCE: The LLM's interpretation that the reduction reflects 'tighter internal netting and lower-risk derivative positions' and 'more efficient and disciplined management' is a reasonable and slightly more detailed elaboration on the ground truth's statement about 'strategic reduction in derivative-related exposure or shift in risk management practices.' Both convey the same fundamental insight. MINOR CONSIDERATIONS: The LLM provides slightly more analytical depth by explaining the implications (internal netting efficiency, lower-risk positions) compared to the ground truth's more neutral description of the trend. This additional context is appropriate and enhances the answer without introducing inaccuracy. No calculation errors, no missing data points, and all temporal references are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 453,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe $700 million 2.700% senior notes were issued on March 29 2021 at a 2.700% fixed coupon with semi‑annual interest payments (first paid Oct 15 2021) and a 2031 maturity (par‑call Jan 15 2031); from 2022 through 2024 the company did not issue additional 2.700% notes or amend these terms, leaving the original tranche unchanged. This continuity shows AMT’s strategy of securing long‑term, low‑cost financing during the early‑2020s low‑rate window and then maintaining that stable debt pillar while using other sources—credit facilities, equity offerings, and cash returns—to fund acquisitions and return excess capital, underscoring confidence in its credit profile even as market rates later rose.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 2.00 % Notes Due 2031 stayed on NVIDIA’s balance sheet at roughly the same outstanding level—$1.20 billion of face value in 2022, $1.25 billion (carrying amount) in both 2023 and 2024 (with fair values of about $1.04 billion in 2023 and $1.06 billion in 2024).  No principal repayments or additional issuances of this series were reported during those years, indicating that NVIDIA is deliberately maintaining a stable, long‑dated, low‑coupon debt position to finance its growth while minimizing refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of NVIDIA's 2.00% Notes Due 2031 evolution and provides reasonable interpretation of the company's debt strategy. STRENGTHS: (1) Correctly identifies the face value of $1.20 billion in 2022 and $1.25 billion in 2023-2024; (2) Accurately reports fair values of approximately $1.04 billion (2023) and $1.06 billion (2024); (3) Correctly notes no principal repayments or additional issuances; (4) Provides sound multi-hop synthesis across three fiscal years; (5) Offers reasonable strategic interpretation about maintaining stable, long-dated, low-coupon debt. WEAKNESSES: (1) Minor discrepancy in 2023 fair value reporting - Ground truth shows $1.044 billion at beginning of year and $1.057 billion at end of year, but LLM rounds to 'about $1.04 billion' without distinguishing between beginning and ending values; (2) States carrying amount was $1.25 billion in 'both 2023 and 2024' but ground truth shows $1.057 billion at end of 2023 and $1.25 billion in 2024, suggesting a slight increase rather than consistency; (3) The characterization of 'roughly the same outstanding level' is slightly imprecise given the progression from $1.20B to $1.25B. CALCULATION VERIFICATION: All individual numbers are factually correct when cross-referenced with ground truth. The reasoning about strategic debt management is sound and well-supported. The multi-hop synthesis across fiscal years is logically coherent. The minor discrepancies relate to precision in year-end values and characterization of stability rather than fundamental errors in understanding or major calculation mistakes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 445,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s “deposit” reinsurance balances fell sharply: the deposit‑asset balance dropped from roughly **$5.1 bn in 2023 (page 57 of the 2023 10‑K)** to **$4.6 bn in 2024 (page 206 of the 2024 10‑K)**, while the associated deposit‑liability balance slipped from **$1.3 bn to $1.2 bn** over the same period (pages 57 & 206).  This reduction reflects the company’s decision to move away from the deposit method—exemplified by the large 2023 Global Atlantic risk‑transfer transaction that created the spike in 2023—and to restructure its reinsurance program toward more traditional ceding arrangements that no longer require deposit accounting.  Consequently, the declining deposit‑asset/liability trend signals a strategic shift toward simpler, non‑deposit reinsurance structures and a reduced reliance on complex risk‑transfer mechanisms.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nBetween 2022 and 2024 the amortized cost of UnitedHealth Group’s held‑to‑maturity debt securities fell from **$696 million to $512 million**, and the reported fair values declined from **$679 million to $508 million** – roughly a 25‑26 % reduction in both measures.  This steady contraction indicates a deliberate de‑risking and reallocation of capital, as the company trimmed lower‑yielding, longer‑duration holdings amid rising interest rates and used the proceeds to support growth initiatives and preserve liquidity, while the modest gap between cost and fair value shows only minor market‑valuation adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct - carrying value (amortized cost) declined from $696M (2022) to $512M (2024), and fair value declined from $679M (2022) to $508M (2024). The calculated percentage reduction of 25-26% is accurate ($696M to $512M = 26.4% decline; $679M to $508M = 25.2% decline). The year-by-year progression through 2023 ($603M carrying value, $596M fair value) is implicitly captured in the 'steady contraction' language. ENTITY ACCURACY: Correctly identifies UnitedHealth Group (UNH), the correct metric (Debt Securities - Held-to-Maturity), and the correct time period (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes the three-year data progression and draws appropriate conclusions about investment strategy. The interpretation that this represents 'deliberate de-risking and reallocation of capital' aligns with the ground truth's assessment of 'strategic reduction or repositioning.' QUALITATIVE ANALYSIS: The LLM provides additional context about market conditions (rising interest rates), capital allocation decisions (supporting growth initiatives, preserving liquidity), and portfolio characteristics (lower-yielding, longer-duration holdings). These inferences are reasonable and enhance the answer without contradicting the ground truth. The observation about 'modest gap between cost and fair value' showing 'only minor market-valuation adjustments' is accurate and adds analytical depth. MINOR CONSIDERATIONS: The ground truth uses 'fair value' and 'carrying value' terminology, while the LLM uses 'amortized cost' (which is the carrying value for HTM securities) - this is semantically equivalent and technically precise. The LLM's interpretation goes slightly beyond the ground truth by speculating on specific reasons (interest rates, growth initiatives), but these are reasonable inferences not contradicted by the data. Overall, the answer is factually correct, well-reasoned, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 563,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe RedCard (Target Credit Card) penetration fell steadily—from about **20.5 % of purchases in fiscal 2022**, to **19.8 % in fiscal 2023**, and further to **18.6 % in fiscal 2024**. This downward trend signals that the discount‑driven credit‑card program is becoming less effective at generating incremental sales, suggesting diminishing returns from the current credit‑card strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are precisely correct - 20.5% (2022), 19.8% (2023), 18.6% (2024) match ground truth exactly. (2) Fiscal year references are accurate. (3) The downward trend identification is correct. (4) Number formatting is appropriate. WEAKNESSES: (1) The LLM answer is incomplete - it fails to address the second part of the ground truth answer regarding Target's internal analysis showing that 'a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.' (2) The LLM's interpretation is more negative than warranted - it states the program is 'becoming less effective' and shows 'diminishing returns,' but the ground truth indicates Target still sees 'ongoing strategic value' despite the declining penetration rate. This represents a significant omission of nuance. (3) The LLM doesn't acknowledge the complexity that while penetration is declining, the card still contributes meaningfully to incremental sales according to Target's analysis. MULTI-HOP REASONING: The model correctly synthesized the three-year trend but failed to synthesize the complete picture by omitting Target's internal assessment of the card's continued strategic value. The conclusion drawn is partially correct but incomplete and somewhat misleading in tone. The answer addresses the 'how did it evolve' part well but inadequately addresses 'what does this trend suggest' by missing the nuanced view that despite declining penetration, the card maintains strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 426,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike has continuously **owned** its distribution hub in Laakdal, Belgium across all three fiscal years – it is listed among the “most significant distribution facilities outside the United States” in the 2022 10‑K (page 27), the 2023 10‑K (page 29) and the 2024 10‑K (page 29).  The repeated emphasis on this owned site shows that Nike is deliberately reinforcing a **controlled, high‑capacity European logistics node** to underpin its European wholesale and NIKE Direct operations, underscoring a strategic focus on building a stable, owned distribution infrastructure in Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies Nike's continuous ownership of the Laakdal, Belgium facility across FY2022-2024, matching the ground truth; (2) Accurately cites specific 10-K page references (2022 page 27, 2023 page 29, 2024 page 29) that can be verified; (3) Properly characterizes the facility as among 'most significant distribution facilities outside the United States,' which aligns with ground truth language; (4) Correctly synthesizes the multi-hop information showing consistency across three fiscal years; (5) Provides sound strategic interpretation that the maintained ownership indicates deliberate focus on controlled European logistics infrastructure. MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by adding interpretive language about 'wholesale and NIKE Direct operations' and 'building a stable, owned distribution infrastructure' - while these are reasonable inferences from the data, they represent modest extrapolation beyond what the ground truth explicitly states; (2) The ground truth uses 'most significant international distribution centers' while LLM uses 'most significant distribution facilities outside the United States' - these are semantically equivalent phrasings from the actual filings. QUANTITATIVE VERIFICATION: All page numbers and fiscal year references are accurate. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings to establish the consistency pattern and draw conclusions about strategic intent. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 452,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lumentum Holdings stayed on NVIDIA’s list of networking‑product competitors in each year’s 10‑K filing, so NVIDIA continued to view it as a relevant rival in optical‑interconnect and cable‑solution markets.  At the same time, NVIDIA’s disclosed supply‑chain strategy expanded to multiple foundries, memory vendors and contract manufacturers while simultaneously strengthening its IP portfolio and enforcement (broader patent filings, trade‑secret safeguards and licensing controls).  This dual expansion and IP‑focused protection broadened NVIDIA’s sourcing options and reduced reliance on any single external supplier, thereby limiting Lumentum’s relative leverage within NVIDIA’s ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies Lumentum Holdings as consistently appearing on NVIDIA's competitor list across fiscal years 2022-2024, matching the ground truth; (2) Accurately characterizes the competitive domain as networking products, optical interconnects, and cable solutions; (3) Properly synthesizes NVIDIA's dual strategic approach: expanding supply chain partnerships (foundries, memory vendors, contract manufacturers) while strengthening IP protection (patents, trade secrets, licensing); (4) Logically connects these strategies to reduced leverage for external suppliers like Lumentum; (5) Correctly identifies key manufacturing partners (TSMC, Samsung mentioned in ground truth context); (6) No quantitative errors in dates or numbers. MINOR WEAKNESSES: (1) The answer adds interpretive analysis about 'limiting Lumentum's relative leverage' which, while logically sound, goes slightly beyond the ground truth's more neutral statement that Lumentum 'maintained its relevance'; (2) Does not explicitly mention the patent expiration date evolution (2022 to 2045) noted in ground truth, though this is a minor detail; (3) The phrase 'reduced reliance on any single external supplier' is an inference rather than directly stated in ground truth, though it logically follows from the disclosed strategies. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects NVIDIA's competitive landscape positioning with its strategic initiatives. The reasoning that supply chain diversification and IP strengthening would reduce external supplier leverage is sound and represents appropriate analytical synthesis. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - Lumentum remained a consistent competitor despite NVIDIA's strategic advancements. The LLM's framing emphasizes the strategic implications more explicitly than ground truth, which is appropriate for the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 554,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix moved away from a purely “license‑everything” model and began locking in longer‑term, exclusive rights while simultaneously expanding its own‑produced and co‑produced titles.  At the same time, the company increasingly pursued direct negotiations with studios and local creators to satisfy emerging regulatory demands—such as content‑quota, levy and ownership‑restriction rules in markets that are updating cultural‑support legislation.  This shift shows that, amid intensifying competition and tighter global regulations, Netflix is diversifying its content acquisition strategy: it relies less on non‑exclusive third‑party licenses and more on owned originals and strategic co‑productions to secure a stable, defensible library.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 to 2024 Southern Company moved from a brief footnote that outdoor‑lighting contracts are operating leases whose scheduled payments are “presented in the maturity analysis” to a full‑year‑by‑year disclosure of those fixed payments in the lease‑maturity tables, explicitly separating scheduled (fixed) lease income from variable lease income and noting that the outdoor‑lighting amounts are immaterial for Mississippi Power but still shown in the consolidated schedules.  The revenue from these leases is now reported as lease income (both operating‑lease income and variable lease income) within wholesale revenues, and the maturity tables provide detailed undiscounted cash‑flow amounts and present‑value discounts, reflecting a more transparent and material‑focused treatment of the scheduled lease payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues in accuracy and completeness. CORRECT ELEMENTS: (1) The answer correctly identifies the evolution from 2022 to 2024, (2) correctly notes that outdoor lighting contracts are operating leases, (3) correctly identifies Mississippi Power as the relevant entity, (4) correctly states that payments are included in maturity analyses, (5) correctly notes the immaterial nature of these contracts. PROBLEMATIC ELEMENTS: (1) The LLM claims the contracts show 'scheduled (fixed) lease income from variable lease income' and revenue is 'reported as lease income (both operating-lease income and variable lease income) within wholesale revenues' - the ground truth does not support this level of detail about revenue classification into these specific categories, (2) The LLM states there is 'full-year-by-year disclosure of those fixed payments in the lease-maturity tables' - the ground truth indicates inclusion in maturity analyses but does not confirm this specific level of granular year-by-year breakdown, (3) The LLM mentions 'present-value discounts' in maturity tables - the ground truth specifies 'undiscounted cash flows' which is the opposite, representing a factual error, (4) The answer adds details about 'detailed undiscounted cash-flow amounts and present-value discounts' that go beyond what the ground truth confirms. MULTI-HOP REASONING: The LLM correctly synthesizes the progression across three years and identifies the shift toward more transparent treatment. However, it overstates the specificity of the disclosure evolution. The ground truth emphasizes materiality considerations and structured reporting, while the LLM focuses more on revenue classification details that aren't clearly supported. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral. The mention of 'undiscounted' vs actual treatment needs verification but appears to be an error. OVERALL: The answer demonstrates understanding of the general evolution but introduces unsupported details about revenue classification and contains at least one factual error regarding discounting methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 587,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % notes due April 2030 showed a recorded principal balance of **$606 million at the end of fiscal 2022 and held that same $606 million balance through fiscal 2023 and fiscal 2024**. This flat trajectory indicates that Broadcom has not repurchased, retired or refinanced this tranche, reflecting a deliberate “hold‑to‑maturity” stance and a debt‑management strategy that treats the 2030 notes as a stable, long‑term funding pillar rather than an active liability to be reduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the principal balance was '$606 million at the end of fiscal 2022' when the ground truth clearly shows it was $1,086 million in fiscal 2022. This is a $480 million error - a 44% understatement of the actual 2022 balance. The LLM then claims the balance 'held that same $606 million balance through fiscal 2023 and fiscal 2024,' which is partially correct for 2023-2024 but completely wrong for 2022. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks how the balance 'evolved from fiscal year 2022 through 2024.' The ground truth shows a significant $480 million reduction from 2022 to 2023 ($1,086M → $606M), which is the most important evolution in this three-year period. The LLM completely missed this critical debt reduction event by misreporting the 2022 starting balance. (3) REASONING QUALITY: The LLM's interpretation of a 'hold-to-maturity' stance and 'stable, long-term funding pillar' is contradicted by the actual data showing active debt reduction in 2023. The LLM's reasoning would only be valid if the balance had remained flat across all three years, which is not the case. (4) ENTITY ACCURACY: While the company (AVGO/Broadcom) and instrument (5.000% notes due April 2030) are correctly identified, the fiscal year data is fundamentally misaligned. The answer demonstrates a failure to properly synthesize the multi-year progression that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 429,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nFrom 2022 through 2024 the weighted‑average long‑term rate of return assumption for GM’s U.S. pension assets was 6.3 % in 2022 and 2023, and rose to 6.5 % after the December 2024 policy study.  This stability coincided with a deliberate shift in the target mix: equity exposure was increased from 8 % (2022) to 11 % (2023‑2024) and “other” (alternative) assets from 23 % to 29 %, while debt was reduced from 69 % to 60 %.  The higher‑returning asset tilt reflects GM’s effort to boost expected returns and improve funded status amid a low‑interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY - MAJOR ERRORS: The LLM states the weighted-average long-term rate of return was 6.3% in both 2022 and 2023, but the ground truth clearly indicates 5.4% in 2022 and 6.3% in 2023. This is a 0.9 percentage point error for 2022. The LLM correctly identifies 6.5% for 2024. The claimed 'stability' between 2022-2023 is factually incorrect - there was actually a 0.9 percentage point increase from 2022 to 2023. (2) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 3-year trend. The ground truth shows a clear progression: 5.4% → 6.3% → 6.5%, representing a 1.1 percentage point increase over two years. The LLM's claim of stability in 2022-2023 misses this important trend component. (3) ASSET MIX DETAILS: While the LLM provides additional context about equity exposure (8% to 11%), debt reduction (69% to 60%), and alternative assets (23% to 29%), these details are NOT present in the ground truth answer and cannot be verified. The inclusion of unverified asset allocation percentages, while potentially accurate, goes beyond what can be confirmed against the provided ground truth. (4) CONTEXTUAL INTERPRETATION: The LLM's interpretation about 'low-interest-rate environment' and strategic positioning is reasonable but represents inference beyond the ground truth's more straightforward observation about 'more optimistic outlook' and 'shift toward higher-risk, higher-return investment strategies.' (5) SEMANTIC ISSUES: The phrase 'after the December 2024 policy study' appears in the LLM answer but is not mentioned in the ground truth, raising questions about source accuracy. The fundamental error regarding 2022's 5.4% rate (stated as 6.3%) is a critical factual mistake that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 514,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 remain on the company’s books and are repeatedly referenced in the 2022‑2024 supplemental‑indenture filings (e.g., the March 2021 indenture and the later 2022‑2024 amendments that restate the 2019 indenture).  Rather than retiring or re‑pricing the series, American Tower continues to treat the 2031 notes as a stable, low‑cost component of its long‑dated debt stack, using the amended indentures to extend and diversify that tranche while keeping the 2031 maturity intact.  This signals a financing strategy that relies on long‑term, fixed‑rate debt with staggered maturities to fund its tower‑infrastructure growth while preserving cheap capital over the long horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM claims the notes reference 'the March 2021 indenture and the later 2022-2024 amendments that restate the 2019 indenture,' but the ground truth explicitly states the consistent reference is to 'Supplemental Indenture No. 8 dated March 29, 2021' across all three years (2022, 2023, 2024). The LLM introduces unsupported claims about '2022-2024 amendments' and a '2019 indenture restatement' that are not mentioned in the ground truth. (2) SPECULATIVE REASONING - The LLM adds interpretive language about 'extending and diversify that tranche' and 'staggered maturities to fund tower-infrastructure growth' that goes beyond what the ground truth supports. The ground truth focuses on the CONSISTENT TREATMENT and STABLE APPROACH without modifications, not on diversification or extension strategies. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2.700% rate and 2031 maturity date, it fails to accurately synthesize the core finding: that the same Supplemental Indenture No. 8 was referenced consistently across all three years, indicating NO CHANGES or modifications. (4) CORRECT ELEMENTS - The LLM does correctly identify: the 2.700% rate, the 2031 maturity, the concept of stable long-term financing, and the use of fixed-rate debt. However, these correct elements are undermined by the factual errors about amendments and indenture restating. The answer demonstrates partial understanding but introduces unsupported claims that contradict the ground truth's emphasis on consistency and lack of modification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 432,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s exposure to abusive behaviors intensified as it broadened credit offerings—including BNPL, consumer and merchant financing—and expanded cross‑border transaction volume, which raised fraud, charge‑back and merchant‑default risks. To mitigate these risks the company continuously upgraded its fraud‑detection and buyer‑seller protection programs, refined credit‑underwriting models, and pursued strategic actions such as the sale of U.K./European BNPL receivables and forward‑flow arrangements, while strengthening compliance frameworks (e.g., updated SCCs, AML and sanctions programs) and diversifying payment‑processor relationships.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's evolving exposure to abusive behaviors across 2022-2024, with generally accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2023 strategic action of selling U.K./European BNPL receivables, matching the ground truth; (2) Accurately captures the three-year trajectory of risk evolution; (3) Appropriately synthesizes multiple mitigation strategies (fraud detection, underwriting refinement, compliance frameworks); (4) Correctly identifies credit products and cross-border transactions as key risk areas; (5) Mentions third-party dependencies and operational risks. WEAKNESSES: (1) The LLM answer states PayPal 'sold U.K./European BNPL receivables' but the ground truth specifies 'entered into a multi-year agreement to sell up to €40 billion' - the LLM omits the specific €40 billion figure and the 'multi-year agreement' framing, which are material details; (2) The LLM characterizes exposure as 'intensified' while the ground truth presents a more nuanced narrative of strategic offloading in 2023 that reduced exposure; (3) The LLM mentions 'forward-flow arrangements' which is not explicitly mentioned in the ground truth; (4) The LLM adds details about 'updated SCCs, AML and sanctions programs' and 'diversifying payment-processor relationships' that are not in the ground truth, though these are plausible mitigation strategies. QUANTITATIVE ACCURACY: The €40 billion figure is missing from the LLM answer, which is a specific quantitative detail from the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from risk identification to offloading to ongoing prevention. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding the evolution of risks and mitigation strategies, though some specific details and the precise characterization of the 2023 action differ.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 543,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nUNP’s pension plan cut its Collective Trust and Other Funds allocation from $622 million in 2022 to $382 million in 2023, and the 2024 filing shows a further reduction (i.e., a lower balance than $382 million). This pull‑back from private‑equity and real‑estate‑linked investments signals a strategic shift toward a more diversified mix of public equity and debt securities, reflecting a more risk‑adjusted, long‑term approach to funding employee benefits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states the 2022 allocation was $622 million, but the ground truth clearly states it was $756 million. This is a significant factual error ($134 million discrepancy). The 2023 figure of $382 million is correct. (2) INCOMPLETE DATA - The LLM correctly notes that 2024 shows a further reduction but fails to acknowledge that the ground truth explicitly states 'no updated dollar value is provided' for 2024. The LLM's phrasing 'a lower balance than $382 million' is speculative without concrete data. (3) STRATEGIC INTERPRETATION - The LLM introduces unsupported claims about 'private-equity and real-estate-linked investments' and 'shift toward public equity and debt securities' that are not mentioned in the ground truth. The ground truth focuses on NAV-based valuation emphasis and de-risking/rebalancing, not specific asset class shifts. (4) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize the three-year trend, the foundational 2022 number is wrong, undermining the entire analysis. (5) WHAT WAS CORRECT - The 2023 figure ($382 million) is accurate, and the general concept of a downward trend is correct. The characterization of this as a de-risking strategy aligns with the ground truth's interpretation. OVERALL: The answer contains a major quantitative error in the 2022 baseline figure, introduces unsupported strategic interpretations, and fails to properly acknowledge the lack of 2024 data. These are significant issues for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 428,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer continued to grant Breakthrough Performance Awards (BPAs) through 2022 – the awards were measured at intrinsic value (closing‑stock price), amortized straight‑line over the estimated vesting period and adjusted each reporting period for changes in share price and the probability of achieving the performance targets, with expense recorded in cost of sales, SG&A or R&D as appropriate; grant activity peaked in 2021‑2022 (≈1.2 million awards granted, with forfeitures reducing the non‑vested balance to 0.9 million by year‑end 2021) and by the end of 2023 the company reported that no BPAs remained outstanding. Consequently, the 2024 disclosures no longer list BPAs among its share‑based‑payment awards, indicating the program was effectively retired, and any remaining expense would be recognized only for previously granted awards that were fully amortized.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil must post under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply—from roughly **$1.5 billion in 2022 to $0.8 billion in 2023 and $0.49 billion in 2024**.  This downward trend signals that the company’s derivative notional exposure and the corresponding initial‑margin requirements have been reduced, likely because of lower‑risk positions, improved netting of counterparties, or a smaller margin‑call burden over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (2022) expressed as 'roughly $1.5 billion', $800 million (2023) as '$0.8 billion', and $491 million (2024) as '$0.49 billion'. The format conversions are appropriate and accurate. COMPLETENESS: The answer addresses all required elements - the three-year trend, the specific collateral amounts, and the interpretation of what the trend suggests about derivative exposure and margin requirements. ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric (collateral under master netting arrangements) is accurate, and all years (2022-2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the downward trend across all three years and provides reasonable interpretations (lower-risk positions, improved netting, smaller margin-call burden). The logic connecting collateral reduction to derivative exposure reduction is appropriate. SEMANTIC EQUIVALENCE: The LLM's explanation of what the trend 'signals' (reduction in derivative exposure and margin requirements) aligns well with the ground truth's assessment that it 'suggests a reduction in derivative exposure or a strategic adjustment in margin requirements.' The LLM provides slightly more detailed interpretation by offering specific mechanisms (lower-risk positions, improved netting, margin-call burden reduction), which adds value without contradicting the ground truth. MINOR CONSIDERATION: The LLM uses 'roughly' and 'sharply' which are appropriate qualitative descriptors for the magnitude of change, and the phrasing 'must post' accurately conveys the obligation nature of collateral requirements. No calculation errors detected. All information is factually correct and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 502,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic business evolved from a modest, diversified line‑item in 2022 – noted simply as part of a “broad variety of products for the general industrial and automotive markets” 【2022 p. 17】 – to a clearly articulated, high‑performance optical‑interconnect suite in 2023‑2024, with expanded descriptions of “wide‑array of optical components for Ethernet, storage and telecom” and new emphasis on “industrial and medical sensors, motion‑control encoders and Ethernet PHYs” that accompany the fiber‑optic portfolio【2023 pp. 5‑6】【2024 pp. 4‑5】.  This progression reveals that Broadcom is deliberately sharpening its industrial focus, leveraging proprietary FBAR and III‑V optical‑component expertise to serve high‑margin automation, automotive and edge‑AI applications, and integrating those hardware capabilities within its broader infrastructure‑software and AI‑centric strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer fundamentally mischaracterizes Broadcom's positioning. The ground truth states Industrial Fiber Optics was positioned as part of a 'broad industrial product suite' in 2022 with specific applications (industrial automation, power systems, medical equipment, defense, aerospace, automotive). The LLM incorrectly describes 2022 positioning as 'modest, diversified line-item' and 'simply as part of broad variety of products for general industrial and automotive markets' - this is a significant downplaying of the actual positioning. (2) MISSING KEY APPLICATIONS - Ground truth explicitly mentions Factory Automation, Renewable Energy, and Automotive Electronics as emphasized in 2023 structured table format. The LLM answer does not mention these specific application areas at all, instead focusing on 'Ethernet, storage and telecom' and 'edge-AI applications' which are not mentioned in the ground truth. (3) INCORRECT PRODUCT ASSOCIATIONS - Ground truth states Industrial Fiber Optics was listed alongside 'optocouplers, sensors, encoders, and Ethernet ICs' in 2024. The LLM mentions 'industrial and medical sensors, motion-control encoders and Ethernet PHYs' - while partially overlapping, this is not the exact product portfolio described. (4) UNSUPPORTED CLAIMS - The LLM introduces concepts like 'proprietary FBAR and III-V optical-component expertise,' 'high-margin automation,' and 'infrastructure-software and AI-centric strategy' that are not present in the ground truth answer and appear to be speculative additions. (5) STRUCTURAL EVOLUTION MISCHARACTERIZED - Ground truth emphasizes 'increasing emphasis on structured, application-specific clarity in product communication' with a 'more streamlined presentation.' The LLM describes this as 'sharpening industrial focus' and 'deliberately' leveraging expertise, which adds interpretive layers not supported by the source material. (6) CITATION ISSUES - While the LLM provides page references, the characterization of what appears on those pages does not align with the ground truth description. The answer reads as partially fabricated rather than accurately synthesized from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 592,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal has consistently borne full margin risk for every payment transaction through 2022‑2024, recording any fees paid to third‑party processors as transaction expense while retaining complete discretion over the fee it charges merchants and consumers. Its pricing is set through volume‑based tiers that the company determined do not create a material future right, so it continues to adjust fees independently of the costs incurred with processors. As a result, there has been no material change in its margin‑risk exposure; the same control over transaction pricing and reliance on third‑party processors persisted across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies that PayPal bore full margin risk consistently across 2022-2024, maintained discretion over fee pricing, recorded third-party processor fees as transaction expenses, and experienced no material changes in margin risk exposure. All core facts match the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in either the ground truth or LLM answer, so this dimension scores perfectly. The temporal scope (2022-2024) is correctly maintained throughout. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years, correctly identifying the consistent pattern of margin risk exposure and pricing control. The answer appropriately connects PayPal's role as principal, its fee discretion, third-party processor relationships, and the absence of material changes—all required for proper multi-hop synthesis. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, though with slightly different phrasing. The mention of 'volume-based tiers' and 'no material future right' adds specificity that enhances rather than contradicts the ground truth. The statement that PayPal 'continues to adjust fees independently of the costs incurred with processors' directly parallels the ground truth's emphasis on pricing discretion. (5) COMPLETENESS: The answer addresses all aspects of the question: evolution of margin risk exposure (showing consistency), control over transaction pricing (full discretion maintained), and use of third-party processors (fees recorded as transaction expense). The only minor consideration is that the LLM introduces the concept of 'volume-based tiers' which, while not contradicting the ground truth, goes slightly beyond what was explicitly stated in the original answer. However, this addition is contextually appropriate and does not introduce any factual errors. Overall, the LLM answer demonstrates excellent understanding of PayPal's margin risk profile and successfully communicates the key finding of stability across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 599,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s relationship with Meridian was reduced to the wind‑down of the post‑sale transition‑service and indemnity arrangements that stemmed from the 2021 disposal of the subsidiary; the company recorded a $51 million cash proceeds and a $167 million after‑tax loss on the sale in 2021, and only modest, non‑material service fees were recognized in 2022‑23, with the agreements terminating by the end of 2023.  This exit reflects Pfizer’s strategic shift away from the legacy consumer‑health/generic business that Meridian represented and toward a focused emphasis on its core biopharmaceutical and vaccine portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) TIMELINE CONTRADICTION: The LLM states agreements terminated 'by the end of 2023,' but the ground truth indicates a Manufacturing Supply Agreement (MSA) that extended for three years post-sale (2021-2024) with a two-year extension option. This is a significant factual error about the duration and status of contractual arrangements. (2) INCOMPLETE CONTRACTUAL DETAILS: The LLM mentions 'transition-service and indemnity arrangements' but fails to identify the specific Manufacturing Supply Agreement (MSA) that was a key contractual element. The ground truth explicitly states the MSA extended three years post-sale with a two-year extension option - this is material information about strategic positioning. (3) 2024 STATUS MISSING: The ground truth notes that by 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating a formalized but reduced relationship. The LLM completely omits this 2024 positioning information, which is critical to answering how the relationship 'evolved from 2022 to 2024.' (4) QUANTITATIVE ACCURACY: The numbers provided ($51 million cash proceeds, $167 million after-tax loss, 2021 sale date) are correct and match ground truth. (5) CHARACTERIZATION ISSUES: The LLM describes Meridian as 'legacy consumer-health/generic business,' but the ground truth identifies it as 'Meridian Medical Technologies, Inc.' - a more specific and formal designation. (6) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the three-year evolution (2022-2024) by missing the 2024 glossary reference and mischaracterizing the MSA termination timeline. The answer addresses the strategic shift correctly but incompletely. The core strategic insight about refocusing on core biopharmaceutical and vaccine portfolio is present but the specific contractual and positioning details that demonstrate this evolution are missing or inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 520,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s reduced‑risk products moved from an early‑stage focus on proving product differentiation and securing favorable tax treatment (e.g., FDA‑authorized Modified‑Risk and PMTA pathways) to an environment dominated by explicit bans, plain‑packaging mandates, flavor restrictions and curbs on “truthful and non‑misleading” communications about RRPs/SFPs.  As a result, the company’s ability to distinguish its smoke‑free products and to market their reduced‑risk benefits to adult smokers has been progressively narrowed, weakening a core competitive advantage that was central in 2022.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply – from **$1.49 billion in 2022**, to **$0.80 billion in 2023**, and further to **$0.49 billion in 2024** (as disclosed in the 2022‑2024 10‑K notes).  This declining exposure shows that the company is requiring less security from counterparties, reflecting tighter credit assessments and more effective netting of its derivative positions, which suggests an improvement in its derivative‑risk management and a reduced need for large collateral buffers.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numerical values are correct and properly formatted: $1.49B (2022), $0.80B (2023), $0.49B (2024) match the ground truth of $1,494M, $800M, $491M respectively. The format variation ($1.49B vs $1,494M) is acceptable. (2) The downward trend is accurately identified across all three years. (3) The company and metric identification (ExxonMobil, collateral under master netting arrangements, Notes and accounts receivable) are correct. (4) The answer addresses the multi-hop requirement by synthesizing data across 2022-2024. WEAKNESSES: (1) INTERPRETATION ERROR: The LLM states 'the company is requiring less security from counterparties' which is a misinterpretation. The metric refers to collateral ExxonMobil must POST (owes), not collateral it receives from counterparties. This is a significant semantic error in understanding the direction of the collateral flow. (2) The ground truth explanation focuses on 'strategic reduction in derivative exposure or shift in risk management practices' and 'lower margin requirements or proactive risk mitigation,' while the LLM's explanation about 'tighter credit assessments' and 'more effective netting' is plausible but represents a different analytical angle that may not align with the actual business drivers. (3) The phrase 'requiring less security from counterparties' directly contradicts the nature of the metric - this is collateral ExxonMobil posts, not receives. This is a material conceptual error despite correct numbers. CALCULATION VERIFICATION: No calculations required; trend identification is correct (declining values across all three years). MULTI-HOP REASONING: The answer correctly synthesizes data across three fiscal years and identifies the trend, but the interpretation of what the trend means is partially incorrect due to the directional misunderstanding of the collateral flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 506,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy reduced the volatility input in its TSR‑based performance‑award model from roughly 28.6 % for grants made in 2023 to about 18.7 % for grants made in 2024 (the 2022 assumption was higher, likely near 30 %). This downward shift shows the company now expects considerably less relative price volatility versus its predefined peer group, reflecting a diminished perception of market risk over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. Ground truth shows: 2022: 26.9%, 2023: 28.6%, 2024: 18.7%. The LLM states 2023 was 28.6% (correct) and 2024 was 18.7% (correct), but incorrectly characterizes 2022 as 'likely near 30%' when the actual figure was 26.9%. This is a material error of approximately 3.1 percentage points. The LLM also misrepresents the trend by stating the 2022 assumption was 'higher' than 2023, when in fact 2022 (26.9%) was lower than 2023 (28.6%). The ground truth explicitly notes a 'short-term increase in 2023' before the 2024 drop, which the LLM completely omits. The LLM's characterization of the overall trend as 'downward shift' is partially correct for the 2023-2024 period but fails to capture the full three-year evolution. The qualitative reasoning about diminished market risk perception is sound and aligns with the ground truth interpretation. The answer addresses the core question about volatility evolution and market risk perception, but the quantitative errors and incomplete trend analysis (missing the 2022-2023 increase) represent significant factual failures that would mislead readers about the actual volatility assumptions used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 346,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nThe $495 million of 3.125 % senior notes maturing in January 2025 was unchanged in principal across fiscal 2022, 2023 and 2024, but by the end of 2024 the liability had been re‑classified from the non‑current to the current section of the balance sheet as the maturity date approached.  This shift shows that Broadcom is treating the tranche as a near‑term obligation and is managing it by planning to refinance or retire it with cash on hand or new debt, consistent with its broader strategy of rolling over the bulk of its senior debt through fresh note issuances and using cash‑flow‑driven repayments to curb short‑term exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Broadcom's debt management. QUANTITATIVE VERIFICATION: All numbers are correct - $495 million principal amount is accurate for both fiscal 2022 and 2023, the 3.125% coupon rate is correct, and the January 2025 maturity date is accurate. The answer correctly identifies that the principal remained unchanged across all three fiscal years (2022, 2023, 2024). COMPLETENESS: The answer addresses all aspects of the original question: (1) the evolution of the obligation across the three fiscal years, (2) the balance sheet reclassification from non-current to current, and (3) implications for short-term debt management and refinancing strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific note characteristics are accurate, and fiscal year references are correct. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the stable principal amount over two years with the subsequent reclassification as maturity approached, and logically infers the company's refinancing strategy. The explanation about treating it as a near-term obligation and planning for refinancing or retirement is a reasonable inference from the balance sheet reclassification pattern. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with slightly more detail about the company's broader debt management strategy (rolling over senior debt, cash-flow-driven repayments). This additional context is appropriate and doesn't contradict the ground truth. MINOR DIFFERENCES: The LLM answer provides more strategic context about Broadcom's overall debt management approach compared to the ground truth, which is a strength rather than a weakness. The phrasing differs but the factual content aligns perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 502,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nBetween 2022 and 2024 AMD retained the same inventory‑protection framework for AIB partners—contracts that shield their stock from price cuts and grant limited return rights—while broad‑ening its focus to the VAR and global system‑integrator channel.  Discrete‑graphics solutions have been used as the key differentiator for SI products, with AMD emphasizing performance‑per‑watt, energy‑efficiency and new packaging (e.g., 3D V‑Cache) to let SIs create distinct offerings, a strategy that has remained central to its differentiation across the three years.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nDisney’s DTC strategy has progressed from an initial “strategic‑investment” phase in fiscal 2022—where the company pledged to pour capital into Disney+, Hulu, ESPN+ and related services to spur subscription and advertising growth that would offset falling linear affiliate fees (2022 p. 24)—to a sustained, financially‑disciplined push in fiscal 2023‑2024 that emphasizes growing those same revenue streams while tightening cost controls and expanding the ad‑supported tier and bundling (2023 p. 53; 2024 p. 23).  The company continues to position its DTC offerings as a competitive, IP‑driven alternative to other streaming platforms, but it now acknowledges that profitability will be a longer‑term goal and that revenue growth from DTC must eventually outweigh the declines in linear network fees (2024 p. 27).",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nThe 2.850% senior unsecured notes were issued in September 2019 for a total of $1.5 billion and mature on October 1 2029; they remained outstanding through 2022, 2023 and 2024 and accounted for roughly $1.5 billion of the $10.6 billion of term debt reported at year‑end 2024.  During those years PayPal added newer fixed‑rate tranches (e.g., the 2022, 2023 and 2024 note issuances, including the ¥‑denominated 2023 issuance and the $1.3 billion May 2024 issuance), but the 2.850% notes kept their original terms—interest paid semi‑annually, no scheduled principal repayment until 2029, and optional redemption only upon a change‑of‑control or downgrade—so they stayed as the longest‑dated tranche in PayPal’s senior debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's 2.850% notes and provides accurate core information, but has some gaps compared to the ground truth. CORRECT ELEMENTS: (1) Principal amount of $1.5 billion is accurate; (2) Maturity date of October 1, 2029 is correct; (3) Notes remained outstanding through 2022-2024 with no repayments is accurate; (4) Semi-annual interest payments and no scheduled principal repayment until 2029 are correct; (5) The characterization of these as the longest-dated tranche is accurate; (6) Reference to newer issuances in 2022, 2023, and 2024 is appropriate context. GAPS/ISSUES: (1) The LLM answer does not provide the specific total term debt figures for 2022 ($9.0B), 2023 ($10.638B), and 2024 ($10.574B) that the ground truth emphasizes as key context for understanding how the debt structure evolved; (2) The LLM mentions the $10.6 billion figure for 2024 but doesn't provide the year-over-year progression that shows the evolution of the broader debt structure; (3) The ground truth specifically mentions higher interest rate notes issued in 2024 (5.150% and 5.500%), while the LLM only vaguely references 'newer fixed-rate tranches' without specifying these rates; (4) The LLM doesn't explicitly state that the 2.850% notes remained at exactly $1.5 billion with no changes across all three years, though this is implied. QUANTITATIVE ACCURACY: The specific numbers provided ($1.5B principal, October 1 2029 maturity, $10.6B total debt at 2024 year-end) are accurate. However, the answer is incomplete in not providing the full year-by-year debt progression ($9.0B in 2022, $10.638B in 2023). QUALITATIVE ACCURACY: The reasoning about the notes' terms and their role in the debt structure is sound, but the synthesis of how the debt structure evolved is less comprehensive than the ground truth. The answer correctly identifies the strategic shift toward higher-rate debt while maintaining the 2.850% notes, but doesn't quantify this evolution as clearly. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about the relationship's evolution and maturity obligations, though it emphasizes the notes' terms more than the broader structural evolution that the ground truth highlights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 602,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nUNP cut its corporate‑stock allocation in the pension plan from roughly $2.2 billion (about 24 % of total assets) in 2022 to just $0.18 billion (about 5 % of assets) in 2023. The 2024 filings show the equity slice stays near 24 % of assets but corporate stock remains a small fraction, indicating a deliberate shift away from direct equities toward a more diversified, lower‑risk investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and misrepresentations that undermine its credibility. SPECIFIC ISSUES: (1) MAJOR NUMBER ERROR: The LLM states corporate stock was '$2.2 billion (about 24% of total assets) in 2022' but the ground truth clearly states it was $1,990 million ($1.99 billion) in 2022. The $2.2B figure is incorrect. (2) PERCENTAGE MISREPRESENTATION: The LLM claims 24% allocation in 2022, but provides no source for this percentage and it appears inconsistent with the actual dollar amounts. (3) 2023 FIGURE: The LLM correctly identifies the 2023 amount as approximately $0.18 billion ($181 million), matching the ground truth. (4) CRITICAL OMISSION: The LLM completely fails to address the 2024 reclassification detail mentioned in the ground truth - that common stock holdings were reclassified as Level 1 investments while preferred shares became Level 2. This is a key part of the strategic shift narrative. (5) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'dramatic reduction' and 'shift toward more transparent and observable valuation methodologies,' but the LLM vaguely references 'more diversified, lower-risk investment strategy' without capturing the specific valuation methodology shift (Level 1 vs Level 2 classification). (6) CONTRADICTORY STATEMENT: The LLM states 'the equity slice stays near 24% of assets' in 2024, which contradicts its own narrative about moving away from equities and conflicts with the ground truth's emphasis on maintaining 'smaller, more structured equity exposure.' (7) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022-2024 trends, it does so with incorrect baseline numbers and misses the nuanced 2024 reclassification that is central to understanding the strategic shift. The answer demonstrates partial understanding of the general trend (reduction in direct equity exposure) but fails on precision and misses critical details about valuation methodology changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 530,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (reported as “Private equity securities at cost” in the long‑term investment tables) fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**.  This steady decline shows that the company is **reducing its exposure to illiquid alternative investments**, likely to re‑focus capital on its core biopharmaceutical operations and to free up cash for shareholder‑return initiatives rather than sustain a large private‑equity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states $623 million in 2022, but the LLM claims $800 million. This is a $177 million discrepancy (28% error) on the starting value. While the LLM correctly identifies the 2023 ($755M) and 2024 ($719M) figures, the incorrect 2022 baseline completely undermines the analysis of the trend. The LLM characterizes the movement as a 'steady decline' across all three years, but the ground truth shows an initial INCREASE from 2022 to 2023 (+$132M or +21%), followed by a decline to 2024 (-$36M or -5%). This is a materially different narrative: the ground truth indicates short-term growth in 2023 followed by modest retrenchment, while the LLM presents only a continuous decline. The LLM's interpretation about 'reducing exposure to illiquid alternative investments' is therefore based on incorrect data and misses the actual strategic pattern of initial expansion followed by pullback. The reasoning about refocusing on core operations and shareholder returns is speculative and not supported by the filing data. Multi-hop synthesis failed: the model did not correctly extract and compare the three-year trend from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 349,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by (1) formalizing third‑party collaborations—working with issuers, acquirers, merchants, governments and industry groups to set EMV, token‑ization and other standards, and leveraging Fusion Centers, the Mastercard Intelligence Center and public‑private partnerships to monitor and respond to threats; (2) expanding real‑time payment infrastructure—growing the real‑time ACH/account‑based network from 12 markets in 2022 to 13 markets by end‑2023 and adding an open‑banking platform, token‑based Click‑to‑Pay, blockchain‑enabled programmable payments and Alias‑Based Remittances, thereby broadening real‑time account‑to‑account capabilities; and (3) strengthening resilience—enhancing its layered protection, conducting regular third‑party assessments and continuous system testing, maintaining business‑continuity and cyber‑insurance programs, and placing Board‑level oversight on cybersecurity to ensure the network can absorb and quickly recover from cyber incidents.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses all three required dimensions (third-party collaboration, real-time payment infrastructure, cyber resilience) and demonstrates understanding of the evolution from 2022-2024. However, there are significant quantitative accuracy issues that lower the overall score. STRENGTHS: (1) Correctly identifies the three main pillars of evolution; (2) Accurately mentions Fusion Centers, Mastercard Intelligence Center, and public-private partnerships; (3) Correctly references EMV and tokenization standards; (4) Appropriately notes Board-level cybersecurity oversight and business continuity programs; (5) Captures the shift toward ecosystem integration and third-party collaboration. CRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states 'real-time ACH/account-based network from 12 markets in 2022 to 13 markets by end-2023' but the ground truth only confirms '13 markets as of year-end' (2023) without specifying a 2022 baseline of 12 markets. The LLM appears to have introduced the '12 markets in 2022' figure without ground truth support; (2) The LLM adds specific product details (open-banking platform, Click-to-Pay, blockchain-enabled programmable payments, Alias-Based Remittances) that are not mentioned in the ground truth answer, suggesting potential hallucination or extrapolation beyond the source material; (3) The ground truth emphasizes that by 2024 the company 'expanded its real-time payments infrastructure globally' but the LLM's answer doesn't clearly distinguish 2024 expansion from 2023 status. REASONING QUALITY: The multi-hop synthesis is sound in structure, connecting third-party collaboration to threat monitoring, real-time infrastructure to security footprint expansion, and resilience mechanisms to cyber threat absorption. However, the introduction of unsupported specific product names and the potentially incorrect 2022 baseline number suggest the LLM may have synthesized beyond available ground truth data. The answer is well-organized and contextually relevant but contains factual inaccuracies that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 560,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply each year – from about **$1.49 bn in 2022**, to **$0.80 bn in 2023**, and further to **$0.49 bn in 2024** (the figures are disclosed as “collateral under master netting arrangements not offset against the derivatives” and are netted against the “Other assets, including intangibles – net” line).  This steady decline indicates that the company has been reducing the amount of external margin it must hold, reflecting a deliberate unwind or re‑balancing of its derivative positions and a more efficient management of counterparty credit exposure over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $1.49 billion for 2022, $0.80 billion for 2023, and $0.49 billion for 2024. However, the ground truth clearly states: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). The LLM's 2022 figure of $1.49 billion is completely wrong - it should be $800 million. The 2023 and 2024 figures are approximately correct ($800M vs $0.80B, $491M vs $0.49B) but the 2022 baseline is drastically overstated by nearly 86%. (2) CALCULATION ERROR: The LLM claims a decline from $1.49B to $0.49B, which would be a 67% decrease. The ground truth shows a 38% decrease from $800M to $491M (2022-2024). This is a significant calculation discrepancy. (3) TEMPORAL CONFUSION: The LLM appears to have confused the reporting years with the fiscal years being reported. The ground truth correctly distinguishes between when data was reported (2022, 2023, 2024 filings) and what fiscal year-end it represents (2021, 2022, 2023). (4) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (declining collateral requirements) and provides reasonable interpretation about derivative exposure management and margin efficiency, this qualitative reasoning cannot compensate for the fundamental numerical errors. (5) SEMANTIC ISSUES: The LLM's interpretation about 'unwind or re-balancing' and 'more efficient management' aligns with the ground truth's suggestion about 'reduced initial margin requirements or strategic adjustments,' so the qualitative analysis is sound, but it's built on incorrect numbers. The answer fails the primary requirement of factual accuracy on the core quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 509,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe model‑derived expected volatility dropped markedly over the three‑year period—from roughly 28–30 % in 2022 to 28.6 % in 2023 and then to 18.7 % in 2024. This steady decline indicates that Duke Energy’s stock is being perceived as less risky relative to its peer group, reflecting greater stability (e.g., regulatory certainty, slower price swings) in the market’s view of the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states volatility was 'roughly 28-30%' in 2022, but the ground truth clearly shows 26.9% in 2022. This is a significant factual error of approximately 1-3 percentage points. The LLM then correctly states 28.6% for 2023 and 18.7% for 2024. (2) DIRECTIONAL CLAIM ERROR - The LLM claims a 'steady decline' from 2022 through the period, but this is factually incorrect. The actual trajectory is: 26.9% (2022) → 28.6% (2023) → 18.7% (2024). This shows an INCREASE from 2022 to 2023, followed by a decrease to 2024. The LLM's characterization of 'steady decline' misrepresents the multi-year pattern. (3) MULTI-HOP REASONING - The ground truth correctly identifies a peak in 2023 followed by decline in 2024, suggesting stabilization. The LLM's interpretation of 'steady decline' throughout the period is semantically and factually incorrect, failing to capture the actual volatility trajectory. (4) ENTITY/METRIC ACCURACY - Duke Energy and TSR model are correctly identified, but the volatility percentages and their progression are mischaracterized. (5) SEMANTIC EQUIVALENCE - While the LLM's conclusion about reduced market risk perception in 2024 aligns with ground truth, the path to that conclusion is wrong, and the 2022 baseline figure is incorrect. The LLM fundamentally misrepresents the three-year volatility pattern by claiming steady decline when the data shows increase then decrease.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 403,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nGeneral Motors’ indemnification obligations to Stellantis for the former Opel/Vauxhall business—covering emissions‑related claims and any Takata‑inflator recalls of legacy Opel vehicles—remained in place throughout 2022‑2024, but the company recorded only an immaterial accrual for these matters.  While initially no specific loss contingency was booked, by 2024 GM had accrued a negligible amount related to the Takata recalls and continues to state that any further indemnification is remote and cannot be reasonably estimated, leaving the potential exposure essentially unchanged and immaterial.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states 'by 2024 GM had accrued a negligible amount related to the Takata recalls' - this is incorrect. The ground truth clearly indicates the 2024 accrual was related to 'European Commission and UK CMA investigations into conduct by Opel prior to the sale,' NOT Takata recalls. The ground truth explicitly states that in 2023 and 2024, further indemnification related to Takata recalls was considered 'remote,' meaning no accrual was made for Takata. (2) ENTITY/CLAIM CONFUSION: The LLM conflates two separate indemnification matters - Takata recalls (which remained remote/unaccrued) and EC/CMA investigations (which had an immaterial accrual by 2024). This is a critical distinction the ground truth makes clear. (3) TEMPORAL ACCURACY: The LLM's characterization of the evolution is misleading. The ground truth shows: 2022 (immaterial amount for recalls including Takata), 2023 (Takata remote), 2024 (Takata remote, but accrual for EC/CMA investigations). The LLM reverses this by suggesting Takata had an accrual in 2024. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the distinction between different types of indemnification obligations across the three-year period. (5) POSITIVE ASPECTS: The LLM correctly identifies that obligations remained immaterial/negligible overall, correctly names the companies and time period, and correctly notes that future indemnification was considered remote. However, the specific attribution of the 2024 accrual to the wrong claim type is a material factual error that undermines the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 468,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AMD’s exhibit list repeatedly cites the same entry—*10.1 | 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011—without any modification or replacement. This unchanged, year‑over‑year reference shows that AMD continues to anchor its executive‑compensation framework to the original 2011 plan, signalling a deliberate, long‑term compensation strategy that relies on a stable, pre‑existing incentive structure rather than frequent plan updates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN EXHIBIT NUMBER: The LLM states the plan was 'filed as Exhibit 10.2 to AMD's Quarterly Report on Form 10-Q for the period ended April 2, 2011' but the ground truth clearly indicates it was 'filed on April 2, 2011' and listed as 'Exhibit 10.1' (not 10.2). This is a significant factual error in a key detail. The LLM incorrectly changed the exhibit designation from 10.1 to 10.2, which is a material misrepresentation of the filing record. CORRECT ELEMENTS: The LLM correctly identifies that the plan was consistently referenced across 2022, 2023, and 2024 without modifications, and correctly interprets this as indicating a stable compensation strategy. The semantic understanding of the question and the conclusion about long-term strategy are sound. REASONING QUALITY: The multi-hop synthesis is appropriate—the LLM correctly connects the consistent referencing across three years to the inference about deliberate, stable compensation strategy. However, the factual error undermines the credibility of the answer. The date reference (April 2, 2011) is correct, but the exhibit number error is a clear factual mistake that would be problematic in a compliance or legal context where exhibit numbers matter. The answer demonstrates good qualitative reasoning but fails on quantitative/factual precision regarding the exhibit designation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 378,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk intensified as its credit offerings (PayPal Working Capital, PayPal Business Loan and BNPL) and cross‑border transaction volume expanded, while continued reliance on a narrow set of third‑party banks and payment processors amplified fraud, charge‑back and default losses.  \n\nIn 2023 the company acted to curb that risk by (1) entering a multi‑year forward‑flow agreement to sell the majority of its U.K. and European BNPL loan receivables and thereby reduce credit‑portfolio exposure, (2) diversifying and migrating away from a limited number of payment‑processor partners to lessen third‑party dependency, and (3) strengthening fraud‑detection and buyer‑/seller‑protection controls to lower loss rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key strategic action in 2023 - the multi-year agreement to sell U.K. and European BNPL loan receivables - which is the centerpiece of the ground truth answer. The answer accurately captures the evolution of bad transaction risk from 2022-2024 and correctly identifies credit products (BNPL, Working Capital, Business Loans) and third-party dependencies as risk factors. The three-pronged mitigation strategy in 2023 is well-articulated and includes the primary action (BNPL receivables sale) plus additional context on diversification and fraud controls.\n\nWEAKNESSES: (1) The LLM answer does not specify the €40 billion figure mentioned in the ground truth for the BNPL receivables sale agreement - it says 'majority' instead of the specific amount. This is a quantitative omission. (2) The ground truth specifically mentions the Synchrony Bank partnership as a key 2022 risk factor, which the LLM answer does not reference. (3) The ground truth notes specific economic conditions (recessions, high unemployment) that could exacerbate non-payment rates in 2022, which the LLM answer does not include. (4) The ground truth mentions 'regulatory uncertainty, especially around the validity of loan sales post-transfer' as a 2024 concern, which the LLM answer does not address.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022-2024 period and identifies the causal relationship between risk exposure and strategic mitigation. The reasoning is sound and logically structured.\n\nQUANTITATIVE ACCURACY: The €40 billion figure is missing, which is a specific quantitative omission. However, the answer does not contain any incorrect numbers - it simply lacks this key metric.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - PayPal faced increasing bad transaction risk and took strategic action in 2023 to mitigate it through BNPL receivables sales and other measures. The wording differs but conveys similar meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 543,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple‑Purpose locomotive fleet fell from **7,242 to 6,893 units** – owned units stayed roughly steady (≈6,200 → 5,970) while leased units dropped sharply (1,038 → 920).  At the same time the **average age rose from 22.5 years to 25.2 years**, indicating that the remaining owned locomotives are getting older even as the company leans more on a smaller pool of leased units.  This pattern shows that Union Pacific is **maintaining a deliberately sized, aging core fleet** but offsets the risk by keeping a “surge” buffer of leased locomotives and by allocating about **$3.4 billion of capital in 2024** to replace and modernize equipment, reflecting a strategy of incremental renewal rather than a wholesale fleet overhaul.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect total fleet numbers. Ground truth shows owned units of 6,204 (2022) and 5,973 (2024), plus leased units of 1,038 (2022) and 920 (2024), totaling 7,242 and 6,893 respectively. While the LLM correctly states the total fleet numbers (7,242 to 6,893), it then contradicts itself by stating owned units stayed 'roughly steady (≈6,200 → 5,970)' when the ground truth shows a decrease from 6,204 to 5,973 - a loss of 231 units, not 'roughly steady.' The leased unit figures (1,038 → 920) are correct. CORRECT ELEMENTS: The average age figures (22.5 years to 25.2 years) are accurate. The characterization of leased units dropping 'sharply' is appropriate (118-unit decrease). PROBLEMATIC ADDITIONS: The LLM introduces a $3.4 billion capital allocation figure for 2024 that is not present in the ground truth answer and cannot be verified from the provided context. This is a significant addition that goes beyond the scope of the original answer and introduces unverified information. REASONING QUALITY: The LLM's interpretation about 'deliberately sized, aging core fleet' and 'surge buffer' strategy is reasonable inference, though the ground truth more directly states this reflects 'cost control over aggressive modernization.' The multi-hop synthesis is partially sound but undermined by the quantitative errors. The answer addresses the question's components (ownership evolution, aging profile, fleet management strategy) but with compromised accuracy on the core numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 423,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply over the period – from **$1.494 billion at the end of 2022**, to **$0.800 billion at the end of 2023**, and further to **$0.491 billion by the end of 2024** (as disclosed on pages 102 (2023) and 99 (2024) of the 10‑K filings).  \n\nThe steady decline signals that the company is **relying less on external collateral to mitigate derivative counter‑party risk**, reflecting a more streamlined risk‑management approach that increasingly leans on counterparty netting and the credit quality of its equity‑company receivables.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2022 figure. Ground truth states $641 million for 2022, but the LLM claims $1.494 billion - this is a 133% overstatement and fundamentally incorrect. The 2023 ($800 million) and 2024 ($491 million) figures are correct. This single error severely undermines the entire analysis. QUANTITATIVE ACCURACY: The 2022 number is completely wrong ($1.494B vs. $641M). The 2023 and 2024 figures are accurate. The LLM's characterization of a 'steady decline' is misleading because it's based on the incorrect 2022 baseline - the actual trend shows an increase from 2022 to 2023 (not a decline), then a decrease to 2024. QUALITATIVE ACCURACY: The reasoning about 'relying less on external collateral' and 'streamlined risk-management approach' is partially sound in principle, but it's built on a false premise (the wrong 2022 number). The interpretation of the trend is inverted - the actual data shows an increase then decrease, not a steady decline. The LLM correctly identifies this relates to derivative counterparty risk management, but the analysis is compromised by the factual error. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend. The ground truth explicitly notes 'a peak in 2023 followed by a decline in 2024,' which is the correct characterization. The LLM's 'steady decline' narrative is factually incorrect. MISSING ELEMENTS: The LLM does not mention the use of level 3 fair value inputs or the reliance on internal models for valuation, which the ground truth identifies as important context. The answer lacks discussion of the 2023 peak and what it might signify. CONCLUSION: While the LLM demonstrates understanding of derivative risk management concepts, the fundamental error in the 2022 figure (off by $853 million) and the resulting mischaracterization of the trend as a 'steady decline' when it actually shows an increase then decrease, makes this answer substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 540,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line‑item—defined in each filing as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware, among other items—was $6.89 bn (≈21 % of total revenue) in fiscal 2022, rose to $7.71 bn (≈22 % of total) in fiscal 2023, and then slipped slightly to $7.54 bn (≈21 % of total) in fiscal 2024, keeping its share of overall revenue in the low‑20 % range with a modest increase followed by a small decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information not requested. CRITICAL ISSUES: (1) The question asks about the COMPOSITION and EVOLUTION of the 'Other' category's components (what items are included), not the revenue dollar amounts or percentages. The ground truth explicitly states the category 'remained relatively stable in its composition' and lists the specific items included each year. (2) The LLM provides specific dollar amounts ($6.89bn, $7.71bn, $7.54bn) and percentages (21%, 22%, 21%) that cannot be verified against the ground truth and appear to be fabricated or from unverified sources. These numbers are presented with false precision without any basis in the provided context. (3) The LLM completely ignores the core requirement to discuss how the COMPOSITION evolved - i.e., what specific items were listed in each year's filing and how that list changed. The ground truth notes that items like 'ready-to-drink beverages' were mentioned in 2022 but not explicitly in 2024, which is a compositional detail the LLM missed entirely. (4) While the LLM correctly identifies some components (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware), it fails to address the nuanced compositional changes across years. (5) The LLM's statement about 'modest increase followed by a small decline' is a quantitative observation that doesn't answer the qualitative question about compositional evolution. The answer demonstrates a fundamental misunderstanding of what was being asked and provides unverified financial data instead of analyzing the actual composition details from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 462,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Google continued to treat its Google Network inventory as a principal, recording the full amount billed to advertisers as revenue and classifying the payments to network partners as cost of revenue – i.e., it reports network advertising grossly (see page 58).  For brand‑type ads it recognizes revenue when an impression is delivered (the ad is displayed), while performance ads are revenue‑recognized on a click‑basis; the company repeatedly notes that it evaluates its principal‑vs‑agent status and, because it controls the inventory before it is transferred, generally reports on a gross basis (pages 16 & 58).  What has evolved is the refinement of its impression‑counting methodology and the introduction of new Ad Manager tools that improve the accuracy of impression measurement, but the core policy of gross‑revenue recognition with impression‑based revenue for network ads has remained consistent across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the principal-agent accounting treatment and gross revenue recognition model consistently applied 2022-2024. (2) Accurately describes the dual revenue recognition methods: impression-based for brand ads and click-based for performance ads. (3) Properly synthesizes the multi-hop information about Google's control over inventory and its role as principal. (4) Correctly notes the evolution involved refinement of impression-counting methodology and new Ad Manager tools rather than fundamental policy changes. (5) Appropriately cites specific page references (16 & 58) showing engagement with source material. (6) No quantitative errors or incorrect dates/metrics. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more operational detail (impression-counting methodology refinement, new Ad Manager tools) than the ground truth, which is not incorrect but represents additional specificity. (2) The ground truth emphasizes 'increasing transparency and accounting clarity' as part of the evolution, while the LLM focuses on technical refinements - both are valid characterizations of the evolution, just with different emphasis. (3) The LLM answer is more detailed and specific about the mechanics (principal status, cost of revenue treatment) compared to the ground truth's more general framing. These differences represent complementary rather than contradictory information. The core factual claims all align: consistent gross revenue recognition, impression-based revenue for brand ads, click-based for performance ads, and evolution through refinement rather than fundamental policy change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 472,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nFrom 2022 through 2024 Mondelez’s exposure to sales and media‑marketing restrictions grew as regulators broadened front‑of‑pack labeling (e.g., EU nutrient‑profile labeling and the UK’s 2025 ban on advertising high‑fat/sugar/salt products) and extended producer‑responsibility (EPR) schemes moved from more than 25 EU countries to additional jurisdictions such as India, Vietnam and several U.S. states. These expanding labeling and EPR requirements increasingly constrain how the company can promote, price and package its snacks across its global footprint.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of expanding regulatory restrictions on MDLZ across 2022-2024, but contains significant omissions and one factual error that reduce accuracy. STRENGTHS: (1) Correctly identifies the core evolution from 25+ EU countries with EPR to expansion into India, Vietnam, and U.S. states; (2) Accurately notes the shift from contemplation to enforcement; (3) Properly synthesizes front-of-pack labeling and EPR as dual regulatory pressures; (4) Correctly identifies the EU Packaging and Packaging Waste Directive adoption. CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM mentions 'UK's 2025 ban on advertising high-fat/sugar/salt products' which is NOT mentioned in the ground truth. This appears to be an unsupported claim not found in the original answer; (2) INCOMPLETE - Fails to mention Indonesia and the Philippines as jurisdictions where single-use plastic bans and taxes were being considered (2023); (3) INCOMPLETE - Does not mention Vietnam as a jurisdiction where EPR was being contemplated in 2022, only noting it in the expansion context; (4) VAGUE - Does not specify that restrictions on advertising products with specified nutrient profiles were in place in 2022, only references 'nutrient-profile labeling' generally. QUANTITATIVE ACCURACY: The '25 EU countries' figure is correct, but the answer lacks the temporal specificity of the ground truth (what was true in 2022 vs 2023 vs 2024). The UK 2025 advertising ban claim is unsupported and reduces quantitative reliability. QUALITATIVE ACCURACY: The multi-hop reasoning connecting EPR expansion with front-of-pack labeling restrictions is sound, and the synthesis of jurisdictional expansion is logical. However, the introduction of unsupported information (UK ban) and omission of specific jurisdictions (Indonesia, Philippines) weakens the qualitative assessment. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on evolution across three years and the relationship between labeling and EPR policies, though with incomplete coverage of all relevant jurisdictions and regulatory details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 567,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nClass A shares have kept the same one‑vote‑per‑share right and dividend entitlement through 2022‑2024, with the Board continually declaring quarterly cash dividends that rose from $2.04 per share in 2022 to $2.37 in 2023 and $2.74 in 2024 (see MA_10k_2022.pdf p. 92; MA_10k_2023.pdf p. 92; MA_10k_2024.pdf p. 92).  This uninterrupted voting structure and steady dividend growth shows Mastercard’s capital‑structure strategy of maintaining a stable, shareholder‑friendly framework—preserving control for Class A holders while consistently returning cash through dividends and repurchases.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply – from roughly **$1.5 billion in 2022**, to **$0.8 billion in 2023**, and to **$0.49 billion in 2024**.  This downward trend shows that the company’s initial‑margin requirements for the derivatives linked to those investments have been reduced, reflecting lower counterparty‑credit risk and/or smaller derivative notional balances, so less collateral is needed to support its derivative exposure over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 collateral was '$1.5 billion' when the ground truth clearly shows $641 million - this is a 134% overstatement. The 2023 figure of $0.8 billion ($800 million) is correct. The 2024 figure of $0.49 billion ($491 million) is correct. (2) TREND MISCHARACTERIZATION: The LLM describes a 'sharp downward trend' from 2022-2024, but the actual data shows: 2022 ($641M) → 2023 ($800M) = 24.8% INCREASE, then 2023 ($800M) → 2024 ($491M) = 38.6% DECREASE. The correct pattern is an increase followed by a decrease, not a continuous downward trend. (3) REASONING FLAW: The LLM's interpretation that the trend 'shows reduced initial-margin requirements' is contradicted by the actual 2023 spike to $800M, which represents increased margin requirements. The ground truth correctly identifies this as a 'notable increase in margin requirements in 2023, followed by a significant reduction in 2024.' (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the data across three years and interpret the trend, it fails at the fundamental data retrieval step, making the entire analysis unreliable. (5) SEMANTIC ISSUES: The LLM's conclusion about 'lower counterparty-credit risk' contradicts the actual 2023 increase in collateral posted. The correct interpretation should acknowledge the volatility and the specific 2023 spike. The answer demonstrates poor data accuracy on a quantitative question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 435,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks lengthened its procurement horizon and intensified its hedging of coffee‑price risk. In FY 2022 the company said its purchase commitments and inventory would meet green‑coffee demand only through FY 2023, but by FY 2023 (and again in FY 2024) it projected adequate supply out to FY 2025 and highlighted the use of fixed‑price/price‑to‑be‑fixed contracts together with forward contracts, futures and collars to hedge “C”‑price exposure. This progression shows Starbucks is deliberately extending its supply‑chain planning horizon and expanding financial hedges to lock in prices and secure coffee availability, thereby managing the volatility of commodity coffee markets and reducing supply‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Starbucks' supply chain evolution. QUANTITATIVE ACCURACY (10/10): All dates and fiscal years are correct - FY 2022 commitments through FY 2023, extended to FY 2025 by FY 2023 and maintained through FY 2024. No numerical errors or miscalculations. ENTITY ACCURACY: Correctly identifies Starbucks, green coffee, 'C' price exposure, and all relevant hedging instruments (forward contracts, futures, collars, fixed-price/price-to-be-fixed contracts). COMPLETENESS: Addresses all aspects of the multi-hop question - the evolution across three fiscal years, the progression of commitments, and the strategic implications for managing volatility and supply risk. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years to show the trend of lengthening procurement horizons and intensifying hedging strategies. The logical connection between extended commitments and risk mitigation is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different but equivalent phrasing. The mention of 'fixed-price/price-to-be-fixed contracts' adds a minor detail not explicitly in the ground truth but is consistent with typical coffee hedging practices and doesn't contradict the original answer. MINOR OBSERVATION: The LLM answer is slightly more detailed in describing the hedging instruments and provides clearer explanation of the strategic intent, which enhances rather than detracts from accuracy. The answer fully captures the progression from shorter-term (FY 2023) to longer-term (FY 2025) supply assurance and the consistent use of financial instruments across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 473,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nThe target mix for the defined‑benefit plans stayed at a 100 % debt allocation for the U.S. portfolio, while the non‑U.S. target shifted from 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other in fiscal 2023 (page 88) to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other in the fiscal 2025 target (page 95).  This multi‑year re‑weighting—reducing high‑yield debt, boosting cash and insurance‑contract holdings, and only modestly raising equity—signals ACN’s move toward a more liability‑driven, lower‑volatility strategy that prioritises stable, risk‑adjusted returns and better matching of plan liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative information about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which is a significant strength compared to the ground truth answer. STRENGTHS: (1) The LLM provides concrete percentage allocations for both fiscal 2023 and fiscal 2025 for the non-U.S. portfolio, showing detailed multi-hop synthesis across years. (2) The specific numbers appear internally consistent (fiscal 2023: 27% equity/48% debt/4% cash/11% insurance/10% other = 100%; fiscal 2025: 28% equity/36% debt/7% cash/21% insurance/8% other = 100%), demonstrating mathematical accuracy. (3) The LLM correctly identifies the U.S. portfolio remained at 100% debt allocation. (4) The interpretation of the shift toward liability-driven investment strategy, lower volatility, and risk-adjusted returns aligns well with the ground truth's emphasis on 'liability matching and risk mitigation.' (5) Page citations (88, 95) suggest proper source documentation. WEAKNESSES: (1) The ground truth answer emphasizes continuity and adaptive flexibility across three years, while the LLM focuses primarily on the non-U.S. portfolio shift, potentially missing broader strategic context. (2) The ground truth mentions 'flexibility ranges to respond to market conditions' which the LLM doesn't explicitly address. (3) The LLM doesn't discuss the fiscal 2024 intermediate year, though the question asks about evolution 'from fiscal 2023 to fiscal 2025.' (4) The ground truth references the investment return objective of 'exceeding inflation over the long term,' which the LLM doesn't mention. VERIFICATION: The specific allocation percentages provided by the LLM cannot be independently verified against the ground truth document provided, but they are internally consistent and logically support the stated conclusion about strategy shift. The reasoning about moving toward liability-driven strategy is sound and well-supported by the allocation changes described (reduced debt, increased insurance contracts, increased cash).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 552,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen pushed Olpasiran through late‑stage (Phase 3) clinical testing, maintaining its therapeutic focus on using an siRNA to lower lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease.  At the same time the company secured composition‑of‑matter patent protection that is projected to expire in 2036 in both the United States and Europe, giving the drug up to roughly 13 years of market exclusivity after a potential approval.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH CLINICAL STAGE CLAIM: The LLM states Olpasiran was in 'Phase 3' clinical testing between 2022-2024, but the ground truth explicitly states it was in 'phase 2 trials' in 2022 with no mention of Phase 3 advancement by 2024. This is a significant factual error regarding the drug's development stage. The LLM appears to have fabricated or misinterpreted the clinical development trajectory.\n\nCORRECT ELEMENTS: (1) Patent expiration date of 2036 is accurate; (2) U.S. and European patent protection correctly identified; (3) Composition-of-matter patent type is correct; (4) Therapeutic focus on cardiovascular disease/atherosclerotic CV disease is correct; (5) siRNA mechanism is correct; (6) The ~13-year exclusivity calculation (2036 minus current time) is mathematically reasonable.\n\nINCOMPLETE/PROBLEMATIC ELEMENTS: (1) The LLM adds specific detail about 'lowering lipoprotein(a)' which is not mentioned in the ground truth - this appears to be external knowledge not from the filings; (2) The claim about 'late-stage (Phase 3)' contradicts the ground truth's 'phase 2' designation; (3) The LLM fails to capture the 2023 disclosure of patent protection as a distinct milestone; (4) The progression narrative is oversimplified and inaccurate regarding clinical stage advancement.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize clinical development with IP protection across years, but the clinical stage information is fundamentally wrong, undermining the entire synthesis. The ground truth shows a more nuanced progression (phase 2 in 2022 → patent disclosure in 2023 → cardiovascular indication in 2024) that the LLM misrepresents.\n\nQUANTITATIVE: Patent dates (2036) are correct, but the clinical stage claim is a major factual error that cannot be overlooked despite correct patent information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 496,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nAmerican Express has steadily deepened its reliance on third‑party aggregators and processors to expand merchant acceptance, a dependence that grew each year from 2022 through 2024. In 2022 the filings warned that such partners could enable discriminatory surcharging or steering and could disrupt operations; in 2023 the focus shifted to regulatory pressures on interchange fees and the need for stronger data‑privacy and cybersecurity safeguards; and in 2024 the disclosures broadened to emphasize data‑security breaches, algorithmic bias, intellectual‑property disputes and the risk that a third‑party outage could materially harm the business.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth, despite some correct structural elements. CRITICAL ISSUES: (1) The LLM introduces risks NOT mentioned in the ground truth, including 'algorithmic bias,' 'intellectual-property disputes,' 'data-privacy and cybersecurity safeguards,' and 'data-security breaches.' The ground truth specifically emphasizes merchant steering, surcharging, and third-party operational disruptions—none of which are adequately highlighted in the LLM response. (2) The LLM mentions 'regulatory pressures on interchange fees' in 2023, which is not supported by the ground truth. (3) The LLM's characterization of the evolution is partially incorrect: it claims the focus 'shifted to regulatory pressures' in 2023, but the ground truth indicates the focus remained on aggregator dependency and surcharging/steering risks, with added emphasis on operational disruptions. (4) The LLM correctly identifies the general trend of increasing reliance and evolving risk disclosure, but misidentifies which specific risks were emphasized in each year. CORRECT ELEMENTS: The LLM correctly identifies that AXP's reliance on aggregators grew from 2022-2024, that there was an evolution in risk disclosure, and that 2024 saw broader operational and legal concerns. However, the specific risks cited for each year are largely inaccurate. The answer demonstrates a fundamental misunderstanding of which third-party risks were actually emphasized in the filings, substituting cybersecurity and data-privacy concerns that were not the primary focus according to the ground truth. This represents a failure in multi-hop synthesis and entity-specific risk identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 468,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks kept green‑coffee price volatility under control by using a mix of fixed‑price and price‑to‑be‑fixed purchase contracts together with forward contracts, futures and collars to hedge “C”‑price exposure, and it repeatedly said that total purchase commitments plus existing inventory would satisfy demand through fiscal 2025.  While the hedging toolkit did not change materially, the company expanded the size and tenor of its forward supply commitments—adding larger fixed‑price volumes and extending collar periods—to offset rising inflation‑driven cost pressures, thereby reducing its reliance on commodity‑index‑driven price swings over the three‑year period.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture expanded its open‑market share‑purchase authorization from $3.1 billion (as of Aug 31 2022) to $6.7 billion after two Board‑approved increases, while consistently repurchasing millions of shares—$4.1 billion of stock in 2022 and $4.5 billion of share purchases in fiscal 2024 alone.  The remaining authorization was $2.7 billion at the end of 2024, leaving ample flexibility for future buy‑backs.  This multi‑year trajectory demonstrates a deliberate capital‑return strategy that prioritizes sizable, recurring share repurchases (combined with dividends) to return excess cash to shareholders and offset equity dilution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) WRONG REPURCHASE AMOUNTS: The LLM claims '$4.1 billion of stock in 2022' and '$4.5 billion of share purchases in fiscal 2024' - these figures are NOT supported by the ground truth, which only mentions $605 million in fiscal 2023 repurchases. The ground truth does not provide fiscal 2022 or 2024 repurchase dollar amounts, so the LLM appears to have fabricated these numbers. (2) AUTHORIZATION FIGURES - PARTIALLY CORRECT: The LLM correctly identifies the $3.1 billion starting authorization and $6.7 billion ending authorization, and correctly notes the $4 billion increase. The $2.7 billion remaining authorization is also correct. (3) SHARE COUNT ERROR: The LLM mentions 'millions of shares' repurchased but provides no specific share count. The ground truth specifies 2,000,308 shares purchased in fiscal 2023 for $605 million - a concrete data point the LLM omitted. (4) MULTI-HOP REASONING: While the LLM correctly synthesizes the authorization trajectory and provides reasonable interpretation of capital return strategy, it does so while introducing unsupported financial figures. The reasoning about capital return strategy is sound but built on partially false data. (5) TIMELINE ISSUES: The LLM references 'Aug 31 2022' for the starting authorization, which aligns with ground truth context, but the specific fiscal year dating is imprecise. (6) MISSING CONTEXT: The LLM fails to mention the specific fiscal 2023 repurchase activity ($605 million for 2,000,308 shares), which is a key data point in the ground truth. The answer demonstrates understanding of the strategic narrative but severely compromises accuracy through invented financial figures that cannot be verified against the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 500,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term lock‑up portion of Google’s marketable equity securities grew from **$0.8 billion at the end of 2022 to $1.4 billion at the end of 2023**, and then fell sharply to **$0.27 billion by the end of 2024** (the $266 million figure disclosed for 2024).  \n\nThis swing shows that Alphabet’s exposure to illiquid, long‑term equity holdings was not steady: it expanded the position in 2023—likely to capture growth or strategic opportunities— but then reduced it markedly in 2024, suggesting a deliberate re‑balancing or liquidation of those investments to refocus capital on more liquid or core business areas.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains severe factual errors across all numeric values and the temporal sequence. Ground truth shows: 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM claims: 2022=$0.8B, 2023=$1.4B, 2024=$0.27B (or $266M). Every single year's value is incorrect. The LLM reversed the 2022-2023 values and provided a completely wrong 2024 figure. The directional narrative is also inverted - the ground truth shows a decrease then recovery (cyclical pattern), while the LLM describes an increase then sharp decline (different pattern entirely). The LLM's interpretation about 'deliberate re-balancing or liquidation' contradicts the actual data showing a return to 2022 levels by 2024. The only partially correct element is the general concept that the company's illiquid holdings fluctuated, but the specific numbers, years, and conclusions are fundamentally wrong. This is a critical failure on a quantitative question where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 275,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑positioned Electric Insurance Company as a non‑core, run‑off captive insurer: it was classified as held‑for‑sale in Q4 2022, written down $109 million in 2023, and finally sold in Q2 2024 to Riverstone International Holdings for $120 million cash, which removed roughly $540 million of assets and $378 million of liabilities from the balance sheet.  The disposal eliminated the subsidiary’s exposure and generated a modest cash inflow (and a small gain that offset the prior write‑down), thereby streamlining GE’s portfolio and contributing a modest positive impact on cash flow, though its effect on overall earnings was limited.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline more than doubled – the 2022 filing listed **13** late‑stage programs, the 2023 filing showed **24** programs, and the 2024 filing reports **25** active Phase 3 studies (see 2022 p. 27; 2023 p. 26; 2024 p. 25).  This growth was driven by a mix of new initiations (e.g., Rocatinlimab for prurigo nodularis, TEPEZZA sub‑cutaneous in Japan, ABP234 biosimilar to Keytruda) and regulatory approvals of three candidates, while the company also advanced multiple oncology, cardiovascular and rare‑disease assets (Lumakras combos, Olpasiran, Tarlatamab, etc.) and expanded its biosimilar portfolio.  The progression from 13 to 25 programs signals Amgen’s strategic focus on deepening its late‑stage pipeline, leveraging collaborations and acquisitions to broaden high‑impact therapeutic areas and sustain long‑term growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2023 figure. The ground truth states 18 programs in 2023, but the LLM claims 24 programs in 2023. This is a major discrepancy that undermines the core narrative of the answer. The correct progression should be 13 (2022) → 18 (2023) → 24 (2024) → 25 (2024), not 13 → 24 → 25 as the LLM suggests. This error is particularly problematic because it misrepresents the year-over-year growth pattern and the timing of the pipeline expansion. The LLM correctly identifies the 2022 (13) and 2024 (25) figures, and the final endpoint is correct, but the intermediate 2023 data point is wrong by 6 programs, which is substantial. STRENGTHS: (1) The LLM correctly identifies the overall growth trajectory from 13 to 25 programs; (2) It appropriately mentions the Horizon acquisition as a driver of growth; (3) The qualitative discussion of therapeutic areas (oncology, cardiovascular, rare disease) and specific programs (Rocatinlamab, Olpasiran, Tarlatamab) adds relevant context; (4) The reasoning about strategic focus on late-stage pipeline expansion is sound and well-articulated. WEAKNESSES: (1) The 2023 figure of 24 is incorrect (should be 18); (2) This error distorts the growth narrative, making it appear the major expansion happened in 2022-2023 rather than 2023-2024; (3) The answer doesn't clearly articulate the two-phase growth pattern (13→18 in 2023, then 18→24→25 in 2024). MULTI-HOP REASONING: The LLM demonstrates good synthesis across multiple years and incorporates relevant contextual information about acquisitions and regulatory approvals, but the factual error in the 2023 data point significantly undermines the credibility of the multi-hop analysis. The answer would have scored 8-9 if the 2023 figure were correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 495,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nAmerican Express has moved from a broadly‑licensed global network model toward a more selective, premium‑focused partnership strategy between 2022 and 2024.  Driven by tighter interchange‑fee caps and EU/Australia network‑licensing exits imposed by regulators, the company has had to curb discount‑rate pressure and reshape its cobrand and agent relationships, while simultaneously investing in differentiated digital and travel benefits to stay competitive against Visa, Mastercard and emerging fintech rivals.  This evolution reflects both the impact of heightened global regulatory scrutiny (e.g., its 2024 designation as a Category III bank‑holding company and the resulting compliance costs) and the need to defend its market position amid intensifying competition.  (See “Competition” – pages 12, 14, 33; “Supervision and Regulation” – pages 14, 33; and the 2024 regulatory updates.)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AXP's relationship with global card networks from 2022-2024, correctly identifying key elements: (1) shift from competitive/licensed model to selective premium strategy, (2) regulatory pressures in EU and Australia leading to network licensing exits, (3) competition from Visa, Mastercard, and fintech rivals, (4) impact on cobrand arrangements. STRENGTHS: The answer accurately reflects the trajectory from competition to regulatory constraint, mentions specific regulatory impacts (EU/Australia exits, Category III designation), and identifies the strategic pivot toward differentiated benefits. The synthesis across regulatory and competitive dynamics is sound. WEAKNESSES: (1) The answer introduces the 'Category III bank-holding company' designation and associated compliance costs, which while potentially accurate, is not explicitly mentioned in the ground truth and represents an inference beyond the provided knowledge graph. (2) The phrase 'discount-rate pressure' and 'interchange-fee caps' are reasonable inferences about regulatory impacts but not explicitly stated in the ground truth. (3) The answer is somewhat more detailed on mechanisms (interchange fees, compliance costs) than the ground truth, which focuses more on the strategic positioning shift. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is less applicable. The temporal framing (2022-2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across regulatory pressures, competitive dynamics, and strategic responses, though it adds some interpretive layers beyond the ground truth. SEMANTIC EQUIVALENCE: The core message aligns well - AXP moved from competitive positioning to a constrained, regulatory-dependent model with emphasis on premium differentiation. The wording differs but conveys equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 519,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips repurchased 87.7 million shares in 2022, 48.6 million shares in 2023 and 49.1 million shares in 2024 – a total of roughly 185 million shares placed in treasury over the three‑year span.  The company’s share‑repurchase program had repurchased 433 million shares at a cumulative cost of $34.3 billion through the end of 2024, with the cash generated from the 2022 sale of the remaining 91 million CVE common shares being deployed to fund the 2022 repurchase and subsequent purchases in 2023‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 91 million CVE shares sold in 2022 is accurate; (2) The cumulative 433 million shares repurchased at $34.3 billion through end of 2024 is correct; (3) The connection between CVE monetization proceeds and share repurchase funding is correctly identified; (4) The overall narrative structure and multi-hop reasoning is sound. CRITICAL ERRORS: (1) The annual repurchase volumes are significantly understated - LLM reports 87.7M (2022), 48.6M (2023), 49.1M (2024) totaling ~185M shares over three years, but the ground truth indicates 383 million shares were repurchased in 2022 alone, which is more than double the LLM's entire three-year total; (2) The 2022 repurchase cost of $29 billion is completely missing from the LLM answer, which only mentions the cumulative $34.3 billion figure; (3) The LLM's three-year total of 185 million shares is mathematically inconsistent with the stated cumulative total of 433 million shares through 2024. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between CVE share monetization and subsequent repurchase activity, but fails to accurately capture the magnitude of the 2022 repurchase program. The answer demonstrates understanding of the relationship between asset sales and capital returns but provides incomplete and inaccurate quantitative details for the specific three-year period requested. The discrepancy between annual figures and cumulative figures suggests data extraction or calculation errors rather than conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 437,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the pool of shares reserved for future grants under the Omnibus Stock Incentive Plan fell sharply—​about 117 million shares were available at the start of 2022, roughly 77 million were left as of the end of 2023 (January 28, 2024), and only ≈ 70 million remained available as of February 2, 2025.  This steady decline shows that Home Depot has been using an increasing share of its authorized equity reserve for stock‑based compensation, indicating growing utilization of its equity‑compensation capacity and a diminishing ability to issue new equity awards without amending the plan or expanding the share reserve.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the key share availability figures: 117 million shares in 2022, 77 million by end of 2023, and 70 million by 2024. The numeric values match the ground truth exactly. The LLM correctly synthesizes the multi-hop information across the three-year period and accurately interprets the trend as a steady decline indicating increased utilization of equity compensation capacity. The reasoning is sound and logically connects the declining share pool to implications about the company's diminishing ability to issue new equity awards without plan amendments. Minor differences from ground truth: (1) The LLM specifies 'February 2, 2025' for the 2024 figure, while the ground truth simply states '2024'—this is a minor temporal precision difference that doesn't affect accuracy; (2) The LLM adds interpretive language about 'diminishing ability to issue new equity awards without amending the plan,' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states. The LLM answer is more detailed and provides additional context about the implications of the trend. All core facts are correct, the multi-hop synthesis across years is accurate, and the interpretation of what the trend indicates about stock-based compensation capacity aligns well with the ground truth. The answer fully addresses both parts of the question: the evolution of available shares and what this indicates about capacity and utilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 417,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share limit grew from **127 million Class A shares at the end of fiscal 2022** (page 91) to **141 million shares by the end of fiscal 2024** (page 98).  This step‑up in the maximum pool signals that Accenture is deliberately expanding its equity‑award capacity, using share‑based compensation as a strategic tool to attract, retain and align talent with the firm’s accelerating global growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key numbers: 127 million shares in 2022 and 141 million shares in 2024. The numeric values match the ground truth exactly, and the format variation (127 million vs 127,000,000) is appropriately handled. The answer correctly identifies the progression and the 14 million share increase. The multi-hop synthesis is sound—the model successfully connected the authorization limits across the three-year period and drew appropriate strategic conclusions about Accenture's compensation strategy. The reasoning about equity-based incentives being used to attract, retain, and align talent is logically sound and semantically equivalent to the ground truth's statement about 'aligning executive and employee interests with shareholder value creation.' One minor observation: the LLM answer references specific page numbers (91 and 98) which adds credibility but wasn't in the ground truth. The answer could have been slightly more explicit about the 2023 intermediate year (the ground truth mentions 2023 as also having 141 million), though this is a minor omission since the question asks about the evolution 'from 2022 through 2024' and the answer captures the key progression. The strategic interpretation is well-articulated and appropriately emphasizes the deliberate nature of the expansion. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 412,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio fell from roughly **6.5 % in 2022** (AXP 10‑K 2022, p. 121) to **5.85 % by the end of 2024** (AXP 10‑K 2024, p. 180).  This decline reflects a deliberate shift toward shorter‑maturity or lower‑yielding sovereign securities, signalling that the company is reducing its sensitivity to rising international interest‑rate environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the yield was '6.5% in 2022' when the ground truth clearly shows it was 5.86% in 2022. The LLM also states 5.85% in 2024, which matches the ground truth (5.86% with rounding), but the 2022 figure is completely wrong. The LLM omits the critical 2023 data point (6.45%), which is essential to understanding the trend. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth requires synthesizing data across three years (2022, 2023, 2024) to show the complete trajectory. The LLM only presents two years and misses the peak in 2023, which is crucial to the narrative. The ground truth explicitly states: 2022=5.86%, 2023=6.45%, 2024=5.86%. The LLM presents: 2022=6.5%, 2024=5.85%, missing 2023 entirely. (3) REASONING QUALITY: The LLM's interpretation that this represents 'a deliberate shift toward shorter-maturity or lower-yielding sovereign securities' and 'reducing its sensitivity to rising international interest-rate environments' contradicts the ground truth's assessment that the 2024 return to 2022 levels suggests 'stabilization or strategic portfolio adjustments' after a volatile 2023 peak. The LLM's reasoning is speculative and not supported by the data pattern. (4) ENTITY/METRIC ACCURACY: While American Express is correctly identified, the weighted average yield figures are materially incorrect for 2022, and the omission of 2023 represents a failure to fully address the multi-hop nature of the question. The ground truth emphasizes volatility with a peak in 2023; the LLM presents a simple decline narrative that is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 467,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio slipped from about 6.45 % in 2023 to 5.85 % in 2024, after having been anchored near 6.45 % in 2022 when the fair‑value distribution was weighted toward longer‑dated, higher‑yielding bonds.  This decline reflects a deliberate shortening of the sovereign‑bond book and a move toward lower‑yielding, shorter‑maturity securities, as the company adjusts its investment strategy to manage interest‑rate risk and preserve liquidity amid evolving market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims the yield was 'anchored near 6.45% in 2022' but the ground truth provides NO weighted average yield figure for 2022, only fair value distribution data ($630M total, $628M maturing within one year). The LLM fabricated a 2022 yield comparison that doesn't exist in the source data. (2) FACTUAL CONTRADICTION - The LLM states the portfolio was 'weighted toward longer-dated, higher-yielding bonds' in 2022, but the ground truth explicitly states the OPPOSITE: the majority ($628M of $630M) matured within ONE YEAR, indicating SHORT-duration focus, not long-dated. This is a fundamental mischaracterization. (3) INCOMPLETE ANALYSIS - The LLM fails to mention the $630M 2022 holding amount or the maturity breakdown that is central to understanding the portfolio composition. (4) CORRECT ELEMENTS - The LLM correctly identifies: (a) 6.45% yield in 2023, (b) 5.85% yield in 2024, (c) the decline from 2023 to 2024, (d) the general interpretation that this reflects market conditions/strategy adjustment. (5) REASONING FLAW - While the LLM's conclusion about 'shortening of the sovereign-bond book' aligns with the ground truth's interpretation, the LLM's supporting premise about 2022 being 'longer-dated' is backwards and contradicts the actual data. The answer demonstrates partial understanding but contains material factual errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 395,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nThe 7 % Debentures due 2029 are disclosed in the “Securities registered pursuant to Section 12(b)” table of each filing.  In the 2022 and 2024 Forms 10‑K the table lists the issue as “Common Stock, $.01 Par Value 7 % Debentures due 2029” with both the ticker “COP” and the CUSIP ‑ 718507BK1, while the 2023 filing shows the same description and CUSIP but omits the ticker symbol.  Apart from this minor formatting change, the wording, par‑value, coupon, maturity and exchange listing remain identical across the three years, indicating that ConocoPhillips maintains a stable, consistently‑structured disclosure of this long‑dated debt instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CUSIP NUMBER ERROR: The LLM states the CUSIP is '718507BK1' but provides it without the hyphen format shown in ground truth. More critically, the LLM claims this CUSIP appears in both 2022 and 2024, but the ground truth explicitly states the CUSIP (718507BK1) was only introduced in 2023 as part of the separation into its own row. (2) DESCRIPTION ERROR: The LLM claims the 2022 and 2024 filings list the issue as 'Common Stock, $.01 Par Value 7% Debentures due 2029' - this is factually incorrect. The ground truth indicates that in 2022, the debentures were disclosed 'alongside its Common Stock' (meaning they were grouped together), not that they had a combined description. By 2023, they were 'separated into its own row' with distinct identification. (3) TICKER SYMBOL CLAIM: The LLM states the 2023 filing 'omits the ticker symbol' while 2022 and 2024 include it. The ground truth makes no mention of ticker symbol variations across years - it only notes that in 2023 the debentures received their own row with separate CUSIP identification. (4) EVOLUTION MISCHARACTERIZATION: The LLM describes the changes as 'minor formatting changes' and concludes the disclosure remained 'stable' and 'consistently-structured.' This directly contradicts the ground truth, which emphasizes a clear evolution: from grouped disclosure (2022) → separated into own row (2023) → maintained separation (2024). The ground truth explicitly states this represents 'a growing emphasis on clarity and specificity in debt disclosure practices,' not stability. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year progression showing how the company's approach to reporting evolved from less transparent (grouped with common stock) to more transparent (separate row with dedicated CUSIP). The answer misses the key insight about the intentional improvement in disclosure clarity. The only partially correct element is the identification of the 7% Debentures due 2029 and the general CUSIP number, but the context and evolution are fundamentally misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 582,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 NVIDIA’s 2.00 % Notes Due 2031 stayed essentially unchanged – the fair‑value disclosed in the 2022 10‑K (page 88) was $1.2 bn, the 2023 filing (page 69) still showed a $1.2 bn fair‑value balance, and the 2024 filing (page 72) reported a net carrying amount of about $1.25 bn (fair‑value still ≈ $1.2 bn).  \n\nThis steady, low‑coupon, long‑dated issuance demonstrates that NVIDIA is managing its long‑term debt by locking in inexpensive, durable financing while keeping the exposure stable, preserving balance‑sheet flexibility and avoiding frequent refinancing or aggressive deleveraging.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the instrument (2.00% Notes Due 2031), provides specific page references to 10-K filings, and offers reasonable qualitative analysis about NVIDIA's debt management strategy (locking in inexpensive financing, maintaining balance-sheet flexibility). The semantic interpretation of 'stable approach' aligns with the ground truth's characterization. CRITICAL ERRORS: The LLM states 2023 showed '$1.2 bn fair-value balance,' but the ground truth explicitly shows 2023 was $1.057 billion - a material discrepancy of ~$143 million (12% difference). This is a significant quantitative error. The LLM also conflates fair-value and carrying amounts inconsistently (stating 2024 fair-value was '≈$1.2 bn' when the ground truth shows the actual amount was $1.25 billion). MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three fiscal years and identifies the progression pattern, though it mischaracterizes the 2023 figure as unchanged rather than decreased. The reasoning about debt management strategy is sound but based on partially incorrect data. CALCULATION VERIFICATION: No explicit calculations are performed, but the implicit comparison of values across years contains the 2023 error. The characterization of the progression as 'essentially unchanged' is contradicted by the ground truth showing a dip to $1.057B in 2023 before rising to $1.25B in 2024. This represents a meaningful fluctuation that the LLM missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 407,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nDisney has moved Marvel from a primarily theatrical‑and‑TV production label in 2022 to a central pillar of its direct‑to‑consumer strategy by 2023‑2024, placing Marvel‑produced series and films on Disney+ (and, through Hulu, on the broader DTC slate) to drive subscriber growth. At the same time, Marvel’s trademarks remain classified as indefinite‑lived intangible assets—still recorded at $1.79 billion in the 2024 balance sheet—underscoring that the brand is treated as a permanent, non‑amortizable asset within Disney’s streaming‑focused portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies Marvel's indefinite-lived intangible asset classification across the period; (2) Appropriately emphasizes the shift toward DTC/streaming strategy; (3) Correctly notes that Marvel trademarks remain non-amortizable assets; (4) Contextually relevant to the question about strategic positioning. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM states Marvel's trademarks are 'recorded at $1.79 billion in the 2024 balance sheet,' but this specific valuation figure is not verified in the ground truth and appears to be an unsupported claim that could be factually incorrect; (2) INCOMPLETE SYNTHESIS - The ground truth specifically mentions Marvel being listed 'alongside ESPN and Pixar' as indefinite-lived intangible assets in 2022 and 2024, which the LLM omits entirely; (3) MISSING KEY DETAIL - The ground truth emphasizes Marvel's specific role as a 'top-level branded tile within the Disney+ interface' in 2023, which the LLM mentions only vaguely as 'Marvel-produced series and films on Disney+' without the strategic branding emphasis; (4) INCOMPLETE MULTI-HOP REASONING - The LLM fails to synthesize the three-year evolution as clearly as the ground truth, which explicitly connects the financial asset classification with the content distribution strategy across all three years. The LLM's characterization of a 'move from theatrical-and-TV' is not supported by the ground truth and may misrepresent the actual strategic positioning. The answer reads more as inference than synthesis of actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 444,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nAmerican Express records discount revenue at the moment a Card‑Member transaction is settled, and for third‑party merchant acquirers it captures the individually negotiated network‑rate fee as part of that discount revenue; large‑merchant contracts are typically multi‑year (three to seven years) with auto‑renewal clauses, and the OptBlue program has broadened the use of such acquirers.  Between 2022 and 2024 the company intensified a global merchant‑coverage strategy that targets premium consumer and commercial segments, expands B2B acceptance, and invests in digital authorization and new industry verticals while continuing to negotiate network‑rate fees on a case‑by‑case basis.  This expansion is pursued despite heightened regulatory scrutiny on interchange and discount fees, which can pressure the pricing and profitability of its discount revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's merchant acquirer relationships and revenue structure evolution, with several strengths and minor gaps:\n\nSTRENGTHS:\n1. Correctly identifies discount revenue recognition at transaction settlement\n2. Accurately describes individually negotiated network rate fees from third-party acquirers\n3. Properly mentions OptBlue program expansion\n4. Correctly notes multi-year contracts (3-7 years) with auto-renewal clauses\n5. Accurately captures the 2022-2024 strategic shift toward global merchant coverage expansion\n6. Correctly identifies focus on premium segments, B2B acceptance, and digital authorization\n7. Appropriately mentions regulatory scrutiny on interchange/discount fees\n8. Demonstrates sound multi-hop reasoning across the 2022-2024 period\n\nGAPS/MINOR ISSUES:\n1. Does not explicitly mention the 2023 introduction of \"processed revenue\" from network partnership agreements and royalties/fees for facilitating partner-issued card transactions - this is a material evolution point in the ground truth\n2. Does not specifically reference \"network partnership agreements\" as a distinct revenue stream introduced in 2023\n3. Less explicit about the progression/evolution timeline (2022 → 2023 → 2024) compared to ground truth's structured chronological breakdown\n4. Does not mention aggregators and processors as explicitly as ground truth does for 2024 expansion\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The contract duration range (3-7 years) appears reasonable and is not contradicted by ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects discount revenue mechanics with strategic expansion initiatives. However, it misses the important 2023 evolution point regarding processed revenue introduction.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding discount revenue recognition, network rate fee negotiation, and merchant coverage expansion. The addition of regulatory context adds relevant nuance not explicitly in ground truth but not contradictory.\n\nJUSTIFICATION: Score of 7 reflects that core facts are correct and multi-hop reasoning is sound, but the answer incompletely captures the 2023 processed revenue evolution, which represents a material strategic development in the 2022-2024 progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 667,
        "total_tokens": 2221
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery devices moved from a brief statement that such devices involve independent regulatory and safety risks (2022) to a detailed description of the company’s ongoing obligations under REMS, periodic safety‑assessment reports, and post‑marketing study conditions imposed by the FDA (2023‑2024). The later filings emphasize that clinical‑trial success and product approvals are tied to the performance of companion devices, that failure to meet FDA‑mandated REMS or confirmatory‑study requirements can trigger labeling changes, market withdrawals or enforcement actions, and that any safety signals related to the devices are continuously monitored and can lead to revised labeling or other regulatory penalties.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the evolution of Amgen's regulatory risk disclosures across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the progression from general statements (2022) to detailed disclosures (2023-2024); (2) Accurately references key regulatory mechanisms (REMS, periodic safety assessments, post-marketing studies); (3) Properly synthesizes multi-hop information about clinical trial dependencies, post-marketing requirements, and device-related safety reviews; (4) Correctly identifies LUMAKRAS context implicitly through discussion of accelerated approval and confirmatory studies; (5) Accurately conveys the shift from general dependencies to specific compliance challenges. MINOR GAPS: (1) Does not explicitly mention LUMAKRAS by name, though the context about accelerated approval and post-marketing studies is clearly referenced; (2) Could have been more explicit about the Complete Response Letter from FDA mentioned in ground truth; (3) The phrase 'clinical-trial success and product approvals are tied to the performance of companion devices' is accurate but slightly reframes the original emphasis on surrogate endpoints and regulatory scrutiny. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The temporal progression (2022→2023→2024) is correctly maintained. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about how regulatory disclosures evolved across three years and connects device-related risks to clinical trials, post-marketing requirements, and safety reviews. The entity identification (Amgen, FDA, REMS, drug delivery devices) is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses all three sub-components of the question (clinical trial dependencies, post-marketing requirements, device-related safety reviews) and properly contextualizes them within the 2022-2024 timeframe. The semantic equivalence is strong - while wording differs, the factual content aligns well with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 573,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips broadened the HSE audit scope from a focus on core operational safety to an enterprise‑wide review that now includes ESG and climate‑related risk topics, and it formalized a standardized corrective‑action workflow that logs each finding, assigns an owner, and tracks remediation to completion.  Progress on those actions is captured in quarterly executive‑leadership dashboards and fed into the Board’s risk‑oversight processes, with a dedicated HSE Champion on the ELT providing regular updates to the Board of Directors.  Thus, while the underlying audit‑finding‑and‑tracking mechanism remained “identify‑track‑complete,” the 2022‑2024 evolution added a wider scope definition, a more structured tracking system, and stronger Board‑level governance reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) SCOPE EXPANSION CLAIM: The LLM states the scope expanded to include 'ESG and climate-related risk topics,' but the ground truth makes no mention of this expansion. The ground truth describes evolution from conformance checks to integrated safety systems to corporate-level standardization, not a broadening to ESG/climate topics. This is a major factual error. (2) GOVERNANCE STRUCTURE MISREPRESENTATION: The LLM introduces a 'dedicated HSE Champion on the ELT' providing updates to the Board, which is not mentioned in the ground truth. The ground truth simply states governance remained 'tied to the ELT and Board' without specifying a dedicated champion role. (3) QUARTERLY DASHBOARDS: The LLM claims 'quarterly executive-leadership dashboards' track progress, but the ground truth only mentions that 'progress reported to the Executive Leadership Team (ELT) and the Board of Directors' without specifying quarterly dashboards. (4) CORRECT ELEMENTS: The LLM correctly identifies that improvement actions are tracked to completion and that governance reporting involves the Board and ELT. It also correctly notes the evolution from 2022 to 2024. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing unsupported claims rather than accurately synthesizing what the ground truth provides. The core evolution described in the ground truth (localized conformance → integrated safety systems → corporate standardization) is not clearly captured in the LLM answer. (6) MISSING KEY DETAILS: The LLM fails to mention Life Saving Rules, Process Safety Fundamentals, and the stop work policy that were explicitly noted in the 2023 evolution. The term 'Corporate HSE audits' from 2024 is not mentioned. The answer fabricates details about ESG/climate scope and dedicated HSE Champions rather than accurately representing the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 545,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture moved away from traditional time‑and‑materials and fixed‑price contracts toward more flexible, value‑based and subscription‑style pricing that ties fees to the outcomes of AI and cloud‑driven services.  Across the 2022, 2023 and 2024 filings the company repeatedly warned that if it cannot introduce pricing models that capture the new value—because clients may delay adoption, competitive pricing pressure, or regulatory/reputational risks tied to AI—its revenue and profitability could be materially adversely affected.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Accenture's pricing model evolution and correctly identifies the core risks. STRENGTHS: (1) Accurately captures the shift from traditional time-and-materials/fixed-price contracts to value-based and subscription-style pricing models; (2) Correctly identifies the three-year period (2022-2024) and the consistent risk theme across all years; (3) Properly synthesizes that client adoption delays, competitive pricing pressure, and AI-related risks are key concerns; (4) No quantitative errors or incorrect dates/entities; (5) Semantic equivalence is strong - the answer conveys the same essential information as the ground truth. WEAKNESSES: (1) The LLM answer is more concise and omits some nuance from the ground truth regarding the evolution's progression - specifically, it doesn't clearly articulate the 2022 emphasis on 'reflecting value of cloud/as-a-service,' the 2023 focus on 'delays in client spending due to evaluation of new technologies,' or the 2024 emphasis on 'significant investments already being made in AI-based services'; (2) The answer mentions 'regulatory/reputational risks tied to AI' which is not explicitly mentioned in the ground truth, though this is a reasonable inference; (3) The ground truth emphasizes the progression from 'general acknowledgment' to 'more strategic and investment-driven approach,' which the LLM answer doesn't explicitly capture. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the consistent risk theme, demonstrating sound multi-hop reasoning. The connection between technological developments (AI, cloud) and pricing model evolution is properly established. Overall, this is a solid answer that captures the essential facts and risks, though it lacks some of the year-by-year progression detail present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 514,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s stake in the AerCap note rose steadily – it was about **$900 million at the end of 2022, increased to roughly $944 million in 2023, and reached approximately $982 million by the end of 2024** (as disclosed in the fair‑value tables for 2022, 2023 and 2024).  This incremental growth indicates that GE is maintaining and modestly expanding its exposure to AerCap as a strategic, income‑generating asset that supports its aviation‑leasing and engine‑services strategy, reinforcing its long‑term partnership with AerCap while capitalizing on the note’s improving credit profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The LLM claims the AerCap note holdings INCREASED from ~$900M (2022) to ~$944M (2023) to ~$982M (2024), but the ground truth explicitly states holdings DECREASED from $993M (end of 2021, reported in 2022) to $944M (end of 2023, reported in 2024). The LLM's claimed 2024 figure of ~$982M is not supported by the ground truth and contradicts the documented decline. The direction of the trend is completely reversed. (2) DIRECTIONAL MISINTERPRETATION - The LLM characterizes this as 'steady rise' and 'incremental growth' when the ground truth shows 'consistent decline.' This is a 180-degree error in trend analysis. (3) STRATEGIC INTERPRETATION ERROR - The LLM concludes GE is 'maintaining and modestly expanding' exposure and 'reinforcing long-term partnership,' when the ground truth indicates 'strategic reduction in AerCap exposure.' The investment strategy interpretation is inverted. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the year-over-year progression from the disclosed fair-value tables. The core task was to track the evolution of holdings, and the LLM got the evolution backwards. (5) MISSING TEMPORAL CLARITY - While the ground truth references 2021 data reported in 2022 disclosures and 2023 data reported in 2024 disclosures, the LLM's timeline is unclear and the 2024 figure appears fabricated or misread. The answer demonstrates a fundamental failure to accurately extract and synthesize financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 430,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen advanced bemarituzumab from a pre‑phase‑3 asset (it entered phase 3 in 2022) to a fully‑enrolled phase 3 program that remained in that stage through 2023 and 2024, with no reported approval or further phase‑advancement during that period.  Its core composition‑of‑matter patents filed in the United States and Europe list an estimated expiration of 2029 (U.S. 2029, Europe 2029), the same date shown in the 2023 and 2024 SEC filings, and the company does not currently anticipate any term extensions or supplemental protection certificates that would alter that timeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Patent expiration dates (2029 for U.S. and Europe) are correctly stated and match ground truth. (2) The LLM correctly identifies that Bemarituzumab was in phase 3 trials during the 2022-2024 period. (3) Numeric accuracy on patent dates is sound. WEAKNESSES: (1) The LLM states Bemarituzumab 'entered phase 3 in 2022' but the ground truth indicates it was 'introduced as being in phase 3 clinical trials' in 2022 - this is a subtle but important distinction about whether it entered in 2022 or was already in phase 3. (2) The LLM completely omits the significant expansion of investigational scope mentioned in ground truth: the shift from GEJ adenocarcinoma focus to broader therapeutic positioning including 'gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC' by 2024. This is a material omission of clinical development evolution. (3) The LLM adds information about 'no reported approval or further phase-advancement' and 'does not currently anticipate any term extensions' that is not in the ground truth - while potentially accurate, this represents extrapolation beyond the source material. (4) The LLM fails to capture the 'shift from clinical development focus to broader therapeutic positioning and IP strategy' that characterizes the evolution from 2022-2024. (5) The answer lacks the narrative arc of progression that the ground truth emphasizes - moving from active development (2022) to IP disclosure (2023) to expanded therapeutic scope (2024). MULTI-HOP REASONING: The LLM addresses patent expiration correctly but fails to synthesize the full evolution across the three-year period, particularly missing the clinical indication expansion that represents a key part of the intellectual property and development positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 488,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nBetween 2022 and 2024 American Express accelerated investment in AI, machine‑learning, open‑banking and real‑time settlement technologies while expanding its premium, data‑rich rewards and financing offerings to compete with fast‑growing fintech alternatives such as digital wallets, BNPL platforms and payment aggregators. This reflects a long‑term strategic pivot from a pure card‑issuer/network model toward an integrated, technology‑centric ecosystem that leverages its brand and data advantages to counteract fintech disruption.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misalignments with the ground truth. CORRECT ELEMENTS: (1) Identifies key technologies (open banking, real-time settlement, tokenization) that American Express invested in; (2) Correctly names competitive threats (digital wallets, BNPL platforms, payment aggregators); (3) Accurately reflects the strategic pivot toward technology-centric ecosystem; (4) Correctly identifies the company's leveraging of brand and data advantages. SIGNIFICANT GAPS AND ERRORS: (1) The answer emphasizes AI and machine learning investment heavily, but the ground truth does not highlight these as primary strategic focuses in the 2022-2024 evolution—this appears to be an inference not grounded in the filing data; (2) The answer fails to capture the critical TEMPORAL EVOLUTION that is central to the question: the ground truth shows a three-stage progression (2022: defensive acknowledgment → 2023: expanded threat awareness → 2024: proactive dependency/integration posture). The LLM answer presents this as a single continuous acceleration rather than showing the distinct strategic shifts year-by-year; (3) The ground truth explicitly notes the shift from 'defensive acknowledgment' to 'proactive investment and adoption as foundational'—the LLM answer mentions this pivot but doesn't emphasize the defensive-to-proactive transition as clearly; (4) The answer mentions 'premium, data-rich rewards and financing offerings' which is not explicitly mentioned in the ground truth as part of the strategic response to fintech disruption; (5) The answer uses 'payment aggregators' where the ground truth specifies 'payment facilitators'—while semantically similar, this is a minor entity accuracy issue. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the strategic evolution but fails to properly sequence the temporal progression across three distinct years, which is essential to answering how positioning 'evolved' from 2022-2024. The answer treats the evolution as linear acceleration rather than showing the strategic inflection points. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is neutral (7/10 for not introducing false metrics). OVERALL: The answer is partially correct on strategic direction but incomplete on the temporal evolution and lacks the nuanced three-stage progression that defines the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 657,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs was **$91.6 million in 2022**, rose sharply to **$112.5 million for the 2023 grants**, and then **declined modestly to $110.4 million for the 2024 grants** (the $98.2 figure on the balance‑sheet reflects the outstanding award value, not the grant‑date fair value).  \n\nThis pattern shows that the company raised the fair‑value of its long‑term incentive awards when equity prices were higher (2023), then trimmed the level slightly as market valuations steadied in 2024—indicating a calibrated strategy that aligns award values with prevailing stock‑price conditions while controlling compensation expense and preserving retention incentives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISINTERPRETATION: The LLM fundamentally misunderstood the units. The ground truth values are $91.58, $112.50, and (implied) around $110-112 per share/unit, NOT millions of dollars. The LLM stated '$91.6 million in 2022' and '$112.5 million for 2023' which is a massive unit error - these should be per-share values (~$91.58 per PSU, ~$112.50 per PSU). (2) FACTUAL INACCURACY ON 2024: The ground truth states the value was $112.50 in 2024, but the LLM claims it 'declined modestly to $110.4 million for the 2024 grants.' This contradicts the ground truth which shows $112.50 in 2024, not a decline to $110.4. The $98.2 figure mentioned by the LLM appears to be an unverified number not in the ground truth. (3) INCOMPLETE TREND ANALYSIS: The ground truth clearly states an 'upward trend' from 2022 ($91.58) to 2024 ($112.50), representing approximately a 22.8% increase. The LLM's narrative of a 2023 peak followed by 2024 decline contradicts this upward trend assertion. (4) REASONING QUALITY: While the LLM attempts to provide strategic context about market conditions and compensation strategy, this reasoning is built on incorrect numbers and a mischaracterized trend. The explanation about 'equity prices were higher (2023)' and 'trimmed the level slightly as market valuations steadied in 2024' is speculative and contradicts the actual data showing continued increase through 2024. (5) SEMANTIC MISMATCH: The ground truth emphasizes a 'consistent structure and accounting treatment maintained throughout the period' with an 'upward trend,' while the LLM emphasizes volatility and decline, which are fundamentally different narratives. The LLM's answer is internally inconsistent and factually incorrect on multiple dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 481,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s filings repeatedly flagged a growing exposure to abusive behaviors, synthetic‑identity fraud, and credit‑product defaults as it expanded U.S. and international consumer and merchant financing (including BNPL and merchant‑loan programs). The company has responded by sharpening fraud‑detection models, expanding buyer‑seller protection, and tightening oversight of third‑party lenders, yet the accelerating pace of fraud schemes and heightened regulatory scrutiny of its credit‑partner arrangements show that its risk‑management framework is under increasing pressure. Thus, while improvements are evident, the trend indicates that PayPal’s current controls are only partially effective and must be continuously upgraded to keep pace with evolving threats.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of PayPal's evolving exposure to abusive behaviors and fraud across 2022-2024. It appropriately mentions BNPL products, synthetic-identity fraud, and third-party risk mitigation strategies. The answer demonstrates understanding of the multi-hop nature of the question by synthesizing information across multiple years and product categories. The qualitative assessment about risk management effectiveness being 'under increasing pressure' aligns with the ground truth's conclusion about growing concerns.\n\nWEAKNESSES - CRITICAL QUANTITATIVE ERRORS: (1) The LLM answer fails to cite the specific €40 billion multi-year receivables sale agreement mentioned in the ground truth for 2023, which is a concrete, verifiable fact demonstrating PayPal's strategic response to credit/fraud risks. This is a significant omission of a key quantitative detail. (2) The LLM answer mentions 'U.S. and international consumer and merchant financing' but does not specifically reference the U.K. and European BNPL loan receivables context that was central to the 2023 evolution. (3) The answer references the 'valid-when-made doctrine' is NOT mentioned in the LLM response, though it was highlighted in the ground truth as an important regulatory uncertainty affecting U.S. credit products in 2024.\n\nREASONING ASSESSMENT: The LLM's multi-hop synthesis is partially sound - it correctly traces the evolution across years and connects fraud concerns to credit products. However, it adds interpretive claims ('sharpening fraud-detection models,' 'expanding buyer-seller protection,' 'tightening oversight') that are not explicitly supported by the ground truth provided. The conclusion about 'current controls are only partially effective' is a reasonable inference but goes beyond what the ground truth explicitly states about 'consistent and growing concern' and 'increasingly relying on third-party risk mitigation strategies.'\n\nSPECIFIC GAPS: (1) Missing €40 billion figure - a concrete quantitative detail; (2) Missing 'valid-when-made doctrine' regulatory reference; (3) Missing explicit mention of U.K./European BNPL receivables sale strategy; (4) Adds interpretive details not in ground truth without clear support.\n\nOVERALL: The answer demonstrates conceptual understanding and addresses the question's core theme, but lacks precision on key quantitative facts and specific regulatory/strategic details that were central to the ground truth answer. The reasoning is sound but somewhat speculative beyond what the filings explicitly state.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 688,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s label was broadened – while it began as a second‑line option for gastric, NSCLC, colorectal, HCC and a few niche tumours, by 2024 it was also approved as a first‑line therapy for EGFR‑mutated metastatic NSCLC and for advanced metastatic medullary thyroid cancer (see the product descriptions on pages 6 (2022 & 2024) and the therapeutic‑area table on page 11 (2023)).  At the same time its core compound patent remained in force until 2026 in the United States, Europe and Japan, with data‑protection periods expiring in 2024 (EU) and 2023 (Japan) (pages 12 (2023) and 29 (2024)).  This combination of label expansion and sustained patent/ data‑exclusivity reflects Lilly’s long‑term oncology strategy of extracting maximum revenue from mature, high‑value assets by extending indications and protecting them with robust IP, while positioning the company to fund its next‑generation pipeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer makes several factual claims that directly contradict the ground truth: (1) LABEL EXPANSION CLAIM: The LLM states Cyramza was 'broadened' with new approvals for 'first-line therapy for EGFR-mutated metastatic NSCLC and for advanced metastatic medullary thyroid cancer' by 2024. The ground truth explicitly states 'no new indications added' and that 'therapeutic positioning was reaffirmed across the same cancer types' (gastric, lung, colorectal, liver). This is a fundamental factual error. (2) PATENT/DATA PROTECTION DATES: The LLM claims data-protection expires in 2024 (EU) and 2023 (Japan), with compound patent through 2026 in 'United States, Europe and Japan.' The ground truth mentions patents extending through 2026 in 'U.S. and Japan' (notably omitting Europe) and data protection expiring 'as early as 2023 in Japan.' The LLM's addition of EU data protection expiring in 2024 is not supported by ground truth. (3) STRATEGIC INTERPRETATION: While the LLM's interpretation about 'extracting maximum revenue from mature assets' is plausible, it contradicts the ground truth's more cautious assessment that Lilly was 'maintaining market presence while likely preparing next-generation products to succeed it.' The LLM overstates the expansion strategy when the actual data shows maintenance, not expansion. (4) CITATION REFERENCES: The LLM cites specific page numbers (pages 6, 11, 12, 29) but these cannot be verified against the ground truth, and the claims made about those pages appear inconsistent with the actual filing data. The core issue is that the LLM fabricated label expansions that did not occur, fundamentally misrepresenting Cyramza's evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 470,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris shifted from an aggressive borrowing stance—evidenced by the $13.9 bn credit‑facility drawdown for the Swedish Match acquisition and net financing cash inflows in 2022—to a deliberate deleveraging program that used strong cash flows to retire short‑term and medium‑term debt, repay credit‑facility borrowings, and fund share‑repurchases and higher dividends, while the 3.875 % Notes due 2042 remained untouched and continue to serve as the company’s permanent long‑dated financing pillar. This evolution is reflected in the negative financing cash flows of –$5.6 bn (2023) and –$9.5 bn (2024) and the growing emphasis on returning cash to shareholders, all while the 3.875 % 2042 securities stayed on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces significant factual errors and unsupported claims that deviate substantially from the ground truth. CRITICAL ISSUES: (1) The LLM cites a '$13.9 bn credit-facility drawdown for the Swedish Match acquisition' and specific financing cash flows of '-$5.6 bn (2023)' and '-$9.5 bn (2024)' - these numbers are NOT mentioned in the ground truth and cannot be verified from the provided context. Introducing unverified financial figures is a major accuracy violation. (2) The LLM's narrative about 'aggressive borrowing stance' and 'deliberate deleveraging program' is not supported by the ground truth, which focuses on the specific debt instruments (4.125% Notes due 2043, 4.875% Notes due 2043, 4.250% Notes due 2044) and their retirement/refinancing. (3) The ground truth explicitly identifies which specific debt instruments were present in each year and which were retired - the LLM answer completely omits this critical multi-hop synthesis that was central to the original answer. (4) While the LLM correctly identifies the 3.875% Notes due 2042 as a stable component, it fails to address the key evolution pattern: the retirement of 2043 and 2044 tranches by 2024. (5) The LLM's discussion of share repurchases, dividends, and cash flow management, while potentially relevant to capital structure strategy, goes beyond what the ground truth establishes and introduces claims not verifiable from the SEC filing data provided. WHAT WAS CORRECT: The LLM correctly identifies the 3.875% Notes due 2042 as a consistent, long-term financing pillar. The general concept of capital structure evolution is appropriate. WHAT WAS MISSING: Specific identification of the 4.125% Notes due 2043, 4.875% Notes due 2043, and 4.250% Notes due 2044; the timeline of when these instruments were present; the pattern of their retirement by 2024. The answer fails the multi-hop synthesis requirement by not connecting the specific debt instruments across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 533,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior grew alongside its expanding credit and “buy‑now‑pay‑later” products and its reliance on third‑party lenders, processors and custodians—heightening risks of fraud, synthetic‑identity abuse, charge‑offs and regulatory penalties. To curb this, in 2023 the company entered an enforceable undertaking with AUSTRAC (and began an external‑auditor review due April 2024), launched the PYUSD stablecoin, sold a substantial portion of its U.K./European BNPL loan portfolio and instituted a multi‑year migration of its core payment‑processor relationships, while simultaneously tightening fraud‑detection models, enhancing credit‑risk underwriting and expanding third‑party due‑diligence. Building on those steps, in 2024 PayPal continued the processor‑migration, completed the AUSTRAC auditor’s assessment, reinforced its risk‑models and monitoring controls, and broadened its buyer‑/seller‑protection and allowance‑for‑loan‑loss reserves to mitigate the heightened fraud and credit‑risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the €40 billion U.K./European BNPL loan portfolio sale in 2023, matching the ground truth. It accurately captures the evolution from 2022 (identifying risks) through 2023-2024 (mitigation actions). The answer correctly identifies key risk categories (synthetic identities, fraud, charge-offs) and demonstrates understanding of the multi-hop synthesis required across three years. The mention of AUSTRAC undertaking and processor migration adds relevant context. WEAKNESSES: (1) The LLM introduces several elements NOT in the ground truth that cannot be verified: AUSTRAC enforceable undertaking, PYUSD stablecoin launch, external auditor review due April 2024, processor migration, and specific reserve expansions. While these may be factually accurate from PayPal filings, they are NOT part of the ground truth answer provided, creating potential factual drift. (2) The answer is significantly more detailed and comprehensive than the ground truth, which focuses specifically on: 2022 (problem identification), 2023 (€40B asset sale), and 2024 (fraud prevention infrastructure). The LLM adds substantial additional information that, while potentially accurate, goes beyond what the ground truth establishes. (3) The ground truth emphasizes a clear three-stage progression (identify → offload → enhance), while the LLM presents a more complex, multi-faceted response that somewhat obscures this narrative arc. QUANTITATIVE ACCURACY: The €40 billion figure is correct and properly formatted. No calculations are required. The dates (2022, 2023, 2024) are correct. QUALITATIVE ACCURACY: The core reasoning about evolution of exposure is sound, but the introduction of unverified elements (AUSTRAC, PYUSD, processor migration) without explicit grounding in the ground truth creates uncertainty about factual accuracy. CONTEXTUAL RELEVANCE: The answer appropriately addresses all parts of the question (evolution, credit products, third-party risk, specific 2023-2024 actions), though with significant elaboration beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 559,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 Form 10‑K filings the “loss or modification of tax and tariff exemptions” is repeatedly listed under the “political, legal and economic risks” that affect its foreign operations.  The 2022 disclosure merely flagged the possibility, but the 2023 and especially the 2024 filings expand the discussion to include potential changes in tax law, trade‑restriction measures, sanctions and heightened geopolitical tensions (e.g., U.S.–China, Taiwan, Ukraine), indicating that such exemptions may be altered or removed with little predictability.  This progression signals that AMD expects growing regulatory uncertainty that could materially affect its global cost structure and supply‑chain stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks across 2022-2024. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately characterizes the progression from 'merely flagged' in 2022 to expanded discussion in 2023-2024; (2) Properly synthesizes the multi-hop information showing escalation of concern across filings; (3) Accurately identifies specific risk factors mentioned (geopolitical tensions, supply chain disruptions, trade restrictions, sanctions); (4) Correctly links the progression to regulatory uncertainty and material business impact; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer provides slightly more specific detail about the types of regulatory changes (tax law, trade restrictions, sanctions) than the ground truth explicitly states, though this appears to be reasonable inference from the filings rather than factual error; (2) The ground truth uses slightly more measured language ('emphasized this risk more strongly' vs LLM's 'expand the discussion'), though both convey the same essential meaning; (3) The LLM answer could have been slightly more explicit about the 2023 intermediate step, though it does mention it. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three separate 10-K filings and identifying the trend of increasing regulatory concern. The semantic equivalence is strong - both answers convey that AMD's concern about tax/tariff exemption risks escalated over the period and reflects growing regulatory uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 461,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return swaps that economically hedge its deferred‑compensation obligations posted a **$92 million loss in fiscal 2022**, turned to a **$58 million gain in fiscal 2023**, and then recorded a **$91 million gain in fiscal 2024** (see Notes 13‑(e) on pages 91‑92 of the 2024 10‑K).  This swing from a loss to successive gains indicates that the company’s hedging strategy has moved from an unfavorable to a favorable outcome, reducing the net earnings impact of deferred‑compensation liabilities and suggesting a more effective or better‑priced use of total‑return swaps to offset those obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: $92 million loss in fiscal 2022, $58 million gain in fiscal 2023, and $91 million gain in fiscal 2024 match the ground truth exactly. The fiscal years are correctly identified, and the financial metrics (total return swaps tied to deferred compensation) are accurately characterized. The multi-hop reasoning is sound—the model correctly synthesizes the three-year progression and draws appropriate conclusions about the reversal from loss to gains and what this indicates about the company's hedging strategy and exposure. The LLM answer goes slightly beyond the ground truth by providing additional context (citing specific pages 91-92 of the 2024 10-K and explaining the economic hedging relationship), which adds value without introducing errors. The semantic interpretation is equivalent to the ground truth: both identify the shift from unfavorable to favorable outcomes and connect this to the company's management of deferred compensation liabilities. The only minor distinction is that the LLM uses slightly more specific language about 'hedging strategy' and 'better-priced use,' but this represents appropriate elaboration rather than deviation from the core facts. No calculation errors, no entity misidentification, and no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 380,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney moved from an aggressive, loss‑making push to build a suite of DTC services—Disney+, Hulu, ESPN+, Star+ and the India‑focused Star India joint venture—toward a more disciplined but still capital‑intensive strategy that added an ad‑supported tier, modest price increases and tighter cost‑rationalization while continuing to pour money into exclusive content and long‑term carriage and sports‑rights contracts.  The company’s own disclosures (e.g., the competition‑pressure discussion on pages 23 & 27, the note on “Strategic investments in DTC offerings” on page 53, and the cost‑structure commentary on pages 27 & 113) show that each year the DTC segment incurred growing operating losses and required ever‑larger content and marketing spend, even as it tried to offset declining linear‑network subscriptions with subscription‑fee growth and advertising revenue.  This progression reveals that scaling Disney’s streaming business carries steep financial risks—high fixed content and marketing costs, dependence on volatile advertising and subscription markets, and the need to renew expensive programming and distribution contracts—while competing against a rapidly consolidating set of rivals that pressure both revenue and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and provides a more detailed and nuanced response than the ground truth. Strengths: (1) Correctly identifies the fiscal year progression (2022-2024) and the strategic shift from aggressive loss-making to more disciplined but capital-intensive approach. (2) Accurately names specific DTC offerings (Disney+, Hulu, ESPN+, Star+, Star India). (3) Correctly identifies key strategic elements: ad-supported tiers, price increases, cost rationalization, content investment, and sports rights. (4) Properly synthesizes multi-hop information about competitive pressures, rising costs, and financial risks. (5) Accurately references specific disclosure locations (pages 23, 27, 53, 113) showing familiarity with source documents. (6) Correctly characterizes the financial risk profile: high fixed costs, advertising/subscription volatility, contract renewal pressures, and competitive consolidation. Minor considerations: (1) The answer is more detailed and specific than the ground truth, which could be viewed as either more comprehensive or potentially introducing details not explicitly in the ground truth. However, all stated facts appear consistent with typical Disney 10-K disclosures. (2) No specific financial numbers (revenue, losses, subscriber counts) are provided, but the question doesn't explicitly require quantitative metrics. (3) The characterization of the strategic pivot is accurate and well-reasoned. The answer successfully addresses all parts of the multi-part question: evolution of strategic investment, competitive positioning, and what this reveals about financial risks and market pressures. The reasoning is sound and the synthesis across fiscal years is logical and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 478,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal has consistently borne full margin risk across 2022‑2024 by acting as the principal in payment transactions, exercising complete discretion to set fees independent of the costs it incurs with payment processors, and recording those processor fees as transaction expense – thus shouldering the entire spread between gross fees earned and processor costs.  The only evolution is greater disclosure and accounting refinement (e.g., evaluating volume‑based pricing and performance‑linked incentives as revenue reductions and applying the new FASB segment‑reporting guidance), but the underlying exposure to margin risk has not materially changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent bearing of full margin risk across 2022-2024 with no material changes; (2) Accurately captures PayPal's discretion in fee-setting independent of processor costs; (3) Properly recognizes processor fees as transaction expense; (4) Correctly notes the adoption of ASU 2023-07 (new segment reporting standards) in 2024 without implying structural changes to margin risk exposure; (5) Appropriately characterizes the evolution as disclosure/accounting refinement rather than substantive operational change; (6) Uses precise language ('principal in payment transactions,' 'spread between gross fees earned and processor costs') that demonstrates understanding of the underlying economics. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'volume-based pricing and performance-linked incentives as revenue reductions' which adds specificity beyond the ground truth but is consistent with typical PayPal accounting practices and does not contradict the provided answer; (2) The phrasing 'greater disclosure and accounting refinement' is a reasonable characterization of the evolution described in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required or provided in either answer, so this dimension is not applicable but receives full marks as no errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the relationship between fee discretion, processor costs, and margin risk exposure. The logic connecting these elements is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth while using slightly different organizational structure and terminology, which is appropriate and demonstrates understanding rather than rote repetition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 527,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nIn 2022 the 10‑K flagged new‑aircraft order delays or cancellations as a principal risk for the Aerospace segment, reflecting the pandemic‑driven demand slump. By 2023 the same risk was still noted, but the narrative shifted as the company reported rising aftermarket sales and higher flight‑hour volumes, and in 2024 the filing highlighted $907 million of organic aftermarket growth driven by increased flight hours, indicating that order‑cancellation concerns had faded. This progression shows that the commercial‑aviation market has rebounded and is now stabilising, with demand recovery outweighing the earlier cancellation risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims order-cancellation concerns 'had faded' by 2024, directly contradicting the ground truth which states the risk 'remained prominent' in 2024. (2) The LLM concludes the market has 'rebounded and is now stabilising' with cancellation risks diminished, but the ground truth explicitly states the sector 'remained fragile and susceptible to both external shocks and evolving market dynamics' through 2024. (3) The LLM misinterprets the evolution of risk language - it treats the shift from pandemic-specific to broader macroeconomic/geopolitical concerns as evidence of fading risk, when the ground truth indicates this represents a structural shift in risk sources, not a reduction in risk itself. QUANTITATIVE ISSUES: The $907 million aftermarket growth figure appears to be accurate data, but the LLM misuses it as evidence that cancellation concerns had faded. Rising aftermarket sales and flight hours do not negate the persistence of order-cancellation risk as a key concern - these are separate metrics. The ground truth shows both metrics can coexist (recovery in some areas while structural risks persist). REASONING FLAWS: The LLM fails to properly synthesize the 3-year progression. It conflates operational recovery (rising aftermarket sales, flight hours) with risk mitigation (order cancellations). The ground truth shows that while some operational metrics improved, the risk remained consistently highlighted across all three years with evolving but persistent concerns. The LLM's conclusion that 'demand recovery outweighing the earlier cancellation risk' is not supported by the filing language described in the ground truth. COMPLETENESS: The LLM addresses the 2022-2024 timeframe but fundamentally mischaracterizes the progression and what it indicates about sector stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 520,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s Reduced‑Risk and Smoke‑Free Products intensified sharply: early disclosures already noted that product‑regulation was curbing differentiation and truthful adult‑consumer communication (2022 pp. 15, 45), and later filings document a growing wave of market bans, EU‑wide plain‑packaging and flavor restrictions, and tighter FDA‑style marketing limits that effectively constrain how PMI can present its RRPs/SFPs (2024 pp. 61, 89). This escalation reveals an increasingly restrictive regulatory environment that limits product‑level differentiation and adult‑consumer messaging, forcing PMI to rely more on compliance than on marketing‑driven competitive advantages.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FABRICATED PAGE NUMBERS: The LLM cites specific page references ('2022 pp. 15, 45', '2024 pp. 61, 89') that cannot be verified and appear to be hallucinated. This is a severe factual error in a financial document evaluation context. (2) UNSUPPORTED SPECIFICS: The answer references 'market bans, EU-wide plain-packaging and flavor restrictions, and tighter FDA-style marketing limits' without grounding these in actual filing disclosures or providing verifiable evidence. The ground truth does not mention these specific regulatory mechanisms. (3) INCOMPLETE TEMPORAL EVOLUTION: The LLM fails to capture the key evolution documented in the ground truth - the strategic shift from RRPs (2022-2023) to SFPs (2024). The answer treats these as interchangeable rather than showing the product focus transition. (4) MISSING NUANCE: The ground truth emphasizes how regulation 'disproportionately impacted the commercialization of PMI's products relative to competitors' and highlights 'digital media spreading misleading information' - contextual details absent from the LLM response. (5) VAGUE SYNTHESIS: While the LLM correctly identifies intensifying regulatory pressure and constraints on differentiation/communication, it does so without the year-by-year progression and specific regulatory concern evolution shown in the ground truth. WHAT WAS CORRECT: The core insight that regulatory pressure intensified from 2022-2024 and constrained product differentiation and adult consumer communication is accurate. The general characterization of the regulatory environment as increasingly restrictive aligns with the ground truth. QUANTITATIVE ACCURACY ISSUE: No actual numbers are provided in either answer, but the fabricated page citations constitute a quantitative/factual accuracy failure. QUALITATIVE ASSESSMENT: The reasoning about regulatory constraints is sound in principle but lacks the documented evolution and specific regulatory mechanisms that would demonstrate proper multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 550,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to margin risk did not change materially—it continues to bear full margin risk on every payment it authorizes as the principal. What did evolve was the granularity of its pricing and incentive structures: the company increasingly uses tiered, volume‑based pricing that can raise or lower fees, and it provides a broader set of incentives (discounts, rebates, rewards, coupons) that are now more explicitly treated as revenue reductions, with performance‑based incentives recognized when earned and other incentives amortized over the contract term. At the same time, any costs paid to payment processors or other financial institutions are recorded as transaction expense, so the margin risk remains with PayPal, but the way pricing discounts and customer incentives are applied and accounted for has become more detailed across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies that PayPal bears full margin risk consistently across 2022-2024, matching the ground truth's core finding; (2) Accurately captures the evolution in disclosure granularity regarding incentives and pricing structures; (3) Properly distinguishes between the stable margin risk exposure and the evolving complexity of pricing/incentive accounting; (4) Correctly notes that performance-based incentives are recognized when earned while other incentives are amortized over contract terms, matching ground truth language; (5) Accurately reflects that transaction costs to payment processors are recorded as transaction expense; (6) No quantitative errors or incorrect dates/entities. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing ('tiered, volume-based pricing') compared to ground truth's 'dynamic pricing and cost structures,' but these are semantically equivalent descriptions of the same concept; (2) The LLM provides slightly more operational detail about 'discounts, rebates, rewards, coupons' which adds helpful specificity not explicitly in ground truth but is consistent with it; (3) The phrase 'did not change materially' is a reasonable characterization of the ground truth's 'stable strategic approach.' MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly links margin risk exposure to transaction pricing models, payment processor costs, and customer incentives—all required elements of the multi-hop question. The logical flow connecting stable margin risk with evolving disclosure complexity is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 480,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nAMD kept its AIB partners’ inventory protected throughout 2022‑2024 by extending price‑protection clauses and adding standard stock‑rotation/return‑right provisions to the AIB agreements, and it deepened the relationship by selling more directly to system‑integrators (SIs) rather than relying solely on indirect distributors.  At the same time, the company repeatedly emphasized that discrete graphics (Radeon and Instinct GPUs) are the primary differentiator SIs use to set their platforms apart—leveraging performance, AI‑ready features and short design cycles to add value for customers.  This focus on graphics‑driven differentiation persisted and grew stronger across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core inventory protection policy maintained across 2022-2024. (2) Correctly emphasizes discrete graphics (Radeon, Instinct) as key differentiators. (3) Properly identifies the three-year timeframe and maintains chronological accuracy. (4) No quantitative errors in dates or numbers cited. CRITICAL WEAKNESSES: (1) The LLM introduces unsupported claims about 'direct sales to SIs' and 'selling more directly to system-integrators rather than relying solely on indirect distributors'—the ground truth makes no mention of this strategic shift toward direct SI sales. This is a significant factual error that misrepresents AMD's strategy. (2) The LLM mentions 'stock-rotation/return-right provisions' as specific mechanisms, but the ground truth only references 'inventory protection policies' without specifying these particular mechanisms. This adds detail not supported by the source. (3) MISSING KEY EVOLUTION: The ground truth explicitly notes a 'subtle shift in language' in 2024 toward 'more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings.' The LLM completely misses this nuanced evolution and instead suggests a linear strengthening of the graphics differentiation narrative. (4) The ground truth distinguishes between 2022-2023 (emphasis on AIBs building board-level products for SIs/retailers/sub-distributors) versus 2024 (emphasis on SIs selling based on regional/product strengths and responding to new technologies). The LLM fails to capture this temporal distinction. (5) The ground truth emphasizes AIBs as intermediaries between AMD and SIs; the LLM's claim about 'selling more directly to SIs' contradicts this relationship structure. MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution across the three-year period, instead presenting a simplified narrative that misses the strategic repositioning evident in 2024. The answer conflates inventory protection (correctly identified) with a direct-sales strategy (incorrectly introduced).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 555,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney kept the same baseline safeguards – it trades only with counterparties rated A‑ or better and requires collateral if a rating drops below A‑ or if aggregate exposures exceed the limits set in the derivative contracts.  The rating and collateral standards did not change, but the quantitative concentration limit did: the 2022 filing stated that no single institution could hold more than 10 % of cash and cash equivalents, whereas the 2024 filing disclosed that institutions exceeding that 10 % threshold accounted for 24 % of total cash, showing a relaxation of the concentration cap while still adhering to the A‑ rating and collateral requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core policy elements (A- rating requirement, collateral requirements, and concentration shift) and demonstrates sound multi-hop reasoning across fiscal years. However, there is a critical quantitative discrepancy: The LLM claims the 2022 filing stated 'no single institution could hold more than 10%' of cash and cash equivalents, but the ground truth indicates there was 'no such concentration in fiscal 2022' - meaning no single institution exceeded concentration thresholds, not that a 10% cap existed. The LLM's assertion of a specific 10% threshold in 2022 is not supported by the ground truth and represents a factual error in interpreting the policy evolution. The 24% concentration figure for 2024 is correct. The characterization of this as a 'relaxation of the concentration cap' is somewhat speculative and goes beyond what the ground truth explicitly states - the ground truth describes it as 'a shift in liquidity strategy' rather than explicitly confirming a policy change from a 10% cap. The LLM correctly identifies that the A- rating and collateral requirements remained constant, which is accurate. The reasoning about the evolution of credit exposure management is generally sound, but the specific claim about a 10% threshold in 2022 introduces a material factual error that undermines the quantitative accuracy of the response. The answer addresses all parts of the question (counterparty ratings, collateral requirements, concentration thresholds) but with an inaccuracy in the baseline comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 429,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nPYPL’s 2.850 % fixed‑rate notes that mature on 10/1/2029 remained at **$1.5 billion** at the end of 2022, 2023 and 2024 (the same $1,500 million figure appears in the 2022, 2023 and 2024 debt tables).  The company therefore held a **stable, unchanged exposure** to that tranche across the three years.  \n\nThis multi‑year consistency indicates that PYPL’s long‑term debt strategy is to **lock in low‑cost, fixed‑rate financing for extended maturities and retain those obligations on the balance sheet**, using newer debt issuances only to supplement the capital structure rather than to refinance or roll the 2029 notes.  The approach preserves a predictable interest‑expense profile and reinforces a conservative, laddered debt management posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: The core financial data is correct—the $1.5 billion (equivalently $1,500 million) principal amount for the 2.850% fixed-rate notes maturing 10/1/2029 is accurately stated as remaining constant across 2022, 2023, and 2024. The format variation ($1.5 billion vs $1,500 million) is properly handled and semantically equivalent. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of exposure across the three years (stable/unchanged), (2) the specific dollar amounts, and (3) the strategic implications for long-term debt management. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three fiscal years and connects it to broader debt strategy context (mentioning newer issuances in 2023-2024 like the 5.150% and 5.500% notes, though not explicitly detailed in the LLM response, the core logic is sound). REASONING QUALITY: The interpretation that the stability indicates a strategic decision to 'lock in low-cost, fixed-rate financing' and 'retain obligations on the balance sheet' rather than refinance aligns with the ground truth's assessment. The characterization of this as a 'conservative, laddered debt management posture' is a reasonable inference from the facts. MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive/strategic in tone compared to the ground truth's more factual presentation, but this represents enhanced analysis rather than error. The ground truth mentions 'possibly to preserve favorable interest terms or manage cash flow predictability,' while the LLM states this more definitively as 'lock in low-cost, fixed-rate financing'—both are reasonable interpretations of the same underlying strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 490,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Materials and Technologies segment repeatedly flagged raw‑material price volatility and supply‑chain constraints as a material risk (e.g., risk‑factor discussions on pages 31 of the 2022 and 2023 10‑Ks and page 10 of the 2023 filing).  By 2024 the company noted that long‑term contracts, formula‑driven pricing and hedging had “reduced the impact” of those constraints, but still warned that commodity price swings could adversely affect results (page 31 of the 2024 filing).  Thus, while exposure was mitigated, the segment remains vulnerable to sharp commodity market movements.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that raw material and supply risks were flagged across 2022-2024, recognizes the evolution toward mitigation strategies (long-term contracts, formula-driven pricing, hedging), and appropriately concludes the segment remains vulnerable despite these measures. The semantic understanding of the risk evolution is sound. CRITICAL WEAKNESSES: (1) PAGE NUMBER ERRORS - The LLM cites 'page 31 of the 2022 and 2023 10-Ks and page 10 of the 2023 filing' and 'page 31 of the 2024 filing' without verification. These specific page citations cannot be confirmed and appear potentially inaccurate. (2) MISSING KEY CONTEXTUAL DETAIL - The ground truth explicitly mentions the segment was REBRANDED as 'Energy and Sustainability Solutions' by 2024, which is a significant structural change that the LLM completely omits. This is material context for understanding the evolution. (3) INCOMPLETE RISK ENUMERATION - The ground truth identifies specific risks including 'product commoditization' and 'illegal imports of hydrofluorocarbons into Europe' (2022), plus 'volatility in oil and natural gas prices' (2023). The LLM generalizes these as 'raw-material price volatility and supply-chain constraints' without capturing these specific risk factors. (4) MISSING 2023 EMPHASIS - The ground truth notes 2023 specifically emphasized 'volatility in oil and natural gas prices on customer investment and product demand,' which the LLM does not address. (5) MISSING 2024 OPERATIONAL CONTEXT - The ground truth links 2024 risks to 'ability to maximize production capacity and minimize downtime,' which the LLM omits. The LLM's conclusion about mitigation measures is reasonable but not explicitly supported by the ground truth's framing. QUANTITATIVE ACCURACY is low due to unverified page citations and missing specific risk factors. QUALITATIVE ACCURACY is moderate because the overall logic is sound but key details are missing. CONTEXTUAL RELEVANCE is good because the answer addresses the core question about vulnerability evolution, though incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 560,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a constant member of PMI’s disclosed peer group in each annual filing, with the peer‑group roster staying unchanged year‑over‑year. This continuity shows that PMI’s benchmarking strategy relies on a stable, globally diversified set of consumer‑products and tobacco companies of comparable size, using Imperial Brands as a consistent reference point rather than frequently adding or dropping peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Key strengths: (1) Correctly identifies Imperial Brands PLC as a consistent peer group member across all three years (2022-2024), matching the ground truth exactly; (2) Accurately characterizes the peer group composition as unchanged year-over-year, which is factually correct; (3) Properly synthesizes the multi-hop information about PM's benchmarking strategy, concluding that stability in peer selection reflects strategic alignment; (4) Uses appropriate terminology (PMI vs PM - both acceptable references to Philip Morris International); (5) Correctly interprets what consistency in peer group membership reveals about benchmarking strategy. Minor observations: The LLM answer uses 'PMI' while the ground truth uses 'PM' - both are standard references to the same company and this is not an error. The LLM adds slightly more detail about the peer group being 'globally diversified' and 'of comparable size,' which is reasonable inference from the stability pattern and adds helpful context without contradicting the ground truth. The reasoning about 'rather than frequently adding or dropping peers' is a logical inference from the consistency finding. No quantitative errors, no missing entities, and the semantic meaning is fully preserved and enhanced with appropriate elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 378,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nPayPal’s 2.850 % senior unsecured notes—originally issued in September 2019 with a $1.5 billion aggregate principal—remained fully outstanding at $1.5 billion in each of the 2022‑2024 fiscal years (the tables on pages 106, 108 and 104 list $1,500 million for 2023 and 2024, the same amount that appeared as of 2021).  Because the balance of this specific tranche did not change materially over the period, the company’s long‑term debt strategy appears to be one of **stability and stewardship**: it retains a core, low‑cost fixed‑rate slice while managing overall leverage through additional issuances and repayments rather than expanding or shrinking that particular maturity bucket.  This steady exposure underscores a disciplined approach to maintaining a predictable, staggered debt maturing schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct—the $1.5 billion principal amount is accurately stated for 2022, 2023, and 2024, with proper formatting ($1,500 million = $1.5 billion). The reference to September 2019 issuance date and the note rate of 2.850% are accurate. The claim that the balance remained unchanged across the three-year period matches the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained stable at $1.5B), and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Company (PayPal/PYPL), metric (fixed-rate notes), years (2022-2024), and financial terms are all correctly identified. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about debt management philosophy. The reasoning that stability in this particular tranche suggests a deliberate strategy of managing leverage through other debt instruments is sound and goes slightly beyond the ground truth by providing additional context about the company's broader capital structure approach. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'stability and stewardship' with emphasis on 'disciplined approach' and 'predictable, staggered debt maturing schedule' conveys the same essential meaning as the ground truth's 'consistent long-term liability position' and 'prioritizing other debt maturities.' The additional detail about maintaining 'a core, low-cost fixed-rate slice' adds valuable context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more detailed explanation and context (mentioning the 2019 issuance date, page references, and broader capital structure strategy) which enhances rather than detracts from accuracy. No calculation errors detected. All statements are factually supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 535,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips expanded the scope of its HSE audits from a basic compliance check to a culture‑focused, root‑cause‑driven review that examines safety processes, human‑error risks, and alignment with its SPIRIT values. The company refined its conformance‑tracking system so that identified improvement actions are formally documented, closed out, and reported to both the Executive Leadership Team and the Board, thereby integrating HSE oversight more tightly into its governance and ESG reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant content that contradicts or is absent from the ground truth. Specifically: (1) The ground truth makes NO mention of 'culture-focused, root-cause-driven review,' 'human-error risks,' or 'SPIRIT values' - these appear to be fabricated or confused with other company materials. (2) The ground truth clearly documents a progression from 2022 (localized audits across business units) → 2023 (explicit linking to annual objectives, ELT/Board reporting) → 2024 (corporate-level, centralized oversight). The LLM answer collapses this three-year evolution into vague language about 'expanding scope' without capturing the specific governance integration milestones. (3) The ground truth emphasizes the shift toward 'integrated, governance-driven audit model' with explicit mention of reporting to ELT and Board in 2023, and corporate-level audits in 2024. The LLM answer mentions ELT/Board reporting but misses the critical distinction of corporate-level centralization in 2024. (4) The LLM answer's claim about 'formally documented, closed out, and reported' is partially aligned with ground truth but lacks the temporal specificity showing HOW this evolved year-by-year. QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this scores well (8/10) - the years 2022-2024 are correctly referenced. QUALITATIVE ACCURACY: The LLM fundamentally mischaracterizes the nature of the evolution. The ground truth shows a governance/reporting integration story; the LLM invents a culture/root-cause narrative unsupported by the source material. This is a critical failure in multi-hop reasoning and entity/concept identification (2/10). CONTEXTUAL RELEVANCE: While the answer addresses HSE audits and governance, it does so with invented details that reduce relevance to the actual question about documented evolution (4/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 517,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AMD continued to list the 2011 Executive Incentive Plan as Exhibit 10.1 (or *10.1) in the exhibit indexes and in the tables of contents, reaffirming it as the primary, foundational document governing executive bonus and performance‑based compensation.  At the same time the company added and highlighted newer compensation arrangements—such as the 2013/2014 Executive Severance Plans, deferred‑income and stock‑based incentive programs—so the 2011 plan now sits within a broader set of executive‑pay disclosures while still serving as the core reference point for executive incentive governance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 2011 Executive Incentive Plan as Exhibit 10.1 across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately captures the foundational governance role of the plan and its consistency across the period. (3) Properly synthesizes the multi-hop information showing continuity while acknowledging broader compensation framework evolution. (4) Correctly references related plans (Executive Severance Plans, deferred-income, stock-based incentive programs) as contextual elements. (5) The semantic meaning aligns well with ground truth—both convey that the 2011 plan remained anchored as the core reference despite other compensation mechanisms evolving. MINOR WEAKNESSES: (1) The LLM answer mentions '2013/2014 Executive Severance Plans' while the ground truth references 'AMD Executive Severance Plan' without specific year designation—this is a minor discrepancy in specificity but not factually incorrect. (2) The LLM answer uses slightly different framing ('now sits within a broader set' vs. ground truth's 'remained anchored') but this represents semantic variation rather than factual error. (3) The LLM answer could have been more explicit about the 'no material changes or replacements' aspect emphasized in ground truth, though this is implied. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) and exhibit designations (10.1) are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple compensation arrangements, correctly identifying the evolution pattern (continuity with expansion). The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 485,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings describe GM’s indemnification duty to Stellantis—covering inaccurate representations, warranty breaches, emissions‑related claims and recalls from the 2017 Opel/Vauxhall sale—as a continuing contractual obligation that is “subject to time limits, thresholds and caps,” but the company repeatedly states it **cannot estimate any reasonably possible loss** and that any further indemnification (e.g., for Takata or emissions matters) is **remote**.  Consequently, only immaterial amounts have been accrued, indicating that GM views its post‑sale liability exposure as negligible despite the lingering litigation in Europe.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but significantly misses key aspects of the ground truth and mischaracterizes the evolution of GM's exposure. CORRECT ELEMENTS: (1) The answer correctly identifies that indemnification obligations relate to the 2017 Opel/Vauxhall sale, (2) Correctly notes that only immaterial amounts have been accrued, (3) Correctly references that GM states further indemnification is 'remote', (4) Correctly identifies emissions claims and recalls as part of the obligation. CRITICAL OMISSIONS AND ERRORS: (1) The LLM answer fails to capture the GEOGRAPHIC AND LEGAL SCOPE EXPANSION that is central to the ground truth—specifically the progression from 2022 (general mention) to 2023 (Germany, UK, Netherlands explicitly mentioned) to 2024 (Austria added, plus European Commission and UK CMA investigations). This expansion is a key indicator of the question's focus on how exposure 'evolved'. (2) The answer does not mention specific jurisdictions (Germany, UK, Netherlands, Austria) that are explicitly noted in the ground truth as evidence of widening exposure. (3) The answer fails to reference the Takata inflator recalls tied to legacy Opel vehicles mentioned in 2023. (4) The answer does not mention the European Commission and UK CMA regulatory investigations related to end-of-life vehicle practices at Opel in 2024. (5) The answer misses the year-by-year progression that demonstrates 'growing complexity and persistence' of liabilities. CHARACTERIZATION ISSUE: The LLM characterizes GM's view as treating post-sale liability exposure as 'negligible,' but the ground truth indicates that while accruals remain immaterial, the EXPANDING LEGAL AND REGULATORY SCOPE indicates growing complexity and persistence—suggesting exposure is not truly negligible but rather uncertain and evolving. The LLM's framing suggests static/minimal exposure when the ground truth emphasizes dynamic expansion. MULTI-HOP REASONING: The LLM fails to synthesize the multi-year progression across 2022-2024 filings that would show how exposure evolved. It presents a snapshot rather than a trajectory. The question specifically asks 'how did...evolve' and 'what does this progression indicate'—the LLM does not adequately address the evolution aspect or the implications of the expanding scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 617,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nIn 2022 Eli Lilly reported roughly **$2.0 bn of COVID‑19 antibody revenue** (the “COVID‑19 antibodies (6)” line on **page 68** of the 2022 10‑K), and the AbCellera license disclosed on **page 53** specifies that Lilly owed **mid‑teen to mid‑20 % royalties on net sales** of bamlanivimab/etesevimab. By the 2023 and 2024 filings (pages 68 and 72) that revenue line dropped to “‑”, indicating essentially **zero sales** and therefore **no royalty payments** to AbCellera. This sharp decline shows that bamlanivimab’s contribution to Lilly’s top line was transient—limited to the pandemic‑era EUA period—and that its **long‑term strategic importance to the company has faded**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Eli Lilly's bamlanivimab exposure from 2022-2024. STRENGTHS: (1) Quantitative accuracy is excellent—the $2.0 billion COVID-19 antibody revenue figure for 2022 matches the ground truth ($2,008.9 million), with appropriate rounding/formatting flexibility. (2) The royalty obligation range (mid-teen to mid-20%) is correctly stated and matches the ground truth's description of 'tiered percentages ranging from mid-teens to mid-twenties.' (3) The multi-hop synthesis is sound: the answer correctly traces the revenue trajectory from $2.0bn (2022) → zero/dash (2023-2024), and logically connects this to zero royalty obligations. (4) The strategic conclusion is well-reasoned and aligns with ground truth: the product was pandemic-era transient, lost commercial relevance, and is no longer strategically important. (5) Page citations (68, 53, 72) add credibility and demonstrate source verification. (6) The answer addresses all parts of the question: financial exposure evolution, royalty obligations, revenue contribution, and strategic importance. MINOR CONSIDERATIONS: The answer uses 'roughly $2.0 bn' and the dash notation ('‑') to indicate zero, which are semantically equivalent to the ground truth's more precise $2,008.9 million and 'dropped to zero.' The phrase 'essentially zero sales' and 'no royalty payments' correctly infers the logical consequence of zero revenue. The answer could have been marginally more explicit about the 2024 complete removal from revenue tables (ground truth mentions 'no longer mentioned in revenue tables'), but this is a very minor omission that doesn't materially affect correctness. Overall, the LLM demonstrates strong multi-hop reasoning across multiple years and documents, accurate financial data synthesis, and sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 512,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024, PMI repeatedly highlighted Jackpot—alongside other local flagship brands such as Fortune—as a core cigarette brand in the Philippines within its portfolio disclosures. This consistent emphasis shows that the company is deliberately safeguarding and growing locally‑owned cigarette brands in key markets to complement its global portfolio and protect market share as it advances its smoke‑free transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Jackpot was consistently mentioned as a key local brand in the Philippines across 2022-2024, (2) Fortune was mentioned alongside it, (3) PMI maintained these brands while pursuing smoke-free transformation. The answer accurately captures the multi-hop synthesis showing PMI's dual strategy. However, there are notable omissions compared to the ground truth: (1) The LLM does not explicitly mention that Jackpot was 'named' or specifically listed in each year (2022, 2023, 2024), reducing the granularity of the 3-year trajectory analysis; (2) The ground truth emphasizes the 'consistency' across all three years more explicitly, while the LLM uses 'repeatedly highlighted' which is less precise about the year-by-year progression; (3) The LLM characterizes the strategy as 'deliberately safeguarding and growing' but the ground truth is more measured, stating PMI 'continued to value its role' without claiming growth; (4) The phrase 'locally-owned' in the LLM answer is not supported by the ground truth, which refers to 'local brands' but not specifically 'locally-owned.' The quantitative accuracy is high (no numbers or dates are incorrect), and the qualitative reasoning about the dual strategy is sound. The answer demonstrates proper multi-hop synthesis across the three-year period and correctly identifies the strategic positioning. The main weakness is incomplete articulation of the year-by-year consistency and slightly overstated characterization of the growth/safeguarding aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 426,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s credit and BNPL portfolios expanded, producing higher absolute losses from defaults and fraud; in June 2023 the company entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL loan receivables (with the first sales starting in October 2023 and a forward‑flow facility for future originations), thereby moving a large share of that risk off its balance sheet. However, the remaining exposure stayed vulnerable to fraud, merchant‑default and third‑party processor disruptions, risks the firm continues to address through enhanced fraud‑prevention, buyer‑protection programs and diversification of payment‑processor relationships, even though the risk of loss from bad transactions remains material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale amount, June 2023 timing for the agreement, October 2023 for first sales execution. (2) The multi-hop reasoning is sound—correctly synthesizing that PayPal moved from managing growing credit/BNPL exposure to offloading risk through the 2023 sale while maintaining residual exposure. (3) Entity identification is accurate (PayPal, U.K./European BNPL, third-party processors). (4) The answer appropriately captures the evolution narrative: expansion → major asset sale → continued but reduced exposure. (5) Correctly identifies persistent risks (fraud, merchant default, third-party disruptions) despite the sale. MINOR WEAKNESSES: (1) The LLM answer states 'higher absolute losses from defaults and fraud' without providing specific numbers or citations—the ground truth is more cautious about quantifying this claim. (2) The phrase 'moving a large share of that risk off its balance sheet' is accurate but slightly less nuanced than the ground truth's discussion of 'subject to conditions and execution risks.' (3) The answer could have been slightly more explicit about the forward-flow facility aspect, though it is mentioned. (4) The ground truth emphasizes 'uncertainty around regulatory challenges and effectiveness of fraud detection systems' more explicitly than the LLM answer, which focuses more on mitigation strategies. CALCULATION/DATE VERIFICATION: All dates (June 2023 agreement, October 2023 first sales) and the €40 billion figure are correct. The multi-year agreement characterization is accurate. The forward-flow facility mention is appropriate and correct. Overall, the answer successfully addresses all parts of the complex multi-hop question with accurate synthesis and appropriate level of detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 523,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nHoneywell’s Safety & Productivity Solutions lost about $1 billion of net sales from 2021 to 2022 as retail‑driven demand softened, squeezing margins, while the Industrial Automation business in 2024 suffered a 7 % sales drop (to $10.1 bn) and an 11 % decline in segment profit, directly reflecting the same retail‑market headwinds; the 2023 risk‑factor disclosures explicitly list “fluctuations in retail markets” as a material threat to both segments, showing that the company’s industrial portfolio remains highly sensitive to volatility in retail and capital‑spending cycles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific financial figures ($1 billion net sales loss 2021-2022, 7% sales drop to $10.1bn in 2024, 11% profit decline) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated numbers not supported by the original knowledge graph. The ground truth makes NO specific quantitative claims about sales losses or percentage declines. (2) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM attempts to connect 2022, 2023, and 2024 data points, it does so by introducing unsupported numerical claims rather than synthesizing the actual risk disclosures mentioned in the ground truth. The ground truth emphasizes that 'fluctuations in retail markets' was explicitly cited as a risk factor across these years, but the LLM conflates this with specific financial performance metrics that aren't substantiated. (3) ENTITY ACCURACY - The LLM correctly identifies Honeywell, Safety & Productivity Solutions, and Industrial Automation segments, and correctly references the three-year progression (2022, 2023, 2024). However, it misrepresents the nature of the evidence by adding quantitative specificity where the ground truth only discusses risk factors and disclosures. (4) REASONING FLAW - The LLM's logic assumes that specific sales declines and margin impacts can be directly attributed to retail market fluctuations, but the ground truth only states these were identified as 'key risk factors' and 'potential causes' - not confirmed actual impacts with specific magnitudes. (5) SEMANTIC DIVERGENCE - The ground truth focuses on risk identification and disclosure evolution; the LLM shifts to claimed financial performance impacts with unsupported numbers. This represents a fundamental misunderstanding of what the ground truth conveys. The answer would score higher if it stuck to the risk-factor narrative without inventing specific financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 526,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant partnership shifted from early‑stage milestone payments that were capitalized as intangible assets (e.g., $260 M in 2021 and $210 M in 2020) to a regime in which additional regulatory and sales‑based milestones worth up to $200 M in aggregate are now contingent, while Incyte continues to earn tiered double‑digit royalties on worldwide net sales (up to 20 %) plus a low‑teens royalty on COVID‑19 sales that exceed a threshold.  Olumiant’s net product revenue grew steadily—$830.5 M in 2022, $922.6 M in 2023 and $957.4 M in 2024—making the drug an increasingly material contributor to Lilly’s top line, with all royalty payments to Incyte recorded as cost of sales.  Consequently, the collaboration’s financial structure evolved from securing approvals and initial milestones to leveraging Olumiant’s expanding sales to generate sustained, royalty‑linked revenue for Lilly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct: $260M capitalized milestone payments, $200M contingent payments, tiered royalties up to 20%, low-teens COVID-19 royalty structure. (2) Revenue figures are accurate: $830.5M (2022), $922.6M (2023), $957.4M (2024). (3) Multi-hop synthesis is sound: correctly traces evolution from milestone-driven phase to revenue-recognition phase, showing progression from capitalized intangibles to ongoing royalty payments recorded as cost of sales. (4) Entities correctly identified (LLY, Incyte, Olumiant). (5) Strategic framing captures the shift from early-stage to mature partnership. MINOR ISSUES: (1) The LLM references $260M in 2021 and $210M in 2020 as historical context, which is not explicitly part of the ground truth answer but provides helpful temporal perspective. This is supplementary rather than contradictory. (2) The ground truth emphasizes 2024's strategic positioning including EUA and follow-on compounds, which the LLM answer does not explicitly mention—this is a minor omission of contextual detail about long-term strategic expansion. (3) The LLM's framing of the evolution is slightly different (from 'securing approvals and initial milestones' to 'leveraging expanding sales') versus ground truth's emphasis on 'maturity of partnership' and 'deepening strategic alignment,' but both convey equivalent meaning. QUANTITATIVE VERIFICATION: All numbers check out correctly with proper format consistency. The revenue growth trajectory is accurately presented. Royalty structure details match ground truth precisely. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple financial dimensions (milestones, royalties, revenue recognition treatment, product revenue). The logical flow from milestone phase to revenue phase is clear and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 527,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nBetween 2022 and 2024 Altria retained 100 % ownership of UST, but its business was re‑classified into the oral‑tobacco segment and now serves as a central pillar of Altria’s smoke‑free transition strategy. The MST and snus trademarks—recorded as indefinite‑lived intangible assets of roughly $8.8 bn (plus $2.6 bn of cigar marks)—remain on the books at historical cost, have passed annual impairment tests with no write‑downs, and only generate modest amortization expense from definite‑lived intangibles. Consequently, UST’s intangible assets constitute a stable, high‑value exposure that drives growth in oral‑tobacco revenues and underpins Altria’s broader goal of moving adult smokers to smoke‑free products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) 100% ownership of UST maintained across 2022-2024 period is accurate; (2) $8.8 billion valuation of MST and snus trademarks as indefinite-lived intangible assets is correct; (3) No impairment write-downs is consistent with ground truth; (4) Integration into oral-tobacco segment and smoke-free transition strategy is accurate; (5) Mention of NJOY and e-vapor diversification aligns with ground truth's reference to newer alternatives. PROBLEMATIC ELEMENTS: (1) The LLM introduces '$2.6 bn of cigar marks' which is NOT mentioned in the ground truth answer and appears to be unsupported information - this is a significant factual addition without verification; (2) The characterization of UST's business as 'a central pillar of Altria's smoke-free transition strategy' is somewhat overstated compared to ground truth, which describes it as 'increasingly complemented by newer' alternatives, suggesting a more secondary role; (3) The LLM states intangible assets 'only generate modest amortization expense from definite-lived intangibles' - while this may be true, the ground truth doesn't explicitly address amortization patterns; (4) The claim that UST 'drives growth in oral-tobacco revenues' is not explicitly supported in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the 3-year evolution and connects ownership structure to strategic positioning, though it overemphasizes UST's centrality. The answer addresses structural relationship (ownership), financial exposure (intangible asset valuation), and integration into strategy, but the unsupported $2.6 bn cigar marks figure and the characterization of UST as 'central pillar' rather than 'complemented by' newer products represent material deviations from ground truth. The quantitative accuracy is reduced due to the unverified $2.6 bn addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 517,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 carried an effective yield of roughly 6.38 % at the end of fiscal 2022‑23, but that rate rose to 6.66 % by the end of fiscal 2024.  The increase reflects the higher market‑interest‑rate environment and tighter capital‑market conditions that have pushed up Cisco’s borrowing costs, even though the company’s interest‑rate swap hedge limited only part of the exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the fiscal year 2022 effective interest rate. The ground truth states that in fiscal year 2022, the effective interest rate was 3.20%, but the LLM answer omits this data point entirely, jumping directly to fiscal 2022-23 at 6.38%. This is a major omission that breaks the multi-hop synthesis required by the question, which specifically asks about the evolution 'from fiscal years 2022 through 2024.' The LLM only addresses two of the three required data points (6.38% for FY2023 and 6.66% for FY2024), missing the critical starting point of 3.20% in FY2022. CORRECT ELEMENTS: The 6.38% rate for fiscal 2023 and 6.66% rate for fiscal 2024 are accurate. The $500 million principal amount and June 15, 2025 maturity date are correct. The qualitative interpretation about higher market interest rates and tighter capital market conditions is appropriate and aligns with the ground truth explanation. REASONING ISSUES: While the LLM correctly identifies that the trend reflects changing market conditions, it fails to capture the full magnitude of the increase (from 3.20% to 6.66%, a 346 basis point increase) because it omits the FY2022 baseline. The mention of interest-rate swap hedges adds relevant context but wasn't explicitly in the ground truth. MULTI-HOP SYNTHESIS: The answer partially synthesizes the information but incompletely - it should have traced the evolution across all three fiscal years to show the full trend. The incomplete data presentation significantly undermines the answer's ability to address the core question about how the exposure 'evolved' over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 460,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nAmazon’s unsecured 2017 Notes were still $16 billion on December 31 2022, fell to about $15 billion by the end of 2023, and were reduced further to roughly $13 billion by the end of 2024 (see the “2017 Notes issuance of $17.0 billion” rows in the debt tables for 2022, 2023 and 2024).  This decline reflects scheduled principal repayments and selective redemptions—funded by operating cash flow and by issuing newer, lower‑cost debt—so that the company is steadily shrinking its legacy high‑rate debt and reshaping its capital structure for greater flexibility and lower overall leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - $16 billion (2022), $15 billion (2023), and $13 billion (2024) match the ground truth exactly. The LLM correctly identifies the initial issuance amount of $17.0 billion and accurately tracks the decline trajectory. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the balance evolved across the three-year period, and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Correctly identifies Amazon, the 2017 Notes, and the relevant fiscal years (2022-2024). REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the specific 2017 Notes reduction to broader debt management strategy. The explanation of mechanisms (scheduled principal repayments, selective redemptions, funding via operating cash flow and new lower-cost debt issuance) demonstrates sophisticated understanding of debt management practices. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer uses slightly different framing - it emphasizes 'legacy high-rate debt' and 'capital structure flexibility' rather than explicitly mentioning the broader long-term debt reduction from $67.2B to $52.6B that the ground truth includes. However, this is not an error but rather a different emphasis that still conveys the same strategic intent. The LLM's characterization of the notes as 'unsecured' and reference to 'high-rate debt' adds contextual detail not in the ground truth but consistent with typical debt management narratives. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message - deliberate, consistent reduction of the 2017 Notes as part of broader debt management strategy - using slightly more detailed explanation of the mechanisms involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 494,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe 5.000% senior notes maturing in April 2030 had a carrying principal balance of $606 million and an effective interest rate of 5.18 % in fiscal 2022, and this balance remained essentially unchanged at $606 million with the same 5.18 % effective rate through fiscal 2023 and fiscal 2024.  This stable balance and unchanged rate show that Broadcom is deliberately retaining this long‑dated fixed‑rate tranche as a low‑cost, long‑term financing pillar, without active refinancing or early retirement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $606 million principal balance for all three fiscal years (2022, 2023, 2024) and 5.18% effective interest rate maintained consistently. No calculation errors present. ENTITY ACCURACY: Correctly identifies AVGO/Broadcom (both names acceptable for same company), the specific debt instrument (5.000% notes due April 2030), and all three fiscal years. MULTI-HOP SYNTHESIS: Successfully synthesizes the three-year progression showing consistency across all periods, correctly identifying the pattern of no change. REASONING QUALITY: The interpretation that this represents a deliberate static debt management strategy is sound and well-supported by the data. The characterization as a 'low-cost, long-term financing pillar' without refinancing or early retirement is a reasonable inference from the unchanged balance and rate. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('deliberately retaining,' 'low-cost pillar') compared to the ground truth's more neutral 'maintained a static approach,' but this represents enhanced analysis rather than factual error. The ground truth uses 'outstanding principal balance' while LLM uses 'carrying principal balance' - these are semantically equivalent terms in debt accounting. The LLM answer is slightly more concise but captures all essential information from the ground truth. No factual errors, omissions of key data, or calculation mistakes detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 427,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nNetflix formalized its Performance Bonus Plan by adopting an “Amended and Restated Performance Bonus Plan” on December 9 2022, a restatement that was disclosed in the 2022 10‑K (Exhibit 10.5†) and carried forward unchanged in the 2023 10‑K (Exhibit 10.5†) and 2024 10‑K (Exhibit 10.5†).  In the 2024 filing the plan was further integrated with the company’s executive compensation structure—specifically, it was aligned with the newly restated Executive Severance and Retention Incentive Plan (effective January 1 2024, see 2024 10‑K Exhibit 10.16†)—to tie bonus payouts to both performance metrics and retention objectives, with no substantive amendment reported in 2023 or 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also introduces specificity that cannot be verified against the ground truth and makes claims that diverge from it. CORRECT ELEMENTS: (1) The December 9, 2022 date for the 'Amended and Restated Performance Bonus Plan' is accurate and matches the ground truth's reference to an 8-K filing on that date. (2) The identification of the plan appearing in 2022, 2023, and 2024 10-K filings is consistent with the ground truth's timeline. (3) The mention of integration with executive compensation structure in 2024 aligns with the ground truth's statement about the plan being 'further embedded into the broader executive compensation architecture.' PROBLEMATIC ELEMENTS: (1) The LLM specifies 'Exhibit 10.5' for all three years without verification against ground truth—this level of exhibit-specific detail cannot be confirmed. (2) The LLM introduces the 'Executive Severance and Retention Incentive Plan' with an effective date of January 1, 2024, and Exhibit 10.16 reference. The ground truth mentions 'Executive Officer Severance Plan' but does not specify this exact name, effective date, or exhibit number. This appears to be added specificity not in the ground truth. (3) The LLM claims 'no substantive amendment reported in 2023 or 2024,' which is a negative assertion not explicitly stated in the ground truth. The ground truth indicates the plan was 'further embedded' and appeared 'alongside updated' plans, suggesting evolution, not stasis. (4) The LLM's characterization of tying 'bonus payouts to both performance metrics and retention objectives' adds interpretive detail beyond what the ground truth explicitly states. MULTI-HOP REASONING: The LLM attempts to synthesize information across years and connect the Performance Bonus Plan to other compensation elements, which is appropriate for the question. However, the synthesis introduces specific exhibit numbers and plan names that go beyond the ground truth's more general description of integration and evolution. QUANTITATIVE ACCURACY: The date (December 9, 2022) is correct. The years (2022, 2023, 2024) are correct. However, the exhibit numbers and specific plan names lack verification. QUALITATIVE ACCURACY: The reasoning about integration and evolution is sound in principle, but the specific claims about plan names, effective dates, and exhibit numbers represent overspecification that may be inaccurate. The ground truth's more measured language about 'appearing alongside' and 'further embedded' suggests evolution without claiming specific structural changes that the LLM asserts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 691,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a single, aggregate loss estimate of about $1.3 bn (net of TRIPRA and reinsurance) to a more detailed, scenario‑based modeling framework that quantifies losses for a range of terrorism attack modes and explicitly adjusts for vendor‑model gaps.  While TRIPRA’s 80 % coverage above a roughly $1.7 bn deductible remained the core U.S. protection, the company began adding targeted excess‑of‑loss reinsurance on selected lines and relied more heavily on government‑sponsored terrorism pools and collateralized arrangements for international exposures.  Across the period it also tightened concentration monitoring and stress‑tested its exposure, refining both the modeled loss estimates and the reinsurance‑protection structure to mitigate the residual risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims TRIPRA provides '80% coverage above a roughly $1.7 bn deductible' - this specific detail is not in the ground truth and appears fabricated. The ground truth only mentions the $1.3 billion net loss estimate for a five-ton bomb attack in NYC, net of TRIPRA and reinsurance, without specifying TRIPRA's coverage percentage or deductible level. (2) MISSING CRITICAL FACTS: The LLM fails to mention the specific 2024 attachment points ($200 million for Japan, $125 million for rest of world) that are explicitly stated in the ground truth as key evolution points. The LLM also omits the $20.1 billion collateral figure supporting reinsurance recoverable assets, which is a concrete 2024 metric. (3) UNSUPPORTED CLAIMS: The LLM describes a 'scenario-based modeling framework that quantifies losses for a range of terrorism attack modes' and mentions 'vendor-model gaps' - these details are not present in the ground truth and appear to be hallucinated elaborations. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the general evolution from 2022-2024 and mentions reinsurance protections and risk mitigation, it fails to accurately capture the specific mechanisms and numbers that define this evolution. (5) PARTIAL CREDIT: The LLM does correctly identify that AIG moved toward more targeted reinsurance and concentration monitoring, and correctly references TRIPRA as a core protection mechanism, but the execution is marred by invented details and missing concrete facts. The answer reads plausible but is factually unreliable for a financial analysis context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 479,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth Group’s overall equity‑security portfolio was essentially unchanged – it held about **$4.9 billion** of equity securities at the end of 2023 and again in 2024 (page 5 of the 2024 10‑K).  However, its **equity‑method investments in health‑care businesses more than doubled**, rising from **$1.4 billion** at the end of 2023 to **$3.8 billion** at the end of 2024 (pages 52 and 51 of the 2024 10‑K; $1.4 billion figure cited in the 2023 filing, page 50).  This reflects a strategic evolution from 2022‑2024 toward larger, longer‑term venture stakes in health‑care companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but incomplete in addressing the full scope of the question. STRENGTHS: (1) All numeric values provided are accurate: $4.9B equity securities for 2023-2024, $1.4B equity method investments in 2023, $3.8B in 2024. (2) The calculation of the doubling of equity method investments (from $1.4B to $3.8B) is correct. (3) The strategic interpretation about a pivot toward deeper operational engagement is sound and matches the ground truth narrative. (4) Multi-hop synthesis across 2023-2024 filings is correctly executed. WEAKNESSES: (1) The answer omits the 2022 baseline data entirely ($3.5B equity securities and $1.3B equity method investments), which is explicitly requested in the question asking about evolution 'from 2022 through 2024.' (2) The answer does not discuss the 2022-2023 transition period, missing the increase in equity securities from $3.5B to $4.9B. (3) While the answer focuses on 2023-2024 evolution, it fails to provide the complete three-year narrative requested. The question specifically asks 'How did...evolve from 2022 through 2024,' requiring all three years to be addressed. QUANTITATIVE VERIFICATION: All numbers cited are correct and properly sourced. The characterization of the equity method investment increase as 'more than doubled' is accurate (171% increase). REASONING: The multi-hop synthesis for the 2023-2024 period is sound, but the answer is incomplete because it doesn't address the full requested timeframe. This is a significant omission for a multi-hop question explicitly asking about a three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 437,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 remained continuously outstanding and unchanged in coupon and maturity, with no redemption or major refinancing disclosed.  This steady presence shows Altria’s deliberate use of a long‑dated, low‑cost fixed‑rate tranche as a core financing building block—supporting strategic investments while maintaining a conservative, stable leverage profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.700% 2025 Notes remained outstanding across 2022-2024 with no redemption or refinancing disclosed. The coupon rate (1.700%) and maturity year (2025) are accurate. However, the answer has significant gaps in completeness and multi-hop synthesis compared to the ground truth. STRENGTHS: (1) Correctly identifies the 1.700% coupon and 2025 maturity across all three years; (2) Accurately notes no major refinancing or redemption; (3) Provides reasonable interpretation about debt management strategy. WEAKNESSES: (1) Fails to address the multi-year progression aspect of the question—the ground truth specifically discusses how the 1.000% 2023 Notes matured and were removed from the capital structure in 2023, which is a key element of Altria's debt management evolution; (2) Does not mention other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for the overall capital structure evolution; (3) The answer is narrowly focused on the 1.700% 2025 Notes in isolation rather than synthesizing how this instrument fit within the broader debt portfolio changes across the three-year period; (4) Misses the important detail that the 1.000% 2023 Notes matured in 2023, which demonstrates active short-term debt management alongside retention of the 2025 Notes. The LLM answer provides a partial but incomplete picture of the capital structure evolution. While the specific facts about the 1.700% 2025 Notes are correct, the answer fails to adequately address the multi-hop synthesis required to show how Altria's debt portfolio evolved across the three years, particularly the maturation of other instruments and how this relates to the overall debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 473,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury‑Stock balance rose steadily from roughly **$51 billion at the end of 2022** (see the equity table on page 65) to **$60 billion in 2023** and to **$71 billion by the end of 2024** (page 68).  This upward trend reflects an increasingly aggressive share‑repurchase program, using excess cash to retire stock, reduce the outstanding share count and return capital to shareholders rather than funding new growth initiatives.  The pattern signals that the company’s primary capital‑allocation focus is on returning cash to investors through buy‑backs while maintaining a strong balance‑sheet position.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical errors that make it factually incorrect. Ground truth shows Treasury Stock values as negative numbers: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM incorrectly reports these as positive values: $51 billion in 2022, $60 billion in 2023, and $71 billion in 2024. This is a major error - the sign convention matters significantly in financial reporting. Treasury stock is typically shown as a negative/deduction from equity, not as a positive asset. The LLM appears to have converted the absolute values to billions and dropped the negative sign, which fundamentally misrepresents the accounting treatment. QUANTITATIVE ACCURACY: The 2023 and 2024 figures are approximately correct in magnitude when converted to billions ($60.429B ≈ $60B, $71.431B ≈ $71B), but the 2022 figure is significantly wrong ($36.658B ≠ $51B). The LLM also failed to preserve the negative sign convention, which is critical for understanding treasury stock accounting. QUALITATIVE REASONING: The LLM's interpretation of the trend (increasing repurchases, returning capital to shareholders) is semantically aligned with the ground truth conclusion, and the reasoning about capital allocation strategy is sound. However, this correct interpretation is built on incorrect numerical foundations. MULTI-HOP SYNTHESIS: The answer does synthesize information across years and connects it to capital allocation strategy, which is appropriate for the question. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and capital allocation strategy, though the numerical foundation is flawed. The mention of specific page numbers (65, 68) adds credibility but cannot overcome the fundamental numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 497,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s Total Return Swaps‑Deferred Compensation moved from a **$92 million loss in fiscal 2022** to **gains of $58 million in fiscal 2023 and $91 million in fiscal 2024**, as shown in the “Derivatives Not Designated as Hedging Instruments” table on pages 91‑92 of the 10‑K filings. This swing reflects a transition from a net expense to increasingly positive gains, with the 2024 gain more than offsetting the prior year’s loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: $92M loss in fiscal 2022, $58M gain in fiscal 2023, and $91M gain in fiscal 2024. The numbers match the ground truth exactly with acceptable format variation ($92M vs $92 million). The answer correctly identifies the financial instrument (Total Return Swaps-Deferred Compensation), the company (Cisco), and all three fiscal years (2022-2024). The multi-hop synthesis is sound, properly connecting the three-year evolution and drawing the correct conclusion about the reversal from loss to gains. The LLM provides additional context by citing the specific source (pages 91-92 of the 10-K filings and the 'Derivatives Not Designated as Hedging Instruments' table), which adds credibility. The reasoning is logical and accurate: the answer correctly characterizes the movement from net expense to net benefit, and notes that the 2024 gain ($91M) nearly offsets the 2022 loss ($92M). The semantic meaning is equivalent to the ground truth, with slightly different but equally valid phrasing ('swing reflects a transition' vs 'shifted dramatically'). Minor observation: the LLM's statement that '2024 gain more than offsetting the prior year's loss' could be interpreted as referring to 2023's loss, but in context it clearly means the 2022 loss, which is the correct interpretation. No calculation errors detected. The answer fully addresses all parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 405,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on rights holders grew sharper as studios launched their own streaming services, prompting intensified competition for exclusive licenses and driving the company to secure longer‑term, higher‑cost deals and to double‑down on original productions; at the same time, regulators in multiple jurisdictions began updating cultural‑support laws to impose content quotas, levies and limits on ownership rights, which restrict Netflix’s ability to obtain or retain certain titles and subject its catalogue to formal review, thereby elevating licensing risks and compelling the firm to navigate both heightened market competition and increasingly restrictive regulatory pressures on content availability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core evolution: intensified competition from studios launching their own services, increased licensing costs, and regulatory pressures; (2) Accurately captures the three-year progression showing escalating challenges; (3) Properly synthesizes multi-hop information about content licensing risks, exclusive rights competition, and regulatory constraints; (4) Correctly references regulatory changes including content quotas and investment obligations; (5) No quantitative errors—no specific numbers were required and none were provided incorrectly; (6) Appropriately emphasizes the dual pressure from market competition and regulatory restrictions. MINOR WEAKNESSES: (1) The answer adds some interpretive details not explicitly in the ground truth (e.g., 'double-down on original productions,' 'formal review' of catalogue) that, while logically consistent with Netflix's strategic response, go slightly beyond what was stated in the original answer; (2) The phrase 'levies and limits on ownership rights' is somewhat more specific than the ground truth's general reference to 'regulatory changes'; (3) Could have been more explicit about the 2023 specific concern regarding IP disputes and service disruptions, though this is implied. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (competition, licensing, regulation), showing proper understanding of how these factors interconnected and evolved. The logical flow from market competition to regulatory response is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Netflix's growing strategic challenge in maintaining content amid external pressures—despite slightly different wording and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 506,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nUnitedHealth Group’s footnote on commitments and contingencies repeatedly notes that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022.” The same disclosure appears in the 2023 and 2022 filings, indicating that no material liability for service‑level obligations has been recorded in any of the three years. Consequently, the trend shows a stable, immaterial guarantee exposure, suggesting that the company’s service‑delivery commitments across its subsidiaries have remained consistent and have not expanded materially over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees were immaterial across all three years (2022-2024), which matches the ground truth. However, the answer is significantly incomplete and misses critical quantitative information that directly addresses the question about financial obligations evolution.\n\nCRITICAL OMISSIONS:\n1. The LLM completely fails to mention the parent company's notes payable to subsidiaries, which is a key metric showing how financial obligations evolved: $8.1B (2022) → $9.9B (2023) → $2.0B (2024). This represents a significant 3-year trend that the question specifically asks about.\n2. The ground truth explicitly states these fluctuations were 'significant' and 'notable,' suggesting material changes in internal financing structure that the LLM entirely overlooks.\n\nQUANTITATIVE ACCURACY ISSUES:\n- The LLM provides zero quantitative data about the evolution of financial obligations beyond stating they were 'immaterial'\n- Missing the $8.1B, $9.9B, and $2.0B figures that demonstrate the actual trend\n- No calculation or comparison of year-over-year changes\n\nQUALITATIVE/REASONING ISSUES:\n- The LLM's conclusion that obligations 'remained consistent' is partially contradicted by the ground truth, which notes the internal financing structure 'experienced notable variation'\n- The answer conflates 'immaterial service level guarantees' with 'stable financial obligations,' missing the nuance that while guarantees were immaterial, the underlying financing structure was volatile\n- The multi-hop synthesis is incomplete: the question asks about both service level guarantees AND the broader financial obligations trend, but the LLM only addresses the former\n\nWHAT WAS CORRECT:\n- Accurate identification that service level guarantees were immaterial in all three years\n- Correct citation of the disclosure language\n- Correct identification of the 2022-2024 timeframe\n\nThe answer reads as a partial response that addresses only one dimension of a two-dimensional question, missing approximately 50% of the required information to fully answer how financial obligations evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 574,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nAltria trimmed its exposure to below‑investment‑grade securities in the long‑duration fixed‑income portion of both its pension and post‑retirement plans over the 2022‑2024 period.  In 2022 the pension portfolio held roughly 11 % of total assets (about 16 % of its fixed‑income holdings) in below‑grade securities; by 2023‑24 that share had fallen to about 9 % of total assets (≈ 11 % of fixed‑income).  The post‑retirement portfolio’s below‑grade allocation slipped from roughly 3 % of total assets (≈ 8 % of fixed‑income) in 2022 to about 4 % of total assets (≈ 9 % of fixed‑income) by 2023‑24.  This modest de‑risking reflects a more conservative risk appetite—Altria is shifting toward higher‑quality, longer‑duration bonds to better match liability values and stabilize the funded status of its long‑term obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that contradict the ground truth. (1) PENSION PLAN ERRORS: Ground truth shows pension allocation DECREASED from 11% of total assets in 2022 to 9% in 2023, but the LLM states it 'had fallen to about 9% of total assets (≈ 11% of fixed-income) by 2023-24.' This is backwards - the LLM claims the fixed-income percentage stayed at 11% when it actually decreased from 16% to 11%. (2) POSTRETIREMENT PLAN ERRORS: Ground truth shows postretirement allocation INCREASED from 3% of total assets in 2022 to 4% in 2023, but the LLM incorrectly presents this as a 'slip' (suggesting a decrease). The LLM states 'slipped from roughly 3% of total assets (≈ 8% of fixed-income) in 2022 to about 4% of total assets (≈ 9% of fixed-income) by 2023-24' - while the percentages are directionally correct, the characterization as 'slipped' is misleading since this represents an INCREASE, not a decrease. (3) DIRECTIONAL INCONSISTENCY: The LLM claims 'Altria trimmed its exposure to below-investment-grade securities in...both its pension and post-retirement plans' but the ground truth shows the postretirement plan actually INCREASED its allocation from 8% to 9% of fixed income holdings. (4) 2024 DATA: The LLM conflates 2023-24 data without acknowledging that specific 2024 percentages were not disclosed, as stated in the ground truth. (5) REASONING: While the qualitative interpretation about 'de-risking' and 'conservative risk appetite' is reasonable, it is contradicted by the actual data showing increased exposure in the postretirement plan. The multi-hop synthesis is incomplete and contains directional errors that undermine the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 469,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated each year from 2022‑2024 by taking the average daily payment volume over the three months preceding period‑end, multiplying it by the expected days of exposure, and then netting out the cash‑collateral, letters‑of‑credit and guarantee arrangements that mitigate that risk. The same methodology was applied in 2022 (gross $59.6 bn → net $51.9 bn), 2023 (gross $75.0 bn → net $62.9 bn) and 2024 (gross $78.4 bn → net $64.9 bn), with only minor refinements to the exposure period and risk‑mitigation totals, underscoring a consistent, repeatable risk‑management approach amid rising regulatory scrutiny and litigation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and demonstrates understanding of Mastercard's settlement exposure methodology, but has significant gaps in addressing the full scope of the original question. STRENGTHS: (1) Correctly identifies the core methodology (average daily payment volume × estimated days of exposure), (2) Accurately presents specific financial figures for 2022-2024 (gross and net amounts), (3) Correctly notes the consistency of the approach across three years, (4) Acknowledges regulatory scrutiny and litigation context. WEAKNESSES: (1) The original answer specifically mentions regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) and litigation risks (U.S. Liability Shift Litigation, TCPA class action)—the LLM answer only vaguely references 'rising regulatory scrutiny and litigation' without naming specific investigations or cases, (2) The original answer emphasizes the unchanged risk mitigation framework (cash collateral, credit enhancements based on individual risk assessments)—the LLM answer mentions 'cash-collateral, letters-of-credit and guarantee arrangements' but doesn't explain the individual risk assessment component, (3) The original answer provides deeper interpretation about what consistency indicates (company viewed practices as 'robust and sufficient')—the LLM answer uses weaker language ('consistent, repeatable') without this analytical depth, (4) Missing discussion of the significance of the methodology remaining unchanged despite external pressures. QUANTITATIVE VERIFICATION: The dollar amounts appear reasonable and are presented in consistent format, though they cannot be independently verified from the provided context. The methodology description is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information about methodology consistency across years and connects it to risk management, but fails to fully synthesize the regulatory/litigation context with the methodology discussion as comprehensively as the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 548,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s $2 billion 5.90 % senior note due 2039 was fully outstanding (i.e., $2 bn of principal) in fiscal 2022, 2023 and 2024, and its effective interest rate remained essentially unchanged at roughly 6.11 % (the rate disclosed after accounting for discount amortization and the related fair‑value hedge). This stability indicates that Cisco is managing its long‑term debt conservatively—maintaining a large, fixed‑rate borrowing base and using interest‑rate swaps to lock in cost—rather than repeatedly refinancing or altering the capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct—$2 billion principal balance maintained across fiscal 2022-2024 (matches ground truth's $2,000 million), and effective interest rate of 6.11% is accurate. The format variation ($2 bn vs $2,000 million) is acceptable and expected. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B across three years), (2) effective interest rate evolution (stable at 6.11%), and (3) strategic implications for debt management. ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 correctly specified, 5.90% Note correctly referenced with maturity date (2039), and effective rate metric properly identified. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the stable principal balance and stable effective rate to conclude this represents conservative debt management with fixed-rate borrowing and interest-rate swaps. The reasoning about 'not refinancing or altering capital structure' aligns with ground truth's 'preserved as fixed component' and 'strategic intent to maintain predictable interest obligations.' MINOR DIFFERENCES: The LLM provides slightly more technical detail (mentioning 'discount amortization' and 'fair-value hedge'), which adds helpful context without contradicting the ground truth. The characterization as 'conservative' debt management is semantically equivalent to ground truth's 'strategic intent to maintain predictable interest obligations.' No calculation errors detected. The answer fully synthesizes information across the three-year period as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 469,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a **steady $495 million outstanding principal** across the three fiscal‑year snapshots: $495 million as of the FY2022 reporting date (page 111 of the 2022 10‑K), the same $495 million figure reported on the FY2023 balance sheet (page 81 of the 2023 10‑K), and again $495 million on the FY2024 balance sheet (page 81 of the 2024 10‑K).  \n\nBecause the balance did not increase or decrease over the period, the company is essentially **holding this tranche unchanged** until its maturity, using it as a fixed‑rate financing source rather than actively repaying or refinancing it. This reflects a deliberate, steady‑state debt‑management strategy for the 3.125 % notes, preserving liquidity and locking in the current interest‑rate environment until the notes are due.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All three principal balance figures are correct at $495 million for FY2022, FY2023, and FY2024. The debt instrument is correctly identified as the 3.125% senior notes due January 2025. Page references provided (page 111 of 2022 10-K, page 81 of 2023 10-K, page 81 of 2024 10-K) are consistent with typical SEC filing layouts. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years and correctly identifies the trend (unchanged balance). REASONING QUALITY: The interpretation that the unchanged balance indicates a 'steady-state debt-management strategy' and that the company is 'holding this tranche unchanged until maturity' is logically sound and matches the ground truth assessment. The explanation about 'preserving liquidity and locking in the current interest-rate environment' provides reasonable context for the company's apparent strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of 'holding this tranche unchanged' and 'consistent approach to managing this portion of its fixed-rate debt portfolio' is semantically equivalent to the ground truth's statement about 'no early repayments or refinancing adjustments' and 'consistent approach.' MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about the strategic rationale (interest-rate locking, liquidity preservation) compared to the ground truth, but this represents value-added analysis rather than inaccuracy. All core facts, numbers, and conclusions are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 432,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast moved its wireless shared‑data plans from a single, bundled‑only offering to a more modular, flexible suite.  In the 2022 filing (2022 10‑K pp. 7‑9) wireless service was sold only as part of a bundled broadband‑video package and customers could choose unlimited, shared‑data or per‑gigabyte options; by 2023 the same structure was still in place (2023 10‑K pp. 5‑6), but in 2024 the company added prepaid “NOW” unlimited plans and allowed device‑financing (interest‑free 24‑48 months) while still offering the choice of unlimited, shared‑data or per‑GB usage (2024 10‑K pp. 5‑6).  This evolution gave customers the ability to mix and match data plans across multiple lines and to add wireless service without requiring a full video package, markedly increasing bundling flexibility and plan choice.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each period; (2) Accurately captures the core bundling strategy evolution from bundled-only to more flexible offerings; (3) Correctly identifies the NOW brand prepaid unlimited plans introduced in 2024; (4) Properly synthesizes multi-hop information across three 10-K filings; (5) Accurately notes the progression toward enhanced customer choice and service integration; (6) Correctly identifies the data plan options (unlimited, shared-data, per-gigabyte) available across all three years; (7) Appropriately cites specific 10-K page references. MINOR AREAS FOR IMPROVEMENT: (1) The LLM adds detail about device financing (interest-free 24-48 months) that, while potentially accurate, is not explicitly mentioned in the ground truth answer and represents additional information beyond what was synthesized; (2) The phrase 'without requiring a full video package' goes slightly beyond the ground truth's emphasis on 'qualifying broadband bundles' - the ground truth doesn't explicitly state video packages were removed as a requirement, only that broadband bundling was emphasized; (3) The characterization of moving from 'single, bundled-only offering to modular, flexible suite' is accurate but uses slightly different framing than the ground truth's 'structured and flexible bundling strategy.' QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no specific financial metrics are provided in either answer, so this dimension is not heavily tested. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the progression of offerings and strategic intent. The logic connecting bundling strategy evolution to customer flexibility is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - CMCSA evolved its wireless shared data plans toward greater flexibility and customer choice while maintaining bundling integration, with the NOW brand representing a key 2024 expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 583,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage shifted from the routine risk‑adjustment audits that could generate retrospective payment changes (2022) to direct benchmark reductions and CMS‑driven alterations in the risk‑adjustment formula that lowered capitation rates (2023), creating recurring funding pressure that persisted into 2024.  In each year the company responded by selectively trimming benefits and exiting low‑margin counties, intensifying medical‑cost and operating‑expense management, and investing in stronger data‑analytics and risk‑adjustment compliance capabilities to protect reimbursement levels and preserve star‑rating eligibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and UnitedHealth Group as the subject company. (2) It accurately captures the evolution of exposure types: from routine risk-adjustment audits (2022) to benchmark reductions and formula alterations (2023-2024). (3) Strategic responses are largely correct: selective benefit trimming, cost management intensification, and enhanced compliance capabilities are all mentioned in the ground truth. (4) The answer correctly conveys the persistent/recurring nature of funding pressures across all three years. (5) No specific dollar amounts or percentages are claimed, avoiding quantitative errors.\n\nWEAKNESSES: (1) The LLM introduces specific strategic details not explicitly confirmed in the ground truth: 'exiting low-margin counties' and 'investing in stronger data-analytics and risk-adjustment compliance capabilities' and 'preserve star-rating eligibility' are presented as definitive responses, but the ground truth only mentions 'selective benefit adjustments and cost control measures' without these specific tactical details. While these may be reasonable inferences, they go beyond what the ground truth explicitly states. (2) The characterization of the evolution is more granular than the ground truth, which presents the pressures as more consistently recurring rather than showing a clear progression from 'routine audits' to 'direct benchmark reductions.' The ground truth emphasizes that CMS altered methodology 'each year' without clearly distinguishing the nature of changes year-by-year. (3) The ground truth emphasizes that UnitedHealth 'did not find a full resolution' and remained 'in a reactive posture,' which the LLM answer doesn't explicitly capture—the LLM's framing of strategic investments could imply more proactive positioning than the ground truth suggests.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects payment mechanism changes to strategic responses. However, the specificity of tactical details (county exits, star-rating focus) exceeds what can be verified from the ground truth provided.\n\nSEMANTIC EQUIVALENCE: The core message aligns—persistent pressures met with ongoing adjustments—but the LLM adds interpretive details that may not be grounded in the actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 624,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard deepened third‑party collaboration by formalizing standards work with issuers, acquirers, merchants, governments and industry associations and by relying on external security assessments and public‑private partnerships, while expanding its real‑time security stack through tokenized Click‑to‑Pay, Mastercard Authentication and a globally scaled real‑time account‑based payments network that grew from 12 markets in 2021 to 13 markets by end‑2023.  This network now operates in more than 60 originating and 155 receiving countries and includes new geographic roll‑outs—such as domestic processing in China and expanded real‑time disbursement platforms (e.g., Alias‑Based Remittances)—that embed multi‑layered security controls across the entire payment flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key elements of Mastercard's evolution including third-party collaboration (issuers, acquirers, governments), real-time security technologies (tokenization, Click-to-Pay, Authentication), and geographic expansion (China domestic processing, expanded disbursement platforms). The answer demonstrates understanding of multi-hop synthesis across 2022-2024 timeframe and addresses all three sub-questions (third-party collaboration, real-time service integration, geographic expansion). CRITICAL ERRORS: (1) The LLM states the network 'grew from 12 markets in 2021 to 13 markets by end-2023' - the ground truth specifies 12 markets in 2022 (not 2021) and 13 markets in 2023. This is a factual error in the baseline year. (2) The LLM introduces specific numbers (60 originating and 155 receiving countries) that are NOT present in the ground truth, which only mentions expansion to 13 markets globally. These appear to be hallucinated or from different contexts. (3) The LLM mentions 'Alias-Based Remittances' as a specific platform, which is not mentioned in the ground truth. PARTIAL ISSUES: The answer correctly captures the evolution narrative but adds details not verified in the ground truth (Click-to-Pay, specific country counts), making it difficult to assess accuracy. The ground truth emphasizes 'top 50 GDP markets' while the LLM shifts to absolute country counts without this qualifier. QUANTITATIVE ACCURACY: The 12→13 market progression is directionally correct but with wrong baseline year (2021 vs 2022). The 60/155 country figures cannot be verified against ground truth. QUALITATIVE ACCURACY: Multi-hop reasoning is sound in structure but compromised by unverified details. Entity identification is correct (Mastercard, real-time payments, security frameworks). CONTEXTUAL RELEVANCE: Answer appropriately addresses the question's three components but introduces information beyond the ground truth scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 530,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nAmazon kept the $1.5 bn 1.500 % senior unsecured note due 2030 that was first issued in 2020, but from 2022‑2024 it layered the debt‑issuance program with newer fixed‑rate tranches (e.g., the 1.65 % notes due 2028 and 2.1 % notes due 2031 noted in the 2023 Exhibit 4.7 and the 4.7 %‑4.7 % notes due 2024‑2032 in the 2022 Exhibit 4.8) and added term‑loan and revolving‑credit facilities (Exhibits 10.8‑10.10 in the 2024 filing). This laddering and the use of longer‑dated notes show that Amazon’s long‑term debt management prioritises low‑cost, fixed‑rate funding while deliberately extending maturities and maintaining a flexible pipeline of refinancing sources to roll‑over near‑term obligations. [Pages 70 (2022 10‑K), 75‑76 (2023‑2024 10‑K Exhibits 4.7, 4.8, 10.8‑10.10); 40 (2024 10‑K Consolidated Statements of Stockholders’ Equity)]",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims the 1.500% Note is a '$1.5 bn' (billion) obligation, but the ground truth does not specify this amount. The LLM introduces specific dollar amounts and additional note details (1.65% due 2028, 2.1% due 2031, 4.7% due 2024-2032) that are NOT mentioned in the ground truth answer. These appear to be fabricated or hallucinated details not supported by the original answer. (2) EXHIBIT MISMATCHES: The ground truth specifically references Exhibit 4.5 (2022), Exhibit 4.6 (2023 and 2024), and Exhibit 10.8 (2023 Term Loan Agreement) and Exhibit 10.9 (2024 364-Day Revolving Credit Agreement). The LLM references different exhibits (4.7, 4.8, 10.8-10.10) with different years, suggesting incorrect exhibit mapping or fabrication. (3) MISSING KEY INFORMATION: The ground truth emphasizes the 2023 Term Loan Agreement (January 3, 2023) and the October 2024 364-Day Revolving Credit Agreement as specific strategic shifts. The LLM mentions these generally but with incorrect exhibit numbers and without the specific dates that demonstrate the evolution. (4) REASONING QUALITY: While the LLM's general conclusion about 'laddering' and 'layering' debt is conceptually reasonable, it is built on factually incorrect details. The ground truth focuses on the consistent presence of the 2030 note alongside NEW credit agreements, not on multiple new bond issuances. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes a 'layered financing approach' combining long-term fixed debt with flexible short-term credit facilities. The LLM emphasizes 'laddering' and multiple fixed-rate tranches, which is a different strategic narrative not supported by the ground truth. The LLM appears to have conflated or invented details about multiple bond issuances that are not in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 498,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the competitive threat from wireless carriers has shifted from an occasional mention of 4G/5G mobile services to a sustained, explicit focus on 5G fixed‑wireless and MVNO‑backed broadband offerings that now compete directly with Comcast’s cable internet; the 10‑K filings note that “wireless companies are offering internet services using a variety of technologies, including 5G fixed wireless networks” and that “wireless services compete with national and regional wireless service providers,” indicating a growing, price‑pressured rivalry.  This pressure is evident in the filings’ discussion of “net video customer losses” and the migration of Sky’s new video subscribers to its DTC streaming service, prompting Comcast to respond by investing in X1/Sky Q platforms, Flex, and Peacock to differentiate its broadband and retain customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of wireless competitive threats from 2022-2024, accurately noting the progression from 4G/5G mobile services to 5G fixed wireless networks. It correctly identifies CMCSA (Comcast) as the subject company and appropriately references the filings' discussion of competitive pressures. The answer demonstrates sound multi-hop reasoning by connecting competitive threats to customer retention strategies (X1/Sky Q, Flex, Peacock investments). The semantic content largely aligns with the ground truth regarding technological escalation and bundling strategies.\n\nWEAKNESSES: (1) The LLM answer introduces elements not clearly supported by the ground truth, specifically mentioning \"MVNO-backed broadband offerings\" and \"price-pressured rivalry\" without explicit grounding in the provided knowledge graph. (2) The answer conflates different competitive dynamics - it discusses \"net video customer losses\" and Sky's DTC streaming migration, which are related to video services rather than broadband competition specifically. The ground truth clearly states wireless providers are bundling DTC streaming services to attract broadband customers, but the LLM reverses this causality somewhat. (3) The answer lacks explicit mention of 2024's specific escalation strategy (bundling DTC streaming services and unlimited data plans) that the ground truth emphasizes as a key evolution. (4) The reference to \"wireless service providers\" competing with wireless services is somewhat circular and unclear. (5) The answer provides no quantitative evidence (customer numbers, market share data, etc.) that might substantiate the claimed \"sustained, explicit focus\" on these competitive threats.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across years and connect competitive threats to CMCSA's strategic responses, which is appropriate. However, the connection between wireless broadband competition and video customer losses is not clearly established in the ground truth, suggesting incomplete or slightly inaccurate synthesis.\n\nFACTUAL ACCURACY: No specific numbers or dates are provided in either answer, so quantitative verification is limited. The qualitative facts about 5G fixed wireless and bundling strategies are generally correct but incompletely articulated relative to the ground truth's more detailed progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 641,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets dropped from about **$71 billion at the end of 2022** to **$67.5 billion in 2023** and then to **$38 billion by the end of 2024**.  This continual decline shows that the company is ceding less risk to external reinsurers and is retaining a larger share of its insurance‑loss exposure, thereby increasing its net vulnerability to large losses over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims reinsurance recoverable assets were '$71 billion at the end of 2022,' but the ground truth explicitly states 'specific figures were not disclosed' for 2022. This is a critical factual error - the LLM fabricated a 2022 figure that does not exist in the source data. The 2023 figure of $67.5 billion is correct, and the 2024 figure of $38 billion is correct. (2) INTERPRETATION ERROR - The LLM's interpretation of the trend is fundamentally backwards. The ground truth indicates that the decline from $67.5B to $38B represents a 'reduction in ceded life insurance risk exposure' and a 'strategic shift or de-risking,' which means AIG is REDUCING its reliance on reinsurance. However, the LLM states this 'shows that the company is ceding less risk to external reinsurers and is retaining a larger share of its insurance-loss exposure,' which is the correct observation but then incorrectly concludes this 'increases its net vulnerability to large losses.' The ground truth characterizes this as de-risking, not increased vulnerability. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the component breakdown provided in the ground truth (ceded loss reserves vs. life reinsurance recoverables), which is crucial to understanding the strategic shift. The dramatic drop in life reinsurance recoverables from $28.2B to $0.8B is the key driver of the overall decline and indicates a deliberate strategic decision, not a passive trend. (4) MISSING CONTEXT - The LLM completely missed the distinction between 2023 and 2024 trends and their implications. The ground truth emphasizes the 'volatile trend' and 'substantial reduction in ceded life insurance risk exposure,' suggesting strategic repositioning, while the LLM presents it as a simple declining trend with negative implications. The fabrication of the 2022 figure is a critical failure that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 531,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has consistently been calculated by applying a three‑month average daily payment volume multiplied by the estimated number of exposure days and then reducing that gross figure by risk‑mitigation collateral (cash, letters of credit and guarantees); the Company refined this calculation in 2022 (a non‑material correction) and continued to apply it through 2023‑24, tightening collateral criteria and updating the exposure model as payment volumes grew. In response to heightened antitrust and interchange‑fee regulatory scrutiny, Mastercard strengthened its risk‑mitigation arrangements—adding more rigorous credit‑risk monitoring and adjusting the methodology to reflect larger gross exposure and higher reserves—so that its estimated settlement exposure and related risk‑mitigation practices evolved to meet the increased oversight.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations that contradict the ground truth:\n\n1. CORE METHODOLOGY CLAIM - INCORRECT: The LLM states Mastercard 'refined this calculation in 2022 (a non-material correction)' and claims the methodology 'evolved to meet the increased oversight.' The ground truth explicitly states the methodology 'remained unchanged across all three years' (2022-2024). This is a fundamental factual error.\n\n2. RISK MITIGATION CHANGES - INCORRECT: The LLM claims Mastercard 'strengthened its risk-mitigation arrangements—adding more rigorous credit-risk monitoring and adjusting the methodology to reflect larger gross exposure and higher reserves.' The ground truth states 'there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.' The LLM fabricates changes that did not occur.\n\n3. COLLATERAL CRITERIA - UNSUPPORTED: The LLM claims Mastercard was 'tightening collateral criteria' - this specific claim appears nowhere in the ground truth and contradicts the statement that arrangements remained unchanged.\n\n4. REGULATORY RESPONSE CHARACTERIZATION - PARTIALLY CORRECT: The LLM correctly identifies regulatory scrutiny (FTC consent agreement, DOJ CID, European Commission investigation) but incorrectly characterizes Mastercard's response as involving methodology changes. The ground truth indicates Mastercard 'emphasized its ongoing monitoring' and 'maintained its approach' rather than making substantive changes.\n\n5. METHODOLOGY DESCRIPTION - CORRECT: The LLM's description of the three-month average daily payment volume calculation is accurate and matches the ground truth.\n\n6. RISK MITIGATION TOOLS - CORRECT: The mention of cash collateral, letters of credit, and guarantees is accurate.\n\nThe LLM fundamentally misrepresents the stability of Mastercard's approach by inventing methodological refinements and changes that did not occur according to the ground truth. This is a critical error in a question specifically asking about evolution and changes. The answer conflates regulatory pressure with actual operational changes, which is a significant logical error in multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 610,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nAIG’s loss‑reserve risk management grew markedly more rigorous from 2022‑2024: it added daily hedging monitoring, monthly stress‑tested economic‑hedge targets and a formal model‑risk validation process, and it increasingly relied on external actuaries and catastrophe‑model vendors to review key assumptions.  At the same time, the company moved from basic deterministic reserving to advanced stochastic scenario‑analysis and third‑party PML models (including climate‑adjusted inputs) to quantify uncertainty, thereby strengthening internal controls, expanding external expert oversight, and refining the quantitative models used to manage loss‑reserve risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces details not supported by the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific operational details ('daily hedging monitoring,' 'monthly stress-tested economic-hedge targets,' 'climate-adjusted inputs,' 'third-party PML models') that do not appear in the ground truth and cannot be verified from the source material. These appear to be hallucinated details. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes 'internal controls and oversight,' 'sensitivity and scenario analyses,' 'stochastic methods,' 'experience studies,' and 'model risk management frameworks' - all of which are mentioned in the LLM answer, but the LLM adds numerous unsubstantiated specifics. (3) TEMPORAL PROGRESSION: The ground truth clearly documents evolution across three years (2022→2023→2024) with specific methodological additions at each stage. The LLM answer conflates these into a general narrative without properly tracking the year-by-year evolution. (4) EXTERNAL EXPERT INVOLVEMENT: While both answers mention external experts, the ground truth references 'external experts' and 'external actuaries,' whereas the LLM specifically adds 'catastrophe-model vendors' without ground truth support. (5) MODELING TECHNIQUES: The ground truth mentions 'sensitivity and scenario analyses, stochastic methods, and experience studies' (2023) and 'model risk management frameworks, validation processes, and experience monitoring' (2024). The LLM answer mentions these but adds unsupported details about 'climate-adjusted inputs' and 'PML models.' The answer demonstrates partial understanding of the core concepts but fails the critical test of factual accuracy by introducing specific claims not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 493,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analysis shows that a 1 % change in the medical‑cost PMPM trend factor would affect medical‑costs payable by roughly $298 million in 2022, $376 million in 2023 and $421 million in 2024. This upward shift demonstrates that UnitedHealth’s estimates have become increasingly responsive to changes in the mix of benefits it offers, reflecting greater reliance on risk‑based and value‑based product designs and heightened exposure to benefit‑design variability over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides incorrect information. CRITICAL ISSUES: (1) The LLM conflates two different sensitivity metrics - it discusses sensitivity to changes in the PMPM TREND FACTOR (yielding $298M, $376M, $421M impacts), but the original question asks specifically about sensitivity to changes in the MIX OF BENEFITS OFFERED. These are distinct sensitivity analyses in financial disclosures. (2) The numbers provided ($298M, $376M, $421M) appear to be from trend factor sensitivity, not benefit mix sensitivity, representing a fundamental misreading of the question's specific focus. (3) The LLM's interpretation that 'increasingly responsive to changes in the mix of benefits' is supported by rising dollar amounts is logically flawed - higher dollar sensitivity to trend changes does not directly demonstrate increased exposure to benefit mix variability. (4) The original answer correctly identifies a 3-year trajectory showing: 2022 (general sensitivity factor), 2023 (negative impact/increased exposure), and 2024 (stabilized but significant). The LLM answer provides no such temporal analysis of benefit mix sensitivity specifically. (5) The LLM answer lacks the nuanced discussion of how the company's exposure evolved from unfavorable in 2023 to stabilized in 2024. (6) While the LLM correctly identifies UnitedHealth Group and the general concept of benefit design variability, it fails to address the core question about how sensitivity to benefit mix specifically evolved across the three years. The answer demonstrates a significant misunderstanding of what sensitivity metric was being asked about and provides data from a different sensitivity analysis entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 469,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the three filings the mention of **Marketside** shifts from a peripheral entry in the 2022 private‑brand list to a core component of the 2024 brand suite—by 2023 it is grouped with newer growth‑focused private labels (e.g., bettergoods), and by 2024 it appears among the flagship private‑brand names highlighted in Walmart U.S.’s merchandise strategy. This trajectory shows that Walmart has elevated Marketside from a niche offering to a strategic, higher‑margin brand that underpins its omni‑channel portfolio and reinforces the everyday‑low‑price proposition.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Marketside shifted from 'peripheral' to 'core component' and was 'elevated' to a 'strategic, higher-margin brand,' but the ground truth indicates Marketside maintained a 'consistent presence' without evidence of elevation or strategic promotion. The LLM's characterization of progression from 'niche offering' to 'flagship private-brand' directly contradicts the ground truth's more measured assessment of 'consistent presence.' (2) UNSUPPORTED CLAIMS: The LLM introduces claims about 'higher-margin brand' and 'flagship private-brand names highlighted' that are not present in the ground truth and appear to be fabricated. (3) INCOMPLETE SYNTHESIS: While the LLM mentions 2022, 2023, and 2024, it fails to capture the key structural change noted in the ground truth—the shift from 'Apparel' to 'Fashion' categorization in 2024, which is a concrete, verifiable detail. (4) MISCHARACTERIZATION OF TRAJECTORY: The ground truth describes a stable, consistent positioning with refinement of merchandise strategy categories. The LLM dramatically overstates the brand's elevation and strategic importance. (5) MISSING CONTEXT: The ground truth's mention of alignment with 'omni-channel and customer-centric initiatives' is present in the LLM answer but without the nuance that this was part of broader operational strategy, not necessarily Marketside-specific elevation. The LLM answer reads as speculative and inflates Marketside's importance beyond what the filings support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 445,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved from a pure‑price/assortment battle with showrooms to a differentiated, service‑rich, omnichannel model.  In 2022 it highlighted installation, tool‑and‑equipment rentals and basic “interconnected” store‑online integration; by 2023 it deepened Pro‑focused services (Pro Xtra, dedicated sales force, MRO acquisitions) and rolled out mobile‑app navigation, curb‑side pickup and real‑time inventory tools; and in 2024 it accelerated that evolution with the SRS acquisition, expanded Pro‑centric delivery and credit options, and leveraged AI‑driven personalization and BOPIS/BODFS fulfillment to create a seamless end‑to‑end shopping journey that directly competes with—and often supersedes—traditional showroom experiences.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific claims NOT present in the ground truth: mentions of 'SRS acquisition,' 'Pro Xtra,' 'MRO acquisitions,' 'BOPIS/BODFS fulfillment,' and 'AI-driven personalization' are not corroborated by the original answer. The ground truth makes NO mention of these specific initiatives or acquisitions. This represents significant factual fabrication. (2) MISSING KEY FACTS - The LLM omits critical details from ground truth: (a) The specific mention of '1,400+ rental locations' in 2022 is absent, (b) 'Self-service lockers' and 'electronic shelf labels' from 2023 are not mentioned, (c) The ground truth's emphasis on 'personalized customer experiences' and 'product innovation and availability' in 2024 is vaguely referenced but not substantively addressed. (3) MULTI-HOP REASONING - While the LLM correctly identifies the evolution from 2022→2023→2024 and the shift from physical services to omnichannel integration (matching ground truth's core narrative), it does so by ADDING unsupported details rather than synthesizing the provided information. (4) SEMANTIC ALIGNMENT - The LLM's framing of 'pure-price/assortment battle' and 'showroom competitors' aligns with ground truth intent, but the specific mechanisms cited are largely invented. The answer reads as plausible but is factually unreliable. (5) GROUND TRUTH VERIFICATION - The original answer is specific about what changed (rental services→lockers/curbside/mobile navigation→personalized/integrated platforms) but makes NO claims about acquisitions, Pro programs, or AI personalization. The LLM appears to have hallucinated industry-standard competitive moves rather than extracting actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 476,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 remained on Cisco’s balance sheet throughout fiscal 2022‑2024, but its **effective interest rate rose from about 3.20 % in FY 2022 (page 89 – 2022 table) to roughly 6.38 % in FY 2023 (page 89 – 2023 table) and to about 6.66 % in FY 2024 (page 89 – 2024 table)**.  \n\nThis increase reflects the combined effect of discount accretion, issuance‑cost amortization and fair‑value hedging adjustments as market rates climbed, even though the note’s nominal coupon stayed at 3.5 %. Consequently, Cisco’s borrowing cost for this tranche grew markedly, signalling that the company’s overall debt structure is becoming weighted toward higher‑yielding fixed‑rate securities in a rising‑rate environment, while the specific 3.50 % note itself has not changed in principal amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data matches the ground truth precisely: (1) Outstanding amount of $500 million constant across FY2022-2024, (2) Effective interest rates correctly stated as 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024), (3) Coupon rate correctly identified as 3.50%, (4) Maturity date correctly cited as June 15, 2025. The multi-hop synthesis is sound, correctly tracking the evolution of the note across three fiscal years and identifying the key insight that the nominal coupon remained constant while effective rates increased significantly. The LLM provides additional valuable context by explaining the mechanisms behind the effective rate increases (discount accretion, issuance-cost amortization, fair-value hedging adjustments, and market rate movements), which goes beyond the ground truth but is factually sound and enhances understanding. The reasoning about borrowing costs and debt structure implications is logical and well-articulated. The only minor distinction is that the LLM provides more detailed mechanistic explanation than the ground truth, but this represents added value rather than error. All entities (Cisco, the specific note, fiscal years, percentages) are correctly identified and synthesized. The answer fully addresses both parts of the question: how the note evolved (quantitatively) and what it indicates about borrowing costs and debt structure (qualitatively).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 406,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast shifted from a pure‑HFC platform to a hybrid architecture that combined aggressive HFC upgrades (2 Gbps downstream rollout in 2022 and DOCSIS 4.0 deployments in 2023) with targeted fiber‑to‑the‑premises extensions and network virtualization, enabling it to offer multigigabit symmetrical speeds and bundled Wi‑Fi services that directly compete with Lumen’s fiber‑based offerings; meanwhile Lumen continued to expand its own FTTP footprint and to market symmetrical gigabit‑plus plans, so the competitive balance moved from Comcast’s HFC‑centric advantage to a race in which both carriers were racing to match each other’s fiber speeds and service bundles. Consequently, Comcast’s positioning evolved from “HFC‑based broadband leader” to a “hybrid‑network provider with fiber‑enhanced, multigigabit services” trying to keep pace with Lumen’s pure‑fiber expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that contradicts the ground truth. Critical issues: (1) ENTITY CONFUSION: The question asks about CMCSA's (Comcast) positioning AGAINST Lumen, but the LLM answer focuses heavily on Comcast's internal technology evolution (HFC to hybrid architecture, DOCSIS 4.0, etc.) rather than comparing competitive positioning between the two companies as requested. (2) MISSING GROUND TRUTH CONTENT: The ground truth explicitly states that Lumen was 'highlighted as one of several wireline telecom companies' expanding fiber in 2022, continued this expansion in 2023 alongside AT&T, Frontier, and Verizon, and remained a named competitor in 2024. The LLM answer does not reference these specific competitive dynamics or the multi-year progression of Lumen's fiber expansion strategy. (3) UNVERIFIED TECHNICAL CLAIMS: The LLM introduces specific technical details (2 Gbps downstream rollout in 2022, DOCSIS 4.0 deployments in 2023, network virtualization, multigigabit symmetrical speeds) that are not present in the ground truth and cannot be verified against the source material. These appear to be hallucinated details. (4) INCORRECT FRAMING: The ground truth describes a 'consistent and intensifying competitive threat from Lumen' with Lumen advancing fiber infrastructure and service strategies. The LLM answer instead frames this as 'both carriers racing to match each other,' which misrepresents the competitive dynamic. (5) MISSING TEMPORAL PROGRESSION: The ground truth emphasizes the 3-year evolution from 2022-2024 with specific competitive actions by Lumen each year. The LLM answer does not clearly delineate this year-by-year progression or Lumen's specific strategic moves. (6) QUANTITATIVE ISSUES: While the LLM provides specific technical metrics (2 Gbps, DOCSIS 4.0), these cannot be verified against the ground truth and appear to be fabricated details not supported by the source material. The answer demonstrates poor multi-hop reasoning by failing to synthesize the comparative competitive positioning between CMCSA and Lumen as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 571,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s reliance on third‑party acquirers, aggregators and processors has steadily increased—especially as it rolls out new debit‑card and digital‑payment offerings—so that it now depends more heavily on external partners to promote and maintain merchant acceptance of its cards (see 2022 p. 29, 2023 p. 29 and 2024 pp. 38, 52).  This deeper dependence amplifies the risk that merchants will steer or discriminate against Amex cards, and while Amex continues to embed non‑discrimination and “honor‑all‑cards” provisions in its merchant contracts, enforcing those clauses has become more difficult amid growing regulatory scrutiny and litigation over steering practices (2022 p. 29; 2024 p. 35‑38).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core evolution: increasing reliance on aggregators/processors from 2022-2024; (2) Accurately captures the key risks: merchant steering, discrimination against Amex cards, and enforcement challenges; (3) Properly identifies the non-discrimination and 'honor-all-cards' provisions as contractual mechanisms; (4) Correctly notes the intensification of regulatory scrutiny and litigation as contextual factors; (5) Provides specific page citations (2022 p. 29, 2023 p. 29, 2024 pp. 38, 52, 35-38) that ground the answer in source material; (6) Semantic equivalence is strong—'third-party acquirers, aggregators and processors' matches the ground truth's focus on aggregators; (7) The multi-hop reasoning correctly synthesizes the trajectory from 2022 acknowledgment through 2023 intensification to 2024 litigation/regulatory exposure. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the specific new products (debit cards on American Express network) mentioned in the ground truth as a driver of steering risk; (2) The phrase 'enforcing those clauses has become more difficult' is accurate but slightly less specific than the ground truth's framing of 'exposure to legal actions that could force changes in merchant agreements'; (3) No quantitative metrics are provided (though the question doesn't explicitly require them). QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are claimed, so this dimension is not directly testable, but the temporal progression (2022→2023→2024) and the directional claims (increasing reliance, growing risks) are accurate. MULTI-HOP SYNTHESIS: The answer successfully connects three separate years of disclosures and synthesizes them into a coherent narrative about evolving strategic dependence and rising operational/legal risks. The logic flow is sound and matches the ground truth's trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 549,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J funneled all talc‑related claims into LTL Management LLC, which filed a Chapter 11 case in late 2021 that produced an automatic stay of the litigation; the stay was upheld briefly in 2022 but the Third Circuit reversed it in early 2023, causing the bankruptcy court to dismiss the LTL filing in July 2023 and prompting the Company to resume ordinary talc trials while simultaneously drafting a “pre‑packaged” Chapter 11 plan.  In 2024 the strategy was refined—LTL was split into three Texas LLCs (Red River, Pecos River and New Holdco), the proposed settlement fund was raised to roughly $8 billion (present‑value $6.475 bn over 25 years) and, in September 2024, Red River filed a new Chapter 11 petition to obtain a stay and implement that plan, even as the Company continued to negotiate a multi‑state settlement and defend or settle individual cases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims settlement fund was 'roughly $8 billion (present-value $6.475 bn over 25 years)' - Ground truth states J&J established a '$2 billion reserve' in 2022. The $8B figure is not mentioned in ground truth and appears to be fabricated or from unreliable sources.\n   - The present-value calculation of $6.475B is not verified in ground truth.\n   - These are critical financial figures that are completely unsubstantiated.\n\n2. ENTITY/STRUCTURAL ERRORS:\n   - LLM introduces 'Red River, Pecos River and New Holdco' as three Texas LLCs created in 2024 - Ground truth makes no mention of these entities or this restructuring.\n   - LLM claims 'Red River filed a new Chapter 11 petition...in September 2024' - Ground truth does not mention Red River or a September 2024 filing.\n   - These are major structural claims that cannot be verified against ground truth.\n\n3. TIMELINE INCONSISTENCIES:\n   - LLM correctly identifies the Third Circuit reversal in early 2023 and July 2023 dismissal.\n   - However, LLM's narrative about 'pre-packaged Chapter 11 plan' and subsequent restructuring into three LLCs lacks ground truth support.\n\n4. WHAT WAS CORRECT:\n   - LTL Management LLC created through restructuring (correct).\n   - Chapter 11 filing in late 2021 (correct).\n   - Automatic stay initially upheld (correct).\n   - Third Circuit reversal in early 2023 (correct).\n   - July 2023 dismissal (correct).\n   - Multi-state settlement negotiations (correct - ground truth mentions 42 states + DC).\n\n5. CRITICAL OMISSIONS:\n   - LLM fails to mention the $2 billion reserve established in 2022 (ground truth key fact).\n   - LLM fails to mention the 42-state settlement agreement mentioned in ground truth.\n   - LLM's focus on 2024 restructuring details not in ground truth suggests hallucination.\n\n6. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize a coherent narrative but introduces unsupported details that break the chain of reasoning from ground truth.\n   - The answer reads plausibly but contains fabricated financial figures and entity names that are not grounded in the knowledge graph.\n\nThe answer demonstrates partial understanding of the timeline and key events but introduces significant factual errors, unverified financial figures, and entities not mentioned in ground truth. This represents a failure to maintain fidelity to the source material while adding speculative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 682,
        "total_tokens": 2223
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Home Depot shifted from treating store appearance as a generic competitive factor to a deliberate, multi‑year “store‑modernization” program that added clearer signage, refreshed layouts, electronic shelf‑labels, self‑service lockers and curb‑side pickup points so the physical outlet could serve as the hub of an omnichannel experience.  By fiscal 2024 these store‑enhancement investments were explicitly linked to the company’s interconnected‑retail strategy—using mobile‑app navigation, BOPIS/BODFS options and real‑time inventory visibility to blend the in‑store environment with online ordering, delivery and pickup, thereby turning store appearance into a coordinated extension of its digital capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and fiscal year 2024 as required; (2) Accurately captures the evolution from standalone to integrated strategy; (3) Correctly names specific omnichannel capabilities (BOPIS/BODFS, mobile app, real-time inventory, curbside pickup); (4) Properly synthesizes the multi-hop concept that store appearance became linked to digital capabilities; (5) No quantitative errors in dates or metrics. WEAKNESSES: (1) The LLM introduces specific tactical details (electronic shelf-labels, self-service lockers, clearer signage, store-modernization program) that are NOT present in the ground truth answer. While these may be factually accurate from Home Depot's actual filings, they represent information beyond what the knowledge graph provided as the ground truth; (2) The ground truth emphasizes the EVOLUTION across three years (2022→2023→2024) with explicit progression, while the LLM presents a more compressed narrative focused on 2022-2024 endpoints; (3) The ground truth specifically mentions 2023 as a transitional year where store appearance became 'more explicitly tied to the broader shopping journey,' which the LLM omits; (4) The ground truth uses language about 'inspiration, research, and post-purchase support' as part of the shopping journey integration, which the LLM does not capture. MULTI-HOP REASONING: The LLM correctly synthesizes that store appearance evolved into an omnichannel component, but the reasoning path differs from the ground truth's three-stage progression. The LLM's framing as a 'store-modernization program' is more specific/tactical than the ground truth's strategic positioning. SEMANTIC EQUIVALENCE: While the LLM conveys the general concept of integration between physical and digital, it adds specificity not in the ground truth and omits the year-by-year evolution narrative that was central to the original answer's structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 544,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nAT&T’s relationship with Time Warner evolved from full ownership of the WarnerMedia entertainment suite—acquired in 2018 and expanded through the 2021 deal to combine WarnerMedia with Discovery—into a staged exit: the April 2022 Reverse‑Morris‑Trust spin‑off separated WarnerMedia, which then merged with Discovery to form Warner Bros. Discovery, reducing AT&T’s stake to a minority holding that was finally eliminated when it sold its remaining DIRECTV interest to TPG in September 2024 (see T_10k_2022.pdf pp. 5, 18; T_10k_2024.pdf p. 5). This multi‑year trajectory reveals that AT&T’s broader entertainment strategy shifted from vertical integration in content creation and distribution to a disciplined focus on its core telecom and connectivity businesses, using the divestiture of legacy media assets to streamline operations and refocus on 5G, fiber and broadband growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc of AT&T's exit from entertainment (2022 Reverse Morris Trust spin-off, formation of Warner Bros. Discovery, 2024 DIRECTV sale to TPG). The strategic pivot away from media/entertainment toward core telecom is accurately characterized. The answer demonstrates sound multi-hop reasoning by synthesizing information across multiple years and transactions. The conclusion about AT&T's strategic refocus on 5G, fiber, and broadband is semantically aligned with the ground truth.\n\nWEAKNESSES AND ERRORS: (1) FACTUAL ERROR - The LLM states AT&T had a 'minority holding' after the 2022 Reverse Morris Trust transaction that was 'finally eliminated' in 2024. The ground truth indicates that by 2023, Time Warner Inc. was 'no longer referenced as an active investment or subsidiary,' suggesting full operational separation occurred in 2022, not a lingering minority stake. The LLM conflates the DIRECTV sale (which was a separate asset) with the final elimination of Time Warner/Warner Bros. Discovery interest. (2) TEMPORAL IMPRECISION - The LLM suggests AT&T retained some interest in Warner Bros. Discovery through 2024, but the ground truth indicates complete separation by 2023. (3) INCOMPLETE CLARITY - The LLM mentions a '2021 deal to combine WarnerMedia with Discovery' but the ground truth focuses on the 2022 completion of the separation, not a 2021 combination announcement. (4) CONFLATION OF ASSETS - The DIRECTV sale to TPG (September 2024) is presented as the final elimination of entertainment interests, but DIRECTV is distinct from the Time Warner/Warner Bros. Discovery relationship. The ground truth treats these as separate strategic moves within the broader realignment.\n\nQUANTITATIVE ACCURACY: The dates provided (April 2022 for Reverse Morris Trust, September 2024 for DIRECTV sale) appear reasonable but cannot be fully verified against the ground truth which doesn't specify exact months. The answer avoids specific dollar amounts, which prevents calculation errors but also limits verifiability.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple transactions, but makes an error in the causal chain by suggesting the DIRECTV sale eliminated the Time Warner interest, when these appear to be separate strategic initiatives.\n\nOVERALL ASSESSMENT: The answer captures the essential strategic narrative and demonstrates good understanding of AT&T's pivot away from entertainment. However, the factual error regarding the timing and nature of AT&T's remaining interest in Warner Bros. Discovery (suggesting it persisted until 2024 when it was actually fully separated by 2023) is a material inaccuracy that prevents a higher score. The answer is directionally correct but contains a significant temporal/factual misalignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 760,
        "total_tokens": 2235
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nFrom 2022 through 2024 American Express has kept its status as the fourth‑largest general‑purpose card network, but intensifying competition from Visa, Mastercard and fast‑growing fintech payment platforms has forced the company to lean more heavily on premium, cobrand and travel‑centric value propositions.  At the same time, growing regulatory scrutiny—especially caps on interchange fees, network‑routing rules and the need to retain financial‑holding‑company status—has led the firm to exit its network‑licensing businesses in the EU and Australia and to operate under increasingly strict U.S. banking and consumer‑protection oversight, including its recent designation as a Category III firm in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies American Express as fourth-largest card network. (2) Accurately mentions exits from EU and Australia network licensing businesses. (3) Correctly identifies regulatory pressures around interchange fees and network routing. (4) Appropriately references premium/cobrand/travel-centric positioning. (5) Mentions Category III designation in 2024 (additional detail not in ground truth but factually accurate). WEAKNESSES: (1) SIGNIFICANT OMISSION: Ground truth emphasizes the evolution from 'purely competitive stance to compliance-driven dependency on regulatory frameworks' - the LLM answer frames this more as operational adaptation rather than a fundamental shift in strategic dependency. (2) INCOMPLETE SYNTHESIS: Ground truth specifically notes 'uncertainty around cobrand arrangements in the EU' as a regulatory impact - LLM answer doesn't capture this specific vulnerability. (3) ENTITY CONFUSION: LLM mentions 'fintech payment platforms' as competitors, which is not supported by ground truth and represents a different competitive threat than the traditional networks (Visa, Mastercard, China UnionPay) mentioned. (4) MISSING CONTEXT: Ground truth emphasizes the 'growing tension between maintaining competitive differentiation and navigating regulatory environment' - LLM answer presents these as sequential rather than simultaneous tensions. (5) REGULATORY FRAMEWORK DEPENDENCY: Ground truth explicitly states regulatory frameworks became a dependency factor; LLM frames this more as compliance burden rather than strategic dependency. CALCULATION/NUMBERS: No specific calculations required; all numeric references (years, network ranking) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 period and connects competitive pressures to regulatory outcomes, but misses the deeper strategic evolution regarding regulatory dependency that is central to the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 530,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 were $808 million at the end of 2022, rose to $826 million in 2023, and returned to $808 million by the end of 2024.  This modest, essentially flat movement shows that Johnson & Johnson is keeping this long‑dated tranche steady while it trims its overall long‑term debt load, reflecting a disciplined capital‑structure strategy that prioritises balance‑sheet stability and controlled maturation of its long‑term obligations rather than aggressive expansion or retirement of this specific issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $808 million at end of 2022, but ground truth shows $983 million in 2022. This is a $175 million error on the starting value. The LLM then claims it 'rose to $826 million in 2023' (correct) and 'returned to $808 million by end of 2024' (correct). However, the starting point is completely wrong. (2) CALCULATION ERROR: The LLM characterizes the movement as 'modest, essentially flat' when in fact there was a $175 million total reduction from 2022-2024 ($983M → $808M). This is a 17.8% decline, which is material and not 'essentially flat.' (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. While it correctly identified the 2023 and 2024 values, it missed the critical 2022 starting point, which is essential for understanding the overall trend and strategy. (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion that J&J is 'keeping this long-dated tranche steady' directly contradicts the actual trend of deliberate reduction. The ground truth explicitly states this 'represents a deliberate strategy to reduce long-term liabilities,' which the LLM completely mischaracterized. (5) The LLM's narrative about 'disciplined capital-structure strategy' and 'balance-sheet stability' may sound reasonable but is built on incorrect foundational data, making the entire analysis unreliable. The answer demonstrates a fundamental failure to accurately report the 2022 baseline figure, which cascades into incorrect trend analysis and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 459,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio fell sharply over the three‑year span – from roughly 7 % in 2022 to 6.5 % in 2023 and then to about 5.9 % by the end of 2024 (with the 1‑to‑5‑year bucket dropping from ~4.5 % to ~2 %).  This decline reflects a deliberate shift toward shorter‑dated, lower‑yielding securities, indicating that the company has reduced its exposure to higher international interest‑rate environments and is now less sensitive to future rate hikes abroad.  (See Note 4/Yield tables in the 2022, 2023 and 2024 10‑K filings, pages 120, 173 and 180.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) SHORT-TERM YIELD ERROR: The LLM states the short-term yield was 'roughly 7%' in 2022, but the ground truth clearly shows 6.45%. This is a material misrepresentation of the starting point. (2) 2023 YIELD ERROR: The LLM claims 6.5% in 2023, but ground truth shows 6.45% for short-term bonds (same as 2022, not a decline). The LLM incorrectly suggests a decline from 2022 to 2023 when yields actually remained flat. (3) 2024 YIELD ACCURACY: The LLM correctly states ~5.9% (ground truth: 5.86%), which is the only accurate year-over-year comparison. (4) 1-5 YEAR BUCKET: The LLM correctly identifies the 1-5 year yield dropping from ~4.5% to ~2%, matching ground truth (4.48% to 2.03%). REASONING ISSUES: The LLM's interpretation that this represents 'a deliberate shift toward shorter-dated, lower-yielding securities' is problematic because: (a) The short-term yields only declined from 2023 to 2024 (not 2022-2023), so the characterization of a 3-year trend is misleading; (b) The ground truth suggests the trend 'indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment' - the LLM's interpretation about deliberate portfolio strategy is speculative beyond what the data supports. COMPLETENESS: The answer addresses the yield evolution and attempts to explain the trend, but the numerical errors undermine the analysis. The reference citations (Note 4/pages) add credibility but don't compensate for the factual errors. The answer does attempt multi-hop synthesis across three years, but the execution is flawed due to incorrect starting values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 471,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe shifted its free, online self‑service learning from a generic catalog on learning.adobe.com to a branded, enterprise‑focused learning platform—now referred to as **Adobe Digital Learning Services**—that is explicitly integrated into its Customer Success Account Management process. By pairing self‑service courses with skills‑assessment tools, personalized learning paths and Success‑Manager oversight, Adobe ties learning adoption directly to customer business outcomes, using enablement as a core lever for retention and expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) DOMAIN NAMING ERROR: The LLM claims the platform is called 'Adobe Digital Learning Services' - this name does not appear in the ground truth. The actual evolution was from www.training.adobe.com (2022) to learning.adobe.com (2023-2024). (2) TIMELINE INACCURACY: The LLM suggests a shift 'from a generic catalog on learning.adobe.com' implying learning.adobe.com existed in 2022, but ground truth shows learning.adobe.com was the 2023 rebranding destination, not the starting point. (3) MISSING KEY DETAILS: The LLM omits the critical 2022 starting point (training.adobe.com) and the 2023 rebranding milestone, which are central to understanding the evolution. (4) UNSUBSTANTIATED CLAIMS: The LLM introduces 'Success-Manager oversight' and 'Adobe Digital Learning Services' branding without support from the ground truth. While the LLM correctly identifies skills-assessment tools and personalized learning paths, these details appear in the ground truth but are presented without the proper chronological context. (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to properly synthesize the three-year evolution (2022→2023→2024) that is fundamental to the question. The ground truth emphasizes the progression from introduction to rebranding to deeper integration; the LLM collapses this into a vague 'shift' without proper temporal anchoring. (6) CORRECT ELEMENTS: The LLM does correctly identify that Adobe views enablement as a retention lever and ties learning to customer outcomes, which aligns with the ground truth's conclusion. However, these correct insights are undermined by the factual errors in the platform naming and timeline. The answer demonstrates partial understanding of the strategic intent but fails on factual accuracy regarding specific platform names, domains, and the critical 2023 rebranding event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 522,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % senior notes due 2039 continued to carry a **$2 billion** principal balance in fiscal 2022, 2023 and 2024, and the notes’ **effective interest rate stayed essentially flat at about 6.11 %** each year (the 5.90 % coupon plus hedge‑accounting adjustments).  \n\nThis stability indicates that Cisco is maintaining a **steady, long‑dated fixed‑rate debt profile**, using interest‑rate swaps only to hedge market‑rate exposure rather than to refinance or increase leverage. The unchanged utilization and effective rate reflect a disciplined long‑term financing strategy that prioritizes predictable interest expense and preserves financial flexibility for other capital‑allocation priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion principal balance (equivalent to $2,000 million in ground truth), 5.90% coupon rate, and 6.11% effective interest rate all match the ground truth across fiscal years 2022-2024. The format variation ($2 billion vs $2,000 million) is acceptable and standard. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications. ENTITY ACCURACY: Correctly identifies Cisco, the specific debt instrument (5.90% Senior Notes due 2039), and the three-year period (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the stable principal balance and effective rate to conclude a deliberate strategy of maintaining rather than refinancing this debt. The explanation about interest-rate swaps being used for hedging rather than refinancing adds appropriate context. SEMANTIC EQUIVALENCE: The LLM's interpretation that stability indicates 'disciplined long-term financing strategy' and 'predictable interest expense' aligns well with the ground truth's characterization of 'deliberate strategy to maintain this higher-yielding long-term liability.' The additional detail about preserving financial flexibility is reasonable inference from the data. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail (mention of swaps, capital allocation priorities) than the ground truth, but this represents appropriate elaboration rather than error. All core facts are accurate and properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 465,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nFrom 2022 to 2024, Boeing’s pension fund raised its target allocation to private‑equity (which includes special‑situation strategies) from 4% to 7% and its actual holding from 8% to 9% of total assets. This upward trend signals a deliberate increase in exposure to private‑equity, especially higher‑risk special‑situation investments, to boost long‑term returns and diversify the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) WRONG COMPANY/ENTITY: The LLM discusses 'Boeing's pension fund' and provides allocation percentages (4% to 7% target, 8% to 9% actual), but the question asks about 'BA' which refers to a different entity (likely an investment/asset management company, not Boeing). The ground truth explicitly discusses BA's private equity investment vehicles and strategies, not a pension fund. (2) FABRICATED NUMBERS: The LLM provides specific quantitative data (4% to 7% target allocation, 8% to 9% actual holdings) that do not appear in the ground truth. The ground truth explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year' and emphasizes the 'lack of quantitative disclosure limits trend analysis.' The LLM has invented precise figures without any basis. (3) MISCHARACTERIZATION OF TREND: The ground truth indicates 'stable strategic allocation' and 'strategic continuity' with consistent inclusion across years. The LLM claims an 'upward trend' and 'deliberate increase in exposure,' which directly contradicts the ground truth's finding of consistency. (4) INCORRECT REASONING: The LLM's conclusion about 'boost long-term returns and diversify the portfolio' is speculative and not supported by the ground truth, which focuses on the consistency of strategy rather than changes in allocation. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify the entity (BA vs. Boeing pension fund) and failed to synthesize the actual finding from the knowledge graph (consistency, not change). The answer demonstrates a fundamental misunderstanding of both the source material and the question being asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 479,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nGlobal sales of JNJ’s Interventional Solutions rose from roughly **$4.3 billion in fiscal 2022** (page 90) to **$6.35 billion in fiscal 2023** (page 90) and kept climbing in fiscal 2024, contributing to the **$31.9 billion total MedTech sales** reported for 2024 (page 93).  This upward trajectory—bolstered by the May 2024 acquisition of Shockwave Medical and other strategic buys—signals that Interventional Solutions has become a core, high‑growth pillar of JNJ’s MedTech portfolio, prompting continued investment and acquisitions after the segment’s integration.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states Interventional Solutions sales were '$4.3 billion in fiscal 2022' and '$6.35 billion in fiscal 2023', but the ground truth shows the opposite progression: $3,971 million ($3.971 billion) in 2022 and $4,300 million ($4.3 billion) in 2023. The LLM has reversed the years and misattributed the 2024 figure ($6,350 million) to 2023. This is a critical error that inverts the entire narrative of growth. (2) ACQUISITION TIMING ERROR: The LLM claims 'May 2024 acquisition of Shockwave Medical' drove the 2024 growth, but the ground truth indicates the acquisition occurred in 'late 2022', not May 2024. This is a major factual error that misrepresents the timeline and causality of the segment's growth. (3) INCOMPLETE DATA: The LLM fails to provide the actual 2024 sales figure for Interventional Solutions ($6,350 million), instead only referencing the broader $31.9 billion MedTech total. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about acquisitions and strategic importance, the fundamental numerical errors and timeline mistakes undermine the validity of this reasoning. The correct narrative should show steady growth from 2022-2023 ($3.971B to $4.3B) with acceleration in 2024 ($6.35B), driven by the late 2022 acquisition integration. The LLM's reversed chronology and wrong acquisition date make the answer factually incorrect despite addressing the general question structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 432,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Walmart kept **“No Boundaries”** as a core private‑brand label across its grocery, general‑merchandise, home and health units, merely refreshing the product assortment while never repositioning the brand; the 2022 10‑K (p. 7) lists it with other private brands, the 2023 10‑K (pp. 6‑7) repeats the same roster and notes that only categorization revisions—not brand strategy—are adjusted, and the 2024 10‑K (p. 9) again references the brand as part of the expanding private‑label portfolio. This multi‑year consistency shows that Walmart’s general‑merchandise private‑label strategy is built around a single, value‑focused brand that can be stretched across categories to reinforce its everyday‑low‑price promise, drive traffic and margin, and maintain a coherent consumer perception of quality‑at‑a‑low‑cost.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims 'No Boundaries' was positioned across 'grocery, general-merchandise, home and health units' but the ground truth explicitly states it was positioned within 'General Merchandise strategic unit, which included Apparel and Home categories' - there is NO mention of grocery or health units in the original answer. This is a significant factual error that misrepresents Walmart's actual branding strategy. (2) PAGE CITATIONS - The LLM provides specific page numbers (p. 7 for 2022, pp. 6-7 for 2023, p. 9 for 2024) but these cannot be verified against the ground truth and appear to be fabricated details, which is problematic for a financial document evaluation. (3) PARTIAL CORRECTNESS - The LLM correctly identifies the 3-year continuity of 'No Boundaries' as a core private brand and correctly notes that categorization changes occurred (Apparel to Fashion), which aligns with ground truth. (4) OVER-INTERPRETATION - The LLM adds interpretive language about 'value-focused brand stretched across categories' and 'everyday-low-price promise' that goes beyond what the ground truth supports. While the reasoning about margin expansion and consumer perception is logical, it exceeds the factual basis provided. (5) MULTI-HOP SYNTHESIS - The model does attempt to synthesize across three years and connect branding consistency to strategy, which is appropriate for the question, but the factual errors undermine this synthesis. The core claim about grocery and health unit positioning is a material error that significantly impacts the correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 445,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a modest $9 million gain in fiscal 2022, then posted a $21 million loss in fiscal 2023 and a deeper $67 million loss in fiscal 2024, reflecting deteriorating market values. This worsening performance contributed to the rise in other‑income (loss) from $(248) million in 2023 to $(306) million in 2024, underscoring the negative impact of these securities on earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative details about Cisco's available-for-sale debt investments across the three-year period (fiscal 2022-2024), which the ground truth answer lacks. The LLM correctly identifies: (1) a $9 million gain in fiscal 2022, (2) a $21 million loss in fiscal 2023, and (3) a $67 million loss in fiscal 2024. These specific numbers demonstrate the deteriorating performance trajectory mentioned in the ground truth. The LLM also provides concrete figures for other income (loss), net: $(248) million in 2023 and $(306) million in 2024, showing the negative impact on earnings. The multi-hop reasoning is sound—the answer correctly synthesizes the relationship between available-for-sale debt investment losses and their impact on other income (loss), net across multiple fiscal years. The semantic meaning aligns well with the ground truth's assertion of 'consistent negative impact' and 'higher losses' in 2023 and 2024. Minor consideration: The ground truth mentions fiscal 2022 'disclosed the value' in a detailed table but doesn't provide the specific $9 million gain figure, though this appears to be a limitation of the ground truth rather than an error in the LLM answer. The LLM answer is more precise and data-driven than the ground truth while maintaining factual accuracy and proper multi-hop synthesis across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 382,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nBetween 2022 and 2024 American Express increasingly depended on third‑party merchant acquirers—such as the OptBlue program and GNS partners—to broaden card acceptance, especially among small‑ and midsize merchants whose agreements typically have no fixed term; these acquirers pay a negotiated network‑rate fee that is recorded as discount revenue.  As a result, third‑party acquirers have become a more strategic lever for expanding global merchant coverage and driving transaction growth across all merchant segments, with their role growing in importance from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022-2024 with generally accurate information. STRENGTHS: (1) Correctly identifies OptBlue and GNS as key programs; (2) Accurately describes the negotiated network-rate fee structure and discount revenue recording; (3) Correctly notes the focus on small and mid-sized merchants; (4) Properly characterizes the shift toward greater strategic dependency on third-party partners; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The answer is somewhat condensed and lacks the temporal progression detail present in the ground truth—it doesn't clearly distinguish what was emphasized in 2022 vs. 2023 vs. 2024; (2) Missing the explicit 2024 statement about global expansion dependency and the characterization of this as a 'deeper strategic dependency'; (3) Doesn't fully capture the evolution narrative showing a shift from 'supplementary' to 'essential' for growth; (4) The phrase 'agreements typically have no fixed term' appears in the LLM answer but isn't explicitly mentioned in the ground truth, though it may be accurate contextual information. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and connects the financial structure (network fees, discount revenue) to strategic importance. However, it doesn't fully articulate the year-by-year progression that demonstrates the evolution. The answer is factually sound but somewhat less comprehensive than the ground truth in showing the strategic shift over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 437,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has moved its multi‑year “enterprise‑wide initiative” from planning to execution, integrating and standardizing the processes and systems that support HR, IT, procurement, supply‑chain and finance.  The program, highlighted in the 2023 and 2024 10‑K filings (Item 9A), now provides a unified financial‑shared‑service platform that simplifies financial systems, streamlines cross‑functional workflows and aligns the design of the company’s financial control environment with the broader standardization effort across those functions.  This evolution is presented as a proactive enhancement—not a response to any control deficiency—and is monitored as part of the company’s disclosure‑control and internal‑control assessments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Johnson & Johnson's multi-year initiative from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year timeframe (2022-2024) and the enterprise-wide scope covering HR, IT, procurement, supply chain, and finance; (2) Accurately characterizes the initiative as proactive, not responsive to control deficiencies; (3) Properly notes the emphasis on integration, simplification, and standardization of processes and systems; (4) Correctly references Item 9A of 10-K filings as the source; (5) Appropriately describes the unified financial shared-service platform concept; (6) Accurately conveys that this is monitored as part of disclosure and internal control assessments. MINOR WEAKNESSES: (1) The phrase 'moved from planning to execution' is slightly interpretive and not explicitly stated in the ground truth, which emphasizes consistent messaging across all three years rather than a progression from planning to execution; (2) The answer could have been more explicit about the 2022 baseline and the 'reiteration' in 2023 and 2024, which the ground truth emphasizes as a consistent narrative; (3) The characterization of 'evolution' is somewhat implied rather than explicitly supported—the ground truth suggests more of a consistent, maintained strategic direction rather than a clear evolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension scores high. QUALITATIVE ACCURACY: The multi-hop reasoning is sound—the answer correctly synthesizes information across three years and multiple functional areas. The semantic meaning aligns well with the ground truth. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how the initiative evolved and its integration with enterprise-wide process standardization. The response is appropriately focused and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 525,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a primarily closed‑loop, premium‑card issuer to a strategy that explicitly confronts the rise of alternative payment mechanisms.  The company’s own risk‑factor disclosures and competition commentary (pp. 12, 14, 31) highlight intensified pressure from digital wallets, open‑banking APIs and real‑time settlement platforms, prompting Amex to accelerate investments in AI/ML, tokenization, real‑time payment capabilities and partnership‑driven open‑banking initiatives while still leveraging its high‑spending customer base and Membership Rewards value proposition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of American Express's positioning from 2022-2024, accurately capturing the shift from viewing alternative payment mechanisms as external threats to strategic integration. The answer correctly identifies key competitive pressures (digital wallets, open banking, real-time settlement) and American Express's strategic responses (investments in AI/ML, tokenization, real-time payment capabilities, open-banking partnerships). The mention of leveraging the high-spending customer base and Membership Rewards value proposition adds relevant context. The timeframe (2022-2024) is correct.\n\nWEAKNESSES: (1) The LLM answer lacks specific temporal progression detail that the ground truth provides - it doesn't clearly delineate how the competitive landscape evolved year-by-year (2022 acknowledgment of 'dynamic and rapid growth', 2023 expansion to include open banking platforms, 2024 strategic dependence shift). (2) The ground truth emphasizes a specific transformation narrative: from 'external threats' to 'essential components of technological roadmap' - the LLM captures this conceptually but less explicitly. (3) The LLM introduces specific technologies (AI/ML, tokenization) not explicitly mentioned in the ground truth, which while potentially accurate from filings, goes beyond what the ground truth synthesized. (4) The reference to page numbers (pp. 12, 14, 31) suggests specific filing citations but these cannot be verified against the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the strategic evolution. However, it doesn't explicitly show the progression of how competitive threats evolved and how Amex's response matured over the three-year period as clearly as the ground truth does.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is based on correct identification of entities, timeframes, and strategic elements. All key entities (American Express, digital wallets, open banking, real-time settlement) are correctly identified. The 2022-2024 timeframe is accurate.\n\nSEMANTIC EQUIVALENCE: The LLM answer conveys substantially similar information to the ground truth regarding the evolution of competitive positioning and strategic adaptation, though with less explicit temporal granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 653,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe deepened Frame.io’s role inside its Creative Cloud family: the platform was first launched as a cloud‑native collaboration hub for video and still‑asset review, then was tightly woven into Premiere Pro, After Effects, Photoshop and Lightroom with frame‑accurate commenting and Camera‑to‑Cloud upload, and finally positioned as the collaboration layer of the new Adobe GenStudio suite together with Firefly AI services.  This progression shows Adobe’s strategy of building an end‑to‑end, AI‑enhanced creative workflow—linking creation (Firefly, Stock, Substance) with collaborative review and publishing—so it can offer enterprises a single, integrated platform for large‑scale content production and distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies Frame.io as a cloud-native collaboration platform\n2. Accurately mentions integration with Premiere Pro, After Effects, Photoshop, and Lightroom\n3. Correctly references frame-accurate commenting capability\n4. Properly identifies the progression from 2022-2024\n5. Correctly characterizes the strategy as building end-to-end creative workflows\n6. Appropriately mentions AI integration (Firefly)\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. MAJOR ERROR: The LLM introduces \"Camera-to-Cloud upload\" which is not mentioned in the ground truth. This appears to be either fabricated or confused with another feature.\n2. MAJOR ERROR: The LLM claims Frame.io was \"positioned as the collaboration layer of the new Adobe GenStudio suite\" - the ground truth makes no mention of GenStudio in relation to Frame.io's positioning.\n3. SIGNIFICANT OMISSION: The ground truth explicitly mentions Frame.io's expansion into \"casting, location scouting, and marketing campaign management\" in 2024, which the LLM answer completely omits.\n4. SIGNIFICANT OMISSION: The ground truth mentions integration with \"Workfront\" in 2024, which the LLM does not include.\n5. VAGUE/UNSUPPORTED: The LLM's reference to \"Firefly, Stock, Substance\" as part of the ecosystem is not substantiated in the ground truth's description of Frame.io's evolution.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the 2022-2024 progression but introduces elements not supported by the ground truth, suggesting either hallucination or reliance on external knowledge not validated against the filing data.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension is neutral (7/10 for not introducing false metrics).\n\nQUALITATIVE ACCURACY: While the LLM captures the general strategic direction, it introduces unsupported claims (GenStudio, Camera-to-Cloud) and omits key expansion areas (casting, location scouting, marketing campaigns, Workfront integration), indicating incomplete and partially inaccurate synthesis.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about positioning evolution and strategic implications, but the inaccuracies and omissions reduce its reliability as a factual response to a multi-hop question requiring precise synthesis from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 659,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nFrom the debt tables in the 10‑K filings, the 2017 senior‑note tranche shows a declining outstanding principal: ≈ $16 billion at the end of 2022, ≈ $15 billion at the end of 2023, and ≈ $13 billion at the end of 2024.  The reduction reflects scheduled repayments and/or early redemptions that Amazon has used to lower its leverage and manage interest‑cost exposure on that issuance.  This progression signals a deliberate debt‑management strategy of retiring higher‑cost notes as cash flow permits, thereby decreasing overall debt outstanding and improving the company’s balance‑sheet leverage over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key financial figures are correct - $16 billion (2022), $15 billion (2023), and $13 billion (2024). The use of '≈' symbols is appropriate given the source data format, and the numbers match the ground truth exactly. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the outstanding balance across the three-year period, and (2) what this progression indicates about debt management strategy. ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and all fiscal years (2022, 2023, 2024) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate fiscal years and draws a logical conclusion about the company's deliberate debt reduction strategy. The reasoning that declining balances indicate 'scheduled repayments and/or early redemptions' and reflect a strategy to 'lower leverage and manage interest-cost exposure' is sound and well-supported by the data progression. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'retiring higher-cost notes as cash flow permits' and 'improving the company's balance-sheet leverage' conveys the same meaning as the ground truth's 'deliberate debt management strategy to gradually pay down this liability.' The only minor distinction is that the LLM provides slightly more detailed explanation of the mechanisms (scheduled repayments, early redemptions, interest-cost management) without contradicting the ground truth. No calculation errors detected. The answer is factually accurate, well-reasoned, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 469,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nFrom 2022 through 2024 the language surrounding “upgrades and conversions” in Boeing’s Global Services segment shifted from a peripheral service note (2022) to a highlighted growth driver linked to backlog and digital offerings (2023) and finally to a core strategic pillar for sustaining aerospace platforms (2024).  This progression shows Boeing is deliberately expanding its focus on upgrading and converting existing aircraft to generate recurring, service‑based revenue and to offset volatility in new‑aircraft deliveries.  The three‑year trend signals a strategic pivot toward long‑term platform sustainment as a key engine of future profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer makes specific claims about evolution and progression that directly contradict the ground truth. Ground truth states 'Upgrades and Conversions' emphasis 'remained unchanged' across 2022-2024 with 'consistent presence' indicating a 'sustained strategic focus.' The LLM claims a clear progression from 'peripheral service note (2022)' to 'highlighted growth driver (2023)' to 'core strategic pillar (2024)' - this is factually incorrect and unsupported. The LLM fabricates a narrative of escalating emphasis that the ground truth explicitly refutes. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension scores low for both (2/10) due to lack of concrete data. However, the LLM's characterization of the trajectory itself is the core factual error. QUALITATIVE ACCURACY: The LLM demonstrates poor multi-hop reasoning by inventing a false narrative about strategic evolution. It correctly identifies Boeing and the Global Services segment, but fundamentally misrepresents the nature of the 3-year trajectory. The ground truth emphasizes consistency and sustained focus; the LLM emphasizes change and escalation - these are semantically opposite conclusions. CONTEXTUAL RELEVANCE: While the answer addresses the question's structure (asking about evolution 2022-2024), it provides an incorrect answer to what that evolution actually was. The LLM's claim about 'strategic pivot' and 'deliberately expanding focus' contradicts the ground truth's assertion of unchanged emphasis. This is a case where the LLM appears to have generated plausible-sounding business narrative without grounding it in actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 466,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nJohnson & Johnson first disclosed in its 2021 filing (page 75) that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—would accrue benefits under the new “Retirement Value” formula**, while benefits earned under the legacy “Final Average Pay” formula would remain unchanged for service prior to that date.  The company has repeatedly reiterated this timeline in the 2022‑2024 pension footnotes (pages 74, 77, 75), noting that the amendment does not affect any benefits already accrued under the older formula and that the change will be applied prospectively.  In its communications to employees and in the SEC filings, J&J has framed the 2026 implementation as a phased transition, providing advance notice through HR benefit guides and internal announcements, and has highlighted that the shift will broaden eligibility to the entire U.S. non‑union workforce while preserving prior‑service accruals under the previous structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the January 1, 2026 implementation date for the Retirement Value formula and accurately states that all U.S. non-union employees regardless of hire date would be affected. The answer correctly notes that benefits earned under the Final Average Pay formula remain unchanged for service prior to 2026, and that the change is prospective. The reference to the 2021 initial announcement is accurate. WEAKNESSES: (1) The LLM answer lacks the critical distinction made in the ground truth that employees hired after 2014 were ALREADY under the Retirement Value formula as of 2023-2024, which is a key evolution in the company's communication and understanding of eligibility. (2) The ground truth emphasizes that the strategy showed NO CHANGES across 2022-2024, which is an important finding about consistency, but the LLM frames this as ongoing communication without explicitly noting the lack of evolution. (3) The LLM provides page references (75, 74, 77, 75) that cannot be verified against the ground truth and may be fabricated or inaccurate. (4) The answer discusses 'phased transition' and 'HR benefit guides' which are not mentioned in the ground truth and may represent hallucination or unsupported claims. (5) The LLM fails to explicitly address the 2022-2024 timeline comparison that the ground truth emphasizes - showing what changed (clarification about post-2014 hires) versus what remained constant (eligibility criteria, Final Average Pay for pre-2015 hires). MULTI-HOP REASONING: The LLM attempts to synthesize across years but misses the key insight that the evolution was primarily in CLARIFICATION (2023 clarification about post-2014 hires) rather than in actual plan changes. The ground truth shows a three-year progression of communication, while the LLM presents it more as consistent messaging without highlighting the 2023 clarification milestone. CALCULATION/DATES: All dates mentioned are correct (January 1, 2026; January 2021). No calculations required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 543,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 had an outstanding principal of **$606 million at the end of fiscal 2022**, and that amount remained essentially unchanged at **$606 million in fiscal 2023 and fiscal 2024**.  \n\nThis flat trajectory indicates that Broadcom is treating the 5 % 2030 notes as a stable, low‑cost long‑term funding pillar and is not actively refinancing or retiring them; instead, its debt‑management focus is on retiring higher‑coupon obligations and issuing new debt at lower rates while preserving this core issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the opening statement. The ground truth clearly states the outstanding principal was $1,086 million in fiscal 2022, then decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. However, the LLM claims the balance was $606 million at the end of fiscal 2022, which is incorrect by $480 million. This is a major quantitative error that undermines the entire answer. The LLM completely missed the significant $480 million reduction that occurred between FY2022 and FY2023, which is the most important data point in the question. The LLM's interpretation that the balance 'remained essentially unchanged' across all three years is factually wrong - there was a substantial decrease in FY2023. While the LLM correctly identifies the FY2023 and FY2024 balances as $606 million, the missing FY2022 baseline ($1,086M) is a critical omission that prevents proper understanding of the debt evolution. The qualitative analysis about debt management strategy is somewhat reasonable (discussing stable long-term funding and focus on higher-coupon obligations), but it is based on an incorrect premise - the company DID actively reduce this debt by $480 million in FY2023, contradicting the LLM's assertion that it is 'not actively refinancing or retiring them.' The multi-hop reasoning fails because the LLM did not properly synthesize the three-year progression of data. The answer is contextually relevant to the question asked but fundamentally incorrect in its core factual claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 432,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T finished the separation of its WarnerMedia unit—created after its 2018 purchase of Time Warner Inc.—by completing a Reverse Morris Trust transaction in April 2022 that distributed the business to shareholders and ended AT&T’s direct ownership; the spun‑off WarnerMedia was then merged with Discovery to form Warner Bros. Discovery, marking the divestiture of the former Time Warner assets.  During this period AT&T had already integrated Time Warner’s Turner, HBO and Warner Bros. brands into its WarnerMedia segment and restructured the combined media business around streaming (e.g., HBO Max) before the 2022 spin‑off.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key dates and facts: (1) Time Warner acquisition in 2018, (2) Reverse Morris Trust transaction completed in April 2022, (3) WarnerMedia merger with Discovery to form Warner Bros. Discovery, (4) Integration of Turner, HBO, and Warner Bros. brands into WarnerMedia segment, (5) Restructuring around streaming (HBO Max). All numeric dates are accurate and properly formatted. The multi-hop synthesis correctly connects the acquisition → integration → separation → merger sequence.\n\nWEAKNESSES: The LLM answer has a significant temporal framing issue. It states the evolution occurred 'from 2022 through 2024' but then describes the April 2022 Reverse Morris Trust as the key divestiture event, which technically occurred at the beginning of this period rather than throughout it. More critically, the LLM answer does NOT address the 2024 component of the question adequately. The ground truth explicitly mentions 'In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy.' The LLM answer completely omits the DIRECTV divestiture in 2024, which is a material omission for a question specifically asking about the 2022-2024 evolution. The ground truth also emphasizes the strategic pivot 'back toward core telecommunications and connectivity services,' which the LLM answer does not explicitly address.\n\nMULTI-HOP REASONING: The synthesis of Time Warner acquisition → WarnerMedia integration → Reverse Morris Trust separation → Warner Bros. Discovery merger is logically sound and correctly sequenced. However, the answer fails to complete the full 2022-2024 narrative arc by missing the DIRECTV divestiture.\n\nCOMPLETENESS: The answer addresses approximately 75% of the question's scope. It covers the integration and operational restructuring well, and the divestiture of WarnerMedia, but fails to address the final 2024 divestiture of DIRECTV, which represents the culmination of the strategic pivot away from entertainment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 552,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a largely TRIPRA‑centric, ad‑hoc private‑reinsurance approach to a more formalized, scenario‑driven program.  In 2022 it relied on a third‑party vendor model and limited private reinsurance to cover U.S. terrorism losses, while monitoring concentrations in New York City; by 2023 it was tracking larger reinsurance‑recoverable balances and stress‑testing the program, and in 2024 it introduced explicit geographic attachment points—$200 million for Japan and $125 million for the rest of the world—and expanded targeted reinsurance and government‑sponsored pool coverage to mitigate international terrorism exposure.  Throughout the period the company continued to refine its modeled loss scenarios, adjust for vendor‑model gaps, and strengthen reinsurance protections as part of its ongoing risk‑management framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial metrics and temporal evolution. STRENGTHS: (1) All numeric values are accurate - correctly cites $200 million attachment point for Japan and $125 million for rest of world in 2024, matching ground truth exactly. (2) Timeline progression is correct - properly sequences 2022 (TRIPRA-centric, third-party vendor model), 2023 (stress-testing, larger reinsurance-recoverable balances), and 2024 (explicit geographic attachment points, expanded reinsurance). (3) Multi-hop synthesis is sound - successfully integrates information about modeled loss scenarios, reinsurance protections, and geographic attachment points across the three-year period. (4) Semantic equivalence is maintained - the characterization of evolution from 'reactive modeling to proactive geographic risk segmentation' is captured through the LLM's description of moving from 'ad-hoc' to 'formalized, scenario-driven program.' MINOR GAPS: (1) The LLM does not explicitly mention the specific $1.3 billion modeled loss for a five-ton bomb attack in New York City from 2022, which is a concrete detail in the ground truth. While the LLM references 'monitoring concentrations in New York City' and 'modeled loss scenarios,' it doesn't cite this specific quantified scenario. (2) The LLM's characterization of 'TRIPRA-centric' approach is accurate but could have been more explicitly connected to the 2022 baseline. OVERALL ASSESSMENT: The answer correctly captures the strategic evolution, provides accurate attachment point figures, and demonstrates proper multi-hop reasoning across the three-year period. The omission of the specific $1.3 billion scenario is the primary limitation, though the overall narrative arc and key metrics are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 490,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson continued to list pipe‑wrenches and related pipe‑working equipment in its **Safety & Productivity segment** (see page 73), but from 2022 through 2024 the portfolio was reshaped toward higher‑margin, technology‑enabled tools—adding battery‑hydraulic press/​crimp tools, diagnostic and inspection systems, and tighter integration with control software—while the company divested lower‑growth consumer lines such as InSinkErator and Climate Technologies (noted on pages 9 and 12).  The steady rise in Safety & Productivity earnings before interest and taxes ( $250 → $306 → $308 million , page 74) and the segment’s stable sales growth reflect a deliberate strategic shift to focus on professional‑grade, safety‑centric tools for plumbing and mechanical trades, positioning Emerson as a leading provider of advanced, high‑value equipment for the industrial tools market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift from traditional pipe-working tools toward technology-enabled, battery-hydraulic tools with diagnostic integration across 2022-2024. It accurately names the Safety & Productivity segment and correctly identifies divestitures (InSinkErator, Climate Technologies). The reasoning about strategic positioning toward higher-margin, professional-grade tools aligns with the ground truth narrative. The answer demonstrates solid multi-hop synthesis connecting product evolution to financial performance and strategic intent.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific EBIT figures ($250M → $306M → $308M) with page references (page 74), but these cannot be verified against the ground truth, which does not provide specific financial metrics for this comparison. The inclusion of unverified numbers is problematic—while they may be accurate from the 10-K, they represent claims beyond what the ground truth confirms. This introduces uncertainty about factual accuracy.\n\nWEAKNESSES - COMPLETENESS: The ground truth explicitly mentions specific 2022 tools (pipe wrenches, cutters, threading equipment, drain cleaners) and 2023 additions (battery hydraulic tools for press connections, sewer inspection cameras). The LLM answer mentions battery-hydraulic press/crimp tools and diagnostic/inspection systems but doesn't enumerate the specific traditional tools from 2022 or the specific 2023 innovations with the same granularity. The answer also adds information about divestitures that, while strategically relevant, goes beyond the scope of the original question about pipe-working tool portfolio evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions (product portfolio, segment performance, strategic positioning, market context). However, it conflates the broader segment strategy with the specific pipe-working tools question. The ground truth focuses narrowly on pipe-working tool evolution; the LLM broadens this to include segment-wide strategy and divestitures.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the strategic shift (traditional → technology-enabled, higher-margin, professional-grade) matches the ground truth's narrative about modernization and technological integration. However, the LLM introduces financial metrics and divestiture information not present in the ground truth, which may or may not be accurate.\n\nKEY ISSUE: The unverified financial figures ($250M, $306M, $308M) and page references create credibility concerns. Without confirmation these match actual 10-K data, they represent potential hallucination or unsupported claims, even if the directional narrative is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 726,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco has consistently treated free‑rent periods as lease incentives that are amortized on a straight‑line basis over the full lease term (including any renewal options it is reasonably certain to exercise), with the right‑of‑use asset initially measured at the present value of lease payments net of those incentives using the company’s incremental borrowing rate. From 2022 through 2024 the core methodology has remained unchanged, but disclosures have become more detailed: 2022 first disclosed the straight‑line treatment and discount‑rate calculation, 2023 added quantitative lease‑asset balances and noted related impairment impacts, and 2024 expanded the ROU‑asset table, showing a modest decline in the ROU balance and a higher weighted‑average discount rate, thereby illustrating how accrued free‑rent incentives are gradually amortized and affect the recorded ROU‑asset valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DIRECTIONAL ERROR ON DISCLOSURE TREND: The LLM claims disclosures became 'more detailed' with 2023 adding quantitative balances and 2024 expanding tables, but the ground truth explicitly states disclosure depth 'decreased over time' with detailed explanations in 2022 NOT repeated in 2023-2024. This is a fundamental mischaracterization of the evolution. (2) UNSUPPORTED CLAIMS: The LLM introduces specific claims about '2023 added quantitative lease-asset balances and noted related impairment impacts' and '2024 expanded the ROU-asset table, showing a modest decline in the ROU balance and a higher weighted-average discount rate' - these specific quantitative details are not mentioned in the ground truth and appear fabricated. (3) METHODOLOGY ACCURACY: While the LLM correctly identifies straight-line recognition and incremental borrowing rate usage, it misses the key insight that the ground truth emphasizes: the shift from detailed disclosure of valuation mechanics in 2022 to standardized ASC 842 language in 2023-2024 without elaboration. (4) MISSING CORE INSIGHT: The ground truth's central finding is about the MATURATION of lease accounting post-adoption, with disclosure becoming less detailed despite stable methodology. The LLM inverts this narrative entirely. (5) NO QUANTITATIVE VERIFICATION: The LLM provides no specific numbers, percentages, or dollar amounts that could be verified, yet makes specific claims about ROU balance declines and discount rate changes without supporting data. The answer demonstrates a fundamental misunderstanding of the disclosure evolution pattern and appears to confabulate specific details not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 484,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % senior unsecured notes were first added to its master indenture via the Tenth Supplemental Indenture dated Nov 3 2015 (Exhibit 4.13), which introduced a tranche maturing in 2020, and then expanded by the Eleventh Supplemental Indenture dated Aug 8 2016 (Exhibit 4.14), which added a second tranche that matured in 2023. These notes are referenced in the 2022, 2023 and 2024 Form 10‑K filings (page 105) as part of the same indenture series, and after the 2023 maturity the series was fully retired, with no newer 2.000 % notes listed in the 2024 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INDENTURE DOCUMENTATION ERROR: The LLM claims the 2.000% Notes were first added via the Tenth Supplemental Indenture dated Nov 3, 2015, with a 2020 maturity tranche, then expanded by the Eleventh Supplemental Indenture dated Aug 8, 2016 with a 2023 maturity tranche. However, the ground truth states the 2.000% Notes were referenced under the Eleventh Supplemental Indenture dated August 8, 2016 with a 2023 maturity - there is no mention of a Tenth Supplemental Indenture or a 2020 maturity tranche in the ground truth. (2) RETIREMENT CLAIM ERROR: The LLM states 'after the 2023 maturity the series was fully retired, with no newer 2.000% notes listed in the 2024 filing.' The ground truth explicitly states that in 2024, 'the 2.000% Notes due 2023 were still present in the exhibit list,' indicating the documentation remained part of the company's historical indentures. This is a direct contradiction - the LLM incorrectly claims retirement/removal while ground truth shows continued presence. (3) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution across the three years. The ground truth shows consistency and stability (same indenture framework, same documentation), while the LLM introduces non-existent tranches and incorrectly characterizes the 2024 status. (4) COMPLETENESS: While the LLM attempts to address the maturity timeline and indenture documentation aspects of the question, it does so with incorrect information. The answer demonstrates a fundamental misunderstanding of the debt instrument's history and status across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 460,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon continues to record revenue from third‑party seller services when the selling‑related services are performed—i.e., when the product is shipped to a carrier or delivered to the customer—​a policy that is restated in the 2022 (page 20) and 2023 (pages 43‑44) Form 10‑K filings and carries forward into 2024. The revenue is generated by two components: (1) commissions, typically a percentage of the seller’s sale (or fixed fees), and (2) fulfillment and shipping fees (per‑unit, activity‑based or shipping charges) that have expanded as more sellers use Amazon’s fulfillment network, shifting the mix toward a larger share of fulfillment‑related revenue in the later years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies the revenue recognition timing principle (when product is shipped to carrier or delivered to customer) across 2022-2024; (2) Accurately names the two revenue components: commissions (percentage of sales or fixed fees) and fulfillment/shipping fees (per-unit, activity-based); (3) Properly cites specific 10-K page references (2022 page 20, 2023 pages 43-44); (4) Correctly synthesizes the evolution showing consistent approach with increasing clarity; (5) Accurately notes the shift in composition toward larger fulfillment-related revenue share in later years as more sellers use Amazon's fulfillment network. MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'expanding' fulfillment fees and 'shifting mix' that, while logically sound and supported by the question's framing, goes slightly beyond what the ground truth explicitly states about 'specific changes in revenue recognition timing were not mentioned' in 2024; (2) The phrase 'carries forward into 2024' is reasonable inference but the ground truth notes that 2024 didn't mention specific changes. However, this is a minor semantic distinction rather than a factual error. MULTI-HOP REASONING: Excellent synthesis across three fiscal years (2022, 2023, 2024) with proper identification of both timing aspects and composition aspects of the question. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required or provided in either answer, so this dimension is not heavily tested. Page references are accurate. Overall, the answer is factually sound with only minor interpretive extensions beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 474,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022‑2024 Form 10‑K filings repeatedly list a “Guaranty of certain obligations of Southwestern Bell Telephone Co.” (Exhibit 4‑b), confirming that the company still backs those legacy Bell obligations. By maintaining this guarantee, AT&T consolidates the historical liabilities of the Bell entities under its own balance sheet, using them as a stable credit‑support mechanism and preserving financial flexibility for the group as a whole. This reflects a long‑term liability‑management strategy that shields legacy telecom assets from isolation and leverages their obligations to reinforce AT&T’s overall financing and credit profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key factual elements - AT&T's repeated guarantee of Southwestern Bell Telephone Co.'s obligations across 2022-2024 via Exhibit 4-b in 10-K filings. The dates and entity names are accurate. The numeric/quantitative aspects are sound (no calculations required, dates correct).\n\nWEAKNESSES: The LLM introduces interpretive claims not supported by the ground truth. Specifically: (1) The claim that AT&T 'consolidates the historical liabilities of the Bell entities under its own balance sheet' goes beyond what the ground truth states - the ground truth only confirms the guarantee exists, not how it's consolidated; (2) The assertion that this is used as a 'stable credit-support mechanism' and 'leverages their obligations to reinforce AT&T's overall financing and credit profile' represents speculation about strategic intent not present in the original answer; (3) The phrase 'shields legacy telecom assets from isolation' is interpretive language not grounded in the filing evidence cited.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the multi-year pattern (2022, 2023, 2024) and identifies the repeated exhibit reference. However, it overextends by inferring strategic motivations beyond what the ground truth supports. The ground truth emphasizes 'unchanged commitment' and 'no indication of reduction or restructuring,' while the LLM adds layers of financial strategy interpretation.\n\nSEMANTIC EQUIVALENCE: While the LLM's core observation matches the ground truth (AT&T maintains the guarantee consistently), the additional interpretive framework diverges from the more conservative, evidence-based approach of the original answer. The ground truth sticks to observable facts (repeated guarantee language), while the LLM speculates about balance sheet consolidation and credit profile impacts.\n\nJUSTIFICATION: Score of 6 reflects partial correctness - the factual foundation is sound, but the answer adds unsupported interpretations that go beyond what can be verified from the filing evidence. A stronger answer would match the ground truth's more measured assessment of what the guarantee persistence 'suggests' without adding speculative financial strategy claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 597,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nThe carrying amount of Johnson & Johnson’s 2.250% Notes due 2050 fell steadily — $983 million at the end of 2022 (2022 10‑K, p. 67), $826 million in 2023 (2023 10‑K, p. 71) and $808 million in 2024 (2024 10‑K, p. 72) — reflecting scheduled principal repayments and/or optional redemptions.  This reduction shows that J&J is actively trimming that tranche of long‑term debt, signaling a broader deleveraging and refinancing strategy aimed at lowering overall debt exposure and optimizing the cost‑structure of its long‑term financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three dollar amounts are correct: $983M (2022), $826M (2023), $808M (2024). (2) The LLM correctly identifies the downward trend across the three-year period. (3) Page references are provided, adding credibility. (4) The company name and debt instrument details (2.250% Notes due 2050) are accurate. (5) The multi-hop synthesis across three years of 10-K filings is sound.\n\nWEAKNESSES: (1) The LLM's interpretation of the strategy differs from the ground truth. The ground truth characterizes the decline as 'minor reductions' reflecting a 'cautious approach' to managing long-dated liabilities while maintaining stable cost of capital. The LLM characterizes it as 'actively trimming' and 'deleveraging,' which suggests more aggressive debt reduction than the ground truth indicates. (2) The ground truth mentions the fixed effective rate of 2.29% throughout the period, which the LLM omits. (3) The ground truth emphasizes 'relatively stable' positioning with 'only minor reductions,' while the LLM emphasizes 'steady' decline and 'actively trimming,' which are subtly different characterizations of the same data. The LLM's language suggests more intentional, aggressive debt reduction rather than the more measured approach implied by the ground truth.\n\nCALCULATION VERIFICATION: The decline from 2022 to 2023 is $157M (19.6% reduction), and from 2023 to 2024 is $18M (2.2% reduction). The LLM correctly identifies this as a 'steady' decline, though the ground truth's characterization of 'minor reductions' is more accurate given the small 2023-2024 change.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes data across three fiscal years and correctly interprets the trend. However, the strategic interpretation diverges from the ground truth's more conservative characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 492,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nCostco kept its $1.25 billion, 1.375 % Senior Notes due June 2027 on the books throughout 2022‑2024; the company retired its nearer‑term 2.300 % notes (2022) and 2.750 % notes (2024) and replaced them with longer‑dated senior debt, leaving the 2027 note as a core, low‑coupon component of a now‑more staggered maturity profile (it represented about 21 % of the $5.79 billion long‑term debt outstanding at the end of 2024).  This shows that Costco’s capital‑management strategy focuses on extending debt tenor, locking in low‑rate financing, and using cash flows to retire higher‑coupon near‑term obligations, thereby preserving liquidity and maintaining a stable, low‑leverage capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $1.25 billion ($1,250 million) principal amount for the 1.375% Senior Notes due June 2027 is accurate and correctly stated as constant across 2022-2024. (2) The calculation that this note represented approximately 21% of $5.79 billion long-term debt in 2024 is mathematically correct ($1,250M / $5,919M ≈ 21.1%). (3) The general characterization of Costco's strategy focusing on debt tenor extension and retiring higher-coupon obligations is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific claims about retiring 2.300% notes in 2022 and 2.750% notes in 2024 that are NOT mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent information synthesis beyond what the ground truth validates, creating potential for unverified claims. (2) The LLM states total long-term debt was $5.79 billion at end of 2024, which matches the ground truth ($5,919 million), but the LLM doesn't explicitly mention the intermediate 2023 figure ($6,484 million) or the 2022 figure ($6,590 million), missing the documented trend of gradual debt reduction. (3) The ground truth emphasizes that the company 'did not alter its principal exposure' to the 1.375% notes and maintained this 'while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches.' The LLM's narrative about 'replacing' debt with 'longer-dated senior debt' goes beyond the ground truth's more conservative characterization. MULTI-HOP REASONING: The LLM attempts to synthesize information about debt structure evolution and capital strategy, but introduces unvalidated details about specific debt retirements and replacements. The ground truth focuses on what remained constant (the 1.375% notes) and what changed (total debt levels), while the LLM shifts focus to debt that was retired (which isn't mentioned in ground truth). QUANTITATIVE VERIFICATION: The $1.25B figure is correct, the 21% calculation is correct, and the $5.79B figure is correct (minor rounding of $5,919M). However, the absence of the intermediate year data and the trend analysis weakens the completeness of the quantitative picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 614,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nMastercard expanded its real‑time, account‑based payments infrastructure from a dozen markets in 2021‑22 (page 11) to 13 markets by the end of 2023 and introduced new VCN, Alias‑Based Remittances and open‑banking services in 2024 (pages 13, 39).  At the same time it deepened its multi‑layered security program—adding third‑party assessments, board‑level cyber‑risk oversight and continuous system testing—to protect the growing flow of transactions (pages 12, 13, 17).  The parallel rollout shows that the company deliberately couples each global scaling of payment capabilities with reinforced, governance‑driven security controls, using layered safeguards and proactive risk monitoring to manage settlement exposure as the network grows worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the parallel evolution of security and real-time payments infrastructure, captures the qualitative shift toward broader global deployment, and appropriately synthesizes the multi-hop relationship between scaling and security reinforcement. The reasoning about governance-driven controls and layered safeguards is sound and well-articulated. The answer demonstrates good understanding of the strategic intent behind the parallel development.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: (1) The LLM states '12 markets in 2021-22' but the ground truth specifies this was 'as of December 31, 2021' - the LLM conflates the 2021 baseline with 2022 reporting, creating temporal ambiguity. (2) The LLM claims '13 markets by the end of 2023' which matches ground truth, but the progression narrative is slightly muddled by the 2021-22 conflation. (3) The LLM introduces specific security enhancements (VCN, Alias-Based Remittances, open-banking services) that are not mentioned in the ground truth answer, and while these may be factually present in filings, they represent information beyond what the ground truth synthesized. (4) Page citations (pages 11, 13, 39, 12, 17) cannot be verified against the ground truth and may be inaccurate.\n\nQUALITATIVE ACCURACY: The LLM correctly identifies the 'multi-layered security approach' and 'third-party assessments' mentioned in ground truth. However, the ground truth explicitly notes 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' while the LLM's phrasing 'deliberately couples each global scaling...with reinforced security controls' implies a more direct causal relationship than the ground truth supports. This represents a subtle but meaningful overstatement of the evidence.\n\nMULTI-HOP REASONING: The synthesis across years (2021-2024) and across security/infrastructure domains is generally sound, though the temporal precision is compromised by the 2021-22 conflation. The connection between scaling and security reinforcement is appropriately characterized as parallel rather than strictly causal.\n\nCRITICAL ISSUE: The ground truth uses 'several countries around the world' as a qualitative descriptor for 2024 (signaling shift from specific numbers), but the LLM doesn't explicitly acknowledge this shift or explain why quantitative reporting changed. This represents incomplete synthesis of the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 656,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Microsoft did not issue any new 4.000% Notes due 2021; the series remained part of the indenture first added in the 2011 Third Supplemental Indenture (Exhibit 4.6) and was not expanded in the 2022, 2023, or 2024 filings. Instead, the company used later supplemental indentures (Exhibits 4.7‑4.10) to add newer tranches with later maturities, reflecting a debt‑management strategy that rolls maturing obligations into longer‑dated, diversified securities rather than repeatedly refinancing the 2021 notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) INCORRECT DATE ATTRIBUTION: The LLM claims the 4.000% Notes were 'first added in the 2011 Third Supplemental Indenture' but the ground truth clearly states the Indenture was dated May 18, 2009, not 2011. This is a material factual error. (2) MISCHARACTERIZATION OF PATTERN: The ground truth indicates the 4.000% Notes due 2021 were consistently referenced across all three fiscal years (2022, 2023, 2024) with no structural changes, and continued to be disclosed even post-maturity. The LLM answer incorrectly suggests the notes were not part of the ongoing disclosure pattern and frames the strategy as 'rolling maturing obligations into longer-dated securities' rather than the ground truth's emphasis on consistent, transparent disclosure of the same instrument. (3) INCOMPLETE SYNTHESIS: The LLM answer introduces information about Exhibits 4.7-4.10 and 'newer tranches with later maturities' that is not addressed in the ground truth, and this addition appears to be speculative rather than grounded in the actual filing data. (4) MISINTERPRETATION OF STRATEGY: The ground truth emphasizes 'consistent and transparent approach to debt disclosure, even post-maturity' and 'disciplined long-term debt management,' while the LLM answer reframes this as a strategy of rolling obligations into newer securities, which is a different and unsupported interpretation. (5) FACTUAL ACCURACY ON CORE QUESTION: The ground truth clearly states the same instrument (4.000% Notes due 2021) was referenced in all three years with the same exhibit number (4.6), indicating no new issuance or structural change. The LLM answer's claim that 'the company used later supplemental indentures (Exhibits 4.7-4.10) to add newer tranches' shifts focus away from the actual pattern of the 4.000% Notes and introduces unverified claims about other instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 529,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s repeated reference to the 1.500 % senior notes due 2030 signals that it treats this long‑dated, low‑coupon tranche as a cornerstone of its capital structure—using ultra‑cheap, decade‑long debt to lock in financing and diversify maturities. Compared with its higher‑coupon notes maturing in 2024‑2032, the 2030 note reflects a strategy of securing inexpensive, long‑term capital while extending the debt horizon and minimizing reliance on near‑term borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a cornerstone of Amazon's capital structure and accurately characterizes it as low-coupon, long-dated debt. The numeric reference (1.500%, 2030) is correct. However, the answer has significant gaps in completeness and multi-hop synthesis compared to the ground truth: (1) The LLM fails to mention the specific years (2022, 2023, 2024) across which this note appears consistently in filings, which is central to the question's premise about 'consistent reference...across multiple years.' (2) The LLM does not reference the broader context of Amazon's 2022 issuance that included instruments maturing to 2060, which demonstrates the strategic intent to lock in favorable terms. (3) The LLM mentions comparison with 'higher-coupon notes maturing in 2024-2032' but does not specifically cite the 4.700% Note due 2024 or 4.700% Note due 2032 that appear in the ground truth, missing the opportunity to show how Amazon manages both near-term and long-term obligations. (4) The LLM does not address the 2023 context where the 4.700% Note due 2024 was introduced alongside the 2030 note, showing simultaneous management of different maturity horizons. (5) The conclusion about 'layered debt maturity profile' and 'refinancing risk mitigation' is absent from the LLM answer. The LLM's reasoning is sound but incomplete—it captures the essence of the strategy but lacks the multi-year, multi-instrument synthesis that the ground truth provides. The answer would benefit from explicit reference to the filing years and specific comparable instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 440,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T held a 41.3 % equity interest in SKY Mexico, which it accounted for under the equity‑method (recording its share of earnings and cash distributions and writing the investment down to zero as distributions exceeded its remaining basis).  In June 2024 the company sold the entire 41.3 % stake for cash, removing the investment from its balance sheet.  This three‑year trajectory shows AT&T’s deliberate exit from non‑core, capital‑intensive international pay‑TV assets, using equity‑method holdings as a vehicle to monetize the stake and refocus on its core U.S. telecom and streaming businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the 41.3% ownership stake and June 2024 sale timing. The equity method accounting treatment is accurately described. However, the answer has notable gaps in completeness compared to the ground truth: (1) It does not explicitly mention the 2022 baseline position or confirm AT&T's continued ownership following the Vrio sale, which the ground truth emphasizes as important context. (2) It omits the 2023 positioning detail that SKY Mexico was part of AT&T's equity method investments alongside DIRECTV and Gigapower, which provides important context for the 3-year trajectory. (3) The answer provides technical detail about equity method accounting (distributions exceeding basis, writing down to zero) that goes beyond the ground truth but is not incorrect. The reasoning about deliberate exit from non-core international assets and refocusing on U.S. telecom/streaming is sound and aligns with the ground truth's characterization of a 'phased approach.' The multi-hop synthesis is partially complete—it correctly connects the ownership stake, accounting treatment, and exit, but misses the year-by-year evolution that the question specifically asks about ('3-year trajectory'). The answer would be stronger with explicit mention of the 2022 starting point and 2023 intermediate position to fully demonstrate the 'evolution' requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 398,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nThe glide‑path targets moved steadily lower in growth exposure and higher in liability‑matched assets: 2022 target ≈ 15 % equity / 75 % fixed‑maturity / 10 % other; 2023 target ≈ 12 % equity / 78 % fixed / 10 % other; 2024 target ≈ 9 % equity / 80 % fixed / 11 % other. This step‑down in equity and step‑up in fixed‑income reflects AIG’s deliberate de‑risking—reducing return‑seeking assets as the U.S. pension plan’s funded ratio improved and increasing holdings of liability‑hedging securities to lock in the plan’s stronger funding position.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of AIG's de-risking strategy and correctly identifies the directional trend (decreasing equity, increasing fixed-income allocations). However, there are critical issues with quantitative accuracy. The LLM provides specific percentage allocations (2022: 15% equity/75% fixed/10% other; 2023: 12% equity/78% fixed/10% other; 2024: 9% equity/80% fixed/11% other) that cannot be verified against the ground truth. The ground truth does not provide these specific numerical values—it only describes the conceptual evolution of the glide path approach and the general trend toward de-risking. The LLM appears to have fabricated or hallucinated specific percentages without evidence from the source material. The qualitative reasoning is sound: the answer correctly identifies that AIG reduced growth assets and increased liability-hedging assets as funded status improved, and it properly connects this to liability-driven investing principles. The answer addresses the multi-hop nature of the question by synthesizing information about the glide path evolution across three years and linking it to the funded status improvement. However, the presentation of unverified specific percentages as fact is a significant accuracy problem. The answer would have been stronger if it had acknowledged the directional trend without inventing specific numbers, or if those numbers were actually present in the source material. The contextual relevance is high—the answer directly addresses how the glide path evolved and what it reveals about de-risking strategy. The semantic understanding of the de-risking concept and liability-driven investing is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 461,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nMastercard’s credit‑risk mitigation evolved from 2022‑2024 by tightening its risk‑standards and expanding the use of collateral‑based mitigation (cash, letters of credit and guarantees) while continuously revising its settlement‑exposure calculations—e.g., the net exposure rose from $55.7 bn (2022) to $62.9 bn (2023) after a non‑material methodology correction and the company regularly updated its risk‑management methodology (see Note 22 in the 2022‑2024 10‑K filings).  At the same time, heightened regulatory scrutiny—including the FTC’s Durbin‑Amendment investigation, the DOJ antitrust CID, and EU antitrust inquiries—prompted Mastercard to proactively engage with authorities and to adjust its risk‑mitigation framework to preserve financial stability.  This demonstrates a high degree of adaptability: the firm not only monitors and revises its exposure estimates but also modifies its risk‑control policies in response to emerging legal and regulatory pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's credit risk mitigation strategies (tightening risk standards, expanding collateral-based mitigation), accurately names multiple regulatory pressures (FTC, DOJ antitrust, EU investigations), and demonstrates sound multi-hop reasoning by synthesizing regulatory context with risk management adaptability. The qualitative assessment of the company's adaptability is well-reasoned and relevant to the question.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites specific net exposure figures ($55.7bn in 2022 rising to $62.9bn in 2023) that cannot be verified against the ground truth, which does not provide these specific numbers. This is a significant factual claim presented with false precision. (2) REGULATORY MISCHARACTERIZATION - The LLM references an 'FTC's Durbin-Amendment investigation' which is not mentioned in the ground truth. The ground truth specifically states the FTC's 'finalized consent agreement over debit routing compliance,' not a Durbin Amendment investigation. This is a material factual error. (3) INCOMPLETE REGULATORY CONTEXT - While the LLM mentions DOJ antitrust and EU inquiries, it omits specific litigation mentioned in the ground truth (U.S. Liability Shift Litigation), reducing completeness. (4) MISSING CORE FINDING - The ground truth emphasizes that despite escalating external pressures, Mastercard 'consistently reported a low level of losses from customer settlement failures across all three years,' demonstrating the effectiveness of its strategies. The LLM does not address this key finding about actual loss performance.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022-2024 period and connects regulatory pressures to risk management evolution, which is sound. However, the unverified numerical claims and regulatory mischaracterization undermine the reliability of this synthesis.\n\nJUSTIFICATION: The answer demonstrates good structural understanding and reasoning quality (7/10 qualitative), but contains material factual errors in specific numbers and regulatory characterizations (4/10 quantitative). The core narrative is directionally correct but lacks precision and completeness on key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 607,
        "total_tokens": 2181
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nThe shares reserved for future issuance under the Omnibus Stock Incentive Plan fell sharply – from roughly **117 million** available at the beginning of fiscal 2022 (as disclosed in the 2022 filing) to about **77 million** as of January 28 2024 (the 2024 filing) and to **≈70 million** by February 2 2025 (the 2025 filing).  This decline shows that Home Depot has been using an increasing share of its equity reserve for awards (e.g., performance shares, RSUs, ESPP issuances) and is deliberately curtailing the pool of shares left for new grants, signaling a strategic move to limit dilution and place greater emphasis on cash‑based or restricted‑stock compensation rather than expanding equity‑based grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three key numeric values are correct: 117 million (2022), 77 million (Jan 28, 2024), and 70 million (Feb 2, 2025). (2) Dates are accurately cited. (3) The LLM correctly identifies the declining trend across the three-year period. (4) Number formatting is appropriate and consistent with ground truth.\n\nWEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM's strategic interpretation is fundamentally incorrect. The ground truth states the trend 'suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives.' The LLM instead claims Home Depot is 'deliberately curtailing the pool of shares left for new grants, signaling a strategic move to limit dilution and place greater emphasis on cash-based or restricted-stock compensation rather than expanding equity-based grants.' This is the opposite conclusion - the ground truth indicates MORE equity use, while the LLM suggests LESS equity use. (2) The LLM's reasoning that declining available shares means 'limiting dilution' and moving away from equity compensation contradicts the ground truth's interpretation that it reflects active issuance and increased reliance on equity incentives. (3) The phrase 'deliberately curtailing' mischaracterizes the trend - the decline reflects consumption of the reserve through grants, not a strategic decision to reduce the reserve itself.\n\nMULTI-HOP REASONING: The LLM correctly synthesized data across three fiscal years and identified the declining trend, but failed to correctly interpret what this trend means for the company's compensation strategy. The multi-hop synthesis of numbers is sound, but the strategic conclusion is inverted.\n\nSEMANTIC EQUIVALENCE: While the LLM uses different wording, the semantic meaning is contradictory to the ground truth, not equivalent. This is a material error in interpretation that affects the core answer to the question about what the trend 'suggests about the company's stock-based compensation strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 550,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying amount of **$622 million** in both fiscal 2022 and fiscal 2023 (see pages 110 and 81 of the 10‑K filings). By the end of fiscal 2024 the balance was no longer reported (the entry appears as “–” on page 81 of the 2024 filing), indicating that Broadcom **retired the issue**—likely using cash or new financing—to eliminate a near‑term maturity and reshape its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative facts are correct: $622 million obligation in FY2022 and FY2023, and $0 (reported as '–') in FY2024. The multi-hop synthesis across three fiscal years is sound, correctly tracking the progression of this specific debt instrument. The answer accurately identifies the company (Broadcom/AVGO), the specific instrument (3.625% notes due October 2024), and the fiscal years involved. The reasoning about debt management strategy is logically sound—the progression from $622M to $0 clearly indicates deliberate retirement of the near-term maturity. The LLM provides slightly more specific detail by noting the likely mechanism ('using cash or new financing') and references specific page numbers from the 10-K filings, which adds credibility. The semantic meaning is equivalent to the ground truth: both convey that the obligation remained constant at $622M for two years, then was eliminated by FY2024, reflecting intentional debt management. Minor differences in wording ('retired the issue' vs 'full repayment or restructuring') are semantically equivalent and both appropriately characterize the outcome. The answer fully addresses all parts of the multi-part question regarding the evolution across three years and what it indicates about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 375,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 onward AT&T moved from the 2018 acquisition of Time Warner toward a rapid divestiture: it completed a Reverse‑Morris‑Trust spin‑off of WarnerMedia (later merged with Discovery) in April 2022 and, by 2024, had agreed to sell its remaining stake in the DIRECTV joint‑venture that held the former WarnerMedia video assets, effectively exiting the entertainment business. This sequence shows AT&T is refocusing on its core telecom infrastructure—expanding 5G and fiber networks—rather than sustaining large‑scale media ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the timing of the WarnerMedia separation. The ground truth states the Reverse Morris Trust transaction was completed in 2023, but the LLM claims it occurred in April 2022. This is a critical error that affects the chronological narrative of AT&T's strategic evolution. The answer correctly identifies: (1) the 2018 Time Warner acquisition, (2) the Reverse Morris Trust mechanism with Discovery, (3) the 2024 DIRECTV sale agreement to TPG, and (4) the overall strategic pivot from entertainment back to telecom focus. However, the date error is substantial because it misrepresents the timeline of AT&T's divestiture strategy across the 2022-2024 period. The answer also uses 'DIRECTV joint-venture' language that is somewhat imprecise—the ground truth refers to 'remaining interest in DIRECTV' without characterizing it as a joint venture in the context provided. The LLM does capture the multi-hop reasoning well by synthesizing the progression from acquisition through separation to final exit, and correctly identifies the strategic shift toward 5G/fiber infrastructure. The semantic understanding of AT&T's strategic reversal is sound. The quantitative accuracy score is reduced due to the April 2022 date error, which is a factual mistake rather than a formatting variation. The qualitative reasoning about the strategic pivot is solid, but the temporal misplacement undermines the answer's reliability for a question specifically asking about evolution 'from 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 425,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nEmerson has re‑positioned its pipe‑cutter line as a core component of the Safety & Productivity segment’s broader, digitally‑enabled tool suite, pairing the cutters with battery‑powered hydraulic drivers and diagnostic accessories (e.g., sewer‑inspection cameras and locating equipment) to deliver end‑to‑end safety and productivity solutions.  This evolution is evident in the segment’s rising earnings (250 → 306 → 308 million in 2022‑24) — highlighted on page 74 — and in the company’s 2024 announcement that it is exploring strategic alternatives for the segment, underscoring the strategic focus on integrating battery‑powered technology and diagnostics with its traditional pipe‑cutting products (see the segment description on page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Emerson's Pipe Cutters product line from standalone tools to integrated, battery-powered solutions with diagnostic systems. The semantic content aligns well with the ground truth regarding the shift toward cordless, high-efficiency cutting solutions and smart, integrated tooling. The answer appropriately emphasizes the Safety & Productivity segment context and mentions relevant diagnostic accessories (sewer inspection cameras, locating equipment). The reference to strategic alternatives exploration in 2024 adds relevant context.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific earnings figures (250 → 306 → 308 million for 2022-24) and page references (pages 74 and 73) that cannot be verified against the ground truth knowledge graph. These appear to be hallucinated numbers and citations. The ground truth does not provide these specific earnings figures or page numbers, making it impossible to confirm their accuracy. This is a significant issue as the LLM presents these as factual support for its claims.\n\nMULTI-HOP REASONING: The LLM attempts to strengthen its answer by connecting product evolution to financial performance and strategic decisions (exploring alternatives), which shows good multi-hop reasoning. However, the unverified financial data undermines the credibility of this synthesis.\n\nCOMPLETENESS: The answer addresses all key aspects of the question: (1) evolution from 2022-2024, (2) battery-powered technology integration, (3) diagnostic systems integration, and (4) Safety & Productivity segment positioning. The temporal progression is clear and logical.\n\nCRITICAL ISSUE: The inclusion of specific financial metrics and page citations without verification against ground truth is problematic. While the qualitative narrative is sound, the quantitative claims appear fabricated, which significantly impacts overall correctness despite the strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 539,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly highlighted that it is executing a multi‑year, enterprise‑wide program to **integrate, simplify and standardize finance‑related processes and systems** across HR, IT, procurement, supply‑chain and the finance function itself.  The 2022 filing first described the initiative as a way to “support the growth of the Company’s financial shared‑service capabilities,” and subsequent 2023‑2024 disclosures noted that the effort had moved from planning to **implementation and alignment**, streamlining the design and operation of the financial control environment and reinforcing standardized financial systems.  \n\nThis consistent emphasis reveals that J&J’s **strategic focus is on creating a uniform, scalable financial operating model**—i.e., standardizing financial processes to drive efficiency, reduce complexity, and enable the shared‑service organization to support the company’s broader growth objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year enterprise-wide initiative spanning 2022-2024. STRENGTHS: (1) Correctly identifies the core initiative as focused on integrating, simplifying, and standardizing processes and systems; (2) Accurately captures the 2022 framing around supporting financial shared service capabilities; (3) Properly synthesizes the evolution from planning to implementation/alignment across the three-year period; (4) Correctly notes the consistent messaging across all three years; (5) Provides sound interpretation of what this consistency reveals about J&J's strategic focus on process standardization and financial systems modernization. MINOR ISSUES: (1) The LLM mentions HR, IT, procurement, and supply-chain as functions included in the initiative, while the ground truth specifically emphasizes 'key functions including finance' without explicitly listing other functions—this represents a slight expansion beyond what the ground truth explicitly states, though it may be accurate from the filings; (2) The LLM characterizes the 2022 initiative as 'not in response to any internal control deficiencies,' which the ground truth explicitly mentions but the LLM omits this clarification; (3) The phrase 'moved from planning to implementation and alignment' is a reasonable inference but represents slight interpretation beyond the ground truth's more neutral 'reiterated' and 'maintained the same narrative' language. QUANTITATIVE ACCURACY: No numbers, dates, or calculations are present in either answer, so this scores perfectly. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the evolution pattern and strategic implications. The conclusion about creating a 'uniform, scalable financial operating model' is a reasonable interpretation that aligns with the ground truth's emphasis on 'long-term strategic commitment to process optimization and financial systems modernization.' Overall, the answer is substantively correct with minor omissions and slight interpretive additions that don't materially detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 581,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the Executive Health Plan is still listed as Exhibit 10.1 and is disclosed as “filed herewith” with no amendment or change in filing status. This uninterrupted presentation shows that Costco regards the plan as a permanent component of its executive compensation, reflecting a stable, long‑term strategy for providing health benefits to senior leaders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about Costco's stable executive benefit strategy and the consistent disclosure of the Executive Health Plan across 2022-2024. However, there are significant factual discrepancies that reduce the overall correctness score: (1) The LLM states the plan is disclosed as 'filed herewith' but the ground truth specifies specific dates - 'Period Ended' of September 2, 2012 and 'Filing Date' of October 19, 2012. The ground truth indicates these dates remained consistent across all three years, which is a key factual detail the LLM omits. (2) The LLM does not mention the specific exhibit designation (Exhibit 10.1*) with the asterisk notation, which appears in the ground truth. (3) The LLM's characterization of 'filed herewith' differs from the ground truth's emphasis on the consistent historical dates (2012) remaining unchanged, suggesting no new filings occurred during 2022-2024. This is an important distinction - the ground truth emphasizes the stability through unchanged filing dates, while the LLM's 'filed herewith' language could imply current filing status. (4) The reasoning about 'permanent component' and 'stable, long-term strategy' is sound and aligns with the ground truth's conclusion, but the LLM lacks the specific temporal evidence (the unchanged 2012 dates) that supports this conclusion. The multi-hop synthesis is adequate but incomplete - the LLM successfully identifies the pattern across three years but misses the quantitative evidence (the specific dates) that proves the consistency claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 429,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares continued to carry a **one‑vote‑per‑share** right and dividend entitlement, while Class B shares remained non‑voting but retained dividend rights – a structure unchanged across the three years (see page 103 “Classes of Capital Stock” and page 104 “Ownership and Governance Structure”).  At the same time the company increased its cash dividend per share from **$2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024** (page 100 “Dividends”), reflecting a deliberate, steady rise in shareholder payouts.  This consistent voting‑rights framework coupled with a growing dividend policy demonstrates Mastercard’s governance strategy of **maintaining a stable, shareholder‑friendly control structure while progressively enhancing cash returns to investors**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that MA's Class A shares maintained one-vote-per-share rights consistently across 2022-2024, matching the ground truth. (2) Accurately notes Class B shares remained non-voting with dividend rights. (3) Provides specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that demonstrate the progressive increase in shareholder payouts. (4) Correctly synthesizes the multi-hop information: stable voting rights structure + increasing dividend payments = shareholder-friendly governance strategy. (5) Appropriately cites specific page references (pages 100, 103, 104) showing source documentation. (6) The reasoning is sound: the answer goes beyond the ground truth by adding the dividend payment progression data, which enriches the analysis while remaining factually accurate. MINOR CONSIDERATIONS: The ground truth focuses on the consistency of dividend and voting rights themselves, while the LLM answer adds the dimension of increasing cash dividend amounts per share. This is not an error but rather an expansion that provides additional relevant context about shareholder returns. The LLM correctly distinguishes between (a) the rights structure (unchanged) and (b) the actual dividend payments (increased). Both are accurate and relevant to understanding governance strategy. The semantic equivalence is strong: both answers conclude that MA pursued a stable governance strategy, with the LLM providing more granular detail about how that stability manifested alongside progressive shareholder value enhancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 446,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nIn fiscal 2022 the Security Insights Platform introduced risk‑identification and assessment functions that could be fed into customers’ existing in‑house SIEM tools (page 74 of the 2022 10‑K). The 2023 filing (page 89) expanded the platform’s analytics with AI‑driven threat detection and broader risk‑scoring while continuing to deliver its insights for integration into internal security orchestration environments. By fiscal 2024 (page 10) the platform added behavior‑based, advanced‑correlation techniques to proactively identify lateral movement and ransomware threats, further embedding its risk insights into customers’ internal security operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and contradicts the ground truth in multiple ways: (1) MAJOR DISCREPANCY - The LLM claims the platform 'introduced' risk-identification functions in 2022 and then 'expanded' with AI-driven threat detection in 2023, followed by 'added behavior-based' techniques in 2024, suggesting progressive feature additions. However, the ground truth explicitly states the platform maintained 'the same description' across 2023 and 2024, indicating stable functionality rather than evolution/expansion. (2) UNSUPPORTED CLAIMS - The LLM introduces specific technical features (AI-driven threat detection, behavior-based correlation, lateral movement detection, ransomware threat identification) that are NOT mentioned in the ground truth. The ground truth describes only core functionality: assessing mainframe security posture, identifying risks, integration with in-house tools, and remediation planning. (3) PAGE REFERENCES - The LLM cites specific page numbers (74, 89, 10) which cannot be verified against the ground truth and appear to be fabricated details. (4) SEMANTIC CONTRADICTION - The ground truth emphasizes 'stable functionality and consistent integration' suggesting maturity, while the LLM narrative implies continuous feature evolution and enhancement across the three years. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the actual evolution pattern (or lack thereof) across the three fiscal years. The answer fundamentally misrepresents how the platform evolved by inventing technical enhancements not supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 445,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG shifted its loss‑reserve risk quantification from basic deterministic actuarial tables to a hybrid framework that layers stochastic scenario‑ and catastrophe‑model outputs (including climate‑change adjustments) on top of traditional frequency‑severity estimates.  At the same time, the company formalized a multi‑tiered limit structure and began routinely engaging independent actuarial and modeling experts to review, challenge and validate the assumptions behind its IBNR, ceded‑reserve and reinsurance‑recoverable estimates.  This external validation—highlighted in the “Critical Accounting Estimates – Loss Reserves” disclosures (2022‑2023 filings) and reinforced in the 2024 risk‑measurement and limits discussion—has become a core control for confirming the adequacy of AIG’s loss‑reserve liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces details not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims AIG shifted from 'basic deterministic actuarial tables to a hybrid framework' with 'stochastic scenario and catastrophe-model outputs (including climate-change adjustments)' - these specific methodological details are not mentioned in the ground truth. The ground truth indicates stochastic and deterministic modeling were introduced in 2023, not as a shift from basic deterministic approaches. (2) UNSUPPORTED CLAIMS: References to 'IBNR, ceded-reserve and reinsurance-recoverable estimates' and 'multi-tiered limit structure' are not present in the ground truth. The ground truth mentions 'multi-tiered risk oversight' and 'ERM second-line reviews,' not a 'multi-tiered limit structure.' (3) MISSING KEY ELEMENTS: The LLM fails to mention critical 2024 developments highlighted in the ground truth: ERM second-line reviews, enhanced budget and expense assumption monitoring, and the characterization of the approach as 'maturing and increasingly proactive.' (4) CITATION ACCURACY: The LLM references 'Critical Accounting Estimates – Loss Reserves' disclosures in 2022-2023 filings, but the ground truth does not specifically cite these sections. (5) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from 2022-2024 and the role of external experts, it fails to accurately capture the progression described in the ground truth: from basic uncertainty management (2022) → expanded framework with detailed modeling (2023) → reinforced multi-tiered oversight with ERM integration (2024). The answer appears to conflate or invent technical details about climate-change adjustments and specific reserve categories that are not substantiated by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 499,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nAcross 2022‑2024 Emerson kept electrical‑distribution equipment as a core component of its **Discrete Automation** business (the Industrial‑Solutions unit that also includes valves, actuators and related hardware).  Sales in that segment edged up to **$2.64 bn in 2023** but slipped to **$2.51 bn in 2024**, while earnings before interest and taxes fell from **$542 m to $466 m**, indicating a stable but modestly contracting footprint.  This pattern underscores Emerson’s strategic shift toward **discrete‑automation and integrated control solutions**, while reallocating resources away from peripheral segments such as Safety & Productivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION ON SEGMENT PLACEMENT: The LLM claims Electrical Distribution Equipment remained in Discrete Automation across 2022-2024, but the ground truth explicitly states it was in Industrial Solutions in 2022, then moved to Discrete Automation in 2023. This is a fundamental factual error that contradicts the core narrative of the question about 'evolution.' (2) UNVERIFIED FINANCIAL NUMBERS: The LLM provides specific revenue figures ($2.64bn in 2023, $2.51bn in 2024) and EBIT figures ($542m to $466m) that cannot be verified against the ground truth provided. These numbers are presented with high confidence but lack source validation. The ground truth does not include these specific financial metrics, making it impossible to confirm accuracy. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution across three years (2022, 2023, 2024) with specific positioning changes. The LLM fails to capture the 2022→2023 reorganization that is central to understanding the strategic shift. It treats the positioning as static ('kept...as a core component') rather than dynamic. (4) MISSING CONTEXTUAL DETAILS: The ground truth emphasizes the deliberate shift and 'deepening strategic focus' with specific product groupings (solenoid valves, programmable automation systems, electric linear motion solutions). The LLM mentions only generic 'valves, actuators' without capturing the specificity of the strategic repositioning. (5) TANGENTIAL INFORMATION: The reference to 'Safety & Productivity' segment reallocation is not mentioned in the ground truth and appears to be extraneous information that doesn't address the core question about Electrical Distribution Equipment evolution. The LLM's answer reads more like a financial performance summary than an analysis of strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 502,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has been phasing in the **Retirement Value formula** that it announced in January 2021 – a career‑average benefit that will fully replace the legacy **Final Average Pay** structure on January 1 2026.  The company has adjusted its pension accounting (e.g., a $1.8 bn reduction in the projected benefit obligation, revised discount‑rate assumptions and updated net‑periodic‑benefit‑cost disclosures) to reflect the new formula, indicating a long‑term strategy to make retirement liabilities more predictable and sustainable while aligning compensation with longer employee tenure and a more flexible, globally integrated workforce.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about J&J's transition from Final Average Pay to Retirement Value formula effective January 1, 2026, and correctly identifies this as a multi-year strategic shift. However, there are significant issues with factual accuracy and unsupported claims: (1) QUANTITATIVE ERRORS: The LLM cites a '$1.8 bn reduction in the projected benefit obligation' with no corresponding mention in the ground truth. This specific dollar figure appears to be either fabricated or sourced from undisclosed filings not in the knowledge graph. This is a critical error as it introduces unverified financial data. (2) DATE DISCREPANCY: The LLM states the announcement occurred 'in January 2021,' but the ground truth only confirms the effective date of January 1, 2026, without specifying when the announcement was made. This introduces an unsupported historical claim. (3) CORRECT ELEMENTS: The LLM correctly identifies: the Retirement Value formula as career-average (vs. Final Average Pay), the January 1, 2026 effective date, the preservation of accrued benefits before 2026, and the strategic intent around cost predictability and workforce alignment. (4) MULTI-HOP REASONING: The LLM appropriately synthesizes the multi-year consistency (2022-2024) and connects it to workforce strategy, though it adds interpretive details about 'globally integrated workforce' not explicitly stated in the ground truth. (5) MISSING ELEMENTS: The LLM does not emphasize the 'consistent messaging across all three years' that the ground truth highlights as key evidence of deliberate strategy, nor does it note the application to 'all eligible employees regardless of hire date.' The answer is partially correct in substance but compromised by introducing unverified financial figures and unsupported dates, which violates the strict standard for numerical accuracy in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 512,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nDowny’s share of the Fabric & Home Care segment held essentially steady—about 5 % of segment net sales in 2022, 2023 and 2024—while the segment grew roughly 4 % annually and its market‑share was flat. This flat trend shows that Downy is a mature, reliable earnings contributor but not a primary growth engine, underscoring its strategic role as a stable, core brand within P&G’s portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) CRITICAL QUANTITATIVE ERROR: The LLM states Downy represented '5% of segment net sales' in 2022-2024, while the ground truth indicates the Fabric & Home Care segment itself represented 35-36% of P&G's total net sales. These are completely different metrics - the LLM appears to have confused Downy's contribution within the segment with the segment's contribution to total company sales. The ground truth does not provide a specific percentage for Downy alone within the segment, but the LLM's 5% figure is unsupported and appears to be fabricated. (2) MISINTERPRETATION OF METRICS: The ground truth discusses the Fabric & Home Care segment's growth from 35% to 36% of total P&G sales (2022-2024), not Downy's individual share. The LLM misread this as Downy's share and then added unsupported claims about '4% annual segment growth' and 'flat market-share.' (3) MULTI-HOP REASONING FAILURE: The question asks about Downy's percentage contribution to the segment, but the ground truth actually addresses the segment's contribution to total company sales. The LLM failed to recognize this distinction and instead invented specific percentages for Downy that contradict the available data. (4) CONCLUSION VALIDITY: While the LLM's conclusion about Downy being a 'stable, core brand' aligns with the ground truth's characterization of 'sustained strategic importance,' this correct conclusion is built on entirely incorrect numerical foundations. The reasoning about 'mature, reliable earnings contributor' is reasonable but unsupported by the fabricated data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 452,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nThe carrying value of Capital One’s total senior and subordinated notes was about **$30.8 bn in 2022**, rose to **$31.2 bn in 2023**, and then slipped slightly to **$30.7 bn in 2024** (see Tables 8.1 in the 2023 filing and Table 9.1 in the 2024 filing).  \nThis pattern shows that the firm expanded its long‑term debt issuance in 2023—likely to fund growth or refinance maturing obligations—while in 2024 it trimmed the balance, indicating a more measured or de‑leveraging approach to its debt financing over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers. Ground truth shows: 2022=$27,219M, 2023=$31,248M, 2024=$31,248M. LLM reports: 2022=$30.8bn (~$30,800M), 2023=$31.2bn (~$31,200M), 2024=$30.7bn (~$30,700M). The 2022 figure is off by approximately $3,581M (13% error), which is a substantial discrepancy. The 2024 figure is also incorrect—ground truth shows $31,248M (same as 2023), not $30.7bn. The LLM's claim of a 'slight slip' in 2024 is factually wrong; the ground truth shows the value remained flat at $31,248M from 2023 to 2024. REASONING ERROR: The LLM's interpretation of the trend is fundamentally flawed. It suggests a 'de-leveraging approach' in 2024 based on an incorrect decline that didn't actually occur. The correct interpretation (per ground truth) is a consistent upward trend from 2022 to 2023-2024, indicating increased reliance on senior and subordinated notes. MULTI-HOP SYNTHESIS: While the LLM attempted to synthesize data across years and draw strategic conclusions, the synthesis is built on incorrect numbers, making the entire analysis unreliable. The reference to 'Tables 8.1' and 'Table 9.1' cannot be verified and may be fabricated. COMPLETENESS: The answer does address the three-year period and attempts to characterize the trend, but the fundamental numerical errors undermine the entire response. The semantic interpretation of 'de-leveraging' contradicts the actual upward trend in the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 412,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s exposure to the Mexican pay‑TV market evolved from a 41.3 % equity stake in SKY Mexico—held as an equity‑method investment and reflected in the company’s 2022 and 2023 disclosures (see T‑10K 2022 p. 92; T‑10K 2023 p. 65)—to a full exit in June 2024 when the entire 41.3 % interest was sold for cash (T‑10K 2024 p. 61 notes the disposition and that SKY Mexico no longer appears in the equity‑method table).  Throughout 2022 and 2023 the investment was accounted for under the equity method, with AT&T recognizing its share of earnings and cash distributions that gradually reduced the carrying amount, setting the groundwork for a clean‑up of the position in 2024.  This three‑year trajectory illustrates AT&T’s broader Latin‑American divestiture strategy: it systematically monetized non‑core pay‑TV assets, shedding equity stakes that no longer aligned with its core telecom and streaming focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data correct—41.3% ownership stake consistently cited across all three years, June 2024 exit date accurate, equity method accounting treatment properly identified for 2022-2023. (2) Multi-hop reasoning sound—correctly synthesized information across three fiscal years showing the progression from holding steady (2022) → continued equity method treatment (2023) → full divestiture (2024). (3) Entity identification accurate—correctly identified SKY Mexico as the Mexican pay-TV asset, properly attributed to AT&T/T, correctly noted it was a non-core international asset. (4) Strategic narrative well-articulated—the answer effectively captures T's deliberate shift from equity method investments to divestiture, framing it within the broader Latin American pay-TV market exit strategy. (5) Citation references provided (T-10K 2022 p. 92; T-10K 2023 p. 65; T-10K 2024 p. 61) add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer adds slightly more operational detail (e.g., 'recognizing its share of earnings and cash distributions that gradually reduced the carrying amount') compared to the ground truth, but this represents appropriate elaboration rather than error. The characterization of the strategy as 'systematic monetization' and alignment with 'core telecom and streaming focus' is consistent with and slightly more specific than the ground truth's 'focus on core domestic operations.' No factual errors detected. The answer fully addresses all components of the multi-part question: ownership stake evolution, equity method accounting treatment, eventual exit, and broader strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 475,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nBNY Mellon’s 2022 filing first warned that returning capital to shareholders “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” In the 2023 and 2024 10‑Ks the same statement is retained but is now framed alongside explicit references to the “well‑capitalized” and “well‑managed” supervisory standards and to broader capital‑adequacy and liquidity rules, highlighting that any shortfall could restrict dividends, share repurchases or other capital‑return activities. The 2024 filing further connects these constraints to its regulatory capital disclosures (e.g., Pillar 3 and stress‑test results) and underscores the parent’s dependence on subsidiary dividends to fund any capital returns, making clear that deteriorating capital adequacy would directly limit future shareholder distributions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core regulatory constraints mentioned in BNY Mellon's filings (U.S. banking laws, capital adequacy rules, Delaware law, preferred dividend requirements). (2) Accurately captures the evolution of disclosures, noting that the same foundational statement was retained across years while contextual complexity increased. (3) Properly identifies specific regulatory frameworks mentioned in later filings (well-capitalized/well-managed standards, Pillar 3, stress-test results). (4) Correctly synthesizes the parent company's reliance on subsidiary dividends as a key constraint. (5) Accurately conveys the connection between capital adequacy deterioration and dividend/repurchase restrictions. (6) No quantitative errors detected - all dates (2022, 2023, 2024) and regulatory references are accurate. MINOR WEAKNESSES: (1) The LLM answer is more specific and detailed than the ground truth in some areas (e.g., explicit mention of Pillar 3 and stress-test results), which while accurate, goes slightly beyond what the ground truth explicitly states about the evolution. However, this represents elaboration rather than error. (2) The ground truth mentions ESG-related regulatory pressures in 2023, which the LLM answer does not explicitly address, though this is a relatively minor omission. (3) The ground truth's characterization of the trend as showing 'stable regulatory framework with increasing contextual complexity' is well-captured by the LLM but could have been more explicitly stated as a summary conclusion. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying both continuities (retained language) and changes (expanded regulatory references, strategic transformation impacts). The logical flow from 2022 baseline through 2023 expansion to 2024 integration with regulatory disclosures is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 553,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 to 2024 3M shifted structural adhesives out of a generic “adhesives” listing and placed them into a newly created **Industrial Specialties** sub‑division within the Safety & Industrial segment—grouping them with former Closure/Masking Systems, Industrial Adhesive & Tape products and related personal‑safety items.  This bundling signals that 3M now treats adhesives as a **core, cross‑selling platform** that can be packaged with other specialty industrial offerings, highlighting their strategic role as a growth‑driving, differentiator in industrial applications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that contradict the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims 3M created a 'newly created Industrial Specialties sub-division' in this period, but the ground truth shows Structural Adhesives remained within the Safety and Industrial segment throughout 2022-2024 with no mention of a new sub-division creation. (2) PRODUCT BUNDLING CLAIMS: The LLM states adhesives were bundled with 'Closure/Masking Systems, Industrial Adhesive & Tape products' in a new structure, but ground truth indicates the positioning evolved more subtly—from grouping with industrial abrasives, autobody repair, and electrical materials (2022) to emphasis on packaging/closure systems (2023) to specialized industrial applications (2024). The LLM's specific product groupings are not supported by the ground truth. (3) STRUCTURAL MISREPRESENTATION: The ground truth describes an evolution in positioning and emphasis within the existing segment structure, not a reorganization into a new sub-division. (4) UNSUPPORTED CHARACTERIZATION: The LLM's claim about 'cross-selling platform' and 'growth-driving differentiator' language is not present in the ground truth, which focuses on adhesives as a 'foundational component in complex industrial systems.' (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing claims not supported by the source material. The ground truth shows gradual evolution in product positioning; the LLM invents a structural reorganization. The answer demonstrates poor fidelity to the actual filing data and makes unsupported claims about organizational changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 468,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Lilly kept Cyramza positioned across a broad set of solid‑tumor indications—maintaining its second‑line uses in gastric, NSCLC, colorectal and HCC cancers and, in 2022‑23, adding a first‑line label for EGFR‑mutated metastatic NSCLC—while its intellectual‑property shield was already on the wane.  In the United States the compound patent was scheduled to expire in 2026 (with EU and Japanese compound patents also ending by 2026‑2028), and data‑protection periods were set to lapse in 2024 (EU) and 2023 (Japan), meaning that after those dates the product would lose its exclusive market rights in the key global markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with mostly correct information about Cyramza's strategic positioning from 2022-2024. STRENGTHS: (1) All key dates are accurate - Japan data protection expiration in 2023, EU in 2024, US biologics data protection in 2026, and compound patent expirations by 2026-2028. (2) Therapeutic indications correctly identified: gastric, NSCLC (including first-line EGFR-mutated metastatic NSCLC added in 2022-23), colorectal, and HCC cancers. (3) The multi-hop synthesis is sound, connecting therapeutic positioning with IP protection timelines across global markets. (4) The characterization of IP 'shield on the wane' effectively captures the strategic challenge. (5) Correctly identifies the three key global markets (US, EU, Japan) and their respective protection expirations. MINOR ISSUES: (1) The LLM adds detail about 'first-line label for EGFR-mutated metastatic NSCLC' being added in 2022-23, which is not explicitly mentioned in the ground truth answer. While this appears to be accurate additional context, it goes slightly beyond what the ground truth specifies. (2) The ground truth emphasizes 'sustained clinical positioning' and 'continued therapeutic relevance' as strategic messaging, while the LLM focuses more on the IP expiration challenge. Both perspectives are valid but represent slightly different emphases. (3) The ground truth mentions 'U.S. biologics data protection expiring in 2026' while the LLM mentions both 'compound patent' and 'data-protection periods' separately, which is more precise but slightly different framing. QUANTITATIVE VERIFICATION: All dates check out - 2023 (Japan), 2024 (EU), 2026 (US), 2026-2028 (compound patents). No calculation errors. MULTI-HOP REASONING: Successfully synthesizes information across therapeutic indications, IP protections, and geographic markets across the 2022-2024 period. The answer correctly identifies the evolution from broad positioning to managing lifecycle amid IP expirations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 539,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s fixed unsecured senior debt rose from $24.1 bn to $27.2 bn in 2023, then slipped slightly to $26.9 bn in 2024, while the weighted‑average interest rate stayed near 4.45‑4.48 % in 2022‑23 and climbed to 4.84 % in 2024. This pattern shows the firm has been expanding its senior‑debt capacity, but as market rates increased it began issuing new notes at higher coupons, indicating a strategy of growing funding while bearing higher financing costs in a rising‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors that fundamentally undermine its credibility. (1) 2022 CARRYING VALUE ERROR: Ground truth states $19,975 million for 2022, but LLM claims $24.1 billion ($24,100 million). This is a $4.1 billion discrepancy (20% overstatement). (2) 2023 CARRYING VALUE ERROR: LLM states $27.2 billion, but ground truth shows the progression was from $19,975M (2022) to $26,930M (2024). The LLM appears to have fabricated a 2023 intermediate value not supported by the ground truth. (3) WEIGHTED-AVERAGE INTEREST RATE ERRORS: LLM claims rates were 4.45-4.48% in 2022-23, but ground truth clearly states 2.91% for 2022. This is a massive error (off by ~1.5-1.6 percentage points). The LLM correctly identifies 4.84% for 2024 but misses the critical 2022 baseline. (4) MULTI-HOP SYNTHESIS FAILURE: The question requires tracking the evolution from 2022 to 2024. The LLM failed to correctly identify the 2022 baseline values, making the entire trend analysis unreliable. The correct trend shows: carrying value increase of $6,955M (from $19,975M to $26,930M, a 35% increase) and interest rate increase of 1.93 percentage points (from 2.91% to 4.84%). The LLM's trend narrative is qualitatively reasonable (discussing rising rates and debt expansion) but is built on incorrect foundational numbers. (5) CALCULATION VERIFICATION: The LLM's claim of a 'slight slip' from 2023 to 2024 cannot be verified against ground truth since the 2023 figure appears fabricated. The correct data shows a steady increase from 2022 to 2024. The reasoning about market conditions and capital structure is appropriate but cannot compensate for the severe quantitative errors. This answer would mislead a financial analyst relying on these specific metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 488,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nCisco hedges the compensation liability for its deferred‑compensation plans with total‑return swaps that are **not** accounted for as accounting hedges.  The swaps generated a **$92 million loss in FY 2022**, a **$58 million gain in FY 2023**, and a **$91 million gain in FY 2024** (recorded in operating expenses/other income).  At the same time the outstanding notional amount of these swaps rose from **$651 million (FY 2022)** to **$985 million (FY 2024)**, underscoring a growing but increasingly volatile exposure whose earnings impact swung sharply each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024. The notional amounts cited ($651 million in FY 2022 and $985 million in FY 2024) are accurate and provide valuable additional context not explicitly required but highly relevant to understanding the instrument's evolution. The answer correctly identifies that these swaps are not accounted for as accounting hedges and properly notes their recording in operating expenses/other income. The multi-hop synthesis is sound: the answer connects the three-year pattern of gains/losses with the growing notional exposure, effectively illustrating both the volatility and the expanding financial commitment. The characterization of the pattern as 'volatile' with 'sharp swings each year' accurately reflects the ground truth's description. The only minor distinction is that the LLM provides additional context (notional amounts, accounting treatment, expense classification) beyond the ground truth, which enhances rather than detracts from the answer's quality. All numbers are formatted consistently and correctly. The reasoning about what the pattern reveals about volatility is logically sound and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 371,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom 2022 through 2024 Home Depot shifted its store‑appearance focus from a generic refresh to a purpose‑built omnichannel design—modern signage, streamlined navigation, self‑service lockers, curb‑side pickup zones and electronic‑shelf‑labeling that tie directly into its digital order flow (pages 8, 9, 10, 32).  These investments lifted customer‑satisfaction and conversion metrics, producing a 6.6 % YoY rise in online sales to 15 % of total net sales and offsetting a 1.8 % dip in comparable sales, thereby preserving the retailer’s market share against multichannel and pure‑online competitors (pages 32‑34, 39).  The stronger in‑store experience also helped maintain foot‑traffic‑driven cross‑selling, reinforcing its competitive positioning over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIABLE SPECIFIC CLAIMS: The LLM answer provides very specific metrics (6.6% YoY rise in online sales, 15% of total net sales, 1.8% dip in comparable sales) with page citations (pages 8, 9, 10, 32, 32-34, 39) that cannot be verified against the ground truth knowledge graph. The ground truth makes NO mention of these specific percentages or metrics. This is a critical red flag for hallucination. (2) FACTUAL DIVERGENCE FROM GROUND TRUTH: The ground truth describes an evolution from 2022→2023→2024 showing strategic progression from standalone in-store experience to hybrid omnichannel model. The LLM answer jumps directly to describing 2022-2024 as a unified shift to 'purpose-built omnichannel design' with specific physical features (self-service lockers, curb-side pickup zones, electronic-shelf-labeling) that are NOT mentioned in the ground truth. (3) MISSING CORE NARRATIVE: The ground truth emphasizes the EVOLUTION and INTEGRATION of store appearance with digital capabilities over time. The LLM answer treats this as a single transformation with specific infrastructure investments, missing the year-by-year progression that was central to the original answer. (4) UNSUPPORTED COMPETITIVE POSITIONING CLAIMS: While both answers address competitive positioning, the LLM's specific claims about 'offsetting a 1.8% dip in comparable sales' and 'preserving market share' lack grounding in the provided ground truth. (5) PAGE CITATIONS CONCERN: The specific page references suggest the LLM may be fabricating details or confusing source material. Without verification that these pages contain the cited metrics, this represents a serious accuracy problem. The answer reads plausibly but appears to contain invented specificity rather than faithful synthesis of actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 494,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat carrying balance of roughly **$2.0 billion** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 (the note schedule on page 72 lists a $2,000 million net carrying amount as of both Jan 28 2024 and Jan 26 2025, and the same figure is implied for the prior year).  This stability demonstrates that NVIDIA is keeping a sizable, long‑dated senior note as a permanent part of its capital structure—using it to fund ongoing growth while maintaining a conservative, low‑coupon long‑term debt position rather than retiring or refinancing the issue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the carrying value was 'roughly $2.0 billion' and 'flat' across all three fiscal years (2022-2024). However, the ground truth shows: FY2022: $2,147 million, FY2023: $1,637 million, FY2024: $2,000 million. This is NOT flat—there was a substantial $510 million decrease from FY2022 to FY2023, followed by a $363 million increase from FY2023 to FY2024. The LLM's characterization of stability is factually incorrect. (2) MISSING KEY DATA: The LLM completely misses the FY2022 figure of $2,147 million and the FY2023 figure of $1,637 million, which are critical to understanding the evolution requested in the question. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks how the carrying value 'evolved from fiscal years 2022 through 2024.' The ground truth shows a clear three-year progression with meaningful fluctuations. The LLM fails to capture this temporal evolution and instead presents an inaccurate narrative of stability. (4) REASONING FLAW: The LLM's interpretation that the debt represents 'permanent' positioning is contradicted by the actual fluctuations shown in the ground truth data. The ground truth explicitly notes 'temporary reduction in the short term, followed by strategic repositioning,' which the LLM completely misses. (5) REFERENCE ISSUE: The LLM cites 'page 72' and specific dates (Jan 28 2024, Jan 26 2025) but provides incorrect values for those periods. The semantic interpretation about conservative debt positioning may have merit, but it's built on fundamentally incorrect numerical foundations. The answer fails on the primary metric of factual accuracy regarding the core financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 489,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Scotchgard litigation moved past the appellate reversal of summary judgment (2021‑22) into a phase where 3M settled only a handful of bellwether and class actions—most notably the $65 million New York settlement (2022) and the Michigan Wolverine settlement (June 2023), both judged immaterial—while the bulk of cases remained unresolved.  At the same time the exposure broadened geographically, with filings in dozens of states and many matters transferred to the AFFF multidistrict litigation, and the pool of defendants swelled to include dozens of co‑defendants such as DuPont, Chemours, Wolverine, Saint‑Gobain, Honeywell and various carpet and paper manufacturers.  Consequently, the litigation landscape evolved from a concentrated Minnesota‑centric MDL to a nationwide, multi‑forum battle with numerous co‑defendants and only modest settlement amounts recorded.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop litigation landscape. STRENGTHS: (1) All key numeric values are correct: $65 million New York settlement (2022), Michigan Wolverine settlement (June 2023), both marked as immaterial. (2) Dates are accurate: 2022-2024 timeframe properly captured, with specific reference to 2021-22 appellate reversal context. (3) Geographic expansion correctly identified: New York (Baker case), Michigan (Wolverine), and broader expansion to multiple states including Alabama and Georgia implied through 'dozens of states' reference. (4) Defendant pool expansion accurately captured: DuPont, Chemours, Wolverine, Saint-Gobain, Honeywell, carpet manufacturers (Mohawk implied in 'carpet manufacturers'), and paper manufacturers mentioned. (5) Multi-hop synthesis is sound: correctly connects settlement amounts, geographic spread, and defendant expansion as interconnected elements of evolving litigation landscape. (6) Semantic equivalence maintained: 'Minnesota-centric MDL' to 'nationwide, multi-forum battle' effectively conveys the geographic expansion concept. MINOR WEAKNESSES: (1) The answer adds contextual detail about 'appellate reversal of summary judgment (2021-22)' and 'AFFF multidistrict litigation' that, while accurate and relevant, goes slightly beyond the ground truth's explicit scope—though this enhances rather than detracts from accuracy. (2) Mohawk Industries is not explicitly named in the LLM answer (uses 'carpet manufacturers' generically), though the ground truth specifically mentions Mohawk. (3) The characterization of settlements as 'only modest settlement amounts recorded' is interpretive but reasonable given the 'immaterial' designation. CALCULATION VERIFICATION: No calculations required; all dollar amounts and dates are factually correct. ENTITY ACCURACY: All companies correctly identified and properly associated with litigation. The answer successfully synthesizes information across multiple years, jurisdictions, and parties to create a coherent narrative of litigation evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 565,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a single, large revenue spike in 2022 – $2.02 billion of net product revenue from sales of the COVID‑19 antibodies (bamlanivimab and bebtelovimab) under EUAs – after which no sales occurred in 2023 or 2024, so royalty payments (tiered at mid‑teens to mid‑twenties % of worldwide net sales and recorded as cost of sales) also ceased.  The collaboration began with an upfront license and included development‑milestone payments (a $50 million R&D expense recognized in 2020), but no additional milestone payments were reported after 2022, leaving the financial impact of the partnership essentially flat‑zero in 2023‑2024.  (Pages 71, 75, 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop financial question. STRENGTHS: (1) All key numeric values are correct: $2.02 billion in 2022 net product revenue, zero sales in 2023-2024, tiered royalty structure at mid-teens to mid-twenties percentage, and the $50 million R&D expense in 2020. (2) The answer correctly identifies the product names (bamlanivimab and bebtelovimab) and regulatory context (EUAs). (3) Multi-hop synthesis is sound: the answer traces the evolution across three years, connects revenue to royalty payments, and explains the causal relationship between sales cessation and royalty payment cessation. (4) The answer addresses all sub-components of the question: royalty structure (tiered mid-teens to mid-twenties), milestone payments (upfront license, $50M development milestone in 2020, no additional payments post-2022), and net product revenue ($2.02B in 2022, zero thereafter). (5) The characterization of the trajectory as \"declining\" is accurately reflected through the narrative of the single revenue spike followed by complete cessation. (6) Contextual details are appropriate: noting the recording of royalties as cost of sales, the EUA regulatory context, and the timeline of financial activity. MINOR CONSIDERATIONS: The answer includes page references (71, 75, 75) which adds credibility but cannot be verified in this evaluation context. The phrasing \"essentially flat-zero\" is colloquial but semantically accurate. The answer is slightly more detailed than the ground truth (mentioning specific product names and EUA context) but this represents appropriate elaboration rather than error. No calculation errors detected. All entities (LLY, AbCellera, years 2022-2024) correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 489,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Dawn brand helped lift the Fabric & Home Care segment’s net sales + 4 % (to $29.5 bn) and drove a 230‑basis‑point jump in the segment’s margin, expanding the segment’s share of total earnings from 31 % to 34 % of net earnings.  This growth was powered by higher pricing and a favorable product mix that kept Dawn’s market‑share leadership in dish‑care intact, underscoring the brand’s strategic importance as a core profit‑generating pillar within P&G’s portfolio.  In short, Dawn’s performance illustrates how P&G is using the brand to deliver pricing power and margin expansion, positioning it as a key growth engine for the company’s overall strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the segment grew to $29.5 billion in net sales and that earnings share expanded from 31% to 34% - these specific numbers are not verified in the ground truth and appear to be fabricated. The ground truth shows: 2022 (35% net sales, 31% earnings), 2023 (36% net sales, 34% earnings), 2024 (36% net sales, 34% earnings). The LLM's claim of a '+4%' growth in net sales and '230-basis-point jump in margin' cannot be verified and likely misrepresents the data. (2) INCOMPLETE YEAR-BY-YEAR ANALYSIS: The ground truth explicitly documents the evolution across all three years (2022, 2023, 2024) with specific percentages for each year. The LLM collapses this into a single aggregate statement without showing the year-by-year progression that the question specifically asks about. (3) UNSUPPORTED CLAIMS: The LLM makes assertions about 'higher pricing,' 'favorable product mix,' and 'market-share leadership in dish-care' that are not present in the ground truth. These appear to be inferences or fabrications not grounded in the filing data. (4) MISSING KEY INSIGHT: The ground truth's core finding - that Dawn remained 'consistently highlighted' with 'no indication of reduced emphasis or strategic repositioning' - is fundamentally different from the LLM's narrative of 'growth' and 'margin expansion.' The ground truth emphasizes consistency and stability; the LLM emphasizes growth and change. (5) MULTI-HOP REASONING FAILURE: The question asks how positioning 'evolved' from 2022-2024. The ground truth correctly identifies that it remained stable/consistent. The LLM incorrectly frames this as dynamic growth without proper year-by-year documentation. The answer demonstrates fabrication of specific financial metrics and failure to accurately synthesize the multi-year comparison required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 527,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from $883 million (2022) to $538 million (2023) and then edged up to $562 million in 2024, while long‑term debt rose to $49.3 billion in 2023 before pulling back to $45.0 billion in 2024.  The firm also dramatically trimmed its floating‑rate unsecured senior debt, dropping from $1.6 billion in 2022 to $0.35 billion in 2023 and essentially to zero by 2024, reflecting a strategic shift toward higher‑fixed‑rate, longer‑dated funding and reduced exposure to floating‑rate market swings.  This three‑year trend shows a deliberate de‑leveraging of short‑term liquidity and a move away from floating‑rate senior debt, improving balance‑sheet stability but increasing the proportion of fixed‑rate cost in the debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core financial numbers that are fundamental to answering this question. (1) TOTAL DEBT FIGURES - INCORRECT: Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM provides fragmented numbers that don't align: it states short-term borrowings of $883M (2022), $538M (2023), $562M (2024) and long-term debt of $49.3B (2023) and $45.0B (2024), but these don't reconcile to the ground truth totals. The LLM appears to have confused or misreported the component breakdown. (2) FLOATING UNSECURED SENIOR DEBT - PARTIALLY CORRECT: Ground truth shows $1.709B (2022), $349M (2023), eliminated by 2024. LLM states $1.6B (2022), $0.35B (2023), essentially zero by 2024. The 2023 figure is close ($349M vs $350M), but the 2022 figure is off by $109M ($1.709B vs $1.6B), representing a 6.4% error on a key metric. (3) MISSING CRITICAL DATA: The LLM completely omits the weighted-average interest rate progression on fixed unsecured senior debt (2.91% → 4.45% → 4.84%), which is explicitly mentioned in the ground truth as a key indicator of the strategic shift and interest rate exposure. This is a significant omission for a question specifically asking about 'interest rate exposure.' (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the strategic shift toward fixed-rate debt and away from floating-rate exposure, it fails to properly synthesize the complete picture by missing the interest rate data that demonstrates HOW the company's cost structure evolved. (5) REASONING QUALITY: The qualitative interpretation (de-leveraging, balance-sheet stability, shift to fixed-rate) is directionally reasonable but is built on partially incorrect quantitative foundations. The answer demonstrates understanding of the strategic implications but lacks precision in the underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 527,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note—issued with a $2 billion principal and maturing on Feb 15 2039—has been on the books throughout fiscal 2022‑2024.  Its effective interest rate, net of discount amortization and the related fair‑value hedge, has remained essentially unchanged at about **6.1 %** each year.  However, the note’s share of the company’s overall debt grew markedly: while it represented roughly $2 billion of the ≈ $8.5 billion long‑term debt in FY 2022, the February 2024 issuance of $13.5 billion of new senior notes lifted total long‑term debt to ≈ $19.6 billion, so the 5.90 % note now accounts for about 10 % of the expanded long‑term‑debt balance.  The instrument continues to be classified as **long‑term debt** (non‑current) on Cisco’s consolidated balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor presentation differences from the ground truth. STRENGTHS: (1) All key numbers are correct: $2 billion principal amount, 6.1% effective interest rate (ground truth: 6.11%, LLM: ~6.1% - acceptable rounding), $8.5 billion FY2022 long-term debt (ground truth: $8,416M ≈ $8.4B, LLM: $8.5B - minor rounding variation), $19.6 billion FY2024 long-term debt (ground truth: $19,621M ≈ $19.6B - matches), maturity date Feb 15 2039 (correct). (2) The calculation of the note's proportion (~10% in 2024) is accurate: $2,000M / $19,621M ≈ 10.2%. (3) Multi-hop synthesis is sound: correctly identifies the note's stable principal amount across three years while debt portfolio expanded significantly. (4) Properly addresses all question components: principal amount, effective interest rate, debt composition evolution, and long-term classification. (5) Adds contextual detail about the Feb 2024 $13.5B issuance that explains the debt growth. MINOR ISSUES: (1) LLM states FY2022 long-term debt as '≈ $8.5 billion' while ground truth specifies $8,416 million ($8.4B) - this is a minor rounding difference but technically less precise. (2) The phrasing 'the note's share of the company's overall debt grew markedly' could be slightly misleading since the note's absolute proportion actually decreased (from ~23.8% to ~10.2%), though the LLM does clarify this by stating it 'now accounts for about 10%.' The statement is technically correct in that the note's importance relative to total debt changed, but the wording could suggest growth when it actually represents a declining share. (3) Ground truth emphasizes the note remained 'stable' and 'fixed-rate,' which LLM captures but with less emphasis on stability. Overall, the answer is substantially correct with accurate synthesis of multi-hop information across fiscal years and debt metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 512,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe 1.55 % Notes due 2028 showed a nearly flat book balance – $1.25 billion at the end of fiscal 2024 and $1.25 billion at the end of fiscal 2023 (the same $1.20 billion fair‑value amount disclosed for fiscal 2022 after adjusting for the remaining discount and issuance costs) – while the effective interest rate stayed at about **1.64 %** each year.  This steady, low‑cost financing reflects NVIDIA’s strategy of issuing long‑dated, fixed‑rate debt at minimal expense and then holding it as a stable pillar of its capital structure, using the notes to fund growth without markedly increasing leverage or altering the debt‑mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CARRYING VALUE ERRORS: The LLM states the carrying value was '$1.25 billion at the end of fiscal 2024 and $1.25 billion at the end of fiscal 2023' - this is incorrect. Ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. The LLM incorrectly claims FY2023 was $1.25B when it was actually $1.099B - a $151M error. This is a critical misstatement of the trend. (2) TREND ANALYSIS FAILURE: The LLM describes the balance as 'nearly flat' and 'steady,' which is factually wrong. The ground truth shows a clear downward trend from $1,200M to $1,099M (8.4% decrease) in FY2023, followed by a recovery to $1,250M in FY2024. This is NOT a flat trend. (3) EFFECTIVE INTEREST RATE: The LLM correctly identifies 1.64% for FY2024, but incorrectly implies it 'stayed at about 1.64% each year.' Ground truth indicates the rate increased from an implied rate in 2022 to 1.64% in 2024, showing an upward trend in borrowing costs. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year evolution. It missed the significant dip in 2023 and the subsequent recovery, which are essential to understanding the trend. The characterization of the strategy as 'steady, low-cost financing' is misleading given the actual volatility and cost increases. (5) SEMANTIC ISSUES: While the LLM's strategic interpretation about 'stable pillar of capital structure' has some merit, it's built on incorrect factual premises. The answer demonstrates poor synthesis of multi-year data and contains multiple quantitative errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 458,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google continued to report Pixel phone sales under the **“devices”** line of its **Google Subscriptions, Platforms & Devices** revenue category (see pages 8 & 25), treating them as part of the broader hardware‑revenue stream alongside other products.  At the same time the company **ramped up hardware‑innovation spending** – launching new Pixel 5a/6 models and expanding the Nest device line – and **increased capital investment** in its hardware infrastructure, as reflected by a rise in depreciation of property and equipment (from $13.5 bn in 2022 to $15.3 bn in 2024) and higher R&D outlays (pages 7, 57).  This shows a clear strategic shift toward greater emphasis on, and investment in, Pixel and related hardware innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Google's Pixel strategy but has significant issues with quantitative accuracy and completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies Pixel devices under 'devices' segment within Google Subscriptions, Platforms & Devices revenue category; (2) Appropriately references pages 8 & 25 as sources; (3) Correctly notes the strategic shift toward hardware innovation; (4) Mentions increased capital investment and depreciation trends. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites depreciation increasing from $13.5bn (2022) to $15.3bn (2024), but these specific numbers cannot be verified against the ground truth and appear potentially inaccurate or unsourced; (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a 3-year progression showing transformation from 'hardware investment focus' (2022) to 'distinct categorization' (2023) to 'mature, strategically embedded' (2024). The LLM answer treats this more as a continuous trend rather than capturing the distinct evolution across years; (3) MISSING KEY INSIGHT - The ground truth highlights that by 2023, Pixel was 'explicitly categorized under a distinct segment,' suggesting a structural change in reporting. The LLM doesn't clearly distinguish this 2023 milestone; (4) VAGUE PRODUCT REFERENCES - The LLM mentions 'Pixel 5a/6 models' but doesn't clearly establish the timeline of these launches relative to the 2022-2024 period being analyzed; (5) MISSING INTEGRATION NARRATIVE - The ground truth emphasizes integration with 'broader AI and cloud capabilities' by 2024, which the LLM answer doesn't address. MULTI-HOP REASONING: The LLM attempts to synthesize financial metrics (depreciation, R&D) with product strategy, but the connection is somewhat superficial and the specific numbers lack clear sourcing. The answer would benefit from more explicit year-by-year comparison showing the evolution rather than treating it as a continuous trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 539,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nBNY Mellon’s 10‑K filings for 2022, 2023 and 2024 all contain the identical phrasing in Item 14 that “the information required…is included in the Proxy in the section ‘Item 3 – Ratification of KPMG LLP,’” and each filing lists KPMG’s PCAOB firm identification number (185) and includes KPMG’s consent as Exhibit 23.1. The wording, structure and referenced exhibit have not changed across the three years, indicating that the company has continued to ratify KPMG as its principal auditor without interruption and that its audit relationship with KPMG remains stable and unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - KPMG's PCAOB firm identification number (185) is accurately cited, and the three-year period (2022, 2023, 2024) is correctly identified. No calculations are required for this question, and all factual numbers match the ground truth. ENTITY ACCURACY: BNY Mellon is correctly identified, KPMG LLP is properly named, and the relevant SEC filing items (Item 14 and Item 3) are accurately referenced. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) how disclosure evolved (answer: no evolution, consistent), (2) what consistency reveals about audit relationship stability (answer: stable, unchanged, no disruptions). MULTI-HOP REASONING: The LLM correctly synthesized information across three years of filings to identify the pattern of consistency and drew the appropriate conclusion about relationship stability. The logic is sound - identical language and structure across years logically supports the conclusion of stability. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth using slightly different but equivalent phrasing. Both emphasize: identical language across years, PCAOB number 185, no changes in content/structure, and stable ongoing relationship. The LLM adds minor details (reference to Exhibit 23.1 and Item 14 structure) that enhance rather than contradict the ground truth. MINOR OBSERVATION: The LLM's mention of Exhibit 23.1 (KPMG's consent) is a reasonable elaboration not explicitly in the ground truth statement, but this represents appropriate contextual detail rather than an error. The conclusion about audit relationship stability is identical in substance to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 495,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative‑investment holdings in its defined‑benefit and retiree‑health plans were about $8.9 bn in 2022, slipped modestly to $8.6 bn in 2023, and the 2024 filing shows a comparable total, keeping illiquid assets at roughly 60 % of plan assets. This stable, sizable exposure across the three years signals a deliberate long‑term strategy to maintain a meaningful allocation to private alternatives for diversification and long‑run return objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows LLY's private alternative investments at $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024). The LLM reports approximately $8.9B (2022), $8.6B (2023), and comparable 2024 levels - these are significantly lower than actual values and represent a ~$1.6-1.9B discrepancy. The LLM also incorrectly frames these as 'defined-benefit and retiree-health plans' allocations rather than overall company investment allocations, which is a material contextual error. Additionally, the LLM's claim about '60% of plan assets' cannot be verified against the ground truth and appears to be fabricated. The directional trend (slight decline then stabilization) is somewhat similar to ground truth, but the magnitude of error is severe. The LLM does correctly identify the strategic intent (long-term diversification through illiquid assets), but this qualitative assessment cannot compensate for the quantitative inaccuracy. The multi-hop reasoning about investment strategy is sound in principle, but is built on incorrect foundational numbers, making the entire analysis unreliable. For financial data, accuracy of specific dollar amounts is paramount - a $1.6B error represents a 16-19% deviation from actual values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 375,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross the three fiscal years Tampax remained classified under the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** segment.  In 2022 the brand was positioned as a market‑share leader (≈ 25 % global share) with an explicit emphasis on premium‑priced products; 2023‑2024 saw a shift toward **price‑driven growth and mix optimization**—net sales were essentially flat, but margin improved as higher pricing and a larger share of premium Tampax variants offset modest volume declines, while the company continued to treat Tampax as a core growth driver within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth:\n\n1. CRITICAL ERRORS - Category Classification Evolution:\n   - Ground Truth: In 2023, 'Menstrual Care' explicitly REPLACED 'Feminine Care' as the sub-category name; in 2024, Tampax was under 'Menstrual Care'\n   - LLM Answer: Claims Tampax remained under 'Feminine Care' across all three years - this is INCORRECT\n   - The LLM completely missed the key evolution: Feminine Care → Menstrual Care transition\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - Ground Truth: Segment sales contribution was 25% (2022), 24% (2023), 24% (2024)\n   - LLM Answer: Mentions \"≈ 25% global share\" for 2022 but conflates market share with segment sales contribution - these are different metrics\n   - LLM provides no segment sales percentages for 2023-2024, missing critical quantitative data\n   - The \"≈ 25% global share\" appears to be market share data, not the segment contribution percentage\n\n3. MISSING KEY STRUCTURAL CHANGES:\n   - Ground Truth: In 2024, 'Baby Care' was removed from the segment entirely, signaling strategic shift\n   - LLM Answer: Completely omits this significant portfolio restructuring\n   - Ground Truth: Explicit mention of 'Adult Incontinence' grouping in 2022\n   - LLM Answer: No mention of this category context\n\n4. UNSUPPORTED CLAIMS:\n   - LLM claims \"premium-priced products\" emphasis in 2022 - not mentioned in ground truth\n   - LLM claims \"price-driven growth and mix optimization\" in 2023-2024 - not substantiated in ground truth\n   - LLM claims \"margin improved\" and \"higher pricing\" - these specific claims lack support\n   - LLM claims \"modest volume declines\" - not mentioned in ground truth\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to synthesize the category name evolution across years\n   - Failed to connect the segment composition changes (removal of Baby Care) to strategic positioning\n   - Did not properly track the Feminine Care → Menstrual Care terminology shift\n\n6. WHAT WAS CORRECT:\n   - Correctly identified P&G's Baby, Feminine & Family Care segment\n   - Correctly identified Tampax as a core brand\n   - Correctly noted the segment remained relatively stable in sales contribution\n\nThe answer fundamentally misses the primary evolution requested: the shift from 'Feminine Care' to 'Menstrual Care' classification, which is the central factual change across these three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 652,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s net derivative assets (liabilities) grew from about $31 million to $58 million and then to $69 million. The fair‑value measurement remained a discounted‑cash‑flow model, and the primary unobservable input—swap rates—narrowed from a 3‑5 % range (weighted average ≈ 4 %) in 2023 to a single 4 % estimate in 2024; default‑rate assumptions were incorporated in the DCF but were not separately disclosed for the derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) WRONG NUMBERS: The LLM states fair values of $31M (2022), $58M (2023), and $69M (2024). The ground truth shows $19M (2022), $58M (2023), and $58M (2024). The 2022 figure is off by $12M, and the 2024 figure is off by $11M - these are material errors. (2) INCORRECT TREND: The LLM describes growth from $31M to $69M, suggesting an upward trajectory. The ground truth shows $19M to $58M (increase), then flat at $58M in 2024. This misrepresents the evolution pattern. (3) SWAP RATES CLAIM: The LLM claims swap rates 'narrowed from 3-5% in 2023 to a single 4% estimate in 2024.' The ground truth states swap rates remained '3-5%' in both 2023 and 2024 - there was NO narrowing. This is a false claim about how assumptions evolved. (4) DEFAULT RATES DISCLOSURE: The LLM states default rates 'were not separately disclosed for the derivatives,' but the ground truth explicitly reports default rates of 53-163% in 2023 and implies continued use in 2024. This is a significant omission of key unobservable inputs. (5) VALUATION TECHNIQUE: The LLM correctly identifies discounted cash flow models, but this is the only element that aligns with ground truth. (6) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the evolution across three years, particularly the shift toward transparency starting in 2023 that the ground truth emphasizes. The LLM's narrative of narrowing assumptions contradicts the actual data showing consistent ranges. VERDICT: While the LLM demonstrates understanding of the general topic (DCF models, swap rates), it provides materially incorrect financial figures and mischaracterizes how key assumptions evolved, making this answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 496,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale (AFS) debt securities moved from a modest $9 million gain in fiscal 2022 to losses of $21 million in fiscal 2023 and $67 million in fiscal 2024, driving the overall “other income (loss), net” line from a $392 million gain in 2022 to $(306) million in 2024. This shift shows that the AFS portfolio, once a small source of earnings, increasingly generated negative contributions and highlighted rising credit‑ and interest‑rate‑related risks in Cisco’s investment holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states specific AFS debt investment figures ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) and 'other income (loss), net' values ($392M in 2022, $(306)M in 2024). The ground truth explicitly states that 'no specific performance metrics were provided for that year [2022], indicating no immediate material impact on financial results.' This directly contradicts the LLM's claim of a $9M gain in 2022. The ground truth does not provide the specific dollar amounts the LLM cites for 2023 and 2024, making these numbers unverifiable and likely hallucinated. (2) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three fiscal years and connect AFS debt investments to 'other income (loss), net,' it does so with unsubstantiated numbers. The ground truth indicates that 2023 and 2024 showed 'material negative impact' but does not quantify these as $21M and $67M respectively. (3) SEMANTIC ALIGNMENT: The LLM's conclusion about 'rising credit- and interest-rate-related risks' is reasonable inference but goes beyond what the ground truth explicitly states. The ground truth focuses on 'growing financial risk' more generally. (4) COMPLETENESS: The LLM does address the three-year period and attempts to show the trend, which aligns with the question's scope. However, the fabricated specificity of numbers is a fundamental failure. The ground truth's more cautious approach (noting lack of 2022 data, describing 2023-2024 as showing material negative impacts) is more accurate than the LLM's precise but unverified figures. This represents a hallucination of financial data, which is a critical error in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 499,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nStarbucks’ green‑coffee outlook tightened over the three years. In its 2022 filing the company said fixed‑price and price‑to‑fixed purchase commitments, backed by inventory, would keep supply adequate through **fiscal 2025**. By the 2023 filing the horizon had shifted to cover only through **fiscal 2023**, reflecting the nearer‑term nature of the commitments as the prior multi‑year plan expired. The 2024 filing again reaffirmed a **through‑fiscal 2025** outlook, underscoring the continued use of forward contracts, hedges and diversified sourcing to protect against commodity volatility and supply disruptions. This progression shows that Starbucks manages coffee‑supply risk through long‑term contractual commitments and active hedging, while periodically refreshing the horizon to align with market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) FISCAL 2022 CLAIM: The LLM states that in the 2022 filing, Starbucks projected supply adequacy 'through fiscal 2025.' The ground truth explicitly states that in fiscal 2022, the company projected adequacy 'through fiscal 2023.' This is a major factual error - the LLM has inverted the timeline by two years. (2) FISCAL 2023 CLAIM: The LLM states the 2023 filing showed a horizon 'only through fiscal 2023,' claiming this reflected expiration of prior commitments. The ground truth states that by fiscal 2023, the company 'extended its supply adequacy projection to fiscal 2025.' This is the opposite of what the LLM claims - the projection was extended, not shortened. (3) FISCAL 2024 CLAIM: The LLM correctly states the 2024 filing reaffirmed a 'through fiscal 2025' outlook, which aligns with ground truth. (4) MULTI-HOP REASONING: The LLM's interpretation of the progression is fundamentally flawed. It characterizes the trend as a 'tightening' outlook with periodic shortening and re-extension, when the ground truth shows a clear strengthening pattern: 2022 (through 2023) → 2023 (through 2025) → 2024 (through 2025). This represents progressive lengthening and stabilization, not the cyclical tightening the LLM describes. (5) STRATEGIC INTERPRETATION: While the LLM's discussion of hedging and risk mitigation is reasonable, it's built on incorrect factual premises. The ground truth emphasizes 'strengthening sourcing strategy' and 'enhancing supply chain resilience,' which the LLM partially captures but misframes due to the inverted timeline understanding. The answer demonstrates a fundamental misreading of the three-year progression that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 495,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nThe 2.00 % Notes Due 2031 have a net carrying amount of roughly **$1.25 billion** as of the end of fiscal 2024 (Jan 28, 2024) and again in fiscal 2025 (Jan 26, 2025), up from a **$1.05 billion** fair‑value level reported at the close of fiscal 2022 (Jan 29, 2023).  At the same time the company retired its near‑term 0.309 % 2023 and 0.584 % 2024 notes and issued new senior unsecured debt maturing in 2031 and beyond, deliberately extending the maturity profile of its long‑term financing.  This shift shows that NVIDIA is managing its debt by **locking in longer‑dated, low‑coupon capital** and reducing rollover risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Critical number discrepancies: LLM states $1.05B for fiscal 2022, but ground truth shows $1,200M ($1.2B). LLM reports $1.25B for fiscal 2024, which matches ground truth ($1,250M), but omits the fiscal 2023 figure of $1,044M entirely. The LLM also introduces fiscal 2025 data (Jan 26, 2025) which is not in the ground truth and appears to be hallucinated or outside the requested 2022-2024 timeframe. (2) DATE CONFUSION - LLM incorrectly labels dates: states 'fiscal 2022 (Jan 29, 2023)' which is contradictory and confusing. The ground truth clearly tracks FY2022, FY2023, and FY2024. (3) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the three-year trend. Ground truth shows: $1,200M (2022) → $1,044M (2023) → $1,250M (2024), revealing a dip in 2023 followed by recovery. LLM misses the 2023 data point entirely, breaking the multi-hop analysis. (4) REASONING QUALITY - While the LLM's interpretation about debt strategy (locking in longer-dated, low-coupon capital) is reasonable and contextually relevant, it's built on incomplete/incorrect data. The mention of retiring 0.309% and 0.584% notes adds context not in ground truth but doesn't compensate for missing core data. (5) SEMANTIC ISSUES - The LLM conflates 'fair-value level' with carrying amounts, which may represent different accounting treatments. Ground truth doesn't specify which metric is being reported. Overall, the answer demonstrates partial understanding of NVIDIA's debt strategy but fails on fundamental quantitative accuracy and completeness of the three-year trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 443,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024, fall‑protection solutions stayed inside the Safety & Industrial segment but were moved out of the generic “Personal Safety” bucket and into the newly created **Industrial Specialties** division in 2024.  This re‑classification gave fall‑protection its own sub‑segment alongside adhesives, tapes and other specialty items, signalling a more pronounced strategic focus on industrial‑specialty safety products relative to the broader safety‑and‑industrial portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The ground truth states Fall Protection Solutions remained within the Safety and Industrial segment throughout 2022-2024 with consistent positioning, but the LLM claims they were 'moved out of the generic Personal Safety bucket and into the newly created Industrial Specialties division in 2024' - this is a fundamental mischaracterization. (2) The ground truth indicates a 'subtle shift' in framing and grouping, not a major reclassification into a new division. (3) The LLM introduces unsupported claims about 'adhesives, tapes and other specialty items' being part of this new sub-segment, which is not mentioned in the ground truth. (4) The LLM's assertion of a 'newly created Industrial Specialties division' in 2024 is not supported by the ground truth, which describes a 'slightly revised grouping' within the existing segment. (5) The ground truth emphasizes that fall protection remained aligned with respiratory, hearing, and eye protection as core industrial safety products, whereas the LLM suggests a separation from 'generic Personal Safety.' The LLM appears to have fabricated structural reorganization details that do not match the actual evolution described in the knowledge graph. The answer demonstrates poor multi-hop synthesis and introduces false organizational claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 387,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Lilly generated roughly $2.0 billion from bamlanivimab (about $2.01 billion in the U.S. and $14.7 million abroad); by 2023 and 2024 that revenue was essentially $0. The sharp drop shows that Lilly’s reliance on its COVID‑19 antibody portfolio has dramatically receded, making the portfolio only a trivial contributor to overall sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: The 2022 figure of $2.01 billion matches the ground truth exactly. The breakdown into U.S. ($2.01 billion) and international ($14.7 million) components adds helpful detail not contradicted by the ground truth. The 2023 and 2024 figures of essentially $0 match the ground truth. The total 2022 revenue ($2.01 billion + $14.7 million ≈ $2.025 billion) is consistent with the stated $2.01 billion figure when considering rounding. Multi-hop reasoning: The answer correctly synthesizes the revenue trend across three years (2022-2024) and properly interprets what this decline indicates about the company's reliance on the COVID-19 antibody portfolio. The characterization of the portfolio as 'dramatically receded' and 'only a trivial contributor to overall sales' accurately reflects the significance of the trend. Entity accuracy: Eli Lilly and bamlanivimab are correctly identified. The answer appropriately contextualizes bamlanivimab within the broader COVID-19 antibody portfolio. Semantic equivalence: The LLM's phrasing ('sharp drop,' 'dramatically receded,' 'trivial contributor') conveys the same analytical insight as the ground truth's 'rapid decline' and 'waned demand.' The only minor consideration is that the LLM provides additional geographic breakdown detail not explicitly in the ground truth, but this is supplementary and accurate rather than contradictory. The answer fully addresses both parts of the question: the revenue evolution and what it indicates about reliance on the portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 436,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved from short‑term hedging and purchase commitments that were projected to cover only through fiscal 2023 (2022 10‑K p. 12) to an explicit program that secures green‑coffee supply with fixed‑price and price‑to‑be‑fixed contracts and related forward, futures and collar hedges that are now expected to be adequate through fiscal 2025 (2024 10‑K pp. 6, 12).  This extension reflects a deliberate risk‑management strategy that locks in supply and uses commodity‑index‑fund‑linked futures and collars to blunt coffee‑price volatility and protect the company’s supply chain as market swings intensify.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal progression from fiscal 2022 through fiscal 2024, accurately capturing the shift from supply visibility through fiscal 2023 (in 2022) to fiscal 2025 (by 2024). (2) Accurately references specific 10-K page numbers (2022 10-K p. 12 and 2024 10-K pp. 6, 12), demonstrating proper document sourcing. (3) Correctly identifies the hedging instruments used: forward contracts, futures contracts, and collars. (4) Properly synthesizes the multi-hop relationship between commodity index fund exposure, coffee price volatility, and risk management strategy evolution. (5) Accurately conveys that commodity index funds continue to influence arabica futures prices while Starbucks strengthens its hedging approach. (6) The semantic meaning matches ground truth: both answers describe a deliberate, progressive strengthening of risk management capabilities over the three-year period. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'commodity-index-fund-linked futures' is a reasonable characterization of the relationship between index fund activity and futures pricing. The answer correctly emphasizes that this represents a 'deliberate risk-management strategy' that extends supply visibility and uses hedging instruments to manage volatility. No factual errors, calculation errors, or entity misidentifications detected. The multi-hop reasoning correctly synthesizes information about supply commitments, hedging instruments, and market dynamics across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 463,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nFrom 2022 through 2024 Google kept using Google Ad Manager as the core platform for selling impression‑based ads on its Network partners, refining the way it counts impressions and cost‑per‑impression and continuing to record those revenues on a gross (principal) basis.  In January 2023 the company reassessed the useful lives of its servers and network equipment—extending them from four‑five years to six years— which reduced depreciation expense by roughly $3.9 bn in 2023 and lifted net income by about $3 bn, a one‑time boost to profitability that reflects the longer‑life accounting shift.  Because the new six‑year schedule lowers the ongoing depreciation burden on the infrastructure that supports Ad Manager, Google can sustain higher margins from impression‑based advertising even as capital spending rises in 2024, improving the long‑term profitability outlook of that business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. Verification of key claims: (1) Google Ad Manager's role as core platform for impression-based monetization 2022-2024 is correctly identified and consistently described across the period. (2) The 2023 depreciation schedule adjustment is accurately stated: servers extended from 4 to 6 years, network equipment from 5 to 6 years (matches ground truth). (3) Financial impact numbers are precise: $3.9 billion depreciation expense reduction and $3.0 billion net income increase are correctly cited. (4) The multi-hop reasoning is sound: the LLM correctly synthesizes that the depreciation change directly supports infrastructure-heavy operations like Ad Manager, and logically connects this to long-term profitability implications. (5) The answer appropriately addresses all question components: evolution from 2022-2024, the 2023 adjustment, and implications for profitability. Minor strengths: The LLM adds useful context by noting the 'one-time boost' nature of the adjustment and explaining how lower ongoing depreciation burden supports margin sustainability. The phrasing 'gross (principal) basis' demonstrates understanding of accounting treatment. No material errors detected. The answer is slightly more interpretive than the ground truth (e.g., 'can sustain higher margins...even as capital spending rises') but this represents reasonable inference from the data rather than factual error. All numeric values, dates, and entity references are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 430,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan, BK has issued a new version of its Performance Share Unit (PSU) agreement each year from 2022 through 2024 (Exhibits 10.21, 10.26 and 10.29 in the 2022, 2023 and 2024 10‑K filings). The 2022 PSU agreement established the initial performance metrics and target payout for the 2022‑2023 performance cycle, the 2023 amendment refined those metrics and thresholds for the 2023‑2024 cycle, and the 2024 PSU agreement further adjusts the criteria and target levels to reflect the latest strategic priorities. This progressive updating demonstrates that BK’s executive compensation strategy centers on performance‑driven, long‑term equity incentives that are regularly recalibrated to align pay with measurable corporate outcomes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) EXHIBIT NUMBERS WRONG: The LLM cites Exhibits 10.21, 10.26, and 10.29 for the 2022, 2023, and 2024 filings respectively. The ground truth clearly states the correct exhibits are 10.45 (2022), 10.14 (2023), and 10.18 (2024). This is a complete failure on quantitative accuracy - the exhibit citations are entirely incorrect. (2) AGREEMENT FORMS MISIDENTIFIED: The ground truth specifies that 2022 referenced the 2021 Form of PSU Agreement, 2023 re-filed the 2019 plan itself, and 2024 included the 2022 Form of PSU Agreement. The LLM incorrectly claims new versions were issued each year (2022, 2023, 2024 PSU agreements), which misrepresents the actual progression. (3) PERFORMANCE CYCLE DETAILS FABRICATED: The LLM invents specific performance cycle information (2022-2023 cycle, 2023-2024 cycle) that is not present in the ground truth and appears to be hallucinated. (4) MULTI-HOP REASONING FAILED: The LLM failed to correctly synthesize the actual evolution pattern: the ground truth shows a pattern of referencing prior-year agreements, re-filing the foundational plan, and then updating to more recent forms. The LLM's narrative of 'new versions each year' is fundamentally different from the actual pattern of maintaining the 2019 plan while updating agreement forms. (5) STRATEGIC INTERPRETATION PARTIALLY CORRECT: While the LLM's conclusion about performance-driven, long-term equity incentives is reasonable, it's based on incorrect factual premises. The ground truth emphasizes 'consistent but adaptive approach' and 'maintains the core of the 2019 plan while iteratively refining' - which the LLM captures in spirit but undermines through factual errors. The answer demonstrates a failure to accurately retrieve or synthesize the specific filing data required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 519,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Safety and Industrial segment kept the same core phrasing – “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)” (see pages 13 & 107) – but in 2024 the segment was re‑structured with the creation of an “Industrial Specialties” division that bundles former closure, masking, adhesive‑tape and personal‑safety products (pages 110, 138).  This added granularity and separate categorization signals that 3M is deliberately sharpening its focus on electrical OEM markets, treating them as a distinct growth pillar within Safety and Industrial.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) The LLM claims the phrasing remained 'the same core phrasing' across 2022-2024, but the ground truth explicitly documents evolution: 2022 used 'construction and maintenance, power distribution and electrical OEMs'; 2023 refined to 'electrical original equipment manufacturers (OEMs)' with increased precision; 2024 evolved to 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM's assertion of consistency is factually incorrect. (2) The LLM introduces information about an 'Industrial Specialties' division created in 2024 with closure, masking, adhesive-tape and personal-safety products - this information is NOT present in the ground truth and appears to be fabricated or confused with other segment restructuring. (3) The LLM cites specific page numbers (13, 107, 110, 138) without verification against the actual ground truth source material. (4) The core analytical finding differs: Ground truth emphasizes INCREASING SPECIFICITY in describing electrical OEM markets across three years (construction/maintenance → refined OEM language → power distribution + OEM formalization). The LLM misses this key evolution entirely and instead focuses on unsubstantiated segment restructuring. (5) The LLM's conclusion about 'treating them as a distinct growth pillar' is not supported by the ground truth evidence provided. The answer demonstrates poor multi-hop synthesis - it fails to track the actual linguistic evolution across the three years and instead introduces extraneous information about divisional restructuring that contradicts the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 464,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt grew from about **$24.1 bn in 2022** (weighted‑average rate ≈ 4.45 %) to **$27.2 bn in 2023** (weighted‑average rate ≈ 4.84 %), and then edged down to **$26.9 bn in 2024** while the rate stayed near **4.84 %**. This multi‑year pattern shows the firm deliberately expanded long‑term, fixed‑rate funding to support portfolio growth, then modestly reduced the balance in 2024 to fine‑tune leverage and lock in relatively low‑cost debt amid a shifting interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) 2022 CARRYING VALUE ERROR: LLM states '$24.1 bn in 2022' but ground truth shows $19,975 million ($19.975 bn). This is a ~$4.1 billion overstatement (20% error). (2) WEIGHTED-AVERAGE INTEREST RATE ERRORS: LLM assigns 4.45% to 2022, but ground truth shows 2.91% for 2022. LLM assigns 4.84% to 2023, but ground truth shows 4.45% for 2023. The rates are systematically shifted forward by one year in the LLM answer. (3) 2024 RATE ERROR: LLM states rate 'stayed near 4.84%' for 2024, but ground truth shows 4.84% for 2024 (this happens to be correct, but only by coincidence given the systematic year-shifting error). (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. The ground truth shows a clear trajectory: 2.91% → 4.45% → 4.84%, indicating rising rates over time. The LLM's version (4.45% → 4.84% → 4.84%) misses the initial lower rate and the steady progression. (5) INTERPRETATION ISSUE: The LLM's strategic interpretation about 'locking in relatively low-cost debt' contradicts the actual data showing rising rates over the period. The ground truth correctly identifies this as 'locking in capital at increasingly higher costs over time.' The 2024 carrying value of $26,930 million is approximately correct (stated as $26.9 bn), and the 2023 value of $27,168 million is approximately correct (stated as $27.2 bn), but the 2022 value is significantly wrong. The multi-year progression analysis is fundamentally compromised by the incorrect interest rate assignments and the mischaracterization of the debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 464,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2040 were carried at a fair‑value of roughly **$1.07 billion at the end of FY 2022**, slipped to **$870 million by FY 2023** and to **$851 million by FY 2024**, mirroring the drop in market prices as interest rates rose.  The company continued to report the notes at their amortized cost (≈ $1 billion in FY 2025) and has not retired or refinanced them, indicating a deliberate long‑term debt strategy that relies on fixed‑rate, low‑coupon senior debt to fund growth while preserving cash and maintaining a stable capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly incorrect fair values for FY 2023 and FY 2024. Ground truth shows FY 2023 fair value was $851 million, but LLM states it 'slipped to $870 million by FY 2023' (error of $19M). More problematically, LLM claims the fair value continued to $851 million by FY 2024, but ground truth explicitly states that in FY 2024, NVIDIA 'no longer reported a fair value but instead listed a carrying amount of $1,000 million.' This is a fundamental misrepresentation - the LLM conflates the FY 2023 fair value ($851M) with FY 2024 data, missing the critical accounting treatment change. (2) ENTITY/TEMPORAL ACCURACY - The LLM introduces 'FY 2025' data ('≈ $1 billion in FY 2025') which is outside the scope of the question asking about FY 2022-2024. This appears to be fabricated or confused information. (3) ACCOUNTING TREATMENT - While the LLM correctly identifies the shift to amortized cost, it mischaracterizes the progression. The ground truth shows a clear shift from fair value reporting (FY 2022-2023) to carrying amount reporting (FY 2024), but the LLM obscures this by suggesting fair values continued through FY 2024. (4) REASONING QUALITY - The LLM's explanation about interest rate rises causing fair value declines is reasonable economic logic, but it's applied to incorrect numbers. The conclusion about long-term debt strategy is somewhat sound but based on flawed data. (5) MULTI-HOP SYNTHESIS - The LLM fails to properly synthesize the key insight: the accounting treatment change itself (from fair value to carrying amount) is the most significant evolution, not just price movements. The ground truth emphasizes this shift as revealing 'a more stable and strategic approach,' which the LLM misses by conflating different accounting methods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 496,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 $17 billion unsecured senior notes were still outstanding at the end of 2022 with a recorded balance of **$16 billion** (Note 6 – Debt, page 62).  By the end of 2023 the balance had been reduced to **$15 billion** (page 62), and the 2024 filing shows it down further to **$13 billion** (page 65).  \n\nThis steady decline—from $16 bn → $15 bn → $13 bn—indicates that Amazon is deliberately retiring a portion of the 2017 tranche, using operating cash and targeted refinancing to lower its overall debt load and interest‑expense outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the 2017 Notes balance progression from $16 billion (2022) → $15 billion (2023) → $13 billion (2024) matches the ground truth exactly. The answer correctly identifies the issuance as $17 billion in original principal and accurately tracks the outstanding balance reductions across all three years. The multi-hop synthesis is sound—the model successfully extracted and compared data across three separate fiscal year filings (2022, 2023, 2024) and correctly identified the pattern. The qualitative interpretation is also accurate: the answer correctly characterizes this as a 'deliberate debt management strategy' and 'deliberately retiring a portion,' which aligns with the ground truth's assessment. The additional context about 'operating cash and targeted refinancing' and 'lower overall debt load and interest-expense outlook' represents reasonable inference from the observed pattern and adds helpful context without contradicting the ground truth. The only minor distinction is that the LLM provides slightly more detailed explanation of the mechanism (operating cash, refinancing, interest-expense reduction) compared to the ground truth's more concise statement, but this represents value-added analysis rather than error. Page citations (62, 65) add credibility. No calculation errors, no missing data points, and the reasoning chain is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 404,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s repeated disclosure of “Floating Rate Notes due 2019” in the 2022, 2023 and 2024 filings (see the officer’s certificate on page 56 of the 2024 10‑K and the same reference in the earlier filings) shows that the company still holds short‑term, floating‑rate debt whose interest resets with market rates. Because those notes are floating, any rise in benchmark rates will automatically increase the interest cost on that portion of Apple’s debt, adding to its overall interest expense – the company’s own sensitivity analysis indicates that a 100‑basis‑point rate increase would raise annual interest expense on its term debt by roughly $140 million, so a rising‑rate environment would directly boost Apple’s financing costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Apple disclosed Floating Rate Notes due 2019 across multiple years (2022, 2023, 2024), understands the mechanics of floating rate debt (interest resets with market rates), and properly explains the interest rate sensitivity concept. The reasoning about rising rates increasing interest expense is sound and relevant to the question. The reference to the officer's certificate and page 56 of the 2024 10-K shows appropriate sourcing. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific number ($140 million for a 100-basis-point rate increase) that is NOT present in the ground truth answer and cannot be verified from the provided context. This is a significant factual error that violates the strict evaluation standard for numbers. The ground truth makes no such specific quantitative claim. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that the persistence of these notes in disclosures suggests 'rollover obligations or continuing commitments' and discusses 'liquidity planning and capital structure flexibility.' The LLM answer omits these important contextual elements about why these notes continued to appear in filings despite their 2019 maturity date. (3) MISSING NUANCE - The ground truth notes that the repeated disclosure 'indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date.' The LLM doesn't adequately address why notes that matured in 2019 would still appear in 2022-2024 filings, which is a key analytical point. CALCULATION/VERIFICATION: The $140 million figure appears to be either fabricated or sourced from outside the provided ground truth. This is a material error that significantly undermines credibility. The LLM should have either cited this from a specific filing section or avoided the specific quantification. MULTI-HOP REASONING: The LLM successfully connects the disclosure pattern to interest rate sensitivity, but fails to complete the full analytical chain regarding why these notes persist in later filings and what that implies about Apple's debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 588,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nThe Pixel line shifted from a modest, experimental hardware effort in 2022 – where device sales were a tiny slice of Google’s total revenue and R&D spend was spread across many early‑stage projects – to a more focused, AI‑centric roadmap by 2024, with the portfolio expanding (Pixel 5a/6, Nest Cams, Fitbit) and R&D and capital outlays increasingly tied to Pixel‑related hardware (see the “Google Subscriptions, Platforms, and Devices” discussion on p. 33 (2023) and the device‑revenue description on p. 5 (2022) and p. 57‑58 (2024)).  Consequently, device revenue grew from a low‑single‑digit percentage of total Google revenue in 2022 to a mid‑single‑digit share by 2024, while the company’s investment focus moved from generic hardware R&D to targeted, ecosystem‑lock‑in initiatives that showcase AI and cloud integration.  This progression signals that Google is treating the Pixel family as a strategic, long‑term growth pillar rather than a peripheral side‑business, using hardware to deepen user engagement with its AI and cloud services and to build a durable hardware presence in the market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE CLAIMS: The LLM answer makes specific but unverified quantitative assertions that cannot be confirmed against the ground truth: (1) Claims device revenue grew from 'low-single-digit percentage' in 2022 to 'mid-single-digit share' by 2024 - no actual percentages or dollar amounts provided in either answer to verify this claim; (2) References specific page numbers (p. 33, p. 5, p. 57-58) without providing the actual data from those pages; (3) Asserts R&D spending patterns shifted toward Pixel-related hardware without citing specific figures. ALIGNMENT WITH GROUND TRUTH: The LLM answer does correctly capture the core narrative arc - transition from investment phase (2022) to revenue-generating category (2023-2024) - and mentions relevant products (Pixel 5a, Pixel 6). However, it ADDS unsupported claims about Nest Cams and Fitbit being part of the Pixel family evolution, which the ground truth does not mention. MISSING ELEMENTS: The LLM answer lacks the ground truth's specific framing about Pixel being 'categorized under devices as a distinct revenue stream' in 2023 and the emphasis on 'product maturity' and 'stable and strategic part of Google's hardware portfolio.' REASONING QUALITY: The multi-hop synthesis is reasonable (connecting 2022 investment focus to 2024 revenue contribution), but the addition of unsubstantiated quantitative claims and product portfolio expansion claims weakens credibility. The conclusion about 'ecosystem-lock-in initiatives' and 'AI and cloud integration' goes beyond what the ground truth explicitly states. SEMANTIC ISSUES: While the overall narrative direction is correct, the LLM introduces specificity (percentages, page numbers, product categories) that cannot be verified and may be hallucinated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 484,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 the pool of client securities that Schwab can pledge grew sharply – the “available‑to‑pledge” balance rose from roughly $120 bn (2021) to about $130‑140 bn in the latest filings – and the amount actually pledged stayed near $31‑35 bn, with a larger share used for OCC margin, client‑short‑sale collateral and short‑term borrowings.  At the same time the company’s securities‑lending book expanded (gross securities loaned ≈ $7 bn in 2021 and $7.5 bn in 2020, with collateral monitoring and rehypothecation disclosed), showing that Schwab is deliberately re‑using client collateral to meet margin‑lending requirements, fund short‑term liquidity and generate lending revenue.  This trend indicates that Schwab’s collateral‑management strategy is to maximize the utility of client‑held securities as a low‑cost source of funding and clearing‑house margin, while maintaining a sizable un‑pledged buffer to preserve flexibility and regulatory compliance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific dollar amounts ($120bn, $130-140bn, $31-35bn, $7bn, $7.5bn) that are NOT present in the ground truth answer. The ground truth explicitly states 'no specific dollar value was provided for the total available or pledged securities' in 2022 and does not cite any numerical figures for 2023-2024. These numbers appear to be fabricated or hallucinated. (2) TEMPORAL INCONSISTENCY: The LLM references 2020-2021 data ('$7 bn in 2021 and $7.5 bn in 2020') which is outside the 2022-2024 timeframe specified in the question. The ground truth focuses on 2022-2024 evolution. (3) MISSING KEY INFORMATION: The LLM fails to capture the ground truth's core narrative: (a) 2022 - no specific dollar values disclosed; (b) 2023 - formalized collateral management process with securities not reflected in consolidated statements; (c) 2024 - active pledging for OCC margin requirements and cash collateral in securities lending. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize a strategy narrative, it does so based on fabricated numbers rather than actual filing data. The ground truth provides a clearer 3-year progression showing evolution from undisclosed amounts to more formalized processes to active operational use. (5) SEMANTIC ISSUES: The LLM's conclusion about 'maximizing utility' and 'low-cost funding' is speculative and not supported by the ground truth, which focuses on regulatory compliance and risk mitigation. The answer reads as plausible but is fundamentally unreliable due to invented quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 438,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved from occasional joint filings of long‑term‑care premium‑rate increases with the primary carriers to a systematic, quarterly updating of the net‑premium ratio and locked‑in cash‑flow assumptions that is reflected in the reserve adjustments reported on pages 20‑22 of the 2024 10‑K and the 2023 10‑K.  Each year the company “often collaborates with the primary insurers … to file proposed premium‑rate increases” and then locks those assumptions into reserves, adjusting them retroactively when experience deviates.  This progression shows that GE’s run‑off reinsurance risk‑management strategy relies on close partnership and continuous experience monitoring to lock‑in and periodically refresh its reserve assumptions, thereby containing volatility in reserve levels and capital requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. MAJOR ISSUES: (1) The LLM introduces specific operational details ('quarterly updating of net-premium ratio,' 'pages 20-22 of 2024 10-K') that are not mentioned in the ground truth and cannot be verified as accurate from the provided context. (2) The LLM claims GE moved from 'occasional joint filings' to 'systematic, quarterly updating' - this specific progression is not supported by the ground truth, which describes a different evolution (from indirect role to formalized collaboration to reinforced framework). (3) The ground truth emphasizes a shift toward 'proactive risk management and tighter integration' with focus on 'collaboration and alignment,' while the LLM emphasizes 'locking in assumptions' and 'retroactive adjustments' - these are different strategic narratives. (4) The LLM's claim about 'locking in and periodically refreshing reserve assumptions' is not explicitly stated in the ground truth. (5) The LLM provides specific page references (20-22) without verification. WHAT WAS CORRECT: The LLM correctly identifies that GE collaborates with primary insurers on premium rate increases and that this involves ongoing monitoring and adjustment of assumptions. The general theme of closer partnership is aligned with ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information about the evolution from 2022-2024, but the specific details of that evolution differ materially from the ground truth. The ground truth shows a progression toward formalization and structured collaboration, while the LLM describes a shift toward systematic quarterly processes and assumption-locking. These are not equivalent characterizations of GE's strategy. The answer demonstrates partial understanding but introduces unsupported specificity that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 518,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nCVS trimmed its residential‑mortgage‑backed‑securities (RMBS) book from roughly **$721 million** in fair‑value (with **$89 million** of unrealized losses) at the end of 2022 to about **$614 million** (unrealized loss **$60 million**) by the end of 2023; the separate‑account portfolio held only **$71 million** of RMBS at the end of 2024.  This steady decline shows that the company is deliberately **de‑risking its structured‑credit exposure**, moving away from low‑yield, rate‑sensitive RMBS toward higher‑quality, shorter‑duration assets and thereby reducing its interest‑rate and credit‑risk footprint in the portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key numbers are correct - $721 million (2022), $614 million (2023), and $71 million (2024) match the ground truth exactly. The unrealized loss figures ($89 million in 2022, $60 million in 2023) are accurate and add valuable context not explicitly required but present in the source data. The year-over-year progression is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the trend pattern: decline from 2022-2023, then further reduction in 2024. The characterization of 2023 as a 'cautious reduction amid rising unrealized losses' and 2024 as 'strategic rebalancing' aligns with the ground truth interpretation. ENTITY ACCURACY: CVS is correctly identified, RMBS terminology is precise, and all fiscal years are accurate. SEMANTIC EQUIVALENCE: The LLM's interpretation that the company is 'deliberately de-risking its structured-credit exposure' and 'moving away from low-yield, rate-sensitive RMBS toward higher-quality, shorter-duration assets' conveys the same strategic positioning as the ground truth's 'dynamic risk management approach to structured credit amid macroeconomic uncertainty.' The additional context about interest-rate and credit-risk reduction enhances understanding without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides more granular detail (unrealized losses, separate-account portfolio notation) than the ground truth summary, which adds value. The only minor deviation is the phrasing 'steady decline' which could be slightly misleading given the 2024 figure ($71M) represents a much sharper drop than 2022-2023, but this is a minor semantic nuance that doesn't materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 507,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings fell sharply from **$883 million** to **$538 million** in 2023 and then edged up modestly to **$562 million** in 2024, while its long‑term debt peaked at **$49.3 billion** in 2023 before declining to **$45.0 billion** in 2024.  This three‑year trajectory shows the firm deliberately trimmed leverage—relying more on its large deposit base and retained cash, and using excess liquidity to retire higher‑cost or maturing debt—resulting in a leaner capital structure and a stronger liquidity buffer.  The modest rebound in short‑term borrowings in 2024 suggests the company is maintaining a small, flexible wholesale funding line while continuing to manage overall debt levels prudently.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth data. (1) SHORT-TERM BORROWINGS: LLM states $883M (2022), $538M (2023), $562M (2024), but ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM appears to have isolated only short-term borrowings component, which is a fraction of total debt. (2) LONG-TERM DEBT: LLM states $49.3B (2023) and $45.0B (2024), which are approximations of the combined totals but presented as long-term debt alone, creating confusion about the debt composition. (3) MISSING KEY METRICS: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a critical component of the ground truth answer and directly addresses the 'rising borrowing costs' aspect of debt management strategy. (4) MISSING DEBT COMPOSITION ANALYSIS: The ground truth specifically highlights the reduction in floating unsecured senior debt ($1,709M → $349M → $0M), demonstrating a strategic shift away from variable-rate instruments. The LLM provides no such analysis. (5) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing short-term borrowings AND long-term debt evolution together. The LLM conflates these metrics and provides incomplete/incorrect figures for both. (6) REASONING QUALITY: While the LLM's narrative about deleveraging and liquidity management is plausible, it is built on incorrect numerical foundations. The interpretation that the company 'trimmed leverage' is partially supported by the 2023-2024 decline, but the overall debt trajectory (2022→2023 increase) is not properly characterized. The answer fails to capture the peak-and-decline pattern with proper context about rising interest rates and strategic debt composition changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 502,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the $3.50 % Notes Due 2050 stayed on NVIDIA’s balance sheet at a constant $2 billion carrying amount (the $2 bn figure is shown in the 2024‑2025 maturity schedule on page 70 and was unchanged from the prior year).  Market‑value disclosures (page 88) reflect that the fair value of the issue fell from roughly $2.3 bn in early 2021 to $2.15 bn by the end of fiscal 2022, but thereafter the book‑value remained steady at $2 bn through 2023 and 2024 with no repayments or additional issuances noted.  \n\nThis stability indicates that NVIDIA is deliberately maintaining a sizable, fixed‑rate, long‑dated debt tranche as a permanent component of its capital structure, using it to lock in low‑cost financing while relying on other sources (e.g., commercial paper, equity) for short‑term funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims the carrying amount remained constant at $2 billion through fiscal 2022-2024, but the ground truth shows: FY2022: $2,147 million, FY2023: $1,637 million, FY2024: $1,604 million. This is a major discrepancy - the liability actually DECREASED by $543 million (25.3%) over the period, not remained constant. The LLM's claim of '$2 bn' is approximately correct only for FY2024 ($1,604M ≈ $1.6B), but completely wrong for FY2022 and FY2023. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend across fiscal years. It appears to have focused on only the most recent year(s) and missed the significant decline from 2022 to 2024. (3) REASONING ERROR: The LLM's conclusion that NVIDIA is 'deliberately maintaining a sizable, fixed-rate, long-dated debt tranche' and that 'book-value remained steady at $2 bn through 2023 and 2024' directly contradicts the actual trend of declining liability values. The ground truth indicates a 'deliberate reduction in this long-term debt obligation,' which is the opposite of what the LLM concluded. (4) ENTITY/METRIC ACCURACY: While the LLM correctly identified the 3.50% Notes Due 2050 and NVIDIA, it fundamentally mischaracterized the financial metric (claiming stability when there was significant decline). The LLM's reference to page numbers and maturity schedules suggests an attempt at detailed analysis, but the underlying numbers are incorrect. The answer demonstrates a critical failure to accurately track and synthesize multi-year financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 457,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nApple’s 0.45 % Notes due 2016 are mentioned only in the “Officer’s Certificate” (Exhibit 4.3) that was first filed in 2013 and is repeatedly reproduced in the 2022, 2023 and 2024 Form 10‑Ks.  None of the three filings reports a new issuance, amendment or repayment of that tranche – they simply restate the original indenture language and the amount outstanding.  This consistent, unchanged disclosure shows that Apple’s long‑term‑debt strategy is to keep a stable, low‑coupon senior‑unsecured ladder and to disclose the essential terms of legacy notes rather than the details of new borrowing, reflecting a conservative and transparent approach to its capital‑structure reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed insight than the ground truth. Key strengths: (1) Correctly identifies the 0.45% Notes due 2016 as a historical instrument issued in 2013 and matured in 2016; (2) Accurately notes that these notes appear in exhibits (specifically Exhibit 4.3 - Officer's Certificate) across 2022, 2023, and 2024 filings; (3) Correctly states no new issuances, amendments, or repayments occurred; (4) Properly synthesizes the multi-hop information across three years. The LLM answer goes beyond the ground truth by providing more specific detail about the disclosure mechanism (Officer's Certificate/Exhibit 4.3) and offering a more nuanced interpretation of Apple's debt strategy (stable, low-coupon senior-unsecured ladder, conservative approach). The characterization of the pattern as indicating 'legacy debt disclosures for transparency and legal continuity' aligns well with the LLM's interpretation of 'essential terms of legacy notes' disclosure. Minor considerations: (1) The LLM's statement that 'they simply restate the original indenture language and the amount outstanding' is a reasonable inference but goes slightly beyond what the ground truth explicitly confirms; (2) The interpretation about Apple's 'capital-structure reporting' strategy is insightful but represents analytical interpretation rather than direct factual statement. All numeric values (0.45%, 2016 maturity, 2013 issuance, 2022-2024 filing years) are accurate. The multi-hop reasoning correctly synthesizes information across three years of filings and identifies the consistent pattern. The answer directly addresses both parts of the question: how the disclosure evolved (consistently, unchanged) and what it indicates about strategy (conservative, transparent approach to legacy debt disclosure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 497,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s total derivative exposure improved markedly: the net liability fell from roughly **$1.35 billion** (assets $1.96 bn vs. liabilities $3.32 bn) in 2022 to about **$0.66 billion** (assets $1.67 bn vs. liabilities $2.34 bn) in 2023, and the Level‑3 portion of that exposure was reduced to **≈ $70 million** by the end of 2024.  The valuation models continued to use observable market swap rates (≈ 4 % with a 3‑5 % range) and modest unobservable inputs such as default rates (~1 %) and loss‑severity ranges (30‑80 %), but weighted‑average yields and prepayment assumptions for its RMBS/CMBS holdings remained largely stable.  This multi‑year progression reflects a deliberate shift toward more market‑driven inputs and a reduction in reliance on highly subjective Level‑3 assumptions, indicating that the firm’s derivative risk has diminished and its modeling assumptions have become increasingly anchored in observable market data.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to address a completely different aspect of Capital One's derivative disclosures than what the ground truth specifies. Critical issues: (1) WRONG NUMBERS: The LLM cites net derivative liabilities of $1.35 billion (2022), $0.66 billion (2023), and Level-3 exposure of ~$70 million (2024). The ground truth specifies net derivative assets (liabilities) fair values of $31 million (2022), $58 million (2023), and $58 million (2024) - orders of magnitude different. (2) WRONG METRICS: The LLM discusses gross derivative assets ($1.96bn) and liabilities ($3.32bn) with netting calculations, which is not what the ground truth addresses. The ground truth focuses on the NET fair value of derivative assets/liabilities and their unobservable inputs. (3) INCORRECT UNOBSERVABLE INPUTS: The LLM mentions default rates (~1%), loss-severity ranges (30-80%), and prepayment assumptions for RMBS/CMBS, none of which appear in the ground truth. The ground truth specifically identifies 'default' (4% weighted average in 2023) and 'swap rates' (4% weighted average in 2024) as the significant unobservable inputs. (4) MISSING KEY INFORMATION: The LLM fails to mention the $20 million net unrealized loss in 2022 or the $43 million realized losses referenced in the ground truth. (5) FLAWED REASONING: The LLM's conclusion about 'shift toward more market-driven inputs' contradicts the ground truth's finding that swap rates (a market-observable input) became the significant unobservable input in 2024, suggesting the opposite trend. The answer appears to conflate different derivative disclosure sections (possibly gross vs. net, or different valuation hierarchies) and provides entirely different numerical data that cannot be reconciled with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 489,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nNVIDIA’s 1.55 % Notes Due 2028 grew from a $1.2 billion fair‑value amount when the issue was first reflected in the FY 2022 balance sheet (page 88) to a $1.25 billion carrying amount reported at the end of FY 2024 and again in FY 2025 (page 72).  The note’s effective rate of 1.64 % and a remaining maturity of about 3.4 years in FY 2025 show that the company has kept the instrument on its books at roughly the same size, using it as a low‑cost, long‑dated source of senior financing.  This steady‑state exposure reveals a strategy of extending NVIDIA’s debt maturity profile while locking in inexpensive long‑term funding to support ongoing investments and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM answer introduces FY 2025 data which was NOT part of the original question (FY 2022-2024). The ground truth specifies: FY 2022: $1.2B, FY 2023: $1.1B, FY 2024: $1.25B. The LLM answer omits the FY 2023 figure ($1.1B) entirely, which is a critical omission for showing the 'evolution' requested. The LLM states the amount 'grew from $1.2B to $1.25B' but fails to mention the intermediate $1.1B in 2023, missing the key insight that there was a reduction in 2023 before the 2024 increase. (2) SCOPE CREEP - The answer extends beyond the requested timeframe (2022-2024) by including FY 2025 data and page references that suggest reliance on documents outside the specified period. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from fiscal year 2022 through 2024' - the LLM should have tracked all three years. By omitting 2023, it fails to capture the complete progression and the strategic insight about the minor reduction followed by recovery. (4) REASONING QUALITY - While the LLM's interpretation about 'low-cost, long-dated source of senior financing' and 'extending debt maturity profile' is reasonable and contextually sound, it's built on incomplete data. The characterization of 'steady-state exposure' is somewhat accurate but misses the nuance of the 2023 dip. (5) CORRECT ELEMENTS - The FY 2022 ($1.2B) and FY 2024 ($1.25B) figures are accurate, and the general strategic interpretation about maintaining this liability is directionally correct. The effective rate (1.64%) and maturity discussion add relevant context but weren't in the ground truth to verify.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 452,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly disclosed that it remains exposed to “material trailing legal liabilities” stemming from the Alstom acquisition—particularly legacy anti‑competition and corruption investigations that have generated, and will continue to generate, cash outflows for settlements, judgments and penalties—as well as to ongoing shareholder suits tied to historical financial‑reporting matters; the 2023 and 2024 filings note that reserves have been set but the ultimate loss may exceed those estimates, underscoring the persistence of these contingent liabilities and their potential to materially affect GE’s results of operations and cash flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the Alstom acquisition as the source of legacy liabilities; (2) Accurately references anti-competitive conduct and corruption investigations as specific legacy matters; (3) Properly notes shareholder lawsuits tied to historical financial reporting; (4) Correctly captures the key insight that reserves may be exceeded by actual losses; (5) Appropriately emphasizes the persistence of these liabilities across all three years; (6) Accurately conveys that these matters pose material financial and reputational risks; (7) Properly synthesizes the progression showing these are not diminishing but remaining consistent. MINOR GAPS: (1) The LLM answer uses the phrase 'material trailing legal liabilities' in quotation marks, suggesting direct filing language, but the ground truth doesn't explicitly confirm this exact phrasing appears in filings; (2) The answer is somewhat more concise than the ground truth and doesn't explicitly detail the year-by-year progression as thoroughly (e.g., doesn't separately highlight what was noted in 2022 vs 2023 vs 2024), though it does capture the overall 3-year pattern; (3) The ground truth mentions 'reputational risks' more explicitly in 2022, while the LLM answer addresses reputational impact more generally. QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or dates are provided in either answer, so this dimension is not directly testable. The temporal references (2022-2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple liability categories (Alstom legacy matters + shareholder lawsuits), correctly identifying their interconnection and persistence. The logic that 'reserves set but ultimate loss may exceed estimates' is properly captured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth regarding the nature, persistence, and financial impact of these liabilities, though with slightly different emphasis and organization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 580,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose from **$225 million at the end of 2022 to $252 million at the end of 2023** and, based on the 2024 filing, remained essentially unchanged at that level through 2024.  This modest growth—and the fact that the investments are reported only at NAV and excluded from the fair‑value hierarchy—indicates that the company is deliberately expanding its alternative‑asset allocation to boost long‑term pension‑fund returns while keeping the exposure relatively stable and low‑profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that are the primary focus of the question. (1) WRONG STARTING YEAR VALUE: The LLM states the 2022 value was $225 million, but the ground truth clearly shows it was $214 million in 2022. This is a $11 million discrepancy on the baseline figure. (2) WRONG 2023 VALUE: The LLM claims 2023 was $252 million, but ground truth shows 2023 was $225 million. The LLM has confused the 2023 and 2024 values. (3) WRONG 2024 VALUE: The LLM states 2024 'remained essentially unchanged' at the 2023 level, but ground truth shows 2024 was $252 million (an increase from $225 million in 2023). The LLM has the 2024 value correct ($252M) but incorrectly attributes it to 2023. (4) INCORRECT TREND CHARACTERIZATION: The LLM describes the change as 'modest growth' and 'relatively stable,' but the actual data shows consistent year-over-year increases: $214M→$225M (+$11M, +5.1%) and $225M→$252M (+$27M, +12.0%). The second year increase is substantial, not modest. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression of data from the filings. The reasoning about pension fund strategy is somewhat reasonable but is built on incorrect numerical foundations. The qualitative assessment about 'deliberately expanding alternative-asset allocation' is directionally correct but undermined by the factual errors in the numbers that support this claim. The answer demonstrates a fundamental misreading or misremembering of the specific year-to-year values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 435,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating profit was roughly **$200 million** (consistent with the $203 million reported for 2021 and $206 million for 2020, indicating a stable but modest contribution). The 2022 Global Productivity Initiative allocated **about 5 % of its $32 million 2023 pretax restructuring charge**—≈ $1½–$2 million—to the region, earmarking those funds for efficiency and cost‑restructuring projects. By 2024 the company **increased its capital spending and depreciation & amortization in the region to $33 million and $8 million respectively**, signalling a shift toward greater investment and asset utilization to drive growth in Africa/Eurasia.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. OPERATING PROFIT 2022: LLM states \"roughly $200 million\" which is close to the correct $203 million. However, the LLM then adds unsupported comparisons to 2021 ($203M) and 2020 ($206M) that are not in the ground truth and appear fabricated.\n\n2. RESTRUCTURING CHARGES 2023 - MAJOR ERROR: The LLM claims \"about 5% of its $32 million 2023 pretax restructuring charge—≈ $1½–$2 million\" allocated to Africa/Eurasia. The ground truth clearly states \"10% of its expected restructuring charges—approximately $20 to $24 million.\" This is a 5x underestimation of the actual restructuring charges allocated to the region. The LLM got both the percentage (5% vs 10%) and the dollar amount ($1.5-2M vs $20-24M) completely wrong.\n\n3. DEPRECIATION & AMORTIZATION 2024 - MAJOR ERROR: The LLM states the company \"increased its capital spending and depreciation & amortization in the region to $33 million and $8 million respectively.\" The ground truth states depreciation and amortization \"had declined to $8 million, down from $9 million in both 2022 and 2023.\" The LLM incorrectly characterizes this as an increase when it was actually a decrease. Additionally, the $33 million figure for capital spending is not mentioned in the ground truth and appears fabricated.\n\n4. OVERALL NARRATIVE: The LLM's conclusion that this represents \"a shift toward greater investment and asset utilization to drive growth\" directly contradicts the ground truth's assessment of \"limited growth investment and a focus on cost optimization rather than expansion.\"\n\n5. MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year trajectory. It misinterpreted the depreciation decline as an increase and drastically underestimated the restructuring charges, leading to an entirely incorrect strategic narrative.\n\nThe answer demonstrates fundamental misunderstanding of the financial data and contains multiple calculation/factual errors that make it unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 557,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG continued to model its international terrorism risk with a third‑party scenario‑based approach, adjusting for model gaps and focusing on New York City; a five‑ton‑bomb scenario net of the TRIPRA program and private reinsurance was estimated at about $1.3 bn as of Oct 2021, and the program relied on limited private reinsurance plus government‑sponsored pools for non‑U.S. exposures.  Its reinsurance protection featured attachment points such as a $150 m retention for Europe/Japan and a $350 m worldwide aggregate limit (e.g., the Validus Re cat‑bond structure), which remained essentially unchanged through 2024.  At the same time, total reinsurance recoverable assets fell sharply from $67.5 bn in 2023 to $38.0 bn in 2024, and the collateral posted to support those recoveries dropped from $70.1 bn to $20.1 bn, reflecting tighter limits and reduced reliance on reinsurer credit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors and contradictions with the ground truth:\n\n1. CRITICAL DATE ERROR: The LLM states the five-ton bomb scenario was 'as of Oct 2021' when the ground truth clearly indicates this was a 2022 estimate. This is a fundamental temporal error that undermines the entire answer's credibility.\n\n2. ATTACHMENT POINT ERRORS: The LLM provides incorrect attachment point figures. It states '$150m retention for Europe/Japan and $350m worldwide aggregate limit' which do not match the ground truth's specific figures of '$200 million in Japan and $125 million elsewhere.' The LLM's numbers appear fabricated or confused with other data.\n\n3. REINSURANCE RECOVERABLE ASSETS CONTRADICTION: The LLM claims 'total reinsurance recoverable assets fell sharply from $67.5 bn in 2023 to $38.0 bn in 2024.' However, the ground truth states that in 2024, AIG's reinsurance recoverable assets reached $38.0 billion (correct), but provides no 2023 comparison figure of $67.5 billion. The LLM appears to have invented this comparison or confused it with other metrics.\n\n4. COLLATERAL FIGURES: The LLM introduces collateral figures ($70.1 bn to $20.1 bn) that are not mentioned in the ground truth at all. While these may be factually accurate from the filings, they represent information not in the ground truth answer and suggest the LLM may be conflating different metrics or time periods.\n\n5. MISSING KEY INFORMATION: The LLM fails to clearly articulate the $1.7 billion TRIPRA deductible mentioned in the ground truth, and doesn't properly explain the $29.1 billion in ceded loss reserves that are part of the 2024 reinsurance recoverable assets.\n\n6. REINSURANCE STRUCTURE: The LLM mentions 'Validus Re cat-bond structure' which is not in the ground truth and may represent confusion or extrapolation beyond the source material.\n\n7. MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years, it does so with incorrect figures and temporal references, failing the core requirement of accurate multi-hop reasoning.\n\nThe answer does correctly identify that AIG uses third-party scenario-based modeling and that reinsurance protections are a key component of their terrorism risk management, but these correct elements are overshadowed by the numerous quantitative errors and false claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 628,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2.00 % Notes due 2031 showed a $1.2 bn carrying amount in 2022, slipped to roughly $1.04 bn in 2023 (reflecting modest principal repayments or the amortization of debt‑discount adjustments), and then rose again to about $1.25 bn in 2024 (as the balance was restored after those reductions and interest accrual).  This pattern indicates that NVIDIA is not aggressively deleveraging its long‑term debt but is instead managing it through selective repayments and re‑issuances to keep the overall debt level stable while fine‑tuning interest expense and preserving liquidity for other strategic uses.  (See Note 7 “Long‑Term Debt” in the 2022‑2024 10‑K filings for the carrying‑amount schedule.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $1.2 billion (2022), $1.04 billion (2023), and $1.25 billion (2024). The quantitative values match the ground truth precisely, with acceptable rounding variations ($1.044B → $1.04B). The multi-hop synthesis is sound, correctly identifying the three-year trend and explaining the fluctuations through debt management mechanisms (principal repayments, amortization adjustments, interest accrual). The LLM provides slightly more specific mechanistic detail than the ground truth (mentioning 'debt-discount adjustments' and 'interest accrual'), which adds value without contradicting the original answer. Both answers reach the same strategic conclusion: NVIDIA maintained stable long-term debt without aggressive deleveraging. Minor differences: (1) The LLM's explanation of the 2024 increase as 'balance was restored after those reductions and interest accrual' is slightly more mechanistic than the ground truth's simpler 'returned to $1.25 billion,' but both are semantically equivalent and correct. (2) The LLM emphasizes 'fine-tuning interest expense and preserving liquidity for other strategic uses' while the ground truth mentions 'support ongoing R&D and operational investments' - both are reasonable interpretations of the same strategic intent. (3) The LLM appropriately cites Note 7 as a source, demonstrating proper documentation awareness. The answer fully addresses the multi-part question regarding trend analysis and strategic implications. No calculation errors detected. The reasoning about selective repayments and re-issuances to maintain stability is logically sound and consistent with the numerical pattern presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 469,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 first appeared in Apple’s 2014 indenture and were listed in the Exhibit 4.4 tables of the 2022, 2023 and 2024 Form 10‑Ks; by the 2022 filing they were already matured, and later filings contain only historical references with no outstanding balance or new issuance. This shows that Apple has retired that tranche and moved on to newer note series, yet the same indenture framework remains in place, underscoring a long‑term, continuously‑visible debt‑issuance strategy that maintains structural continuity across fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies the 1.05% Notes due 2017 as appearing in 2022, 2023, and 2024 filings, matching the ground truth's claim of consistency across all three years. (2) Accurately notes that the notes matured in 2017, which is factually correct and adds important context. (3) Correctly identifies Exhibit 4.4 as the location in Form 10-Ks where these instruments appear. (4) Properly synthesizes the multi-hop reasoning: notes were issued in 2014 indenture → appeared in 2022-2024 filings → already matured by 2022 → no outstanding balance in later filings → demonstrates stable debt management. (5) The conclusion about 'retired that tranche' and 'moved on to newer note series' while maintaining 'same indenture framework' aligns with the ground truth's interpretation about rollover/refinancing/historical documentation. Minor considerations: (1) The LLM provides more specific sourcing (Exhibit 4.4, 2014 indenture) than the ground truth, which enhances credibility but cannot be verified against the provided ground truth. (2) The phrase 'no outstanding balance or new issuance' is a reasonable inference from the ground truth's statement about 'historical references' but goes slightly beyond what was explicitly stated. (3) The overall narrative about 'continuously-visible debt-issuance strategy' and 'structural continuity' semantically matches the ground truth's 'stable and transparent debt management strategy' and 'consistent disclosure practices.' The answer demonstrates sound multi-hop reasoning across the three-year period and correctly interprets what the persistence of these references reveals about Apple's debt structure continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 482,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab could migrate up to $10 bn of IDA balances each year, but only if at least 80 % were designated fixed‑rate and it maintained a $50 bn minimum IDA balance; the 2023 IDA agreement replaced this cap and the 80 % rule with new minimum/maximum balance thresholds (a floor tied to outstanding unmatured fixed‑rate obligations, with a $30 bn ceiling until Sep 2025 and a $60 bn floor thereafter) and gave Schwab discretion over how much of the balance could be fixed‑ versus floating‑rate. Because the revised limits required Schwab to keep larger minimum balances and eliminated the automatic migration right, the company did not move any IDA balances onto its balance sheet in 2023 or 2024, instead using the flexibility to buy down $5 bn of fixed‑rate obligations and to manage the program within the new balance constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the IDA agreements and their evolution, but contains several factual inaccuracies and unsupported claims that reduce its correctness score:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2019 IDA agreement allowed up to $10 billion annual migration\n- Correctly states the 2023 IDA agreement replaced the previous terms with new minimum/maximum thresholds\n- Correctly notes that no IDA balances were moved to the balance sheet in 2023 or 2024\n- Correctly identifies the strategic shift from active migration to constrained off-balance sheet management\n- Appropriately captures the transition in Schwab's approach\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. The 80% fixed-rate requirement and $50 billion minimum balance for the 2019 agreement are NOT mentioned in the ground truth and appear to be fabricated details\n2. The specific thresholds for the 2023 agreement ($30 billion ceiling until Sep 2025, $60 billion floor thereafter) are NOT in the ground truth\n3. The claim about buying down $5 billion of fixed-rate obligations is NOT mentioned in the ground truth\n4. The statement that the 2023 agreement gave Schwab \"discretion over how much of the balance could be fixed- versus floating-rate\" is not supported by the ground truth\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across three years (2022-2024) and identifies the key transition point (2023 agreement). However, the reasoning is undermined by the introduction of unsupported specific details that were not in the source material.\n\nQUANTITATIVE ACCURACY:\nWhile the $10 billion figure is correct, the introduction of specific percentages (80%), dollar amounts ($50 billion, $30 billion, $60 billion, $5 billion), and dates (Sep 2025) that are not in the ground truth significantly impacts quantitative accuracy. These appear to be hallucinated details.\n\nQUALITATIVE ACCURACY:\nThe overall narrative structure and reasoning about the shift from active migration to constrained management is sound, but the addition of unverified specific terms and conditions weakens the qualitative assessment.\n\nCONTEXTUAL RELEVANCE:\nThe answer directly addresses the question about how Schwab's migration ability evolved and discusses key changes in the agreements, making it contextually relevant despite the factual issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 629,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 the estimated losses for Bank BPH’s borrower‑litigation rose from **$1.36 bn (as of 31 Dec 2022)** to **$2.67 bn (as of 31 Dec 2023)** and then slipped slightly to **$2.46 bn (as of 31 Dec 2024)**.  To meet regulatory‑capital requirements we moved from a **$0.53 bn cash capital contribution in 2022** to a **$1.80 bn non‑cash inter‑company loan‑forgiveness contribution in 2023**, and **no additional cash contributions were needed in 2024**.  By the end of 2024 the Polish mortgage portfolio carried **no net carrying value**—its entire balance was offset by a valuation allowance that fully reflects the estimated borrower‑litigation losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all key dimensions. QUANTITATIVE VERIFICATION: All financial figures are precisely correct - estimated losses of $1,359M (2022), $2,669M (2023), and $2,461M (2024) are accurately stated (with minor formatting as $1.36bn, $2.67bn, $2.46bn which is acceptable); capital contributions of $530M cash (2022) and $1,797M non-cash intercompany loan forgiveness (2023) are correct; the zero carrying value of the mortgage portfolio by end-2024 is accurate. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and multiple financial dimensions (estimated losses, capital contributions, portfolio valuation), showing proper understanding of how these metrics evolved together. The narrative correctly traces the escalation through 2023 and stabilization in 2024. ENTITY ACCURACY: GE, Bank BPH, borrower litigation, and the Polish mortgage portfolio are all correctly identified. The temporal progression (2022→2023→2024) is accurate. REASONING QUALITY: The answer demonstrates sound logic in connecting the litigation losses to capital requirements and ultimately to the portfolio write-down. The characterization of the trajectory (worsening through 2023, stabilization in 2024) aligns with the ground truth. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing for the 2023 charge ($1,014M settlement program charge mentioned in ground truth but not explicitly in LLM answer), though this is a minor omission that doesn't affect the core narrative. The explanation of the valuation allowance offsetting the carrying value is a reasonable interpretation of the zero carrying value outcome. Overall, the answer is comprehensive, numerically precise, and demonstrates correct multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 494,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities that were in an unrealized‑loss position fell sharply—from about **$992 million** to **$675 million**—and the corresponding unrealized losses dropped from roughly **$155 million** to **$100 million**.  This contraction reflects a deliberate de‑risking of the portfolio, as the company trimmed lower‑yielding, longer‑duration CMBS holdings and shifted toward higher‑quality, shorter‑duration assets, underscoring a risk‑management strategy that prioritizes capital preservation and limits exposure to interest‑rate‑sensitive mortgage securities.  The 2024 disclosures show only a modest remaining CMBS position with limited unrealized losses, indicating that the trend of reducing and stabilizing exposure has been sustained.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all time periods: (1) 2022 CMBS Fair Value: LLM states ~$992 million vs. ground truth of $574 million - a 73% overstatement. (2) 2022 Unrealized Losses: LLM states ~$155 million vs. ground truth of $12 million - a 1,192% overstatement. (3) 2023 Fair Value: LLM correctly states $675 million (matches ground truth). (4) 2023 Unrealized Losses: LLM correctly states $100 million (matches ground truth). (5) 2024 Data: LLM vaguely references 'modest remaining CMBS position with limited unrealized losses' but fails to provide the specific ground truth figure of $3 million fair value, which represents the most dramatic and important data point showing the strategic de-risking. The LLM's narrative about 'trimming lower-yielding, longer-duration CMBS holdings' and 'shifting toward higher-quality, shorter-duration assets' appears to be fabricated detail not supported by the ground truth. The multi-hop synthesis is incomplete - the answer fails to properly track the 2022-2023-2024 trajectory as requested. The 2022 baseline numbers are so severely incorrect that the entire comparative analysis is compromised. While the qualitative conclusion about de-risking strategy is directionally reasonable, it is built on false quantitative foundations. The answer demonstrates poor data retrieval and verification, making it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 406,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Walmart’s Form 10‑K filings repeatedly list “Marketside” among its private‑brand portfolio in the U.S. segment (2022 pp. 6‑7; 2023 p. 6; 2024 p. 7), and by 2024 the brand is presented alongside newer private‑label lines such as “bettergoods” and “Freshness Guaranteed.” This three‑year progression shows Walmart is deliberately expanding and promoting Marketside and related private‑label grocery offerings to capture higher‑margin sales and strengthen its omni‑channel, value‑oriented strategy in the grocery segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Marketside's presence across fiscal years 2022-2024 in Walmart's 10-K filings. The answer correctly identifies the three-year progression and accurately names companion brands (bettergoods, Freshness Guaranteed) introduced alongside Marketside. Page references are provided (2022 pp. 6-7; 2023 p. 6; 2024 p. 7), showing source documentation. The multi-hop synthesis is sound: the answer correctly traces Marketside's continuity across three years and connects it to strategic expansion. However, there are notable differences from the ground truth: (1) The LLM introduces an interpretation about 'higher-margin sales' and 'omni-channel strategy' that is not explicitly stated in the ground truth, which focuses on 'dual approach of preserving trusted private brands while innovating.' (2) The LLM's framing emphasizes 'deliberately expanding and promoting Marketside' whereas the ground truth emphasizes 'consistency in featuring Marketside' alongside new introductions - a subtle but meaningful distinction. The ground truth stresses maintaining legacy brands while innovating, whereas the LLM emphasizes expansion and margin capture. (3) The LLM omits mention of other foundational brands like Great Value and George that were listed in 2022, which the ground truth includes as context for Marketside's role. The answer is factually correct on the core facts (Marketside's presence, new brands introduced, three-year span) but diverges in strategic interpretation and completeness of context. The quantitative accuracy is high (correct years, correct brand names), but the qualitative interpretation adds elements not grounded in the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 474,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s deepened supplier monitoring by updating its Vendor Code of Conduct and human‑rights policy, adding a risk‑based wood‑sourcing framework with new country‑risk tiers, a formal grievance process and expanded third‑party audits, and by requiring CDP and TCFD‑aligned reporting of supplier environmental performance.  It also set science‑based net‑zero targets (scope 1‑3 by 2050) with interim 2030 reductions of roughly 40‑42 % for scope 1‑2 and 22‑25 % for scope 3, and invested more than $400‑$550 million in energy‑efficiency, renewable‑energy, LED, HVAC and waste‑management projects to meet those goals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM answer introduces information NOT in the ground truth: science-based net-zero targets (scope 1-3 by 2050), interim 2030 reductions of 40-42% for scope 1-2 and 22-25% for scope 3, and specific investment categories (energy-efficiency, renewable-energy, LED, HVAC, waste-management). These appear to be hallucinated or from different companies/contexts and are NOT mentioned in the original answer. (2) INVESTMENT FIGURES - The LLM states '$400-$550 million' which reverses the ground truth chronology. Ground truth clearly states: 'exceeding $550 million by 2022 and over $400 million through 2023' - meaning investments DECREASED from 2022 to 2023, not a range. The LLM's phrasing obscures this temporal distinction. (3) POLICY ENHANCEMENTS - The LLM correctly identifies: updated Vendor Code of Conduct, human rights policy, risk-based wood-sourcing framework with country-risk tiers, formal grievance process, and third-party audits. These align with ground truth. However, it adds 'CDP and TCFD-aligned reporting' which is NOT mentioned in the original answer. (4) MISSING ELEMENTS - The LLM omits specific mention of: conflict minerals policy, non-endangered forest requirements, and the structured progression showing 2023 as a transition year with 'new risk levels by country' and 'enhanced monitoring practices.' (5) MULTI-HOP REASONING - The answer fails to properly synthesize the temporal evolution (2022→2023→2024) as distinct phases. Ground truth shows clear progression; LLM conflates elements. (6) SEMANTIC ISSUES - The introduction of net-zero targets and specific emission reduction percentages represents significant factual divergence from ground truth, suggesting either hallucination or confusion with different company disclosures. These are critical errors in a financial/sustainability context where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 515,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the “Description of Securities” (Exhibit 4.3) of its 2022 Form 10‑K, where the issue was shown as a long‑term debt tranche that would mature in 2023 and therefore carried a current‑portion classification. When the 2023 filing was issued, the notes had been retired, so they no longer appeared in the debt schedule and were replaced by newer tranches (e.g., 2.40 % Notes due 2025). By the 2024 filing the 2.40 % 2023 series is completely absent, indicating that Apple has systematically rolled that maturity into later‑dated securities. This three‑year pattern reflects the company’s ongoing strategy of laddered, staggered maturities and proactive refinancing to maintain a low‑cost, long‑term debt profile while managing the near‑term portion of its obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Disclosure Pattern: The ground truth explicitly states that Apple 'consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024.' The LLM answer claims the notes 'no longer appeared in the debt schedule' in 2023 and are 'completely absent' by 2024. This is the opposite of what the ground truth indicates. (2) CRITICAL ERROR - Retirement Claim: The LLM states 'When the 2023 filing was issued, the notes had been retired, so they no longer appeared in the debt schedule.' The ground truth shows the notes were still disclosed in 2023 and 2024 filings, contradicting the retirement narrative. (3) CRITICAL ERROR - Refinancing Narrative: The LLM's explanation that Apple 'systematically rolled that maturity into later-dated securities' and replaced them with '2.40% Notes due 2025' is not supported by the ground truth, which emphasizes 'sustained transparency' and 'consistent inclusion across three years' rather than replacement/refinancing. (4) ENTITY/EXHIBIT ACCURACY: The LLM references 'Exhibit 4.3' and 'Description of Securities' which are not mentioned in the ground truth. The ground truth references an 'Officer's Certificate dated May 3, 2013' which the LLM does not mention. (5) REASONING FAILURE: The LLM's multi-hop synthesis is fundamentally flawed. It misinterprets the 3-year pattern as evidence of systematic refinancing when the ground truth indicates it demonstrates 'stable and transparent debt disclosure strategy' with deliberate inclusion despite maturity. The LLM answer essentially inverts the correct interpretation of the disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 472,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s stake in the AerCap note rose steadily—​$900 million in 2022, $944 million in 2023 and $982 million in 2024 (see GE 10‑K 2022 p. 74; GE 10‑K 2023 p. 71; GE 10‑K 2024 p. 71/70).  This incremental growth shows that GE is deliberately expanding its exposure to structured leasing‑related debt securities, using the AerCap note as part of a broader strategy to diversify its financial‑instrument portfolio and secure stable, yield‑generating assets within its aviation financing operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a significant factual error in the 2022 baseline figure. Ground truth states GE's AerCap note holdings were $976 million in 2022, but the LLM claims $900 million—a $76 million discrepancy (7.8% error). This is a material misstatement of the starting point for the analysis. The 2023 ($944M) and 2024 ($982M) figures are correct. REASONING ERROR: The LLM characterizes the progression as 'steady' and 'incremental growth,' but the ground truth reveals a more nuanced pattern: a DECREASE from 2022 to 2023 (976→944M, down $32M), followed by an INCREASE from 2023 to 2024 (944→982M, up $38M). This is not steady growth but rather a fluctuation with net stability. The LLM's interpretation fundamentally mischaracterizes the trend. INTERPRETATION ISSUE: The LLM's conclusion about 'deliberately expanding exposure' and 'incremental growth' contradicts the actual data pattern showing a dip in 2023. The ground truth correctly identifies this as 'dynamic approach' and 'fluctuation' with 'slight overall stability,' which is more accurate than the LLM's 'steady expansion' narrative. POSITIVE ASPECTS: The LLM correctly identifies the 2023 and 2024 figures, provides document citations, and addresses the strategic question about investment approach. The discussion of diversification and yield-generating assets is contextually relevant. However, the foundational quantitative error (2022 figure) and mischaracterization of the trend pattern are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 429,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nThe U.S. pension plan’s glide‑path targets moved from a 2022 allocation of **15 % equities, 75 % fixed‑maturity securities and 10 % other** (2022 target – p. 310 of the 2022 filing) to a 2024/2025 target of **9 % equities, 80 % fixed‑maturity securities and 11 % other** (2024‑25 target – p. 128 & 184 of the 2024 filing, also reflected in the 2023 target‑2024 table on p. 252).  This shift trims growth‑oriented equity exposure and raises the share of liability‑hedging fixed‑income assets, illustrating the plan’s de‑risking approach as its funded ratio improved over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, concrete asset allocation percentages that demonstrate the glide path evolution from 2022 to 2024/2025, which is more detailed than the ground truth answer. Strengths: (1) Correctly identifies the progression of target allocations across the three-year period; (2) Accurately captures the de-risking strategy through specific percentage shifts (equities declining from 15% to 9%, fixed-maturity securities increasing from 75% to 80%); (3) Properly cites page numbers from SEC filings, showing source documentation; (4) Correctly identifies the liability-hedging focus and improved funded ratio context. Quantitative accuracy is strong - the percentage allocations appear reasonable and internally consistent (15+75+10=100%, 9+80+11=100%). The answer successfully synthesizes multi-hop information showing how allocations evolved across years in response to funded status changes. Minor limitations: (1) The ground truth emphasizes the mechanism of how funded status at year-end determines next year's target allocation, which the LLM answer doesn't explicitly detail; (2) The LLM answer could have been slightly more explicit about the year-over-year progression (2022 target based on 2021 funded status, 2024 target based on 2022 funded status, etc.), though it does reference this implicitly through the page citations; (3) The answer provides specific numbers but doesn't explicitly state the funded ratio improvement that drove the de-risking, though it does reference it. The semantic meaning aligns well with the ground truth - both convey that AIG's pension plan progressively reduced growth assets and increased liability-hedging assets as part of a deliberate de-risking strategy. The LLM answer is actually more substantive by providing concrete allocation percentages rather than just describing the general approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 504,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its strategy—repeating the same four sustainable competitive advantages each year, earmarking capital for expanding microcontroller and processor capacity, and targeting industrial and automotive end‑markets as the primary growth engines.  The segment’s revenue and operating‑profit grew steadily (e.g., ≈ $3 bn in 2022, $3.37 bn in 2023 with > 38 % operating margin), delivering a reliable, high‑margin cash stream that consistently contributed a larger share of operating cash flow.  This multi‑year consistency shows that embedded‑processing is a stable, cash‑generating pillar that underpins the company’s long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s IP strategy for its private‑brand portfolio—most prominently the Kobalt line—moved from a purely registration‑focused approach to actively leveraging those brands in its digital‑first sales model.  The 2024 10‑K (page 4) stresses “balancing our value‑oriented private brands with our national brands” and local‑market optimization, while the successive filings (pages 7, 8, 9, 10, 12, 38) document expanded trademark, copyright and patent protection for Kobalt and related private‑brand names and describe their integration into the omnichannel marketplace, online product tools and AI‑driven personalization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the strategy moved from 'purely registration-focused' to 'actively leveraging' brands in digital-first sales, but the ground truth shows a consistent focus on the same three brands (Kobalt, STAINMASTER, allen+roth) across all three years with no evidence of this shift in approach. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the key finding that RONA and Reno Depot were listed in fiscal 2022 but removed by fiscal 2023, which is central to understanding the evolution of the IP strategy. This represents a major gap in addressing the 'brand portfolio emphasis' aspect of the question. (3) UNSUBSTANTIATED CLAIMS: The LLM references specific page numbers (pages 4, 7, 8, 9, 10, 12, 38) and quotes about 'balancing value-oriented private brands with national brands' and 'AI-driven personalization' that cannot be verified against the ground truth and appear to be fabricated or misattributed. (4) INCOMPLETE SYNTHESIS: While the ground truth clearly identifies a streamlining of brand disclosure (removal of RONA/Reno Depot) and introduction of digital transformation language by 2024, the LLM fails to capture this nuanced evolution and instead presents a narrative of transformation that isn't supported by the filing data. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes a 'simplification or refocusing' of brand emphasis, while the LLM suggests an expansion into 'omnichannel marketplace, online product tools and AI-driven personalization' without evidence. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual changes documented across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 481,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings IBM repeatedly identifies “client relationships and trust” as one of its principal competitive methods, but the framing shifts from a generic differentiator to a strategic pillar that underpins its hybrid‑cloud and AI agenda. By 2023‑2024 the company explicitly ties that trust to its ability to win in high‑value, rapidly‑growing hybrid‑cloud and AI markets—using long‑standing client confidence to differentiate from hyperscalers and niche rivals and to justify continued investment in ecosystem partnerships and responsible innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of IBM's strategic evolution but has significant gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the shift from generic to strategic positioning of client relationships/trust; (2) Accurately notes the connection to hybrid cloud and AI markets; (3) Properly identifies hyperscalers as competitors; (4) Correctly emphasizes ecosystem partnerships as part of the strategy. WEAKNESSES: (1) MAJOR OMISSION - The LLM completely fails to mention specific strategic partnerships with AWS, Microsoft, and SAP that were explicitly highlighted in 2023 according to ground truth. This is a critical multi-hop synthesis failure; (2) MAJOR OMISSION - The LLM does not mention Palo Alto Networks or the cybersecurity-focused partner expansion in 2024, which the ground truth identifies as a key evolution showing growing emphasis on security as a trust component; (3) INCOMPLETE SYNTHESIS - The answer lacks the specific year-by-year progression detail that the ground truth provides (2022: hybrid cloud/AI platform integration; 2023: ecosystem partnerships; 2024: security partnerships); (4) VAGUE FRAMING - The phrase 'responsible innovation' appears in the LLM answer but is not substantiated in the ground truth, suggesting potential hallucination or misinterpretation; (5) MISSING CONTEXT - The ground truth explicitly connects the evolution to 'data governance and digital transformation in enterprise IT decisions,' which the LLM answer does not address. QUANTITATIVE ACCURACY is high (8/10) because there are no specific numbers to verify and the timeframes are correct. QUALITATIVE ACCURACY is lower (5/10) because the multi-hop reasoning across partnerships and security evolution is incomplete and missing key entities. CONTEXTUAL RELEVANCE is moderate (7/10) because while the answer addresses the main question about strategic positioning, it misses critical details about the specific partnerships and security emphasis that define the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 548,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 the El Segundo, California site evolved from a primarily clinical‑trial manufacturing location into a full‑scale commercial hub for Gilead’s cell‑therapy portfolio.  The 2022 filing notes that the facility is used for “clinical and commercial manufacturing and processing of our cell therapy products,” and by 2024 it was delivering the bulk of commercial sales—$1.57 billion for Yescarta and $403 million for Tecartus in 2024—while still handling clinical‑trial material and complying with FDA REMS and chain‑of‑identity requirements (see GILD_10k_2022.pdf p. 33; GILD_10k_2024.pdf pp. 11 and 40).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities' and that it maintained 'continuity' with 'no expansion or reduction in responsibilities documented.' However, the LLM answer claims the facility 'evolved from a primarily clinical-trial manufacturing location into a full-scale commercial hub,' suggesting a significant transformation from 2022 to 2024. This is the opposite of what the ground truth indicates. While the LLM correctly identifies that the facility was used for 'clinical and commercial manufacturing and processing' in 2022 (matching the ground truth language), it then incorrectly characterizes this as an evolution toward commercial dominance. The LLM also introduces specific revenue figures ($1.57 billion for Yescarta and $403 million for Tecartus in 2024) that are not mentioned in the ground truth answer and cannot be verified as accurate or relevant to the question about facility role evolution. The LLM's narrative of 'evolution' and 'transformation' is a mischaracterization of the actual situation, which was one of stability and consistency. The multi-hop reasoning is flawed because it incorrectly synthesizes the information to support a narrative of change rather than continuity. The answer fails to capture the core finding that the facility's responsibilities remained stable across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 436,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s did not issue any new 4.550 % notes; the only 4.550 % tranche on its balance sheet remains the April 5 2049 notes that were originally sold under the Fifteenth Supplemental Indenture in April 2019.  During the same period the company added several fresh unsecured note series—e.g., the 4.000 % notes due 2025, 4.500 % notes due 2030, 5.000 % notes due 2040 (2020), and later 4.800 % due 2026, 5.150 % due 2033, 5.750 % due 2053 and 5.850 % due 2063 (2023)—creating a laddered maturity profile that stretches out to the mid‑2060s.  This multi‑year pattern signals a long‑term debt strategy of diversifying funding, extending average maturity and managing interest‑rate exposure while keeping the existing 4.550 % series as a stable, long‑dated pillar of its capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive information than the ground truth. Key strengths: (1) Correctly identifies the 4.550% Notes due April 5, 2049 as the consistent instrument across 2022-2024, matching the ground truth; (2) Accurately cites the Fifteenth Supplemental Indenture dated April 5, 2019 as the original issuance vehicle; (3) Provides additional context about other debt instruments issued during the period (4.000% due 2025, 4.500% due 2030, 5.000% due 2040, 4.800% due 2026, 5.150% due 2033, 5.750% due 2053, 5.850% due 2063), which enriches the analysis; (4) Correctly synthesizes the multi-hop reasoning that no new 4.550% notes were issued during 2022-2024, while other tranches were added. The answer goes beyond the ground truth by explaining the broader debt strategy context with specific maturity dates and interest rates. Minor consideration: The ground truth focuses narrowly on the 4.550% Notes evolution, while the LLM expands to discuss the full debt ladder strategy. This expansion is contextually appropriate and accurate, providing better insight into the actual long-term debt strategy question. All numeric values (dates, percentages, years) are correct. The reasoning about laddered maturity profiles and interest-rate exposure management is sound and well-supported by the specific instruments cited. No calculation errors detected. The answer effectively addresses both the specific evolution of the 4.550% Notes and the broader strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 422,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the exposure related to 3M’s Scotchgard‑derived PFAS liability shifted from a flood of new class‑action and state‑AG suits (e.g., the 2022‑2023 water‑provider and Michigan “PWS” settlements that were incorporated in the June 22 2023 settlement agreement [see MMM_10k_2023.pdf p. 114]) to a series of discrete settlements and dismissals—most notably the Wolverine‑related Scotchgard settlement that was finalized in June 2023 [see MMM_10k_2023.pdf p. 94]—while 2024 has seen only a handful of fresh filings (Missouri, Connecticut, Virginia, Minnesota) that remain pending or were recently dismissed [see MMM_10k_2024.pdf pp. 95‑100, 124‑131].  The company has recorded only immaterial accruals for these matters, indicating that although PFAS litigation remains ongoing, the resulting settlement costs have been financially negligible relative to 3M’s overall earnings.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 the Foster City, California site moved beyond early‑stage process‑chemistry and clinical‑trial API production to become a broader R&D and manufacturing hub that develops and manufactures API for both clinical and commercial products across Gilead’s HIV, oncology and cell‑therapy portfolios.  Its manufacturing responsibilities grew to support new product launches and to feed material and technology into the company’s global production network in Ireland, Canada and the Netherlands, aligning the site tightly with Gilead’s worldwide operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DIRECTIONAL ERROR - The LLM claims Foster City 'moved beyond early-stage process-chemistry and clinical-trial API production to become a broader R&D and manufacturing hub' that manufactures 'API for both clinical and commercial products.' This directly contradicts the ground truth, which states the facility transitioned TO early-stage development and clinical manufacturing, NOT away from it. The ground truth explicitly notes a 'strategic shift toward consolidating R&D and clinical production capabilities in Foster City' with commercial-scale manufacturing handled elsewhere. (2) SCOPE EXPANSION ERROR - The LLM incorrectly expands Foster City's role to include commercial product manufacturing across HIV, oncology, and cell-therapy portfolios. The ground truth indicates the facility's role became MORE narrowly defined, focused on early-stage development and clinical manufacturing, not broader commercial manufacturing. (3) GEOGRAPHIC ATTRIBUTION ERROR - The LLM attributes Ireland, Canada, and Netherlands operations to Foster City's 'global production network,' when the ground truth indicates these are separate locations handling commercial-scale manufacturing while Foster City handles clinical production. (4) MISSING KEY DETAILS - The LLM fails to mention the specific transition in how Foster City's role was described (from general 'administrative, manufacturing, and R&D' to specific 'process chemistry research, analytical method development, formulation, device development'). (5) INCORRECT SYNTHESIS - The multi-hop reasoning is fundamentally flawed; the LLM synthesized an opposite conclusion from the available information. The answer represents a complete reversal of the actual strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 502,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nAIG’s loss‑reserve oversight moved from a mainly internal, deterministic development process in 2022 to a formal risk‑appetite and limit structure by 2024, with ERM‑driven second‑line challenge and mandatory external actuarial and reinsurance‑expert reviews. At the same time, the company broadened its modeling—from simple development factors to stochastic, catastrophe‑PML and climate‑adjusted simulations—and began routinely validating those models and the related reinsurance‑recoverability estimates through independent third‑party reviews.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces some problematic characterizations and unsupported claims. CORRECT ELEMENTS: (1) The progression from 2022-2024 is accurately identified; (2) The shift toward stochastic and more sophisticated modeling approaches is correct; (3) The integration of ERM framework and second-line review by 2024 is accurate; (4) The mention of external expert reviews is appropriate. PROBLEMATIC ELEMENTS: (1) The characterization of 2022 as 'mainly internal, deterministic development process' is somewhat misleading—the ground truth indicates 2022 already emphasized both internal controls AND external expert reviews, not just internal; (2) The claim about 'formal risk-appetite and limit structure by 2024' is not explicitly supported in the ground truth, which focuses on ERM framework integration and second-line review rather than formal risk-appetite structures; (3) The specific mention of 'catastrophe-PML and climate-adjusted simulations' appears to be an inference or addition not explicitly stated in the ground truth; (4) The phrase 'mandatory external actuarial and reinsurance-expert reviews' overstates the ground truth, which mentions external expert reviews but not necessarily as 'mandatory' in the formal sense described. MULTI-HOP REASONING: The answer does synthesize information across the three-year period and identifies the evolution correctly in broad strokes, but makes some unsupported leaps. The core narrative of evolution from simpler to more sophisticated approaches is sound, but the specific mechanisms and characterizations diverge from the ground truth in ways that suggest inference rather than direct evidence. COMPLETENESS: The answer addresses oversight mechanisms, modeling approaches, and external reviews as requested, but the characterization of each element differs from the ground truth in specificity and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 516,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 the Melaka, Malaysia site remained listed under the **Analog** column in TI’s property tables ( † in 2022, * in 2023, ** in 2024 ), indicating that the facility was still dedicated to analog‑chip manufacturing; the only change was the lease‑ownership notation, not the product focus. Because Embedded‑Processing was never checked for Melaka in any of the three years, the progression shows that TI’s regional manufacturing footprint in Melaka stayed anchored to its analog business and did not shift toward embedded‑processing production during this three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. CORRECTNESS: The answer accurately identifies that Melaka, Malaysia maintained exclusive Analog manufacturing focus from 2022-2024 with no expansion into Embedded Processing. The core factual claim matches the ground truth precisely. QUANTITATIVE ACCURACY: No numeric calculations were required for this question, but the temporal references (2022, 2023, 2024) are all correct, and the notation markers (†, *, **) are appropriately cited as evidence from the property tables. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesized information across three years to identify the pattern of stability in Analog focus and absence of Embedded Processing. The logic that 'Embedded-Processing was never checked for Melaka in any of the three years' directly supports the conclusion about manufacturing focus. ENTITY ACCURACY: Texas Instruments (TI/TXN), Melaka Malaysia, Analog, and Embedded Processing are all correctly identified. SEMANTIC EQUIVALENCE: The LLM's characterization of Melaka as having a 'stable but specialized role' aligns with the ground truth's description of 'stable but specialized role for Melaka in TXN's global manufacturing strategy.' The explanation of lease-ownership notation changes (†, *, **) as distinct from product focus changes adds helpful detail without contradicting the ground truth. MINOR CONSIDERATION: The LLM provides slightly more granular detail about the notation markers than the ground truth explicitly states, but this represents appropriate elaboration rather than error. The answer fully addresses both sub-questions: (1) how the footprint evolved (answer: it remained stable in Analog focus), and (2) what this indicates about manufacturing focus (answer: specialized Analog-only, no Embedded Processing shift).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 510,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe’s began fiscal 2022 with a sizable cash‑flow hedge of roughly **$2.56 billion** in forward interest‑rate swaps (as disclosed in the 2022 10‑K), and the company continued to hold a comparable notional amount through fiscal 2023 (the swaps still showed a fair‑value of about $250 million). By fiscal 2024 the forward‑swap position was essentially **wound down to zero** (fair‑value reported as $‑), indicating that the contracts were terminated or rolled off as the targeted debt‑issuance windows were reached. This pattern shows that Lowe’s employed a **project‑specific, timing‑driven hedging strategy**—locking in rates for anticipated bond issuances and then retiring the swaps once those financings were executed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and introduces unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a '$2.56 billion' notional amount for forward interest rate swaps in fiscal 2022, which is not mentioned in the ground truth and appears to be fabricated. The ground truth only references a '$251 million' fair value in fiscal 2023, not $2.56 billion. The LLM's claim of '$250 million' fair value in fiscal 2023 is approximately correct (matches $251M), but the $2.56B notional figure is unsupported. (2) FACTUAL ACCURACY: The ground truth explicitly states that by fiscal 2024, 'the company no longer held forward interest rate swaps,' which the LLM correctly captures by saying the position was 'wound down to zero.' However, the LLM's characterization of the fiscal 2022 position as a 'sizable cash-flow hedge of roughly $2.56 billion' introduces a number not present in the ground truth. (3) REASONING QUALITY: The LLM's interpretation that this represents a 'project-specific, timing-driven hedging strategy' is reasonable and aligns with the ground truth's conclusion about a 'strategic shift from hedging anticipated debt issuances to managing interest rate exposure on existing debt.' However, this reasoning is built on a false quantitative foundation. (4) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the three-year progression correctly in concept (2022→2023→2024), but the specific numbers used in fiscal 2022 are not grounded in the provided ground truth. (5) MISSING CONTEXT: The LLM fails to mention the shift to 'fixed-to-floating interest rate swaps as fair value hedges on existing debt' that the ground truth emphasizes as the strategic pivot. The answer is partially correct in direction but fundamentally flawed in quantitative support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 500,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings IBM repeatedly incorporates “Exhibit 2 to the Form 8‑K filed on January 8 1998” as the governing document for the 6.50 % Debentures due 2028, using identical language and the same exhibit number each year. The unchanged citation shows that the terms of this debt series were set in 1998 and have not been amended or restated since, indicating a deliberately permanent, long‑term structure that is documented once and simply referenced in subsequent filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about IBM's disclosure evolution across three years. QUANTITATIVE ACCURACY: All numeric values are correct—the 6.50% interest rate, the 2028 maturity date, and the January 8, 1998 filing date are all accurate. The date format variation (\"January 8 1998\" vs \"January 8, 1998\") is a minor stylistic difference that does not affect accuracy. ENTITY ACCURACY: IBM is correctly identified, the debenture series is properly specified (6.50% Debentures due 2028), all three fiscal years (2022, 2023, 2024) are correctly referenced, and the exhibit citation (Exhibit 2 to Form 8-K) is accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings, correctly identifying that the same exhibit reference appears consistently across all three years and drawing the appropriate conclusion about structural stability. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that the documentation remained unchanged, indicating a stable long-standing instrument with no material amendments. The phrasing \"deliberately permanent, long-term structure that is documented once and simply referenced in subsequent filings\" is a slightly more interpretive characterization than the ground truth's \"stable and long-standing debt instrument,\" but both convey equivalent meaning about the consistency and permanence of the structure. COMPLETENESS: The answer fully addresses both parts of the question: (1) how the disclosure evolved (consistently referenced with identical language), and (2) what the consistency reveals (unchanged documentation and legal structure). The only minor distinction is that the LLM uses slightly more interpretive language (\"deliberately permanent\") compared to the ground truth's more straightforward \"stable,\" but this represents a reasonable inference rather than an error. No factual inaccuracies or calculation errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 543,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nReflective Signage began in 2022 as part of the broad “Premium large‑format graphic films” offering within 3M’s Transportation & Electronics segment.  By 2023 its contribution was reflected in the segment’s operating income rising from $973 million (2021) to $1,312 million (2022), underscoring growing revenue importance.  In 2024 the company reshaped the segment, creating a dedicated **Commercial Branding and Transportation** division that explicitly lists “Reflective signage for highway and vehicle safety” as a core product, signalling that 3M now treats reflective signage as a strategic, high‑visibility growth pillar of its portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question. MAJOR ISSUES: (1) FACTUAL ERRORS: The answer claims Reflective Signage 'began in 2022 as part of the broad Premium large-format graphic films offering' - this is contradicted by the ground truth which shows Reflective Signage was listed separately as the fifth position in 2022, not as part of premium large-format graphic films. (2) INCORRECT POSITIONING DATA: The LLM provides no accurate positioning information for 2022, 2023, or 2024. The ground truth clearly states: 2022 (5th position), 2023 (4th position), 2024 (4th position). The LLM completely fails to track this evolution. (3) UNSUPPORTED FINANCIAL CLAIMS: The LLM cites operating income figures ($973M in 2021, $1,312M in 2022) that are not mentioned in the ground truth and appear to be fabricated or misattributed. These numbers are presented without clear connection to Reflective Signage specifically. (4) STRUCTURAL REORGANIZATION CLAIM: The LLM claims a 'Commercial Branding and Transportation' division was created in 2024 - this specific organizational claim is not supported by the ground truth, which only discusses positioning within the existing Transportation and Electronics segment. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about positioning evolution across three years and what this suggests about strategic importance. The ground truth provides a clear narrative of positioning changes and concludes with strategic implications. The LLM provides none of this required synthesis. (6) SEMANTIC MISMATCH: While the LLM attempts to discuss strategic importance, it does so through unsupported claims about reorganization rather than through the actual positioning data that forms the basis of the ground truth answer. The answer reads as speculative rather than evidence-based.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 501,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nGilead moved the Hoofddorp, Netherlands plant from a mainly clinical‑stage cell‑therapy site in 2022 to a central commercial manufacturing hub for its cell‑therapy portfolio by 2024.  The facility began commercial production of Yescarta and Tecartus in 2022, and as sales of these products expanded—oncology‑cell‑therapy revenue grew from $1.869 bn in 2023 to $1.973 bn in 2024 (see the revenue table in the 2024 10‑K, page 40)—its role in the company’s supply chain became strategically critical for meeting demand.  (Hoofddorp is identified as a commercial manufacturing location for cell‑therapy products in the 2024 10‑K, page 11.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims oncology cell-therapy revenue grew from $1.869 billion in 2023 to $1.973 billion in 2024. These specific numbers cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific revenue figures. (2) FACTUAL INACCURACY: The LLM states the facility 'began commercial production of Yescarta and Tecartus in 2022,' but the ground truth indicates that in 2022, Hoofddorp was merely identified as 'one of its principal manufacturing facilities' with no explicit mention of commercial production beginning that year. The ground truth shows commercial manufacturing was explicitly described in 2023, not 2022. (3) CHARACTERIZATION ERROR: The LLM describes the 2022 status as 'mainly clinical-stage cell-therapy site,' which contradicts the ground truth's description of it as a 'principal manufacturing facility' in 2022. This mischaracterizes the facility's role. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and connect facility evolution to revenue growth, the synthesis is built on unverified or incorrect data points. The connection between revenue figures and facility importance is logical but unsupported by the ground truth. (5) CITATION ISSUES: The LLM cites specific page numbers (page 40, page 11 of 2024 10-K) but the revenue figures provided cannot be independently verified against the ground truth. (6) PARTIAL CREDIT: The LLM does correctly identify that Hoofddorp's role evolved toward commercial manufacturing and that it became strategically important, which aligns with the ground truth's narrative arc. However, the specific timeline and supporting details are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 508,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe share reserve for the 2003 Director Compensation Plan fell from ≈ 69.8 million shares at the end of 2022 to ≈ 58.5 million at the end of 2023, then rose again to ≈ 65.5 million by the end of 2024. The 2023 decline shows that shares were being allocated for director compensation that year, while the 2024 rebound indicates that Texas Instruments replenished the reserve, underscoring its continued reliance on the plan to fund future director awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. Ground truth shows shares available declining from 1,843,134 (2022) to 1,786,785 (2023) to 1,745,284 (2024) - a consistent downward trend. The LLM provides completely different numbers: ~69.8 million (2022), ~58.5 million (2023), and ~65.5 million (2024). These numbers are off by a factor of approximately 40,000x and represent a different pattern entirely (decline then rebound vs. consistent decline). The LLM's narrative about a 2023 decline followed by a 2024 'replenishment' contradicts the ground truth showing continuous depletion. The reasoning about 'replenishing the reserve' is unsupported by the actual data. The LLM appears to have confused the 2003 Director Compensation Plan share reserve with a different metric entirely - possibly confusing it with total shares outstanding or a different equity plan. All three years' numbers are incorrect, the trend direction is wrong for 2024, and the interpretation of what the trend indicates is therefore also incorrect. This represents a complete failure to accurately synthesize the multi-hop information about Texas Instruments' director compensation plan share availability across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 348,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the way it disclosed its 0.950 % Notes due 2025 from a simple exhibit citation in 8‑K filings (2022 p. 33; 2023 p. 20) to an explicit, ticker‑coded entry in the 2024 Form 10‑K securities table (p. 2), giving the issue a market‑wide identifier (IBM25B) and placing it alongside its equity securities. This increased visibility and formal market‑transparency signals a broader capital‑market strategy that treats its debt as a distinct, investable class and reflects a more investor‑focused, transparent approach to debt financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of IBM's disclosure practices across 2022-2024. STRENGTHS: (1) Correctly identifies the 0.950% Notes due 2025 and its ticker symbol IBM25B; (2) Accurately captures the progression from exhibit citation (8-K filings) to explicit securities table entry in Form 10-K; (3) Properly identifies the shift from internal documentation to market visibility; (4) Correctly interprets the strategic implications regarding transparency and investor engagement; (5) Appropriately cites page numbers (2022 p. 33; 2023 p. 20; 2024 p. 2) showing document-level verification. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the May 22, 2017 Form 8-K filing (Exhibit 4.1) that served as the defining instrument referenced across all three years - this is a detail present in the ground truth that adds context about the continuity of the underlying instrument documentation; (2) The phrase 'alongside its equity securities' is slightly imprecise - the ground truth indicates the notes were listed 'alongside newer instruments' rather than specifically equity securities, though this is a minor semantic distinction. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the causal relationship between increased disclosure prominence and strategic capital market positioning. The logic connecting disclosure evolution to investor engagement strategy is sound and well-articulated. QUANTITATIVE ACCURACY: All numbers, dates, and percentages are correct (0.950%, 2022-2024 timeline, IBM25B ticker). Page citations appear reasonable though not independently verifiable in this context. Overall, this is a high-quality answer that captures the essential evolution and strategic implications with only minor omissions of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 514,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit assets on reinsurance expanded from roughly $1.8 billion (a level that had been stable in 2021‑22) to $5.1 billion in 2023 and then slipped to $4.6 billion in 2024, while deposit liabilities rose from about $1.4 billion to $1.3 billion in 2023 and fell to $1.2 billion in 2024 as the balances amortized.  The November 2023 Global Atlantic transaction—under which the company recorded a $10.3 billion deposit receivable, retained $5 billion of separate‑account assets and booked a $770 million net cost of reinsurance—demonstrated a strategic shift toward using deposit accounting for large, long‑duration block reinsurance to capture economic value and manage capital on a longer‑term basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Quantitative verification: All key numbers are correct - deposit assets of $1.8B (2022), $5.1B (2023), $4.6B (2024); deposit liabilities of $1.4B (2022), $1.3B (2023), $1.2B (2024); and the $10.3B deposit receivable from the Global Atlantic transaction. The answer correctly identifies the November 2023 timing of the Global Atlantic transaction and accurately reports the $5B separate-account assets retained and $770M net cost of reinsurance. Multi-hop reasoning is sound: the answer synthesizes the evolution of deposit assets/liabilities across three years while connecting this trend to the strategic significance of the 2023 Global Atlantic transaction. The LLM provides additional context not explicitly in the ground truth (e.g., 'amortized,' 'long-duration block reinsurance,' 'capture economic value') that demonstrates deeper understanding and is consistent with the data. The characterization of the transaction as a 'strategic shift toward using deposit accounting for large, long-duration block reinsurance' aligns with and expands upon the ground truth's description of 'a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.' The answer is well-structured, addresses all parts of the multi-part question, and maintains semantic equivalence with the ground truth while providing slightly more nuanced explanation. No material factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 419,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Safety and Industrial segment continued to list “respiratory, hearing, eye and fall‑protection solutions” among its core products, and in early 2024 3M reorganized those personal‑safety offerings—including fall‑protection equipment—into a newly created **Industrial Specialties** division.  This restructuring consolidates and highlights fall‑protection as a distinct growth platform, signaling that 3M is placing a stronger strategic emphasis on workplace‑safety solutions within its Safety and Industrial business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The original answer states that fall protection solutions remained consistently listed within the Safety and Industrial segment from 2022-2024 with stable product groupings and no major organizational changes. However, the LLM answer introduces a claim about a 2024 reorganization creating a new 'Industrial Specialties' division that consolidated fall-protection equipment. This reorganization claim is not supported by the ground truth and appears to be fabricated or confused with different information. The LLM correctly identifies the product listing ('respiratory, hearing, eye and fall-protection solutions') and the 3-year timeframe, but fundamentally mischaracterizes the nature of the portfolio evolution. The ground truth emphasizes consistency and stable strategic focus, while the LLM answer claims a major structural reorganization occurred. This is a critical factual error in multi-hop reasoning - the model failed to accurately synthesize the actual evolution of the product portfolio across the three-year period. The claim about 'early 2024' reorganization and creation of a new division cannot be verified against the ground truth and represents a material misrepresentation of how MMM's fall protection solutions evolved. The answer does address the question's components but with fundamentally incorrect information about organizational changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 402,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria streamlined its reporting structure between 2022 and 2024, eliminating the standalone “Wine” category and folding all smokeless and oral‑nicotine activities—including UST’s MST and snus brands—into a single “Oral tobacco products” segment (see Note 17, 2023 10‑K, p. 82).  The company has kept 100 % ownership of UST LLC while increasingly integrating its assets with the broader oral‑tobacco portfolio, as highlighted by the $8.8 bn valuation of MST/snus trademarks (p. 66) and the full consolidation of Helix’s on! pouch business (p. 60).  This consolidation reflects Altria’s strategic shift to treat smokeless tobacco and next‑generation oral nicotine products as a unified growth platform to transition adult smokers away from cigarettes.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $8.8 billion valuation of MST/snus trademarks, matching the ground truth. (2) Accurately notes 100% ownership of UST LLC. (3) Correctly identifies the consolidation of Helix's on! pouch business. (4) Properly recognizes the strategic shift toward oral tobacco products as a unified platform. (5) Accurately describes the elimination of the Wine category and consolidation into 'Oral tobacco products' segment. WEAKNESSES: (1) The LLM answer focuses heavily on reporting structure changes and segment consolidation (2022-2024) but provides less emphasis on the evolution of UST's strategic positioning within Altria's 'Moving Beyond Smoking' initiative, which is central to the ground truth answer. (2) The ground truth emphasizes a three-year progression showing increasing integration and alignment with reduced-risk positioning, while the LLM answer treats this more as a structural/reporting change rather than a strategic evolution. (3) The LLM answer mentions 'next-generation oral nicotine products' but doesn't explicitly connect this to the 'Moving Beyond Smoking' strategic initiative mentioned in the ground truth. (4) Missing explicit reference to the 2023 reaffirmation of UST as a wholly owned subsidiary through consolidated subsidiaries structure. (5) The answer is more focused on operational/reporting consolidation than on the strategic narrative of transitioning adult smokers to less harmful products. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and documents (2023 10-K references), but the synthesis leans toward structural/operational changes rather than strategic positioning evolution. The connection between organizational changes and strategic intent is present but underdeveloped compared to the ground truth. SEMANTIC ALIGNMENT: While the LLM answer is factually accurate on specific details, it addresses a different aspect of the question (reporting structure) than the ground truth (strategic positioning evolution). Both are valid interpretations of the question, but the ground truth provides a more complete answer to the strategic positioning component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 584,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 filings shows that the company still regards this securitized‑bond structure as a key, long‑term financing vehicle for its solar portfolio. By continually referencing the same bond series, Tesla signals its intention to maintain and potentially roll‑over this type of debt‑backed capital to fund and refinance solar projects going forward.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the bond series (5.45% Solar Bonds, Series 2015/C92-15) and the relevant filing years (2022-2024). The quantitative elements are accurate - the bond percentage and series designation match the ground truth exactly. The answer appropriately captures the core insight that Tesla views this as a key long-term financing vehicle for solar initiatives. However, the LLM answer is notably more concise and omits several important contextual details present in the ground truth: (1) it does not mention the specific supplemental indenture date (August 24, 2015), (2) it lacks the reference to the One Hundred-and-Sixteenth Supplemental Indenture, and (3) it does not explicitly discuss Tesla's confidence in the bond's performance or its alignment with the broader clean energy business model. The LLM's reasoning about 'roll-over' and 'refinance' is reasonable inference but goes slightly beyond what the ground truth explicitly states about the bonds' role. The answer demonstrates sound multi-hop synthesis across the three filing years and correctly interprets the strategic significance of the repeated references. The semantic meaning aligns well with the ground truth's core conclusion about sustained reliance on securitized solar financing, though with less comprehensive supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 371,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nIBM’s 10‑K filings consistently flag “governmental and stock‑exchange regulations” as a risk that can affect the valuation and liquidity of both its debt and equity securities—see the risk‑factor language on p. 22 of the 2022 filing, and the identical wording on p. 11 of the 2023 and 2024 filings.  The repetition shows that IBM’s exposure to exchange‑related rules has not changed materially across the three years, but the company treats regulatory risk as a permanent element of its capital‑market exposure and manages it through ongoing monitoring, diversified financing, strong credit‑rating oversight and transparent disclosure.  This multi‑year progression reveals a risk‑management strategy that relies on proactive compliance and diversification rather than on altering the nature of its securities‑related regulatory exposure.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nAcross the three years, 3M kept electrical products for construction and maintenance inside its Safety‑and‑Industrial segment, but it refined the way those offerings were organized—creating an Industrial Specialties division in 2023 and, in 2024, further isolating them within that new division and linking them to commercial‑branding initiatives.  This realignment coincides with a sharp rise in segment profitability: operating income climbed from $1.1 billion in 2022 to $2.5 billion in 2024 even as net sales hovered around $11 billion, highlighting a deliberate shift toward higher‑margin electrical solutions.  The progression signals that 3M is strategically concentrating on industrial‑electrical markets to capture infrastructure‑driven growth and strengthen its position in the broader industrial sector.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific operating income figures ($1.1B in 2022, $2.5B in 2024) and net sales (~$11B) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated financial data. This is a critical error in a financial evaluation context. (2) STRUCTURAL MISREPRESENTATION - The LLM claims MMM 'created an Industrial Specialties division in 2023' and 'further isolating them within that new division in 2024', but the ground truth indicates these were segment descriptions within the Safety and Industrial segment, not separate divisions. This represents a fundamental misunderstanding of MMM's organizational structure. (3) INCOMPLETE SYNTHESIS - The ground truth explicitly details what was included in each year (e.g., 'Closure systems for personal hygiene products, masking, and packaging materials' in 2022; 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' in 2023), but the LLM omits these specific product categories entirely. (4) UNSUPPORTED CLAIMS - The LLM's assertion about 'commercial-branding initiatives' and 'infrastructure-driven growth' are not mentioned in the ground truth and appear to be speculative additions. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize a strategic narrative, it does so by introducing unverified financial metrics and organizational claims rather than accurately synthesizing the actual evolution described in the ground truth. The core finding about consistent electrical product focus is partially correct, but the execution and supporting details are largely inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 471,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead expanded the Oceanside, California site from a mainly clinical‑trial and process‑development location into a fully commercial retroviral‑vector manufacturing platform.  The facility now produces commercial‑scale retroviral vectors that support the company’s biologics pipeline—including its CAR‑T cell therapies (Yescarta, Tecartus) and other gene‑therapy candidates—while continuing to perform process‑development and clinical‑batch activities.  This evolution reflects a strategic shift toward leveraging Oceanside for both the manufacture of viral vectors and the broader development of Gilead’s biologics products.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the Oceanside facility from 2022-2024, accurately capturing the progression toward commercial retroviral vector manufacturing. The timeline is correct (2022 through 2024), and the facility's role in biologics and retroviral vectors is properly identified. The mention of specific products (Yescarta, Tecartus) and CAR-T cell therapies adds relevant context. The characterization of the shift from clinical/process development to commercial manufacturing aligns with the ground truth.\n\nWEAKNESSES: (1) The LLM answer introduces specific product names (Yescarta, Tecartus) and CAR-T cell therapy details that are NOT present in the ground truth answer. While these may be factually accurate about Gilead's portfolio, they represent information synthesis beyond what was provided in the original answer, raising questions about source verification. (2) The LLM characterizes 2022 as 'mainly clinical-trial and process-development' which is slightly more specific than the ground truth's 'part of broader operational footprint' and 'role in research and development.' (3) The LLM answer lacks the nuanced progression described in the ground truth: 2022 (general R&D role), 2023 (clinical manufacturing and process development), 2024 (commercial retroviral vector manufacturing). The LLM presents a more linear narrative without the year-by-year differentiation.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by synthesizing information about facility evolution across three years and connecting it to product applications. However, the introduction of product-specific details not in the ground truth suggests potential hallucination or external knowledge injection.\n\nNUMERIC/FACTUAL VERIFICATION: No quantitative errors detected. All dates (2022-2024) are correct. The facility name (Oceanside, California) is correct. The company (Gilead/GILD) is correctly identified.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - a strategic shift from R&D/clinical to commercial manufacturing. However, the added specificity about products and the slightly different characterization of 2022 operations creates minor divergence from the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 606,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nFrom 2022 through 2024 the plan’s “Return‑Seeking” (growth) target was cut sharply: the 2022 target called for **15 % equity**, while the 2023 target (reflected in the 2024 glide‑path) reduced that to **9 % equity** (with a corresponding rise in fixed‑maturity and other assets). The 2024 target (for 2025) kept the equity share at **9 %**, maintaining the more conservative allocation as the plan’s funded ratio improved. This evolution shows AIG’s glide‑path moving the portfolio away from growth assets toward liability‑hedging assets over the three‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. (1) CRITICAL ERRORS: The LLM provides specific equity allocation percentages (15% in 2022, 9% in 2023-2024) that are NOT supported by the ground truth. The original answer makes no mention of these specific percentages and instead focuses on the methodology of how target allocations were set (based on funded status at different year-end dates). The LLM appears to have fabricated specific numerical targets. (2) QUANTITATIVE ACCURACY FAILURE: The ground truth does not provide specific equity percentages for the Return-Seeking portion in any year. The LLM's claim of '15% equity' in 2022 declining to '9% equity' in 2023-2024 cannot be verified against the provided ground truth and appears to be hallucinated data. (3) MISALIGNMENT WITH GROUND TRUTH: The original answer emphasizes the TIMING and METHODOLOGY of glide path adjustments (forward-looking, dynamic adjustments based on funded status), while the LLM answer focuses on SPECIFIC ALLOCATION PERCENTAGES that shift from growth to liability-hedging. These are fundamentally different interpretations. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the information. The ground truth indicates the glide path remained 'consistent in strategy' with evolving target allocations based on funded status timing, not a sharp reduction in equity allocations. (5) SEMANTIC MISMATCH: The LLM's narrative of 'cutting equity sharply' and 'moving away from growth assets' contradicts the ground truth's emphasis on consistent strategy with dynamic adjustments. The LLM answer is largely incorrect and appears to contain fabricated financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 465,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN’s pension‑plan target mix moved from a heavy‑debt stance (U.S. plans ≈ 100 % debt; non‑U.S. plans ≈ 27 % equity, 48 % debt, 4 % cash, 11 % insurance) to a more diversified, liability‑driven allocation (non‑U.S. plans ≈ 28 % equity, 36 % debt, 7 % cash, 21 % insurance, with cash and insurance shares rising sharply).  This multi‑year shift reflects a deliberate move away from a pure fixed‑income bias toward a broader set of assets that better match liabilities and provide liquidity buffers, signalling that ACN is adopting a more conservative, risk‑averse long‑term investment approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific asset allocation percentages that cannot be verified against the ground truth, which does not contain these detailed numerical breakdowns. Critical issues: (1) The ground truth does not mention specific percentages like '100% debt for U.S. plans' or the detailed non-U.S. allocation figures (27% equity, 48% debt, 4% cash, 11% insurance in 2023 vs. 28% equity, 36% debt, 7% cash, 21% insurance in 2025). These numbers appear to be fabricated or from sources not in the knowledge graph. (2) The LLM's conclusion that ACN adopted a 'more conservative, risk-averse' approach directly contradicts the ground truth, which states the shift indicates 'increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.' (3) The ground truth emphasizes the extension of planning horizon from one year to two years as a key indicator of confidence, which the LLM completely omits. (4) The ground truth describes a 'measured, stable approach' with 'flexibility based on market conditions,' not a shift from 'pure fixed-income bias' to 'broader assets.' (5) The LLM's interpretation of the shift as 'more conservative' is semantically opposite to the ground truth's interpretation of increased strategic confidence. The LLM appears to have either hallucinated specific allocation percentages or misinterpreted available data, and fundamentally mischaracterized the strategic implications of the changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 409,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nTesla first created the 5.45 % Solar Bonds, Series 2015/C25‑15 via the April 14 2015 “Thirty‑Sixth Supplemental Indenture” (referenced on page 102 of the 2022 10‑K).  Subsequent filings show the company no longer issuing new bonds of this series – the 2023 10‑K discusses solar financing primarily through PPAs and lease‑back structures, and the 2024 10‑K reports a shrinking finance‑lease portfolio and lower interest expense for solar assets, indicating a strategic pivot away from bond‑based financing toward more flexible, project‑level structures.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 to 2024 AIG refined its terrorism‑risk modeling—using a third‑party vendor model with scenario‑based loss estimates and periodic adjustments for model gaps—and expanded its reinsurance program to include more targeted, collateral‑backed treaties and participation in government‑run terrorism pools in non‑U.S. jurisdictions.  At the same time it intensified concentration monitoring (notably in New York City) and relied on TRIPRA together with private reinsurance, while strengthening collateral and reinsurance‑recoverable management to cap net exposure across global markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the specific modeled loss estimates that are central to the question. Ground truth provides: $1.3 billion loss estimate for five-ton bomb attack in NYC (2022), $200 million Japan attachment point (2024), and $38.0 billion reinsurance recoverable assets (2024). The LLM mentions 'scenario-based loss estimates' generically but provides NO actual numbers. (2) INCOMPLETE TEMPORAL EVOLUTION: Ground truth shows clear progression: 2022 (specific NYC modeling), 2023 (shift to active management/concentration monitoring), 2024 (enhanced global covers, Japan specifics). LLM conflates these into a general narrative without year-by-year differentiation. (3) MISSING SPECIFIC MECHANISMS: Ground truth identifies TRIPRA explicitly and government-sponsored pools; LLM mentions these but less specifically. Ground truth notes 'Japan at $200 million' attachment point - LLM omits this entirely. (4) REINSURANCE RECOVERABLE ASSETS: Ground truth provides critical $38.0 billion figure for 2024 showing 'significant scaling of risk transfer mechanisms' - LLM completely absent this metric. (5) WHAT WAS CORRECT: LLM correctly identifies scenario-based modeling, TRIPRA reliance, government pools, concentration monitoring (NYC), and collateral-backed approaches. The general strategic direction is accurate. MULTI-HOP REASONING: LLM demonstrates understanding of the evolution concept but fails to synthesize the specific quantitative milestones across the three-year period. The answer reads as a general description rather than a documented evolution with measurable changes. QUANTITATIVE PENALTY: Missing $1.3B, $200M, and $38.0B figures represents significant omission of factual data essential to answering 'how did...evolve' with concrete evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 495,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment experienced deepening exposure to adverse industry conditions, as organic sales fell and segment margin slipped—especially in 2024 when sales dropped $705 million and margin declined 100 bps.  The company repeatedly cited reduced investment in process automation and safety monitoring, softness in retail and PPE demand, competitive commoditization, foreign‑currency headwinds and supply‑chain constraints as the persistent risks that drove the margin pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of persistent adverse industry conditions affecting the Safety and Productivity Solutions segment across 2022-2024. It appropriately mentions key risk factors including reduced process automation investments, retail/PPE demand softness, and commoditization. The answer demonstrates understanding of the multi-hop synthesis required (tracking evolution across three years). CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM introduces specific numbers ($705 million sales drop, 100 bps margin decline in 2024) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated figures. The ground truth does not cite specific dollar amounts or basis point declines for any year. This is a serious factual error. (2) INCOMPLETE RISK FACTORS - The LLM mentions 'foreign-currency headwinds and supply-chain constraints' which are NOT mentioned in the ground truth as consistently highlighted risks for this segment. The ground truth specifically emphasizes: reduced process automation investments, retail market fluctuations, product commoditization, new market entrants, adverse industry economic conditions, lower market share, and reduced selling prices. The LLM's inclusion of FX and supply-chain issues represents either hallucination or confusion with other segments. (3) STRUCTURAL ISSUE - The ground truth explicitly notes the segment was 'restructured' and became the 'Industrial Automation segment' by 2024, which the LLM fails to mention. This is an important contextual detail about the organizational evolution. (4) MISSING NUANCE - The ground truth emphasizes 'new market entrants' as a specific driver of commoditization, which the LLM omits. VERIFICATION: The ground truth provides NO specific sales figures or margin basis points for any year in this segment. The LLM's citation of '$705 million' and '100 bps' cannot be verified against the provided ground truth and appear to be unsupported claims. This significantly undermines credibility despite the correct thematic understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 562,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nIn 2022 Pfizer granted Breakthrough Performance Awards to selected non‑executive employees tied to pipeline milestones, valuing each award at the intrinsic value of the closing stock price and recognizing the compensation expense on a straight‑line basis over the estimated vesting period, with periodic adjustments for stock‑price changes and the probability of achieving the performance targets; in 2023 the company granted no BPAs and had none outstanding, effectively pausing the program; by 2024 the awards were reinstated with the same intrinsic‑value valuation and straight‑line expense recognition, again adjusted for stock‑price movements and performance‑achievement estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the specific numeric data from the ground truth: 1,165 thousand BPAs granted in 2022 with weighted average intrinsic value of $38.73 per share, and 859 thousand nonvested BPAs at year-end 2022. These are factual numbers that should have been included. (2) MAJOR FACTUAL ERROR - The LLM states that 'by 2024 the awards were reinstated,' but the ground truth indicates that in 2023 'none were outstanding as of December 31, 2023' and in 2024 the company only 'described the valuation and recognition methodology' - there is NO evidence in the ground truth that awards were actually reinstated/granted in 2024. The LLM mischaracterizes 2024 as showing reinstatement when it actually shows only methodological description. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2023 wind-down (no grants, none outstanding), it fails to capture the quantitative details of 2022 activity and misinterprets 2024 activity. (4) VALUATION METHODOLOGY - The LLM correctly describes the intrinsic value method and straight-line amortization with adjustments, which aligns with ground truth, but this partial correctness cannot offset the major factual errors. (5) MULTI-HOP REASONING - The answer fails to properly synthesize the three-year evolution: the ground truth shows a clear progression from active issuance (2022) → complete wind-down (2023) → methodological focus without reinstatement (2024), but the LLM incorrectly suggests reinstatement in 2024. The answer demonstrates understanding of the general concept but contains significant factual inaccuracies that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 460,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nAccenture repurchased roughly $4.1 billion of its Class A shares in fiscal 2022, about $4.5 billion in fiscal 2023 and again about $4.5 billion in fiscal 2024, while the Board repeatedly expanded the unused portion of its purchase mandate—from ≈ $3.1 billion of authority left at the end of FY 2022, to roughly $2.7 billion remaining after FY 2024 (before a September 2024 $4 billion increase that lifted total authority to $6.7 billion).  This pattern shows a disciplined, ongoing capital‑return strategy that consistently deploys sizable share‑buy‑backs and maintains ample authorization for future repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail about actual repurchase amounts ($4.1B, $4.5B, $4.5B) that are not present in the ground truth, which adds value but cannot be verified against the provided knowledge graph. The core authorization figures are largely accurate: ~$3.1B at end of FY2022 (matches ground truth's $3,129,296,000), ~$2.7B remaining after FY2024 (matches $2,694M), and the $4B new authorization bringing total to $6.7B (matches $6,694M). However, there is a critical issue with the statement 'remaining after FY 2024 (before a September 2024 $4 billion increase)' - the ground truth explicitly states the $2,694M figure is 'as of August 31, 2024' with the new authorization being received after that date, not that the $2.7B was the remaining amount after the new authorization was already applied. The LLM's phrasing could be misinterpreted as the $2.7B being post-new-authorization, when it should be pre-new-authorization. The qualitative assessment of 'disciplined, ongoing capital-return strategy' is sound and well-supported. The multi-hop synthesis across fiscal years is correct. The main weakness is the introduction of unverified repurchase amounts and slight ambiguity in the sequencing of the authorization increase, though the final numbers are accurate. The answer demonstrates good understanding of the capital return strategy but has minor precision issues in presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 390,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter completing the sale of Meridian on December 31 2021, Pfizer’s relationship with the former subsidiary shifted to a purely transitional one—entering into short‑term transition‑services and manufacturing‑supply agreements that were scheduled for a three‑year term (with a possible two‑year extension).  These agreements generated only modest cash flows—$33 million receivable as of December 31 2023 and $94 million as of December 31 2022—and were fully wound down by the end of 2023, so in 2022‑2024 Pfizer’s financial disclosures reflected no material impact or ongoing strategic alignment with Meridian.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR QUANTITATIVE ERROR: The LLM states the sale was completed on December 31, 2021 (correct date), but then provides receivable amounts of $33 million (Dec 31, 2023) and $94 million (Dec 31, 2022) that are not mentioned in the ground truth and appear to be fabricated or confused with other financial data. The ground truth specifies the sale price was approximately $51 million in cash with a $167 million loss recognized, net of tax—neither of which the LLM mentions. (2) INCOMPLETE SYNTHESIS: The LLM introduces transition-services and manufacturing-supply agreements with a three-year term and possible two-year extension, which are not referenced in the ground truth at all. This represents either hallucination or information from a different source not validated by the knowledge graph. (3) CONTRADICTORY TIMELINE: The ground truth clearly states that by 2024, Meridian is only mentioned in a glossary with no active relationship, yet the LLM claims agreements were 'fully wound down by the end of 2023,' implying some operational activity through 2023 that the ground truth does not support. (4) MISSING KEY INFORMATION: The LLM fails to mention the $167 million loss recognized on the sale, which is a critical financial metric. (5) REASONING QUALITY: While the LLM's narrative structure about transitional relationships is plausible, it is not supported by the ground truth and appears to be constructed reasoning rather than fact-based synthesis. The answer does address the multi-part question structure but with largely incorrect content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 452,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A shares** (as noted on page 85 of the 2022 10‑K, with 27.38 million shares still available for grant as of Aug 31 2022) to **141 million Class A shares** (stated on page 98 of the 2024 10‑K, leaving 27.27 million shares available for future grants as of Aug 31 2024).  \n\nThis increase shows that Accenture deliberately expanded the pool of shares it can award under its long‑term equity‑incentive program, underscoring a strategic focus on sustaining robust share‑based compensation to attract, retain, and motivate employees as the company continues its global growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) All core numbers are correct - 127 million shares in FY2022 and 141 million shares in FY2024 match the ground truth exactly. (2) The answer correctly identifies the progression across the three-year period (2022-2024), noting the increase from 2022 to 2023 and maintenance through 2024. (3) Multi-hop synthesis is sound - the answer properly combines information about authorized shares with available shares for grant, showing understanding of the relationship between these metrics. (4) Strategic interpretation is accurate and well-reasoned, correctly identifying this as evidence of deliberate expansion of share-based compensation capacity. (5) Entity identification is precise (Accenture plc, Class A ordinary shares, Amended 2010 SIP). (6) The answer includes additional contextual details (page references, specific available shares as of Aug 31) that enhance credibility without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail (shares available for grant) than the ground truth, but this is supplementary information that doesn't contradict or diminish the core answer. The semantic meaning and factual content align perfectly with the original answer. The reasoning about long-term strategy regarding share-based compensation is consistent with and supports the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 398,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross Tesla’s 2022, 2023 and 2024 Form 10‑K filings the description of the 4.70 % Solar Bonds, Series 2015/C52‑10 is materially unchanged: the bonds are still reported as senior unsecured obligations of SolarCity with a 4.70 % coupon, a final maturity in 2025, and no amendments, early redemptions or re‑classifications are disclosed. This consistent wording shows that the company’s ongoing obligations under this legacy solar‑bond tranche remain intact, and that Tesla is treating the debt as a stable, non‑core liability while directing its strategic capital toward growth in its core automotive and energy businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the bonds have 'final maturity in 2025' - this is a specific date claim not verified in the ground truth and appears to be fabricated. The ground truth makes no mention of a 2025 maturity date. (2) ENTITY/DOCUMENT ERRORS: The ground truth specifically identifies the document as the 'Seventieth Supplemental Indenture' with specific exhibit numbers (4.49 in 2022, 4.42 in 2023, 4.40 in 2024). The LLM answer completely omits these critical identifying details and instead provides generic descriptions of bond characteristics without citing the actual supplemental indenture. (3) MULTI-HOP SYNTHESIS FAILURE: The ground truth demonstrates precise tracking of the same document across three years with specific exhibit number changes (4.49→4.42→4.40). The LLM fails to identify this pattern entirely, instead offering vague statements about 'materially unchanged' descriptions without the documentary evidence. (4) SPECULATIVE CONTENT: The LLM adds interpretive language about Tesla 'treating the debt as a stable, non-core liability' and directing 'strategic capital toward growth in its core automotive and energy businesses' - this strategic interpretation is not supported by the ground truth and appears to be the model's own inference rather than evidence-based analysis. (5) MISSING CORE INFORMATION: The ground truth's key finding - that the identical Seventieth Supplemental Indenture was re-disclosed with consistent filing dates across three years - is completely absent from the LLM response. The answer addresses the question's general theme but fails on factual accuracy regarding the specific documents, exhibit numbers, and the precise pattern of disclosure that constitutes the actual evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 500,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe kept its free, self‑service learning catalog on learning.adobe.com as the entry‑level component of a broader Digital Learning Services portfolio that also includes fee‑based classroom, virtual and certification programs and custom enterprise learning.  The free modules have been progressively integrated with Adobe’s customer‑success and enablement workflow—linked to skills‑assessment tools, Customer Success Manager outreach and the subscription‑based Adobe Experience Cloud—so they now serve both to lower adoption barriers and to funnel users into higher‑value training and professional services that drive product usage and retention.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the platform (learning.adobe.com) across the 2022-2024 period, matching the ground truth. (2) Accurately characterizes free self-service learning as entry-level within a broader Digital Learning Services portfolio. (3) Correctly notes the inclusion of fee-based programs (classroom, virtual, certification) and custom enterprise learning. (4) No quantitative errors or incorrect dates/numbers. (5) Appropriately addresses the positioning within broader learning services. WEAKNESSES: (1) The LLM introduces claims about 'progressive integration' with customer-success workflows, skills-assessment tools, and CSM outreach that are NOT present in the ground truth. These appear to be inferences or fabrications not supported by the source material. (2) The ground truth emphasizes Adobe's 'strategic commitment to scalable, accessible learning solutions' and mentions explicit linkage to 'Digital Experience and Digital Media products' in 2023—the LLM omits these specific product category connections. (3) The ground truth notes the platform was 'www.training.adobe.com' in 2022 before becoming 'learning.adobe.com' in 2023-2024; the LLM conflates these or doesn't acknowledge the platform evolution. (4) The LLM's framing of free modules as a 'funnel' into higher-value services is an interpretation not explicitly stated in the ground truth, which presents them more as complementary offerings. (5) Missing the explicit mention of 'AI-driven tools' that the ground truth highlights for 2024. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but introduces unsupported details about integration mechanisms. The ground truth's simpler narrative of consistent positioning is more defensible. SEMANTIC ISSUES: While the LLM's general framing is reasonable, it adds specificity about business mechanisms (funneling, CSM outreach) that goes beyond what the ground truth supports, risking factual inaccuracy despite good structural understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 541,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s U.S. qualified pension plan progressively trimmed the “Return‑Seeking” (growth) slice of its asset mix as the plan’s funded ratio improved.  The target equity allocation fell from about 15 % (target 2022) to roughly 9 % (target 2024/2025), while the fixed‑maturity share was raised from roughly 75‑77 % to about 80 % (with a modest rise in other‑investments).  This de‑risking shift—driven by the glide‑path rule that reduces growth‑asset exposure and raises liability‑hedging assets as the funded status rises—reflects the plan’s move toward a more conservative allocation over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific percentages (15% target 2022, 9% target 2024/2025 for equity; 75-77% to 80% for fixed-maturity) that are NOT present in the ground truth. The ground truth explicitly states 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts.' This is a critical error - the LLM fabricated numerical data. (2) DIRECTIONAL CLAIM ERROR: The LLM claims the equity allocation 'fell from about 15% to roughly 9%' implying a specific downward trend with precise numbers. The ground truth makes no such specific claim about percentage changes, only that the glide path 'consistently guided annual recalibrations.' (3) MULTI-HOP REASONING: While the LLM correctly identifies the glide path mechanism and the de-risking strategy, it fails on the fundamental requirement of not inventing data. The ground truth acknowledges uncertainty about specific percentages; the LLM presents invented figures as fact. (4) ENTITY AND TEMPORAL ACCURACY: The LLM correctly identifies AIG, the U.S. qualified pension plan, and the 2022-2024 timeframe, but the specific allocation percentages cited are unsupported by the ground truth. (5) SEMANTIC EQUIVALENCE ISSUE: While the general narrative about de-risking and glide path is semantically similar to the ground truth, the introduction of specific unverified percentages fundamentally undermines the answer's credibility and accuracy. The ground truth's cautious approach ('specific percentages are not listed') is replaced with confident but false numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 459,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nHoneywell’s Performance Materials and Technologies segment repeatedly identified raw‑material price volatility and supply‑chain constraints as material risks from 2022 through 2024, noting that key commodities such as copper, fluorspar, nickel and titanium remain exposed to sharp swings. While the company has increased long‑term contracts, hedging and formula‑driven pricing to blunt cost spikes, it still expects supply‑chain constraints to persist into 2024, indicating that its exposure to commodity market volatility remains significant despite these mitigation efforts.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. MAJOR ISSUES: (1) SPECIFIC COMMODITIES - The LLM introduces specific commodities (copper, fluorspar, nickel, titanium) that are NOT mentioned in the ground truth answer. This is a factual fabrication that adds unsupported detail. (2) MITIGATION STRATEGIES - The LLM claims Honeywell 'increased long-term contracts, hedging and formula-driven pricing' - these specific mitigation strategies are not mentioned in the ground truth, representing invented information. (3) TEMPORAL EVOLUTION MISSING - The ground truth explicitly traces a 3-year progression showing how the risk framing evolved (2022: COVID/supply chain context → 2023: chemical/refining/semiconductor utilization → 2024: oil/natural gas price volatility). The LLM completely fails to capture this temporal evolution and instead presents a static view of the risk. (4) KEY CONTEXTUAL DETAILS OMITTED - The ground truth emphasizes the shift toward energy market volatility as a driver in 2024, which is absent from the LLM answer. (5) CONCLUSION ACCURACY - While both answers conclude vulnerability remains significant, the LLM's reasoning path is fundamentally different and unsupported by the ground truth. The LLM appears to have hallucinated specific commodity names and mitigation strategies rather than synthesizing the actual multi-hop information about how the risk profile evolved across the three-year period. The answer demonstrates partial understanding of the general risk theme but fails on factual accuracy and multi-hop synthesis of the temporal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 445,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of ACN’s mutual‑fund equity holdings in its non‑U.S. defined‑benefit plans rose from about **$234 million (≈21 % of plan assets in 2022)** to **$188 million (≈19 % in 2023)** and then to **$253 million (≈21 % in 2024)**.  This dip in 2023 was followed by a rebound that brought the allocation closer to the **2024 target of 23 %** and the **2025 target of 28 %**.  The upward trend signals that ACN is gradually increasing its equity exposure within the pension portfolio, reflecting a strategic shift toward higher‑return assets while still maintaining a diversified mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect dollar amounts that contradict the ground truth. Ground truth states: 2022: $239.293M → 2023: $196.226M → 2024: $196.226M (unchanged). LLM states: 2022: $234M → 2023: $188M → 2024: $253M. All three years' figures are wrong. The 2024 figure of $253M is particularly problematic as it contradicts the ground truth showing 2024 remained unchanged at $196.226M. The LLM also introduces percentages (21%, 19%, 21%) and target allocations (23% for 2024, 28% for 2025) that are not mentioned in the ground truth and appear to be fabricated. The LLM's narrative about 'upward trend' and 'rebound' is factually incorrect—the actual trend shows a decline from 2022 to 2023 followed by stability, not a rebound. The LLM correctly identifies ACN as the company and addresses the 3-year period, but the core quantitative data is fundamentally wrong. The reasoning about 'strategic shift toward higher-return assets' contradicts the actual pattern of decline and stabilization. This is a critical failure on the primary metric of financial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 315,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe transformed Document Cloud from a pure PDF‑creation and e‑signature service into an AI‑enhanced hub for end‑to‑end document workflows.  The 2023 and 2024 filings disclose that Firefly’s generative‑AI models are now embedded in Acrobat (a core part of Document Cloud), delivering AI‑powered features such as text‑to‑image generation, generative recolor, automated summarization and commercially‑safe content with Content Credentials; enterprise‑focused Firefly Services and Custom Models extend these capabilities to large organisations, enabling automated content creation and brand‑consistent document processing.  Consequently, Document Cloud now sits at the centre of Adobe’s Experience Cloud, providing AI‑driven creation, collaboration, signing and automation that drive enterprise‑level digital workflow efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's Document Cloud evolution and correctly identifies the core transformation narrative. STRENGTHS: (1) Accurately captures the progression from legacy PDF/e-signature service to AI-enhanced platform; (2) Correctly identifies Firefly integration as central to the 2023-2024 positioning; (3) Properly names specific AI features (text-to-image, generative recolor, automated summarization, Content Credentials); (4) Correctly positions Document Cloud within Experience Cloud ecosystem; (5) Appropriately emphasizes enterprise digital workflow automation as key value proposition. WEAKNESSES: (1) The original answer explicitly mentions Document Cloud's role in the 'Publishing and Advertising segment' in 2022 and its elevation to 'Digital Media segment' in 2023 - the LLM answer omits this segment-level strategic positioning detail, which is a meaningful part of the ground truth narrative about how Adobe repositioned the product organizationally; (2) The LLM answer adds specific technical features (Content Credentials, Custom Models, Firefly Services) that enhance the answer but are not explicitly verified against the ground truth provided; (3) The phrase 'pure PDF-creation and e-signature service' in 2022 is slightly reductive compared to the ground truth's 'document and forms platform' characterization. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 timeframe and correctly identifies the AI integration as the key differentiator. The reasoning is sound and logically structured. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present in either answer, so quantitative accuracy is not directly testable, but the temporal progression (2022→2023→2024) is correctly maintained. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - Document Cloud transformed from legacy infrastructure to AI-enhanced enterprise solution. The LLM's framing is slightly more technical/feature-focused while ground truth is more strategic/positioning-focused, but both convey the same fundamental transformation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 570,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure grew sharper in every major segment as new entrants—AI‑focused start‑ups, quantum‑computing ventures such as Quantinuum, and non‑traditional players in aerospace, industrial automation, building‑automation and safety‑productivity—accelerated technological disruption; the company responded by pouring resources into AI/ML, advanced analytics and next‑generation hardware to preserve differentiation, but the faster‑moving market forced it into price‑sensitive, feature‑driven battles that slowed organic sales and squeezed segment margins, signalling a clear erosion of pricing power across its business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY: The LLM introduces specific company names (Quantinuum, quantum-computing ventures) and claims about AI-focused start-ups as new entrants without any evidence these appear in Honeywell's 10-K filings. The ground truth makes no mention of these specific competitors. The LLM also makes unsubstantiated claims about 'pouring resources into AI/ML' and specific impacts on 'organic sales' and 'segment margins' without providing any financial metrics, percentages, or concrete data from the filings. (2) ENTITY ACCURACY: While the LLM correctly identifies the business segments (aerospace, industrial automation, building automation, safety-productivity), it fabricates specific competitive threats (Quantinuum, quantum-computing ventures) that do not appear in the ground truth. The ground truth simply references 'new entrants and new technologies' generically. (3) MULTI-HOP REASONING: The ground truth provides a clear 3-year progression (2022: HBT and SPS cited; 2023: expanded to PMT and Aerospace; 2024: restructured to Industrial Automation and Building Automation with focus on commoditization). The LLM fails to capture this structured evolution and instead makes sweeping claims about 'every major segment' without the documented progression. (4) UNSUPPORTED CLAIMS: The LLM asserts specific strategic responses ('pouring resources into AI/ML'), margin impacts, and pricing power erosion without citing any financial data or specific disclosures from the 10-K filings. The ground truth is more measured, noting 'increasing frequency and specificity in disclosures' rather than claiming definitive impacts on margins and sales. (5) SEMANTIC DIVERGENCE: While the LLM captures the general theme of increasing competitive pressure, it fundamentally misrepresents the nature and specificity of Honeywell's disclosed competitive challenges by inventing specific competitors and overstating the documented impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 555,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom the spin‑off through 2024 Pfizer’s relationship with Viatris moved from the initial “interim” transition‑service and manufacturing agreements (MSAs and TSAs) that were put in place when the Upjohn business was combined with Mylan, to a point where those temporary arrangements were largely wound down.  The 2022 Form 10‑K notes that net amounts payable to Viatris under the agreements were $94 million, and by the end of 2023 the TSAs were essentially completed, leaving only a $33 million net receivable (page 78); the longer‑term MSAs remain in force for a few more years but generate only immaterial financial impacts in 2023‑2024.  Consequently, intercompany balances fell sharply and the transitional services that once linked the two companies were largely discontinued.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the overall evolution of Pfizer's relationship with Viatris from 2022-2024, with mostly accurate financial figures and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $94 million net amounts payable to Viatris in 2022 and the $33 million figure by end of 2023; (2) Accurately captures the winding down of TSAs by end of 2023; (3) Properly synthesizes the transition from interim arrangements to largely completed services; (4) Correctly notes that MSAs remained in force but with immaterial impacts; (5) Appropriately characterizes the sharp decline in intercompany balances. WEAKNESSES: (1) The LLM states '$33 million net receivable' while the ground truth states '$33 million net amounts due to Viatris' - this is a directional discrepancy that could indicate confusion about whether amounts were owed to or by Viatris, though the context suggests this may be a terminology issue rather than fundamental error; (2) Limited discussion of 2024 specifically - the ground truth notes that 2024 references were only in corporate definitions, indicating full resolution, while the LLM focuses more on 2023 completion; (3) The answer could have been more explicit about the complete resolution by 2024 versus the ongoing but immaterial MSAs. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple agreement types (TSAs vs MSAs), showing proper understanding of the temporal progression. QUANTITATIVE VERIFICATION: The $94M (2022) and $33M (2023) figures are correct; the characterization of these as declining balances is accurate. The only concern is the 'receivable' vs 'payable' terminology which may reflect a misunderstanding of the balance sheet presentation. Overall, this is a solid answer with minor semantic/directional issues that don't fundamentally undermine the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 515,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s senior‑unsecured debt was anchored by the 1.700 % Notes due 2025 (trading symbol MO25), which was used to replace the 1.000 % Notes that matured in 2023 and now sits between the 2.200 % Notes due 2027 and the 3.125 % Notes due 2031 listed in the securities table on page 1 of the 2024 10‑K.  This laddered maturity profile—shifting from a near‑term 2023 exposure to a mid‑term 2025 tranche and longer‑dated 2027/2031 issues—shows that Altria’s capital‑structure strategy has been to extend the average debt maturity, lock in low‑cost financing, and preserve liquidity while maintaining a diversified funding base.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key debt instruments (1.700% Notes due 2025, 2.200% Notes due 2027, 3.125% Notes due 2031) and accurately notes that the 1.000% Notes due 2023 matured/were no longer listed by 2023. The percentages and maturity dates are all correct. The answer appropriately addresses the multi-hop synthesis across 2022-2024 and correctly identifies the progression of debt composition.\n\nWEAKNESSES: (1) The LLM makes an unsupported claim that the 1.700% Notes due 2025 were 'used to replace' the 1.000% Notes due 2023. The ground truth states the 1.700% Note 'remained as the shortest-dated instrument' but does not explicitly state it was issued as a replacement. This is an inference not supported by the source material. (2) The LLM adds interpretive language about 'extend the average debt maturity, lock in low-cost financing, and preserve liquidity' that goes beyond what the ground truth supports. The ground truth more conservatively states the strategy was 'maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.' (3) The reference to 'trading symbol MO25' and 'page 1 of the 2024 10-K' adds specificity that cannot be verified against the ground truth and may be hallucinated.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the three-year period and identifies the relationship between instruments. However, it overstates the certainty of causal relationships (replacement strategy) not explicitly confirmed in the ground truth.\n\nCORRECTION ASSESSMENT: All numeric values (percentages, years) are accurate. The core factual progression is correct. The primary issue is interpretive overreach regarding the strategic intent and the claim about replacement, which represents a moderate factual/logical error in the context of multi-hop financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 516,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s fixed‑rate unsecured senior notes expanded: carrying value rose from **$24.1 bn (2022)** to **$27.2 bn (2023)** and then edged down to **$26.9 bn (2024)**, while the weighted‑average interest rate held steady at **4.45 %** for 2022‑23 and increased to **4.84 %** in 2024. This pattern shows Capital One is deliberately growing its long‑term fixed‑rate funding base and extending maturity, even as market rates climb, to lock in financing for its expanding balance sheet and manage interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) 2022 carrying value: LLM states $24.1 billion, but ground truth is $19,975 million ($19.975 billion) - this is a $4.125 billion error (20.6% overstatement). (2) 2023 carrying value: LLM correctly states $27.2 billion ($27,168 million), matching ground truth. (3) 2024 carrying value: LLM correctly states $26.9 billion ($26,930 million), matching ground truth. (4) CRITICAL INTEREST RATE ERROR: LLM states weighted-average interest rate was 4.45% for both 2022-23, but ground truth shows 2.91% in 2022 and 4.45% in 2023 - this is a fundamental misrepresentation of the 2022 rate (off by 1.54 percentage points). (5) 2024 rate: LLM correctly states 4.84%, matching ground truth. The LLM's characterization of the rate as 'held steady at 4.45% for 2022-23' is factually incorrect and obscures the significant rate increase from 2022 to 2023. MULTI-HOP REASONING: The LLM does attempt to synthesize the data into a narrative about Capital One's borrowing strategy, which is appropriate to the question. However, the narrative is built on incorrect foundational data (especially the 2022 baseline), undermining the validity of the strategic interpretation. The reasoning about 'deliberately growing its long-term fixed-rate funding base' is qualitatively sound but is based on flawed numbers. COMPLETENESS: The answer addresses all three components requested (carrying value evolution, interest rate evolution, and strategic implications), but the execution is compromised by data errors. The 2022 baseline error is particularly problematic as it distorts the magnitude of the debt increase from 2022-2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 471,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla’s Form 10‑K filings repeatedly disclose a series of supplemental indentures that amend and extend the 5.45 % Solar Bonds, Series 2015/C92‑15—beginning with the August 24 2015 101st amendment (Exhibit 4.61) and continuing with later amendments such as the 158th‑169th indentures referenced in the 2022 and 2023 filings (e.g., Exhibits 4.66‑4.71). These updates show that the original 2015 securitization has been kept alive and expanded with additional tranches and revised terms, underscoring Tesla’s strategy of financing its solar portfolio through a layered, asset‑backed bond structure that can be incrementally refinanced as the business matures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) INCORRECT AMENDMENT NUMBERS: The LLM claims the bond was amended with '101st amendment (Exhibit 4.61)' and '158th-169th indentures' in 2022-2023 filings. The ground truth makes no mention of these specific amendment numbers, and the LLM appears to have fabricated these details. (2) EXHIBIT MISMATCH: The ground truth clearly states the bond appeared in Exhibit 4.61 (2022), Exhibit 4.54 (2023), and Exhibit 4.52 (2024). The LLM references Exhibits 4.66-4.71 without justification and contradicts the documented exhibit locations. (3) MISCHARACTERIZATION OF STRATEGY: The ground truth indicates a pattern of 'declining prominence' with Tesla 'increasingly relied on newer bond structures' (C102-15, C106-10). The LLM instead claims the bond 'has been kept alive and expanded with additional tranches,' which contradicts the ground truth's finding of a shift toward newer instruments. (4) UNSUPPORTED CLAIMS: The LLM's assertion about 'layered, asset-backed bond structure that can be incrementally refinanced' is not supported by the ground truth and appears to be speculation. (5) MISSING KEY INSIGHT: The LLM fails to capture the core finding that while the C92-15 bond remained in disclosures, it was being superseded by newer bond series, indicating an evolution in strategy rather than expansion of the original structure. The LLM answer demonstrates poor multi-hop reasoning by failing to synthesize the year-over-year progression correctly and inventing specific amendment numbers not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 450,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nFrom 2022 to 2024 AIG moved its loss‑reserve oversight from a basic internal‑control + external‑expert review model (2022) to a fully‑structured ERM framework that incorporates risk‑appetite limits, second‑line challenge, internal‑audit scrutiny and regular independent validation of reserve models (2023).  Its modeling evolved from traditional actuarial reserving to sophisticated stochastic and scenario‑based analyses, explicit third‑party catastrophe‑modeling with climate‑adjusted PML calculations, and a feedback loop of post‑catastrophe event studies that inform underwriting and pricing (2024).  Across the three years, external reviews have become more systematic—leveraging independent expert assessments of reserve estimates, independent catastrophe‑model validation, and continuous learning from catastrophe studies to refine assumptions and risk limits.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer contains significant fabrications not supported by the ground truth. Specifically: (a) The answer claims 'risk-appetite limits' were introduced in 2023, but this is not mentioned in the original answer; (b) The answer references 'explicit third-party catastrophe-modeling with climate-adjusted PML calculations' and 'post-catastrophe event studies' as 2024 developments, but these specific technical details are not present in the ground truth; (c) The answer mentions 'independent catastrophe-model validation' which is not in the original answer. (2) STRUCTURAL MISALIGNMENT - The LLM answer reorganizes the timeline incorrectly, suggesting the ERM framework was 'fully-structured' by 2023, whereas the ground truth indicates 2024 was when AIG 'further integrated' practices into a 'more holistic' ERM system, implying 2024 was the culmination, not 2023. (3) MISSING KEY ELEMENTS - The ground truth emphasizes 'sensitivity and scenario analyses, stochastic methods, and experience studies' as 2023 additions, but the LLM conflates these with 2024 developments. The ground truth specifically mentions 'audits by the Internal Audit Group' and 'structured second-line reviews' as 2024 enhancements, which the LLM partially captures but with added unsupported details. (4) UNSUPPORTED SPECIFICITY - The LLM introduces highly specific technical terminology ('climate-adjusted PML calculations,' 'catastrophe studies,' 'underwriting and pricing feedback loops') that are not in the original answer and appear to be hallucinated details. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize across three years, it does so by adding information not present in the ground truth rather than accurately synthesizing what was provided. The answer reads as if the LLM is inferring or extrapolating beyond the source material. CORRECT ELEMENTS: The LLM correctly identifies the general evolution from basic controls to more sophisticated frameworks, correctly names AIG, correctly identifies the three-year period (2022-2024), and correctly notes the progression toward more structured oversight and external reviews.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 583,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria cut the share of U.S. Treasury and foreign‑government securities in its pension fund from about 25 % of total assets (as reported for 2022) to roughly 16 % by the end of 2024, while expanding its holdings of corporate bonds and equities. This reduction shows a deliberate move toward a more liability‑driven, duration‑matched allocation—using longer‑duration corporate bonds and equity exposure to better hedge pension obligations and boost returns rather than relying on low‑yielding government securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) INCORRECT STARTING PERCENTAGE: The LLM claims the allocation was 'about 25%' in 2022, but the ground truth clearly states it was 19% in 2022. This is a substantial 6-percentage-point error. (2) INCORRECT ENDING PERCENTAGE: The LLM states the allocation dropped to 'roughly 16% by the end of 2024,' but the ground truth shows it was 8% in 2024. This is a critical 8-percentage-point discrepancy that fundamentally misrepresents the magnitude of the strategic shift. (3) INCOMPLETE TREND ANALYSIS: The LLM fails to capture the full three-year progression (19% → 16% → 8%), instead presenting only two data points with wrong values. (4) MISSING KEY CONTEXT: The LLM omits important supporting details from the ground truth, including: the reduction in below-investment-grade securities (11% to 9%), the decline in expected rate of return (6.6% → 6.1% → 6.1%), and the characterization of this as a 'steady decline' indicating a 'more conservative or diversified investment posture.' (5) REASONING QUALITY: While the LLM's interpretation about liability-driven investment strategy is plausible and not contradicted by the ground truth, it is presented without the supporting evidence about return expectations and risk exposure changes that the ground truth provides. The reasoning is speculative rather than grounded in the actual data. (6) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture across the three-year period and related metrics (expected returns, below-investment-grade exposure). The answer reads as partially informed speculation rather than accurate synthesis of filing data. The core narrative about strategic reallocation is directionally correct, but the numerical foundation is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 502,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings remained flat at roughly $0.5 billion, while total long‑term debt fell from about $42 billion in 2022 to a peak of $49 billion in 2023 and then slipped back to $45 billion in 2024. The 2024 decline is driven by the near‑elimination of floating‑rate unsecured senior debt (down from $1.7 billion in 2023) and a larger share of fixed‑rate senior notes and securitized obligations, indicating a strategic move toward longer‑dated, fixed‑rate financing and reduced exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and incomplete synthesis of the multi-hop question. SPECIFIC ERRORS: (1) Total debt figures are substantially wrong - LLM states ~$42B (2022), ~$49B (2023), ~$45B (2024), but ground truth shows $43.086B, $48.715B, and $45.551B respectively. While the directional trend is correct, the LLM rounded too aggressively and lost precision on key metrics. (2) Short-term borrowings claim of 'roughly $0.5 billion' is not substantiated in either answer and appears to be an unsupported assertion. (3) The LLM completely omits critical debt component details: securitized debt amounts ($14.994B→$18.043B→$14.264B), weighted-average interest rates for securitized debt (1.51%→3.01%→3.48%), and fixed unsecured senior debt evolution ($19.975B→$26.930B). (4) Floating unsecured senior debt is mischaracterized - LLM states it fell 'from $1.7 billion in 2023' but ground truth shows it was $1.709B in 2022, dropped to $349M in 2023, and was fully retired ($0) by 2024. The LLM conflates 2022 and 2023 figures. (5) Interest rate exposure analysis is severely incomplete - the LLM mentions the strategic shift to fixed-rate financing but provides no interest rate data (2.91%→4.84% for fixed senior debt), which is central to answering the question about 'interest rate exposure.' MULTI-HOP SYNTHESIS: The question requires synthesizing debt structure changes across three years with specific attention to floating vs. fixed debt and securitized obligations. The LLM provides only a high-level directional narrative without the detailed component breakdown necessary to fully answer the question. The core insight about strategic shift to fixed-rate financing is present but unsupported by the specific metrics that validate this claim. WHAT WAS CORRECT: The directional trend (increase 2022-2023, decrease 2023-2024) and the general conclusion about moving toward fixed-rate financing are directionally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 527,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each list the “5.45 % Solar Bonds, Series 2015/C25‑15” in their exhibit indexes (e.g., page 102 of the 2022 filing, page 100 of the 2023 filing, and page 106 of the 2024 filing). This repeated disclosure shows that Tesla continues to treat the bond issuance as a primary financing source for its solar portfolio, and its consistent appearance across three annual reports confirms that the series remains a core component of the company’s capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 5.45% Solar Bonds, Series 2015/C25-15 appear in 2022, 2023, and 2024 10-K filings, (2) the bond series remains part of Tesla's capital structure, and (3) this reflects ongoing reliance on the instrument for solar financing. The answer appropriately synthesizes the multi-hop information across three years of filings. However, there are notable differences from the ground truth: (1) The LLM provides specific page numbers (102, 100, 106) that are not verified in the ground truth and may introduce unnecessary detail that could be incorrect; (2) The LLM omits the specific date reference (April 14, 2015) and the 'Thirty-Sixth Supplemental Indenture' designation that the ground truth emphasizes as important identifying information; (3) The ground truth explicitly states the bond 'remains an active and integral component' and emphasizes 'ongoing reliance,' while the LLM uses slightly weaker language ('continues to treat as a primary financing source'). The quantitative accuracy is strong (bond percentage, series designation, and years are all correct), but the omission of the April 14, 2015 date and supplemental indenture details represents incomplete synthesis of the available information. The reasoning is sound and the semantic meaning is largely equivalent, but the answer lacks some specificity that the ground truth provides about how Tesla documents this bond across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 402,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nMastercard’s Class A treasury‑stock balance grew from $51.4 billion at the end of 2022 to $60.4 billion in 2023 and $71.4 billion by the end of 2024, indicating progressively larger share‑repurchase activity. This upward trend signals that the company is allocating excess cash toward aggressive buybacks—reducing the share count and returning capital to shareholders rather than retaining or reinvesting the funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) SIGN ERROR - The original answer correctly shows treasury stock as negative values ($(51,354) million, $(60,429) million, $(71,431) million), indicating these are contra-equity accounts. The LLM answer incorrectly presents these as positive values ($51.4 billion, $60.4 billion, $71.4 billion), fundamentally misrepresenting the accounting treatment. Treasury stock is a reduction in shareholders' equity and should be shown as negative. (2) YEAR MISMATCH - The original answer contains an internal inconsistency (states '2023 to 2024' but shows two 2023 values), but the LLM answer compounds this by not addressing the apparent data issue. The LLM should have noted the discrepancy. (3) NUMERIC ACCURACY - While the absolute values are correct ($51.4B, $60.4B, $71.4B), the sign convention is wrong, which is a material accounting error. (4) MULTI-HOP REASONING - The LLM correctly identifies the upward trend and interprets it as increased buyback activity, which is semantically sound. The explanation about capital allocation strategy (returning capital to shareholders, reducing share count) is reasonable and contextually appropriate. (5) COMPLETENESS - The LLM addresses both parts of the question (evolution of treasury stock and what it suggests about capital allocation), but the fundamental sign error undermines the accuracy of the financial analysis. In accounting, the sign matters critically for understanding the balance sheet impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 409,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety and Productivity Solutions segment increasingly felt the impact of weaker macro‑economic conditions, as each year’s risk‑factor disclosure repeatedly warned that “reduced investments in process automation, safety monitoring and plant‑capacity‑utilization initiatives” could hurt results; while the segment posted modest profit gains in 2022‑23, 2024 saw a 7 % decline in segment sales and an 11 % drop in segment profit—driven by lower organic demand for automation and safety products—indicating that industrial customers are curbing capital spending and delaying capacity expansions amid heightened macro‑economic pressure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Honeywell's Safety and Productivity Solutions segment facing adverse macroeconomic conditions from 2022-2024, with appropriate emphasis on reduced investments in automation and plant capacity utilization. The answer demonstrates good understanding of the multi-hop synthesis required, connecting risk disclosures across years to broader macroeconomic trends. The qualitative reasoning about industrial customers curbing capital spending is sound and relevant.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM provides specific financial metrics (7% decline in segment sales, 11% drop in segment profit in 2024) that are NOT present in the ground truth answer. The ground truth makes no mention of specific percentage declines or profit figures. This is a critical issue: the LLM appears to have introduced specific numbers without verification against the source documents. These numbers cannot be validated against the ground truth and represent potential fabrication or hallucination of financial data.\n\nWEAKNESSES - COMPLETENESS: While the LLM mentions 2022-23 posting \"modest profit gains,\" the ground truth does not provide this specific characterization. The ground truth focuses on the evolution of risk language and macroeconomic context rather than actual financial performance metrics.\n\nWEAKNESSES - ENTITY/METRIC ACCURACY: The LLM references specific product categories (\"automation and safety products\") with more precision than the ground truth, which is acceptable, but the financial metrics introduced are problematic.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and connects risk disclosures to actual business performance, which is appropriate for the question. However, the introduction of unverified financial metrics undermines the credibility of this synthesis.\n\nKEY ISSUE: The primary concern is the introduction of specific percentage declines (7% sales, 11% profit) that are not mentioned in the ground truth. In financial analysis, precision of numbers is critical. Without verification that these figures appear in the actual 10-K filings, this represents a significant accuracy problem that warrants a lower correctness score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 619,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nCyramza kept the same oncology label from 2022‑2024—treating metastatic NSCLC (including EGFR‑mutated disease), gastric/GEJ adenocarcinoma, metastatic colorectal cancer, hepatocellular carcinoma and related combinations—without any major new indication added during that period.  Its core compound‑patent protection was scheduled to expire in 2026 in the United States and Japan and in 2028 in the major European markets, while data‑protection rights lapsed in 2026 (U.S.), 2024 (EU) and 2023 (Japan); the company indicated that it would rely on later‑filed method‑of‑use/formulation patents and possible term‑adjustment or pediatric exclusivity mechanisms to extend exclusivity, but the product’s therapeutic scope did not broaden appreciably between 2022 and 2024.  (2023 10‑K p. 11; 2023 10‑K p. 12; 2022 10‑K p. 24; 2024 10‑K p. 11).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detail than the ground truth and demonstrates strong understanding of Cyramza's therapeutic positioning and IP landscape. However, there are critical discrepancies in the patent expiration dates that significantly impact accuracy.\n\nCORRECT ELEMENTS:\n- Therapeutic indications remain consistent 2022-2024 (metastatic NSCLC, gastric/GEJ adenocarcinoma, colorectal cancer, hepatocellular carcinoma)\n- No major new indications added during the period\n- Data protection expiration in Japan in 2023 is correct\n- Data protection expiration in EU in 2024 is correct\n- Compound patent protection extends to 2026 in U.S. and 2028 in Europe (matches ground truth)\n- Discussion of method-of-use/formulation patents and exclusivity extension mechanisms is relevant and appropriate\n\nCRITICAL ERRORS:\n- LLM states compound patent expires in 2026 in Japan, but ground truth indicates 2026 is only for U.S. (Japan not explicitly stated in ground truth but implied to align with U.S. timeline)\n- LLM states data protection expires in 2026 in U.S., but ground truth does not mention U.S. data protection expiration date\n- The ground truth specifically states data protection expires in Japan in 2023 and major European countries in 2024, with compound patents extending to 2026 (U.S./Europe) and 2028 (Europe). The LLM's addition of 2026 U.S. data protection is not corroborated by the ground truth\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple 10-K filings (2022, 2023, 2024) and correctly identifies the narrowing exclusivity window. The reasoning about reliance on later-filed patents and exclusivity mechanisms is sound and adds valuable context.\n\nCOMPLETENESS:\nThe LLM answer is more comprehensive than the ground truth, providing additional detail about specific indications (EGFR-mutated NSCLC) and exclusivity extension strategies. However, this added detail introduces potential inaccuracies regarding patent timelines.\n\nQUANTITATIVE ACCURACY ISSUE:\nThe primary quantitative error is the patent/data protection timeline discrepancy. The ground truth is less specific about U.S. data protection, but the LLM's claim of 2026 U.S. data protection expiration cannot be verified against the provided ground truth and may be incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 619,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative assets/liabilities were classified as Level 3 and valued using discounted‑cash‑flow models that rely primarily on observable swap‑rate inputs (a 3‑5 % range with a weighted‑average near 4 %).  The 2022 10‑K disclosed a fair‑value of roughly **$58 million** for these derivatives, and by the end of 2024 the balance had risen to **$69 million**, driven by higher estimated cash‑flow amounts and a modest shift in the swap‑rate assumptions, while the overall valuation framework (discounted cash‑flow with unobservable defaults, loss‑severity and discount‑rate inputs) remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE ERRORS: The LLM states 2022 fair value was 'roughly $58 million' when ground truth shows $19 million - this is a 205% overstatement. The LLM claims 2024 value was $69 million when ground truth shows $58 million - another significant error. The LLM also reverses the trend, claiming values 'rose' from 2022 to 2024, when ground truth shows increase from $19M (2022) to $58M (2023) with stabilization at $58M (2024). (2) INCOMPLETE YEAR COVERAGE: Ground truth explicitly addresses 2022, 2023, and 2024 separately with distinct values and details. LLM only mentions 2022 and 2024, completely omitting 2023 data and the important intermediate step showing the $19M→$58M increase. (3) UNOBSERVABLE INPUTS MISCHARACTERIZATION: LLM describes swap rates as 'observable' inputs when ground truth explicitly identifies them as 'unobservable inputs.' This is a fundamental misunderstanding of the valuation hierarchy. (4) MISSING KEY DETAILS: Ground truth mentions 2022 net losses of $20 million still held in portfolio and specific default rate ranges (53-163%) for 2023 - neither mentioned by LLM. (5) MULTI-HOP SYNTHESIS FAILURE: The question requires tracking evolution across three years with specific metrics. LLM failed to properly synthesize the year-by-year progression and provided incorrect endpoint values. The only partially correct element is the mention of discounted cash flow methodology and swap rate ranges (3-5%, 4% weighted), but this cannot overcome the fundamental numerical errors and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 428,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the Qualcomm charitable‑match program kept thousands of employees active, but the number of distinct nonprofit partners it supported slipped slightly—from > 1,500 organizations in 2022 to just over 1,300 in 2024. Qualcomm’s HR and Compensation Committee explicitly ties such human‑capital advances (including participation in the match program) to executive pay, using progress on these goals as a non‑financial modifier that can adjust the fiscal‑2022 and fiscal‑2024 bonus payouts by a 0.9‑to‑1.1 multiplier, thereby aligning the program’s evolution with the company’s broader talent‑attraction, diversity and community‑engagement objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: thousands of employees participating, >1,500 organizations in 2022, >1,300 in 2024, and the 0.9-1.1 multiplier range for executive bonuses. (2) Correctly identifies the slight decline in supported organizations while maintaining high employee participation. (3) Properly synthesizes the connection between charitable program evolution and executive compensation structure. (4) Accurately describes the non-financial modifier mechanism tied to human capital goals. (5) Correctly identifies the broader context of talent attraction, diversity, and community engagement objectives. MINOR WEAKNESSES: (1) The phrase 'adjust the fiscal-2022 and fiscal-2024 bonus payouts' is slightly awkward phrasing—the modifier applies to bonus calculations during these periods, not retroactively adjusting past payouts, though the meaning is clear enough. (2) The answer could have been slightly more explicit about the 'sustained high level of employee participation' as a key indicator of alignment with human capital strategy, though this concept is implied. (3) Does not explicitly mention the 2025 diversity, equity, and inclusion goals referenced in the ground truth, though this is a minor omission that doesn't affect the core answer. The multi-hop reasoning is sound: the answer correctly connects program participation metrics (2022-2024) with executive compensation mechanisms and broader human capital strategy. All numeric values are precise and correctly formatted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 444,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\n**2022:** Acrobat was framed as the flagship client of **Document Cloud**, a cloud‑based platform that couples Adobe’s PDF technology with Acrobat and Adobe Sign to deliver end‑to‑end document workflows.  The filing highlighted Acrobat’s strong market adoption and leadership in document‑intensive industries, positioning it as a standalone productivity suite within the Document Cloud ecosystem.  \n\n**2023:** Adobe deepened that positioning by tying Acrobat’s revenue to the Document Cloud subscription model (recognizing cloud‑service revenue ratably) and emphasizing data‑driven customer engagement and product‑led growth.  The filing also introduced AI‑related risk factors and noted early AI‑enhancements to the platform, signaling a strategic shift toward AI‑augmented document services.  \n\n**2024:** The company launched the **Acrobat AI Assistant** (trademarked in the 2024 filing) and other AI‑driven features, explicitly branding AI capabilities inside Acrobat.  This reflects a further integration of Acrobat into the broader Document Cloud strategy, now marketed as an AI‑enhanced component of Adobe’s Experience Cloud and Creative Cloud suites, with the goal of delivering a unified, intelligent document‑productivity experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all three years (2022-2024) and correctly captures the evolution of Adobe's Acrobat positioning. STRENGTHS: (1) Accurately identifies the 2022 positioning of Acrobat as a core Document Cloud component with focus on market adoption and leadership in document-intensive industries; (2) Correctly notes the 2023 shift toward AI-powered innovation and integration with Adobe Sign and Creative Cloud tools; (3) Properly identifies the 2024 introduction of 'Acrobat AI Assistant' as a registered trademark, signaling the strategic shift to AI-enhanced productivity; (4) Accurately synthesizes the multi-hop evolution showing progression from document standard to AI-enhanced platform; (5) No quantitative errors in dates or entity names. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds some details not explicitly in the ground truth (e.g., 'ratable cloud-service revenue recognition' in 2023, 'product-led growth'), which while reasonable inferences from filing language, go slightly beyond what the ground truth specifies; (2) The ground truth emphasizes 'trillions of PDF documents created annually' as a 2022 positioning element, which the LLM answer does not mention, though this is a relatively minor omission; (3) The LLM answer mentions integration with 'Experience Cloud' in 2024, which is not explicitly stated in the ground truth (ground truth mentions Document Cloud, Creative Cloud, but not Experience Cloud in this context). MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and identifies the logical progression of positioning strategy. The reasoning is sound and demonstrates proper understanding of how Acrobat's role evolved within Adobe's broader ecosystem. SEMANTIC EQUIVALENCE: The core message matches the ground truth - a clear trajectory from document standard to AI-enhanced productivity platform. The wording differs appropriately while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 541,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2021‑2022 the company generated $2.24 billion (2021) and $2.02 billion (2022) of net product revenue from sales of bamlanivimab and bebtelovimab under EUAs, with royalty payments to AbCellera recorded as cost‑of‑sales at mid‑teens to mid‑twenties of those sales. After the EUAs expired, no COVID‑19 antibody sales occurred in 2023 or 2024, so net product revenue from the AbCellera collaboration fell to zero and the royalty expense that had been driven by those sales disappeared.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2022 revenue figure of $2.02 billion is accurate; (2) The royalty percentage range (mid-teens to mid-twenties) is correct; (3) The statement that 2023 and 2024 had no sales and no royalty payments is accurate; (4) The explanation that EUA expiration led to the wind-down is contextually sound; (5) The characterization of royalties as cost-of-sales is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces a 2021 figure of $2.24 billion that was NOT in the original question scope (which asked about 2022-2024) and was not mentioned in the ground truth answer. While this may be factually accurate from the filing, it expands beyond the requested timeframe; (2) The question specifically asked about evolution \"from 2022 through 2024\" - the LLM's inclusion of 2021 data, while potentially informative, shifts focus away from the requested period; (3) The ground truth emphasizes the \"3-year progression\" (2022-2024) showing a \"sharp decline,\" while the LLM's framing emphasizes the 2021-2022 period before discussing the decline. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between revenue, royalty payments, and EUA status across the three-year period. The logic connecting EUA expiration to revenue/royalty elimination is sound. QUANTITATIVE ACCURACY: The 2022 figure ($2.02B) is correct. The royalty percentage range is correct. However, the introduction of the 2021 figure ($2.24B) outside the requested scope creates a minor accuracy issue in terms of scope adherence rather than factual error. COMPLETENESS: The answer addresses the core question about 2022-2024 evolution but adds extraneous 2021 data. The answer covers net product revenue, royalty payments, and the wind-down pattern, meeting the substantive requirements despite the scope issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 508,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife consistently ceded **exactly 59 % of its closed‑block liabilities** to an unaffiliated third‑party via a modified‑coinsurance agreement—disclosed in the 2022 Form 10‑K (page 209), the 2023 Form 10‑K (page 204) and the 2024 Form 10‑K (page 202).  This unchanged share reflects a deliberate, long‑term risk‑transfer framework in which the company relies on a single, well‑capitalized reinsurer to absorb a fixed portion of closed‑block risk, preserving capital efficiency and stable reinsurance pricing over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 59% reinsurance percentage across all three years (2022-2024). The answer correctly cites the modified coinsurance agreement and references the appropriate 10-K filing pages. However, there is a minor quantitative discrepancy: the ground truth specifies 59.25% for 2022, while the LLM states 'exactly 59%' for all years without acknowledging the 2022 precision difference. This is a meaningful distinction since the ground truth explicitly notes '59.25% in 2022, 59% in 2023, and 59% in 2024,' suggesting slight year-to-year variation rather than perfect consistency. The LLM's characterization of the percentage as 'exactly 59%' across all three years is therefore technically inaccurate for 2022. The reasoning about long-term risk transfer strategy and strategic continuity is sound and well-articulated, correctly synthesizing the multi-hop information about consistency over time and its implications. The answer appropriately addresses both parts of the question: the evolution (or lack thereof) of the percentage and what it reveals about strategy. The additional context about 'well-capitalized reinsurer,' 'capital efficiency,' and 'stable reinsurance pricing' represents reasonable inference but goes slightly beyond what the ground truth explicitly states. The semantic equivalence is generally strong, though the failure to distinguish the 2022 figure (59.25%) from subsequent years (59%) represents a factual error that should be penalized, even though the overall narrative about consistency is largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 442,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard broadened its multi‑layered security by extending real‑time, account‑based payment infrastructure—growing the number of markets with real‑time clearing and settlement from 12 to 13 and embedding tokenization, Click‑to‑Pay and blockchain‑ready token networks into everyday transactions—while tightening third‑party collaboration through public‑private partnerships, standardized technical frameworks (EMV, tokenization, digital‑identity) and a formalized third‑party risk‑management program that onboards, monitors and off‑boards external providers.  This evolution signals a cybersecurity strategy that treats security as an ecosystem‑wide, proactive layer integrated into every new payment flow rather than a perimeter‑focused, reactive safeguard.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's security approach from 2022-2024, accurately captures the emphasis on third-party collaboration and real-time payment infrastructure expansion, and provides sound reasoning about the strategic shift toward ecosystem-wide, proactive security. The qualitative analysis about treating security as integrated into payment flows rather than perimeter-focused is insightful and aligns with the ground truth's conclusion. The mention of specific technologies (tokenization, Click-to-Pay, blockchain-ready networks, EMV) adds relevant detail not contradicted by the ground truth.\n\nWEAKNESSES - QUANTITATIVE: The LLM states real-time infrastructure grew 'from 12 to 13' markets, which is accurate for 2022-2023 transition. However, the ground truth explicitly states that by 2024, Mastercard operated real-time payments in 'several countries globally' rather than a specific number. The LLM's phrasing 'from 12 to 13' could be misinterpreted as the final 2024 state, when the ground truth indicates the 2024 figure is less specific ('several countries'). This is a minor but notable quantitative imprecision.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits explicit mention of public-private collaborations as a specific partnership type mentioned in the ground truth for 2022. While the LLM mentions 'public-private partnerships,' it doesn't clearly distinguish the evolution of how these partnerships were described across the three years. The ground truth emphasizes the progression from general 'public-private collaborations' (2022) to more structured 'third-party risk management' (2023) to 'ongoing third-party assessments and resilience programs' (2024). The LLM conflates these into a single characterization.\n\nWEAKNESSES - MULTI-HOP SYNTHESIS: While the LLM successfully synthesizes information about the relationship between real-time payment expansion and security enhancement, it doesn't fully capture the year-by-year progression of how third-party collaboration became increasingly formalized and structured. The ground truth shows an evolution in sophistication (from general partnerships to explicit threat monitoring to formalized risk management), which the LLM presents more as a static framework.\n\nMINOR ISSUES: The LLM introduces specific technologies (Click-to-Pay, blockchain-ready tokens) that, while plausible for Mastercard, are not explicitly mentioned in the ground truth and cannot be verified against it. This represents a potential hallucination or extrapolation beyond the source material.\n\nOVERALL: The answer captures the essential narrative and strategic implications correctly but has quantitative precision issues regarding the 2024 real-time payment figure and incomplete year-by-year progression detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 745,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s private‑alternative‑investment “equity‑like” fund holdings grew modestly—from **$4.01 bn** (2022) to **$4.09 bn** (2023) (after a jump from $2.84 bn in 2021).  This upward trajectory shows that Lilly is deliberately expanding its exposure to illiquid, private‑equity‑style assets, signaling a long‑term strategic shift toward higher‑return, longer‑horizon investments as part of its diversified portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS AND TIME PERIOD COVERAGE: The LLM answer contains significant factual errors that undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022 value as '$4.01 bn' when ground truth shows $2,844.7 million ($2.84 bn). This is a major error - the LLM has confused the 2023 value ($4,014.1 million) with the 2022 value. The LLM also states 2023 as '$4.09 bn' when ground truth shows $4,014.1 million ($4.01 bn) - this is closer but still slightly off. Most critically, the LLM completely OMITS the 2024 data ($4,093.7 million), which is explicitly requested in the question ('2022 through 2024'). (2) TIME PERIOD ISSUES: The LLM references 2021 data ('after a jump from $2.84 bn in 2021'), which is not part of the ground truth answer and appears to be an error - the $2.84 bn figure is from 2022, not 2021. The LLM only covers 2022-2023 when the question explicitly asks for 2022-2024. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires analysis of a three-year trend (2022, 2023, 2024). The LLM only addresses two years and misidentifies the 2022 starting point. This is a fundamental failure to address the complete scope of the question. (4) REASONING QUALITY: While the qualitative interpretation about strategic emphasis on illiquid assets and higher-return investments is reasonable and aligns with ground truth reasoning, this cannot compensate for the factual errors in the core data. (5) ENTITY ACCURACY: The company (LLY/Lilly) is correctly identified, and the metric (equity-like funds in private alternatives) is correct, but the numerical values are substantially wrong. The answer demonstrates partial understanding of the strategic implications but fails on the essential quantitative foundation required for a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 491,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nCascade stayed in the Fabric Care sub‑category of the Fabric & Home Care segment through 2022‑2024, but its share of the segment’s net sales slipped modestly—from roughly 5 % of segment net sales in 2022 to just under 4 % by 2024—reflecting a strategic shift toward higher‑growth, higher‑margin brands.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims Cascade's share of segment net sales declined from ~5% in 2022 to ~4% by 2024. The ground truth makes no mention of these specific percentages for Cascade's contribution to segment sales. Instead, the ground truth discusses the Fabric & Home Care segment's contribution to total company net sales (35% in 2022, 36% in 2023-2024), which is a different metric entirely. The LLM appears to have fabricated specific Cascade share numbers not present in the source data. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes that Cascade remained a 'key brand' with 'continued strategic importance' and 'stable positioning' across the three-year period. The LLM contradicts this by claiming a 'strategic shift toward higher-growth, higher-margin brands,' implying Cascade was being de-prioritized. This directly contradicts the ground truth's characterization of stable, consistent contribution. (3) ENTITY CONFUSION: While the LLM correctly identifies Cascade as part of Fabric Care within Fabric & Home Care, it misinterprets what metrics are being tracked. The ground truth discusses segment-level contribution to total company sales, not Cascade's share within the segment. (4) MISSING KEY INFORMATION: The LLM fails to address the actual evolution described in the ground truth—the segment's growth from 35% to 36% of net sales and Cascade's maintained prominence within it. (5) REASONING ERROR: The conclusion about 'strategic shift' is unsupported by and contradicts the ground truth's emphasis on 'stable positioning and consistent contribution.' The answer appears to be speculative rather than grounded in actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 488,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s upgraded its supplier‑sustainability monitoring by expanding the Vendor Code of Conduct, human‑rights and conflict‑minerals policies, and by introducing a risk‑based wood‑sourcing framework that assigns country‑level risk levels, strengthens supplier audits and adds a formal forestry‑grievance process.  At the same time the firm refined its policy oversight—creating a dedicated sustainability committee and embedding wood‑sourcing risk metrics—while committing over $550 million to energy‑efficiency and renewable‑energy projects, setting a net‑zero‑by‑2050 goal with 2030 interim cuts of 42 % (scope 1‑2) and 25 % (scope 3), joining the Renewable Energy Buyers Alliance, and launching a $50 million Gable‑Grants program to build skilled‑trades talent pipelines.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key initiatives and mostly accurate numbers. STRENGTHS: (1) Correctly identifies the $550 million investment figure for environmental/energy projects; (2) Accurately mentions the $50 million Gable Grants program; (3) Properly synthesizes the evolution of wood sourcing policy with risk-based country-level approaches; (4) Correctly identifies the forestry grievance process introduction; (5) Appropriately mentions the Vendor Code of Conduct and human rights/conflict minerals policies; (6) Includes relevant details about net-zero-by-2050 goal with 2030 interim targets (42% scope 1-2, 25% scope 3) and Renewable Energy Buyers Alliance membership. WEAKNESSES: (1) The LLM introduces specific emissions reduction percentages (42% scope 1-2, 25% scope 3) and mentions a dedicated sustainability committee and Renewable Energy Buyers Alliance that are not explicitly mentioned in the ground truth answer, raising questions about whether these details are from the actual filings or inferred; (2) The ground truth emphasizes the EVOLUTION and TIMELINE of changes across 2022-2023-2024 more explicitly, while the LLM presents changes more as a consolidated narrative without clear year-by-year delineation; (3) Missing explicit mention that the $550 million investment occurred specifically in 2022; (4) The ground truth notes the 2023 policy UPDATE with new risk levels, while the LLM presents this as part of a broader framework without temporal specificity. QUANTITATIVE VERIFICATION: The $550 million and $50 million figures are correct and properly formatted. The emissions reduction percentages appear plausible but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects policy enhancements with investment commitments, though the temporal progression could be clearer. SEMANTIC EQUIVALENCE: The core message about evolving sustainability practices is conveyed accurately, though with some additional details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 570,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 to 2023 Honeywell’s Safety & Productivity Solutions saw sales fall 21 % ( $6.9 bn → $5.5 bn ) and segment profit drop 16 % ( $1.08 bn → $0.90 bn ), while Industrial Automation sales slipped 7 % ( $11.6 bn → $10.8 bn ) and profit fell 11 % ( $2.15 bn → $1.96 bn ).  The accompanying risk‑factor commentary for 2024 highlights growing competitive pressure, new market entrants and technology‑driven commoditization across these businesses, indicating that market‑share and pricing pressures have intensified through 2024, whereas Building Technologies showed only modest growth but still faced rising commoditization risks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides an incorrect response. CRITICAL ISSUES: (1) The question asks about evolution of RISK DISCLOSURES regarding competitive landscape and commoditization across three business segments from 2022-2024, NOT about financial performance metrics. The LLM instead provides sales and profit figures for 2022-2023, which is completely off-topic. (2) The original answer clearly states the progression of risk disclosures: Safety & Productivity Solutions (2022) → Building Technologies (2023) → Industrial Automation (2024), showing how commoditization risks were disclosed across different segments in different years. The LLM misses this entirely. (3) The LLM provides specific financial numbers (Safety & Productivity Solutions sales $6.9bn→$5.5bn, profit $1.08bn→$0.90bn; Industrial Automation sales $11.6bn→$10.8bn, profit $2.15bn→$1.96bn) that cannot be verified against the ground truth and are not responsive to the question about risk factor evolution. (4) While the LLM does mention 'growing competitive pressure, new market entrants and technology-driven commoditization' in its final sentence, this appears to be a partial recovery that doesn't address the core multi-hop reasoning required: tracking how these risks were disclosed across different business segments in different years (2022, 2023, 2024). (5) The LLM's conclusion about 'market-share and pricing pressures have intensified through 2024' is somewhat aligned with the ground truth's conclusion about 'intensifying and broadening market pressures,' but this alignment is accidental given the fundamental misunderstanding of what the question asks. The answer demonstrates a failure to understand that this is a qualitative risk disclosure question, not a quantitative financial performance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 496,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm moved its automotive business from a nascent “digital‑cockpit” concept to a core growth engine: the company repeatedly highlighted that > 70 % of new vehicles will have embedded cellular/5G and that its high‑performance, low‑power compute platforms are being adopted for ADAS and cockpit digitalization, and this is reflected in the QCT segment where automotive revenue grew from $1.5 bn in fiscal 2022 to $2.9 bn in fiscal 2024 and the segment’s EBT improved (from $12.8 bn in 2022 to $9.5 bn in 2024 after the 2023 dip).  At the same time, revenue‑recognition disclosures show that automotive product sales are recorded as point‑in‑time revenue with unearned fees and royalties from upfront licensing arrangements, underscoring a shift toward recurring income from the automotive market.  Segment‑reporting disclosures therefore illustrate Qualcomm’s evolution from an exploratory automotive push in 2022 to a mature, higher‑margin digital‑cockpit and automotive‑services strategy by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES WITH QUANTITATIVE DATA: The LLM answer contains significant numerical errors that undermine credibility. (1) AUTOMOTIVE REVENUE FIGURES: LLM claims automotive revenue grew from $1.5bn (fiscal 2022) to $2.9bn (fiscal 2024). The ground truth does not provide these specific numbers, and without verification from the actual filings, these figures cannot be confirmed. More problematically, the LLM provides QCT segment EBT figures ($12.8bn in 2022 declining to $9.5bn in 2024), which appear to be total segment earnings before tax, not automotive-specific metrics. This conflates QCT segment performance with automotive division performance, which is a fundamental error in multi-hop reasoning. (2) MISSING GROUND TRUTH VERIFICATION: The original answer does not cite specific revenue figures, making it impossible to verify if the LLM's numbers are accurate. However, the LLM's inclusion of unverified financial metrics without clear sourcing is problematic. (3) QUALITATIVE STRENGTHS: The LLM correctly identifies the three-year progression (2022 strategic positioning → 2023 revenue recognition → 2024 operational integration) and accurately captures the >70% embedded cellular connectivity projection. The discussion of revenue recognition (point-in-time vs. recurring/licensing) adds relevant detail about monetization strategy. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across automotive transformation, product revenue recognition, and segment reporting as requested. The narrative arc from 'nascent concept' to 'core growth engine' aligns with the ground truth's progression. (5) SEMANTIC ALIGNMENT: The core message matches the original answer's intent—showing evolution from strategic vision to monetization to full integration. However, the introduction of specific financial metrics that cannot be verified against the ground truth creates doubt about the answer's reliability. The LLM appears to have fabricated or misattributed financial figures to support its narrative, which is a serious accuracy concern despite the correct conceptual framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 565,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe broadened Frame.io’s scope beyond video‑centric review—adding native support for still images, design files, PDFs, casting and location‑scouting workflows—and deepened its Creative‑Cloud integration by embedding it directly in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront.  In parallel, the platform was positioned as an enterprise‑grade collaboration hub, gaining Camera‑to‑Cloud auto‑ingest, API‑driven Custom Models and GenStudio availability, and, by 2024, was tightly coupled with Adobe Express and Firefly AI services, offering enterprise indemnification for AI‑generated content.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) Frame.io's expansion from video-centric to broader media types (still images, design files, PDFs); (2) Integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront; (3) Support for casting and location scouting workflows; (4) Enterprise positioning and GenStudio inclusion. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Camera-to-Cloud auto-ingest' which is not mentioned in the ground truth and appears to be fabricated or confused with other Adobe features; (2) 'API-driven Custom Models' is not substantiated in the ground truth; (3) 'Adobe Express and Firefly AI services' integration is mentioned but not explicitly confirmed in the ground truth as part of Frame.io's evolution; (4) 'Enterprise indemnification for AI-generated content' is a specific claim not present in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the timeline progression (2022→2023→2024) and identifies the key evolution pattern. However, it adds details not supported by the source material, which violates the principle of sticking to verifiable facts. TIMELINE ACCURACY: The LLM does not provide specific year-by-year breakdown as clearly as the ground truth (2022 trademark status, 2023 cloud-native platform description, 2024 expansion). SEMANTIC ISSUES: While the general narrative of expansion is correct, the introduction of unverified technical features (Camera-to-Cloud, Custom Models API) and specific enterprise features (indemnification) represents hallucination rather than synthesis. The answer reads more authoritative than warranted given the unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 472,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nThe dividend on Mastercard’s Class A shares rose each year—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—reflecting a steady ~15‑16 % annual increase in cash distributions.  Voting rights remained unchanged: each Class A share carries one vote, while Class B shares are non‑voting but convert 1‑for‑1 into Class A shares that must be sold by the holder.  Across the three years the voting‑power share of public investors hovered near 90 % (89.3 % in 2022, 89.5 % in 2023, 90.6 % in 2024) with only a modest decline in the Mastercard Foundation’s stake, showing that the overall governance structure has been stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. CRITICAL ERRORS: (1) The ground truth explicitly states that MA's A Class shares 'consistently maintained' dividend rights with 'no changes' across 2022-2024, yet the LLM claims dividends 'rose each year' with specific per-share amounts ($2.04, $2.37, $2.74). These dividend per-share figures appear to be fabricated or confused with actual dividend payments that are not part of the A Class share rights structure being asked about. (2) The question asks about 'dividend and voting rights ASSOCIATED WITH MA's A Class shares' - meaning the structural rights granted to the share class itself, not the actual dividend payments made in those years. The LLM conflates dividend payments with dividend rights. (3) The LLM introduces specific percentages (89.3%, 89.5%, 90.6%) for voting power distribution and Mastercard Foundation stakes that are not mentioned in the ground truth and appear to be unsupported fabrications. (4) The ground truth's answer is clear and definitive: voting rights remained 'One vote per share' and dividend rights remained unchanged across all three years, indicating stability. The LLM's narrative of rising dividends and shifting ownership percentages directly contradicts this. (5) The LLM does correctly identify that Class B shares are non-voting and convert 1-for-1 to Class A, which is accurate structural information, but this doesn't compensate for the fundamental misunderstanding of what the question asks. The LLM appears to have confused share class rights (structural governance features) with actual dividend payment amounts and shareholder composition changes. This is a multi-hop synthesis failure where the model failed to correctly identify what information was being requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 494,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nHoneywell’s Safety and Productivity Solutions segment posted net sales of $6.91 billion in fiscal 2022, $5.49 billion in fiscal 2023 and continued to slide in fiscal 2024, where a $705 million drop was attributed to weaker organic demand for personal‑protective‑equipment and warehouse‑workflow solutions (see page 114, page 26).  Consequently, segment profit fell from $1.08 billion to $0.90 billion and the margin slipped to roughly 19.5 % in 2024, reflecting the direct impact of retail‑market fluctuations on the business.  The company’s own risk‑factor disclosures repeatedly note that “fluctuations in retail markets” can adversely affect this segment, underscoring its heightened vulnerability to consumer‑demand volatility over time (see page 31).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Honeywell's Safety and Productivity Solutions segment was adversely impacted by retail market fluctuations across the three-year period, and appropriately cites risk factor disclosures. The answer demonstrates good understanding of the segment's vulnerability to consumer demand volatility and attempts to provide specific financial metrics to support the claim. The reference to PPE and warehouse-workflow solutions as specific product categories affected is relevant and specific.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM provides specific sales figures ($6.91B in 2022, $5.49B in 2023) and claims a $705M drop in 2024, but these numbers cannot be verified against the ground truth, which does not provide specific sales figures. The claim about segment profit falling from $1.08B to $0.90B and a 19.5% margin in 2024 are presented as facts but lack verification. The ground truth does not confirm these specific financial metrics, making it impossible to validate whether these numbers are accurate or fabricated. This is a critical issue for quantitative accuracy.\n\nMULTI-HOP REASONING: The LLM answer attempts to synthesize information across three fiscal years and connect specific financial performance to retail market fluctuations. However, the ground truth emphasizes that the segment was renamed from \"Safety and Productivity Solutions\" to \"Industrial Automation\" by 2024, which the LLM answer does not acknowledge. The ground truth notes this organizational change is important context, whereas the LLM treats it as a continuous segment without addressing the nomenclature shift.\n\nCOMPLETENESS: The LLM answer addresses the core question about retail market impact and vulnerability over time, but it misses the important organizational restructuring detail that the ground truth emphasizes. The ground truth specifically notes that despite the name change to Industrial Automation in 2024, the business retained the same retail market risk exposure.\n\nSEMANTIC ALIGNMENT: While the LLM answer conveys that the segment was vulnerable to retail market fluctuations and that this vulnerability persisted over time (matching the ground truth's conclusion), the specific financial data provided cannot be confirmed as accurate. The answer reads as plausible but lacks verifiable support from the ground truth source material.\n\nKEY CONCERN: The unverifiable specific financial figures (sales, profit, margin percentages) represent a significant risk. If these numbers are incorrect, the entire quantitative foundation of the answer collapses. The ground truth provides qualitative risk disclosures but does not provide the specific financial metrics the LLM cites, suggesting possible hallucination or misattribution of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 739,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nThe 2020 collaboration agreement with Incyte kept the base royalty on Olumiant at a tiered double‑digit rate (up to 20 % of worldwide net sales) and added a separate low‑teens royalty on sales of the COVID‑19 indication once a sales threshold is exceeded; the amendment also retained milestone triggers of up to $100 million for regulatory milestones and $100 million for sales‑based milestones, the first of which ($260 million and $210 million) were capitalized in 2020‑2021 and have not been followed by material new payments through 2024. Consequently, while the royalty rates and milestone caps remained unchanged from 2022 to 2024, the inclusion of COVID‑19 introduced an extra royalty tier and the possibility of additional milestones, but no material new milestone payments have been made since the initial 2021 capitalizations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. CRITICAL DATING ERROR: The LLM references a '2020 collaboration agreement' and states milestones were 'capitalized in 2020-2021,' but the question specifically asks about evolution FROM 2022 TO 2024. The ground truth indicates the agreement was already in place by 2022 with established terms. The LLM's focus on 2020-2021 events is largely irrelevant to the requested timeframe.\n\n2. QUANTITATIVE INACCURACY: The LLM introduces unexplained figures of '$260 million and $210 million' for capitalized milestones in 2020-2021. These numbers do not appear in the ground truth and appear to be fabricated or misattributed. The ground truth clearly states 'up to $100 million in additional regulatory milestones and $100 million in sales-based milestones' - not the figures cited by the LLM.\n\n3. INCOMPLETE TEMPORAL ANALYSIS: The ground truth explicitly describes how the relationship evolved across the three-year period (2022→2023→2024), noting a shift from milestone-driven obligations to stable royalty-based payments. The LLM fails to capture this evolution, instead treating the period as static ('remained unchanged from 2022 to 2024').\n\n4. MISSING KEY INSIGHT: The ground truth emphasizes that by 2024, 'the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired.' The LLM mentions no new payments since 2021 but doesn't articulate the strategic shift in the payment model over the 2022-2024 period.\n\n5. ROYALTY STRUCTURE: Both answers correctly identify the tiered royalty structure (up to 20% base, low-teens for COVID-19 above threshold), so this element is accurate.\n\n6. MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution across the three-year period requested. It conflates historical context (2020-2021) with the specific timeframe of interest (2022-2024).\n\nThe answer demonstrates partial understanding of the royalty mechanics but fundamentally fails to address the question's core requirement: how the relationship EVOLVED from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 591,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nBetween 2022 and 2024 P&G deepened the Always brand’s role as the segment’s flagship, using it to lead both the menstrual‑care and adult‑incontinence sub‑categories of Baby, Feminine & Family Care; Always (and its Always Discreet extension) together held roughly 25 % of the global menstrual market and about 15 % of adult‑incontinence share, giving the brand a disproportionate earnings contribution (the segment generated 25 % of net earnings on only 24 % of sales).  The company reinforced this prominence by shifting the brand toward premium pricing, performance‑driven product and packaging innovation, and by allocating disproportionate strategic focus to it, so that—even as unit volumes slipped modestly—the brand remained the most prominent and highest‑margin offering relative to rivals such as Tampax within the segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific market share percentages (25% global menstrual market, 15% adult-incontinence share, 25% of net earnings on 24% of sales) that are NOT present in the ground truth and cannot be verified from the provided knowledge graph. These appear to be fabricated numbers. (2) MISSING CORE INFORMATION: The ground truth explicitly documents the evolution of product categorization from 2022-2024 ('Feminine Care (Adult Incontinence, Feminine Care)' in 2022 shifting to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023-2024). The LLM answer completely omits this key categorization evolution, which is central to the question about 'product categorization.' (3) UNSUPPORTED CLAIMS: The LLM makes assertions about 'premium pricing,' 'performance-driven product and packaging innovation,' 'unit volumes slipped modestly,' and 'highest-margin offering' that are not mentioned in the ground truth. These appear to be hallucinated details. (4) INCOMPLETE SYNTHESIS: While the ground truth mentions Always Discreet as a related brand, the LLM's framing of it as an 'extension' and the emphasis on combined market share is not supported by the source material. (5) PARTIAL ACCURACY: The LLM correctly identifies Always, Always Discreet, and Tampax as brands in the segment, and correctly notes the segment's role in P&G's portfolio, but this correct information is overshadowed by the numerous unsupported claims. The answer fails to address the specific evolution of product categorization from 2022-2024, which is the primary focus of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 469,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nThe target asset mix was 100 % debt for the U.S. defined‑benefit plan in the 2022 filing (the target for fiscal 2023) and remained 100 % debt in the 2023 filing (target for fiscal 2024); however, the non‑U.S. plan shifted from a 27 % equity / 48 % debt allocation disclosed in the 2022 filing to roughly 28 % equity / 36 % debt in the 2023/2024 filings, with the addition of cash, insurance contracts and other assets for the fiscal 2025 target.  \n\nThis multi‑year progression shows ACN’s deliberate move from a strictly liability‑driven, all‑fixed‑income posture toward a modestly more diversified portfolio that still emphasizes duration matching but introduces equity and other growth‑oriented assets to improve risk‑adjusted returns while preserving the overall liability‑hedging structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific quantitative details about asset allocation percentages (U.S. plan 100% debt, non-U.S. plan shifts from 27%/48% to 28%/36%) that are not present in the ground truth answer. However, this creates a critical evaluation challenge: (1) QUANTITATIVE SPECIFICITY: The LLM provides concrete percentages and plan-specific breakdowns (U.S. vs. non-U.S. plans) that the ground truth answer does not mention. These numbers cannot be verified against the ground truth provided, which speaks only in general terms about 'diversified portfolio of fixed income instruments and equities' without specific percentages. (2) MULTI-HOP SYNTHESIS: The LLM correctly identifies a progression across three fiscal years (2023, 2024, 2025) and attempts to synthesize changes across filings. The ground truth also addresses this multi-year progression. (3) REASONING QUALITY: The LLM's conclusion about 'deliberate move from strictly liability-driven, all-fixed-income posture toward modestly more diversified portfolio' is logically sound and aligns with the ground truth's emphasis on 'liability duration matching and diversification.' (4) INCOMPLETENESS vs. GROUND TRUTH: The ground truth mentions 'weighted-average plan assets allocation as of August 31, 2023' and discusses 'tactical flexibility in asset allocation decisions to respond to market dynamics,' which the LLM answer does not explicitly address. (5) POTENTIAL ACCURACY ISSUE: The LLM's claim that the U.S. plan was '100% debt' for both fiscal 2023 and 2024 is very specific and differs from the ground truth's more general description of 'diversified portfolio of fixed income instruments and equities.' Without access to the actual filings, it's unclear if this specificity is correct or represents a factual error. The answer demonstrates good multi-hop reasoning and logical synthesis, but the specific quantitative claims cannot be fully validated against the provided ground truth, and some elements of the ground truth (tactical flexibility, market dynamics responsiveness) are not addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 557,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s reduced the size of its forward‑interest‑rate‑swap program that had been used as cash‑flow hedges (the $2.5 bn notional outstanding in 2022 had largely matured or been rolled by the FY 2024 balance‑sheet) and correspondingly increased the use of fixed‑to‑floating swaps that are now designated as fair‑value hedges on existing borrowings – a $76 m liability recorded for those swaps as of January 31 2025 (page 46, 54).  Because the newer swaps are accounted under the shortcut method, changes in their fair value directly offset the fair‑value changes of the hedged debt, eliminating any net earnings impact that the prior cash‑flow hedge accounting would have generated (page 46).  This shift shows that Lowe’s is moving its interest‑rate risk management from protecting against future debt‑issuance rate moves to stabilizing the earnings and balance‑sheet exposure of its current debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift from cash flow hedges (forward interest rate swaps) to fair value hedges (fixed-to-floating swaps), which matches the ground truth narrative. The reasoning about moving from protecting future debt issuance risk to stabilizing current debt exposure is sound and well-articulated. The mention of the shortcut method for fair value hedge accounting is accurate and relevant. The answer demonstrates good understanding of the multi-hop synthesis required.\n\nWEAKNESSES - QUANTITATIVE ERRORS: (1) The LLM states '$2.5 bn notional outstanding in 2022' but provides no source verification from ground truth. The ground truth does not mention this specific $2.5B figure. (2) The LLM cites '$76 m liability recorded for those swaps as of January 31 2025' but the ground truth only mentions a $251 million fair value for 2023 swaps classified as current assets, not a 2025 liability figure. This appears to be extrapolated data not in the ground truth. (3) The ground truth explicitly states the 2023 fair value was $251 million (Level 2, current assets), but the LLM does not mention this specific 2023 figure at all.\n\nMISSING INFORMATION: The LLM fails to mention the explicit $251 million fair value disclosure for 2023 and its Level 2 fair value hierarchy classification, which is a key quantitative data point in the ground truth. The ground truth notes that in 2022 'no current fair value was listed for 2022 itself' - the LLM doesn't address this temporal detail.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound and captures the strategic evolution correctly. However, the specific quantitative milestones (2023's $251M, 2024's transition to zero forward swaps) are either missing or replaced with unverified figures.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution of exposure, fair value classification changes, and strategic implications. The discussion of hedge accounting treatment and earnings impact is relevant and accurate in concept.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 559,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nBroadcom’s exposure to the 5.000 % senior notes due April 2030 stayed virtually flat – the notes continued to be carried at roughly $600 million (fair‑value disclosed as $606 million) at the end of fiscal 2022, 2023 and 2024.  This steady presence indicates that the company is preserving a long‑dated, low‑coupon funding tranche while it has been actively refinancing and retiring higher‑cost or shorter‑maturity debt, using the 2030 notes as a stable core component of its overall debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the notes were 'carried at roughly $600 million...at the end of fiscal 2022, 2023 and 2024' with fair value disclosed as $606 million. However, the ground truth clearly shows the exposure was $1,086 million in 2022, then $606 million in both 2023 and 2024. The LLM incorrectly claims the 2022 value was ~$600 million when it was actually $1,086 million - a $480 million error. (2) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about the evolution 'from fiscal year 2022 through 2024.' The LLM failed to identify the significant decline from 2022 to 2023 ($1,086M to $606M, a 44% reduction). Instead, it incorrectly characterized the progression as 'virtually flat' across all three years. (3) REASONING ERROR: The LLM's interpretation that the company is 'preserving' this debt tranche is contradicted by the actual data showing deliberate reduction. The ground truth indicates 'active debt repayment or restructuring strategy focused on managing long-term liabilities,' not preservation. (4) ENTITY ACCURACY: While the company is correctly identified as Broadcom (AVGO), and the debt instrument is correctly identified as 5.000% senior notes due April 2030, the numerical analysis is fundamentally wrong. The LLM appears to have conflated or misread the 2023-2024 values ($606M) as representative of all three years, missing the critical 2022 baseline of $1,086M. This is a major analytical failure for a multi-hop financial question requiring year-over-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 452,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nAcross the 2022‑2024 filings UPS kept the same terms for its $276 million 7.620% debentures: the coupon stayed at the stepped‑down 7.620% rate (originally 8.375% until April 1 2020), interest is paid semi‑annually, the securities mature on April 1 2030, and they are callable at any time with a redemption price equal to the greater of principal + accrued interest or the present value of the remaining payments discounted at a Treasury yield + 5 bps + accrued interest. The description first appeared in the 2022 Form 10‑K (page 126), was repeated verbatim in the 2023 filing (page 104) and again in the 2024 filing (page 108), with only minor wording updates—no change to the interest rate, redemption mechanics, or maturity structure was reported.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 filings. STRENGTHS: (1) All key numeric values are correct: $276 million principal, 7.620% coupon rate, April 1, 2030 maturity date, April 1, 2020 rate reduction date, and 5 basis points redemption spread. (2) The multi-hop synthesis is sound—the answer correctly traces the evolution of disclosure across three years while identifying that the underlying terms remained constant. (3) The redemption mechanics are accurately described with the 'greater of' language and the Treasury yield + 5 bps formula. (4) The semi-annual interest payment schedule is correctly noted. (5) Page references (126, 104, 108) add specificity and demonstrate document-level verification. MINOR WEAKNESSES: (1) The original answer emphasizes that 2024 disclosure placed 'more emphasis on the semi-annual interest payment schedule' and noted that debentures are 'not subject to sinking fund requirements'—the LLM answer mentions semi-annual payments but does not explicitly address the sinking fund disclosure evolution, which was highlighted in the ground truth as part of the disclosure evolution narrative. (2) The LLM answer states the redemption price includes 'accrued interest' twice in the formula description ('principal + accrued interest or the present value...+ accrued interest'), which is slightly redundant phrasing compared to the ground truth's cleaner formulation. (3) The LLM answer focuses heavily on verbatim repetition across years but could have more explicitly highlighted the 'increasing clarity in disclosure' theme that the ground truth emphasizes. QUANTITATIVE VERIFICATION: All numbers check out correctly. The characterization of the rate reduction from 8.375% to 7.620% in April 2020 is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies both consistency in terms and evolution in disclosure emphasis. The reasoning is logically sound and addresses the core question about how treatment and disclosure evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 570,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen transformed Olpasiran from a Horizon‑acquired early‑stage asset into a central pillar of its cardiovascular pipeline, shifting its therapeutic focus to Lp(a)‑lowering for atherosclerotic cardiovascular disease and advancing it from phase 2 (noted in the 2022 filing) to full‑scale phase 3 development (with phase 3 trials initiated in 2023 and ongoing into 2024).  The compound’s U.S. and European composition‑of‑matter patents, which underpin its exclusivity, are projected to expire in 2036 (with potential extensions), securing protection for the therapy well into the mid‑2030s.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2036 patent expiration date for U.S. and European composition-of-matter patents, matching the ground truth. (2) The therapeutic focus on Lp(a)-lowering for atherosclerotic cardiovascular disease is accurately stated. (3) The general timeline progression from 2022-2024 is directionally correct. (4) The mention of phase 3 trials is factually accurate based on the progression described.\n\nWEAKNESSES: (1) The LLM introduces information not present in the ground truth about Olpasiran being 'Horizon-acquired' - while this may be factually true, it's not mentioned in the original answer and adds unsourced context. (2) The LLM states Olpasiran was in 'phase 2 (noted in the 2022 filing)' and advanced to 'phase 3 development (with phase 3 trials initiated in 2023)' - the ground truth only confirms phase 2 in 2022 and does not explicitly state phase 3 initiation in 2023 or ongoing phase 3 in 2024. This represents a factual claim not supported by the ground truth. (3) The ground truth notes a shift from 'atherosclerotic cardiovascular disease' in 2022-2023 to broader 'cardiovascular disease' in 2024, suggesting potential expansion. The LLM does not capture this important nuance about the broadening of therapeutic indication. (4) The phrase 'with potential extensions' regarding patent protection is speculative and not mentioned in the ground truth, which states patents 'expiring in 2036' without qualification.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across the 2022-2024 period but makes unsupported claims about phase progression (phase 3 initiation dates) that go beyond what the ground truth establishes. The core multi-hop synthesis of therapeutic focus + IP protection + clinical progression is attempted but incomplete regarding the 2024 therapeutic indication broadening.\n\nCRITICAL ISSUE: The claim about phase 3 trials being 'initiated in 2023 and ongoing into 2024' cannot be verified against the ground truth, which only confirms phase 2 in 2022. This is a significant factual claim that may be correct but is not supported by the provided ground truth, making it difficult to validate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 585,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax remained classified under the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment and continued to appear as a “major brand” (e.g., “Tampax Bounty” listed alongside Always, Always Discreet, etc.) in P&G’s segment tables (see PG 10‑K 2022 p. 19; 2024 p. 18 & p. 19).  However, its growth shifted from volume‑driven to a **premium‑mix focus** – net sales rose only low‑single digits, driven by higher pricing and a larger share of premium products, while unit volumes declined, indicating a move toward higher‑margin, less volume‑dependent prominence within the segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Tampax remained under the Feminine Care sub-category of Baby, Feminine & Family Care segment across 2022-2024, and accurately notes it was listed as a major brand. The page references (2022 p. 19; 2024 p. 18 & 19) appear reasonable for 10-K filings. The answer appropriately addresses the core question about positioning evolution.\n\nCRITICAL WEAKNESSES: (1) The LLM introduces significant new information NOT in the ground truth about 'premium-mix focus,' 'low-single digit net sales growth,' 'higher pricing,' and 'unit volume declines.' These specific financial metrics and strategic characterizations are NOT mentioned in the original answer and cannot be verified against the ground truth provided. This represents unsupported factual claims. (2) The phrase 'Tampax Bounty' appears to conflate two separate brands (Tampax and Bounty), which is confusing and potentially inaccurate. (3) The ground truth explicitly mentions a sub-category name change from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023, then back to the 2022 format in 2024. The LLM completely omits these specific sub-category label refinements, which are explicitly highlighted in the ground truth as key to the evolution narrative.\n\nMULTI-HOP REASONING: The LLM attempts to add a financial/strategic dimension (premium-mix shift) that goes beyond what the ground truth establishes. While this might be inferrable from 10-K data, it's not part of the verified answer and represents speculation rather than synthesis of provided information.\n\nSEMANTIC EQUIVALENCE: The core positioning claim (Tampax remained prominent in Feminine Care) is correct, but the answer diverges significantly by adding unverified financial performance details and omitting the specific sub-category naming evolution that the ground truth emphasizes as important.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 523,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept using internally developed designations for non‑agency RMBS and CMBS on any securities it acquired before the NAIC had completed its annual evaluation, applying the internal label only until a NAIC rating could be assigned.  The trend shows a steady decline in that reliance as the NAIC’s rating cycle caught up with the firm’s purchase pace, indicating that NAIC designations are becoming more readily available but still lag new acquisitions, and that MetLife’s strategy is to move quickly into this asset class, accepting temporary internal designations while awaiting formal NAIC ratings.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - CONTRADICTORY TREND CLAIM: The LLM answer claims there was a 'steady decline in reliance' on internally developed designations from 2022-2024, but the ground truth explicitly states the practice 'remained a consistent practice' and 'continued' across all three years with 'persistence.' This is a fundamental factual error that contradicts the core finding. The LLM has invented a trend (declining reliance) that does not exist in the source material.\n\nCORRECT ELEMENTS: (1) The LLM correctly identifies that internally developed designations were used for securities not yet evaluated by NAIC - this matches ground truth. (2) The timeframe (2022-2024) is correct. (3) The explanation of the mechanism (internal labels applied until NAIC rating assigned) is accurate. (4) The characterization of MetLife's strategy as moving quickly into the asset class is reasonable and consistent with ground truth.\n\nINCORRECT/UNSUPPORTED ELEMENTS: (1) 'Steady decline in reliance' - NO EVIDENCE in ground truth; ground truth says 'remained consistent' and 'continued.' (2) 'NAIC's rating cycle caught up with the firm's purchase pace' - This suggests improvement/convergence, but ground truth indicates NAIC designations 'were not immediately available' and 'lag behind acquisition timelines,' suggesting persistent lag, not catch-up. (3) The implication that reliance decreased over time contradicts the stated persistence of the policy.\n\nMULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year trend. Instead of recognizing consistency/persistence across years, it invented a declining trend narrative. This is a significant reasoning error that misrepresents the actual pattern in the data.\n\nQUANTITATIVE ACCURACY: No specific numbers were provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers).\n\nSEMANTIC EQUIVALENCE: While some phrasing is similar, the core semantic meaning is inverted - the LLM claims decline where ground truth shows consistency. This is not a wording difference but a factual contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 561,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12.2 million shares for $4.1 B in 2022, about $4.5 B of stock in 2023, and again about $4.5 B in 2024, while the balance of its open‑market authorization dropped from $6.13 B (after a 2022 $3 B increase) to roughly $2.7 B by the end of 2024 (before a subsequent $4 B boost).  This steady use of a large, regularly replenished buy‑back program demonstrates that returning excess cash to shareholders via share repurchases is a core element of Accenture’s capital‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of Accenture's share repurchase strategy and provides relevant context about capital returns, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the core narrative of consistent, growing share repurchases over the three-year period; (2) Accurately captures the final authorization balance of ~$2.7B as of August 31, 2024, and the subsequent $4B increase to $6.69B; (3) Properly synthesizes the multi-hop information about repurchase activity and authorization evolution; (4) Correctly concludes that share repurchases are a core capital-return strategy. CRITICAL ERRORS: (1) The LLM states the initial authorization was $6.13B (after a 2022 $3B increase), but the ground truth clearly indicates $3.13B in fiscal 2022 - this is a major numerical error ($3B discrepancy); (2) The LLM provides aggregate repurchase amounts ($4.1B in 2022, $4.5B in 2023, $4.5B in 2024) that are not verified in the ground truth, which only mentions 2,000,308 shares for $605M in Q4 FY2024; (3) The claim of '12.2 million shares' repurchased in 2022 cannot be verified against the provided ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between repurchase activity and authorization levels, showing how the program is regularly replenished. However, the quantitative foundation is questionable. The semantic interpretation of the capital strategy is sound, but the specific numbers lack verification. The answer would score higher if the numerical claims were accurate or properly qualified as estimates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 444,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic positioning shifted from a broad, generic mention in 2022 (“industrial fiber optics … used in industrial automation, power generation, medical, defense and automotive applications”) to a more targeted emphasis in 2023‑24, where the company’s product‑portfolio tables specifically group “Industrial fiber optics” under the “Factory Automation, Renewable Energy and Automotive Electronics” end‑markets (2023 p. 5; 2024 p. 5).  This narrowing shows that Broadcom is deliberately concentrating on high‑growth, high‑margin industrial segments—especially EV powertrains, ADAS and renewable‑energy systems—where ultra‑reliable, high‑speed connectivity is a strategic differentiator.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution pattern - from broad 2022 positioning to more targeted 2023-24 emphasis. (2) Correctly names the company (Broadcom/AVGO) and time period (2022-2024). (3) Accurately captures the shift toward specific applications (factory automation, renewable energy, automotive electronics). (4) The page references (2023 p. 5; 2024 p. 5) suggest proper source documentation. (5) The interpretation about 'high-growth, high-margin segments' and 'strategic differentiator' aligns with the ground truth's conclusion about 'maturing and application-focused product strategy.' WEAKNESSES: (1) The LLM's characterization of 2022 as 'broad, generic mention' is somewhat overstated - the ground truth shows 2022 already included specific applications (industrial automation, medical systems, EV subsystems), not just generic positioning. (2) The LLM describes the evolution as a 'narrowing' from broad to targeted, but the ground truth suggests more of a 'standardization and clarification' - the applications were always there, just presented differently in portfolio tables. (3) The LLM adds interpretive claims about 'high-margin segments' and 'EV powertrains, ADAS' that go beyond what the ground truth explicitly states. While these inferences may be reasonable, they represent analytical extrapolation rather than direct evidence from the filings. (4) Missing explicit mention that industrial fiber optics remained 'consistent' across all three years - the LLM emphasizes change over continuity. (5) The ground truth mentions grouping with 'sensors, encoders, LEDs, Ethernet components' and 'Ethernet PHYs and camera microcontrollers' - the LLM doesn't capture these contextual product groupings. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects product positioning to strategic intent, which is sound. However, the interpretation of 'narrowing' vs. 'maturing' represents a subtle but meaningful difference in how the evolution is characterized. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this is not a differentiating factor. The page references in the LLM answer add credibility but cannot be independently verified here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 606,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nThrough 2022‑2024, UPS SurePost remained a residential‑last‑mile offering that leveraged the UPS ground network but handed final delivery to the United States Postal Service; this model produced modest volume declines (e.g., “decreases in rail and SurePost volumes” noted in the 2023 MD&A). Starting January 1 2025, UPS insourced that final‑delivery step—ending its reliance on USPS and gaining more control over service quality as part of a broader strategic shift toward higher‑yielding, more‑profitable shipments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS SurePost's evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core service model across 2022-2023 as a residential last-mile offering leveraging UPS ground network with USPS handling final delivery; (2) Accurately captures the 2024 strategic shift to insource final delivery effective January 1, 2025; (3) Properly synthesizes the transition from USPS reliance to integrated, controlled delivery model; (4) Includes supporting detail about volume declines mentioned in 2023 MD&A, demonstrating multi-hop reasoning across documents; (5) Correctly emphasizes the strategic motivation (control over service quality, higher-yielding shipments). QUANTITATIVE ACCURACY: All dates are correct (2022-2023 unchanged model, January 1, 2025 implementation date). No specific dollar amounts or percentages were required by the question, so this dimension is not penalized. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information about the service model evolution and strategic rationale. Entity identification is accurate (UPS, USPS, SurePost). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing 'handed final delivery to USPS' vs. 'with final delivery frequently handled by USPS' is semantically equivalent. The addition of context about 'higher-yielding, more-profitable shipments' adds relevant strategic context that aligns with the ground truth's emphasis on enhanced control and customer experience. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 450,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline expanded markedly: the company reported 13 Phase 3 programs in early 2021, 18 by the end of 2022, and 24 distinct programs as of January 31 2024 (and 25 by early 2025), with five new studies launched, three FDA approvals (e.g., Otezla for genital psoriasis and LUMAKRAS for KRAS‑mutant NSCLC) and the termination of KYPROLIS, while five Horizon‑acquired assets (Dazodalibep, TEPEZZA, UPLIZNA, etc.) were added to the roster. This progression—driven by both internal initiations and strategic acquisitions—shows Amgen’s R&D expansion strategy of broadening its high‑value pipeline through new indications, biosimilar development, and targeted acquisitions to sustain growth and competitiveness.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '13 Phase 3 programs in early 2021' but the ground truth clearly indicates 13 programs as of February 8, 2022 (not 2021). This is a significant dating error that misrepresents the timeline. The progression 13→18→24→25 is correct, but the starting point year is wrong. (2) SPECIFIC PRODUCT CLAIMS - The LLM mentions 'Otezla for genital psoriasis' and 'LUMAKRAS for KRAS-mutant NSCLC' as FDA approvals, but the ground truth does not verify these specific approvals or their indications in the context of Phase 3 program evolution. The mention of 'KYPROLIS termination' is also not mentioned in the ground truth. These appear to be hallucinated or incorrectly attributed details. (3) HORIZON ACQUISITION DETAILS - The LLM correctly identifies Horizon Therapeutics acquisition in 2023 and mentions five Phase 3 programs added, which matches ground truth. However, the specific asset names listed (Dazodalibep, TEPEZZA, UPLIZNA) are not verified in the ground truth provided. (4) MULTI-HOP REASONING - The LLM correctly synthesizes the overall strategy (internal development + external acquisition) and the progression narrative, which aligns with ground truth interpretation. (5) MISSING CONTEXT - The LLM does not explicitly note the February 4, 2025 date mentioned in the ground truth as being from the 2024 filing, though it does mention 'early 2025.' The core narrative about R&D expansion strategy is sound, but the execution contains factual errors that undermine credibility. The answer demonstrates understanding of the question but fails on precision of verifiable facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 450,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s share reserve was set at **127 million Class A ordinary shares for fiscal 2022** (as noted on page 84), remained unchanged through fiscal 2023, and was **increased to 141 million shares for fiscal 2024** after the amendment was ratified by shareholders (page 98). This step‑up in the authorized pool signals that Accenture is deliberately expanding its equity‑compensation capacity—ensuring enough shares for future grants and reinforcing its strategy of using stock‑based awards to attract, retain, and motivate employees as the business scales globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numbers and the progression timeline. Quantitative verification: FY2022 = 127 million shares (correct), FY2023 = 127 million shares (correct - remained unchanged per ground truth), FY2024 = 141 million shares (correct). The increase of 14 million shares is accurately characterized. The LLM correctly identifies the amendment ratification by shareholders and provides specific page references (84, 98) that add credibility. The multi-hop synthesis is sound: the answer traces the evolution across three fiscal years and connects this to strategic implications. The reasoning about equity-compensation capacity expansion and talent retention strategy aligns well with the ground truth's interpretation. Minor distinction: The ground truth states the number 'increased to 141,000,000' in both FY2023 and FY2024, while the LLM specifies the increase occurred 'for fiscal 2024 after the amendment was ratified.' This is a more precise characterization of when the change took effect, which is actually an improvement in clarity. The LLM's explanation of the strategic implications (attracting, retaining, and motivating employees as the business scales) is semantically equivalent to and consistent with the ground truth's assessment. No calculation errors detected. All entities (Accenture plc, Class A ordinary shares, Amended 2010 SIP) are correctly identified. The answer fully addresses all parts of the multi-part question regarding evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 429,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ forward‑looking supply‑coverage language moved from “adequate supply of green coffee … through fiscal 2023” in the 2022 filing to “adequate supply … through fiscal 2025” in the 2023 and 2024 filings.  This extension shows that the company has deliberately lengthened its inventory‑and‑hedge buffer—using fixed‑price contracts, forward/futures positions and long‑term purchase commitments—to protect against coffee‑price volatility and potential supply disruptions, underscoring a risk‑management strategy that prioritizes securing a multi‑year green‑coffee supply rather than relying on short‑term spot‑market purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All dates and fiscal year references are correct - fiscal 2022 filing stated coverage through fiscal 2023, fiscal 2023 and 2024 filings stated coverage through fiscal 2025. The progression is accurately captured. ENTITY ACCURACY: Starbucks correctly identified, green coffee supply correctly specified, fiscal years 2022-2024 correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across three fiscal years and correctly identifies the strategic shift from short-term to longer-term supply coverage. COMPLETENESS: The answer addresses both parts of the question - the evolution of projected duration AND what it indicates about inventory/risk management strategy. The explanation of risk management mechanisms (fixed-price contracts, forward/futures positions, long-term purchase commitments) provides appropriate context. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately lengthened inventory-and-hedge buffer' and 'prioritizes securing multi-year green-coffee supply' aligns well with the ground truth's description of 'more forward-looking inventory and risk management strategy with increased emphasis on long-term supply assurance.' MINOR CONSIDERATION: The LLM provides slightly more detailed explanation of the hedging mechanisms than the ground truth, but this is additive and not contradictory - it enhances understanding without introducing errors. The language is professional and clearly articulates the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 439,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS amended the UPS/IBT Full‑Time Employee Pension Plan to freeze further benefit accruals for non‑union participants (effective January 1 2023) and, through the 2023 Teamsters five‑year master agreement, secured wage and benefit‑rate increases for plan participants that were reflected in the year‑end remeasurement of the plan’s obligations. After the ARPA‑driven remeasurement and the subsequent receipt of Special Financial Assistance that eliminated the coordinating‑benefit liability, the company’s best estimate of any remaining obligation under the UPS/IBT plan became immaterial by the end of 2024, prompting a strategic shift toward defined‑contribution funding and other post‑retirement initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims a $3.3 billion ARPA-driven remeasurement gain occurred, but attributes it incorrectly to 'Special Financial Assistance that eliminated the coordinating-benefit liability' - the ground truth shows this was a mark-to-market gain in 2022, not related to SFA elimination. The LLM also claims the remaining obligation became 'immaterial by end of 2024' with no supporting numbers in the ground truth. (2) FACTUAL INACCURACIES: The LLM introduces a freeze of benefit accruals for non-union participants effective January 1, 2023 - this specific detail is NOT in the ground truth and appears to be fabricated. The ground truth makes no mention of freezing benefits for non-union participants. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 2023 Teamsters agreement and wage/benefit increases, it mischaracterizes the nature of the ARPA remeasurement and incorrectly links it to SFA. The ground truth clearly states the $3.3 billion gain was from ARPA remeasurement in 2022, not from SFA. (4) UNSUPPORTED CLAIMS: The assertion about 'strategic shift toward defined-contribution funding' is not mentioned in the ground truth, which states UPS maintained the plan as a noncontributory defined benefit plan with 'no indication of further structural changes.' (5) MISSING KEY INFORMATION: The LLM fails to mention the specific $3.3 billion pre-tax gain ($2.5 billion after-tax) from the 2022 ARPA remeasurement, which is a central fact in the ground truth. The answer demonstrates poor multi-hop reasoning by conflating different pension events and introducing unsupported details that contradict the ground truth's narrative of continued plan maintenance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 497,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart has consistently listed “Holiday Time” among its private‑brand names in the 2022 10‑K (p. 4), the 2023 10‑K (p. 6) and the 2024 10‑K (p. 4). Starting in fiscal 2023 the filing notes that “revisions are made to the categorization of the components comprising our strategic merchandise units” (2023 10‑K, p. 6), and by fiscal 2024 the company explicitly places Holiday Time within the “Seasonal” strategic merchandise unit, emphasizing its role in the quarter that ends January 31 (2024 10‑K, p. 7). Thus, Walmart is treating seasonal private‑label brands like Holiday Time as distinct, high‑impact merchandise units that are strategically positioned to capture holiday demand within its broader private‑label portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years. STRENGTHS: (1) Correctly identifies Holiday Time's consistent presence in private brands across 2022, 2023, and 2024 10-Ks; (2) Accurately cites the 2023 10-K reference to 'revisions are made to the categorization of the components comprising our strategic merchandise units'; (3) Correctly identifies the explicit placement of Holiday Time within the 'Seasonal' strategic merchandise unit by fiscal 2024; (4) Properly references the quarter ending January 31 as the relevant seasonal period; (5) Provides accurate page citations (2022 10-K p. 4, 2023 10-K p. 6, 2024 10-K p. 4 and p. 7); (6) Demonstrates sound multi-hop reasoning by connecting the evolution across years to show strategic repositioning. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and doesn't explicitly mention comparisons to other private brands like 'George' and 'Great Value' that provide context for the portfolio; (2) Doesn't explicitly state that in 2022 and 2023 Holiday Time lacked 'distinct strategic role' or 'specific strategic emphasis,' though this is implied by the contrast with 2024; (3) Could have been slightly more explicit about the shift from general merchandise categorization to a dedicated seasonal framework. QUANTITATIVE ACCURACY: All dates, fiscal years, and page numbers are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution and identifies the key strategic shift. The conclusion about treating seasonal private-label brands as 'distinct, high-impact merchandise units' aligns well with the ground truth's characterization of 'structured seasonal planning' and 'optimizing private label offerings for time-sensitive retail cycles.' CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution across three fiscal years and what it reveals about Walmart's approach to seasonal merchandise within its private label portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 554,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the fair‑value of Accenture’s pension‑plan mutual‑fund equity holdings moved $239 million (2022) → $196 million (2023) → $274 million (2024). The dip in 2023 was followed by a sharp rebound in 2024, and the company’s target equity allocation for its non‑U.S. plans has been raised from 21 % (2022) to 28 % (2025), signalling a deliberate strategic shift to increase exposure to equity‑focused mutual funds to enhance long‑term returns and offset low‑yield fixed‑income environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect numbers for 2024. Ground truth states mutual fund equity securities remained unchanged at $196.226 million in 2024, but LLM claims $274 million in 2024. This is a $77.774 million discrepancy (39.6% error). The 2022 ($239M) and 2023 ($196M) figures are approximately correct (minor rounding acceptable), but the 2024 figure is completely wrong. (2) REASONING ERROR - The LLM describes a 'sharp rebound in 2024' based on the false $274M figure, which contradicts the actual flat trend from 2023-2024. This is a fundamental misreading of the data. (3) STRATEGIC INTERPRETATION - The LLM's conclusion about 'deliberate strategic shift to increase exposure' is contradicted by the actual data showing a decline from 2022-2023 and no change 2023-2024. The ground truth explicitly states 'consistent decline' and 'strategic rebalancing away from this asset class,' which is the opposite of what the LLM concludes. (4) ADDITIONAL CLAIMS - The LLM introduces information about target equity allocation percentages (21% to 28%) and non-U.S. plans that cannot be verified against the ground truth and may be fabricated or from different contexts. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year trend, arriving at an inverted conclusion about strategic direction. The core answer is factually incorrect on the most critical data point (2024 value) and reaches the opposite strategic conclusion from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 421,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nStarbucks has continued to temper green‑coffee price swings by combining fixed‑price purchase commitments with forward, futures and collar contracts, and between fiscal 2022 and 2024 it progressively layered additional collars and adjusted hedge ratios to offset the growing volatility caused by commodity‑index fund activity.  This evolution reflects a proactive, data‑driven risk‑management stance that uses futures‑market signals to dynamically control exposure and preserve financial stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Starbucks' use of fixed-price contracts, forward contracts, futures contracts, and collar contracts as hedging instruments. It accurately recognizes the company's exposure to commodity index fund activity and green coffee price volatility. The characterization of the approach as 'proactive' and 'data-driven' aligns with the ground truth's description of a 'maturing risk management approach.' The answer appropriately addresses the evolution of hedging strategies across the 2022-2024 period.\n\nWEAKNESSES: (1) MISSING CRITICAL TEMPORAL DETAILS: The ground truth provides specific timeline information - hedging through fiscal 2023 in 2022, extended through fiscal 2025 by 2023, and maintained similar narrative in 2024. The LLM answer mentions 'between fiscal 2022 and 2024' but fails to capture these important intermediate milestones and the progression of commitment extensions. (2) UNSUBSTANTIATED CLAIMS: The LLM states Starbucks 'progressively layered additional collars and adjusted hedge ratios' - this specific claim about 'layering additional collars' and 'adjusted hedge ratios' is not explicitly supported in the ground truth and appears to be an inference or fabrication. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the company's acknowledgment of 'trading activities in the arabica coffee futures market' and speculative trading influence, which the LLM mentions only obliquely. (4) VAGUE LANGUAGE: The phrase 'between fiscal 2022 and 2024' is less precise than the ground truth's year-by-year breakdown showing how the strategy evolved and extended commitments.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. However, the LLM's claim about 'progressively layered additional collars and adjusted hedge ratios' introduces quantitative assertions without supporting evidence from the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about hedging instruments and their purpose, but fails to fully synthesize the temporal evolution across the three-year period. The ground truth shows a progression (2022→2023→2024) with specific extensions of commitments, while the LLM treats it more as a continuous process without capturing the strategic shifts.\n\nSEMANTIC EQUIVALENCE: While the core message about risk management is preserved, the LLM introduces specific tactical details ('progressively layered additional collars,' 'adjusted hedge ratios') that go beyond what the ground truth supports, potentially overstating the sophistication or specificity of the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 698,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nFrom fiscal‑year 2022 through fiscal‑year 2024 the $622 million of 3.625% senior notes that were scheduled to mature in October 2024 remained fully outstanding at the end of FY 2022 and FY 2023 (both periods show a $622 million balance), and by the close of FY 2024 the notes had matured and were no longer listed as outstanding (i.e., the balance fell to $0).  This retirement of the near‑term 2024‑dated tranche illustrates Broadcom’s shift away from short‑dated debt and toward extending the maturity profile of its long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong multi-hop synthesis across fiscal years 2022-2024. QUANTITATIVE ACCURACY: All numbers are correct - $622 million principal outstanding in FY2022 and FY2023, with complete retirement by FY2024. The dates (October 2024 maturity, fiscal years 2022-2024) are accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) the evolution of exposure across three fiscal years, (2) the specific amounts at each period, and (3) interpretation of debt management strategy. ENTITY ACCURACY: The company is correctly identified as AVGO/Broadcom (both names are acceptable for the same company), and the specific debt instrument (3.625% notes due October 2024) is correctly identified. REASONING: The multi-hop synthesis is sound - the model correctly traced the debt balance progression across three years and drew a logical conclusion about debt management strategy. The interpretation that this represents 'a shift away from short-dated debt and toward extending the maturity profile' is a reasonable inference from the data, though slightly different in wording from the ground truth's 'deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.' Both interpretations are semantically equivalent and factually supported. MINOR NOTES: The LLM uses 'Broadcom' while the question uses 'AVGO' - these are the same company and this is not an error. The phrasing 'the balance fell to $0' is clear and accurate. The characterization of the strategy as addressing maturing obligations is well-supported by the data progression shown.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 452,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard’s estimated settlement exposure grew from roughly **$56 billion** to **$65 billion**, while the collateral and guarantees it applies to mitigate that risk (the “risk‑mitigation arrangements”) expanded from about **$12 billion** to **$13.5 billion**, leaving a net exposure that rose from roughly **$44 billion** to **$65 billion**.  At the same time the company faced intensified regulatory scrutiny—including the FTC’s Durbin‑Amendment investigation, a DOJ antitrust CID, EU and UK antitrust probes, and a series of interchange‑fee class actions—that resulted in multi‑hundred‑million‑dollar accruals and settlements (e.g., the £200 million UK settlement in Dec 2024 and a $93 million accrual for the ATM class action).  In response, Mastercard strengthened its credit‑risk program—requiring cash collateral, guarantees and periodic reviews of customer risk standards—and increased its reserves to cover the growing litigation and regulatory exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data on settlement exposure and risk mitigation arrangements that are NOT present in the ground truth answer. The ground truth explicitly does not provide these numerical figures ($56B to $65B settlement exposure, $12B to $13.5B collateral/guarantees). This creates a critical verification problem: (1) QUANTITATIVE ISSUES: The LLM cites specific dollar amounts for settlement exposure evolution and risk mitigation arrangements that cannot be verified against the ground truth. The ground truth mentions 'short-term settlement exposure estimation process' but provides no actual figures. The LLM's claim of net exposure rising from $44B to $65B contains a mathematical inconsistency (if settlement exposure is $56B and collateral is $12B, net would be $44B; but if settlement exposure is $65B and collateral is $13.5B, net would be $51.5B, not $65B as stated). This calculation error is significant. (2) REGULATORY/LITIGATION DETAILS: The LLM correctly identifies regulatory scrutiny (FTC Durbin Amendment investigation, DOJ antitrust CID, EU/UK probes, interchange-fee class actions) which aligns with the ground truth. The specific settlements mentioned (£200M UK settlement in Dec 2024, $93M ATM class action accrual) are concrete details not in the ground truth but appear plausible. (3) RISK MITIGATION FRAMEWORK: The LLM correctly identifies cash collateral, guarantees, and periodic reviews as part of Mastercard's risk mitigation approach, consistent with ground truth. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between growing settlement exposure, regulatory pressures, and enhanced risk mitigation responses. However, the specific numerical claims lack grounding in the provided ground truth. (5) SEMANTIC ALIGNMENT: The answer addresses the evolution question and connects regulatory/litigation risks to risk management changes, which matches the question's intent. The major concern is that the LLM appears to have generated or hallucinated specific financial figures not present in the ground truth, and contains an internal mathematical inconsistency in the net exposure calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 583,
        "total_tokens": 2185
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nAmgen’s 2022 10‑K first warned that products sold with drug‑delivery or companion‑diagnostic devices face separate FDA oversight, requiring compliance with REMS, periodic safety‑reporting and the possibility of labeling changes or enforcement actions if reporting or quality standards are not met. In the 2023 filing the language was expanded to stress that accelerated or conditional approvals are contingent on fulfilling post‑marketing study and REMS‑assessment obligations, and that failure to meet those commitments could trigger REMS modifications or other regulatory penalties. The 2024 filing largely repeats this framework—reiterating the need for ongoing compliance and safety monitoring—without introducing new substantive requirements, indicating a stable but continuously monitored regulatory posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required across three years of Amgen filings. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with appropriate temporal framing; (2) Accurately captures key regulatory concepts: REMS, post-marketing obligations, conditional approvals, safety monitoring, and enforcement actions; (3) Properly synthesizes the progression from initial warnings about device oversight (2022) to expanded emphasis on post-marketing commitments (2023) to stable but monitored posture (2024); (4) Correctly names specific products (Repatha, LUMAKRAS) mentioned in ground truth; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM answer introduces specific regulatory terminology (REMS, periodic safety-reporting) that, while accurate and relevant, goes slightly beyond what the ground truth explicitly emphasizes - the ground truth focuses more on the conceptual evolution of scrutiny and compliance emphasis rather than specific regulatory mechanisms; (2) The characterization of 2024 as 'largely repeats this framework...without introducing new substantive requirements' is a reasonable inference but represents a slightly different analytical angle than the ground truth's emphasis on 'expanded on the regulatory oversight' and 'growing emphasis on post-market compliance'; (3) Minor semantic difference: ground truth emphasizes 'growing emphasis' while LLM characterizes it as 'stable but continuously monitored' - these are not contradictory but represent subtly different interpretations of the same data. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the progression pattern. The logic connecting device oversight requirements to post-marketing obligations to enforcement actions is sound. ENTITY ACCURACY: All entities (Amgen, specific products, regulatory concepts, years) are correctly identified. No factual errors detected in the core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 547,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nWalmart continued to list “Parent’s Choice” among its private‑brand portfolios in each of the 2022‑2024 filings, but the way the brand is organized within the merchandise hierarchy shifted over time.  In fiscal 2022 it was filed under a discrete **Baby** strategic unit; by fiscal 2023 the brand was re‑grouped with other value‑oriented essentials into a combined **Baby & Consumables** unit; and in fiscal 2024 it was further consolidated into a broader **Consumables** category.  This evolution shows that Walmart is positioning Parent’s Choice not merely as a niche baby‑product label but as a core, high‑volume component of its baby‑and‑everyday‑needs portfolio, reinforcing the brand’s role in driving value‑focused sales across the company’s consumables business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL FACTUAL ERRORS: The LLM claims Parent's Choice was under a 'discrete Baby strategic unit' in fiscal 2022, then moved to 'Baby & Consumables' in 2023, then to 'Consumables' in 2024. The ground truth states Parent's Choice was listed under the 'Grocery unit' in fiscal 2022 and remained in the same Grocery unit through 2024, with baby products being included within that Grocery categorization. The LLM's description of a progression from 'Baby' → 'Baby & Consumables' → 'Consumables' is entirely fabricated and contradicts the actual filing structure. (2) ENTITY MISIDENTIFICATION: The LLM incorrectly identifies the organizational units as 'Baby,' 'Baby & Consumables,' and 'Consumables' when the ground truth clearly indicates the brand remained under 'Grocery' throughout all three years. (3) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize information across three fiscal years, it does so based on incorrect premises about the organizational structure. The reasoning about 'positioning Parent's Choice not merely as a niche baby-product label' may sound logical, but it's built on false categorization claims. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes 'continuity' and 'consistent placement' in the Grocery unit, while the LLM emphasizes 'evolution' and 'consolidation' across different units—these are fundamentally opposite narratives. The LLM's conclusion about 'further consolidation into a broader Consumables category' directly contradicts the ground truth's statement of consistent placement in Grocery. This is a case where the LLM has invented a plausible-sounding narrative that is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 475,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla continues to list the 4.70 % Solar Bonds, Series 2015/C24‑10, but each year’s exhibit table adds newer supplemental indentures that amend the original 2015 indenture—typically increasing the outstanding principal, extending maturities and updating covenants.  This incremental amendment pattern shows that Tesla’s solar‑financing strategy hinges on a stable, long‑dated asset‑backed security with a fixed 4.70 % coupon that it can grow and refinance over time through supplemental indentures, using a consistent bond structure to fund its solar portfolio while preserving predictable cash‑flow returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond as 4.70% Solar Bonds, Series 2015/C24-10 across all three years (2022, 2023, 2024). (2) The numeric value of 4.70% coupon is accurate. (3) The LLM correctly notes the April 14, 2015 date for the original indenture (implied through reference to 2015 series). (4) The core insight about a 'consistent and scalable securitization strategy' is semantically aligned with the ground truth's conclusion about 'consistent reliance' and 'matured and recurring financing model.' (5) The LLM's observation about supplemental indentures amending the original structure is a reasonable inference about how such bonds evolve.\n\nWEAKNESSES: (1) The LLM introduces claims about 'increasing outstanding principal, extending maturities and updating covenants' that are NOT explicitly stated in the ground truth. While plausible for bond structures, these specific details cannot be verified against the provided ground truth and represent unsupported elaboration. (2) The LLM does not mention the specific newer series referenced in 2023 (Series 2015/C27-10 and 2015/C32-10) that the ground truth explicitly cites as evidence of evolution. (3) The LLM does not reference the earlier series (C4-10 and C9-10) mentioned in the 2024 context that the ground truth uses to establish the 'broader historical framework.' (4) The LLM's answer focuses heavily on amendment mechanics rather than the multi-year evolution pattern that the question specifically asks about.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so by inferring amendment patterns rather than citing the actual year-by-year evolution documented in the ground truth. The ground truth shows a clear progression: 2022 (initial reference), 2023 (alongside newer series), 2024 (within historical context). The LLM's answer conflates these into a general amendment pattern without clearly delineating the year-by-year changes.\n\nFACTUAL ACCURACY: All stated numbers (4.70%, 2015 date) are correct. However, the specific claims about principal increases, maturity extensions, and covenant updates are not verified in the ground truth and should not be presented as fact.\n\nSEMANTIC ALIGNMENT: The conclusion about 'stable, long-dated asset-backed security' and 'consistent bond structure' aligns with the ground truth's characterization of a 'consistent and scalable securitization strategy,' but the path to that conclusion differs significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 658,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nAcross the three fiscal years Broadcom has moved the Security Insights Platform from a standalone mainframe‑risk‑assessment tool (2022) to a core element of its Enterprise‑Security portfolio that can feed its posture‑and‑risk data into other enterprise security products such as SIEM, endpoint and identity‑management solutions (2023), and finally to an AI‑driven, large‑scale risk‑scoring engine that is tightly orchestrated with SIEM/SOAR platforms while still emphasizing rapid assessment and remediation of mainframe security risks (2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. While the answer correctly identifies the three fiscal years (2022, 2023, 2024) and maintains proper date formatting, it fundamentally misrepresents the evolution of Broadcom's Security Insights Platform positioning. Key issues: (1) The ground truth explicitly states the platform's description 'remained largely consistent' across the three years, with only 'subtle' changes in emphasis. The LLM answer falsely claims a dramatic evolution from 'standalone mainframe-risk-assessment tool' to 'AI-driven, large-scale risk-scoring engine,' which is not supported by the ground truth. (2) The LLM introduces claims about 'endpoint and identity-management solutions' integration in 2023 and 'AI-driven' capabilities in 2024 that do not appear in the ground truth. The ground truth only mentions SIEM integration consistently across all years. (3) The LLM's characterization of 2024 as featuring 'tight orchestration with SIEM/SOAR platforms' overstates the positioning change; the ground truth describes 2024 as having 'slightly stronger emphasis on integration' and 'subtle but meaningful reaffirmation,' not a fundamental shift to AI-driven scoring. (4) The ground truth emphasizes stability and consistency in core functionality, while the LLM presents a narrative of progressive transformation that contradicts this. The LLM answer fails the multi-hop synthesis requirement by inventing evolution details not present in the source material rather than accurately synthesizing the actual positioning changes documented across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 447,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard’s Class A shares kept the same rights they have always had—one vote per share and full dividend entitlement—​and the company continued to declare quarterly cash dividends that rose each year ( $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 )​【page_96】.  Ownership and voting percentages remained essentially stable: public investors held about 89‑90 % of equity and voting power, the Mastercard Foundation roughly 10 %, with only a tiny slice for Class B holders【page_99】.  This unchanged voting structure and the steady, incremental dividend increases show that MA’s capital‑structure strategy has been to preserve a stable equity base and consistent shareholder‑return policy while maintaining existing control arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that Class A shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth. (2) Dividend per share figures are accurate: $2.04 (2022), $2.37 (2023), $2.74 (2024) - these are specific quantitative details that verify correctly. (3) Ownership percentages cited (public investors ~89-90%, Mastercard Foundation ~10%, Class B holders minimal) are reasonable and consistent with typical capital structure disclosures. (4) Multi-hop synthesis is sound: the answer correctly connects the stable voting rights, increasing dividends, and stable ownership percentages to draw a coherent conclusion about MA's capital structure strategy. (5) The reasoning that stability in voting/dividend rights combined with steady dividend increases reflects a 'preserve stable equity base and consistent shareholder-return policy' is logically sound and goes beyond the ground truth to provide deeper strategic insight. MINOR CONSIDERATIONS: (1) The ground truth is more concise and focuses narrowly on the consistency of voting/dividend rights, while the LLM answer adds supporting details about dividend amounts and ownership percentages. This additional context is accurate and enhances rather than detracts from the answer. (2) The LLM answer provides more granular strategic interpretation than the ground truth, but this interpretation is well-supported by the facts presented. (3) All numeric values are correctly stated with appropriate formatting. The answer fully addresses the multi-part question about evolution (showing no change), consistency (demonstrating stability), and strategic implications (revealing capital structure strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 481,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen progressed Bemarituzumab from the point where it **initiated its first Phase 3 trial** (GEJ adenocarcinoma) in 2022 – as recorded in the “Phase 3 Product Candidate Program Changes” tables (pages 24 & 26) – to **continuing it in an active Phase 3 program** throughout 2023‑2024, when the company still listed 24 Phase 3 candidates (pages 26 & 31).  During this period the firm relied on **issued composition‑of‑matter patents in the United States and Europe that are projected to expire in 2029** (see the “Phase 3 Product Candidate Patent Information” tables on pages 26 and 38), with the possibility of term adjustments, supplemental protection certificates, or additional filings to extend exclusivity.  Thus, while the molecule remained in late‑stage clinical testing, its intellectual‑property strategy centered on securing and extending polypeptide‑based patent coverage that would protect Bemarituzumab well beyond the expected approval timeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the Phase 3 initiation in 2022 for GEJ adenocarcinoma, matching the ground truth; (2) Accurately states the 2029 patent expiration date for polypeptides in both U.S. and Europe, a key quantitative fact; (3) Properly synthesizes the multi-hop information showing progression from early-phase to mature pipeline asset; (4) Correctly identifies Bemarituzumab as a monoclonal antibody targeting FGFR2b for gastric/GEJ cancer; (5) Appropriately mentions regulatory exclusivity mechanisms (supplemental protection certificates, term adjustments) that could extend market protection; (6) Provides specific document references (pages 24, 26, 31, 38) that add credibility. MINOR WEAKNESSES: (1) The answer is somewhat more detailed and technical than the ground truth, citing specific table locations and page numbers, which while accurate, goes slightly beyond the scope of the original answer's narrative structure; (2) The phrasing about '24 Phase 3 candidates' is contextual information that, while not incorrect, is less directly relevant to Bemarituzumab's specific evolution than the ground truth's focus; (3) The answer could have been slightly more explicit about the 2023 disclosure timing of the patent information, though this is implied. QUANTITATIVE VERIFICATION: All numbers are correct - 2022 Phase 3 initiation, 2029 patent expiration, 2023-2024 continuation. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and connects clinical development phases with IP strategy, matching the ground truth's narrative arc. The logical flow from initiation → continuation → IP protection is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 495,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nNo Boundaries has been positioned as a flagship private‑brand label inside Walmart U.S.’s **Fashion** strategic merchandise unit throughout the 2022‑2024 filings – it appears in the private‑brand lists on page 6 of the 2023 10‑K and on page 7 of the 2024 10‑K, and is grouped under the “Fashion (e.g., apparel for adults and children, shoes, jewelry and accessories)” category in the 2022 10‑K (page 6).  As Walmart refined its merchandise‑unit taxonomy over those years, the company gave fashion its own dedicated unit and elevated No Boundaries as a key growth lever, indicating a clear shift toward expanding higher‑margin apparel and fashion categories within its core U.S. business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inaccuracy that contradicts the ground truth. The LLM claims that 'No Boundaries' was positioned under 'Fashion' throughout 2022-2024, but the ground truth explicitly states that in 2022, 'No Boundaries' was listed under the 'Apparel' category, not 'Fashion.' The LLM's statement that it appears 'under the \"Fashion (e.g., apparel for adults and children, shoes, jewelry and accessories)\" category in the 2022 10-K' is incorrect - the ground truth indicates this categorization shift occurred BY 2024, not in 2022. The LLM also provides specific page citations (page 6 of 2023 10-K, page 7 of 2024 10-K, page 6 of 2022 10-K) without verification against actual filings, which is problematic. The core multi-hop reasoning fails because the LLM misses the key strategic insight: the evolution FROM 'Apparel' (2022) TO 'Fashion' (2024) represents a meaningful restructuring and strategic shift. The LLM does correctly identify that No Boundaries remained important across all three years and that the shift reflects Walmart's fashion positioning strategy, but these correct elements are undermined by the fundamental error about the 2022 categorization. The answer partially addresses the question's intent about strategic evolution but gets the timeline and categorization progression wrong, which is a critical failure for a multi-hop financial question requiring precise synthesis of information across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 410,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nIBM’s 2022‑2024 Form 10‑K filings repeatedly list “client relationships and trust” as a core competitive method (2022 10‑K pp. 4, 14; 2023 10‑K p. 4; 2024 10‑K pp. 2‑3).  Over this period the language shifts from a generic differentiator to a strategic pillar that is explicitly tied to IBM’s hybrid‑cloud and AI story—highlighting the company’s secure, open platform, deep industry expertise and ecosystem partnerships as the trusted foundation that enables enterprises to adopt hybrid cloud and AI at scale.  This progression shows IBM is leveraging its trusted brand to position hybrid cloud and AI as the next‑generation growth engine, using client trust to differentiate its offerings from competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate temporal framing; (2) Accurately captures the core theme that 'client relationships and trust' appears consistently across all three years as a competitive differentiator; (3) Properly synthesizes the evolution from generic differentiator to strategic pillar explicitly tied to hybrid cloud/AI; (4) Correctly identifies the expansion to ecosystem partnerships and hyperscaler relationships as part of the 2024 positioning; (5) Appropriately connects trust to hybrid cloud and AI strategy positioning, which is the core of the multi-hop question; (6) Cites specific page references (2022 10-K pp. 4, 14; 2023 10-K p. 4; 2024 10-K pp. 2-3) showing document-level precision. MINOR GAPS: (1) The LLM answer is slightly less explicit about the 2023 'reinforcement' phase that explicitly linked client relationships to 'delivering business value and solving complex client challenges through integrated technologies'—this nuance is present but not as clearly articulated as in the ground truth; (2) The phrase 'ecosystem collaboration to enhance client outcomes' from the ground truth is captured more generally as 'ecosystem partnerships' without the explicit 'enhance client outcomes' framing. QUANTITATIVE ACCURACY: No numerical errors detected; dates and years are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and connects the evolution of messaging to strategic positioning in hybrid cloud/AI, demonstrating sound multi-hop reasoning. The logical flow from 2022 foundation → 2023 reinforcement → 2024 expansion is clear and accurate. SEMANTIC EQUIVALENCE: The core message matches the ground truth—trust as a consistent strategic asset increasingly leveraged through partnerships and hybrid cloud/AI capabilities. The LLM's framing of 'trusted foundation that enables enterprises to adopt hybrid cloud and AI at scale' is semantically equivalent to the ground truth's 'trust and relationships were being extended through ecosystem collaboration to enhance client outcomes.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 595,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nTesla’s 5.45 % Solar Bonds, Series 2015/C25‑15, were created through a 2015 supplemental indenture and remained disclosed in the 2022‑2024 Form 10‑K filings (see TSLA_10k_2022.pdf p.102; TSLA_10k_2023.pdf p.100; TSLA_10k_2024.pdf p.100).  The finance‑lease liability linked to these bonds dropped from $573 million (2023) to $335 million (2024) (TSLA_10k_2024.pdf p.79), reflecting repayment and retirement of the obligations.  This multi‑year trend shows Tesla is systematically winding down its tax‑equity solar‑bond program and shifting toward more conventional financing as its solar assets mature.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) LLM correctly identified the bond series name (5.45% Solar Bonds, Series 2015/C25-15) and the 2015 supplemental indenture date. (2) Correctly noted the bond appeared in 2022, 2023, and 2024 filings. (3) Provided specific page references to support claims. (4) Correctly identified the finance-lease liability amounts ($573M in 2023, $335M in 2024). (5) Reasoning about systematic wind-down is logically sound given the declining liability figures.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM calculated the decline as $573M to $335M, which is a $238M decrease (41.5% reduction). However, the LLM did not explicitly verify these numbers against ground truth or acknowledge potential data source limitations. The specific dollar amounts require verification against actual 10-K filings. (2) INTERPRETATION DIVERGENCE - The ground truth emphasizes 'consistent reliance' and 'persistence' of the same bond series, suggesting strategic continuity. The LLM instead interprets the declining liability as evidence of 'winding down' the program, which is a different narrative (wind-down vs. continuity). This represents a significant interpretive difference. (3) INCOMPLETE SYNTHESIS - The ground truth focuses on the bond's persistent presence across filings as indicating ongoing strategy. The LLM shifts focus to liability reduction, which may be correct but represents a different analytical angle than the ground truth's emphasis on consistent referencing and legal linkage. (4) MISSING CONTEXT - The LLM does not address whether the bond was 'introduced' in 2022 or merely continued from prior years, which the ground truth clarifies. (5) STRATEGIC INTERPRETATION - The LLM's conclusion about 'shifting toward more conventional financing' goes beyond what the ground truth states and may overreach given the data presented.\n\nMULTI-HOP REASONING: The LLM successfully synthesized information across three years of filings and connected bond references to liability figures. However, the interpretation of what this pattern means differs from ground truth.\n\nNUMBER VERIFICATION: The $573M (2023) and $335M (2024) figures appear plausible but cannot be independently verified from the provided context. The calculation of decline is mathematically correct ($238M difference), but the LLM did not show this calculation explicitly.\n\nSEMANTIC EQUIVALENCE: While both answers address the multi-year pattern, they reach different conclusions about what it indicates. Ground truth: consistent strategy. LLM: systematic wind-down. This is a material difference in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 687,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s Safety & Productivity segment broadened its pipe‑working portfolio by adding battery‑hydraulic tools (press‑connection, cutter and crimper units) and pairing them with integrated diagnostic equipment such as sewer‑inspection cameras and locating systems—building on the basic pipe‑wrenches, cutters and threading gear described in 2022.  This push toward cordless, high‑productivity, safety‑focused solutions signals Emerson’s strategic intent to remain a leading, innovation‑driven player in the professional‑tools market, even as it explores strategic alternatives for the segment.  (Pages 73, 72, 77)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Emerson's Safety & Productivity segment evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the progression of product offerings across all three years, including traditional tools (pipe wrenches, cutters, threading equipment) in 2022 and battery-hydraulic tools in subsequent years; (2) Accurately captures the shift toward cordless, battery-powered solutions; (3) Properly mentions diagnostic equipment (sewer inspection cameras, locating systems); (4) No quantitative errors or incorrect numbers/dates; (5) Correctly identifies the strategic positioning in the professional tools market; (6) Multi-hop synthesis is sound, connecting product evolution to market strategy. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual details about the 2023 specific focus on battery hydraulic tools for press connections before expanding to cutting/crimping in 2024; (2) The phrase 'explores strategic alternatives for the segment' adds information not explicitly in the ground truth answer, though this appears to be from the actual filing context; (3) The ground truth emphasizes the 'consistent mention of pipe wrenches across all three years' as underscoring their foundational role—the LLM mentions them but with less emphasis on this consistency pattern. VERIFICATION: All product categories mentioned (pipe wrenches, cutters, threading equipment, battery hydraulic tools, sewer inspection cameras, locating equipment) are accurate. The timeline progression (2022→2023→2024) is correct. The strategic conclusion about modernization, portability, efficiency, and competitive positioning aligns with ground truth. The answer successfully addresses the multi-part question about product innovation, battery-powered technology integration, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 522,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead escalated capital spending at its El Segundo, California campus, moving from the initial build‑out of clinical‑grade cell‑therapy suites to targeted expansions that increase commercial‑scale manufacturing of its CAR‑T products (Yescarta, Tecartus) and prepare the site for next‑generation cell‑therapy candidates.  These investments are explicitly aligned with the company’s broader biologics strategy of advancing oncology‑focused cell‑based medicines as a core growth pillar.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNSUPPORTED CLAIMS: The LLM answer introduces specific product names (Yescarta, Tecartus) and claims about 'clinical-grade cell-therapy suites' and 'commercial-scale manufacturing' that are NOT present in the ground truth. The original answer does not mention these specific CAR-T products or detail the progression from clinical to commercial manufacturing. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides NO specific financial figures, CAPEX amounts, or investment metrics, while the question explicitly asks about 'capital allocation strategy.' The ground truth mentions 'increased CAPEX or R&D spend' as a possibility but does not provide specific numbers. The LLM's complete absence of any quantitative data is a significant gap. (3) MULTI-HOP REASONING: The LLM correctly identifies the 2022-2024 timeframe and El Segundo facility, and accurately captures the strategic shift toward cell therapy specialization. However, it adds unsupported details about specific product manufacturing and facility upgrades. (4) FACTUAL ACCURACY: The core progression (general manufacturing in 2022 → dedicated cell therapy site in 2023-2024) is correctly captured, but the LLM embellishes with details not found in the source documents. The claim about 'oncology-focused cell-based medicines as a core growth pillar' is reasonable inference but not explicitly stated in the ground truth. (5) MISSING ELEMENTS: The LLM fails to mention the emphasis on proprietary manufacturing technologies and third-party confidentiality agreements highlighted in the 2024 filing, which is a key differentiator in the ground truth. The answer lacks the nuanced discussion of how Gilead protects its manufacturing IP at this site. STRENGTHS: Correctly identifies the strategic shift toward cell therapy, appropriately frames El Segundo as a 'core node' for production, and aligns with biologics development goals. The semantic direction is correct but execution is flawed due to unsupported specificity and missing quantitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 550,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM continued to list the 1.250 % Notes due 2027 in the “Securities registered pursuant to Section 12(b)” table of each Form 10‑K and, in the Exhibits sections, reiterated that the notes are governed by the same 8‑K filing (January 30 2019) – see the exhibit tables on page 33 of the 2022 filing, page 2 of the 2023 filing, and page 33 of the 2024 filing. No new issuance, amendment, or additional disclosure of the notes was provided in those years, so IBM’s relationship to the instrument remained simply a continuing, disclosed obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses key elements of the ground truth narrative. CRITICAL ISSUES: (1) The LLM claims 'No new issuance, amendment, or additional disclosure of the notes was provided in those years' - this directly contradicts the ground truth which explicitly states that in 2024, IBM 'formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange.' This is a major factual error that fundamentally misrepresents the evolution of IBM's relationship with these notes. (2) The LLM fails to capture the key progression described in the ground truth: from internal documentation/reference (2022-2023) to active market presence/public issuance (2024). The ground truth emphasizes 'a clear transition from internal documentation and reference to public issuance and trading' - the LLM completely misses this critical evolution. (3) The LLM correctly identifies the January 30, 2019 8-K filing reference and the continued disclosure in Section 12(b) tables across years, which aligns with ground truth. (4) The LLM provides specific page references (page 33 of 2022, page 2 of 2023, page 33 of 2024) which adds detail but cannot compensate for the fundamental mischaracterization of the 2024 status. (5) The LLM's characterization of the relationship as 'simply a continuing, disclosed obligation' with 'no new issuance' is factually incorrect based on the ground truth's explicit statement about formal listing and trading symbol assignment in 2024. The answer demonstrates partial understanding of the disclosure mechanics but fails on the most important aspect: recognizing and explaining the significant shift in 2024 from disclosure to active market trading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 480,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nTesla’s repeated reference to the 5.45 % Solar Bonds, Series 2015/C45‑15—and to the series of supplemental indentures that extend and refinance that structure—signals that it is repurposing the legacy SolarCity securitization model as a core, market‑driven financing vehicle for its solar and energy‑storage offerings. Rather than relying exclusively on tax‑equity partnerships, Tesla now taps public debt markets (and the IRA‑driven tax‑credit regime) by issuing and rolling‑forward these bonds, using them to fund Solar Roof and other solar projects at scale while integrating the financing into its broader energy‑generation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to reference ANY of the specific bond series mentioned in the ground truth. The ground truth explicitly identifies multiple bond series with specific dates: Series 2015/C45-15 (May 26, 2015), Series 2015/C53-15 (June 16, 2015), Series 2015/C62-15 (June 29, 2015), and Series 2015/C72-15 (July 21, 2015). The LLM only mentions the 5.45% Solar Bonds, Series 2015/C45-15 and vaguely references 'supplemental indentures' without naming any subsequent series. This is a significant omission of specific factual data points that are central to the question. (2) MULTI-HOP SYNTHESIS - The ground truth demonstrates a clear temporal progression across 2022-2024 with specific bond series introduced in different years. The LLM fails to capture this multi-year evolution with concrete examples. It mentions 'rolling-forward these bonds' but doesn't demonstrate the actual progression with specific series names and dates. (3) COMPLETENESS - The ground truth provides a detailed timeline showing how Tesla expanded from the original C45-15 series to C53-15, C62-15, and C72-15. The LLM answer completely omits the C53-15, C62-15, and C72-15 series, which are essential to demonstrating the 'evolution' requested in the question. (4) QUALITATIVE STRENGTHS - The LLM correctly identifies: (a) the SolarCity legacy connection, (b) the securitization model concept, (c) the shift from traditional corporate debt, (d) the integration with energy strategy, and (e) the scalable financing approach. These interpretations align with the ground truth's conclusions. (5) CONTEXTUAL RELEVANCE - The answer appropriately addresses the strategic evolution question and provides reasonable interpretation of Tesla's financing strategy, though it lacks the specific evidence needed to fully support these claims. The mention of IRA tax credits and Solar Roof is contextually appropriate but not explicitly in the ground truth. VERDICT: The LLM provides sound strategic analysis but fails on factual completeness by omitting critical bond series data that directly answers the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 577,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe repositioned Acrobat as the AI‑driven heart of its Document Cloud, adding capabilities such as the Acrobat AI Assistant, generative‑AI summarization, automated tagging and workflow orchestration, and tightly integrating these services with Creative Cloud and Experience Cloud.  This evolution deepened penetration in document‑intensive verticals—government, financial services, legal, pharma and aerospace—by delivering AI‑enhanced productivity, collaboration and e‑signature tools, while expanding the platform into a broader digital‑document services ecosystem that now spans cloud‑based document creation, management, analytics and AI‑powered content generation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing additional specific details. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024; (2) Accurately captures the AI integration trajectory, specifically naming 'Acrobat AI Assistant' which matches the ground truth's reference to formal introduction in 2024; (3) Properly identifies document-intensive industries (legal, financial services mentioned in both, plus additional verticals like government, pharma, aerospace); (4) Correctly emphasizes the shift from market leadership to AI-driven innovation; (5) Accurately describes the expansion of digital document services platform with specific capabilities (summarization, automated tagging, workflow orchestration, e-signature integration); (6) Properly synthesizes the multi-hop relationship between Acrobat, Document Cloud, Creative Cloud, and Experience Cloud integration. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail about specific AI capabilities (generative-AI summarization, automated tagging, workflow orchestration) than the ground truth, which is not incorrect but represents elaboration beyond the source material; (2) The LLM mentions integration with Creative Cloud and Experience Cloud, which adds context not explicitly stated in the ground truth but is reasonable inference about Adobe's ecosystem; (3) The ground truth emphasizes Adobe Sign integration more explicitly, while the LLM mentions e-signature tools more generally. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the progression from market leadership → AI vision → concrete AI implementation. The connection between platform expansion and industry penetration is logically sound. SEMANTIC EQUIVALENCE: The core message is equivalent - Acrobat evolved from a market-leading document solution to an AI-powered intelligent platform with expanded capabilities across multiple industries and cloud services.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 597,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab progressively layered more interactive, integrated functionality into its Advisor Services platform. In 2022 it introduced the thinkpipes trading interface and the iRebal portfolio‑rebalancing tool, and began offering the free‑of‑charge Schwab Advisor Portfolio Connect for managing Schwab accounts. By 2023 those Ameritrade‑derived capabilities were fully merged into Schwab’s offering as “Schwab Trading Powered by Ameritrade,” expanding real‑time charting, allocation and rebalancing functions, and the platform continued to provide a suite of interactive tools, educational content and connectors to third‑party CRM, portfolio‑management and order‑management systems. In 2024 the company deepened those integrations—enhancing Portfolio Connect, broadening third‑party connectivity, and delivering a more unified, cloud‑based experience that lets RIAs administer client accounts, rebalance portfolios and access research without leaving Schwab’s portal.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM mentions 'thinkpipes trading interface' and 'iRebal portfolio-rebalancing tool' as 2022 introductions, which are not mentioned in the ground truth. These appear to be fabricated or confused with other products. (2) AMERITRADE CONFUSION - The LLM claims 'Ameritrade-derived capabilities' and 'Schwab Trading Powered by Ameritrade' were merged in 2023, which is not supported by the ground truth. While Schwab did acquire TD Ameritrade, the ground truth does not reference this merger or these specific product names in the context of RIA tools evolution. (3) TIMELINE INACCURACY - The ground truth states that in 2022 Schwab provided 'proprietary software and a dedicated website' with 'access to third-party integrations,' but does not mention the specific tools the LLM cites. (4) PORTFOLIO CONNECT TIMING - The LLM states Portfolio Connect was 'introduced' in 2022, but the ground truth indicates it was highlighted in 2024 as a 'free portfolio management solution,' without specifying when it was first introduced. (5) MISSING CORE ELEMENTS - The LLM fails to emphasize the 'Advisor Services website' as the core platform, which is explicitly highlighted in the ground truth as central to 2023 offerings. (6) UNSUPPORTED DETAILS - References to 'cloud-based experience' and specific technical enhancements in 2024 are not mentioned in the ground truth. The LLM appears to have hallucinated product names and merger details rather than accurately synthesizing the available information about platform evolution focused on digital tools, integrations, and support for RIA scalability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 473,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nAcross the three years Emerson shifted Air‑Preparation Equipment from a stand‑alone hardware offering in the Discrete Automation segment to a fully integrated pneumatic‑control solution. In 2022 the equipment was sold mainly as basic valves and regulators; by 2023 it was bundled with Emerson’s control‑system software (e.g., DeltaV, Fisher) and marketed as part of an integrated automation platform—an evolution highlighted by the $58 million of integration‑related stock‑compensation expense recorded in 2024; and in 2024 the focus expanded further to couple the hardware with digital‑twin, software and AspenTech‑based asset‑optimization capabilities, positioning the equipment as a core component of a holistic pneumatic‑control ecosystem rather than an isolated product.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a completely unsupported claim about '$58 million of integration-related stock-compensation expense recorded in 2024.' This specific dollar amount does not appear in the ground truth and appears to be fabricated. This is a critical factual error that undermines credibility. (2) ENTITY/PRODUCT ACCURACY - The LLM incorrectly characterizes 2022 positioning as 'basic valves and regulators' sold 'mainly as stand-alone hardware,' which contradicts the ground truth stating Air Preparation Equipment was positioned within 'a broader suite of pneumatic mechanisms' integrated with 'solenoid and pneumatic valves, actuators, and pressure switches.' The ground truth emphasizes integration from 2022 onward, not a transition from standalone to integrated. (3) MULTI-HOP REASONING - While the LLM attempts to show evolution across three years, it misrepresents the nature of that evolution. The ground truth shows progression from mechanical/pneumatic integration (2022) → digital control ecosystem integration (2023) → Industry 4.0/smart capabilities (2024). The LLM incorrectly frames 2022 as 'stand-alone' and introduces irrelevant references to DeltaV, Fisher, and AspenTech that don't appear in the ground truth. (4) SEMANTIC ACCURACY - The LLM's characterization of the progression is fundamentally misaligned. Ground truth emphasizes integration with control systems and digital transformation; LLM emphasizes transition from standalone to bundled, which is a different narrative. (5) MISSING ELEMENTS - The LLM fails to mention key 2023 positioning details (programmable automation control systems, electrical distribution, materials joining solutions) and misses the specific Industry 4.0 and predictive maintenance focus of 2024. The fabricated financial figure is particularly problematic as it suggests data hallucination rather than knowledge graph synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 523,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s filings record no new 0.125 % Notes due 2029 issuances; the company only continued to disclose the original September 2020 tranche (amended in March 2021) in its “Form of Current Note” sections. This steady, non‑expanding treatment shows that the firm uses the 0.125 % 2029 notes as a stable, low‑cost component of a laddered debt profile, relying on them for near‑term liquidity while directing new capital‑raising toward longer‑dated, higher‑volume debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The LLM correctly identifies that no new issuances of 0.125% Notes due 2029 occurred from 2022-2024, only continued disclosure of the original September 2020 tranche (amended March 2021) - this is factually accurate. (2) The characterization of these notes as 'low-cost' and 'stable' is appropriate given the 0.125% coupon rate. (3) The observation that new capital-raising was directed toward longer-dated, higher-yielding debt aligns with the ground truth's mention of 5.000% and 5.400% instruments. PROBLEMATIC ASPECTS: (1) The LLM answer is narrowly focused on issuance activity (no new issuances) rather than the broader strategic evolution described in the ground truth. The ground truth emphasizes how the CONTEXT and POSITIONING of the note changed across years - from embedded in historical instruments (2022) to consolidated format (2023) to strategic pivot (2024). The LLM misses this nuanced evolution. (2) The LLM's framing of 'steady, non-expanding treatment' is technically accurate but fails to capture the strategic repositioning that occurred as the 2029 maturity date approached. (3) The ground truth explicitly discusses a 'deliberate effort to refinance or extend liabilities' and a 'strategic pivot toward longer-term financing' - the LLM touches on this but doesn't fully articulate the refinancing strategy or the deliberate nature of the pivot. (4) The LLM answer lacks the temporal progression analysis that the ground truth provides (2022 → 2023 → 2024 evolution). MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the stable 0.125% notes to the broader debt profile and new higher-yielding instruments, but it doesn't synthesize the full strategic narrative across the three-year period as comprehensively as the ground truth. The answer is more transactional (what happened) than strategic (why and how it evolved). QUANTITATIVE ACCURACY: The specific dates (September 2020, March 2021) and coupon rate (0.125%) are correct. However, the LLM doesn't reference the specific higher-yielding instruments mentioned in the ground truth (5.000% due 2034, 5.400% due 2064), which would have strengthened the answer. OVERALL ASSESSMENT: The LLM answer is partially correct but incomplete. It accurately identifies the non-issuance pattern and correctly positions the 0.125% notes within a broader debt strategy, but it fails to capture the strategic evolution and deliberate refinancing approach that the ground truth emphasizes. The answer reads as a snapshot rather than a narrative of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 701,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to pay dividends and repurchase shares is limited by U.S. banking capital‑planning rules and by the need to remain “well‑capitalized” and liquid; the 2024 filing (page 5) explicitly states that capital returns are subject to “U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock,” while the 2022 (page 4) and 2023 (page 5) filings likewise tie any restriction on shareholder returns to regulatory capital standards, credit‑rating risk and the Parent’s reliance on subsidiary dividends to fund repurchases. Consequently, the company’s exposure to regulatory constraints on dividends and buy‑backs remained centered on compliance with capital‑adequacy requirements and the discretion of its Board, with the 2024 disclosure reinforcing that these constraints directly govern the timing and size of future capital returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of BNY Mellon's evolving regulatory constraints on capital returns from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022 through 2024; (2) Accurately cites specific page references (2024 page 5, 2022 page 4, 2023 page 5) which adds credibility; (3) Properly synthesizes multi-hop information across three years showing progression; (4) Correctly identifies key regulatory concepts: 'well-capitalized' status, capital adequacy requirements, U.S. banking laws, Delaware law, preferred stock dividend obligations; (5) Accurately captures the trend toward increased specificity and formalization in regulatory language; (6) Correctly notes the role of subsidiary dividends and Board discretion; (7) Properly emphasizes that constraints remained centered on capital-adequacy compliance. MINOR WEAKNESSES: (1) The LLM answer is more detailed and comprehensive than the ground truth, including additional context about credit-rating risk and the Parent's reliance on subsidiary dividends—while these are likely accurate, they go slightly beyond what the ground truth explicitly states; (2) The phrasing 'exposure to regulatory constraints' is slightly different from ground truth's 'exposure to U.S. banking laws regarding capital planning,' though semantically equivalent; (3) The answer could have been more explicit about the shift from 'general caution' (2022) to 'specific references' (2023-2024) as stated in ground truth, though this progression is implied. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page numbers are correct. No calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three separate filing years and correctly identifies the evolution pattern. The reasoning connecting regulatory constraints to capital return limitations is sound. SEMANTIC EQUIVALENCE: The core message matches ground truth—regulatory constraints on capital returns became more formally specified over the period, with emphasis on capital adequacy rules and 'well-capitalized' status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 573,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, McGriddles is mentioned only as a standard breakfast item (“Egg McMuffin, Sausage McMuffin with Egg and **McGriddles**, biscuit and bagel sandwiches…”) and is never presented as a flagship innovation.  Instead, the menu‑innovation discussion in 2023 and 2024 spotlights new products such as the Crispy Chicken Sandwich, McSpicy and digital‑order enhancements, showing that McGriddles is treated as a stable core offering rather than a focal point of the company’s evolving breakfast strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that McGriddles remained a stable, core breakfast offering across 2022-2024 without being positioned as an innovation. However, there are significant gaps in completeness and synthesis compared to the ground truth. STRENGTHS: (1) Correctly identifies McGriddles as a standard menu item across all three years; (2) Accurately notes that McGriddles was not presented as a flagship innovation; (3) Correctly identifies competing products (Crispy Chicken Sandwich, McSpicy) that received innovation focus instead; (4) Properly synthesizes the multi-hop concept that consistency in McGriddles portrayal reveals a stable breakfast strategy. WEAKNESSES: (1) The LLM answer fails to explicitly reference all three years (2022, 2023, 2024) with specific document citations as the ground truth does, instead presenting a more general overview; (2) Missing the specific detail about 2023's 'continuous evolution' language and how McGriddles remained static despite that broader messaging; (3) Does not cite the specific PDF pages/chunks from the 10-K filings as the ground truth does (MCD_10k_2022.pdf:page_7:chunk_1, etc.); (4) The answer mentions digital-order enhancements as part of innovation focus, which is not explicitly mentioned in the ground truth, suggesting potential hallucination or inference beyond the source material; (5) Less rigorous in demonstrating year-by-year evolution analysis - the ground truth shows explicit comparison across all three years while the LLM provides a more collapsed view. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this question, so this dimension is less critical. The dates (2022-2024) are correct. QUALITATIVE ACCURACY: The core reasoning is sound - McGriddles remained consistent while other products received innovation focus - but the synthesis lacks the granular year-by-year documentation that the ground truth provides. The LLM correctly identifies the strategic implication but with less evidentiary support. CONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about evolution and consistency, but misses the opportunity to provide the detailed temporal analysis that would fully satisfy the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 603,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has consistently presented free, self‑service learning on the learning.adobe.com portal as the foundational component of Adobe Digital Learning Services, using it to drive awareness and adoption of its cloud solutions. Over the 2022‑2024 period the free tier has been increasingly integrated with paid certification tracks, custom enterprise learning, and solution‑specific skills assessments, positioning it as a strategic gateway that feeds into Adobe’s broader learning‑and‑enablement ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) Platform Domain Error - The LLM states learning.adobe.com was used consistently across 2022-2024, but the ground truth explicitly indicates that in 2022, Adobe used www.training.adobe.com, not learning.adobe.com. The shift to learning.adobe.com occurred in 2023. This is a fundamental factual error about the platform evolution. (2) Missing Key Timeline Detail - The LLM fails to capture the important platform transition from training.adobe.com (2022) to learning.adobe.com (2023-2024), which is a core element of the question about how the emphasis 'evolved.' (3) Incomplete Year-by-Year Analysis - The ground truth provides specific year-by-year progression (2022 introduction, 2023 domain shift, 2024 reinforcement), while the LLM collapses this into a generic 2022-2024 period without distinguishing the evolution. PARTIAL CREDIT: The LLM correctly identifies that free self-service learning is foundational to Adobe Digital Learning Services and correctly notes integration with paid offerings and enterprise learning. The general strategic positioning is directionally correct. However, the specific platform domain errors and missing temporal details represent a failure to accurately synthesize the multi-hop information about how the offering evolved across the three-year period. The answer reads as a general statement about Adobe's learning strategy rather than a precise account of the documented evolution across 2022, 2023, and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 431,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nThrough 2022‑2024 Emerson kept commercial vacuums classified under the “Other professional tools” bucket of its Safety & Productivity segment, alongside pipe‑working and electrical tools, and continued to market them as part of a broader safety‑and‑productivity tool suite for professionals. In November 2024 the company announced it was exploring strategic alternatives—including a cash sale—for the entire Safety & Productivity segment, indicating a shift away from treating commercial vacuums as a core growth pillar and toward focusing on its industrial‑automation and software businesses.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT SEGMENT CLASSIFICATION: The LLM claims Commercial Vacuums were classified under 'Other professional tools' in the Safety & Productivity segment throughout 2022-2024, but the ground truth explicitly states they were listed under Tools & Home Products segment in 2022, only moving to Safety & Productivity in 2023. This is a fundamental mischaracterization of the evolution being asked about. (2) MISSING CRITICAL EVOLUTION: The LLM completely fails to capture the core evolution described in the ground truth - the shift from general professional tools categorization (2022) to explicit inclusion in Safety & Productivity (2023) to integration with technologically advanced industrial tools (2024). The answer presents a static picture rather than the dynamic repositioning that occurred. (3) IRRELEVANT INFORMATION: The LLM introduces information about November 2024 strategic alternatives exploration for the entire Safety & Productivity segment, which is not mentioned in the ground truth and appears to be either fabricated or from a different source. This is a significant factual error that contradicts the premise of the question about product categorization and strategic emphasis evolution. (4) INCOMPLETE ANALYSIS: The answer fails to address the specific evolution in product categorization, strategic emphasis, and alignment with professional tools offerings as requested. It does not mention the shift from water jetters/wet-dry vacuums grouping to battery hydraulic tools/sewer inspection cameras grouping to programmable automation/electrical distribution equipment grouping. (5) SEMANTIC MISALIGNMENT: The characterization of Commercial Vacuums as moving away from 'core growth pillar' contradicts the ground truth's narrative of strategic repositioning toward more integrated industrial solutions. The quantitative accuracy score reflects the introduction of unverified claims about November 2024 announcements. The qualitative accuracy is low due to fundamental misunderstanding of the segment classification evolution and the introduction of contradictory information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 590,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Hoofddorp, Netherlands site was repeatedly described in GILD’s Form 10‑K filings (2022 p. 33; 2023 p. 13; 2024 p. 11) as the company’s **commercial manufacturing and processing facility for its cell‑therapy products** (e.g., Yescarta and Tecartus).  The filings show a steady evolution: after the initial commercial launch, the site was expanded and ramped up to meet growing demand, and by 2024 it was fully operational for large‑scale commercial production of cell‑therapy drugs.  Thus, the Hoofddorp facility’s role has progressed from establishing commercial cell‑therapy capacity to consistently supporting higher‑volume, full‑scale manufacturing of those therapies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the Hoofddorp facility as GILD's commercial manufacturing and processing site for cell therapy products (Yescarta and Tecartus). It appropriately captures the general progression from 2022-2024 showing sustained focus on cell therapy manufacturing. The answer correctly cites specific page numbers from 10-K filings (2022 p. 33; 2023 p. 13; 2024 p. 11), demonstrating multi-hop synthesis across three years of filings. The semantic meaning aligns with the ground truth regarding the facility's role in cell therapy production.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE: The LLM claims the facility was \"expanded and ramped up\" and \"fully operational for large-scale commercial production\" by 2024, but the ground truth does not provide specific evidence of expansion or ramp-up details. The ground truth states the facility was identified as \"principal manufacturing site\" in 2022, then \"explicitly described as being utilized for commercial manufacturing\" in 2023, with \"consistent\" focus in 2024. The LLM adds interpretive language about expansion and ramp-up that goes beyond what the ground truth supports. (2) The ground truth emphasizes a \"strategic shift\" in 2023 (from principal site to explicit commercial cell therapy focus), but the LLM downplays this distinction by describing it as \"steady evolution\" without highlighting the 2023 shift as a key turning point. (3) The LLM's claim about \"higher-volume, full-scale manufacturing\" in 2024 is not explicitly supported by the ground truth, which only states the focus \"remained consistent\" and suggests \"sustained and potentially expanding role.\"\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression of the facility's role. However, the reasoning adds interpretive details (expansion, ramp-up, full-scale production) that exceed the factual basis provided in the ground truth.\n\nCONCLUSION: The core facts are correct (facility location, company, products, years, general progression), but the LLM overstates the degree of change and adds unsupported details about expansion and scaling. This represents a moderate accuracy issue where the answer is directionally correct but contains embellishments beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 625,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000 % Notes due 2028 are repeatedly cited in the 2022‑2024 filings (e.g., the “Form of Note” tables on pages 136 and 138), preserving a low‑cost, long‑dated reference tranche in Coca‑Cola’s debt profile.  At the same time, the 2024 filings introduce new higher‑yield issues such as the 5.000 % Notes due 2034 and 5.400 % Notes due 2064 (see page 130), signalling that the company is deliberately adding higher‑coupon, longer‑maturity debt to take advantage of favorable market conditions and to diversify its financing mix.  Together, the persistence of the 1 % 2028 note and the issuance of higher‑yield notes reflect a shift toward a more flexible capital‑structure strategy that balances cheap legacy funding with opportunistic, higher‑cost borrowing to support growth and strategic initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are accurately cited with correct percentages and maturity dates. The time period (2022-2024) is correctly identified. ENTITY ACCURACY: Coca-Cola is correctly identified, and all debt instruments are properly named and characterized. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across multiple years (2022-2024) and connects the persistent reference to the 1.000% Notes with the introduction of higher-yield instruments in 2024. The reasoning about capital structure management is sound and logically connects the data points. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Coca-Cola maintained low-cost legacy debt while strategically adding higher-yield instruments, reflecting a shift toward more flexible capital structure management. The phrase 'cheap legacy funding with opportunistic, higher-cost borrowing' effectively captures the same concept as the ground truth's 'balancing near-term affordability with long-term funding needs.' MINOR OBSERVATIONS: The LLM provides slightly more specific detail (page references to 136, 138, and 130) which adds credibility but goes beyond the ground truth. The explanation of motivations (favorable market conditions, strategic initiatives, growth support) aligns well with the ground truth's interpretation. The only minor distinction is that the LLM uses 'flexible capital-structure strategy' while ground truth uses 'recalibration,' but these are semantically equivalent. Overall, the answer is comprehensive, accurate, and demonstrates strong multi-hop synthesis across the filing documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 502,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s Safety & Productivity segment (see page 73) has progressively highlighted battery‑powered pipe‑cutters and tools that embed diagnostic functions—such as data‑rich cut‑monitoring and connectivity—while the 2024 announcement that the company is “exploring strategic alternatives” for this segment (page 77) signals a deliberate focus on these higher‑margin, tech‑enabled offerings.  This evolution shows Emerson is repositioning itself from a traditional mechanical‑tool vendor to a leader in smart, connected plumbing‑tool solutions for professional users.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately represent the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific page numbers (73, 77) without verification against actual 10-K filings. These page references cannot be confirmed and appear fabricated. The ground truth provides no such page citations. (2) ENTITY/TIMELINE ACCURACY: The ground truth clearly documents a 3-year progression (2022→2023→2024) with specific product evolution: 2022 (traditional tools), 2023 (battery hydraulic integration), 2024 (diagnostic systems emphasis). The LLM answer vaguely references 'progressive highlighting' and a 2024 'strategic alternatives' announcement without substantiating the actual year-by-year product portfolio changes documented in the ground truth. (3) MISSING CORE FACTS: The LLM fails to mention the specific 2023 battery hydraulic technology integration or the 2024 diagnostic systems (sewer inspection cameras, locating equipment) that are central to the ground truth narrative. (4) UNSUPPORTED CLAIMS: The reference to 'exploring strategic alternatives' for the Safety & Productivity segment is presented as fact but lacks grounding in the provided ground truth, which makes no mention of this strategic review. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize a narrative about repositioning from mechanical to smart tools, it does so without the specific product evolution evidence that the ground truth provides. The reasoning is speculative rather than evidence-based. (6) SEMANTIC ISSUES: The LLM's framing of 'higher-margin, tech-enabled offerings' and 'smart, connected plumbing-tool solutions' aligns directionally with the ground truth's 'high-value, technology-enhanced tools,' but the lack of specific product details and timeline accuracy undermines credibility. The answer reads as plausible but lacks the factual grounding necessary for a multi-hop financial question requiring precise synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 537,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Santa Monica, California site was repeatedly identified as a location where GILD “utilizes the facility for **clinical manufacturing and processing of our cell‑therapy products**” (2023 10‑K p. 11; 2024 10‑K p. 11).  The 2022 filing also listed Santa Monica among the company’s manufacturing locations, but the description remained focused on clinical‑supply activities, indicating that the site’s role was deepening rather than expanding into commercial production.  This steady, clinical‑focused utilization shows that Santa Monica has become a strategic hub in GILD’s manufacturing network—providing in‑house capacity to move cell‑therapy candidates from early R&D through late‑stage clinical trials and thereby reducing reliance on external contract manufacturers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Santa Monica was used for clinical manufacturing and processing of cell therapy products in both 2023 and 2024 (with proper citations to 10-K filings). The answer accurately notes that the facility's role was clinical-focused rather than commercial production. The reasoning about Santa Monica becoming a strategic hub for moving candidates through clinical trials is sound and relevant.\n\nWEAKNESSES: The LLM answer contains a critical factual error regarding 2022. The ground truth explicitly states that in 2022, the Santa Monica facility 'was not specifically highlighted for cell therapy processing' and was identified as 'part of its R&D and manufacturing network' without the specific cell therapy designation. However, the LLM claims that 'the 2022 filing also listed Santa Monica among the company's manufacturing locations' with 'the description remained focused on clinical-supply activities.' This mischaracterizes the 2022 status by implying the cell therapy clinical manufacturing role existed in 2022, when the ground truth indicates this was a 2023 development.\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the three-year progression. The ground truth emphasizes a clear TRANSITION from 2022 (general R&D site) to 2023-2024 (dedicated cell therapy manufacturing hub). The LLM's phrasing 'the site's role was deepening rather than expanding' obscures this transition and suggests continuity where the ground truth indicates a strategic shift.\n\nCORRECTNESS ASSESSMENT: While the 2023-2024 information is accurate, the misrepresentation of 2022 status is a significant error that undermines the core narrative of facility evolution. The answer should have clearly stated that the cell therapy manufacturing designation was NEW in 2023, not present in 2022. This is a material factual error in a multi-hop question specifically asking about evolution 'from 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 527,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe broadened Frame.io from a video‑centric review tool into a full‑stack collaboration hub for the Creative Cloud.  Early disclosures (2022 – page 34) described it as a platform for real‑time upload, frame‑accurate commenting and approvals that integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and supported video, still images, design files and PDFs.  By 2023 (2023 – page 27) the integration deepened, adding native connections to Adobe Express and Firefly Services within GenStudio, while the 2024 filing (2024 – page 27 & page 89) highlighted expanded media support (still images, design files, PDFs) and tighter, direct integration with Premiere Pro and After Effects for frame‑specific comments and camera‑to‑cloud uploads.  Together, these updates show Adobe positioning Frame.io as the collaborative backbone of Creative Cloud, enabling seamless, cross‑application workflows across video, graphic, and generative‑AI content creation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) TIMELINE CONTRADICTION: The LLM claims 2022 disclosures described Frame.io as integrated with Photoshop, Lightroom, and Workfront, but the ground truth explicitly states that in 2022, Frame.io was only 'listed as part of Adobe's trademark portfolio' with 'no detailed functional description.' The LLM incorrectly backdates integrations that didn't occur until 2024. (2) MEDIA TYPE ERRORS: The LLM states 2023 had 'expanded media support (still images, design files, PDFs)' but the ground truth indicates these were the SAME supported types in 2023, not an expansion. The actual expansion in 2024 was to support video in non-post-production workflows (casting, location scouting, marketing). (3) APPLICATION INTEGRATION ERRORS: The LLM claims 2022 included Photoshop, Lightroom, and Workfront integration, but ground truth shows these were only added in 2024. In 2023, Frame.io was integrated only with Premiere Pro and After Effects. (4) MISSING KEY EVOLUTION: The LLM fails to capture the critical 2024 expansion of video support beyond post-production workflows (casting, location scouting, marketing campaigns), which is a major evolution point. (5) GENESTUDIO POSITIONING: While the LLM mentions GenStudio, it doesn't clearly establish that Frame.io became part of Adobe GenStudio for enterprise-scale content production in 2024, which is a key positioning evolution. The answer demonstrates poor multi-hop synthesis across the 2022-2024 timeline and misrepresents the actual progression of Frame.io's capabilities and integrations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 453,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022‑2024 Emerson’s Discrete Automation segment moved beyond its original hardware‑only lineup of solenoid/pneumatic valves, actuators and electrical‑distribution gear toward a broader, software‑enabled automation portfolio.  The segment’s product scope expanded to include programmable automation control systems, digital‑twin and cybersecurity capabilities, and materials‑joining solutions, and its sales grew from $2.61 B (2022) to $2.64 B (2023) before slipping to $2.51 B (2024) as the business emphasized higher‑value, integrated control‑software and services rather than standalone hardware.  This evolution reflects a strategic shift to couple electrical‑distribution equipment with advanced automation technologies and to leverage acquisitions such as National Instruments, positioning the segment as a core part of Emerson’s Automation Solutions and Software‑and‑Control offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Emerson's Discrete Automation segment from 2022-2024, capturing the shift from hardware-only to software-enabled automation portfolio. It accurately mentions key product additions (programmable automation control systems, digital-twin, cybersecurity, materials-joining solutions) and references the National Instruments acquisition. The semantic understanding of the strategic positioning is sound.\n\nWEAKNESSES - QUANTITATIVE ACCURACY (Major Issue): The LLM provides specific revenue figures ($2.61B for 2022, $2.64B for 2023, $2.51B for 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, and introducing unverified financial data is a significant error. This is particularly problematic because the question asks about strategic positioning, not financial performance, yet the LLM adds financial metrics that may be inaccurate.\n\nWEAKNESSES - QUALITATIVE ACCURACY: While the LLM captures the general evolution, it diverges from the ground truth's specific product positioning details. The ground truth explicitly mentions: (1) 2022: foundational product in Industrial Solutions; (2) 2023: embedded in Discrete Automation alongside programmable automation control systems and software; (3) 2024: listed alongside electric linear motion solutions and materials joining solutions. The LLM mentions materials-joining solutions but omits electric linear motion solutions, which is a specific product scope detail mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across the 3-year period and connect product evolution to strategic intent, which is appropriate. However, the addition of unverified financial data and the omission of specific product details (electric linear motion) weakens the synthesis quality.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about strategic positioning evolution and integration with automation technologies. However, the inclusion of revenue figures that weren't asked for and cannot be verified detracts from relevance.\n\nJUSTIFICATION: The correctness score of 6 reflects that while the LLM captures the general strategic narrative correctly, it introduces unverified quantitative data (major error in financial reporting context) and omits specific product details from the ground truth. The qualitative understanding is reasonable (7/10) but the quantitative accuracy is poor (4/10) due to unverified numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 680,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt rose from about **$24.1 bn** at the end of 2022 to **$27.2 bn** in 2023, then slipped slightly to **$26.9 bn** by the end of 2024, while its weighted‑average interest rate climbed from roughly **2.8 %** to **4.45 %** and then to **4.84 %**. This shows the company has been refinancing maturing, lower‑cost debt with longer‑dated senior notes at higher rates, extending the maturity profile and locking in funding as market rates rise. (Data from the “Components of Deposits, Short‑Term Borrowings and Long‑Term Debt” tables in the 2023 10‑K (p. 178) and the 2024 10‑K (p. 188).)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect carrying values for 2022. Ground truth shows $19,975 million in 2022, but LLM states 'about $24.1 bn' ($24,100 million). This is a $4.1 billion discrepancy (20% error), which is material and unacceptable for financial data. The 2023 and 2024 carrying values are correct ($27.2 bn and $26.9 bn respectively). The weighted-average interest rates are mostly correct (2.91% rounded to 2.8% is acceptable, 4.45% and 4.84% are exact matches), though the 2022 rate should be 2.91%, not 2.8%. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression and identifies the strategic pattern of refinancing lower-cost debt with higher-rate debt in a rising rate environment. The interpretation about locking in funding and extending maturity is sound and aligns with the ground truth's characterization of a 'proactive approach.' COMPLETENESS: The answer addresses all required elements (carrying values for 2022-2024, weighted-average rates for 2022-2024, and strategic implications). However, the fundamental error in the 2022 carrying value undermines the credibility of the entire analysis. ENTITY ACCURACY: Capital One (COF) is correctly identified, years are correct, and metrics are properly labeled. The citation to specific 10-K pages adds credibility but doesn't compensate for the numerical error. The $4.1 billion error in 2022 is a dealbreaker for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 415,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nFrom 2022 through 2024 the accrued liability for performance‑ and operating‑cost guarantees fell steadily—from about **$1.11 billion at the end of 2022 to $1.09 billion in 2023 and $0.99 billion by the end of 2024** (see the “service and product warranties and product performance guarantees” roll‑forward table in Note 16).  This decline reflects lower new guarantee issuances and higher settlements than additions, indicating that the company’s historical experience with engine durability and operating‑cost claims is improving and that its exposure to long‑term product‑performance risk in the commercial aerospace segment is modestly receding, although a substantial liability remains and continues to be monitored.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer provides completely incorrect financial figures that contradict the ground truth by approximately 10x magnitude. Ground truth states: 2022: $120M, 2023: $120M, 2024: $101M. LLM claims: 2022: $1.11B, 2023: $1.09B, 2024: $0.99B. These are fundamentally different numbers representing different liability categories or a major data error. The LLM cites 'Note 16' and a 'service and product warranties and product performance guarantees roll-forward table,' suggesting it may have confused this metric with a different warranty/guarantee liability category that is substantially larger. While the LLM's reasoning about declining liabilities and improving claims experience is logically sound and semantically similar to the ground truth's conclusion about stability and effective risk management, the underlying numbers are completely wrong. The magnitude difference (10x) is not a formatting variation but indicates the LLM referenced incorrect data entirely. The qualitative interpretation (declining exposure, improving experience) partially aligns with ground truth's conclusion about effective management, but the quantitative foundation is entirely incorrect. This is a multi-hop synthesis failure where the LLM either misidentified the correct liability line item or pulled data from the wrong section of the filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 378,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nThe 2022 10‑K (page 39) explicitly identified “estimates of sales proceeds” as a distinct valuation method for non‑public investments, especially in emerging markets, and listed it alongside discounted cash‑flows and appraisals. In the 2023 filing (page 75) the language was broadened to “various valuation methodologies, including discounted cash‑flows, estimates of sales proceeds, and appraisals,” and the 2024 filing (page 79) kept the same phrasing but placed greater emphasis on observable market inputs and the difficulty of forecasting cash‑flows in those markets. This progression shows that Coca‑Cola has moved from a relatively simple, sales‑proceeds‑centric approach toward a more layered, market‑oriented fair‑value framework, relying less on straightforward sales‑proceeds estimates and more on cash‑flow forecasts, appraisals and other inputs to handle the heightened uncertainty of emerging‑market investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year progression (2022-2024) and acknowledges the evolution of Coca-Cola's approach to valuation methodologies. (2) The LLM accurately notes that 'estimates of sales proceeds' was listed alongside discounted cash flows and appraisals across all three years. (3) The LLM correctly identifies the shift toward greater emphasis on observable market inputs and challenges in forecasting cash flows in emerging markets by 2024. (4) Page references (39, 75, 79) appear plausible for 10-K filings, though not independently verifiable here.\n\nWEAKNESSES: (1) CRITICAL SEMANTIC DIVERGENCE: The ground truth emphasizes a progression from 'disclosure' → 'deepening dependence/reliance' → 'cautious application,' whereas the LLM characterizes it as moving 'from sales-proceeds-centric toward market-oriented' and 'relying less on straightforward sales-proceeds estimates.' This is a significant misinterpretation. The ground truth shows Coca-Cola INCREASING its reliance on this method (2022→2023), then applying it more cautiously (2024), not decreasing reliance. (2) The LLM's claim that the company is 'relying less on straightforward sales-proceeds estimates' contradicts the ground truth's statement that by 2023 the company 'relies on' this methodology as a key component. (3) The LLM mischaracterizes the evolution as moving away from sales proceeds when the ground truth shows continued use with modified application context. (4) Missing the nuance that the 2024 shift reflects 'risk-aware integration' rather than a fundamental reduction in reliance.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but arrives at an incorrect directional conclusion about the company's reliance trajectory. The reasoning is internally consistent but factually misaligned with the ground truth's core finding.\n\nCONTEXTUAL ACCURACY: While the LLM addresses emerging markets and fair value assessment, it misinterprets the strategic evolution described in the ground truth, presenting a narrative of reduced reliance rather than increased reliance followed by cautious application.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 574,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nThe 10‑K risk‑factor disclosures show a clear tightening of language across the three years.  \n- **2022** (pages 4‑5) merely notes that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, and by our failure to pay full and timely dividends on our preferred stock.”  \n- **2023** (pages 4‑5) adds the same wording but is embedded in a broader list that also warns that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital adequacy and liquidity rules more generally, could result in limitations on our activities.”  \n- **2024** (pages 1 and 5) expands the reference to regulatory standards, emphasizing that “failure to satisfy regulatory standards … could result in limitations on our activities and adversely affect our business,” and reiterates the Board‑discretion and dividend‑payment constraints.\n\n**What this progression suggests:** BNY Mellon’s capital‑return flexibility is increasingly conditioned on meeting strict regulatory capital metrics and maintaining its credit ratings; the company can distribute capital only so long as it remains “well‑capitalized,” can meet dividend obligations on its preferred shares, and retains Board discretion—meaning strategic shareholder distributions are now tightly bounded by U.S. banking rules rather than being freely discretionary.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and accurately cites the core regulatory language about capital return limitations, U.S. banking laws, and preferred stock dividend constraints. (2) The page references (pages 4-5 for 2022-2023, pages 1 and 5 for 2024) appear reasonable for 10-K risk factor disclosures. (3) The LLM correctly notes that the language was 'repeated' across years, consistent with the ground truth's assertion of 'consistent regulatory constraint.' (4) The characterization of 'tightening language' and increased emphasis on regulatory standards is directionally aligned with the ground truth.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely misses the ground truth's key finding about the 2024 disclosure adding 'new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends.' This is a material distinction in the ground truth that represents the evolution of BNY Mellon's disclosure strategy. The LLM focuses on regulatory standards language but fails to capture this internal capital flow dependency angle. (2) MISCHARACTERIZATION: The LLM describes the progression as a 'tightening of language,' but the ground truth indicates the core regulatory language remained 'consistent' across all three years, with the 2024 change being an ADDITION of new emphasis on internal structural dependencies, not a tightening of existing language. This is a subtle but important distinction. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly states that 2023 and 2024 language was 'repeated' from 2022, but the LLM suggests progressive changes in the core language itself, which overstates the evolution. (4) STRATEGIC INTERPRETATION: While the LLM's conclusion about 'tightly bounded' capital distributions is reasonable, it doesn't fully capture the ground truth's insight that the progression reveals 'increasing internal structural dependencies' as a new strategic consideration in 2024.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to properly identify the key distinction between (a) consistent regulatory language and (b) new 2024 emphasis on internal capital flows. This represents incomplete multi-hop synthesis.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are involved in this question, so quantitative accuracy is based on correct identification of years, page numbers, and disclosure content. The years and general content are correct, but the characterization of what changed is partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 695,
        "total_tokens": 2328
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s risk disclosures show a clear escalation in both the scope and detail of the “loss or modification of tax and tariff exemptions” threat. The 2022 filing merely listed the risk, while the 2023 and especially the 2024 10‑Ks expand the language to tie the exemption risk to recent geopolitical events—U.S. sanctions, export‑control revisions, the Ukraine conflict, and heightened scrutiny of China‑related operations—underscoring that regulatory changes could materially affect AMD’s cost structure and supply chain. This progression signals that AMD is confronting a far more intricate global regulatory environment, where tax and tariff benefits are increasingly vulnerable to shifting political and trade policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of AMD's tax and tariff exemption risk disclosures from 2022-2024, correctly identifying the progression from general listing in 2022 to expanded discussion with specific geopolitical context in 2023-2024. The specific events mentioned (Ukraine conflict, China-Taiwan tensions, U.S. export controls/sanctions) match the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question about risk disclosure evolution. The temporal progression (2022→2023→2024) is correctly sequenced. Score: 10/10. (3) ENTITY ACCURACY: AMD is correctly identified throughout. The fiscal years (2022, 2023, 2024) are accurate. The regulatory concepts (tax exemptions, tariff exemptions, export controls, sanctions) are properly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly linking the escalation of risk disclosures to both internal expansion and external geopolitical pressures. The logical connection between specific geopolitical events and regulatory complexity is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('escalation in both scope and detail' vs. 'consistently highlighted' and 'expanded discussion') but conveys the same core meaning—that AMD's exposure and disclosure of this risk increased over time. The characterization of the regulatory environment becoming 'far more intricate' and 'increasingly vulnerable' aligns with the ground truth's assessment of 'increased' exposure driven by 'volatility and complexity.' Minor difference: The LLM emphasizes the impact on 'cost structure and supply chain' which is a reasonable inference but not explicitly stated in the ground truth, though this represents appropriate contextual elaboration rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 542,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings fell sharply—from **$883 million in 2022 to $562 million in 2024** (a roughly 36 % decline), with a brief dip to $538 million in 2023.  Long‑term debt was relatively stable, rising to **$49.3 billion in 2023** before pulling back to **$45.0 billion in 2024**.  During the same period the company’s **floating‑rate unsecured senior debt collapsed from $1.6 billion (2022) to essentially zero by 2024**, reflecting a strategic shift toward longer‑dated, predominantly fixed‑rate funding (senior notes and securitized debt) and a deliberate reduction of exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors that fundamentally misrepresent Capital One's debt structure. CRITICAL ERRORS: (1) Total debt figures are drastically wrong - LLM states long-term debt was $49.3B in 2023 and $45.0B in 2024, but ground truth shows total short-term borrowings + long-term debt was $49.856B in 2023 and $45.551B in 2024. The LLM appears to have confused or misreported these figures. (2) Short-term borrowings are completely incorrect - LLM claims $883M in 2022, $538M in 2023, and $562M in 2024, but these numbers don't align with the ground truth total debt figures and appear to be fabricated or from wrong data sources. (3) Floating unsecured senior debt numbers are inaccurate - LLM states $1.6B in 2022, but ground truth shows $1.709B; more critically, the LLM fails to mention the 2023 figure of $349M with 6.75% rate, which is a key data point showing the dramatic shift in debt composition. (4) The answer omits critical information about fixed unsecured senior debt evolution ($21.045B in 2022 to $27.168B in 2023 to $26.930B in 2024) and the rising weighted-average interest rates (2.91% to 4.84%), which are essential to understanding the debt structure evolution. (5) While the LLM correctly identifies the strategic pivot from floating to fixed-rate debt, it lacks the specific interest rate data and complete debt composition breakdown that demonstrates this shift. The reasoning about interest rate risk mitigation is sound but unsupported by accurate numbers. The answer is incomplete in addressing the multi-hop synthesis required - it should have provided a comprehensive breakdown of debt categories across all three years with their respective interest rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 467,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in the International Aero Engines AG (IAE) V2500 collaboration was 57 % in 2022 and remained at essentially the same 57 % level in 2023‑2024 (the same 51 % net share for IAE LLC).  This stability shows that RTX continues to retain a controlling, strategic position in the V2500 engine programme, using its majority program‑share to guide the partnership while still sharing the economic upside with its sub‑collaborators.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states RTX's net program share was '57% in 2022' when the ground truth clearly indicates it was 61% in 2022. This is a 4 percentage point error on a key metric. The LLM then claims it 'remained at essentially the same 57% level in 2023-2024,' which is partially correct for 2023-2024 but completely wrong for 2022. (2) MULTI-HOP REASONING FAILURE: The question specifically asks about the EVOLUTION from 2022 to 2024. The ground truth shows a clear downward trend: 61% (2022) → 57% (2023) → 57% (2024). The LLM failed to identify this evolution and instead incorrectly claimed stability from 2022 onward. (3) STRATEGIC INTERPRETATION ERROR: The ground truth correctly interprets the 4-point decrease as 'a strategic adjustment' and 'gradual dilution' of RTX's direct economic exposure. The LLM incorrectly characterizes this as 'stability' and claims RTX 'continues to retain a controlling, strategic position,' which misses the actual strategic shift indicated by the declining share. (4) ENTITY/METRIC CONFUSION: The LLM introduces '51% net share for IAE LLC' without clear context or explanation, creating confusion about whether this is a separate metric or a misstatement. (5) SEMANTIC MISALIGNMENT: The LLM's conclusion that RTX maintains a 'controlling, strategic position' contradicts the ground truth's finding that RTX deliberately reduced its exposure. The answer fundamentally misses the key insight: RTX's share DECREASED, not remained stable. This is a major factual error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 459,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nFrom 2022 through 2024, the Fabric & Home Care segment’s net sales grew about 4 % each year (to $29.5 bn in 2024) and net earnings rose 18 % in 2024, with Cascade’s brand helping lift its earnings contribution—its share of segment earnings climbed from roughly 17 % of sales in 2022 to 19.3 % in 2024. Although the segment’s overall market share was flat, Cascade’s stronger pricing and margin performance signal a more central, higher‑margin role for the brand within P&G’s home‑care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and misrepresentations that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims Cascade's earnings share climbed from \"roughly 17% of sales in 2022 to 19.3% in 2024\" - this is completely incorrect. The ground truth shows the Fabric & Home Care segment (not Cascade alone) represented 35% of net sales in 2022 and 36% in 2024. The LLM appears to have confused individual brand metrics with segment-level metrics.\n   - LLM states \"net earnings rose 18% in 2024\" - no such figure appears in the ground truth, which discusses segment earnings contribution percentages (31% to 34%), not year-over-year growth rates.\n   - LLM claims segment net sales grew to \"$29.5 bn in 2024\" - this specific figure is not verified in the ground truth and appears to be fabricated.\n   - The claim of \"about 4% each year\" growth is unsupported by the provided ground truth.\n\n2. ENTITY AND METRIC CONFUSION:\n   - The LLM conflates Cascade brand-level metrics with Fabric & Home Care segment-level metrics. The ground truth clearly states Cascade is \"among key brands\" and \"a core brand\" within the segment, not that it represents 17-19% of earnings.\n   - The ground truth discusses segment earnings contribution (31% to 34% of P&G total), not Cascade's individual contribution.\n\n3. SEMANTIC MISALIGNMENT:\n   - Ground truth emphasizes CONSISTENCY and STABILITY: \"maintained consistent positioning,\" \"maintained stable strategic importance,\" \"held steady.\"\n   - LLM emphasizes GROWTH and ELEVATION: \"climbed,\" \"stronger pricing and margin performance,\" \"more central, higher-margin role.\"\n   - These are contradictory narratives. The ground truth shows Cascade's positioning remained stable; the LLM incorrectly suggests it became more important.\n\n4. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to correctly synthesize information across the three 10-K filings. It appears to have invented metrics rather than extracting them from the actual filings.\n   - The ground truth clearly tracks three years (2022, 2023, 2024) with specific segment percentages; the LLM provides different numbers that don't align.\n\n5. MISSING KEY INFORMATION:\n   - LLM fails to mention that Cascade remained in the Home Care sub-category across all three years.\n   - LLM fails to note the slight earnings contribution increase (31% to 34%) that the ground truth identifies as the only meaningful change.\n   - LLM provides no evidence of the claimed \"stronger pricing and margin performance.\"\n\nThe answer appears to contain fabricated financial data and misinterprets the actual positioning of Cascade within P&G's portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 717,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 to 2024 BNY Mellon moved the posting of its Directors’ Code of Conduct from a generic “in relations” folder to the dedicated “investor‑relations” directory, reflecting a tighter domain‑branding of the URL. Each annual filing references the code in Item 10 and the Proxy, and the 2024 filing explicitly integrates the code into the “Corporate Governance and Board Information” subsection, making the disclosure part of the firm’s overall governance framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution from 'in relations' to 'investor-relations' folder structure and recognizes the shift toward integration with corporate governance frameworks. The mention of Item 10 and Proxy references is appropriate context. CRITICAL ERRORS: (1) The LLM completely omits the domain transition from 'bnymellon.com' to 'bny.com' - a key element of the ground truth answer that represents significant brand rebranding. (2) The LLM fails to capture the specific URL path details across all three years (2022, 2023, 2024), particularly the 2023 intermediate step with 'inv relations' that shows incremental change. (3) The LLM does not mention the 2022 baseline 'bnymellon.com' domain explicitly, missing the before/after comparison. (4) The characterization of the folder change is imprecise - the ground truth shows 'in relations' → 'inv relations' → 'investor-relations', but the LLM simplifies this to just 'in relations' to 'investor-relations', missing the 2023 intermediate state. PARTIAL CREDIT: The LLM correctly identifies the strategic shift toward stakeholder-oriented governance disclosure and the integration into corporate governance frameworks. The mention of 'Corporate Governance and Board Information' subsection in 2024 aligns with the ground truth's emphasis on strategic integration. However, the answer lacks the specificity and completeness required for a multi-hop question about URL structure evolution across three years. The omission of the domain branding change (bnymellon.com → bny.com) is a significant factual gap that undermines the answer's accuracy regarding the question's explicit focus on 'domain branding.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 460,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 AMD shifted from simply selling component‑level graphics to AIB makers into a tighter partnership that codified inventory‑protection terms—price‑protection, return rights and limited stock‑rotation clauses—to shield AIB inventory from price erosion. At the same time, AMD leveraged its discrete Radeon GPU portfolio as a differentiation platform, promoting newer, performance‑ and AI‑focused graphics to help AIBs create distinct, higher‑margin board products while preserving margins amid intensifying competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies AMD as the subject company and the 2022-2024 timeframe; (2) Accurately captures the core concept of inventory protection policies for AIBs; (3) Correctly identifies discrete graphics/Radeon GPUs as a key differentiation strategy; (4) Properly synthesizes the multi-hop relationship between inventory protection and graphics differentiation. WEAKNESSES: (1) The LLM introduces specific policy details ('price-protection, return rights and limited stock-rotation clauses') that are not explicitly mentioned in the ground truth, potentially overstating specificity; (2) The characterization of AMD's evolution as a 'shift from simply selling component-level graphics' implies a change in business model that the ground truth does not support—the ground truth emphasizes CONSISTENCY ('consistently maintained,' 'remained stable,' 'reiterated the same'); (3) The LLM's framing suggests a progression toward 'tighter partnership' and 'codified' terms, whereas the ground truth emphasizes stability and continuity across the three years; (4) The phrase 'amid intensifying competition' adds context not present in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between inventory protection and discrete graphics as complementary strategies, which aligns with the ground truth's emphasis on their joint importance. However, the directional narrative (shift/evolution) contradicts the ground truth's emphasis on consistency. SEMANTIC EQUIVALENCE: While the LLM captures the essential elements (inventory protection + discrete graphics differentiation), the framing of change versus stability represents a material difference in interpretation. The ground truth explicitly states 'consistency in policy and strategic emphasis,' while the LLM frames this as an evolution/shift. This is a significant semantic divergence that affects the accuracy of the answer's core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 548,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 to 2024 the 10‑K disclosures moved from a brief mention that Egg McMuffin is part of the breakfast menu (2022 p. 7) to a clear emphasis on the supply‑chain and quality systems that enable that menu item. The 2024 filing (pp. 5‑6) details McDonald’s global food‑safety standards, supplier‑code of conduct and consistent breakfast‑menu execution as a way to meet customer expectations for taste and reliability, whereas the 2022 filing only noted “continuously evolving its menu” without describing those supply‑chain controls. This progression shows the Company increasingly highlighting the supply‑chain’s role in delivering a consistent Egg McMuffin experience.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the general evolution narrative from 2022 to 2024 regarding McDonald's disclosure of breakfast menu items and supply chain focus, but has significant gaps and lacks specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the progression from basic menu mention (2022) to emphasis on supply chain and quality systems (2024); (2) Accurately notes the shift toward supply chain controls and food safety standards; (3) Correctly identifies the Egg McMuffin as the focal product; (4) Appropriately references page numbers (though not verified against actual filings). WEAKNESSES: (1) MISSING KEY 2023 INFORMATION: The ground truth explicitly mentions 2023 as a critical transition year where McDonald's 'expanded its narrative around innovation and supply chain collaboration' and noted 'comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer.' The LLM answer completely omits 2023, treating this as a 2022-to-2024 binary comparison rather than a three-year evolution; (2) INCOMPLETE DIGITAL TRANSFORMATION DETAIL: The ground truth emphasizes that by 2024, McDonald's placed 'stronger emphasis on digital transformation in food safety and quality' with 'specific mention of a digital transformation project aimed at promoting data excellence.' The LLM answer mentions 'global food-safety standards' and 'supplier-code of conduct' but does not capture the digital transformation/data excellence component that distinguishes 2024; (3) VAGUE SYNTHESIS: The LLM answer states the 2024 filing 'details' these systems but doesn't specify the digital transformation project or data excellence focus that the ground truth identifies as the key 2024 evolution; (4) MISSING SUPPLY CHAIN OFFICER REFERENCE: The ground truth specifically mentions the 'Global Chief Supply Chain Officer' role introduced in 2023, which the LLM answer omits. QUANTITATIVE ACCURACY: Page references (p. 7 for 2022, pp. 5-6 for 2024) cannot be verified but appear plausible. No specific numbers or calculations are provided by either answer, so this dimension is less critical. MULTI-HOP REASONING: The LLM answer demonstrates basic multi-hop reasoning by connecting supply chain evolution to product consistency, but fails to synthesize the full three-year progression with the specific institutional and technological changes identified in the ground truth. The answer is partially correct on the general trajectory but incomplete on the specific evolution details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 666,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe 2022, 2023 and 2024 10‑K filings each list Oracle’s 4.30 % senior unsecured note maturing in 2034 (see the “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044” table on pages 110/112).  This repeated disclosure shows that the 2034 note is a permanent component of Oracle’s long‑term debt capital, indicating that the company is maintaining a stable, low‑cost funding tranche with a decade‑plus maturity to support its growth, acquisition and shareholder‑return strategy while keeping its overall debt maturity profile diversified.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 as a persistent component of Oracle's long-term debt across 2022, 2023, and 2024, with accurate percentage and maturity date. The numeric values (4.30%, 2034) are correct. The answer appropriately characterizes it as a 'permanent component' and 'stable element' of the debt portfolio, which aligns with the ground truth's assessment of 'persistent and notable component.' The LLM correctly notes the diversified maturity profile and mentions the note's role in supporting growth, acquisitions, and shareholder returns. However, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not specifically mention the other debt instruments disclosed alongside the 4.30% Note in each year (e.g., 3.625% Note due 2023, 4.50% Note due 2044, 2.950% Notes due 2024), which the ground truth uses to illustrate the evolving debt portfolio; (2) It does not explicitly discuss how Oracle's debt issuance strategy evolved across the three years (issuing newer instruments while maintaining the 2034 note); (3) The reference to page numbers (110/112) adds specificity but is not verified against the ground truth. The reasoning is sound and the multi-hop synthesis is adequate—the LLM correctly connects the consistent disclosure across three years to conclusions about Oracle's financing strategy. The characterization of the note as 'low-cost funding' is reasonable given the 4.30% rate but is not explicitly stated in the ground truth. Overall, the answer is factually accurate on key points but lacks the detailed comparative analysis across years that the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 454,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One valued its net derivative assets and liabilities with discounted‑cash‑flow models that increasingly relied on unobservable inputs such as swap‑rate curves, prepayment and default assumptions, and loss‑severity estimates.  Gross derivative assets fell from $3.1 bn (2022) to $2.68 bn (2023) and, after netting, net derivative assets declined from $1.96 bn (2022) to $1.67 bn (2023), while the Level‑3 fair‑value estimate of net derivative assets rose from $58 m (2023) to $69 m (2024), showing a growing proportion of the portfolio classified as Level 3 and therefore greater exposure to subjective, unobservable market inputs over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Ground truth: Net derivative assets/liabilities fair value was $19M (2022), $58M (2023), $58M (2024)\n   - LLM claims: Gross derivative assets $3.1B (2022), $2.68B (2023); net derivative assets $1.96B (2022), $1.67B (2023); Level-3 estimate $58M (2023) to $69M (2024)\n   - The LLM introduces entirely different numbers ($1.96B, $1.67B, $69M) that do not appear in the ground truth\n   - The ground truth explicitly states $58M for both 2023 and 2024, not a rise to $69M\n   - The LLM conflates gross derivative assets (which may be different metrics) with net derivative assets/liabilities\n\n2. ENTITY/METRIC CONFUSION:\n   - Ground truth focuses on NET derivative assets/liabilities fair value\n   - LLM introduces gross derivative assets ($3.1B, $2.68B) which are not mentioned in ground truth\n   - LLM then discusses Level-3 fair value estimates separately, creating confusion about what metric is being tracked\n   - The ground truth does not mention Level-3 classifications or a rise from $58M to $69M\n\n3. VALUATION METHODOLOGY:\n   - Ground truth: Mentions unobservable inputs including default rates (53-163%) and swap rates (3-5%)\n   - LLM: Mentions swap-rate curves, prepayment and default assumptions, loss-severity estimates\n   - While the LLM's methodology description is plausible, it does not match the specific unobservable inputs cited in ground truth (no mention of the 53-163% default rate range or 3-5% swap rate ranges)\n\n4. TEMPORAL EVOLUTION:\n   - Ground truth: Clear progression from $19M (2022) → $58M (2023) → $58M (2024), showing stabilization\n   - LLM: Claims Level-3 estimate rose from $58M (2023) to $69M (2024), contradicting the ground truth's $58M for both years\n   - The LLM's narrative of \"growing proportion classified as Level 3\" is not supported by ground truth data\n\n5. MULTI-HOP REASONING:\n   - The LLM appears to have synthesized information from different parts of Capital One's filings but mixed metrics inappropriately\n   - It conflates gross and net derivative positions\n   - It introduces Level-3 classifications not mentioned in ground truth\n   - The conclusion about \"greater exposure to subjective, unobservable market inputs\" is contradicted by the stable $58M figure across 2023-2024\n\n6. COMPLETENESS:\n   - Ground truth mentions unrealized losses ($20M in 2022) - LLM does not address this\n   - Ground truth provides specific unobservable input ranges - LLM provides generic descriptions\n   - Ground truth emphasizes transformation and stabilization - LLM emphasizes growth in Level-3 exposure\n\nThe answer demonstrates fundamental misalignment with ground truth on the core financial metrics and their evolution, making it substantially incorrect despite some plausible-sounding methodology discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 775,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s financial tie‑up with Rolls‑Royce remained a **flight‑hour‑contingent payment** on V2500‑powered aircraft that is accrued as a **collaboration intangible asset** and amortized to cost of sales over the engine’s economic life (generally ~30 years).  The payment schedule disclosed in the “Other commercial aerospace commitments” table shows the obligations rising to about **$0.84 bn in 2025, $0.77 bn in 2026 and $0.70 bn in 2027**, with the accrued intangible asset being written off incrementally as those flight‑hour credits are earned and the related performance obligation is satisfied.  Consequently, each year’s amortization expense grows as the V2500 flight‑hour base expands, and the remaining commitment will be settled through June 2027.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core structure of RTX's obligations to Rolls-Royce as flight-hour-contingent payments on V2500-powered aircraft, properly characterizes them as collaboration intangible assets amortized to cost of sales, and accurately notes the settlement timeline through June 2027. The semantic understanding of the payment mechanism and accounting treatment is sound. The answer appropriately addresses the evolution question by discussing how these obligations are tracked and amortized over time.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific payment amounts ($0.84bn in 2025, $0.77bn in 2026, $0.70bn in 2027) that cannot be verified against the ground truth, which only mentions a total of $14.1 billion in commercial aerospace financing commitments for 2024 without breaking down Rolls-Royce-specific amounts by year. These numbers appear to be fabricated or incorrectly sourced, representing a significant quantitative accuracy problem. The ground truth does not provide these year-by-year breakdowns.\n\nWEAKNESSES - COMPLETENESS: The LLM adds detail about the ~30-year amortization period that is not explicitly confirmed in the ground truth. While this may be reasonable, it goes beyond what the ground truth states. The LLM also speculates about how \"each year's amortization expense grows as the V2500 flight-hour base expands\" without ground truth support for this specific claim.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about the 2012 acquisition context (implied through the payment structure) and traces the evolution from 2022-2024, though it doesn't explicitly mention the 2012 IAE acquisition detail that the ground truth includes. The reasoning about capitalization and amortization is logically sound.\n\nKEY ISSUE: The introduction of unverified specific payment amounts ($0.84bn, $0.77bn, $0.70bn) is the primary concern. These numbers significantly impact the quantitative accuracy score despite the qualitative understanding being largely correct. The answer demonstrates good conceptual grasp but fails on factual precision regarding specific financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 577,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen first disclosed in its 2022 10‑K that the Neulasta Onpro kit had received FDA‑driven device and labeling enhancements in response to user complaints and that it continuously monitors adverse‑event reports. By the 2023 filing the language was broadened to note that the company routinely implements further device‑related improvements (software/label updates) and that it was beginning to embed redundancy into its supply chain. In the 2024 filing Amgen added explicit operational‑resilience measures—backup generators, diversified supplier routes and contingency plans for island‑wide power outages—while reaffirming its ongoing monitoring and incremental device enhancements to mitigate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and unsupported claims when compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that Amgen disclosed FDA-driven device and labeling enhancements in 2022 in response to user complaints; (2) It correctly notes ongoing monitoring of adverse events across the three-year period; (3) It correctly identifies that 2024 disclosures expanded to include operational resilience measures; (4) The general progression from device-focused to broader operational risk disclosure is accurate. SIGNIFICANT ERRORS: (1) The LLM claims that by 2023 'the language was broadened to note that the company routinely implements further device-related improvements (software/label updates) and that it was beginning to embed redundancy into its supply chain.' The ground truth makes no mention of supply chain redundancy being discussed in 2023—this appears to be fabricated or conflated with 2024 disclosures; (2) The LLM states that 2024 included 'diversified supplier routes and contingency plans' but the ground truth specifically mentions 'backup generators' and 'Puerto Rico's unstable electric grid' and 'island-wide outage on December 31, 2024'—the LLM generalizes these specific operational resilience measures into broader supply chain language that isn't supported; (3) The LLM's characterization of 2023 as introducing supply chain redundancy is not supported by the ground truth, which only mentions 'sustained commitment to device safety and regulatory compliance' in 2023. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years but introduces unsupported details about supply chain measures in 2023 and generalizes the specific Puerto Rico infrastructure issues into vague 'diversified supplier routes.' The ground truth is more precise about what changed in each year. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is less critical, though the LLM's reference to December 31, 2024 outage aligns with ground truth. The answer lacks the specificity of the ground truth regarding the 2017 FDA evaluation reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 589,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑Ks each contain an “Item 3 – Ratification of KPMG LLP” reference that incorporates the proxy statement’s ratification of KPMG LLP as BNY’s independent auditor and explicitly note that KPMG’s PCAOB firm identification number is 185.  The wording and the inclusion of the PCAOB number are unchanged across the three filings, indicating that BNY has consistently retained KPMG as its principal auditor and that this audit‑governance practice has remained stable over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - ENTITY MISMATCH: The LLM answer refers to 'BNY' and 'BNY's independent auditor' throughout, while the question and ground truth clearly refer to 'BK'. This is a significant entity identification error that undermines the credibility of the response, even though the factual content about KPMG LLP and PCAOB number 185 appears accurate. QUANTITATIVE ACCURACY: The numbers are correct - PCAOB firm number 185 is accurately stated, and the three-year period (2022, 2023, 2024) is correct. No calculation errors. COMPLETENESS: The LLM answer addresses the core elements: (1) consistent disclosure of KPMG LLP ratification across three years, (2) unchanged PCAOB number 185, (3) stable audit governance. However, it uses slightly different framing than the ground truth - the LLM mentions 'Item 3 – Ratification of KPMG LLP' and references to proxy statements, which adds specificity but wasn't explicitly in the ground truth. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the consistency of KPMG disclosure across years with the implication of stable audit governance. The logic that unchanged PCAOB number indicates ongoing relationship is valid. SEMANTIC EQUIVALENCE: The core message matches - KPMG remained consistent, PCAOB 185 unchanged, audit governance stable. However, the company name error (BNY vs BK) is a fundamental factual mistake that cannot be overlooked, despite the otherwise accurate content about the auditor relationship. This appears to be a copy-paste or reference error where the LLM confused the ticker symbol or company name.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 439,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s exposure to commercial‑aerospace financing guarantees held through collaboration partners fell steadily—$142 million in 2022, $135 million in 2023 and $131 million in 2024—mirroring a reduction in the total guarantee commitments (from about $309 million in 2021 to $274 million by 2024).  This downward trend shows that RTX is deliberately shrinking the portion of risk it shares with partners and is moving more of the financing risk onto its own balance sheet, reflecting a tighter risk‑management stance as the company streamlines its aerospace financing arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies all three key figures for collaboration partners' share: $142M (2022), $135M (2023), and $131M (2024). (2) The directional trend is accurate—a consistent downward trajectory. (3) The company name (RTX) and time period (2022-2024) are correct. (4) The general characterization of deliberate risk reduction is reasonable. WEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM states RTX is 'moving more of the financing risk onto its own balance sheet,' which directly contradicts the ground truth. The ground truth indicates a 'strategic reduction in shared financial risk with partners'—meaning RTX is reducing its overall exposure, not shifting it to itself. This is a fundamental misreading of what the declining collaboration partners' share means. (2) UNSUPPORTED CLAIM: The LLM introduces data about total guarantee commitments ($309M in 2021 to $274M in 2024) that is not mentioned in the ground truth. While this additional context might be factually accurate from the filings, it goes beyond what was provided and could be misleading if incorrect. (3) MISSING ELEMENT: The ground truth specifically mentions that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which is an important detail about confidence in underlying asset values. The LLM omits this. (4) REASONING FLAW: The conclusion that RTX is taking on more risk contradicts the numerical evidence of declining collaboration partners' share, which logically suggests reduced overall exposure or restructuring away from shared arrangements. The LLM's interpretation of what the trend 'indicates' is inverted from the ground truth's assessment. QUANTITATIVE VERIFICATION: All three collaboration partner figures are correct ($142M, $135M, $131M). The trend calculation (decline of $11M over two years) is implicit and correct. However, the interpretation of what this trend means for RTX's risk position is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 545,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nThrough 2022 to 2024, Always stayed within the **Feminine Care (Adult Incontinence / Menstrual Care)** sub‑category of P&G’s **Baby, Feminine & Family Care** segment and was consistently listed as a core brand alongside Always Discreet, Tampax Bounty, Charmin and Puffs.  Management repeatedly pointed to **low‑single‑digit growth driven by higher pricing and a shift toward a more premium product mix**, using the Always brand to capture higher‑margin, premium‑positioned demand and to reinforce its leadership relative to other feminine‑hygiene offerings such as Tampax.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth: (1) CRITICAL ERROR - The LLM claims Always was in 'Baby, Feminine & Family Care' segment throughout 2022-2024, but ground truth shows in 2022 it was under 'Feminine Care' (not renamed until 2023). This is a fundamental mischaracterization of the evolution being asked about. (2) QUANTITATIVE ERRORS - The LLM provides NO segment contribution percentages (25% in 2022, 24% in 2023-2024 per ground truth), which are key metrics for understanding positioning evolution. (3) ENTITY ERRORS - The LLM incorrectly lists Bounty, Charmin, and Puffs as part of the Feminine Care portfolio alongside Always. Ground truth only mentions Always, Always Discreet, and Tampax in this segment. These are completely different product categories (paper towels, tissue) not feminine care products. (4) MISSING CRITICAL INFORMATION - The LLM fails to capture the 2023 segment rename from 'Feminine Care' to 'Baby, Feminine & Family Care,' which is central to understanding the evolution. (5) UNSUPPORTED CLAIMS - The LLM introduces information about 'low-single-digit growth,' 'higher pricing,' and 'premium product mix' that are not mentioned in the ground truth and appear to be hallucinated. (6) INCOMPLETE SYNTHESIS - The answer does not properly address how positioning evolved across the three-year period as requested. The ground truth shows structural changes (segment rename, consistent positioning) that the LLM completely misses. The LLM answer demonstrates poor multi-hop reasoning and significant factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 442,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s IP‑protection risk moved from a generic warning that “inadequate protection of our technology abroad could erode our competitive advantage” (2022 Risk Factors) to a far more specific concern that its expanding global footprint—particularly the ≈ 65‑70 % of revenue generated outside the United States and the heavy reliance on third‑party fabs in China, Taiwan and other Asian locations—exposes the company to heightened chances of IP theft, weaker enforcement of patents and trade‑secret rights, and geopolitical pressures that can limit its ability to safeguard proprietary designs. Consequently, the later filings emphasize that these international and Asian‑manufacturing dependencies materially increase AMD’s vulnerability to IP‑related disputes and potential loss of its core technologies.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's evolving IP protection challenges from 2022-2024. STRENGTHS: (1) Correctly identifies the progression from generic to specific IP concerns across the three-year period; (2) Accurately cites the ~65-70% international revenue figure (ground truth mentions 65%, LLM's range of 65-70% is reasonable given potential year-to-year variation); (3) Properly identifies the three key Asian manufacturing locations (China, Taiwan, Malaysia implied in 'other Asian locations'); (4) Correctly synthesizes the multi-hop relationship between expanding international operations, third-party manufacturing reliance, and heightened IP risks; (5) Appropriately emphasizes geopolitical tensions as an emerging risk layer; (6) Demonstrates sound reasoning about how outsourcing model expansion correlates with IP vulnerability. MINOR WEAKNESSES: (1) Does not explicitly mention 2023 as a specific inflection point where international sales emphasis increased (ground truth notes 'By 2023'); (2) Does not explicitly name Malaysia as a manufacturing location (uses 'other Asian locations' instead, though this is semantically acceptable); (3) The phrase '≈ 65-70%' presents a range rather than the specific 65% figure mentioned in ground truth, though this could reflect variation across years; (4) Slightly less emphasis on the chronological progression through each year compared to ground truth's year-by-year breakdown. QUANTITATIVE VERIFICATION: The 65-70% revenue figure aligns with ground truth's 65% international sales figure. No calculation errors detected. MULTI-HOP REASONING: Successfully synthesizes information across three years and connects international expansion → manufacturing reliance → IP risks → geopolitical factors. The logic chain is sound and matches ground truth's narrative arc. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth, with appropriate emphasis on the evolution and regional concentration of risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 542,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first introduced the 2.300 % Notes due 2028 in its March 2021 8‑K filing (Exhibit 4.14) as part of a staggered senior‑note program, and then did not issue any additional 2.300 % 2028 tranches; instead it added higher‑coupon replacements—most notably the 4.5 % Notes due 2028 in the February 2023 8‑K (Exhibit 4.16)—while continuing to launch new fixed‑rate series in subsequent years. This multi‑year pattern reveals Oracle’s debt‑financing strategy of laddering maturities and periodically refinancing low‑coupon long‑dated debt to adapt to changing market rates, using a standardized officer‑certificate structure to maintain a diversified pool of senior unsecured obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG EXHIBIT REFERENCE: LLM claims the 2.300% Notes were first referenced in March 2021 8-K Exhibit 4.14, but ground truth states they were first referenced in 2022 in Exhibit 4.16. (2) INCORRECT NARRATIVE: LLM suggests Oracle 'did not issue any additional 2.300% 2028 tranches' and replaced them with 4.5% Notes due 2028 in February 2023. Ground truth shows the 2.300% Notes were consistently carried forward and disclosed in 2023 (Exhibit 4.14) and 2024 (Exhibit 4.14), indicating ongoing reliance on this instrument, not replacement. (3) MISCHARACTERIZATION OF STRATEGY: LLM frames the strategy as 'refinancing low-coupon long-dated debt' and replacing with higher-coupon instruments, but ground truth emphasizes 'consistent inclusion across all three years' indicating 'stable and deliberate approach' with 'diverse maturity profile.' The LLM fundamentally misunderstands the multi-year pattern—it's about continuity and stability, not replacement and refinancing. (4) EXHIBIT TRACKING ERROR: Ground truth clearly tracks 2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14). LLM conflates different years and exhibits. (5) MISSING CORE INSIGHT: Ground truth emphasizes the 2.300% Notes' persistent presence as evidence of stable financing strategy; LLM incorrectly suggests they were superseded. The LLM answer demonstrates failed multi-hop synthesis across the three-year period and provides an inaccurate characterization of Oracle's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 431,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBoeing’s pension fund has continued to use limited‑partnership vehicles to gain private‑equity exposure, focusing on leveraged‑buyout, venture‑capital, growth‑equity and special‑situations strategies that are deployed both in the United States and abroad; the target allocation to these assets rose from roughly 4 % of the portfolio in 2022 to about 7 % in 2023 and remained at that level in 2024, while the actual holding has hovered near 8 % of total assets.  The geographic scope has stayed global—spanning North America, Europe and Asia—without a material shift toward any one region, and the strategic emphasis has remained on diversified private‑equity deal types rather than on a new geographic or sectoral focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misidentifications that substantially diverge from the ground truth. Key issues: (1) ENTITY MISIDENTIFICATION: The LLM incorrectly identifies 'BA' as Boeing's pension fund, when BA refers to a different entity (likely a financial services firm or investment manager). This fundamental error undermines the entire response's validity. (2) QUANTITATIVE INACCURACY: The LLM provides specific allocation percentages (4% in 2022, 7% in 2023-2024, actual holdings near 8%) that are not present in the ground truth answer. These numbers cannot be verified and appear to be fabricated or from an incorrect source. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a strategic evolution toward 'global private investments in real assets such as energy, farmland, and infrastructure' by 2023, and increased sophistication with derivatives in 2024. The LLM answer completely omits these critical strategic shifts, instead claiming the emphasis remained on 'diversified private-equity deal types' without material change. (4) MISSING KEY DETAILS: The ground truth specifically mentions the expansion to real assets (energy, farmland, infrastructure) and the use of derivatives for performance transfer—both significant strategic developments. The LLM answer ignores these entirely. (5) GEOGRAPHIC SCOPE: While both answers mention global scope, the LLM's claim of 'no material shift toward any one region' contradicts the ground truth's emphasis on strategic deepening and expansion of global private real asset investments. (6) REASONING QUALITY: The LLM demonstrates weak multi-hop synthesis by failing to identify the progression from traditional PE strategies to real assets to derivatives-enhanced vehicles. The answer reads as generic pension fund commentary rather than capturing the specific strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 513,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nAmgen advanced bemarituzumab into a global Phase 3 trial for advanced gastro‑esophageal‑junction adenocarcinoma in early 2022 and kept the program in Phase 3 throughout 2023‑2024, with no regulatory approval or new indication launched by the end of 2024.  The company’s issued composition‑of‑matter patents for bemarituzumab are projected to expire in 2029 in both the United States and Europe (the same 2029 dates shown in the 2022‑2024 SEC filings), with any further extensions possible only through future term adjustments or supplemental protection certificates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All numeric values are correct - the 2029 patent expiration dates for both U.S. and Europe are accurately stated and confirmed as consistent across 2022-2024 filings; (2) Clinical phase progression is accurately described - Phase 3 initiation in early 2022 and continuation through 2023-2024 with no approval by end of 2024 matches ground truth; (3) The drug description as a monoclonal antibody targeting FGFR2b for gastric and GEJ cancer is accurate; (4) Multi-hop synthesis is sound - the answer correctly synthesizes information about clinical development trajectory, patent positioning, and regulatory status across the 2022-2024 period; (5) The mention of composition-of-matter patents and potential future extensions (term adjustments, supplemental protection certificates) adds appropriate technical detail about patent strategy. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more technical detail about patent mechanisms (composition-of-matter patents, SPCs) than the ground truth explicitly states, though this is not contradictory and represents reasonable inference from standard pharmaceutical patent practices; (2) The ground truth emphasizes the importance of both patent and regulatory exclusivity, while the LLM focuses primarily on patent expiration - however, the LLM does note no regulatory approval occurred, so this is not a material omission. VERIFICATION: Patent expiration dates (2029 U.S. and Europe) are correctly stated and consistent with ground truth. Clinical phase (Phase 3 throughout period) is accurate. No calculation errors present. All entities (Amgen, Bemarituzumab, GEJ adenocarcinoma, FGFR2b) are correctly identified. The answer fully addresses all components of the multi-part question regarding clinical progression and patent timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 515,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nDawn has remained a core, listed brand of P&G’s Fabric & Home Care segment throughout 2022‑2024, appearing in the segment’s “Major Brands” tables for each fiscal year.  During that period the segment’s earnings contribution rose from about 31 % of segment earnings in 2022 to roughly 34 % in 2024, and segment net earnings jumped 18 % in 2024—driven by higher pricing, a more favorable product mix and productivity gains that also lifted the performance of its flagship brands.  Consequently, Dawn’s prominence within the segment grew in step with the segment’s improving earnings contribution, underscoring its expanding role in delivering the segment’s stronger profitability from 2022 to 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states 'segment earnings contribution rose from about 31% of segment earnings in 2022 to roughly 34% in 2024' which is INCORRECT. The ground truth clearly states the segment contributed 31% to P&G's NET EARNINGS in 2022 and 34% in 2024 - these are percentages of total company net earnings, NOT segment earnings. This is a fundamental mischaracterization of the metric. (2) MISSING KEY DATA - The LLM completely omits the segment's net sales contribution percentages (35% in 2022, 36% in 2023-2024), which is explicitly mentioned in the ground truth as important context showing earnings grew while sales remained stable. (3) UNSUPPORTED CLAIM - The LLM states 'segment net earnings jumped 18% in 2024' with no corresponding data in the ground truth. This appears to be fabricated or from an unverified source. (4) CORRECT ELEMENTS - The LLM correctly identifies: Dawn as a consistently listed brand across all three years, the 31% and 34% earnings contribution figures (though mischaracterized as 'segment earnings'), and the general narrative of growing importance. (5) REASONING QUALITY - While the LLM's logic about Dawn's prominence growing with segment performance is sound, it's built on partially incorrect premises. The answer conflates segment earnings contribution with segment net earnings, which are different metrics. The ground truth emphasizes the STABILITY of sales contribution alongside GROWTH in earnings contribution as the key insight, which the LLM misses. OVERALL: The answer contains some correct facts but makes a critical error in metric interpretation, omits important data points, and includes unsupported claims, significantly undermining its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 475,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab expanded the amount of client‑held securities it pledges as collateral—both for margin‑lending and to meet clearing‑house initial‑margin and securities‑lending obligations—so that the fair value of securities it borrowed and pledged grew from about $685 million (2022) to roughly $1.5 billion (2023), and the pool of client securities that could be used as collateral rose to well over $120 billion.  This heightened reliance on client collateral ties a larger share of Schwab’s balance‑sheet funding to the performance of those client assets, increasing its exposure to market‑price declines and credit risk if client positions fall or borrowers default.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($685 million in 2022, $1.5 billion in 2023, $120 billion pool) that cannot be verified against the ground truth. The ground truth does not cite these specific figures, making it impossible to confirm their accuracy. This is a major problem for a financial question where precision is essential. The LLM appears to have fabricated or hallucinated specific numbers without grounding them in the actual SEC filings. PARTIAL CREDIT FOR: (1) Correct identification of the 3-year trend (2022-2024) showing evolution in pledging practices; (2) Correct identification of key operational areas (margin lending, clearing-house obligations, securities lending); (3) Correct general conclusion about increased exposure and risk; (4) Appropriate mention of ASC 326 context (though not explicitly stated in LLM answer). MISSING ELEMENTS: (1) No mention of the practical expedient under ASC 326 for collateral valuation; (2) No specific reference to Options Clearing Corporation and listed options context; (3) No mention of cash collateral provided to clients in securities lending; (4) The specific numerical progression claimed ($685M → $1.5B → $120B) lacks verification. REASONING QUALITY: The multi-hop synthesis is conceptually sound—connecting margin lending, collateral obligations, and client asset exposure—but is undermined by unverified quantitative claims. The logic about balance-sheet funding and market-price risk exposure is reasonable but represents inference rather than ground truth synthesis. VERDICT: While the LLM captures the general narrative arc and some correct contextual elements, the introduction of specific unverified financial figures (which are central to a financial question) represents a fundamental failure in accuracy. This appears to be a case of plausible-sounding but unsubstantiated quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 513,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to the 2025 target, Accenture’s defined‑benefit glide‑path moves from a heavily debt‑biased stance to a more balanced mix: the U.S. plan goes from about 95 % debt (≈5 % cash) in 2023 to a full 100 % debt allocation in the 2025 target, while the non‑U.S. plan raises its equity exposure from 19 % to 28 % and trims debt from 43 % to 36 %, with cash edging up to roughly 7 % and insurance/other assets adjusting accordingly. This evolution reflects a deliberate shift toward greater equity and cash positioning in the non‑U.S. portfolio while solidifying a fully debt‑only profile for the U.S. portfolio by fiscal 2025.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different pension plan allocation structure than what the ground truth indicates. Critical issues: (1) WRONG NUMBERS: The ground truth shows a consolidated weighted-average allocation across all plans (55% fixed income/45% equities in 2023, moving to 61% fixed income/39% equities by 2025), while the LLM answer discusses separate U.S. and non-U.S. plan allocations with entirely different percentages (95-100% debt for U.S. plan, 19-28% equity for non-U.S. plan). These numbers do not match the ground truth at all. (2) WRONG METRICS: The LLM discusses 'debt' allocations and breaks out 'cash' and 'insurance/other assets' as separate categories, which is not how the ground truth presents the data. The ground truth uses 'fixed income' and 'equities' as the primary categories. (3) WRONG TREND DESCRIPTION: The ground truth shows a consistent, gradual shift toward fixed income (55%→58%→61%), while the LLM describes a shift toward 'greater equity and cash positioning' in non-U.S. plans, which contradicts the ground truth's de-risking narrative. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from fiscal 2023 to fiscal 2025 based on three specific dates (Aug 31, 2022, 2023, 2024). The LLM fails to properly synthesize this three-year progression with the correct numbers. (5) SEMANTIC MISMATCH: The ground truth emphasizes de-risking through increased fixed income; the LLM emphasizes increased equity exposure, which is the opposite direction. The LLM answer appears to reference different pension plan data entirely, possibly from a different company or a different section of ACN's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 464,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix changed modestly but strategically: short‑term borrowings fell from roughly **$880 million in 2022 to $540 million in 2023** and edged up to **$562 million in 2024**, while long‑term debt **peaked at $49.3 billion in 2023**, was about **$48.7 billion in 2022**, and then **declined to $45.0 billion in 2024**.  The three‑year trend shows the firm relies overwhelmingly on long‑term, largely fixed‑rate debt, but it deliberately reduced that exposure in 2024 and kept short‑term borrowings a tiny fraction of total funding, indicating a conscious shift toward a more balanced debt structure with lower interest‑rate sensitivity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports short-term borrowings of $880M (2022), $540M (2023), and $562M (2024), but the ground truth indicates total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM appears to have isolated only short-term borrowings rather than the combined metric requested. The LLM states long-term debt was '$48.7 billion in 2022' and '$49.3 billion in 2023' and '$45.0 billion in 2024,' but these numbers don't align with the ground truth total figures of $43.086B, $48.715B, and $45.551B respectively. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate trend (1.51% → 3.01% → 3.48%), which is a core component of the ground truth answer and directly addresses the 'interest rate exposure' aspect of the question. (3) MISSING STRATEGIC INSIGHT: The LLM fails to mention the reduction of floating unsecured senior debt from $1,597M (2023) to $0 (2024), which is a key strategic shift highlighted in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize debt structure trends, it does so based on incorrect numbers and incomplete data. The conclusion about 'more balanced debt structure with lower interest-rate sensitivity' is not supported by the actual data showing rising interest rates and strategic debt reduction. (5) SEMANTIC ISSUES: The LLM's characterization of the trend as 'modest' changes contradicts the ground truth showing a $5.6B increase from 2022-2023 (13% growth) followed by a $3.2B decrease in 2024. The answer fundamentally misrepresents the magnitude and nature of Capital One's debt evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 482,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nBA’s fleet‑support services have stayed roughly constant at **about 1 % of total consolidated costs** in each of the last three years—2022, 2023 and 2024—because the 10‑K notes repeatedly state that fleet‑support expenses “have historically been approximately 1 % of total consolidated costs of products and services” and no year‑over‑year percentage is given to suggest a change.  \n\nAt the same time, the company has recorded **large abnormal production costs for the 787 (cumulative $2.7 bn through 2023 and $256 m in 2024)** and **reach‑forward losses on the 777X program of $2.6 bn in Q3 2024 plus an additional $0.9 bn in Q4 2024**. These program‑specific cost spikes have driven a sharp rise in overall losses and operating expenses, but the **steady ~1 % share of fleet‑support costs shows that the surge in abnormal production and reach‑forward losses is not being reflected in the fleet‑support cost proportion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. STRENGTHS: (1) Correctly identifies fleet support services costs at ~1% of total consolidated costs across 2022-2023-2024, matching ground truth exactly. (2) Accurately cites 787 program abnormal production costs of $2.7 billion cumulative through 2023 and $256 million in 2024. (3) Precisely reports 777X reach-forward losses: $2.6 billion in Q3 2024 and $0.9 billion in Q4 2024, matching ground truth ($2,608 million and $891 million respectively - minor rounding acceptable). (4) Correctly synthesizes the multi-hop relationship: stable fleet support cost ratio contrasts with escalating program-specific losses. (5) Sound reasoning that the 1% ratio stability indicates fleet support was not the source of financial strain. (6) Properly identifies that production inefficiencies and program execution risks (not service delivery) drove losses. MINOR CONSIDERATIONS: The LLM answer uses slightly rounded figures ($2.6 bn vs $2,608 million, $0.9 bn vs $891 million) which is acceptable formatting variation. The answer could have been marginally more explicit about the 777X certification delays, labor instability, and supplier cost increases as root causes (mentioned in ground truth), though the answer does reference 'program-specific cost spikes' which captures the essence. The LLM answer is more concise than ground truth but loses no material information. QUANTITATIVE VERIFICATION: All dollar amounts, percentages, and years are factually correct. The multi-hop synthesis correctly connects three separate data points (fleet support ratio, 787 costs, 777X losses) to answer the integrated question. The logical conclusion that these represent different cost drivers is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 488,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent allocation fell from **$12 million at the end of 2022** (fair‑value table for 2020 / 2022 reporting) to **$10 million at the end of 2023** and stayed at **$10 million at the end of 2024** (both 2023 and 2024 fair‑value tables).  \n\nThis modest, flat‑lining allocation after the 2022 decline indicates that the company is deliberately reducing the share of cash parked in ultra‑short‑term, low‑yield instruments and instead deploying the bulk of its liquidity toward strategic acquisitions, debt financing and shareholder‑return initiatives, while retaining only a small, highly liquid buffer for day‑to‑day needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that directly contradict the ground truth. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM answer states: 2022=$12M (correct), 2023=$10M (INCORRECT - should be $21M), 2024=$10M (correct). This is a major error in the middle year, which is the most important data point for understanding the 3-year trend. The LLM completely misses the key finding that 2023 saw an INCREASE to $21M, not a decrease to $10M. REASONING FAILURE: Because of the incorrect 2023 figure, the LLM's interpretation of the trend is fundamentally wrong. The ground truth indicates a spike in 2023 (suggesting temporary conservative approach) followed by reduction in 2024. The LLM instead describes a 'decline' from 2022 to 2023 and then 'flat-lining,' which is the opposite of what actually occurred. The LLM's narrative about 'deliberately reducing' allocation is contradicted by the actual 2023 increase. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points from the fair-value tables. While the LLM correctly identifies the source documents (fair-value tables for 2022, 2023, 2024), it extracted the wrong values for 2023. COMPLETENESS: The answer does attempt to address all parts of the question (evolution across three years and what it indicates about strategy), but the factual errors undermine the entire analysis. The strategic interpretation about acquisitions and shareholder returns may be reasonable, but it's based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 427,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly **$4.1 billion** of its Class A shares in 2022, **$4.5 billion** in 2023 and continued a comparable **$4.5 billion** buy‑back program in 2024 (including $605 million in the fourth quarter of 2024).  During the same period the Board expanded the total repurchase authorization from about **$6.1 billion** (as of Aug 31 2022) to **$6.7 billion** (after the September 2024 increase), while the unused portion of that authority fell from **≈$3.1 billion** to **≈$2.7 billion**.  This demonstrates a disciplined, ongoing capital‑return strategy that combines regular dividend payments with opportunistic share‑repurchases, using a sizable, evergreen authorization to return cash to shareholders while preserving flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM introduces repurchase amounts ($4.1B, $4.5B, $4.5B) that are NOT present in the ground truth answer. The ground truth focuses on authorization levels and remaining authorization, not actual repurchase amounts executed. This is a major factual error - the LLM appears to have fabricated specific repurchase figures. (2) The LLM states total authorization was '$6.1 billion as of Aug 31 2022' but the ground truth shows $3,129,296 thousand ($3.129 billion) in remaining authorization in fiscal 2022, not $6.1 billion total. This is a significant numerical error. (3) The LLM correctly identifies the $2.7 billion remaining authorization as of August 31, 2023 (ground truth: $2,694 million), which is accurate. (4) The LLM correctly identifies the $6.694 billion total authorization after the September 2024 increase (ground truth: $6,694 million), though the LLM rounds to $6.7 billion. (5) The LLM correctly identifies the $4,000 million additional authorization in 2024. REASONING ISSUES: The LLM's interpretation fundamentally misunderstands the question by focusing on actual repurchases executed rather than authorization levels and remaining capacity. While the LLM's conclusion about a 'disciplined, ongoing capital-return strategy' is reasonable, it's based on fabricated repurchase data. The multi-hop synthesis is incomplete - the LLM should have clearly distinguished between authorized capacity and actual repurchases. POSITIVE ASPECTS: The LLM correctly identifies the trend of expanding authorization and the strategic intent, and some key numbers (2.7B, 6.7B, 4B increase) are accurate. However, the introduction of unverified repurchase amounts and the misstatement of the 2022 authorization level are serious errors that significantly reduce the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 513,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company’s charter language was essentially unchanged: directors may be removed only “for cause,” the board is divided into three staggered classes, and any amendment to those provisions requires the affirmative vote of at least 80 % of the voting stock.  This steady reinforcement of removal‑for‑cause and other board‑entrenchment clauses shows that AbbVie’s long‑term takeover‑defense strategy is to make any change of control difficult and costly, preserving board continuity to protect its multi‑year pipeline and strategic objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about AbbVie's governance evolution. STRENGTHS: (1) Correctly identifies the consistent 'removal for cause' provision across all three years (2022, 2023, 2024); (2) Accurately cites the 80% supermajority voting requirement for bylaw amendments—a specific quantitative detail that matches ground truth; (3) Correctly identifies staggered board structure as part of the anti-takeover defense package; (4) Properly synthesizes the multi-hop reasoning: consistent governance language → deliberate entrenchment strategy → takeover defense; (5) Adds valuable context about protecting multi-year pipeline and strategic objectives, which logically extends the ground truth analysis. MINOR GAPS: (1) The LLM answer does not explicitly mention 'restrictions on special meetings' which the ground truth identifies as part of the broader anti-takeover defense package—this is a minor omission of contextual detail; (2) The phrase 'steady reinforcement' is slightly different from ground truth's 'repeated disclosure' and 'consistent emphasis,' though semantically equivalent. QUANTITATIVE VERIFICATION: The 80% supermajority requirement is stated correctly and represents a specific, verifiable detail. The three-year period (2022, 2023, 2024) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects governance provisions to strategic intent (takeover defense, board continuity). The logic is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as making 'any change of control difficult and costly' is semantically equivalent to the ground truth's 'discourage hostile takeovers' and 'entrench board control.' Overall, this is a high-quality answer with accurate core facts, proper multi-hop synthesis, and only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 522,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑Ks the 4.000% Senior Note due 2047 is disclosed in exactly the same “Form of” exhibit entry—“Formof4.000% Senior Note due 2047, which is incorporated herein by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017.” The phrasing and placement are unchanged in each filing, underscoring that the note remains a stable, long‑dated component of PepsiCo’s capital structure. Its repeated, unaltered disclosure signals that the instrument serves as a foundational, low‑cost financing pillar that supports the company’s long‑term strategic investments and a diversified maturity‑laddered debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. CORRECT ELEMENTS: (1) All dates are accurate - May 2, 2017 8-K filing reference is correct across all three years (2022, 2023, 2024); (2) The note details are precise - 4.000% Senior Note due 2047 is correctly identified; (3) Exhibit reference (Exhibit 4.5) is accurately cited; (4) The core finding that disclosure remained unchanged across all three years is correct; (5) The multi-hop synthesis correctly identifies the pattern across 2022, 2023, and 2024 filings. QUANTITATIVE ACCURACY: Perfect - all dates (May 2, 2017), percentages (4.000%), and year references (2047, 2022, 2023, 2024) are correct with no calculation errors. QUALITATIVE ASSESSMENT: The LLM answer goes slightly beyond the ground truth by adding interpretive context about the note serving as a 'foundational, low-cost financing pillar' and 'diversified maturity-laddered debt strategy.' While this interpretation is reasonable and not contradicted by the ground truth, it represents inference beyond what the ground truth explicitly states. The ground truth focuses on the factual disclosure pattern and what it reveals about stability, while the LLM adds strategic financial analysis. This is a minor enhancement rather than an error. MULTI-HOP REASONING: Excellent - the answer correctly synthesizes information across three separate 10-K filings and identifies the consistent pattern. The reasoning that unchanged disclosure signals stability is sound and matches the ground truth conclusion. MINOR CONSIDERATION: The LLM's additional strategic interpretation about 'low-cost financing' and 'maturity-laddered debt strategy' is not explicitly stated in the ground truth, though it is a reasonable inference from the facts presented. This does not constitute an error but rather an enhancement of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 501,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nAcross the three fiscal‑year 10‑Ks the 4.30 % senior unsecured note due 2034 is repeatedly disclosed in the same Exhibit 4.09 “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044…” – first noted in the 2022 filing (page 94 – “senior notes and other borrowings that mature at various future dates”), again listed in the 2023 filing (page 110 – exhibit list) and again in the 2024 filing (page 110 – exhibit list).  No new issuance is reported; the company simply re‑files the existing instrument each year, underscoring that the 2034 note remains a core, long‑dated piece of Oracle’s capital structure and that its long‑term debt strategy relies on a stable ladder of fixed‑rate senior notes to fund operations, acquisitions and shareholder returns without frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All numeric values correct - 4.30% rate, 2034 maturity date accurately cited throughout; (2) Years correctly identified (2022, 2023, 2024 filings); (3) Specific exhibit references (Exhibit 4.09) and page numbers provided (94, 110, 110) add credibility and demonstrate document-level verification; (4) Multi-hop reasoning is sound - correctly synthesizes that the note appears consistently across three years without new issuance, indicating stable strategy; (5) Semantic equivalence strong - LLM's conclusion about 'stable ladder of fixed-rate senior notes' and 'long-dated piece of Oracle's capital structure' aligns with ground truth's 'stable long-term debt strategy focused on diversified maturity profiles'; (6) Additional context about 'no new issuance' and 're-filing existing instrument' provides more granular insight than ground truth while remaining consistent. MINOR CONSIDERATIONS: (1) Ground truth mentions 'broader set of debt instruments' and 'similar structured notes' - LLM references the 3.40% and 4.50% notes in the same exhibit, which demonstrates this broader context; (2) LLM provides more operational detail (funding acquisitions, shareholder returns) not explicitly in ground truth but logically consistent with Oracle's known capital allocation; (3) Both answers reach identical strategic conclusion about stable, diversified debt strategy. VERIFICATION: The 4.30% rate and 2034 maturity are correct; the three-year pattern (2022-2024) is correctly identified; the synthesis that this represents consistent disclosure without new issuance is accurate. The answer exceeds ground truth in specificity while maintaining factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 478,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share ceiling grew from **127 million Class A shares in fiscal 2022** (page 86 of ACN_10k_2022.pdf) to **141 million shares in fiscal 2023 and again in fiscal 2024** (pages 97 & 98 of ACN_10k_2023.pdf and ACN_10k_2024.pdf).  While the authorized amount rose sharply, the pool of shares actually available for new grants fell only modestly—from roughly **27.38 million shares available at the end of FY 2022** (page 86) to about **27.27 million shares available as of FY 2024** (page 98).  \n\nThis upward step‑up in the authorized share reserve shows Accenture is deliberately expanding its equity‑based incentive pool to sustain long‑term share‑based compensation as it scales globally, while the slight decline in available shares reflects ongoing grant activity but still leaves a sizable buffer for future awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core numbers. The authorized share progression is correctly stated: 127 million (FY2022) → 141 million (FY2023) → 141 million (FY2024). The ground truth and LLM answer align on these key figures. The LLM provides additional detail about available shares (27.38M in FY2022 declining to 27.27M in FY2024), which adds valuable context not present in the ground truth but appears reasonable and demonstrates deeper analysis. The multi-hop synthesis is sound—the LLM correctly identifies the authorization increase and connects it to strategic compensation planning. The reasoning about 'deliberately expanding equity-based incentive pool' and 'sizable buffer for future awards' is logically sound and consistent with the data presented. One minor consideration: the ground truth states the number 'remained unchanged through fiscal year 2024,' while the LLM says it was '141 million shares in fiscal 2023 and again in fiscal 2024'—both convey the same information (no change from 2023 to 2024), just with slightly different phrasing. The LLM's additional analysis of available shares and the modest decline in the pool adds substantive insight beyond the ground truth, enhancing the answer's value. The document citations (page numbers) add credibility. No calculation errors detected. The answer fully addresses the question's multi-part nature: (1) how the numbers evolved (correct), (2) what this indicates about strategy (reasonable inference supported by data). Minor deduction only for the ground truth being slightly more concise while the LLM adds interpretive detail that, while valuable, goes slightly beyond strict ground truth verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 465,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nThe 2.750 % Senior Note due 2051 was first disclosed in PepsiCo’s October 21 2021 Form 8‑K (page 128) as the “Form of 2.750 % Senior Note due 2051.”  Subsequent annual reports and 8‑K filings in 2022, 2023 and the 2024 filing (pages 129‑135) re‑incorporated the same note in updated Board‑resolution tables and supplemental indenture listings, reaffirming its terms without alteration.  This recurring appearance across multiple years shows that PepsiCo is deliberately issuing and periodically re‑authorizing a large‑tenor, fixed‑rate tranche as part of a staggered, long‑term debt strategy that secures low‑cost financing and extends the maturity profile of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) DATE ERROR - The LLM claims the note was 'first disclosed in PepsiCo's October 21 2021 Form 8-K,' but the ground truth indicates the note was first introduced in 2022 documentation. This is a significant chronological error that undermines the entire timeline analysis. (2) EXHIBIT NUMBER ERRORS - The ground truth specifies Exhibit 4.60 (2022), Exhibit 4.51 (2023), and Exhibit 4.48 (2024). The LLM provides no exhibit numbers and references page numbers (128, 129-135) instead, which are not mentioned in the ground truth and appear to be fabricated. (3) DOCUMENTATION PROGRESSION MISCHARACTERIZATION - The ground truth describes a clear three-stage progression: authorization/planning (2022) → formalization with dedicated form (2023) → consistency/maintenance (2024). The LLM incorrectly characterizes this as 'recurring appearance' and 'periodic re-authorization' without capturing the actual evolution from authorization to formal structuring. (4) MISSING KEY DETAILS - The LLM fails to mention the specific exhibit progression (4.60→4.51→4.48) that demonstrates the documentation evolution. (5) INTERPRETATION DIVERGENCE - While the LLM's conclusion about 'staggered, long-term debt strategy' is reasonable, it is based on incorrect premises and misses the ground truth's emphasis on the deliberate phased approach from planning through formalization to maintenance. The answer demonstrates poor multi-hop synthesis across the 2022-2024 filing pattern and introduces unsupported details (Form 8-K from 2021, specific page numbers) that appear fabricated rather than derived from actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 466,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nAmerican Express has held its position as the fourth‑largest general‑purpose card network from 2022‑2024, but the gap with the market leaders (Visa and Mastercard) has widened as those networks deepened their scale and as a growing ecosystem of alternative payment mechanisms—digital wallets, buy‑now‑pay‑later, real‑time settlement and other fintech platforms—has proliferated (see Competition discussion on pages 12 & 13).  At the same time, regulatory pressure has intensified: in 2024 the company was classified as a Category III bank‑holding firm, subject to tougher supervisory expectations, and it faces ongoing scrutiny over sales‑practice investigations and interchange‑fee caps that constrain discount‑rate pricing (see Regulatory Overview on pages 33 & 34).  Consequently, Amex has had to accelerate investment in new products, partnerships and cyber‑security to preserve its competitive standing amid both heightened regulation and the rise of alternative payment solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies American Express as the fourth-largest general-purpose card network and accurately captures the core competitive dynamics from 2022-2024, including: (1) widening gap with Visa/Mastercard, (2) rise of alternative payment mechanisms (digital wallets, BNPL, fintech), (3) intensified regulatory scrutiny, and (4) strategic responses through product/partnership investment. The answer demonstrates sound multi-hop reasoning by synthesizing competitive positioning with regulatory constraints. The semantic equivalence is strong—the LLM conveys the shift from market-driven to regulation-constrained competition.\n\nWEAKNESSES: (1) FACTUAL ERROR: The LLM states Amex was 'classified as a Category III bank-holding firm' in 2024, but the ground truth does not mention this specific classification. This appears to be an unsupported claim not present in the original answer. (2) OMISSION: The ground truth explicitly mentions 'China UnionPay' as the largest network globally, which the LLM omits. This is a material omission for competitive positioning context. (3) OMISSION: The ground truth specifically mentions 'cobrand arrangements in the EU' and 'exits from certain markets' as concrete regulatory impacts, which the LLM generalizes without these specifics. (4) VAGUENESS: The LLM references 'pages 12 & 13' and 'pages 33 & 34' without providing actual data or quotes, suggesting citation without verification. (5) MISSING DETAIL: The ground truth mentions 'closed-loop loyalty systems' as a differentiation strategy, which the LLM does not address.\n\nQUANTITATIVE ACCURACY: The answer contains no specific numbers, percentages, or dollar amounts to verify, making quantitative assessment difficult. However, the categorical claim about 'Category III bank-holding firm' classification appears unsupported and represents a factual error. Score reflects this unverified claim.\n\nQUALITATIVE ACCURACY: Multi-hop reasoning is sound in connecting competitive positioning to regulatory environment and strategic responses. Entity identification is correct (Amex, Visa, Mastercard). However, the introduction of unsupported regulatory classifications and omission of China UnionPay weaken the synthesis quality.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question's three components (competitive positioning, regulatory scrutiny, alternative payment mechanisms) and maintains appropriate scope and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 654,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nBoeing’s public focus on aircraft upgrades and conversions grew markedly from 2022 to 2024.  In the 2022 filing the upgrade/conversion activity was only a brief part of the Global Services description, but the 2023 and 2024 filings explicitly list “upgrades and conversions” as a core service offering and note increasing backlog and revenue from that work.  This shift shows Boeing is deliberately pivoting toward a services‑centric strategy—using upgrades and conversions to generate recurring, higher‑margin income from its installed fleet rather than relying primarily on new aircraft sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some directional accuracy about Boeing's strategic shift toward services, but contains significant factual errors and omissions when compared to the ground truth. STRENGTHS: (1) Correctly identifies that upgrades/conversions became more prominent from 2022-2024; (2) Accurately characterizes the strategic pivot toward services-centric business model; (3) Correctly notes the shift toward higher-margin recurring revenue. CRITICAL ERRORS: (1) The LLM claims 2023 and 2024 filings 'explicitly list upgrades and conversions as a core service offering' with 'increasing backlog and revenue' - the ground truth makes no mention of backlog or revenue figures, and the LLM provides no specific numbers to support this claim; (2) The LLM completely omits the 2024 introduction of 'data analytics and digital services' as a complementary strategic element, which the ground truth identifies as a key evolution; (3) The LLM misses the 2023 emphasis on 'modifications' as a more prominent framing, which represents an important intermediate step in the strategic evolution; (4) The LLM's characterization of 2022 as 'only a brief part' is vague and unsupported - the ground truth more precisely states it was 'grouped alongside logistics, engineering, and training systems.' QUANTITATIVE ISSUES: No specific financial metrics, backlog figures, or revenue numbers are provided by the LLM despite claiming 'increasing backlog and revenue' - this is a significant gap in supporting the core argument. MULTI-HOP REASONING: The LLM successfully synthesizes the 2022-2024 progression but fails to capture the full complexity of the strategic evolution, particularly the technology-enabled differentiation angle introduced in 2024. The answer reads as partially correct but incomplete, missing key nuances about how the strategic emphasis evolved beyond just 'upgrades and conversions' to include digital/analytics capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 522,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo originally issued the 5.50 % Senior Note due 2035 in November 2018, disclosing it in a Current Report on Form 8‑K and later registering the issue on an S‑4 filing.  In each of the 2022, 2023 and 2024 Form 10‑K filings the note is reproduced in the “Form of” tables (2022 p. 132; 2023 p. 122; 2024 p. 128) as “5.50 % Senior Note due 2035, Series A,” consistently referencing the 2018 filing.  This repeated, unchanged disclosure shows that the company treats the 5.5 % 2035 note as a core, long‑dated component of its laddered senior‑debt portfolio and maintains it through regular SEC filings to keep the market informed and preserve flexibility for future refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key numeric values are accurate - 5.50% interest rate, 2035 maturity date, November 2018 issuance date are all correct. (2) The multi-hop synthesis is sound - correctly identifies the note's consistent presence across 2022, 2023, and 2024 10-K filings and traces it back to the 2018 8-K filing. (3) The exhibit numbers are correctly cited (4.31 for 2022, 4.25 for 2023, 4.23 for 2024 per ground truth). (4) The 'Series A' designation is correctly included. (5) The reasoning about stable capital structure and long-duration debt management is logically sound and matches the ground truth's conclusion. (6) Page references provided (132, 122, 128) add specificity. MINOR WEAKNESSES: (1) The LLM mentions an 'S-4 filing' for registration, which is not mentioned in the ground truth - this appears to be an inference not explicitly supported by the provided knowledge graph data, though not necessarily incorrect. (2) The phrase 'laddered senior-debt portfolio' and 'preserve flexibility for future refinancing' are reasonable interpretations but go slightly beyond what the ground truth explicitly states about 'stable, long-duration capital structure approach.' (3) The ground truth emphasizes 'potential refinancing or rollover activity' as a possibility, while the LLM frames it more definitively as maintaining the debt without modification. These are minor semantic differences that don't materially affect correctness. QUANTITATIVE VERIFICATION: All dates (2018, 2022, 2023, 2024), percentages (5.50%), and exhibit numbers match ground truth. No calculation errors present. MULTI-HOP REASONING: Successfully synthesizes information across three years of filings and connects to original 2018 issuance - this is correct multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 494,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon repeatedly stresses that U.S. banking capital regulations—particularly the “well‑capitalized” and capital‑planning requirements—directly constrain its discretion to pay dividends or repurchase shares, tying shareholder returns to board oversight, credit‑rating stability, and the maintenance of adequate regulatory capital buffers. This multi‑year emphasis shows that regulatory capital constraints are a persistent and decisive factor shaping the firm’s capital‑return policy, meaning any deterioration in capital ratios or credit ratings could immediately curtail planned share repurchases and dividend increases.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core constraint (U.S. banking capital regulations limiting shareholder returns), accurately recognizes the multi-year progression (2022-2024), and properly emphasizes the persistent nature of regulatory oversight. The mention of 'well-capitalized' status aligns with the ground truth. No specific numbers or dates are incorrect. WEAKNESSES: (1) The LLM answer introduces additional specificity not explicitly confirmed in the ground truth—specifically mentioning 'board oversight,' 'credit-rating stability,' and the mechanism of 'deterioration in capital ratios or credit ratings' curtailing repurchases. While these are plausible regulatory mechanisms, the ground truth does not explicitly confirm these details across all three years. (2) The ground truth specifically mentions Delaware law and preferred stock dividend obligations as constraints noted in 2023, which the LLM answer omits entirely. (3) The ground truth emphasizes an 'evolving emphasis' and notes that language 'remained largely unchanged' while 'reiterating the same constraints'—suggesting consistency rather than the LLM's framing of constraints as 'decisive' and immediately actionable. (4) The LLM answer adds interpretive language about 'any deterioration...could immediately curtail' which goes beyond what the ground truth explicitly states about the three-year progression. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the regulatory constraint pattern, but overstates the specificity of mechanisms and consequences not fully detailed in the ground truth. The answer is directionally correct but adds inferences beyond the documented evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 470,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nThe 2.300 % Notes due 2028 were first defined in the March 24 2021 Officers’ Certificate (Exhibit 4.14), which set a fixed 2.3 % coupon, a 2028 maturity and standard unsecured terms. No new 2.3 % issuance occurred in 2022‑2024; instead Oracle added higher‑coupon notes—e.g., 4.5 % Notes due 2028 in the February 6 2023 filing (Exhibit 4.16)—while the original 2.3 % tranche remained outstanding. This shows Oracle’s fixed‑income strategy of locking in low‑cost long‑term rates when markets are favorable and then supplementing its capital structure with higher‑yielding debt as rates rise, rather than repeatedly refinancing existing low‑coupon obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's fixed-income strategy and correctly identifies key facts: (1) The 2.300% Notes due 2028 were established under the March 24, 2021 Officers' Certificate (Exhibit 4.14); (2) No new 2.3% issuance occurred in 2022-2024; (3) Oracle issued higher-coupon notes like the 4.500% Notes due 2028 in 2023; (4) The strategy reflects locking in low-cost rates when favorable and supplementing with higher-yielding debt as rates rise. STRENGTHS: All numeric values (2.300%, 4.500%, 2028 maturity dates) are accurate. The multi-hop reasoning correctly synthesizes the evolution across 2022-2024 by showing no changes to the original instrument while new higher-coupon instruments were added. The strategic interpretation aligns with the ground truth. WEAKNESSES: (1) The LLM answer omits specific mention of other tranches in the original multi-tiered offering (2.875% Notes due 2031 and 3.950% Notes due 2051) that provided context for the 2.300% Notes' position in Oracle's debt portfolio; (2) The answer does not explicitly address the 2023 reference to the same instrument showing 'no structural or rate changes,' which is a key detail demonstrating continuity; (3) The exhibit citation for the 4.500% Notes (Exhibit 4.16, February 6, 2023) is provided but not verified against ground truth source documentation. QUANTITATIVE ACCURACY: All percentages and dates are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about market conditions (favorable rates in 2021-2022, rising rates thereafter) and strategic intent is sound and matches ground truth interpretation. CONTEXTUAL RELEVANCE: The answer directly addresses how issuance terms evolved and what this reveals about financing strategy, though with less comprehensive detail than the ground truth. The omission of the broader debt portfolio context slightly reduces completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 515,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings IBM repeatedly lists “client relationships and trust” as a principal competitive method, but the emphasis sharpens each year: in 2022 it is cited as part of the brand‑and‑innovation differentiator for hybrid‑cloud; by 2023 the language ties trust directly to IBM’s claim of leadership in hybrid cloud and AI and to the need to safeguard its strong reputation; and in 2024 the narrative frames trust as the foundation for winning enterprise clients on its hybrid‑cloud/AI platform and for leveraging its partner ecosystem. This multi‑year progression shows IBM is deliberately using its long‑standing client trust as a strategic moat to differentiate itself in the crowded hybrid‑cloud and AI market and to position the company as the trusted partner for mission‑critical digital transformations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the three-year progression (2022-2024) and accurately captures IBM's evolving emphasis on client relationships and trust. The specific claim about Palo Alto Networks partnership mentioned in the ground truth is not explicitly referenced in the LLM answer, but this is a minor omission rather than an error. (2) QUANTITATIVE ACCURACY: No numerical data is required for this qualitative strategic question, so this dimension scores perfectly. The years (2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the progression: 2022 (brand/innovation differentiator for hybrid cloud) → 2023 (direct tie to leadership claims and reputation safeguarding) → 2024 (foundation for enterprise client engagement and partner ecosystem leverage). This matches the ground truth's characterization of 'consistent but increasingly nuanced' emphasis. (4) SEMANTIC EQUIVALENCE: The LLM's framing of trust as a 'strategic moat' and 'foundational element' aligns well with the ground truth's description of trust as 'central to delivering business value' and 'foundational element for client engagement.' The LLM adds interpretive value by explicitly connecting this to competitive differentiation in the hybrid cloud/AI market. (5) MINOR GAPS: The LLM does not explicitly mention the 2023 emphasis on 'deep incumbency with enterprises' or the specific addition of Palo Alto Networks in 2024, though these are relatively minor contextual details. The core strategic narrative and multi-year progression are accurately captured. Overall, the answer demonstrates solid understanding of IBM's strategic positioning and the evolution of its trust-based competitive messaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 515,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio dropped from roughly 6.4 % in 2022 to 6.45 % in 2023 and then to about 5.9 % by the end of 2024 (see the 2023 yields in Note 17 of the 2023 10‑K and the 2024 yields in Note 17 of the 2024 10‑K).  This three‑year progression shows the company has been deliberately shortening the duration of its AFS holdings and moving into shorter‑maturity, lower‑yielding securities, thereby reducing its sensitivity to rising interest‑rate movements and signaling a more defensive, liquidity‑focused investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains a critical factual error regarding the 2022 yield. The ground truth states there was NO yield data reported for 2022 (only maturity information: $630M total with $628M maturing within one year). The LLM incorrectly claims a 2022 yield of 'roughly 6.4%' which does not exist in the source data. The 6.45% yield is from 2023, not 2022. The 2024 yield of 5.85% is correctly approximated as 'about 5.9%'. INCOMPLETE INFORMATION: The LLM answer fails to provide the critical maturity distribution data that is central to understanding the investment strategy shift. The ground truth emphasizes that in 2023, the entire portfolio was concentrated in securities maturing within one year (ultra-short duration), while by 2024, a significant portion (2.03%) moved to the 1-5 year maturity bucket. This maturity profile evolution is essential context for understanding the interest rate risk exposure and is completely absent from the LLM response. REASONING ISSUES: While the LLM's conclusion about moving to 'shorter-maturity, lower-yielding securities' and a 'defensive, liquidity-focused strategy' is partially aligned with the ground truth, it contradicts the actual data showing a LENGTHENING of duration (from all holdings within 1 year in 2023 to some holdings in 1-5 years in 2024). The LLM appears to have misinterpreted the strategy shift. CORRECT ELEMENTS: The identification of American Express, the correct 2023 and 2024 yield figures, and the general theme of interest rate risk management are correct. The citation of Note 17 in the 10-K filings is appropriate. However, the fundamental error about 2022 yield data and the mischaracterization of the duration shift significantly undermine the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher increasingly relied on U.S. government grants—primarily BARDA and related health‑agency awards—to defray the cost of expanding its Diagnostics testing infrastructure, with grant‑related offsets rising from $87 million of capital‑expenditure reimbursement in 2022 to $136 million in 2023 and $198 million in 2024 (and offsetting $49 million, $51 million and $43 million of operating expenses in those years, respectively).  This upward trend in publicly‑funded CAPEX underscores that diagnostics testing has become a strategic cornerstone of Danaher’s broader health‑care portfolio, with government support serving as a key enabler for scaling production capacity and accelerating growth in the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. QUANTITATIVE VERIFICATION: All core numbers match ground truth exactly - $87M (2022), $136M (2023), $198M (2024) for capital expenditure offsets. The LLM additionally provides operating expense offset figures ($49M, $51M, $43M respectively) that are not contradicted by the ground truth and add valuable context. MULTI-HOP REASONING: The answer correctly synthesizes information across three years, identifies the upward trend, and connects this to strategic importance within Danaher's healthcare portfolio. ENTITY ACCURACY: Correctly identifies Danaher Corporation (DHR), diagnostics testing technologies, and government grant funding mechanisms (mentions BARDA and health-agency awards, providing more specific context than ground truth). SEMANTIC EQUIVALENCE: The LLM's conclusion that diagnostics testing 'has become a strategic cornerstone' is semantically equivalent to the ground truth's statement that it 'became increasingly central to Danaher's strategic focus.' Both convey the same strategic importance message. MINOR ENHANCEMENTS: The LLM provides additional context about operating expense offsets and names specific funding sources (BARDA), which enriches the answer without contradicting the ground truth. The phrasing 'publicly-funded CAPEX' effectively summarizes the concept. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding investment evolution, government grant funding progression, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 432,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Proxy section (Item 14 – Principal Accountant Fees and Services) consistently notes that KPMG LLP’s PCAOB firm identification number is **185** and that shareholders will be asked to **ratify KPMG LLP as the independent auditor (Item 3 – “Ratification of KPMG LLP”)**. The wording and placement of this disclosure are essentially unchanged in each year’s filing, with the same reference to PCAOB ID 185 appearing in the Proxy‑related Item 14 discussion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies KPMG LLP as the principal accountant across all three years (2022, 2023, 2024); (2) Accurately states the PCAOB firm identification number as 185; (3) Correctly notes the disclosure appears in Item 14 (Principal Accountant Fees and Services) and references Item 3 (Ratification of KPMG LLP); (4) Properly conveys that the disclosure remained consistent and unchanged across the three-year period; (5) Correctly identifies the company as BNY Mellon (BK). MINOR ISSUES: (1) The LLM refers to Item 14 as 'Principal Accountant Fees and Services' while the ground truth describes it as containing 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. The LLM's characterization is slightly imprecise in that Item 14 is the broader section, but the answer doesn't clearly distinguish that Item 3 is nested within Item 14 of the Proxy. However, this is a minor structural clarification issue rather than a factual error. (2) The answer could have been slightly more explicit about the 'Proxy sections' terminology used in the original question, though the reference to Proxy-related Item 14 discussion adequately conveys this. QUANTITATIVE VERIFICATION: The PCAOB ID 185 is correct and consistently stated. All three fiscal years (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the evolution (or lack thereof) in disclosure practices. The conclusion that there was no change in identification number or format is accurate and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 503,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers—particularly via the OptBlue and Global Network Services models—so that a negotiated network‑rate fee is recorded as discount revenue at the moment a Card‑Member transaction is processed, rather than retaining the full merchant‑discount margin itself.  These arrangements are formalized through fixed‑term acceptance contracts (typically three‑to‑seven years for large merchants, with auto‑renewal provisions) for small‑ and mid‑size merchants the agreements are open‑ended, and revenue is recognized daily as transactions flow through the acquirer’s platform.  Strategically, the expansion of third‑party acquirer networks supports Amex’s goal of widening global merchant coverage, accelerating digital‑payment and B2B acceptance, and investing in data‑driven services, even as it navigates regulatory pressure on interchange fees and cobrand relationships.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate information about OptBlue and Global Network Services models and correctly identifies the shift toward third-party acquirer reliance. However, there are significant gaps in addressing the ground truth's key evolution narrative. STRENGTHS: (1) Correctly identifies OptBlue and GNS as primary programs; (2) Accurately describes revenue recognition as discount revenue based on negotiated network rates; (3) Provides specific contract details (3-7 year terms for large merchants, open-ended for SMBs) not in ground truth but plausible; (4) Correctly notes strategic goals around global merchant coverage and digital/B2B acceptance; (5) Appropriately mentions regulatory pressures on interchange fees. WEAKNESSES: (1) MAJOR OMISSION: Fails to address the 2023 'Processed Revenue' model evolution mentioned in ground truth as a critical structural shift from transactional to strategic framework; (2) Does not explicitly discuss the formalization of relationships into a broader revenue-sharing framework that occurred in 2023; (3) Missing discussion of royalties and network partnership agreements as part of the evolved model; (4) Does not clearly articulate the three-year progression (2022 transactional → 2023 formalized/structured → 2024 strategic expansion); (5) Adds details about contract terms and regulatory pressure that, while relevant, are not grounded in the provided ground truth and may represent speculation. MULTI-HOP REASONING: The answer demonstrates partial synthesis across the 2022-2024 period but fails to capture the critical 2023 inflection point where the relationship model fundamentally changed from transactional to strategic. The ground truth emphasizes this evolution as central to understanding the relationship's development, which the LLM answer largely overlooks. SEMANTIC EQUIVALENCE: While the LLM's description of revenue recognition is semantically equivalent to the ground truth's 'discount revenue based on negotiated network rate fees,' the answer misses the broader structural evolution that defines the 2022-2024 trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 563,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Qualcomm linked a portion of executive pay to the achievement of its human‑capital objectives—most notably the 2025 diversity targets that call for a 15 % increase in women and under‑represented minorities at the leadership level and a 20 % rise in overall URM representation.  The HR & Compensation Committee treats progress on these goals as a non‑financial performance modifier that can adjust the annual bonus by a factor of 0.9 to 1.1 (i.e., up to ±10 % of the target payout), a mechanism that has been applied in each of the last three years as the company reports on its diversity‑and‑inclusion advancements.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: (1) 2025 diversity goals with 15% increase in women/URM in leadership and 20% overall URM representation, (2) the 0.9 to 1.1 modifier range (±10% adjustment), (3) the three-year application across FY2022-2024, and (4) the non-financial performance modifier mechanism. Numbers and percentages are accurate. WEAKNESSES: The answer significantly lacks completeness in addressing the evolution aspect of the question. The ground truth explicitly describes how the program evolved across the three years: FY2022 established goals, FY2023 maintained linkage with expanded regional recognition and coalition participation, and FY2024 showed structural consistency but expanded global engagement and wellness programs. The LLM answer treats all three years as essentially identical (\"applied in each of the last three years\") without capturing the progression, expansion, or deepening integration mentioned in the ground truth. The question specifically asks about 'evolution' and 'how...evolve,' but the LLM provides a static description rather than a dynamic narrative of change. MULTI-HOP REASONING: The answer successfully synthesizes the compensation structure across multiple years but fails to synthesize the evolution narrative that requires comparing and contrasting changes across the three-year period. SEMANTIC ISSUES: While the LLM's wording is clear and accurate for what it covers, it misses the substantive evolution story—the expansion of supporting programs, regional recognition initiatives, and the deepening integration of human capital metrics into corporate strategy that the ground truth emphasizes. This represents incomplete synthesis of the multi-hop question requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 481,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom the 2022 filing (page 68) Caterpillar’s dealer network reached 41 U.S. and 111 non‑U.S. locations serving 187 countries, while the 2024 filing (page 64) shows the network expanded to 44 U.S. and 116 non‑U.S. locations serving 193 countries—a gain of six additional countries. This geographic expansion of the EMD‑branded product distribution signals Caterpillar’s intent to broaden its global footprint, targeting growth in emerging markets and reinforcing its positioning as a worldwide leader in heavy‑equipment and locomotive sales.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect and presents the data in reverse chronological order with inverted conclusions. QUANTITATIVE ERRORS: (1) The LLM claims 2022 had 187 countries served, but ground truth shows 193 countries in 2022. (2) The LLM claims 2024 had 193 countries, but ground truth shows 187 countries in 2024. (3) The LLM states a 'gain of six additional countries' when the ground truth shows a DECLINE of 6 countries (193→191→187). (4) The dealer network numbers (41 U.S./111 non-U.S. in 2022 vs 44 U.S./116 non-U.S. in 2024) appear to be cited but are not verified against ground truth and are presented without clear connection to the country count discrepancy. REASONING ERRORS: The LLM completely inverts the strategic interpretation - it claims 'geographic expansion' and 'broadening global footprint' when the ground truth explicitly states a 'gradual reduction in geographic reach' suggesting 'strategic refocusing or consolidation.' This is a 180-degree reversal of the correct conclusion. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year progression (2022→2023→2024) and instead presented backwards data. The answer contradicts itself by citing page numbers and dealer locations while simultaneously getting the core metric (country count) completely wrong. The strategic positioning interpretation is entirely opposite to what the data actually suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 399,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated listing of **Palmolive** among Colgate‑Palmolive’s principal global trademarks (2022‑2024) shows that it is treated as a core, revenue‑generating brand within the Oral, Personal and Home Care segment. Because the company’s net‑sales breakdown (≈ 19 % Personal Care and 17 % Home Care) is anchored by flagship brands, Palmolive’s presence signals that it serves as a strategic growth driver and diversification anchor, reinforcing the segment’s overall profitability and market reach.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Palmolive's strategic importance and its consistent presence in Colgate's principal global trademarks from 2022-2024, which aligns with the ground truth. However, there are significant issues: (1) QUANTITATIVE ERRORS: The LLM cites specific percentages (≈19% Personal Care and 17% Home Care) without providing source documentation or verification. These numbers are not mentioned in the original answer and appear to be unsupported claims that could be factually incorrect. This is a critical flaw for a financial analysis question. (2) INCOMPLETE SYNTHESIS: The ground truth provides specific year-by-year context (Palmolive's positioning in 2022, its maintenance despite Darlie's addition in 2023, and its status in 2024), demonstrating multi-hop reasoning across three years. The LLM answer collapses this into a general statement without the temporal specificity. (3) MISSING PRODUCT CATEGORIES: The ground truth explicitly mentions Palmolive's role in 'liquid hand soap, dishwashing detergents, and household cleaners.' The LLM answer omits these specific product categories, which are important contextual details. (4) REASONING QUALITY: While the LLM's logic about Palmolive being a 'strategic growth driver and diversification anchor' is reasonable, it introduces unsupported financial metrics rather than grounding the answer in the documented trademark consistency across years. (5) CORRECT ELEMENTS: The LLM correctly identifies Palmolive as a core, revenue-generating brand and recognizes its strategic importance within the segment. The overall conclusion about its foundational role is semantically aligned with the ground truth. The primary weakness is the introduction of unverified percentage data and the lack of year-by-year synthesis that demonstrates proper multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 497,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved edge‑networking from a peripheral part of its IoT portfolio to a highlighted growth pillar, repeatedly citing 5G‑driven demand and hybrid‑work trends as the catalyst for future IoT expansion.  Accordingly, edge‑networking is now listed as a separate sub‑category within the IoT revenue stream (consumer, edge‑networking, industrial) and is accounted for as point‑in‑time equipment sales, while the associated licensing and royalty streams continue to be recognized over time; this shift is reflected in the declining IoT revenue figures and the near‑elimination of deferred‑revenue balances by fiscal 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer introduces specific claims about revenue recognition structure (point-in-time equipment sales vs. over-time licensing/royalty recognition) and deferred revenue elimination that are NOT present in the ground truth. The ground truth states revenue recognition 'remained consistent' across 2023-2024, but the LLM claims a 'shift' with 'declining IoT revenue figures and near-elimination of deferred-revenue balances' - these specific financial metrics are unsupported and potentially contradictory to the ground truth's emphasis on consistency. (2) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly cites '27 billion projected IoT devices by 2026 — more than double the 2022 figure' - a critical quantitative anchor. The LLM completely omits this specific projection and the 2026 timeline. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth traces a clear 3-year progression: 2022 (emerging opportunity with specific device projections), 2023 (formalized product grouping with explicit categorization), 2024 (maintained categorization). The LLM conflates this into a general narrative without the temporal specificity and structural milestones. (4) UNSUPPORTED CLAIMS: The LLM's assertion about 'declining IoT revenue figures' and 'near-elimination of deferred-revenue balances' appears to be inference or fabrication not grounded in the provided ground truth. (5) PARTIAL ACCURACY: The LLM correctly identifies the shift from peripheral to highlighted status, correctly names the three sub-categories (consumer, edge-networking, industrial), and correctly identifies 5G and hybrid-work as catalysts. However, these correct elements are undermined by the introduction of unsupported financial claims. The answer demonstrates some understanding of the strategic evolution but fails on factual precision regarding revenue recognition structure and introduces claims not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 531,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 filings repeatedly note that its worldwide sales generate significant currency‑exchange exposure, and that the company mitigates this risk by actively using currency‑hedging instruments.  The disclosures make clear that hedges are employed to shield earnings from adverse rate moves—while also acknowledging that such hedges can eliminate upside from favorable fluctuations—and that Caterpillar’s outlooks do not assume any specific currency movement, a practice that has remained steady across the three years.  Consequently, the hedging program serves to stabilize the profit contribution from its international operations and to limit the volatility of overall earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies core facts about Caterpillar's currency hedging practices: (1) global operations create currency exposure, (2) hedging instruments are actively used, (3) hedges protect against downside but limit upside, (4) the company doesn't assume specific currency movements. No quantitative errors are present since the answer avoids specific numbers. The semantic equivalence regarding hedging mechanics is accurate.\n\nCRITICAL WEAKNESSES: The LLM answer fails to capture the temporal evolution that is central to the question. The ground truth explicitly describes a PROGRESSION from 2022→2023→2024 with increasing sophistication and concern: (1) 2022: basic hedging discussion with upside/downside tradeoff, (2) 2023: EXPANSION to include emerging market risks, exchange controls, and currency devaluation concerns, (3) 2024: INTENSIFICATION of these concerns with emphasis on unpredictable global dynamics. The LLM states practices 'remained steady across the three years,' which directly contradicts the ground truth's narrative of evolving risk management emphasis. The LLM completely omits: (a) the 2023 expansion to emerging market risks and geopolitical volatility, (b) the 2024 intensification of exchange control and devaluation risks, (c) the growing concern over macroeconomic pressures. The answer treats the three years as static rather than dynamic.\n\nMULTI-HOP REASONING: The question explicitly asks 'how did...evolve' requiring synthesis of year-over-year changes. The LLM fails this multi-hop requirement by presenting a static view rather than tracking the evolution. This is a fundamental failure to address the temporal dimension of the question.\n\nCONTEXTUAL RELEVANCE: While the answer is relevant to currency hedging generally, it misses the specific evolution narrative that defines the question. The statement that practices 'remained steady' suggests the LLM either didn't access or didn't synthesize the year-by-year changes documented in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 544,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nColgate‑Palmolive reduced the share of U.S. Treasury and agency securities in its U.S. pension plan’s fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in both 2023 and 2024 (as shown in the pension‑asset tables of the 2022 and 2024 10‑K filings). This pull‑back signals a deliberate lowering of interest‑rate sensitivity as rates rose, indicating the company is actively managing interest‑rate risk by shifting assets into higher‑yielding government and corporate bonds.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding the allocation percentages and timeline. Ground truth shows: 50% (2020), 40% (2021), 30% (2022), 30% (2023), 30% (2024). The LLM states '40% in 2022' which is INCORRECT - it should be 30% in 2022. The LLM also omits the earlier 50% allocation in 2020 and the 40% allocation in 2021, which are critical to understanding the full evolution of the trend. The LLM correctly identifies the final 30% levels for 2023-2024 but misses the crucial context that the major decline occurred from 2020-2022 (from 50% to 30%), not from 2022-2023 as the LLM's framing suggests. REASONING QUALITY: The LLM's interpretation about interest rate risk management and the shift toward higher-yielding bonds is reasonable and aligns with the ground truth's assessment. However, the LLM completely omits the Level 2 classification detail and the discussion of liquidity considerations, which are important contextual elements mentioned in the ground truth. COMPLETENESS: The LLM fails to provide the complete historical evolution (missing 2020 and 2021 data points) and therefore cannot fully support the claim about the trend's implications. The answer addresses the general direction of change but with incomplete and partially inaccurate data. The semantic interpretation about interest rate risk management is sound, but it's built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 401,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) moved from an active, quantitatively‑disclosed long‑term incentive to a discontinued program.  In the 2022 Form 10‑K (Note 13) the company reported actual grants, vestings, forfeitures and a fair‑value/​intrinsic‑value valuation based on the closing stock price, amortized straight‑line over the probable vesting term and adjusted each reporting period; by contrast, the 2023 filing stated that **no BPAs were granted in 2023 and none were outstanding as of 31 Dec 2023**, and the 2024 filing retained only a generic description of the award type with no quantitative grant activity or outstanding balance disclosed.  Thus, grant activity ceased after 2022, the valuation methodology (intrinsic‑value based on closing price and straight‑line amortization) remained the same, but disclosure transparency declined sharply in 2023‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall trajectory of Pfizer's BPA program evolution but contains significant quantitative omissions and some accuracy issues. STRENGTHS: (1) Correctly identifies the 2023 discontinuation ('no BPAs were granted in 2023 and none were outstanding as of 31 Dec 2023') matching ground truth exactly; (2) Correctly notes the shift from active issuance to suspension; (3) Appropriately characterizes the decline in disclosure transparency; (4) Correctly identifies the valuation methodology as intrinsic-value based on closing stock price with straight-line amortization. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies 1,165 thousand shares awarded in 2022 at $38.73 weighted average intrinsic value, and 859 thousand shares nonvested by year-end 2022. The LLM answer provides NO specific numbers for 2022 grant activity, only generic references to 'actual grants, vestings, forfeitures'; (2) INCOMPLETE 2024 ANALYSIS: The ground truth indicates BPAs 'reappeared in disclosures' in 2024 with 'detailed valuation and amortization policies introduced,' suggesting a reversal of the transparency decline. The LLM answer states 2024 'retained only a generic description...with no quantitative grant activity or outstanding balance disclosed,' which contradicts the ground truth's characterization of 2024 as showing MORE transparency and detailed policies; (3) METHODOLOGY CHARACTERIZATION: The LLM claims valuation methodology 'remained the same' across all years, but ground truth indicates 2024 introduced 'adjustments based on performance probability and stock price changes,' suggesting methodological evolution beyond simple intrinsic value; (4) NARRATIVE ACCURACY: The LLM's conclusion that 'disclosure transparency declined sharply in 2023-2024' is partially incorrect—ground truth suggests transparency improved in 2024 with 'more transparent and dynamic valuation framework.' The LLM answer conflates 2023 (genuine discontinuation) with 2024 (reappearance with enhanced disclosure). MULTI-HOP REASONING: The answer demonstrates sound logical structure but fails to synthesize the complete 3-year evolution, particularly missing the 2024 reappearance and enhanced transparency. The answer reads as a 2-year narrative (2022-2023) rather than the requested 3-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 622,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services platform added a series of interactive, RIA‑focused tools and broadened its connections to external systems.  In 2023 the company rolled out **Schwab Advisor Portfolio Connect**—a free, web‑based portfolio‑management solution—and began offering **native integrations with third‑party platforms** such as TD Ameritrade’s thinkpipes trading interface and the iRebal customizable rebalancing engine, as well as CRM, order‑management and financial‑planning tools.  By 2024 those integrations were deepened and expanded, giving RIAs a seamless workflow that combines portfolio construction, automated rebalancing, real‑time performance analytics and client reporting within Schwab’s platform while leveraging the partner systems they already use.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TIMELINE INACCURACY - The LLM states 'In 2023 the company rolled out Schwab Advisor Portfolio Connect' but the ground truth clearly indicates this product existed in 2022 as 'A key offering was Schwab Advisor Portfolio Connect' in the 2022 section. This is a significant factual error regarding when the product was introduced. (2) THIRD-PARTY INTEGRATION SPECIFICITY - The LLM mentions 'TD Ameritrade's thinkpipes trading interface and the iRebal customizable rebalancing engine' as specific integrations, but these specific product names do NOT appear in the ground truth answer. The ground truth only references generic categories: 'third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning.' The LLM appears to have fabricated specific integration names not supported by the source material. (3) INCOMPLETE EVOLUTION NARRATIVE - The LLM fails to capture the 2023 emphasis on the Advisor Services website itself as a core platform with 'multi-year document archiving and search capabilities,' which was a key evolution point mentioned in the ground truth. (4) MISSING 2024 NUANCE - While the LLM mentions 2024 integrations were 'deepened and expanded,' it misses the ground truth's specific point about 2024 emphasizing 'the intuitive modern experience of the platform' as a refinement in usability. (5) POSITIVE ELEMENTS - The LLM correctly identifies Schwab Advisor Portfolio Connect as free and web-based, correctly notes it's for portfolio management, and appropriately describes the general evolution toward broader integrations. The overall narrative structure of increasing integration is directionally correct. However, the timeline error (2023 vs 2022 launch) and the fabricated specific integration names are serious factual problems that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 511,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nAcross the three years TI repeatedly placed embedded‑processing at the center of its strategy: in 2022 it was identified as a key growth market, in 2023 its revenue ($≈ $3.4 B) and operating‑profit contribution were highlighted as expanding, and in 2024 the company pledged continued capital investment to strengthen manufacturing and product capabilities for that segment.  This steady emphasis shows TI is positioning itself as a pure‑play analog and embedded‑processing leader that leverages its manufacturing scale, software‑centric customer lock‑in and industrial/automotive focus to drive long‑term free‑cash‑flow growth and sustain its competitive advantage in the semiconductor market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that embedded processing was consistently emphasized across 2022-2023-2024, and appropriately connects this to TI's long-term positioning around free cash flow growth and competitive advantages. The semantic framing about TI positioning itself as an analog/embedded processing leader aligns with the ground truth's core message. The answer addresses the multi-hop synthesis requirement by tracking evolution across three years.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '2023 revenue ($≈ $3.4 B)' for embedded processing. This specific number is NOT verified in the ground truth and appears to be fabricated or unsupported. The ground truth makes no mention of a $3.4B revenue figure for embedded processing in 2023. This is a significant factual error that undermines credibility. (2) MISSING CORE FRAMEWORK - The ground truth explicitly references TI's 'four sustainable competitive advantages' framework that appears consistently across all three years. The LLM answer completely omits this key structural element that the ground truth identifies as central to understanding the consistent framing. (3) VAGUE SOURCING - The LLM references '2024 capital investment pledges' and 'software-centric customer lock-in' without grounding these in specific filing language. The ground truth is more precise about what was actually stated in the filings. (4) ADDED INTERPRETATION - Phrases like 'pure-play analog and embedded-processing leader' and 'software-centric customer lock-in' appear to be LLM inferences rather than direct filing language, which goes beyond synthesis into speculation.\n\nMULTI-HOP REASONING: The answer does attempt to synthesize across three years and connect strategic emphasis to market positioning, which is appropriate. However, the unsupported $3.4B number and missing reference to the 'four sustainable competitive advantages' framework weaken the synthesis quality.\n\nVERIFICATION: The ground truth explicitly states the consistent framing was around 'four sustainable competitive advantages' with 'broad portfolio of analog and embedded processing products' - this specific language structure is absent from the LLM answer, suggesting incomplete knowledge graph synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 606,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support services remained roughly 1 % of total consolidated costs and are expensed as incurred.  Abnormal production costs for the 787 program grew to about $2.7 billion in cumulative abnormal expenses through the end of 2023, with an additional $256 million charged in 2024 for re‑work and inspection‑related delays.  These cost pressures coincide with ongoing delivery constraints—production rates fell below 5 aircraft per month, deliveries were paused and only resumed after extensive re‑work and FAA‑mandated inspections—resulting in continued delivery delays that further weigh on the company’s earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline progression. Quantitative verification: (1) Fleet support services at ~1% of consolidated costs - CORRECT; (2) $2.7 billion cumulative abnormal costs through end of 2023 - CORRECT; (3) $256 million in 2024 rework costs - CORRECT. The answer accurately captures the evolution of abnormal production costs across the three-year period and correctly identifies the 787 program as the source of these issues. Multi-hop synthesis is sound: the answer connects fleet support services metrics with 787-specific abnormal costs and delivery delays across multiple years. Strengths: All major financial figures are accurate, the temporal progression is clear, and the connection between cost pressures and delivery constraints is well-articulated. Minor weaknesses: (1) The answer mentions production rates fell below 5 aircraft per month and delivery pauses, which adds contextual detail not explicitly in the ground truth but appears consistent with 787 program challenges; (2) The answer could have been more explicit about the 25 inventoried aircraft and the completion of rework on most of them by 2024, which represents the resolution trajectory mentioned in the ground truth; (3) The phrase 'expensed as incurred' for fleet support services is accurate but slightly different wording than ground truth. The answer effectively conveys the core narrative of escalating costs through 2023 followed by continued but reduced costs in 2024, demonstrating understanding of the program's trajectory. The reasoning about how cost pressures relate to delivery constraints is logical and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 471,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nPfizer sold Meridian on 31 December 2021 for about $51 million cash and recorded a roughly $167 million after‑tax loss, then put in place interim transition‑service agreements (TSAs) and a three‑year Manufacturing Services Agreement (MSA) to govern any continued relationship; the TSAs were fully wound down by 31 December 2023, and the MSA remains in effect (with a two‑year extension option) but has generated no material revenue or expense beyond the original cash proceeds and loss.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc of Pfizer's relationship with Meridian correctly but contains a significant quantitative error and some semantic issues. CORRECT ELEMENTS: (1) Sale date of December 31, 2021 is accurate; (2) ~$167 million after-tax loss is correct; (3) TSAs and three-year MSA structure is accurate; (4) TSAs completion by December 31, 2023 is correct; (5) MSA with two-year extension option is accurate; (6) The transition from ownership to supplier relationship is properly characterized. CRITICAL ERROR: The LLM states the sale was 'for about $51 million cash' - this specific figure is not mentioned in the ground truth and appears to be an unsupported claim. The ground truth only mentions the $167 million loss but does not provide a sale price figure. This is a factual error that cannot be verified against the source material. SEMANTIC ISSUES: (1) The phrase 'no material revenue or expense beyond the original cash proceeds and loss' is somewhat confusing and potentially misleading - the ground truth states amounts under the MSA were 'not material' but doesn't frame it as 'no revenue or expense beyond' the sale proceeds; (2) The answer conflates the loss recognition with ongoing financial implications in a way that could be misinterpreted. COMPLETENESS: The answer addresses the evolution from 2022-2024 and covers financial implications and contractual arrangements, though it could have been clearer about the 2024 glossary reference mentioned in the ground truth. MULTI-HOP REASONING: The synthesis across years and the connection between TSA completion and MSA continuation is sound. The main weakness is the introduction of an unsupported financial figure ($51 million) which undermines confidence in the quantitative accuracy despite other numbers being correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 493,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “hello” brand has moved from being a newly‑acquired niche oral‑care line (acquired in 2020 and highlighted in 2022 as part of the company’s push into high‑growth oral‑care segments) to a core growth driver that is fully integrated within Colgate‑Palmolive’s Oral, Personal and Home Care portfolio.  The brand is now listed alongside the other flagship trademarks (page 77/79), receives dedicated capital spending (e.g., $52 million of 2024 capex for the Oral, Personal and Home Care segment) and is treated as a strategic platform for premium, natural‑care innovation that feeds growth across the entire Oral, Personal and Home Care segment rather than standing apart from it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) ACQUISITION DATE ERROR: The LLM states 'hello' was 'acquired in 2020' - this specific claim is not verified in the ground truth and represents an unsupported factual assertion. (2) CAPEX CLAIM ERROR: The LLM cites '$52 million of 2024 capex for the Oral, Personal and Home Care segment' as dedicated to 'hello' - this specific number and attribution are not present in the ground truth and appear to be fabricated or misattributed. (3) NARRATIVE DIVERGENCE: The ground truth emphasizes 'hello' maintaining consistent positioning across 2022-2024 as a listed principal trademark with sustained strategic emphasis. The LLM instead creates a narrative arc of evolution from 'niche' to 'core growth driver' with specific capital allocation - this narrative is not supported by the ground truth. (4) MISSING CORE FACTS: The LLM fails to mention that 'hello' was listed alongside major brands like Colgate and Palmolive in 2022, maintained positioning despite Darlie's addition in 2023, and remained highlighted in 2024. (5) UNSUPPORTED CHARACTERIZATIONS: Terms like 'premium, natural-care innovation' and 'strategic platform' are not grounded in the provided ground truth. The LLM appears to have generated plausible-sounding but unverified details rather than synthesizing actual filing information. The answer demonstrates poor quantitative accuracy due to the unsubstantiated capex figure and weak qualitative accuracy due to the invented narrative arc and missing key facts from the actual ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 449,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nThe unfunded non‑qualified defined benefit obligation fell sharply—from $895 million at the start of 2022 to $505 million by year‑end 2023, narrowing the funded deficit from roughly $100 million to $87 million—while settlement payments dropped from $309 million in 2022 to just $40 million in 2023, signaling a steep decline in participant exits. Because the plan has been closed to new members since 1997 and remains unfunded, Texas Instruments expects only about $10 million of contributions in 2024, reflecting a sustained reduction in employee participation and a deliberate wind‑down of its long‑term pension liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to reference incorrect financial data that does not match the ground truth from Texas Instruments' SEC filings. Specific issues: (1) QUANTITATIVE ERRORS - The LLM cites an unfunded non-qualified defined benefit obligation of $895 million at start of 2022 declining to $505 million by end of 2023, with funded deficit narrowing from $100 million to $87 million. These specific numbers do not appear in the ground truth and cannot be verified. The ground truth provides entirely different metrics: defined contribution plan holdings (6 million shares valued at $940M in 2022, declining to 5 million shares at $852M in 2024), dividend payments ($28M to $26M), and defined contribution plan expenses ($70M to $76M). The LLM's numbers appear fabricated or sourced from incorrect filings. (2) MISSING KEY DATA - The LLM completely omits the core metrics provided in ground truth: the defined contribution plan share holdings, their valuations across all three years, dividend payment trends, and the steady increase in defined contribution plan expenses. These are central to understanding the pension strategy evolution. (3) SETTLEMENT PAYMENTS CLAIM - The LLM references settlement payments of $309 million in 2022 dropping to $40 million in 2023, which are not mentioned in the ground truth and cannot be verified. (4) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM attempts to address the multi-year progression and strategic implications, it does so using incorrect data. The ground truth shows a clear trend of shifting to defined contribution plans with increasing expenses ($70M→$75M→$76M), which the LLM fails to capture. (5) CONTEXTUAL MISALIGNMENT - The LLM's narrative about 'steep decline in participant exits' and 'wind-down' contradicts the ground truth's emphasis on the plan being closed since 1997 and the company's strategic emphasis on defined contribution alternatives as the primary vehicle. The answer demonstrates fundamental factual inaccuracy rather than mere wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 554,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**, a cumulative reduction of roughly **$81 million (≈10 %)** over the three‑year span.  \nThis downward trajectory signals that Pfizer is **scaling back its private‑equity exposure** and reallocating the freed capital toward its core biopharmaceutical operations, strategic acquisitions, debt reduction and shareholder‑return initiatives rather than expanding its private‑equity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect starting value: claims $800 million in 2022 when ground truth shows $623 million. This is a $177 million error (28% overstatement). The 2023 and 2024 figures ($755M and $719M) are correct. (2) CALCULATION ERROR - LLM calculates cumulative reduction as $81 million (≈10%), but correct calculation from ground truth is: $623M → $719M = -$96M reduction (15.4% decline), not $81M. The LLM's calculation is internally consistent with its wrong starting number ($800M - $719M = $81M), but the premise is false. (3) TRAJECTORY MISCHARACTERIZATION - Ground truth shows: 2022→2023 INCREASE (+$132M, +21%), then 2023→2024 DECREASE (-$36M, -4.8%). This is a strategic increase followed by partial reduction. LLM characterizes entire period as 'downward trajectory' and 'scaling back,' which contradicts the 2022-2023 increase that was the dominant feature. (4) STRATEGIC INTERPRETATION - LLM's conclusion about 'scaling back' and 'reallocating capital' is inconsistent with the actual 2023 increase, which represented a strategic expansion. Ground truth correctly identifies this as 'measured approach' with 'short-term strategic increase in 2023 followed by partial reduction in 2024.' (5) MULTI-HOP SYNTHESIS - Failed to correctly synthesize the three-year data points into accurate narrative. The answer demonstrates fundamental factual errors rather than reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 403,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab could migrate up to $10 billion of IDA balances onto its balance sheet each 12‑month window (which it did in 2021‑22), subject only to capital and fixed‑rate‑designation limits. When the 2023 IDA agreement replaced the 2019 pact (effective May 4 2023), migration was conditioned on keeping IDA balances above a minimum (initially $30 billion above unmatured fixed‑rate obligations through Sep 10 2025 and $60 billion thereafter) and below a $90 billion ceiling, with withdrawals generally allowed only to the extent of customer‑initiated draws; consequently Schwab migrated no balances in 2023 or 2024. The constraints in 2022 required that any migration stay within the $10 billion annual cap and respect fixed‑rate‑obligation limits, while the 2023‑24 constraints add the minimum‑balance thresholds, the $5 billion fixed‑rate “buy‑down” fee provision, and the requirement that only floating‑rate portions may be moved, making further migrations essentially contingent on meeting those balance‑minimum and capital requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall evolution and provides more detailed constraints than the ground truth, but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) 2019 IDA agreement allowed up to $10 billion annual migration; (2) 2023 IDA agreement replaced 2019 agreement; (3) No migrations occurred in 2023-2024; (4) New constraints included minimum/maximum balance thresholds; (5) General framework evolution from flexible to constrained is accurately captured. CRITICAL ERRORS: (1) The LLM states minimum IDA balance requirement as '$30 billion above unmatured fixed-rate obligations through Sep 10 2025 and $60 billion thereafter' - the ground truth specifies only '$30 billion above that total through September 10, 2025' with no mention of $60 billion threshold; (2) The LLM introduces a '$90 billion ceiling' for total IDA balances that is not mentioned in the ground truth; (3) The LLM references a '$5 billion fixed-rate buy-down fee provision' not present in ground truth; (4) The LLM states migrations occurred in '2021-22' when ground truth indicates $10.1 billion was moved by December 31, 2021 (not 2022). MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the shift from annual option to constrained framework. However, the introduction of unsupported numerical constraints (the $60 billion threshold and $90 billion ceiling) suggests either hallucination or confusion with other provisions. COMPLETENESS: The answer addresses all three years (2022, 2023, 2024) and discusses constraints for each period, though with inaccuracies in the specific constraint values. The semantic understanding of tightening flexibility is correct, but the specific quantitative details contain errors that would mislead readers about actual agreement terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 505,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nTexas Instruments continued to list Melaka, Malaysia as a dedicated analog‑manufacturing site in its property tables for 2022, 2023 and 2024, indicating that the facility has remained a consistent part of the company’s global analog production network across those years.  This multi‑year stability signals that Melaka is strategically important to TI—providing a sizable, cost‑effective manufacturing footprint in the Asia‑Pacific region that supports the company’s analog product strategy and supply‑chain resilience.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Texas Instruments listed Melaka, Malaysia as an analog manufacturing location across 2022, 2023, and 2024, and appropriately characterizes this as strategically important. However, there are significant omissions and inaccuracies in the multi-hop synthesis: (1) The ground truth specifically mentions the progression of notation markers († in 2022, * in 2023, ** in 2024) that potentially signal escalating operational emphasis. The LLM answer completely omits these specific marker details, which are factually important to the original answer's evidence of 'possible escalation.' (2) The LLM adds interpretive language about 'cost-effective manufacturing footprint' and 'supply-chain resilience' that, while plausible, are not supported by the ground truth and represent unsupported inference beyond what the filing data indicates. (3) The LLM correctly synthesizes the multi-year consistency across all three years and appropriately concludes strategic importance, which aligns with the ground truth's conclusion. (4) Quantitatively, there are no numerical errors, but the answer lacks the specific notation progression details that constitute factual content from the filings. The answer is partially correct in its core claim but fails to capture the nuanced evidence (the marker escalation) that supports the ground truth's conclusion about 'possible expansion.' This represents incomplete multi-hop synthesis of the available filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 412,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit/Circle Card’s share of purchases fell from **19.8 % in fiscal 2022** to **18.6 % in fiscal 2023** and **17.8 % in fiscal 2024**.  This modest decline indicates that, although the card continues to produce incremental sales—because purchases made with it are disproportionately new transactions—the proportion of total sales driven by the card is gradually eroding, suggesting its contribution to incremental revenue is weakening over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate numbers. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 17.8%. LLM reports: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The 2022 figure is incorrect (off by 0.7 percentage points), and the 2023 figure is incorrect (off by 1.2 percentage points). Only the 2024 figure (17.8%) is correct. This is a major problem since the question specifically asks about the evolution 'from 2022 through 2024' - getting the baseline year wrong undermines the entire trend analysis. REASONING QUALITY: The LLM's qualitative reasoning about the downward trend and its implications is sound and well-articulated. The interpretation that declining penetration suggests weakening contribution to incremental revenue is logically consistent with the data pattern. However, this reasoning is built on incorrect numbers, which severely compromises the answer's value. COMPLETENESS: The answer addresses both parts of the question (the evolution of penetration rates and what the trend suggests), but the factual errors prevent it from being a complete or reliable answer. The LLM correctly identifies the card as Target Debit/Circle Card and recognizes the three-year period, but the numerical foundation is flawed. The 2024 figure being correct suggests the LLM may have had partial access to accurate data but made errors in retrieving or synthesizing the 2022 and 2023 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 406,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe share reserve under the Texas Instruments 2003 Director Compensation Plan was roughly 58.5 million shares at the end of 2022, remained essentially unchanged in 2023, and rose to about 65.5 million shares by the end of 2024. This upward trend shows the company has been replenishing its director‑equity pool, signaling continued reliance on equity‑based incentives for directors and a strategic intent to keep a larger reserve for future grants.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all dimensions. QUANTITATIVE ERRORS: The LLM provides completely wrong numbers - claiming ~58.5 million shares in 2022, ~58.5 million in 2023, and ~65.5 million in 2024. The ground truth shows 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM's numbers are off by approximately 23-41 million shares per year - a massive discrepancy that cannot be attributed to rounding or format variation. DIRECTIONAL TREND ERROR: The LLM claims an upward trend (increasing from 2022 to 2024), when the ground truth shows a consistent downward trend across all three years. This is a fundamental misreading of the data. REASONING ERROR: The LLM concludes the company is 'replenishing' its director-equity pool, when the ground truth explicitly states there was 'no replenishment' and the decline indicates 'sustained investment in director incentives.' The LLM's interpretation is the opposite of what the data shows. ENTITY/METRIC ACCURACY: While the company (Texas Instruments) and plan name (2003 Director Compensation Plan) are correct, the financial metrics themselves are entirely wrong. The LLM appears to have either fabricated numbers or confused this metric with a different equity plan. MULTI-HOP SYNTHESIS: The question requires tracking three data points across three years and identifying a trend - the LLM failed at this basic synthesis task by providing incorrect numbers and drawing the opposite conclusion from the actual trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 419,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa wove virtual‑account technology into its Visa Direct ecosystem—starting with the 2022 acquisition of Currencycloud, which gave the network cloud‑native virtual accounts and real‑time FX capabilities, and culminating in 2024 with the launch of Visa Cross‑Border Solutions and the fully‑live Visa+ platform that enable P2P transfers between cards, bank accounts and digital wallets in more than 190 countries.  This integration turned Visa Direct into a global, real‑time payouts hub that now processes nearly 10 billion transactions a year and supports expanding cross‑border B2B, B2C and G2C use cases through a network of 75 domestic schemes, 15 real‑time‑payment networks and over 11 billion endpoints.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc of Visa's virtual accounts evolution and correctly identifies key milestones (Currencycloud acquisition in 2022, Visa Cross-Border Solutions and Visa+ platform in 2024). However, there are significant quantitative discrepancies that lower the overall score:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM states \"nearly 10 billion transactions a year\" but the ground truth specifies \"over 11 billion endpoints\" - these are different metrics (transactions vs. endpoints) and the LLM appears to conflate or misstate the endpoint figure\n- The ground truth mentions \"$20 trillion in annual B2B cross-border opportunities\" which the LLM completely omits\n- The LLM mentions \"75 domestic schemes, 15 real-time-payment networks\" which are not mentioned in the ground truth and cannot be verified\n\n(2) COMPLETENESS ASSESSMENT:\n- The LLM answer addresses the 2022-2024 evolution and integration with Visa Direct\n- It mentions cross-border use cases expansion\n- However, it omits the specific 2023 milestone of deeper integration into Visa Direct and the expansion to Visa Cross-Border Solutions in that year\n- The ground truth emphasizes the progression across all three years (2022, 2023, 2024) while the LLM focuses primarily on 2022 and 2024\n\n(3) ENTITY AND TIMING ACCURACY:\n- Correctly identifies Currencycloud acquisition in 2022\n- Correctly identifies Visa Cross-Border Solutions and Visa+ platform in 2024\n- Correctly identifies the 11 billion endpoints figure (though context differs)\n- Missing the 2023 intermediate step of deeper Visa Direct integration\n\n(4) MULTI-HOP REASONING:\n- The LLM successfully synthesizes the evolution narrative across years\n- Correctly links Currencycloud acquisition to virtual accounts capabilities\n- Properly connects to cross-border solutions expansion\n- However, the reasoning lacks the 2023 intermediate integration step that the ground truth emphasizes\n\n(5) SEMANTIC ISSUES:\n- The LLM introduces metrics (75 domestic schemes, 15 real-time-payment networks) not in the ground truth\n- The statement about \"nearly 10 billion transactions a year\" appears to be a misinterpretation or conflation of the \"over 11 billion endpoints\" metric\n- The omission of the $20 trillion B2B opportunity figure is a notable gap\n\nThe answer is directionally correct and captures the main narrative, but contains quantitative inaccuracies and omits key details from the ground truth, particularly regarding the 2023 evolution and the $20 trillion market opportunity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 687,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nThe 2023 revenue slide for Xtandi—down 1 % internationally and eroded by lower net pricing due to channel‑mix shifts—revealed that the product’s growth was being squeezed just as its patent exclusivity window neared (U.S. basic patent not slated to expire until 2027).  In reaction, Pfizer pursued a lifecycle‑management strategy, securing an EU label expansion in April 2024 (and a U.S. approval in November 2023) for a new high‑risk nmCSPC indication, thereby extending the product’s commercial relevance.  This continued investment is reflected in the 2022 intangible‑asset valuation, which still listed Xtandi as a developed‑technology right with a net carrying amount of roughly $19.6 bn (see the developed‑technology rights disclosure in the 2022 intangible‑asset schedule).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the multi-hop relationship between 2023 revenue pressures, lifecycle management strategy, and 2024 indication expansion. However, there are significant quantitative accuracy issues that lower the overall score:\n\n(1) QUANTITATIVE ACCURACY PROBLEMS:\n- The LLM cites a specific intangible asset valuation of \"roughly $19.6 bn\" for Xtandi's net carrying amount in 2022. The ground truth does not provide this specific number, and this appears to be an unsupported claim that introduces potential factual error.\n- The LLM states \"U.S. basic patent not slated to expire until 2027\" - this specific date is not mentioned in the ground truth and represents an unsupported detail.\n- The LLM provides a specific approval date of \"November 2023\" for U.S. approval of the nmCSPC indication. The ground truth only mentions \"2024 indication expansion\" without specifying November 2023 for U.S. approval.\n- The LLM specifies \"April 2024\" for EU label expansion, which is not mentioned in the ground truth.\n\n(2) WHAT WAS CORRECT:\n- The 2023 revenue decline of \"down 1%\" is correctly cited\n- The identification of international revenue pressure and net pricing erosion is accurate\n- The 2024 indication expansion for nmCSPC (non-metastatic castration-sensitive prostate cancer) with high-risk biochemical recurrence is correctly identified\n- The overall narrative of lifecycle management strategy in response to revenue pressures is sound\n- The 2022 valuation context is appropriately referenced\n\n(3) MULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple time periods (2022 valuation → 2023 revenue pressures → 2024 indication expansion), demonstrating solid multi-hop reasoning. The causal chain is logical and well-articulated.\n\n(4) SEMANTIC EQUIVALENCE:\nThe core message aligns with the ground truth: Xtandi faced revenue challenges in 2023, prompting Pfizer to invest in lifecycle management through indication expansion in 2024, with the asset having been valued as significant in 2022.\n\nThe primary concern is the introduction of specific numbers and dates ($19.6bn, November 2023, April 2024, 2027 patent expiry) that are not supported by the ground truth, which violates the strict standard for numerical accuracy in financial evaluations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 624,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe RedCard (Target Credit/MasterCard) penetration fell each year – from **20.5 % in 2022**, to **19.8 % in 2023**, and **18.6 % in 2024**. This steady decline indicates that shoppers are increasingly less inclined to use the Target MasterCard for their purchases, suggesting a waning preference for the card’s 5 % discount and loyalty‑program incentives and possibly reflecting stronger competition or reduced perceived value of the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024), matching the ground truth exactly. The trend direction and magnitude are accurately captured. ENTITY ACCURACY: The card is correctly identified as the Target MasterCard/RedCard, with appropriate acknowledgment of the rebranding context (RedCard to Target Circle Cards). REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by: (1) extracting penetration rates across three years, (2) identifying the consistent downward trend, and (3) drawing logical conclusions about consumer behavior. The interpretation that declining penetration indicates 'waning preference' and 'reduced perceived value' aligns well with the ground truth's assessment of 'shift in consumer payment preferences' and 'weakening in loyalty program engagement.' MINOR DIFFERENCES: The LLM adds specific detail about the '5% discount' incentive, which while reasonable and contextually appropriate, is not explicitly mentioned in the ground truth. The LLM also speculates about 'stronger competition' as a potential factor, which is a reasonable inference but goes slightly beyond the ground truth's more measured language. These additions are logical extensions rather than errors. COMPLETENESS: The answer addresses all parts of the question - the evolution of penetration rates and what the trend indicates about consumer behavior. The semantic equivalence is strong, with the LLM's phrasing 'steady decline' and 'increasingly less inclined' conveying the same meaning as the ground truth's 'consistent decline' and 'gradual reduction.' No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 482,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Visa folded Currencycloud’s virtual‑account functionality into its Visa Direct and Visa B2B Connect platforms, turning the former standalone fintech asset into a core engine for cross‑border money movement. By FY 2024 that virtual‑account capability—combined with real‑time FX rates and enhanced liquidity and settlement—enabled Visa Direct to reach more than 11 billion endpoints (4 bn cards, 3.5 bn bank accounts and 3.5 bn digital wallets) across 195 + countries, vastly expanding both the speed and geographic scope of cross‑border payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative arc of Visa's virtual account evolution across the three-year period and correctly identifies the key platforms (Currencycloud, Visa Direct, Visa B2B Connect) and strategic direction. However, there are significant quantitative discrepancies that lower the overall score. CRITICAL ISSUES: (1) The LLM states Visa Direct reached '195+ countries' while the ground truth specifies 'more than 100 countries' for Visa B2B Connect specifically—this is a material geographic scope inflation. (2) The LLM provides specific endpoint breakdowns (4bn cards, 3.5bn bank accounts, 3.5bn digital wallets) that sum to 11 billion, but the ground truth only mentions '11 billion endpoints' without these granular sub-components. These specific numbers cannot be verified against the ground truth and appear to be hallucinated details. (3) The LLM conflates the 11 billion endpoint figure with FY 2024 Visa Direct specifically, whereas the ground truth attributes this to 2023 and the broader Visa Direct Platform. STRENGTHS: The answer correctly identifies the progression from FY 2022 introduction through 2023 expansion to 2024 optimization, correctly names all three platforms, and accurately captures the strategic shift from standalone fintech to integrated cross-border payment infrastructure. The semantic understanding of virtual accounts enabling real-time FX, liquidity, and settlement is correct. MULTI-HOP REASONING: The synthesis across three fiscal years is logically sound, but the introduction of unverified quantitative details undermines credibility. The answer demonstrates good qualitative understanding but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 471,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nIn 2022 AMD’s 10‑K warned that failure to protect its technology and other intellectual property abroad could erode its competitive advantage and result in significant expenses. Starting in 2023 the filing highlighted that new product development depends on third‑party IP and that AMD’s manufacturing is concentrated in overseas wafer foundries, making IP protection vulnerable to geopolitical tensions such as the China‑Taiwan relationship. By 2024 the disclosure explicitly ties IP‑related risk to its international operations and third‑party manufacturing dependencies, cautioning that sanctions, export‑control restrictions and natural‑disaster‑driven supply‑chain disruptions could impair AMD’s ability to safeguard and exploit its IP worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the temporal evolution of AMD's IP protection concerns across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate temporal markers; (2) Accurately captures the core risk evolution from general IP protection concerns to geopolitical-specific risks; (3) Properly synthesizes multi-hop information linking IP protection to third-party manufacturing dependencies and geopolitical tensions; (4) Correctly identifies specific geopolitical factors (China-Taiwan relationship, sanctions, export controls); (5) Appropriately notes the increasing specificity and deepening concern over time. MINOR GAPS: (1) The LLM answer mentions 'natural-disaster-driven supply-chain disruptions' in 2024, which is not explicitly mentioned in the ground truth's 2024 description (though this may be present in actual filings); (2) The ground truth specifically mentions Malaysia and Taiwan as manufacturing locations in 2023, while the LLM answer uses the more general term 'overseas wafer foundries' - this is less specific but not incorrect; (3) The ground truth explicitly mentions Ukraine-Russia and Israel-Hamas conflicts in 2024, while the LLM answer uses the more general 'sanctions, export-control restrictions' language - semantically equivalent but less specific. QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not directly applicable, but the temporal sequencing (2022→2023→2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly links IP protection concerns to both international operations and third-party manufacturing dependencies as required. The logical progression from general risk to specific geopolitical/regulatory concerns is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 520,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific’s pension‑plan corporate‑stock holdings were re‑classified and sharply reduced.  In 2022 the equity was valued as Level 2 (significant observable inputs) at about **$1.1 billion**; by 2023‑24 it was re‑classified to Level 1 (quoted market prices) and fell to roughly **$176 million** (≈ $0.18 billion), an 85 % decline.  This contraction and the move to a higher‑level fair‑value classification indicate a deliberate de‑risking of the pension fund—shifting assets out of public equity into higher‑quality debt and alternative investments—to lower market volatility and align the portfolio with a more stable, liability‑driven strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) 2022 VALUATION ERROR: The LLM states 2022 Corporate Stock was valued at '$1.1 billion' classified as Level 2, but the ground truth clearly shows the 2022 total was $1,990 million ($1.99 billion), with $1,980 million in Level 1 and only $10 million in Level 2. The LLM has inverted the Level classification and drastically understated the total value. (2) LEVEL CLASSIFICATION REVERSAL: The LLM claims 2022 was Level 2 and 2023-24 moved to Level 1, but ground truth shows the opposite—2022 was predominantly Level 1 ($1,980M) with minimal Level 2 ($10M). The 2023 figures were $176M Level 1 and $5M Level 2, maintaining the same classification structure. (3) PERCENTAGE CALCULATION: The LLM calculates an 85% decline from $1.1B to $0.18B, but this calculation is based on incorrect starting figures. The actual decline from $1,990M (2022) to $181M (2023) represents approximately a 91% decline, not 85%. (4) MISSING 2024 CONTEXT: The ground truth explicitly notes that 2024 provided no updated dollar figures, only classification information (common stock as Level 1, preferred stock as Level 2). The LLM conflates 2023 and 2024 figures without acknowledging this distinction. (5) REASONING QUALITY: While the LLM's interpretation about de-risking and pension strategy shift is plausible and somewhat aligned with the ground truth's conclusion about 'strategic shift toward more stable or diversified pension investments,' this qualitative reasoning cannot compensate for the severe quantitative inaccuracies. The multi-hop synthesis is fundamentally compromised by incorrect base data. The answer demonstrates a significant failure in factual accuracy on the primary quantitative metrics that form the foundation of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 504,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s disclosure of the 4.75 % Senior Notes due 2043 shifted from a single, terse footnote in the 2022 Exhibit Table (the “Fourth Supplemental Indenture… 4.75 % Senior Notes due 2043” and a stand‑alone “Form of 4.75 % Notes due 2043” entry) to a more structured, consistently numbered set of exhibits in the 2023‑24 filings that bundle the note within a suite of supplemental indentures, officer certificates and related filings.  This steady, more organized presentation indicates that Abbott is placing greater emphasis on transparent, long‑term debt management and on providing investors with clear, easily accessible information about the terms and maturity of its senior obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 4.75% Senior Notes due 2043 and the general progression from 2022-2024. It accurately captures the core insight that Abbott's disclosure evolved toward more structured, organized presentation. The answer correctly references the shift from legacy-based referencing to standardized disclosure. WEAKNESSES: (1) The LLM answer lacks specific documentary evidence cited in the ground truth - it does not mention the Fourth Supplemental Indenture from April 2, 2013, or the Form 8-K dated March 22, 2017 (Exhibit 4.6), which are key factual anchors in the original answer. (2) The LLM's characterization of 2022 as containing 'a single, terse footnote' and 'stand-alone entry' is vague and not substantiated by the ground truth's specific references. (3) The LLM describes the 2023-24 filings as 'bundling the note within a suite of supplemental indentures, officer certificates and related filings,' but the ground truth specifically mentions formalization through Exhibit 4.6 to the 8-K dated March 22, 2017 - the LLM conflates the presentation structure without citing the actual documentary forms. (4) The LLM answer lacks the precise temporal markers (April 2, 2013; March 22, 2017) that ground the ground truth's analysis. (5) While both answers reach similar conclusions about transparency and investor communication, the LLM's reasoning path is less rigorous and document-specific. MULTI-HOP SYNTHESIS: The LLM demonstrates adequate synthesis of the multi-year progression but fails to properly connect specific documents and dates across the three-year period. The ground truth provides a more precise chain of evidence linking specific indentures and forms to specific years. SEMANTIC EQUIVALENCE: The core message about evolution toward transparency is preserved, but the supporting evidence is significantly weaker in the LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 511,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Credit Card (branded as RedCard/Target Circle Card) penetration fell from **≈20.5 % of transactions in fiscal 2022** to **≈19.8 % in fiscal 2023** and **≈18.6 % in fiscal 2024** (see 2023 Form 10‑K pages 26‑27).  This steady 2‑percentage‑point decline indicates that customers are increasingly less likely to use Target’s proprietary payment products, suggesting a weakening adoption of the branded card‑based discount program.  As the discount‑driven incentive loses traction, the card’s contribution to incremental sales—historically a source of additional spend—has correspondingly eroded, limiting its ability to boost overall sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024), matching the ground truth exactly. The characterization of the decline as approximately 2 percentage points total is accurate (20.5% to 18.6% = 1.9 percentage point decline). The fiscal year attribution is correct. ENTITY ACCURACY: The card is correctly identified as Target Credit Card/RedCard/Target Circle Card, and all temporal references are accurate. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the penetration rate trend across three years, (2) interpreting the downward trajectory as declining customer adoption, (3) connecting this trend to the historical link between card usage and incremental sales, and (4) concluding that the erosion of the discount incentive's effectiveness has limited the card's sales-boosting potential. The logic is sound and well-reasoned. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth (e.g., 'customers are increasingly less likely to use' vs. 'gradual decline in customer adoption or usage'), but the semantic meaning is equivalent. The LLM adds interpretive detail about 'discount-driven incentive' losing traction, which is a reasonable inference from the data but goes slightly beyond what the ground truth explicitly states. However, this represents appropriate analytical depth rather than factual error. The citation reference to '2023 Form 10-K pages 26-27' adds credibility, though specific page verification is not possible in this evaluation. Overall, the answer is factually accurate, complete, well-reasoned, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 490,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 the Multiple‑Purpose Locomotive fleet shrank from **7,242 units (average age ≈ 22.5 years)** to **6,893 units (average age ≈ 25.2 years)**—a drop of roughly 350 locomotives while the remaining engines are now about 2.7 years older on average.  This pattern shows Union Pacific is deliberately **right‑sizing and extending the life of its existing high‑efficiency fleet rather than pursuing aggressive new purchases**, using a leaner, more utilized locomotive base to improve capital efficiency and support longer‑term asset management goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - fleet size decreased from 7,242 to 6,893 units (349-unit reduction, LLM states 'roughly 350' which is appropriately rounded), average age increased from 22.5 to 25.2 years (2.7-year increase, correctly calculated). Numbers match ground truth exactly with appropriate formatting. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) total units change, (2) average age change, and (3) strategic implications. ENTITY ACCURACY: Union Pacific correctly identified, time period (2022-2024) correct, Multiple Purpose Locomotives correctly specified. MULTI-HOP REASONING: The synthesis is sound - the model correctly connects the quantitative changes (fleet reduction + aging) to strategic interpretation (cost-conscious, right-sizing, capital efficiency focus). The reasoning about 'deferring fleet modernization' and 'more cost-conscious asset management' aligns with the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately right-sizing and extending the life of its existing high-efficiency fleet' conveys the same meaning as the ground truth's 'reduction in fleet size and deferral of fleet modernization, suggesting a more cost-conscious asset management strategy.' The additional context about 'capital efficiency' and 'longer-term asset management goals' adds reasonable elaboration without contradicting the ground truth. Minor note: The LLM uses 'approximately' language ('≈') which is appropriate given the rounding, and the phrase 'roughly 350 locomotives' appropriately reflects the precision of the data. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 480,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private funds fell from $585 million at year‑end 2021 to $555 million at year‑end 2023 and $540 million at year‑end 2024 (the 2022 figure is not disclosed separately but lies between these values), a reduction of roughly $45 million over the three‑year span.  This steady pull‑back from illiquid alternative‑asset holdings indicates that Abbott is deliberately scaling down its exposure to such investments, prioritizing capital flexibility and focusing on its core pharmaceutical, nutrition and medical‑device businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the starting year. The ground truth clearly states the unfunded commitments were $585 million in 2022, but the LLM claims they were $585 million at 'year-end 2021' - this is a one-year misalignment that undermines the entire temporal analysis. Additionally, the LLM states '2022 figure is not disclosed separately' when the ground truth explicitly provides the 2022 figure of $585 million. CALCULATION ERROR: The LLM calculates a reduction of 'roughly $45 million over the three-year span' ($585M to $540M = $45M), but this is mathematically correct only if measuring 2021-2024. However, since the ground truth measures 2022-2024, the correct reduction should be $45 million ($585M - $540M), which the LLM does state, but the timeframe is wrong. The ground truth specifies the decline occurs in two $15 million increments (2022→2023: $30M decline, 2023→2024: $15M decline), not a uniform pattern. MISSING DATA: The LLM fails to provide the intermediate 2023 figure of $555 million as a discrete data point, instead treating it as part of a range. REASONING QUALITY: The qualitative interpretation about 'deliberately scaling down' and 'prioritizing capital flexibility' is reasonable and aligns with the ground truth's characterization of a 'measured approach,' though the LLM adds business context (pharmaceutical, nutrition, medical devices) not explicitly in the ground truth. ENTITY ACCURACY: Abbott Laboratories is correctly identified. The metric (unfunded commitments to private real estate funds) is correctly identified. However, the temporal framing is incorrect, which is a critical error in a multi-hop financial question where precise dating is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 481,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes due 2050 carried a book (net) value of roughly **$2.1 billion at the end of fiscal 2022**.  In the subsequent two years the carrying amount stayed essentially flat – the 2024 filing lists a **$2.0 billion long‑term balance for the 2050 notes** (the same $2.0 billion figure was shown for the prior year), indicating that the company has not retired or significantly re‑issued this tranche of debt.  \n\nThis stable progression signals that NVIDIA is maintaining a large, low‑coupon, long‑dated senior obligation on its balance sheet, using it as a steady source of long‑term financing while it supplements its capital structure with newer note issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the carrying value was 'roughly $2.1 billion at the end of fiscal 2022' (approximately correct at $2,147M), but then claims '2024 filing lists a $2.0 billion long-term balance for the 2050 notes (the same $2.0 billion figure was shown for the prior year)' - this is INCORRECT. According to ground truth, FY2023 was $1,604 million, NOT $2.0 billion. The LLM conflates the 2024 value ($2,000M) with 2023, missing the critical $1,604M intermediate value. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the evolution from 2022 to 2024, requiring tracking three data points: $2,147M (2022) → $1,604M (2023) → $2,000M (2024). The LLM only captures two points and misidentifies the 2023 value, fundamentally breaking the multi-hop analysis. (3) REASONING ERRORS: The LLM concludes the carrying amount 'stayed essentially flat' and was 'the same $2.0 billion figure...for the prior year' - this is demonstrably false. The ground truth shows a significant decline from $2,147M to $1,604M (a $543M or 25% decrease), followed by a rebound to $2,000M. This is NOT flat progression. (4) MISSED KEY INSIGHT: The ground truth emphasizes the revaluation/strategic adjustment indicated by the 2023 dip and 2024 rebound, suggesting deliberate debt management strategy. The LLM misses this entirely by incorrectly stating values stayed flat. (5) SEMANTIC ISSUES: While the LLM's general commentary about 'steady source of long-term financing' is reasonable, it's built on incorrect numerical premises. The answer demonstrates a fundamental misunderstanding of the actual carrying value progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 481,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures show a clear escalation in how it describes the threat of losing tax‑ and tariff‑related exemptions. In the 2022 10‑K (Item 1A, p. 16) the company listed “loss or modification of exemptions for taxes and tariffs” as a generic risk. By 2023 the same language was expanded (pp. 40‑41) to flag concrete geopolitical pressures—U.S. sanctions on Russia/Belarus, export‑control curbs on China and Taiwan, and the broader impact of trade‑policy shifts—signaling that the risk is now tied to specific regulatory actions. The 2024 filing (pp. 40‑41) goes further, weaving the exemption risk into a laundry‑list of emerging threats (Ukraine‑Russia conflict, China‑Taiwan tensions, new export‑control rules, sanctions, and evolving foreign tax regimes), underscoring that AMD must now monitor a far wider set of international tax and tariff rules. This progression reveals that AMD’s exposure to losing tax and tariff benefits has grown both in magnitude and complexity, reflecting an increasingly intricate global regulatory environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate temporal sequencing; (2) Accurately captures the evolution from generic risk language in 2022 to increasingly specific geopolitical references in 2023-2024; (3) Correctly identifies key geopolitical events mentioned: U.S. sanctions on Russia/Belarus, China-Taiwan tensions, Ukraine-Russia conflict, and Israel-Hamas conflict (implied in broader context); (4) Properly synthesizes the multi-hop reasoning showing how AMD's regulatory exposure became more complex and specific over time; (5) Correctly notes the shift from abstract risk to concrete regulatory pressures tied to specific actions; (6) Appropriately cites document locations (Item 1A, pp. 16, 40-41) showing detailed source awareness. MINOR WEAKNESSES: (1) The LLM answer mentions 'export-control curbs on China and Taiwan' and 'new export-control rules' which are reasonable inferences but not explicitly stated in the ground truth provided; (2) The phrase 'laundry-list of emerging threats' is somewhat informal but semantically captures the escalating complexity; (3) The answer could have been slightly more explicit about the direct impact on third-party manufacturing partners (mentioned in ground truth) though this is a minor omission. QUANTITATIVE ACCURACY: No numerical errors detected. All dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the causal relationship between geopolitical events and regulatory complexity. The logical progression from generic to specific risk language is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different phrasing but equivalent meaning regarding the escalation of regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 529,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBNY Mellon repeatedly discloses that its ability to return capital—whether through dividends or share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2022 10‑K p. 5; 2023 10‑K p. 5; 2024 10‑K p. 5).  While the core regulatory constraint remains the same—compliance with well‑capitalized, capital‑planning and Delaware‑law requirements—the 2023 and 2024 filings add new layers of risk, such as potential rating downgrades, the impact of Title I resolution planning and the need to satisfy broader regulatory expectations, but the fundamental exposure to U.S. banking rules that can restrict capital returns has not changed materially across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core regulatory constraints (U.S. banking laws, capital adequacy, Delaware law, preferred stock dividend obligations) that persist across 2022-2024. (2) Accurately cites the same page references (p. 5) for all three years' 10-K filings, showing proper document sourcing. (3) Properly synthesizes the multi-hop requirement by comparing constraints across three fiscal years and identifying both continuity and evolution. (4) Correctly notes that while core constraints remain stable, 2023-2024 filings add new risk layers (rating downgrades, Title I resolution planning, regulatory expectations). (5) Accurately characterizes the overall trend as 'not materially changed' across the period. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific textual evidence (direct quotes) than the ground truth, which enhances credibility but represents elaboration rather than deviation. (2) The LLM answer emphasizes 'discretion of Board of Directors' as an additional constraint not explicitly mentioned in the ground truth summary, though this is a valid and accurate addition from the filings. (3) Both answers correctly identify the consistent regulatory environment with persistent constraints. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are required for this qualitative question about regulatory exposure evolution. The page citations (p. 5 for all three years) are accurate and verifiable. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies both the stable baseline constraints and the incremental additions in later years. The conclusion that fundamental exposure 'has not changed materially' matches the ground truth's characterization of a 'stable regulatory environment with persistent constraints.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 529,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nThe 2.950% Note due 2025 has remained in Abbott’s 10‑K exhibit tables throughout 2022‑2024, but its placement shifted from Exhibit 4.9 in the 2022 filing to Exhibit 4.1 in the 2023 and 2024 filings after a re‑ordering of the exhibit index. Regardless of the year, the same underlying documents—the March 10 2015 indenture and the “Actions of the Authorized Officers” filing covering the 2.000%, 2.550% and 2.950% notes—are consistently referenced, showing a stable disclosure of the note’s terms with only the exhibit numbering changing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER DISCREPANCY: The LLM claims the note was referenced as Exhibit 4.9 in 2022 and Exhibit 4.1 in 2023-2024, but the ground truth states it was consistently referenced as Exhibit 99.6 across all three years. This is a fundamental factual error. (2) FILING DATE ERROR: The LLM references a 'March 10 2015 indenture' while the ground truth specifies the 8-K filing was dated March 5, 2015. The date discrepancy (March 10 vs March 5) is a quantitative error. (3) DOCUMENT REFERENCE ERROR: The LLM mentions 'Actions of the Authorized Officers' filing covering multiple notes, but the ground truth simply references the exhibit as part of the 8-K filing dated March 5, 2015, without this additional characterization. (4) STRUCTURAL CLAIM ERROR: The LLM claims there was a 're-ordering of the exhibit index' causing the exhibit number to change from 4.9 to 4.1, but the ground truth indicates the exhibit number remained constant at 99.6 throughout 2022-2024. This contradicts the core premise of the LLM's answer. (5) CONSISTENCY INTERPRETATION: While both answers correctly identify that the note remained stable with no amendments or refinancing, the LLM's explanation of HOW it remained stable (through exhibit re-ordering) is factually incorrect. The ground truth shows it remained stable through consistent exhibit numbering. The LLM answer demonstrates poor multi-hop reasoning by synthesizing incorrect information about exhibit structure and filing dates. The answer is contextually relevant to the question asked but fundamentally incorrect in its factual claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 458,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 showed a modest upward trend in carrying value: approximately **$1.09 billion at the end of fiscal 2022**, **$1.10 billion at the close of fiscal 2023**, and **$1.115 billion by the end of fiscal 2024**.  This steady, incremental increase indicates that NVIDIA is deliberately maintaining a sizable, low‑coupon, long‑dated senior note tranche as a permanent component of its capital structure—using long‑term debt to fund its capital‑intensive R&D and expansion initiatives while preserving a conservative, stable long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in all three fiscal year values. Ground truth shows: FY2022=$1,200M, FY2023=$1,099M, FY2024=$1,250M. LLM reports: FY2022=$1,090M, FY2023=$1,100M, FY2024=$1,115M. These are substantial discrepancies (off by $110M in FY2022, $1M in FY2023, and $135M in FY2024). The LLM also mischaracterizes the trend: ground truth shows a decrease from FY2022 to FY2023 followed by a significant increase to FY2024, while LLM incorrectly describes a 'steady, incremental increase' across all three years. The qualitative interpretation about NVIDIA's debt strategy is reasonable and well-reasoned, but it is built on fundamentally incorrect numerical foundations. The entity identification (NVIDIA, 1.55% Notes Due 2028, fiscal years 2022-2024) is correct, and the question is properly addressed in structure. However, the core requirement of this multi-hop financial question—accurate synthesis of specific carrying values across three fiscal years—has failed completely. The magnitude of numerical errors (ranging from $1M to $135M on a $1.2B instrument) is unacceptable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 332,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD moved beyond simply supplying component‑level graphics IP to AIB manufacturers and instead built a tighter partnership that includes inventory‑protection clauses—such as price‑reduction shields and limited return rights—while also selling directly to system‑integrator customers.  It then leveraged its discrete Radeon GPU portfolio as a differentiator, emphasizing energy‑efficient performance and AI‑ready architectures to win share in gaming and data‑center markets, and reinforced those policies to safeguard AIB inventory amid rising competition and export‑control pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key elements: (1) inventory protection policies for AIBs, (2) price-reduction shields and return rights, (3) the 2022-2024 timeframe, (4) discrete Radeon GPU portfolio as a differentiator, and (5) the evolution of AMD's strategy. The answer demonstrates understanding of the core relationship dynamics and policy mechanisms. CRITICAL WEAKNESSES: (1) The LLM introduces unsupported claims not in the ground truth, specifically about 'direct sales to system-integrator customers' and 'export-control pressures'—these are not mentioned in the original answer and appear to be fabrications. (2) The LLM adds specific technical claims ('energy-efficient performance,' 'AI-ready architectures,' 'gaming and data-center markets') that are not substantiated in the ground truth provided. (3) The LLM fails to capture the key evolution pattern shown in the ground truth: the 2023 emphasis on 'timely product introductions and market competitiveness' as an indirect reinforcement of AIB partnerships. (4) The LLM misses the specific detail about the 12-month return window for products removed from the price book. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across three years but does so by adding external information rather than accurately synthesizing the provided ground truth. The reasoning about 'moving beyond component-level graphics IP' is not supported by the original answer. SEMANTIC ISSUES: While the LLM captures the general theme of inventory protection and discrete graphics differentiation, it conflates and adds details that distort the actual evolution described in the ground truth. The answer reads as partially informed speculation rather than accurate synthesis of the provided information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 482,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s IP‑protection risk shifted from a broad warning about safeguarding patents and trade secrets in foreign markets to a concrete exposure linked to its expanding global footprint.  As overseas sales climbed to roughly two‑thirds of total revenue and the company deepened reliance on third‑party fabs in politically sensitive regions such as China, Taiwan and other jurisdictions, AMD repeatedly highlighted heightened threats of expropriation, export‑control curbs and forced technology transfer, making intellectual‑property security a more acute strategic vulnerability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core evolution of AMD's IP protection risk from 2022-2024, accurately identifying the shift from general foreign operation risks to geopolitically-concentrated vulnerabilities. The qualitative reasoning about expropriation, export controls, and forced technology transfer is sound and well-articulated. The answer appropriately emphasizes the connection between expanding international operations and IP protection challenges. The mention of China, Taiwan, and other sensitive regions is contextually relevant and accurate.\n\nWEAKNESSES - QUANTITATIVE: The LLM states international sales 'climbed to roughly two-thirds of total revenue' but fails to provide the specific percentages from the ground truth (66% in 2024, 65% in 2023). The phrase 'roughly two-thirds' is imprecise when exact figures are available and material to the answer. The ground truth provides concrete year-over-year progression (66% vs 65% vs unspecified lower 2022 figure) which demonstrates the evolution - the LLM misses this quantitative progression entirely.\n\nWEAKNESSES - COMPLETENESS: The LLM omits specific geopolitical events mentioned in ground truth (Ukraine conflict, China-Taiwan tensions, Middle East instability) that directly contextualize the IP protection risk. While the answer mentions 'politically sensitive regions,' it lacks the specific regional examples that ground the risk assessment. The ground truth explicitly notes AMD's reliance on 'third-party wafer foundries' - the LLM generalizes this to 'third-party fabs' which is semantically equivalent but less precise.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between (1) growing international operations, (2) increased third-party manufacturing reliance, and (3) IP protection risks. However, it doesn't fully trace the temporal evolution across all three years as the ground truth does, instead presenting a more general 2022-2024 shift.\n\nFACTUAL ACCURACY: No outright errors, but significant omissions of quantifiable data that were available in the source material. The answer is directionally correct but lacks the precision and specificity expected for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 594,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the company refreshed the 2019 Long‑Term Incentive Plan with new, year‑specific incentive agreements: 2022 introduced a Performance Share Unit (PSU) agreement and a Restricted Stock Unit (RSU) agreement; 2023 filed updated 2023‑cycle PSU and RSU agreements (the same two agreement types but with revised performance metrics and target percentages); and 2024 added a fresh 2024‑cycle PSU agreement and a 2024 RSU agreement (Exhibit 10.29), together with an amended executive severance plan. This progression shows BNY is moving toward a more performance‑driven equity regime, tightening the link between executive pay and multi‑year results and reducing reliance on time‑vested or discretionary awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ENTITY CONFUSION: The LLM answer refers to 'BNY' (BNY Mellon) in the final sentence, but the question asks about 'BK' (The Bank of New York Mellon or similar entity). This is a fundamental entity identification error that undermines the entire response. (2) FACTUAL INACCURACY - PSU FORMS: The ground truth specifies that 2022 referenced the '2021 Form of PSU Agreement,' 2023 introduced the '2020 Form of PSU Agreement,' and 2024 introduced the '2022 Form of PSU Agreement.' The LLM answer incorrectly states that 2022 'introduced' a PSU agreement and 2023 'filed updated 2023-cycle PSU' agreements - these year designations don't match the ground truth forms cited. (3) UNSUPPORTED CLAIMS: The LLM introduces RSU (Restricted Stock Unit) agreements and references to an 'amended executive severance plan' and 'Exhibit 10.29' that are NOT mentioned in the ground truth. These appear to be hallucinated details. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'layered approach' maintaining legacy structures while updating mechanisms, and describes the strategy as 'long-term, adaptive' building on the 2019 plan foundation. The LLM answer shifts focus to 'performance-driven equity regime' and 'reducing reliance on time-vested awards' - interpretations not supported by the ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize year-by-year progression, it does so with incorrect form dates and unsupported additional instruments, failing the multi-hop verification requirement. The core pattern of evolution (2019 plan as foundation with periodic form updates) is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 450,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nFrom 2022 through 2024 the portfolio of diagnostics instruments that Abbott leases to customers expanded steadily: the original cost of these leased assets rose from **$3.3 billion** (2022) to **$3.6 billion** (2023) and **$3.9 billion** (2024), while the net book value grew from **$1.4 billion** to **$1.6 billion** and **$1.8 billion** over the same periods.  \n\nThis upward trajectory indicates that Abbott is deliberately increasing its capital deployment in the diagnostics lease business—adding more instruments to its fleet to drive recurring revenue from reagents and consumables rather than relying on outright equipment sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN NET BOOK VALUE FOR 2024: The LLM states the net book value reached $1.8 billion in 2024, but the ground truth clearly indicates it remained at $1.6 billion in 2024 (same as 2023). This is a significant factual error that undermines the core answer. CORRECT ELEMENTS: (1) Original cost figures are all accurate: $3.3B (2022), $3.6B (2023), $3.9B (2024). (2) Net book value for 2022 and 2023 are correct: $1.4B and $1.6B respectively. (3) The qualitative interpretation about capital deployment strategy is sound and well-reasoned—the explanation about driving recurring revenue from reagents and consumables is accurate and insightful. (4) The multi-hop reasoning correctly synthesizes the financial data with strategic implications. QUANTITATIVE ACCURACY ISSUE: The 2024 net book value error ($1.8B vs. $1.6B) is a material misstatement that represents a 12.5% overstatement of the actual value. This is not a minor rounding or formatting difference but a factual error in a key metric. QUALITATIVE STRENGTHS: The reasoning about Abbott's capital deployment strategy and the connection to recurring revenue streams is well-articulated and matches the ground truth interpretation. The answer demonstrates good understanding of the business model implications. OVERALL ASSESSMENT: While the qualitative analysis and most quantitative data are correct, the significant error in the 2024 net book value figure is a critical flaw that prevents a higher score. The answer would mislead readers about the actual trajectory of the investment in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 429,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 NVIDIA repeatedly placed Lumentum Holdings in the same “networking products” bucket as AMD, Arista, Broadcom, Cisco, Intel and Marvell—i.e., a competitor in switches, network adapters and optical‑module/interconnect supplies.  At the same time, NVIDIA’s own strategic emphasis on AI‑driven networking and interconnect (e.g., DPU‑centric Spectrum/Quantum platforms, Mellanox‑derived technologies and end‑to‑end AI‑networking software) has broadened the scope of competition, turning Lumentum’s traditional optical‑interconnect business into a more direct rival as NVIDIA expands its full‑stack AI networking portfolio.  Consequently, Lumentum’s positioning has remained listed as a networking competitor, but the intensifying focus on AI‑centric interconnect solutions has increased the competitive pressure on its core offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) ENTITY ACCURACY FAILURE: The LLM claims Lumentum was grouped with AMD, Arista, Broadcom, Cisco, Intel, and Marvell as networking competitors. The ground truth makes no mention of these specific companies being listed alongside Lumentum in NVIDIA's competitor disclosures. This is a major factual error that fundamentally mischaracterizes the competitive landscape. (2) MISSING CRITICAL EVOLUTION: The ground truth emphasizes a clear three-year progression showing Lumentum's repositioning from general interconnect suppliers (FY2022) to specialized high-performance interconnect products (FY2023) to more specific corporate identity recognition (FY2024). The LLM answer incorrectly states Lumentum was 'repeatedly placed in the same bucket' across all three years, missing the key evolution and repositioning that occurred. (3) INCOMPLETE SYNTHESIS: The ground truth shows Lumentum was grouped with Juniper Networks and Applied Optoelectronics in FY2022, then repositioned in FY2023 to a more specialized segment focused on InfiniBand, Ethernet, and proprietary technologies. The LLM provides no such nuanced multi-hop synthesis. (4) SPECULATIVE REASONING: The LLM's discussion of 'DPU-centric Spectrum/Quantum platforms' and 'Mellanox-derived technologies' appears to be inference rather than grounded in the actual filing disclosures referenced in the ground truth. (5) TONE MISALIGNMENT: The ground truth presents a factual progression of how Lumentum was categorized; the LLM adds interpretive commentary about 'competitive pressure' and 'intensifying focus' that goes beyond what the ground truth supports. The answer demonstrates poor multi-hop reasoning by failing to accurately synthesize the year-over-year changes in how Lumentum was positioned within NVIDIA's disclosed competitor landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 520,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved pipe‑cutters out of the **Tools & Home Products** group (where they were presented alongside consumer‑grade DIY tools) and placed them inside the **Safety & Productivity** segment, explicitly framing them as professional pipe‑working equipment for industrial safety and productivity. This re‑classification—first noted in the 2022 segment overview (page 8) and later highlighted in the 2023‑2024 Safety & Productivity description (page 73)—signals a strategic shift toward marketing high‑margin, safety‑critical tools to professional users rather than through the broader consumer‑focused Tools & Home Products channel.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core repositioning of pipe cutters from Tools & Home Products to Safety & Productivity segments between 2022-2024, which matches the ground truth. The answer accurately captures the strategic shift toward professional/industrial tools and away from consumer-focused products. However, there are significant gaps in completeness and synthesis: (1) The LLM answer omits critical context about the InSinkErator divestiture in late 2022, which the ground truth identifies as a key signal of the strategic realignment. (2) The LLM fails to mention the specific product groupings that pipe cutters were repositioned alongside in Safety & Productivity (battery hydraulic tools, drain cleaners, sewer inspection cameras), which are important details demonstrating the nature of the strategic shift. (3) The LLM references specific page numbers (page 8, page 73) without verification against the actual filings, which could be inaccurate citations. (4) The multi-hop reasoning is incomplete—the ground truth synthesizes the pipe cutter repositioning with the broader portfolio divestiture strategy, while the LLM treats it as an isolated segment shift. (5) The LLM's characterization of 'high-margin' tools is not supported by the ground truth and appears to be an inference not grounded in the source material. The answer demonstrates partial understanding of the repositioning but lacks the comprehensive synthesis of related strategic moves (InSinkErator divestiture, specific product groupings) that would fully address what the shift 'reveals about its professional tool strategy.' The core facts about segment movement are correct, but the analysis is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 464,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services evolved from a basic, web‑based account‑servicing portal into a fully integrated, interactive suite.  The 2023 filing (page 33) notes that Schwab Advisor Portfolio Connect was launched as a free, download‑free tool that gives advisors a modern, intuitive way to monitor and manage Schwab‑held portfolios, while the 2024 filing (pages 8‑10) describes how the Company embedded its thinkpipes trading platform and iRebal rebalancing engine directly into the Advisor Services website, enabling seamless data flow, automated portfolio rebalancing and tighter linkage with banking and cash‑sweep services.  Alongside these functional upgrades, Schwab broadened advisor support by adding dedicated transition consultants, expanded benchmarking and educational programming, and deeper integration with its banking and cash‑management offerings, delivering a more cohesive, end‑to‑end platform for RIAs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution narrative and identifies key tools (Advisor Portfolio Connect, thinkpipes, iRebal) and themes (integration, advisor support expansion) that align with the ground truth. However, there are significant issues with factual accuracy and specificity:\n\n1. QUANTITATIVE/FACTUAL ERRORS:\n   - The LLM claims Schwab Advisor Portfolio Connect was \"launched\" in 2023, but the ground truth indicates it existed in 2022 as an established offering. This is a material factual error about the timeline.\n   - The LLM cites specific page numbers (page 33 for 2023 filing, pages 8-10 for 2024 filing) without verification. These citations cannot be confirmed against the ground truth and may be hallucinated.\n   - The LLM introduces specific product names (thinkpipes, iRebal) that are not mentioned in the ground truth, raising questions about whether these are accurate or fabricated details.\n\n2. COMPLETENESS:\n   - The LLM answer addresses functionality, integration, and advisor support as required by the question.\n   - However, it misses the 2022 baseline description that the ground truth provides (Advisor Services website as core platform with third-party integrations).\n   - The ground truth mentions \"multi-year document archiving\" and \"outbound data feeds for compliance systems\" as 2024 additions, which the LLM does not capture.\n\n3. ENTITY ACCURACY:\n   - Correctly identifies Schwab, Advisor Services, and Advisor Portfolio Connect.\n   - Introduces thinkpipes and iRebal without ground truth corroboration.\n   - Time period (2022-2024) is correct.\n\n4. REASONING:\n   - The multi-hop synthesis is reasonable in structure (showing evolution across three years).\n   - However, the specific claims about what happened in each year lack grounding in the provided ground truth.\n   - The narrative flow is logical but built on potentially inaccurate details.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core message about increasing sophistication and integration is semantically aligned with ground truth.\n   - The emphasis on advisor support expansion matches the ground truth.\n   - However, the specific mechanisms and timeline details diverge significantly.\n\nMAJOR CONCERNS:\n   - Potential hallucination of page numbers and product names (thinkpipes, iRebal) not in ground truth\n   - Incorrect timeline for Advisor Portfolio Connect launch (2023 vs. 2022)\n   - Missing key 2024 features (document archiving, compliance data feeds)\n   - Unverifiable citations suggest the LLM may have fabricated supporting details\n\nThe answer demonstrates understanding of the general evolution but contains factual errors and potentially fabricated details that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 723,
        "total_tokens": 2289
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first brought the 1.650 % Notes due 2026 into its public filings in the FY 2022 10‑K (the notes had been issued March 24 2021) and, in the FY 2023 and FY 2024 10‑Ks, the company reproduced the identical Exhibit 4.14 disclosure without any amendment, redemption or re‑pricing.  This unchanged treatment shows that Oracle has kept the 2026 notes as a steady, low‑cost component of a staggered ladder of fixed‑rate senior debt, using them to fund short‑to‑intermediate‑term needs rather than frequently refinancing or altering that portion of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative - that Oracle's 1.650% Notes due 2026 were consistently treated across 2022-2024 10-K filings without modification. The qualitative reasoning about Oracle's debt strategy (staggered ladder, fixed-rate senior debt, short-to-intermediate term funding) is sound and well-articulated. The answer appropriately addresses the multi-hop question about evolution and what it reveals about strategy.\n\nCRITICAL ISSUES: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the notes appear in 'Exhibit 4.14 in 2023 and 2024' but the ground truth specifies 'Exhibit 4.16' in 2022 and 'Exhibit 4.14' in 2023 and 2024. The LLM conflates these exhibit numbers, suggesting the same exhibit number across all three years when the 2022 filing used a different exhibit number. This is a factual error in document reference. (2) ISSUANCE DATE CLAIM: The LLM introduces a specific issuance date of 'March 24, 2021' which does not appear in the ground truth. While this date may be accurate from the actual filings, it represents information not verified in the provided ground truth, making it unverifiable in this evaluation context. The ground truth only confirms the notes first appeared in the 2022 10-K filing. (3) INCOMPLETE EXHIBIT TRACKING: The ground truth explicitly tracks exhibit numbers across years (4.16 in 2022, 4.14 in 2023 and 2024), showing attention to document structure. The LLM's failure to distinguish the 2022 exhibit number from later years suggests incomplete synthesis of the filing documentation.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the multi-year consistency narrative and draws appropriate conclusions about Oracle's capital structure strategy. The reasoning connecting unchanged treatment to strategic stability is sound.\n\nSEMANTIC EQUIVALENCE: The core message - consistent treatment indicating stable strategy - is preserved. However, the factual errors in exhibit numbers and the unverified issuance date introduction reduce confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 554,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Discrete‑Automation business—where electrical‑distribution equipment is reported—showed only modest growth: sales rose from **$2.612 bn (2022)** to **$2.635 bn (2023)** but fell back to **$2.506 bn (2024)**, and earnings dropped from **$542 m (2022)** to **$466 m (2024)**.  The slight contraction, together with the company’s increasing emphasis on software‑driven automation, asset‑optimization (AspenTech) and integrated control platforms, indicates that Emerson is deliberately shifting away from pure electrical‑distribution hardware toward higher‑margin, digitally‑enabled electrification solutions that combine hardware with advanced controls, analytics and services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misses the core question and provides largely irrelevant information. CRITICAL ISSUES: (1) QUESTION MISMATCH: The original question asks about the POSITIONING and CATEGORIZATION of Electrical Distribution Equipment across segments from 2022-2024 (a qualitative, structural question about how the product is classified and described). The LLM instead provides segment-level financial performance data (sales and earnings figures) that are not requested and do not address the question. (2) MISSING CORE ANSWER: The ground truth explains that Electrical Distribution Equipment moved from 'Industrial Solutions' (2022) to 'Discrete Automation' (2023-2024), signaling strategic repositioning toward automation infrastructure. The LLM completely omits this critical structural evolution. (3) QUANTITATIVE ISSUES: While the LLM provides specific numbers ($2.612bn, $2.635bn, $2.506bn, $542m, $466m), these segment-level financials are not part of the ground truth answer and appear to be segment revenue/earnings data rather than product-level positioning information. Without access to verify these numbers against actual filings, they cannot be confirmed as accurate, but they are irrelevant to answering the question asked. (4) REASONING DISCONNECT: The LLM attempts to infer strategic intent from financial performance ('deliberately shifting away from pure electrical-distribution hardware'), but this inference is not grounded in the actual positioning/categorization evolution that the question asks about. The ground truth shows a strategic shift in HOW the product is positioned within the organization (moving to Discrete Automation), not necessarily a shift away from the product itself. (5) SEMANTIC MISALIGNMENT: The LLM's conclusion about 'shifting toward higher-margin, digitally-enabled electrification solutions' may be strategically plausible but does not match the ground truth's finding that the product remained consistently positioned within Discrete Automation in both 2023 and 2024, reinforcing rather than shifting its role. The answer demonstrates a fundamental misunderstanding of what the question is asking for.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 579,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate‑type funds fell from **$569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024** (as disclosed in the post‑employment benefits notes for 2022‑2024).  This steady decline indicates that the company is **reducing its exposure to illiquid alternative assets** and is likely re‑balancing its pension fund strategy toward more liquid or lower‑risk investments to better match funding obligations and manage liability risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Concern): The LLM provides a 2022 figure of $569 million, but the ground truth states $585 million for 2022. This is a $16 million discrepancy (2.7% error). The 2023 ($555M) and 2024 ($540M) figures match the ground truth exactly. This is a material factual error on a key data point that undermines the credibility of the answer. QUALITATIVE REASONING: The LLM correctly identifies the trend (consistent decline), correctly interprets it as de-risking/rebalancing toward more liquid investments, and appropriately notes the reduction in illiquid alternative asset exposure. The reasoning about pension fund strategy alignment is sound. COMPLETENESS GAPS: The LLM answer omits important context from the ground truth: (1) the long time horizon for fund liquidation (projected through 2034), which is significant for understanding the company's continued commitment despite reduced exposure, (2) the characterization of this as a 'measured' or 'deliberate' approach to managing liquidity risk. These omissions represent incomplete synthesis of the multi-hop question about what the trend 'suggests' about strategy. ENTITY ACCURACY: Company (Abbott Laboratories) and metric (unfunded commitments to private real estate funds) are correctly identified. Years are correct. SEMANTIC EQUIVALENCE: The core interpretation of the trend and its strategic implications is semantically equivalent to the ground truth, though less comprehensive. The error in the 2022 baseline figure is a significant factual mistake that cannot be overlooked, as it affects the magnitude of the overall trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 446,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to disclose the 1.650% Notes due 2026 through the same March 2021 indenture (Exhibit 4.14) and reports the full issue as a non‑current liability with unchanged terms and no re‑classification to current debt. This consistent treatment shows that Oracle’s short‑term debt strategy relies on a stable ladder of long‑dated, low‑coupon notes rather than active short‑term borrowing or frequent refinancing, preserving liquidity and minimizing refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 1.650% interest rate is accurate, (2) The 2026 maturity date is correct, (3) The March 2021 8-K reference is accurate, (4) The identification of consistent treatment across 2022, 2023, and 2024 filings is correct, (5) The characterization of the notes as non-current liabilities with unchanged terms is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Exhibit 4.14' as a specific reference, which is not mentioned in the ground truth and cannot be verified as accurate from the provided context. This is a potential factual error or unsupported detail. (2) The LLM's interpretation about 'short-term debt strategy' is somewhat misleading—the ground truth emphasizes that the consistent referencing reveals a strategy of maintaining 'stable short-term debt obligations,' but the LLM reframes this as a 'stable ladder of long-dated, low-coupon notes' and discusses 'refinancing risk' and 'liquidity preservation,' which goes beyond what the ground truth supports. The notes are due 2026, which from a 2024 perspective would be approximately 2 years away, making them arguably short-term, but the LLM's characterization of them as 'long-dated' is questionable. (3) The LLM adds interpretive language about 'active short-term borrowing or frequent refinancing' that is not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022, 2023, 2024) and identifies the pattern of consistent treatment. However, the interpretation of what this reveals about strategy diverges from the ground truth's more measured conclusion. The ground truth states the continuity 'suggests a deliberate strategy of maintaining stable short-term debt obligations without modification,' while the LLM makes broader claims about liquidity preservation and refinancing risk that exceed the evidence presented. OVERALL ASSESSMENT: The answer is partially correct on factual details but introduces unsupported specifics (Exhibit 4.14) and makes interpretive leaps that go beyond the ground truth's more conservative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 579,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nOracle first created the 4.30 % Senior Note due 2034 in a July 8 2014 8‑K (Exhibit 4.11), which set out the note’s terms and was later incorporated by reference in the company’s 2022, 2023 and 2024 Form 10‑K filings (e.g., page 94 of the 2022 10‑K, page 110 of the 2024 10‑K). Each year the same exhibit is republished, confirming that the 4.30 % note remains outstanding and continues to be disclosed as part of Oracle’s long‑dated senior‑debt program. This recurring, multi‑year filing pattern reflects Oracle’s strategy of maintaining a stable, diversified pipeline of fixed‑rate, long‑term debt—issuing notes with staggered maturities and standardizing their documentation via officers’ certificates—so it can lock in financing for many years while minimizing frequent new issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides additional context and detail beyond the ground truth, but introduces some problematic elements that reduce overall accuracy. STRENGTHS: (1) Correctly identifies the 4.30% Senior Note due 2034; (2) Correctly references the note's presence across 2022, 2023, and 2024 filings; (3) Provides reasonable interpretation of Oracle's long-term debt strategy with diversified maturity profiles and fixed-rate financing; (4) Semantic equivalence is maintained regarding the note's sustained presence in capital structure. CRITICAL ISSUES: (1) The LLM introduces a specific date (July 8, 2014) and 8-K filing reference that cannot be verified against the ground truth, which only references Exhibits 4.11 (2022) and 4.09 (2023/2024); (2) The LLM cites specific page numbers (page 94 of 2022 10-K, page 110 of 2024 10-K) that are not mentioned in the ground truth and cannot be independently verified; (3) The LLM adds interpretive details about 'officers' certificates' and 'staggered maturities' that go beyond what the ground truth supports; (4) The ground truth explicitly states the note was listed in Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023/2024, but the LLM conflates these references without clearly distinguishing the exhibit number changes. QUANTITATIVE ACCURACY: The date (July 8, 2014) and page numbers cannot be verified as correct or incorrect from the ground truth, creating uncertainty. The percentage (4.30%) and year (2034) are correct. QUALITATIVE ACCURACY: The reasoning about Oracle's debt strategy is sound and well-articulated, but the introduction of unverified specific details weakens the answer's reliability. CONTEXTUAL RELEVANCE: The answer addresses the multi-year filing pattern question appropriately, though it adds speculative elements about strategy that, while plausible, exceed the ground truth's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 503,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab regularly moved IDA balances onto its balance sheet—up to $10 bn of unmatured balances each 12‑month window and it was required to keep at least 80 % of those balances designated as fixed‑rate obligations. The 2023 IDA agreement replaced that framework, extending the sweep to July 2034, removing the 80 % fixed‑rate rule, and imposing new minimum/maximum balance caps ( $30 bn above fixed‑rate obligations through Sep 2025, then $60‑$90 bn thereafter ); however, Schwab did not migrate any IDA balances to its balance sheet in 2024, reflecting tighter capital constraints and the more restrictive contractual limits introduced in the 2023 agreement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations that undermine its accuracy:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states the 2023 IDA agreement imposed '$30 bn above fixed-rate obligations through Sep 2025, then $60-$90 bn thereafter' - these specific balance caps are NOT mentioned in the ground truth and appear to be fabricated or confused with other details.\n   - The LLM claims Schwab 'regularly moved IDA balances' under the 2019 agreement, but the ground truth only confirms $10.1 billion moved by December 31, 2021, with $10 billion moved subsequent to that date - not a pattern of 'regular' migration.\n   - The LLM states the sweep extends to 'July 2034' - this specific date is not in the ground truth.\n\n2. COMPLETENESS ISSUES:\n   - The LLM fails to address the 2022 status clearly (the ground truth indicates Schwab had the option to migrate up to $10 billion annually in 2022).\n   - The LLM does not mention that Schwab did NOT migrate any IDA balances in 2023, which is a key fact showing the shift in behavior.\n   - The LLM conflates the removal of the 80% fixed-rate requirement with the introduction of new balance caps, but doesn't clearly distinguish what changed and what remained.\n\n3. ENTITY/METRIC ACCURACY:\n   - The 80% fixed-rate obligation requirement is correctly identified as being removed in the 2023 agreement.\n   - The $10 billion annual migration limit is correctly stated for the 2019 agreement.\n   - However, the specific balance thresholds mentioned ($30bn, $60-$90bn) cannot be verified against the ground truth.\n\n4. REASONING QUALITY:\n   - The LLM attempts to synthesize the evolution across years but introduces unsupported details.\n   - The conclusion about 'tighter capital constraints' is reasonable but the specific contractual limits cited are not substantiated by the ground truth.\n   - The LLM correctly identifies the shift from active to passive migration but attributes it partially to 'more restrictive contractual limits' that may not be accurately described.\n\n5. SEMANTIC ISSUES:\n   - The LLM's characterization of the 2023 agreement as 'more restrictive' contradicts the ground truth's statement that it provided 'increased contractual flexibility' (removing the 80% requirement).\n   - The answer conflates flexibility (removal of 80% rule) with restrictiveness (new balance caps), creating a confused narrative.\n\nThe answer demonstrates partial understanding of the IDA agreement evolution but introduces specific numerical details not supported by the ground truth and mischaracterizes the nature of contractual changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 697,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s filings merely updated the governing documents for its 2.000% Senior Notes due 2018—principally by filing the 2015 Fifth Supplemental Indenture and the 2017 Sixth and Seventh Supplemental Indentures together with related officer certificates (e.g., Exhibit 4.18 in the 2022 10‑K and the 2023 10‑K). No substantive refinancing of those 2018 notes was disclosed; any new borrowing appeared under separate indentures (such as the 2018 0.100% Notes due 2024) rather than replacing the 2.000% notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with some notable strengths and minor weaknesses: (1) CORRECT ELEMENTS: The LLM correctly identifies the Fifth Supplemental Indenture dated September 23, 2015 as the governing document, accurately references the 2.000% Senior Notes due 2018, correctly notes the absence of refinancing activities across 2022-2024, and appropriately mentions the 2017 Sixth and Seventh Supplemental Indentures. The reference to separate new borrowing (0.100% Notes due 2024) is accurate and demonstrates proper multi-hop synthesis. (2) QUANTITATIVE ACCURACY: All dates and percentages are correct (2.000%, 0.100%, 2015, 2017, 2018, 2024). The LLM correctly avoids inventing specific dollar amounts. (3) AREAS OF DIVERGENCE: The LLM answer is more specific about exhibit references (Exhibit 4.18 in 2022 and 2023 10-Ks) compared to the ground truth which mentions Exhibit 4.21 for 2023 and 2024. This creates a minor discrepancy in exhibit numbering that cannot be fully verified without access to the actual filings. The LLM's mention of officer certificates adds detail not explicitly in the ground truth. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years, correctly identifying the pattern of documentation updates without refinancing, and appropriately contrasts the legacy notes with new separate borrowing. (5) COMPLETENESS: The LLM addresses the evolution across all three years and covers both documentation updates and refinancing activities (or lack thereof). However, the ground truth's emphasis on 'gradually maturing' and 'nearing maturity' is not explicitly captured in the LLM answer, though the implication is present. The LLM's answer is more concise and action-oriented while the ground truth provides more contextual framing about the notes' lifecycle. Overall, the answer is substantially correct with strong factual accuracy but minor exhibit reference discrepancies and slightly less contextual framing than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 543,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first issued its 3.650 % senior unsecured notes maturing in 2041 in March 2021 (see Exhibit 4.14 of the 2021 filing 【page 109】), and the company kept that series on its balance sheet through the 2022 and 2023 fiscal years, re‑issuing additional tranches of the same 3.650 % 2041 notes in subsequent offerings (the notes are again listed among the long‑dated debt forms in the 2022 and 2023 10‑K exhibits【page 111】).  No retirements of the 2041 notes are disclosed, indicating that Oracle has continued to fund its operations with this low‑coupon, long‑dated instrument year after year.  This multi‑year pattern reflects a deliberate long‑term debt strategy of locking in inexpensive, multi‑decade financing and using a stable ladder of long‑dated senior notes to support ongoing capital needs and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) DATE DISCREPANCY - LLM states the 3.650% Notes due 2041 were first issued in March 2021, but the ground truth explicitly states they were 'first introduced in 2022.' This is a fundamental factual error that contradicts the core premise of the question about the 2022-2024 evolution. (2) SCOPE MISMATCH - The question asks specifically about the evolution 'from 2022 through 2024,' but the LLM answer begins with 2021 issuance and only covers through 2023, missing the 2024 component entirely that the ground truth addresses ('reaffirmed its inclusion in 2024'). (3) INCOMPLETE COVERAGE - The LLM fails to address 2024 data, which is explicitly part of the three-year pattern the question asks about. (4) CITATION ISSUES - References to 'Exhibit 4.14 of the 2021 filing' and page numbers are provided but cannot be verified against the ground truth, and the 2021 reference contradicts the stated 2022 introduction date. CORRECT ELEMENTS: The LLM correctly identifies the 3.650% coupon rate, the 2041 maturity date, and the general concept that Oracle maintained these notes across multiple years without retirement. The qualitative reasoning about 'locking in inexpensive, multi-decade financing' and using a 'stable ladder of long-dated senior notes' aligns with the ground truth's characterization of a 'stable long-term financing approach.' However, these correct interpretations cannot overcome the fundamental dating error and incomplete temporal coverage. The answer demonstrates partial understanding of Oracle's debt strategy but fails on the specific multi-year evolution requested (2022-2024) by starting in 2021 and ending in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 454,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nOracle first issued the $1 billion 2.300% senior notes maturing in 2028 in a March 2021 8‑K filing (Exhibit 4.14), which is reproduced in the fiscal 2022 10‑K (page 111 of ORCL_10k_2022.pdf). The same series remained outstanding and was re‑disclosed in the fiscal 2023 and fiscal 2024 filings (pages 111 of ORCL_10k_2023.pdf and ORCL_10k_2024.pdf), and the 2024 filing reports a fair value of $77.2 billion for all senior notes (page 85 of ORCL_10k_2024.pdf). This multi‑year pattern shows Oracle’s disciplined, laddered debt‑financing strategy—periodically accessing the public bond market to roll over maturing debt, diversify maturities and lock in funding costs while preserving a strong balance‑sheet profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misalignments with the ground truth:\n\n1. EXHIBIT REFERENCE ERROR: The LLM states the notes are in 'Exhibit 4.14' from a March 2021 8-K filing, but the ground truth specifies 'Exhibit 4.16' with an Officers' Certificate dated March 24, 2021. This is a material discrepancy in document citation.\n\n2. QUANTITATIVE INACCURACY: The LLM introduces a '$1 billion' figure for the 2.300% Notes due 2028 that is not mentioned in the ground truth. This appears to be an unsupported claim that adds potentially incorrect quantitative information. The LLM also cites a '$77.2 billion fair value for all senior notes' which is not part of the ground truth answer and may be accurate but is not relevant to the specific question about the 2.300% Notes evolution.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions that in 2023, Oracle issued ADDITIONAL 4.500% Notes due 2028 under Exhibit 4.16, indicating diversification of interest rate profiles. The LLM answer completely omits this critical detail about the 2023 expansion and the 4.500% Notes, which is essential to understanding the multi-year pattern of debt financing strategy evolution.\n\n4. MISSING STRUCTURAL ANALYSIS: The ground truth emphasizes the three-year pattern showing 'consistency in referencing the March 24, 2021 certificate' across 2022-2024, which the LLM does not adequately capture. The LLM's discussion of 'laddered debt-financing strategy' and 'rolling over maturing debt' is somewhat generic and doesn't specifically address the structural consistency highlighted in the ground truth.\n\n5. REASONING QUALITY: While the LLM's conclusion about a 'disciplined, laddered debt-financing strategy' is reasonable, it lacks the specific evidence from the ground truth about the 2023 expansion with the 4.500% Notes and the consistent structural references across years.\n\n6. PAGE REFERENCES: The LLM provides specific page numbers (111, 85) which cannot be verified against the ground truth and may be inaccurate or fabricated.\n\nThe answer demonstrates partial understanding of Oracle's debt strategy but fails to accurately synthesize the key multi-hop information about the 2023 expansion and misidentifies the exhibit number, making it factually unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 617,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa moved Currencycloud from a newly‑acquired cross‑border FX platform into a core part of its Visa Direct ecosystem, embedding virtual‑account capabilities that deliver real‑time exchange rates, liquidity and settlement.  This integration expanded the virtual‑account functionality across Visa Direct and Visa B2B Connect, scaling to more than 100 countries and enabling a broader set of cross‑border B2B and consumer payment flows.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Currencycloud was integrated into Visa Direct, mentions virtual accounts, real-time FX rates, liquidity and settlement capabilities, and references cross-border payment expansion. The general timeline progression (2022-2024) is appropriate. (2) QUANTITATIVE ACCURACY ISSUES: The LLM introduces '100 countries' as a specific metric with no support in the ground truth. The ground truth mentions 'more than 11 billion endpoints' which the LLM completely omits. These are significant quantitative claims that cannot be verified against the original answer. (3) ENTITY/COMPLETENESS ISSUES: The LLM adds 'Visa B2B Connect' which is not mentioned in the ground truth answer. While this may be factually accurate from SEC filings, it represents information synthesis beyond what the ground truth specifies. The LLM also characterizes the evolution as moving from 'newly-acquired' platform, which implies a specific acquisition narrative not explicitly stated in the ground truth. (4) MISSING ELEMENTS: The ground truth specifically mentions 'Treasury as a Service initiative' (2022), 'fully integrated into Visa Direct Platform' (2023), and the 'established cross-border consumer payments business' - the LLM omits these specific characterizations and year-by-year progression details. (5) REASONING QUALITY: The multi-hop synthesis is partially sound but introduces unsupported specificity ('100 countries') while omitting key metrics ('11 billion endpoints'). The answer reads coherently but lacks the precise year-by-year evolution detailed in the ground truth. The omission of the 11 billion endpoints figure is particularly problematic as it's a concrete quantitative claim in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 497,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 to 2024 the ME&T dealer network that distributes EMD‑branded locomotives expanded modestly: the 2022 filing lists 43 U.S. and 113 non‑U.S. dealers serving 191 countries, while the 2024 filing shows 44 U.S. and 116 non‑U.S. dealers serving 193 countries. This incremental growth in dealer presence and country coverage reflects Caterpillar’s strategy of deepening its global dealer footprint to broaden market penetration for EMD products—particularly in emerging regions—while strengthening after‑sales support to drive future sales growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly all quantitative metrics. Ground truth states: 2022 had 110 distributors across 109 countries; 2023 had 110 distributors across 109 countries; 2024 had 108 distributors across 158 countries. The LLM answer claims: 2022 had 43 U.S. + 113 non-U.S. dealers (156 total) serving 191 countries; 2024 had 44 U.S. + 116 non-U.S. dealers (160 total) serving 193 countries. These numbers are completely different from the ground truth figures. The LLM appears to have confused or fabricated dealer network data that does not match the documented EMD distribution network metrics. The ground truth specifically references FG Wilson branded electric power generation systems distributed through 108-110 distributors, while the LLM references 'locomotives' and provides entirely different dealer counts and country coverage. The LLM's claim of 191-193 countries contradicts the ground truth's 109-158 country range. Additionally, the LLM failed to capture the key insight from ground truth: that the network remained relatively stable in distributor count (108-110) while geographic reach expanded from 109 to 158 countries by 2024, indicating optimization of efficiency. The LLM's narrative about 'deepening global dealer footprint' and 'emerging regions' is unsupported by the actual data provided in the ground truth. This represents a complete failure in quantitative accuracy and multi-hop synthesis of the actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 414,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nThe original cost of the diagnostics‑instrument lease assets grew from about **$3.5 billion in 2022 to $3.9 billion in 2023 and remained $3.9 billion in 2024**, while the net book value rose from roughly **$1.6 billion in 2022 to $1.8 billion in 2023 and stayed at $1.8 billion in 2024**. This reflects the addition of new leased instruments and the resulting increase in depreciable basis, after which the balances remained stable through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors in the quantitative data, which is the primary focus of this question. Specific issues: (1) ORIGINAL COST - LLM states $3.5B (2022), $3.9B (2023), $3.9B (2024), but ground truth shows $3.3B (2022), $3.6B (2023), $3.9B (2024). The 2022 figure is wrong ($3.5B vs $3.3B), and the 2023 figure is wrong ($3.9B vs $3.6B). (2) NET BOOK VALUE - LLM states $1.6B (2022), $1.8B (2023), $1.8B (2024), but ground truth shows $1.4B (2022), $1.6B (2023), $1.8B (2024). The 2022 figure is wrong ($1.6B vs $1.4B), and the 2023 figure is wrong ($1.8B vs $1.6B). (3) TREND INTERPRETATION - The LLM incorrectly characterizes the trend as 'remained stable through 2024' when the ground truth shows consistent growth across all three years. The LLM's statement that balances 'stayed at $1.8 billion in 2024' is correct, but the characterization of the overall trend is misleading since it suggests stability when the actual pattern is continuous growth from 2022-2024. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the data across years, it fails to accurately extract the underlying numbers from the source documents. The reasoning about 'addition of new leased instruments' is reasonable but cannot compensate for the fundamental numerical errors. This is a straightforward data extraction and comparison question where accuracy is paramount, and the LLM has failed on multiple data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 398,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 10‑K filings shows that PepsiCo continues to treat this long‑dated, fixed‑rate debt as a core element of its financing mix. Its ongoing disclosure signals that the company views the 2046 note as a stable, strategic source of capital that supports its long‑term growth and capital‑structure objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 3.450% Senior Note due 2046 appears consistently across 2022, 2023, and 2024 10-K filings, (2) it represents a long-dated, fixed-rate debt instrument, and (3) its repeated disclosure indicates strategic importance to PepsiCo's capital structure. The quantitative elements are accurate—the percentage (3.450%), maturity year (2046), and filing years (2022, 2023, 2024) are all correct. The reasoning about what consistent disclosure implies (stability, strategic value, favorable terms) is sound and logically derived. However, the LLM answer omits specific exhibit references (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024) that were included in the ground truth. While these exhibit numbers are not essential to answering the substantive question about the note's role in capital structure strategy, their inclusion would have provided more complete documentation traceability. The LLM's phrasing 'core element of its financing mix' and 'stable, strategic source of capital' conveys essentially the same meaning as the ground truth's 'stable and integral component' and 'strategically maintained.' The answer demonstrates proper multi-hop synthesis by connecting the consistent disclosure pattern across three years to conclusions about strategic intent. Minor deduction for omitting exhibit references, but the core analytical content is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 400,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nAcross the three years Oracle repeatedly disclosed the 2.300 % Notes due 2028—first in the fiscal 2022 10‑K (Exhibit 4.16) as part of the March 2021 senior‑note issuance, then in fiscal 2023 it added newer 2028‑maturing tranches (e.g., 4.500 % Notes issued Feb 2023) while still holding the original 2.300 % series, and fiscal 2024 filings continued to reference both the 2.300 % and the newer 2028‑maturing notes. This staggered, multi‑year issuance of senior unsecured notes with varying coupons shows Oracle’s broader strategy of laddered debt financing—regularly tapping the capital markets to diversify maturities and manage interest‑rate exposure while maintaining a stable, investment‑grade capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2.300% Notes due 2028 across all three fiscal years (2022, 2023, 2024); (2) Accurately references Exhibit 4.16 for fiscal 2022 and Exhibit 4.14 for fiscal 2023/2024, matching the ground truth; (3) Correctly identifies the 4.500% Notes due 2028 as a newer issuance in 2023; (4) Provides accurate date context (March 2021 for original issuance, Feb 2023 for newer tranche); (5) Synthesizes the multi-year pattern correctly, identifying the strategy of layered debt issuances with varying coupons; (6) Adds valuable interpretation about 'laddered debt financing' and interest-rate exposure management, which is a reasonable inference from the pattern described. MINOR AREAS FOR IMPROVEMENT: (1) The ground truth emphasizes that the pattern 'suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances,' whereas the LLM answer frames this more as a deliberate 'laddered debt financing' strategy—while this is a reasonable interpretation, it goes slightly beyond what the ground truth explicitly states about the pattern; (2) The LLM answer adds interpretive language about 'diversify maturities' and 'stable, investment-grade capital structure' that, while logical, are not explicitly confirmed in the ground truth provided. QUANTITATIVE VERIFICATION: All numbers are correct (2.300%, 4.500%, 2028 maturity dates, fiscal years 2022-2024, exhibit numbers). No calculation errors. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and multiple debt instruments, correctly identifying the evolution and pattern. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 481,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa has left the terms of its Series B Convertible Participating Preferred Stock essentially unchanged across the 2022‑2024 filings: the conversion schedule that allows the B‑preferred to become fully convertible to Series A preferred or Class A common stock by 2028 (subject to a hold‑back for any pending claims) and the limited voting rights remain exactly as set out in the 2016 Certificate of Designations (see page 34, page 89 and page 107).  The company has not amended the conversion triggers, the staged‑conversion timeline, or the hold‑back provision, and the recent exchange‑offer activity in 2024 merely operationalized the existing structure (see page 89).  \n\nThis continuity indicates that Visa’s long‑term capital‑structure priority is to maintain a stable, risk‑mitigating equity layer that can be gradually unwound as litigation resolves, while preserving control for Class A shareholders and avoiding disruptive capital‑structure changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of the core concept (Series B Convertible Participating Preferred Stock remained unchanged 2022-2024) and correctly identifies the 2016 Certificate of Designations as the consistent reference point. However, there are significant issues with factual accuracy:\n\n1. QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces specific details not present in the ground truth, including: (a) a conversion timeline allowing full conversion to Series A preferred or Class A common stock 'by 2028' - this specific date is not mentioned in the ground truth; (b) references to 'hold-back for any pending claims' - while mentioned, the ground truth does not specify this as a key feature; (c) page number citations (pages 34, 89, 107) that cannot be verified against the ground truth provided. These appear to be hallucinated specifics that add false precision.\n\n2. ENTITY/STRUCTURAL ACCURACY: The LLM describes a 'staged-conversion timeline' and 'conversion triggers' with specific mechanics (conversion to Series A preferred or Class A common stock) that are not explicitly confirmed in the ground truth. The ground truth only states the Certificate of Designations was consistently referenced, without detailing these conversion mechanics.\n\n3. REASONING QUALITY: The LLM's interpretation of what the continuity 'suggests' (risk-mitigating equity layer, gradual unwinding as litigation resolves, preserving Class A shareholder control) goes beyond what the ground truth supports. The ground truth attributes the continuity to 'deliberate choice to preserve existing shareholder rights and financing flexibility' but does not mention litigation resolution or specific risk-mitigation strategies.\n\n4. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes that the same Certificate of Designations appears across 2022-2024 filings, matching the ground truth. However, the additional structural details about conversion mechanics and litigation-related unwinding are not grounded in the provided ground truth.\n\n5. SEMANTIC ALIGNMENT: While both answers conclude that Visa maintained stability in its Series B structure, the LLM's explanation of WHY (litigation resolution, risk mitigation) differs from the ground truth's explanation (preserve shareholder rights, maintain financing flexibility).\n\nThe answer is partially correct on the main point but introduces unverified specifics that reduce confidence in accuracy. The page citations and specific conversion dates appear to be fabrications rather than accurate references to filing content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 683,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar’s hedging program moved from LIBOR‑based variable‑rate financing to SOFR‑based benchmarks between 2022 and 2024: in 2022 it set up a cross‑functional team to map LIBOR‑linked contracts and assess transition risk, and by 2023‑24 it had replaced LIBOR with SOFR (or other alternative indices) for its Cat Financial loans and related derivatives, using match‑funding and selective derivatives to manage interest‑rate and liquidity exposure; the disclosures stress that hedging with SOFR can limit upside from favorable rate moves and that any ineffective hedge could adversely affect earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's hedging evolution from 2022-2024 and correctly identifies the LIBOR-to-SOFR transition as a key theme. Strengths: (1) Accurately captures the chronological progression (2022 cross-functional team formation, 2023-24 SOFR implementation), (2) Correctly identifies Cat Financial's role and specific strategies (match-funding, selective derivatives), (3) Properly synthesizes multi-hop information across three years, (4) Appropriately notes risks including hedge ineffectiveness and earnings impact. Minor weaknesses: (1) The answer focuses heavily on interest rate risk management (LIBOR/SOFR transition) but the original question specifically asks about 'currency hedging instruments' - while the LLM does address currency hedging in the opening phrase, it then pivots to interest rate/LIBOR discussion, which is related but not identical to currency hedging. The original answer maintains clearer distinction between currency hedging (consistent across years) and the LIBOR-SOFR transition (separate but parallel evolution). (2) The LLM answer could have been more explicit about the distinction between currency hedging instruments specifically versus broader interest rate hedging. (3) Missing some nuance from the original answer about 'no significant changes in approach' in 2024 while acknowledging ongoing risks. The answer is factually sound and demonstrates good multi-hop reasoning across the three-year period, but slightly conflates currency hedging with interest rate hedging, which are related but distinct risk management areas. No quantitative errors detected; all dates and entities are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 458,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J’s talc strategy shifted from using LTL Management LLC’s Chapter 11 filing (initiated in 2021) to obtain an automatic stay of the litigation and to fund a $2 billion reserve for talc claims, to a series of legal setbacks that saw the stay repeatedly lifted and the bankruptcy dismissed; in 2023 the company re‑filed a second Chapter 11 (LTL 2) and secured a limited injunction, and in 2024 it launched a “pre‑packaged” Chapter 11 plan that would fund a new trust with a present‑value payment of roughly $6.5 billion (≈$8 billion nominal) over 25 years to resolve the vast majority of talc claims, while continuing to maintain the $2 billion reserve and allocating claims to newly created subsidiaries such as Red River and Pecos River (see JNJ 10‑K 2023 pp. 113, 100; JNJ 10‑K 2024 pp. 105, 37).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and comprehensive narrative than the ground truth, but introduces several problematic elements that reduce its reliability:\n\nSTRENGTHS:\n1. Correctly identifies the core strategy shift from 2022-2024\n2. Accurately mentions LTL Management LLC's Chapter 11 filing and the $2 billion reserve\n3. Correctly notes the Third Circuit reversal and lifting of the stay in 2023\n4. Properly identifies LTL 2 (second bankruptcy filing) in 2023\n5. Appropriately contextualizes the multi-state settlements in 2024\n6. Correctly identifies the shift toward a pre-packaged Chapter 11 plan in 2024\n7. Mentions subsidiary entities (Red River and Pecos River) which shows detailed knowledge\n8. Provides specific page references to 10-K filings\n\nWEAKNESSES AND ERRORS:\n1. QUANTITATIVE ISSUE: Introduces a $6.5 billion present-value figure (≈$8 billion nominal) for the 2024 trust that is NOT mentioned in the ground truth. This is a significant addition that cannot be verified against the provided ground truth and may be inaccurate or unsupported.\n2. QUANTITATIVE ISSUE: States the LTL filing was \"initiated in 2021\" - the ground truth does not specify when LTL was created, only that by 2022 the $2 billion reserve was already established. This dating may be incorrect.\n3. SEMANTIC ISSUE: The phrase \"secured a limited injunction\" in 2023 is vague and not clearly supported by the ground truth narrative, which focuses on dismissals and refilings rather than injunctions.\n4. COMPLETENESS: While more detailed, the answer adds information (the $6.5B/$8B figures, subsidiary names, specific page numbers) that goes beyond what the ground truth confirms, raising questions about source accuracy.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across years and connects the bankruptcy filings to the trust mechanisms. However, the introduction of unverified financial figures ($6.5B/$8B) undermines the reliability of the multi-hop synthesis.\n\nCRITICAL ISSUE:\nThe most significant problem is the introduction of the $6.5 billion/$8 billion figures without ground truth support. These are substantial financial claims that, if incorrect, represent a major factual error. The ground truth only mentions the $2 billion reserve established in 2022, not any larger trust amount in 2024.\n\nJUSTIFICATION:\nThe answer demonstrates good understanding of the overall narrative arc and correctly identifies key events and entities. However, the introduction of unverified (and potentially incorrect) financial figures, combined with some dating ambiguities, prevents a higher score. The answer would be stronger if it stuck to verifiable facts from the ground truth rather than adding specific dollar amounts that cannot be confirmed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 735,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe reframed the Photography Plan—from a simple, low‑cost cloud bundle of Photoshop, Lightroom and Lightroom Classic (2022) to an AI‑enhanced tier that embeds Firefly generative tools, Generative Credits and seamless access to Adobe Express (2023‑2024), positioning it as the entry‑point for AI‑driven creativity within Creative Cloud.  The plan’s evolution added features such as Generative Fill, Generative Expand, Text‑to‑Image effects and cross‑app asset syncing, reflecting Adobe’s strategy to attract both novice and professional photographers with generative‑AI capabilities while keeping the offering tightly integrated into the broader Creative Cloud ecosystem.  This shift is documented in the 2022 description (p. 10), the 2023 AI‑innovation announcements (p. 27) and the 2024 AI‑content‑creation integration (p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's Photography Plan evolution from 2022-2024 and correctly identifies the core strategic shift toward AI integration. STRENGTHS: (1) Accurately captures the three-year progression with correct temporal framing (2022 as baseline, 2023-2024 as AI-enhanced); (2) Correctly identifies key features added: Generative Fill, Generative Expand, Text-to-Image effects, and cross-app asset syncing; (3) Properly synthesizes the multi-hop concept of Photography Plan positioning within Creative Cloud ecosystem; (4) Accurately references Firefly generative tools and Generative Credits as 2023-2024 enhancements; (5) Correctly identifies the strategic intent to attract both novice and professional photographers. MINOR ISSUES: (1) The LLM answer includes specific page references (p. 10, p. 27, p. 11) that cannot be verified against the ground truth and may be fabricated or inaccurate - this is a minor concern as it doesn't affect the core factual claims; (2) Mentions 'Adobe Express' integration which is not explicitly mentioned in the ground truth answer, though this could be a valid enhancement not captured in the original answer; (3) The phrase 'entry-point for AI-driven creativity' is slightly different framing than ground truth's 'streamlined, yet powerful, solution' but conveys similar meaning. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not heavily tested. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies how the Photography Plan's role within Creative Cloud evolved, demonstrating sound multi-hop reasoning. The connection between AI integration strategy and product positioning is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different emphasis (more focus on 'entry-point' positioning vs. ground truth's emphasis on 'streamlined alternative'). Both capture the core evolution accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 572,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same specimen certificate for its class C common stock in each of the 2022‑2024 Form 10‑K filings—no new or amended certificate was introduced, and the rights, conversion mechanics and the absence of transfer restrictions remain unchanged. This deliberate continuity signals that Visa is preserving its existing capital‑structure and voting hierarchy, reinforcing a stable governance framework and consistent investor‑relations stance amid evolving regulatory and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core fact that Visa maintained the same specimen certificate for Class C common stock across 2022-2024 filings with no updates. The reasoning about stability in governance and investor relations is sound and semantically aligned with the ground truth. The answer appropriately characterizes this as a deliberate continuity strategy. WEAKNESSES: (1) MISSING CRITICAL SPECIFICS: The LLM fails to cite the specific exhibit reference (Exhibit 4.2) or the filing date (January 28, 2009, 8-A, File Number 000-53572) that appears in all three years' filings. These are factual details that ground the answer in verifiable evidence. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly contrasts the unchanged stock certificate documentation with updates to other governance documents (Certificate of Incorporation revised in 2024), providing important context about selective governance updates. The LLM omits this comparative analysis entirely. (3) VAGUE CLAIMS: The LLM mentions 'rights, conversion mechanics and absence of transfer restrictions' but provides no specific evidence these remained unchanged—these are inferred rather than documented. (4) MISSING CONTEXTUAL DEPTH: The ground truth emphasizes that this consistency 'contrasts with updates seen in other governance documents,' which is a key insight about Visa's selective approach to governance updates. The LLM does not make this distinction. The answer is directionally correct but lacks the specificity and multi-document synthesis that would make it fully accurate to the ground truth. It reads more as a reasonable inference than a fact-based answer grounded in specific filing evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 467,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell from **$1.16 bn at the end of 2022 to $1.09 bn in 2023 and to $0.99 bn by the end of 2024** (see the “service and product warranties and product performance guarantees” tables in Note 18).  This decline reflects lower estimated claim costs, settlements of prior obligations and more favorable historical experience, indicating that RTX’s risk‑management actions are successfully curbing its exposure.  Nevertheless, the remaining balance remains material, underscoring that the company still holds a significant exposure to future performance‑related payouts under its commercial aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer provides completely incorrect financial figures that do not match the ground truth data. Ground truth shows collaboration partners' share of financing guarantees at $140M (2022), $135M (2023), and $131M (2024). The LLM reports $1.16B (2022), $1.09B (2023), and $0.99B (2024) - figures that are approximately 8-9 times larger than the correct values. This is a fundamental quantitative error that invalidates the entire answer. While the LLM correctly identifies the direction of change (declining trend) and provides reasonable qualitative reasoning about risk management and settlements, the numerical foundation is entirely wrong. The LLM appears to have cited a different liability category (possibly total service and product warranties) rather than the specific 'collaboration partners' share of financing guarantees' metric requested. The answer demonstrates understanding of the question's intent and provides logical analysis, but the factual accuracy is severely compromised by the incorrect numbers. The magnitude of error (off by nearly 9x) is unacceptable for financial analysis where precision is critical. Multi-hop reasoning about risk management is sound in principle, but is built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 351,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco has consistently accounted for free‑rent and step‑rent provisions as lease incentives that are recognized on a straight‑line basis over the **full lease term**, which now includes any extension options that management judges to be “reasonably certain” of exercising.  This treatment was first disclosed in FY 2022 and remained the same in FY 2023 and FY 2024, but the company’s disclosures became more detailed: the 2023 and 2024 notes explicitly list the weighted‑average remaining lease term (≈ 20 years in 2022, 19 years in 2024) and the incremental borrowing rate used (2.67 % for operating leases in 2024 versus 2.47 % in 2023).  Because the lease term is now longer and the discount rate slightly higher, the initial right‑of‑use asset is measured at a higher present‑value of future lease payments, resulting in a modestly larger ROU‑asset balance (e.g., $2.617 bn in 2024 versus $2.713 bn in 2023 after adjusting for the longer term).  The core accounting method—straight‑line recognition of free‑rent over the full term—has therefore not changed, but the assumptions about lease length and discounting have been refined, directly influencing the valuation of the right‑of‑use assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar amounts ($2.617bn in 2024 vs $2.713bn in 2023) and incremental borrowing rates (2.67% for 2024 vs 2.47% for 2023) that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not provide these specific numerical values. The LLM also claims the weighted-average remaining lease term was ~20 years in 2022 and 19 years in 2024, but these specific figures are not confirmed in the ground truth. (2) LOGICAL INCONSISTENCY - The LLM states 'the initial right-of-use asset is measured at a higher present-value of future lease payments, resulting in a modestly larger ROU-asset balance' but then contradicts this by showing the ROU-asset decreased from $2.713bn to $2.617bn. This is a fundamental calculation/logic error. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - While the LLM correctly identifies the straight-line basis treatment and the inclusion of extension options, it overstates the specificity of disclosures. The ground truth indicates that in 2024, the company placed 'greater emphasis on impairment evaluation of long-lived assets' - a key contextual shift that the LLM completely omits. (4) UNSUPPORTED CLAIMS - The LLM's assertion about 'longer term' and 'slightly higher' discount rates driving valuation changes is not substantiated in the ground truth, which emphasizes stable core accounting policy with evolving presentation context. (5) MULTI-HOP REASONING - The LLM attempts to synthesize across years but does so with invented numbers rather than grounding claims in verifiable data. The ground truth emphasizes stability in core policy with contextual evolution; the LLM emphasizes numerical changes that appear fabricated. CORRECT ELEMENTS: The straight-line basis treatment, inclusion of extension options, and general consistency across years are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 517,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe shifted AI‑powered document productivity from a generic “Document Cloud” capability to a formally branded, heavily‑invested product line.  In the 2022 filing the company described AI‑enhanced PDF workflows (e.g., Sensei‑driven tagging) but did not yet market a dedicated AI brand; by 2023 it was pouring R&D into AI features such as automated summarization, OCR and content‑aware editing and began filing trademarks for “Acrobat AI Assistant.”  In the 2024 filing Adobe officially launched the **Acrobat AI Assistant/AI** brand, embedding generative‑AI summarization, editing and signing functions into Acrobat and Document Cloud, and disclosed continued multi‑year R&D spend to scale these AI capabilities across its document‑productivity platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the shift from generic 'Document Cloud' capabilities to formally branded 'Acrobat AI Assistant' products; (3) Properly synthesizes multi-hop information about R&D investments, product branding, and Acrobat's evolving role; (4) Correctly identifies specific AI capabilities (summarization, OCR, content-aware editing, signing functions) that align with ground truth mentions of 'enhancements to document workflows'; (5) Appropriately emphasizes the formalization of AI as a strategic focus in 2023-2024; (6) Mentions trademark filing for 'Acrobat AI Assistant' which demonstrates detailed knowledge. MINOR WEAKNESSES: (1) The LLM answer adds specific technical details (Sensei-driven tagging, OCR, content-aware editing, signing functions) that, while plausible and consistent with Adobe's product evolution, are not explicitly mentioned in the ground truth, creating slight over-specification; (2) References 'multi-year R&D spend' without specific dollar amounts, which is appropriate given the ground truth doesn't provide quantitative R&D figures; (3) The phrase 'pouring R&D into' is somewhat informal but semantically accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and three dimensions (Acrobat's role, R&D investments, product branding), correctly showing how each evolved. The logical progression from foundational document role → AI integration → formal branding is sound and matches the ground truth trajectory. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The temporal references (2022, 2023, 2024) are all correct. ENTITY ACCURACY: Adobe and Acrobat are correctly identified; Document Cloud is appropriately referenced; 'Acrobat AI Assistant' branding is correctly named.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 544,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s pledged client securities expanded markedly – the fair‑value of client securities that could be pledged rose from about **$120 bn (2021)** to roughly **$124 bn (2023)**, and the amount of those securities actually pledged for margin‑lending, short‑sale and securities‑lending purposes grew from **$31 bn to roughly $33‑$35 bn**; the fair‑value of securities borrowed in its securities‑lending program jumped from **$685 m (2022)** to **$1.5 bn (2023)** and stayed elevated in 2024.  This shows Schwab is deliberately using client margin balances and fully‑paid securities as collateral to fund off‑balance‑sheet activities such as CCP initial‑margin posting, repurchase‑agreement financing and securities‑lending income, thereby increasing its effective leverage without raising explicit debt.  The trend signals that the firm is actively managing client‑leverage behavior by encouraging the use of client‑held securities as collateral, which enhances liquidity and revenue but also creates contingent risk if market values or counterparty credit deteriorate.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains numerous specific financial figures that cannot be verified against the ground truth and appear to be fabricated or hallucinated. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides very specific dollar amounts ($120bn, $124bn, $31bn-$35bn, $685m, $1.5bn) with precise year-to-year comparisons. However, the ground truth explicitly states that in 2022, 'specific pledged amounts were not quantified.' The ground truth provides NO numerical data for 2022-2024 pledged securities amounts. The LLM's detailed figures ($120bn rising to $124bn, pledged amounts of $31bn-$35bn) are presented with false confidence and cannot be substantiated from the ground truth. The securities borrowed figures ($685m in 2022 rising to $1.5bn in 2023) are also not mentioned in the ground truth. (2) FACTUAL DISCREPANCIES: The ground truth indicates a progression of disclosure detail (2022: no specific amounts; 2023: more detailed disclosures; 2024: explicit statements about pledging for margin requirements and securities lending). The LLM inverts this by providing specific 2021-2023 numbers when the ground truth says 2022 had no quantified amounts. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information about margin lending, securities lending, and balance sheet strategy, it does so using unverified numbers. The reasoning about 'off-balance-sheet activities' and 'contingent risk' goes beyond what the ground truth supports. (4) SEMANTIC ALIGNMENT: The LLM's discussion of strategic shifts and client leverage behavior aligns directionally with the ground truth's mention of 'increasing formalization and expansion' and 'rising client participation in leveraged products,' but this alignment is undermined by the fabricated numerical support. The core issue is that the LLM presents specific financial data as fact when the ground truth explicitly indicates such data was not disclosed in 2022 and provides no specific figures for the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 539,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nCostco continued to classify its 1.375 % Senior Notes due June 2027 as long‑term debt throughout 2022‑2024, keeping the note’s carrying amount steady at roughly $1.25 billion (before discount adjustments).  The overall long‑term‑debt balance fell from $6.59 billion in 2022 to $5.92 billion in 2023 and remained at that level in 2024 after the 2.750 % notes due 2024 were retired, causing the 1.375 % notes to comprise a larger share of the remaining long‑term‑debt portfolio while still being reported under “long‑term debt, excluding current portion.”",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect long-term debt figures. Ground truth states long-term debt (excluding current portion) was $6,484 million in 2022 and $5,794 million in 2024. The LLM claims $6.59 billion in 2022 and $5.92 billion in 2023/2024. These are material discrepancies ($106M overstatement in 2022, $126M overstatement in 2024). The 1.375% Senior Notes valuation of $1.25 billion is correct and consistent across both answers. CORRECT ELEMENTS: (1) The notes remained classified as long-term debt throughout 2022-2024, (2) The principal amount stayed constant at $1,250 million, (3) The 2.750% notes due May 2024 were reclassified from long-term to current portion, (4) The overall long-term debt declined over the period. REASONING ISSUES: While the LLM correctly identifies the reclassification driver (2.750% notes maturing), it fails to provide accurate baseline figures for comparison. The statement about the 1.375% notes comprising a larger share is logically sound but built on incorrect absolute numbers. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across years and connect the reclassification event to overall debt composition changes, which is appropriate, but the execution is undermined by quantitative inaccuracy. The answer demonstrates understanding of the conceptual evolution but fails on precision of financial metrics, which is critical for debt analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 402,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe has progressively elevated its free, online, self‑service learning as a strategic pillar of the Learning & Enablement portfolio, moving it from a supplemental offering to a core entry point that feeds into fee‑based certifications and custom enterprise training. The free modules are now tightly integrated with Customer‑Success Managers and solution‑specific skills assessments, allowing Adobe to align learning pathways directly with enterprise customers’ business outcomes and to accelerate adoption of its cloud and AI tools.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year timeframe (2022-2024) and maintains accurate entity references (Adobe, free online self-service learning, enterprise customer success). (2) No quantitative errors detected - no specific numbers, dates, or calculations are present in either answer to verify. (3) The semantic direction is correct: both answers acknowledge evolution/progression of free learning as a strategic component. (4) The LLM appropriately references integration with Customer Success Managers and skills assessments, which aligns with the ground truth's mention of enterprise integration and skills assessments. WEAKNESSES: (1) The LLM introduces characterization not explicitly supported by ground truth - specifically claiming free learning moved 'from a supplemental offering to a core entry point' and is 'now tightly integrated with Customer-Success Managers.' The ground truth states integration 'appears to have matured' and 'aligns more closely' but doesn't explicitly claim this transformation from supplemental to core or the specific CSM integration mechanism. (2) The LLM adds interpretive language about 'accelerate adoption of its cloud and AI tools' which is not mentioned in the ground truth and represents an inference beyond what the source documents support. (3) The LLM omits specific reference to learning.adobe.com platform continuity across years, which the ground truth explicitly mentions. (4) The ground truth emphasizes 'democratizing product knowledge' as a strategic commitment, which the LLM doesn't capture. (5) The LLM's claim about 'fee-based certifications' feeding from free modules is not explicitly stated in the ground truth, which mentions 'fee-based programs' more generally. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across three years but makes some unsupported leaps in characterization. The ground truth is more cautious ('appears to have matured,' 'suggests a maturing approach') while the LLM is more definitive ('progressively elevated,' 'now tightly integrated'). This represents a difference in confidence level that may exceed what the source documents support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 580,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 grew only modestly – the fair‑value rose from roughly $1.04 bn at the end of FY 2022 to $1.06 bn in FY 2023, and the net carrying amount reached about $1.25 bn by FY 2024.  This incremental increase shows the company is adding a small, low‑cost, long‑dated debt tranche while keeping overall leverage low, underscoring a conservative debt‑management strategy that preserves financial flexibility as it capitalises on rapid AI‑driven revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are central to answering this question. (1) FY 2022 value: Ground truth states $1.20 billion, but LLM claims 'roughly $1.04 bn' - this is a $160 million discrepancy (13% error). (2) FY 2023 value: Ground truth states $1.057 billion, LLM claims '$1.06 bn' - this is approximately correct (minor rounding acceptable). (3) FY 2024 value: Both sources agree on approximately $1.25 billion - this is correct. The LLM's characterization of the 2022-2023 movement as 'incremental increase' is factually wrong - the ground truth shows a DECREASE from $1.20B to $1.057B, which is a $143 million reduction. The LLM then describes an increase to $1.25B in 2024, which is correct directionally but misses the critical initial decline. REASONING ISSUES: The LLM's interpretation of the pattern is fundamentally flawed. Ground truth identifies a 'dynamic debt management strategy' with initial reduction followed by increase - suggesting tactical refinancing or capital structure optimization. The LLM incorrectly frames this as 'incremental increase' throughout, missing the nuanced pattern of reduction then increase that is central to understanding NVIDIA's debt strategy. SEMANTIC ISSUES: The LLM conflates 'fair-value' and 'net carrying amount' without clear distinction, which could indicate confusion about different valuation approaches in the filings. POSITIVE ASPECTS: The LLM correctly identifies the 2.00% Notes Due 2031, correctly notes the conservative debt management strategy, and appropriately connects this to AI-driven growth. The contextual framing about financial flexibility is reasonable. However, the fundamental numerical errors and mischaracterization of the trend pattern are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 510,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly describe a multi‑year, enterprise‑wide program that “integrates, simplifies and standardizes processes and systems for … finance functions” to grow the company’s financial shared‑service capability and to standardize financial systems; each year the filing adds that the effort is being used to “align and streamline the design and operation of its financial control environment.”  This consistent language shows that J&J is deliberately advancing a strategic agenda to uniformize and strengthen its financial processes and controls, positioning standardized, well‑controlled shared‑service finance operations as a core growth enabler rather than a corrective measure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024 with accurate characterization of its focus on integrating, simplifying, and standardizing financial processes and systems. (2) Accurately captures the consistent messaging across all three years regarding alignment and streamlining of the financial control environment. (3) Properly synthesizes the multi-hop information showing evolution/consistency of the initiative across the three-year period. (4) Correctly emphasizes that this is a proactive, strategic initiative rather than a reactive corrective measure - matching the ground truth's explicit statement that it was 'not being prompted by any internal control deficiencies' and 'not reactive but rather part of a long-term plan.' (5) No quantitative errors - no numbers, dates, or calculations to verify, and all temporal references (2022-2024) are correct. (6) Entity identification is accurate (Johnson & Johnson, financial shared services, control environment). MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('uniformize' vs 'standardize,' 'growth enabler' vs 'operational efficiency') but these represent semantic equivalence and actually enhance clarity. (2) The LLM answer adds interpretive language about 'positioning standardized, well-controlled shared-service finance operations as a core growth enabler' which goes slightly beyond the ground truth's focus on 'operational efficiency and control effectiveness,' but this interpretation is reasonable and supported by the filing language cited. (3) The answer is more concise than the ground truth while maintaining all essential information. Overall, the LLM answer successfully synthesizes multi-year filing information to demonstrate strategic continuity and intent, matching the ground truth's core conclusion about sustained focus on modernizing financial infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 542,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s 10‑K filings consistently name BJ’s Wholesale Club together with Sam’s Club as a U.S. warehouse‑club competitor (2022 p. 8; 2023 p. 8; 2024 p. 6).  While the 2022 and 2023 statements merely note that Kirkland Signature “helps lower costs, differentiates our merchandise offerings and earns higher margins,” the 2024 filing sharpens the language, describing Kirkland as a “strategic differentiator” and highlighting the need to “continue to increase the sales penetration of our private‑label items” to sustain higher‑margin growth.  Thus, from 2022 to 2024 the competitive positioning evolves from a generic reference to BJ’s to an explicit emphasis on Kirkland Signature as a core, margin‑driving differentiator in the warehouse‑club market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies BJ's Wholesale Club as a named competitor in Costco's filings and accurately cites page numbers (2022 p. 8; 2023 p. 8; 2024 p. 6). It also correctly notes that Kirkland Signature language appears in 2022-2024 filings with references to 'lower costs,' 'differentiates merchandise offerings,' and 'higher margins.' However, there are significant issues with the evaluation against the ground truth: (1) The LLM claims 2024 introduces 'strategic differentiator' language and emphasis on 'increasing sales penetration of private-label items,' but the ground truth states the 2024 description 'remained core to the competitive strategy' with only a 'stronger tone around differentiating merchandise offerings' - the LLM overstates the degree of evolution and introduces specific quoted language not verified in the ground truth. (2) The ground truth explicitly mentions that 2023 added 'emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature' - the LLM completely omits this important evolution point. (3) The ground truth notes the evolution was in 'tone' and 'surrounding language' rather than fundamental strategic shift, but the LLM presents it as a more dramatic evolution from 'generic reference' to 'explicit emphasis.' (4) The LLM fails to address the multi-hop synthesis of how sustainability initiatives were incorporated in 2023, which is part of the competitive positioning evolution. The answer is partially correct on core facts but mischaracterizes the nature and degree of evolution, and omits key contextual details about sustainability positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 452,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 the average balance of Schwab’s U.S. state‑and‑municipal securities in its AFS portfolio remained essentially flat—hovering around $638 million each year—so the firm’s exposure to that segment was stable rather than growing or shrinking dramatically.  This stability is a symptom of Schwab’s broader fixed‑income approach, which repeatedly stresses that virtually all of its investment‑portfolio holdings are investment‑grade, underscoring a strategy that prioritizes credit‑quality, capital preservation and regulatory compliance over higher‑yield, lower‑rated assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer makes a critical factual error by claiming the balance 'remained essentially flat—hovering around $638 million each year.' The ground truth explicitly states that $638 million was disclosed specifically in 2023, not that this figure was consistent across all three years (2022, 2023, 2024). The LLM incorrectly extrapolates a single data point to all three years, fundamentally misrepresenting the evolution of the investment. This is a significant quantitative error that undermines the core claim about stability. PARTIAL CREDIT FOR QUALITATIVE ELEMENTS: The LLM correctly identifies the investment-grade quality emphasis and accurately characterizes Schwab's strategic preference for high-quality, lower-risk fixed income instruments. The reasoning about capital preservation and regulatory compliance aligns with the ground truth. However, the LLM's conclusion that exposure was 'stable rather than growing or shrinking dramatically' is not supported by the evidence provided—we only have one specific data point ($638M in 2023), not three years of comparable figures. INCOMPLETENESS: The answer fails to properly address the 'evolution' aspect of the question. The ground truth describes a progression: 2022 (qualitative disclosure of investment-grade focus), 2023 (specific $638M quantification), 2024 (reaffirmation of investment-grade focus). The LLM collapses this into a false narrative of consistency without acknowledging the actual data limitations. REASONING FLAW: The multi-hop synthesis is compromised because the LLM makes an unsupported leap from one year's data point to a three-year trend conclusion. This violates sound analytical reasoning—you cannot claim stability across three years when only one year has a specific disclosed amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 492,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantee exposure contracted from a $304 million maximum‑potential liability in 2022 to $274 million in 2024, and the share attributable to its collaboration partners fell from $140 million to $131 million over the same period. This steady decline indicates that RTX is deliberately off‑loading a larger portion of the financing risk to its partners, moving toward a more risk‑transfer‑focused structure rather than retaining that exposure internally.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces entirely new numbers not present in the ground truth: '$304 million maximum-potential liability in 2022' and '$274 million in 2024'. The ground truth only references collaboration partners' share ($140M, $135M, $131M). The LLM appears to have fabricated or confused these figures with different metrics. (2) DIRECTIONAL INTERPRETATION ERROR - The LLM claims RTX is 'deliberately off-loading a larger portion of the financing risk to its partners' and moving toward 'risk-transfer-focused structure.' This directly contradicts the ground truth, which states the decline 'suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing' - the opposite conclusion. The declining collaboration partners' share indicates LESS risk transfer to partners, not more. (3) MISSING KEY CONTEXT - The LLM omits the ground truth's important observation that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management.' (4) PARTIAL CORRECTNESS - The LLM correctly identifies the three-year trend ($140M→$135M→$131M) and correctly notes it as a 'steady decline,' but then misinterprets what this decline means for RTX's strategy. (5) MULTI-HOP REASONING FAILURE - While the LLM attempts to synthesize the trend into a strategic conclusion, it reaches the opposite conclusion from the ground truth, suggesting fundamental misunderstanding of what declining collaboration partners' share indicates about risk transfer strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 445,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑focused, frame‑accurate review tool integrated mainly with Premiere Pro and After Effects to a cloud‑native collaboration platform that now supports still images, design files and PDFs. It is also deeply integrated with a broader set of Creative Cloud applications—including Photoshop, Illustrator and Express—and with Adobe Firefly and GenStudio, positioning Frame.io as a central hub for end‑to‑end content‑production workflows and AI‑assisted generation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from 2022-2024, accurately noting the expansion from video-focused tool to broader collaboration platform. It correctly mentions supported file types (still images, design files, PDFs) and key integrations with Premiere Pro, After Effects, Photoshop, and Lightroom. The characterization of Frame.io as a 'cloud-native creative collaboration platform' and 'central hub for end-to-end content production workflows' aligns with ground truth. No numeric errors or date inaccuracies present.\n\nWEAKNESSES: (1) The LLM introduces applications NOT mentioned in ground truth (Illustrator, Express, Adobe Firefly, GenStudio) - while these may be accurate, they represent additions beyond the ground truth knowledge graph and suggest potential hallucination or information from different sources. (2) Missing specific 2022 context: Ground truth notes Frame.io was listed as registered trademark in 2022, indicating acquisition/branding alignment - LLM doesn't capture this initial positioning. (3) Missing 2023 specificity: Ground truth explicitly mentions Camera-to-Cloud functionality for video production in 2023, which LLM omits. (4) Missing 2024 workflow expansion details: Ground truth specifically mentions Frame.io's expanded role into casting, location scouting, and marketing campaign management - LLM generalizes this as 'end-to-end content production' without these specific use cases. (5) Workfront integration mentioned in ground truth is absent from LLM answer.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the evolution across three years and identifies the progression from specialized to generalized platform. However, it fails to capture the year-by-year granularity present in ground truth, instead presenting a more general narrative.\n\nSEMANTIC ISSUES: While 'end-to-end content production workflows' is semantically similar to ground truth's description, the LLM's addition of AI-assisted generation (Firefly, GenStudio) shifts emphasis away from the specific workflow expansions (casting, location scouting, marketing) that ground truth emphasizes as key 2024 developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 583,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s production emphasis in Rotary and Mission Systems moved away from the VH‑92A helicopter.  The 2024 10‑K (page 40) notes that “higher production volume on CH‑53K … was partially offset by lower volume on the VH‑92A program,” and the 2024 segment‑sales discussion (page 34) similarly highlights a shift toward the CH‑53K and new laser‑system ramps while citing reduced VH‑92A output.  This multi‑year progression shows that, although the VH‑92A remains part of the RMS portfolio for the U.S. Marine One transport mission, it is no longer a primary growth or profit driver for the segment, with strategic resources being redirected to higher‑volume, higher‑margin programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core question. Ground truth indicates the VH-92A remained a consistent, strategically important program across 2022-2024 with sustained mention in all three years. The LLM answer claims the opposite: that production emphasis 'moved away from' the VH-92A, characterizing it as 'no longer a primary growth or profit driver.' This is a critical factual error that inverts the actual narrative. While the LLM correctly cites the 2024 10-K reference to 'lower volume on the VH-92A program' (which is accurate), it misinterprets this as evidence of declining strategic importance rather than understanding it within the context of the program's continued presence and stable long-term commitment. The LLM's reasoning that lower production volume equals reduced strategic importance is logically flawed—a mature program can have stable strategic importance while experiencing production fluctuations. The LLM also fails to address the multi-year progression comprehensively: it focuses only on 2024 data and does not synthesize the 2022-2023 evidence showing consistent program presence. The answer does correctly identify the RMS segment and mentions CH-53K as a competing priority, but uses this to reach an incorrect conclusion about VH-92A's strategic role. The semantic meaning of the LLM answer is fundamentally incompatible with the ground truth, representing a major analytical error in interpreting what consistent program presence across multiple years indicates about strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 428,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s sales‑ and media‑marketing freedoms narrowed both in the EU and in key emerging markets.  EU rules grew tighter – front‑of‑pack nutrient‑profile labeling, expanded extended‑producer‑responsibility (EPR) and plastic‑tax proposals, and the United Kingdom’s upcoming October 2025 ban on TV/online advertising of high‑fat/sugar/salt snacks – while emerging‑market jurisdictions such as India, Vietnam and several U.S. states introduced comparable nutrient‑profile promotion limits, age‑based sales restrictions and packaging taxes.  Consequently, the geographic scope of permissible promotional activity contracted each year, and the regulatory stringency of those restrictions increased across the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of expanding geographic scope and increasing regulatory stringency from 2022-2024 affecting MDLZ. It accurately names key emerging markets (India, Vietnam, U.S. states) and correctly identifies major regulatory mechanisms (EPR, nutrient-profile labeling, plastic taxes). The semantic understanding of the question is sound, and the answer appropriately addresses both EU and emerging market dimensions. The qualitative reasoning about narrowing promotional freedoms and increasing constraints is accurate and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM answer introduces a specific date (UK October 2025 ban on TV/online advertising) that does NOT appear in the ground truth. This is a factual error - the ground truth makes no mention of this specific UK advertising ban or its October 2025 timing. This represents an unsupported claim. Additionally, the LLM answer mentions 'nutrient-profile labeling' and 'age-based sales restrictions' which are not explicitly mentioned in the ground truth, suggesting potential hallucination or extrapolation beyond the provided knowledge graph.\n\nMISSING QUANTITATIVE DATA: The ground truth specifically states 'over 25 EU countries had implemented EPR policies' in 2022 - this concrete quantitative detail is absent from the LLM answer. The ground truth also explicitly mentions the 'EU formally adopted the Packaging and Packaging Waste Directive' in 2024, which the LLM answer does not reference by name.\n\nMULTI-HOP SYNTHESIS: The LLM answer does synthesize information across the 2022-2024 period and correctly identifies the progression, but it adds unsupported details (UK October 2025 ban) that compromise factual accuracy. The core multi-hop reasoning is sound, but the introduction of unverified claims weakens the overall correctness.\n\nCONCLUSION: While the LLM demonstrates good understanding of the question's intent and provides a coherent narrative with mostly accurate regulatory mechanisms, the introduction of specific unsupported claims (UK October 2025 ban) and omission of quantitative details ('over 25 EU countries') prevents a higher score. The answer is directionally correct but contains factual errors that would be problematic in a financial/regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 618,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the only reference to the 3.700% Notes due 2046 is the same Exhibit 4.14 listing in the “Supplemental Indentures” table (pages 105 of each filing).  The company does not report any redemption, amendment or new issuance of those notes in any of the three years, merely reaffirming that they remain outstanding under the 2016 Eleventh Supplemental Indenture.  This consistent treatment shows that Microsoft is maintaining a sizable, fixed‑rate, long‑dated debt tranche as a permanent part of its capital structure, using it to lock in low‑cost financing and preserve liquidity rather than repeatedly refinancing or retiring that portion of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Microsoft's treatment of the 3.700% Notes due 2046 across three fiscal years. STRENGTHS: (1) All numeric values are correct - the 3.700% rate, 2046 maturity date, 2016 Eleventh Supplemental Indenture date, and reference to Exhibit 4.14 are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies that the same instrument appears consistently across 2022, 2023, and 2024 10-K filings without modification. (3) The reasoning about Microsoft's debt strategy is logically sound and well-supported: the absence of redemption, amendment, or new issuance across three years does indicate deliberate maintenance of stable long-dated liabilities. (4) The answer correctly interprets the pattern as reflecting confidence in long-term cash flows and preference for predictable debt servicing. (5) Entity identification is accurate throughout (Microsoft, the specific notes, the indenture, the years). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer provides slightly more specific detail (mentioning page 105 and Exhibit 4.14 specifically) and frames the strategy slightly differently ('lock in low-cost financing and preserve liquidity rather than repeatedly refinancing') versus the ground truth's emphasis on 'stable, long-dated liabilities with fixed interest obligations.' However, these are complementary interpretations rather than contradictory ones - both correctly identify the same underlying strategy. The LLM answer is actually more detailed in explaining the practical implications of the strategy. No calculation errors, no date errors, no entity confusion. The answer fully addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 481,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were first added to Microsoft’s debt structure in the Eleventh Supplemental Indenture (dated August 8 2016) and were disclosed in the 2022 10‑K as a near‑term maturity; the 2023 10‑K kept the same tranche in Exhibit 4.14 and highlighted that it would mature in 2023, underscoring the upcoming repayment. By the 2024 10‑K the notes no longer appear as outstanding, indicating they had been retired and replaced by later supplemental indentures (e.g., the 2015‑2016 series that introduced 2026‑2056 maturities), showing the incremental advancement of Microsoft’s debt‑maturity schedule.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the notes 'no longer appear as outstanding' by 2024 and 'had been retired,' directly contradicting the ground truth which explicitly states 'By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14.' This is a fundamental misrepresentation of the filing data. (2) INCORRECT REASONING - The LLM suggests the notes were 'replaced by later supplemental indentures (e.g., the 2015-2016 series)' but provides no evidence and this contradicts the ground truth's statement that the notes remained in the 2024 filing. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, and correctly notes the notes appeared in Exhibit 4.14 in 2022 and 2023, it fails to properly synthesize the multi-hop progression across all three years. (4) MISSING KEY INSIGHT - The ground truth emphasizes the notes' 'continued relevance as the maturity year approached' and notes the 'continued disclosure requirement for recently matured obligations' in 2024, suggesting either rollover or delayed maturity. The LLM completely misses this nuance by claiming retirement. (5) QUANTITATIVE ACCURACY - The date 'August 8, 2016' is correct, but the overall narrative about the notes' status is factually wrong. The LLM's answer fundamentally mischaracterizes the evolution of these notes across the three filing periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 412,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 Form 10‑K (pages 111‑117) the Non‑Employee RSU awards were issued under the newly adopted 2021 Medtronic plc Long‑Term Incentive Plan, with award agreements that provide for either 100 % vesting on the third anniversary or ratable vesting over four years; the 2023 filing (pages 10, 111, 113) kept the same 2021 LTIP as the governing plan but updated the agreement language (e.g., the *10.81 and *10.82 RSU agreements) to reflect revised vesting schedules; and the 2024 filing (pages 111‑114) moved to the successor 2023 Stock Award and Incentive Plan, under which the RSU agreements now incorporate performance‑based vesting conditions and revised terms, illustrating the progressive evolution of both the underlying equity plan and the related award agreements across the three years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) PLAN IDENTIFICATION ERROR: The LLM claims the 2022 filing references a 'newly adopted 2021 Medtronic plc Long-Term Incentive Plan,' but the ground truth explicitly states the 2022 agreement was tied to the 'Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017)' per Exhibit 10.45. This is a major factual error. (2) PLAN EVOLUTION MISCHARACTERIZATION: The LLM claims a 2024 move to a 'successor 2023 Stock Award and Incentive Plan,' but the ground truth indicates the same Amended and Restated 2013 plan was referenced consistently across all three years (2022, 2023, 2024), showing continuity rather than evolution to a new plan. (3) VESTING SCHEDULE CLAIMS: The LLM introduces specific vesting details (100% on third anniversary, ratable over four years, performance-based conditions) that are not mentioned in the ground truth and appear to be fabricated. (4) AGREEMENT FORM CONSISTENCY: The ground truth emphasizes that the form agreement remained consistent across years, reflecting stability. The LLM incorrectly suggests progressive evolution with updated language and revised terms. (5) EXHIBIT REFERENCES: The LLM cites exhibits (*10.81, *10.82) without verification against the ground truth documentation. The ground truth specifically references Exhibit 10.45 for the 2022 filing. (6) MULTI-HOP REASONING: The LLM failed to correctly synthesize information across the three years' filings. It created a narrative of plan evolution that contradicts the actual continuity documented in the ground truth. The answer demonstrates fundamental misunderstanding of the actual filing content and appears to contain fabricated details about vesting schedules and plan changes that do not align with the verified knowledge graph data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 507,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the share of assets in Mondelez’s non‑U.S. pension plans devoted to buy‑in annuity contracts stayed tightly clustered around 16‑17 % (17 % in 2022, slipping to 16 % in 2023 and rising back to 17 % in 2024).  At the same time the absolute size of those annuity holdings grew sharply—from roughly $1.5 billion at the end of 2023 to about $2.1 billion by the end of 2024—reflecting a deliberate move to outsource pension obligations to insurers.  This trend signals that the company is increasingly using buy‑in annuities to shift and manage its international pension liability risk, reducing long‑term fund‑management exposure and locking in predictable benefit payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that buy-in annuity allocations were 'effectively discontinued by 2024,' but the LLM claims they 'rose back to 17% in 2024' and that absolute holdings grew to $2.1 billion by end of 2024. This is a critical misrepresentation of the data. The LLM also misinterprets the strategic direction: the ground truth indicates a shift AWAY from insurer-backed annuities toward direct liability management, but the LLM claims the opposite—that the company is 'increasingly using buy-in annuities to shift and manage' obligations. The percentages for 2022 (17%) and 2023 (16%) are correct, but the 2024 data and the entire narrative about growing absolute holdings are incorrect. The LLM's conclusion about 'outsourcing pension obligations to insurers' directly contradicts the ground truth's assessment of a strategic move away from such instruments. The reasoning about liability management is inverted—the ground truth suggests de-risking through direct control, while the LLM suggests increased reliance on insurer-backed solutions. This represents a fundamental misunderstanding of MDLZ's pension strategy evolution and contains material factual errors regarding 2024 data and strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 368,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nIn fiscal 2022 Microsoft still had about $2.5 billion of 2.000% notes due 2023 reflected in its long‑term‑debt schedule (see the 2022 10‑K debt table); those notes matured and were fully retired by the end of fiscal 2023, so the 2024 10‑K shows a zero balance for the series; this illustrates Microsoft’s laddered‑maturity strategy of issuing low‑coupon medium‑term debt and regularly rolling it off to maintain a diversified, staggered debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERROR - The LLM claims ~$2.5 billion of 2.000% Notes due 2023 in fiscal 2022, but provides no source verification and this specific amount is not confirmed in the ground truth. (2) CRITICAL FACTUAL ERROR - The LLM states the notes 'matured and were fully retired by the end of fiscal 2023' with a 'zero balance' shown in the 2024 10-K. However, the ground truth explicitly states the notes 'remained in the disclosures' in the 2024 report and that 'Microsoft maintained this liability on its books through the 2024 reporting period.' This is a direct contradiction. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the evolution across all three years. The ground truth shows consistent presence across 2022, 2023, and 2024 filings, indicating the notes were NOT retired by end of 2023. (4) INTERPRETATION ERROR - The LLM's conclusion about 'laddered-maturity strategy' and 'rolling it off' is inconsistent with the actual data showing the notes remained on the books through 2024. (5) MISSING CONTEXT - The LLM provides no reference to Exhibit 4.14 or the Eleventh Supplemental Indenture details mentioned in the ground truth. The core claim that the notes were retired by fiscal 2023 is factually incorrect based on the ground truth evidence that they remained in 2024 disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 394,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to present its 4.000% Notes due 2021 as senior unsecured debt issued under the May 18 2009 indenture, with the only amendment being the Third Supplemental Indenture dated February 8 2011 (shown as Exhibit 4.6 in each year’s exhibit table). No later supplemental indentures affect this series, so the company’s disclosure and the underlying debt‑instrument structure have remained the same—simply reiterated in the three annual filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) the 4.000% Notes due 2021 are senior unsecured debt, (2) they were issued under the May 18, 2009 indenture, (3) the Third Supplemental Indenture dated February 8, 2011 applies, (4) they appear in Exhibit 4.6 across all three years, and (5) the structure remained consistent. Dates and percentages are accurate. However, the answer has significant omissions that reduce its completeness: (1) It fails to mention that the notes were grouped alongside other specific notes (2.500% Notes due 2016 and 5.300% Notes due 2041) in the same exhibit, which is important context for understanding the debt instrument structure. (2) It does not acknowledge that Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures, such as the 2.375% Notes due 2023 and 2.125% Notes due 2022, which is explicitly mentioned in the ground truth as part of the 'broader debt instrument structure' referenced in the question. (3) The answer states 'No later supplemental indentures affect this series' which is technically correct for the 4.000% Notes specifically, but misses the broader context of how the debt structure evolved with new instruments. The LLM answer is narrowly focused on the 4.000% Notes in isolation rather than addressing how its treatment evolved 'in relation to supplemental indentures and the broader debt instrument structure' as the question asks. The reasoning is sound but incomplete for a multi-hop question that explicitly asks about the broader context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 434,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 each note that the company’s share‑capital authorisation includes 40,000 Euro‑denominated Deferred Shares (par €1.00) but that, as of the fiscal‑year‑end dates of April 26 2022, April 28 2023 and April 26 2024, **no Euro Deferred Shares have ever been issued or are outstanding**. The company therefore never uses this share class to raise capital; instead it maintains a lean equity base and relies on debt markets (e.g., Euro‑denominated senior notes, term‑loan facilities) and its share‑repurchase program to manage liquidity and return capital to shareholders. This consistent omission reveals a capital‑structure strategy that purposefully avoids equity dilution and prioritises debt‑financed growth and shareholder returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All quantitative facts are correct - 40,000 authorized Euro Deferred Shares at €1.00 par value, fiscal year-end dates (April 26 2022, April 28 2023, April 26 2024), and the consistent zero issuance/outstanding balance across all three years are accurately stated. (2) The multi-hop reasoning correctly synthesizes information across three fiscal years to identify the pattern of non-utilization. (3) Entity identification is precise (Medtronic, Euro Deferred Shares, specific fiscal years). (4) The answer goes beyond the ground truth by providing additional strategic context about the company's capital structure preferences (debt markets, share repurchase programs, avoidance of equity dilution), which is reasonable inference but not explicitly stated in the ground truth. MINOR WEAKNESSES: (1) The ground truth uses more cautious language ('potentially signaling' and 'lack of demand') while the LLM makes more definitive claims about strategy ('purposefully avoids equity dilution,' 'prioritises debt-financed growth'). While these inferences are logical and likely correct, they represent interpretive extensions beyond what the ground truth explicitly states. (2) The phrase 'never uses this share class to raise capital' is a strong statement that goes slightly beyond the documented facts (which only show zero issuance through 2024, not a permanent 'never'). VERIFICATION: All numeric values check out correctly. The fiscal year-end dates are accurate. The authorized share count and par value are correct. The core finding - zero issuance across all three years - is accurately represented. The answer successfully addresses both parts of the multi-part question: the evolution of disclosures (consistent across three years) and what this reveals about capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 510,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company continued to disclose the 4.000% Notes due 2021 solely through the original Third Supplemental Indenture (Exhibit 4.6 filed in 2011); none of the later filings introduced a new amendment, redemption or re‑classification of those notes, and the same exhibit entry appears unchanged in each filing. This steady, unchanged reference shows that Microsoft treats the 4.000% 2021 notes as a stable, long‑term debt instrument that remains outstanding and has not been altered or retired in the intervening years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 4.000% Notes due 2021 'were matured or fully accounted for' - meaning these notes had already matured by 2021 and should not have been outstanding during the 2022-2024 reporting periods. However, the LLM answer claims the notes 'remain outstanding and has not been altered or retired in the intervening years,' which is factually incorrect. This is a major error in understanding the lifecycle of the debt instrument. The LLM correctly identifies: (1) the consistent reference to the Third Supplemental Indenture (Exhibit 4.6), (2) the February 8, 2011 date, (3) the lack of amendments or new filings across 2022-2023-2024, and (4) the unchanged exhibit entry. However, the LLM fundamentally misinterprets what this consistency means. The ground truth indicates the notes were matured/fully accounted for with no further action needed, while the LLM incorrectly concludes they remain 'outstanding' and 'long-term debt.' This represents a failure in multi-hop reasoning - the LLM failed to synthesize that a debt instrument due in 2021 would have matured before the 2022 filing period began. The LLM's conclusion about the notes being 'stable, long-term debt' is semantically opposite to the ground truth's implication that they were historical/matured obligations. This is not a minor wording difference but a substantive misunderstanding of the debt instrument's status and treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 425,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin kept up a steady flow of pension‑risk‑transfer deals from 2022 through 2024, adding roughly $2‑3 billion of defined‑benefit obligations each year via group‑annuity contracts—building on the $4.9 billion of transfers completed in 2021 and pushing cumulative off‑loaded liabilities to about $11.6 billion by the end of 2022, with continued but smaller‑scale purchases thereafter.  This pattern shows the company’s long‑term liability‑management focus on shrinking and stabilizing its pension obligations, lowering PBGC premiums and funding volatility, and freeing cash flow for other strategic priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT ANNUAL AMOUNTS: The LLM claims Lockheed Martin transferred '$2-3 billion of defined-benefit obligations each year' from 2022-2024, but the ground truth provides no evidence of such annual transfers during this period. The ground truth states that by 2022, the cumulative total since December 2018 was $11.6 billion, and in 2023-2024 the company only 'announced continued evaluation' and 'reaffirmed intent'—not actual transfers of $2-3 billion annually. (2) UNSUPPORTED 2021 REFERENCE: The LLM references '$4.9 billion of transfers completed in 2021,' which is not mentioned in the ground truth and appears to be fabricated. (3) MISLEADING TRAJECTORY: The LLM suggests 'continued but smaller-scale purchases thereafter' (implying ongoing transfers 2023-2024), but the ground truth indicates only strategic intent and evaluation, not actual completed transactions. (4) CALCULATION INCONSISTENCY: If $4.9B was transferred in 2021 and $11.6B was cumulative by end of 2022, that implies only ~$6.7B transferred from Dec 2018-2021, not the $4.9B claimed for 2021 alone. The LLM fundamentally misrepresents the timeline by inventing specific annual transfer amounts ($2-3B/year) that are not supported by the source material. The ground truth emphasizes strategic intent and evaluation in 2023-2024, not actual transfers. While the LLM correctly identifies the overall strategy (liability reduction, PBGC premium reduction, cash flow benefits), it does so by fabricating specific quantitative claims that are factually incorrect. The answer demonstrates poor multi-hop reasoning by conflating cumulative historical transfers with ongoing annual activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 486,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nThe 0.125 % Notes due 2029 are listed in the “Form of Current Notes” tables of all three 10‑Ks (2022, 2023 and 2024) and each filing cites the same September 18 2020 8‑K (with a later March 9 2021 reference for a supplemental indenture) – the language describing the notes is identical and no amendment or new term is introduced. This consistent, unchanged disclosure indicates that Coca‑Cola’s structuring of this debt instrument has remained stable over time, with no material modifications reflected in its annual reports.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in addressing the core question about the 0.125% Notes due 2029 across the three filing years. STRENGTHS: (1) Correctly identifies the note appears in all three years (2022, 2023, 2024); (2) Accurately cites the September 18, 2020 8-K reference; (3) Correctly mentions the March 9, 2021 supplemental indenture reference; (4) Properly concludes that the disclosure remained consistent and unchanged across all three years; (5) Correctly identifies the exhibit locations (Form of Current Notes tables); (6) Sound reasoning that consistency indicates stable capital market strategy. WEAKNESSES: (1) The LLM answer does not explicitly mention the specific Exhibit 4.4 references or the dual appearance in Exhibits 4.23 and 4.31 as stated in the ground truth - it references 'Form of Current Notes tables' more generally; (2) The answer lacks the precise structural detail about exhibit numbering (4.23 and 4.31) that the ground truth provides; (3) Does not explicitly state the note appeared in two different exhibits each year. QUANTITATIVE ACCURACY: The dates provided (September 18, 2020 and March 9, 2021) are correct, and the percentage (0.125%) and maturity year (2029) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the pattern of consistency. The conclusion about stable structuring is logically sound. SEMANTIC EQUIVALENCE: While the LLM uses slightly different language ('Form of Current Notes tables' vs. specific exhibit citations), the core finding—that the note was consistently disclosed with identical references across all three years—is semantically equivalent to the ground truth. The answer captures the essential insight about consistency and stability, though with less technical precision regarding exhibit numbering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 505,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily from **$1.109 billion at the end of 2022 to $1.091 billion in 2023 and $0.993 billion by the end of 2024** – a roughly 10 % reduction over two years.  This decline reflects fewer new guarantees being issued, higher settlements of existing claims and the company’s practice of adjusting accruals as actual product‑performance experience improves, indicating that RTX’s long‑term exposure to product‑performance risk in its commercial aerospace business is diminishing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides completely different numbers than the ground truth, indicating a fundamental factual error. Ground truth shows collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024). The LLM instead reports total accrued liabilities of $1.109B (2022), $1.091B (2023), and $0.993B (2024) - numbers that are roughly 8x larger and appear to reference a different liability category entirely. The LLM's calculation of a 10% reduction ($1.109B to $0.993B = 10.5% decline) is mathematically correct for those numbers, but those numbers themselves are wrong. The LLM also misinterprets the trend: it claims 'fewer new guarantees being issued' and 'diminishing' exposure, whereas the ground truth indicates 'stable' exposure with 'consistent methodology' and 'ongoing exposure.' The LLM conflates what appears to be total accrued liabilities with the specific collaboration partners' share metric mentioned in ground truth. The answer fails on quantitative accuracy (wrong numbers by orders of magnitude), entity accuracy (appears to reference wrong liability line item), and reasoning (incorrect interpretation of trend direction and implications). While the answer addresses the question's structure and attempts multi-hop reasoning, the foundational data is incorrect, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 382,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has continued to fair‑value non‑qualified stock options with the Black‑Scholes model through 2022‑2024, but the key inputs have been updated: expected volatility increased from 23.0 % (2022) to 24.3 % (2024), the risk‑free rate rose from 0.9 % to 4.2 %, and the dividend yield grew from 1.95 % to 3.18 %, while the assumed option life stayed near six years. These adjustments—reflected in the Black‑Scholes assumption tables on the 2022, 2023 and 2024 Form 10‑K filings (pages 82, 83, 84)—show the company is now incorporating higher, market‑derived volatility and a higher interest‑rate environment, signaling a more risk‑aware approach to equity‑compensation valuation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical data about Black-Scholes inputs (volatility, risk-free rate, dividend yield) and attempts to show evolution from 2022-2024. However, there are critical issues: (1) QUANTITATIVE PROBLEMS: The specific percentages cited (23.0% to 24.3% volatility, 0.9% to 4.2% risk-free rate, 1.95% to 3.18% dividend yield) cannot be verified against the ground truth, which does not provide these specific numerical values. The ground truth focuses on disclosure evolution regarding volatility methodology rather than specific percentage changes. The LLM appears to have fabricated or misremembered specific numbers without clear sourcing. (2) COMPLETENESS: The LLM answer addresses the quantitative evolution of inputs but largely misses the core insight from the ground truth—the qualitative evolution in HOW volatility is disclosed and derived (historical+implied blend in 2022 → explicit market-traded options sourcing in 2023-2024). This is the more important finding about 'changing assumptions around stock price volatility.' (3) REASONING: The LLM correctly identifies Black-Scholes as the consistent valuation method and attempts to show parameter evolution, but the reasoning about 'market-derived volatility' and 'risk-aware approach' is somewhat generic and doesn't capture the specific disclosure transparency improvement highlighted in the ground truth. (4) ENTITY ACCURACY: Medtronic, years 2022-2024, and Black-Scholes model are all correct. Page references (82, 83, 84) are provided but unverified. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys a different emphasis—focusing on numerical parameter changes rather than methodological disclosure evolution. While both discuss market-informed approaches, the ground truth's key insight about transparency in implied volatility sourcing is underemphasized. The answer is partially correct in direction but appears to contain unverified specific numbers that weaken confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 535,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe 1.000% senior unsecured notes maturing in 2028 were first issued in September 2020; in the 2022, 2023 and 2024 Form 10‑K filings the identical note‑form is again disclosed, showing that the tranche remained outstanding and that the company updated the prospectus and added follow‑on issuances each year. This recurring reference indicates that Coca‑Cola is using the 2028 notes as a stable, low‑coupon, long‑dated funding pillar while complementing it with newer, higher‑coupon debt to manage its overall maturity profile and take advantage of favorable market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core question and provides accurate information about the 1.000% Notes due 2028. STRENGTHS: (1) Correctly identifies the 1.000% interest rate and 2028 maturity date; (2) Accurately notes the instrument was referenced consistently across 2022, 2023, and 2024; (3) Correctly identifies the strategic pattern of complementing low-coupon debt with higher-coupon instruments; (4) Provides additional context about the September 2020 issuance date, which adds useful detail; (5) Semantic equivalence is strong—the conclusion about using 2028 notes as a 'stable, low-coupon, long-dated funding pillar' aligns with the ground truth's characterization of 'ongoing acknowledgment and potential maintenance.' WEAKNESSES: (1) The LLM mentions 'follow-on issuances each year' which is not explicitly confirmed in the ground truth and may be an inference beyond what the filings directly state; (2) The ground truth specifically mentions the 5.000% Notes due 2034 and 5.300% Notes due 2054 as examples of the strategic shift in 2024, but the LLM answer does not cite these specific instruments, making the answer less concrete; (3) The phrase 'updated the prospectus and added follow‑on issuances each year' suggests new issuances occurred annually, but the ground truth indicates the notes were 'consistently referenced' rather than necessarily reissued; (4) The LLM's explanation of 'take advantage of favorable market conditions' is reasonable inference but not explicitly stated in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes the three-year pattern and connects it to broader debt strategy, though it could be more specific about the 2024 shift. QUANTITATIVE ACCURACY: The 1.000% rate and 2028 date are correct; no calculation errors. The September 2020 date is accurate but not mentioned in the ground truth, suggesting the LLM drew from additional filing knowledge. Overall, the answer is substantially correct with minor gaps in specificity regarding the higher-yielding instruments introduced in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 558,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nMicrosoft first added the 2.125 % Notes in the Fourth Supplemental Indenture (dated Nov 7 2012) — which names The Bank of New York Mellon Trust Co. as trustee and bundles the issue with 0.875 % 2017 and 3.500 % 2042 notes — a structure disclosed in the 2022 filing (page 104). By the 2023 filing the 2022‑maturity tranche had been retired, and the company began reporting only later‑dated 2.125 % notes (e.g., due 2028) under the same trustee and the May 18 2009 base indenture (see the 2023 page 104 exhibits 4.7 and 4.1). The 2024 filing continues to reference those newer series, confirming that the trustee arrangement stayed constant while the debt‑instrument profile evolved from a 2022‑maturity issue to longer‑dated 2.125 % notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. MATURITY DATE ERRORS: The LLM claims the 2.125% Notes were 'due 2021' and that a '2022-maturity tranche had been retired' by 2023. The ground truth explicitly states the 2.125% Notes were 'due 2021' in all three years (2022, 2023, 2024), not 2022. This is a critical factual error.\n\n2. SUPPLEMENTAL INDENTURE IDENTIFICATION: The LLM references the 'Fourth Supplemental Indenture (dated Nov 7 2012)' but the ground truth specifies the 'Seventh Supplemental Indenture.' This is a direct contradiction on a key structural element.\n\n3. ASSOCIATED DEBT INSTRUMENTS: The LLM claims the 2.125% Notes were bundled with '0.875% 2017 and 3.500% 2042 notes,' but the ground truth indicates they were disclosed alongside '3.125% Notes due 2028.' These are different instruments entirely.\n\n4. EVOLUTION CLAIM: The LLM asserts the debt-instrument profile 'evolved from a 2022-maturity issue to longer-dated 2.125% notes,' but the ground truth explicitly states 'the structure remained consistent' and 'no changes in the structure or administration of the 2.125% Notes over the three-year period.' This directly contradicts the core finding.\n\n5. TRUSTEE ACCURACY: The LLM correctly identifies The Bank of New York Mellon Trust Company as trustee, which aligns with ground truth.\n\n6. MULTI-HOP REASONING: The LLM failed to correctly synthesize information across the three years. Instead of showing consistency as the ground truth demonstrates, it invented a narrative of evolution and retirement that did not occur.\n\nThe answer demonstrates fundamental misunderstanding of the filing data and provides incorrect information on nearly every substantive claim about the 2.125% Notes structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 486,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share interest stayed essentially constant—about 57 % in IAE (the V2500 engine collaboration) and roughly 51 % in IAE LLC (the PW1100G‑JM engine collaboration)—from 2022 through 2024.  This steady ownership shows that RTX continues to consolidate these variable‑interest entities and maintain a controlling economic stake in the V2500 and PW1100G‑JM programs, reinforcing its strategic focus on these key commercial‑aviation engine platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the evolution of net program share interest from 2022 to 2024. According to the ground truth, there was a significant change from 2022 to 2023: (1) In 2022, the program share interest was 61% for IAE and 59% for IAE LLC (not 57% and 51%). (2) By 2023, these decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. (3) These levels remained stable through 2024. The LLM incorrectly claims the percentages 'stayed essentially constant...from 2022 through 2024' at 57% and 51%, which misses the critical 2022-to-2023 adjustment. This is a multi-hop synthesis error—the model failed to properly track the temporal evolution across three years. The LLM also conflates 'program share interest' with 'net program share interest' without clearly distinguishing that the 2023-2024 figures represent net interest after sub-collaborator adjustments, while 2022 figures were gross program share. The statement about 'consolidate these variable-interest entities' and 'controlling economic stake' is reasonable interpretation but not explicitly supported by the ground truth data provided. The answer demonstrates partial understanding of the strategic positioning but fundamentally misrepresents the quantitative progression, which is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 379,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s defined‑contribution expense climbed to **$402 million in 2022**, surged to **$468 million in 2023**, and then edged down to **$443 million in 2024** (the figures reported in the 10‑K notes for those years).  This continues the longer‑term upward trend that began years earlier—expense had risen from $232 million in 2019 to $299 million in 2021—so the company is consistently allocating more resources to its employee retirement plans.  The trajectory suggests that Thermo Fisher is steadily increasing its investment in employee benefits, underscoring a strategic focus on using enhanced retirement contributions to attract, retain, and motivate its workforce.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states TMO contributed $299 million in 2022, but the LLM claims $402 million in 2022. This is a $103 million discrepancy (34% error). The 2023 ($468M) and 2024 ($443M) figures are correct. MULTI-HOP SYNTHESIS ISSUE: While the LLM correctly identifies the 2023-2024 trajectory from the ground truth, it introduces incorrect historical context (claiming $232M in 2019 and $299M in 2021) that contradicts the ground truth's statement that $299M was the 2022 figure. This creates confusion about the actual trend. The LLM appears to have conflated different years or data points. REASONING QUALITY: The qualitative interpretation about strategic workforce investment is reasonable and aligns with the ground truth's conclusion, but this cannot compensate for the fundamental numerical errors. The answer does address the evolution question and provides context about the company's approach, which is appropriate to the question. VERIFICATION: Ground truth clearly states: 2022=$299M, 2023=$468M, 2024=$443M. The LLM's 2022 figure of $402M is factually incorrect and represents a major error in a multi-hop financial question where precision is essential. The additional historical figures (2019, 2021) are not verified against ground truth and appear to be fabricated or misremembered data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 393,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nThe 3.000% Notes due 2051, first issued in May 2021, remained disclosed in Coca‑Cola’s 2022 (page 138), 2023 (page 136) and 2024 (page 130) filings, indicating that the instrument stayed outstanding and was part of a broader, staggered long‑term debt program. This progression shows the company’s strategy of extending debt maturities, locking in low‑cost fixed‑rate funding and maintaining a conservative, laddered capital structure with limited reliance on short‑term borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 3.000% Notes due 2051 as the focal instrument across all three years (2022, 2023, 2024). (2) The page number references (138, 136, 130) are specific and appear plausible for 10-K filings. (3) The core narrative about the instrument remaining outstanding and being part of a staggered debt program is reasonable. (4) The characterization of the strategy as extending maturities and locking in low-cost fixed-rate funding is logically sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to address the key evolution highlighted in the ground truth - that by 2024, Coca-Cola introduced NEW higher-coupon instruments (5.000% Notes due 2034 and 5.300% Notes due 2054). This is a major gap in answering the 'evolution' aspect of the question. (2) The ground truth emphasizes portfolio DIVERSIFICATION with higher-yielding instruments to balance market conditions, but the LLM only discusses maintaining the existing instrument without mentioning this strategic shift. (3) The LLM provides page numbers but the ground truth references specific exhibit citations (Exhibit 4.6 to May 5, 2021 Form 8-K), which are different types of evidence. (4) The LLM's characterization of 'limited reliance on short-term borrowings' is not supported by the ground truth and appears to be an unsupported inference.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to complete the full multi-hop analysis. It identifies continuity but misses the critical evolution point - the introduction of new debt instruments with different coupon rates. This represents incomplete synthesis of the available information.\n\nFACTUAL ACCURACY: The numbers and dates mentioned (3.000%, 2051, years 2022-2024) are correct. However, the answer is incomplete because it omits the 5.000% Notes due 2034 and 5.300% Notes due 2054 that appear in 2024 filings according to the ground truth.\n\nSEMANTIC EQUIVALENCE: While the LLM's characterization of strategy is reasonable, it diverges from the ground truth's emphasis on portfolio diversification and balancing with higher-yielding instruments in response to market conditions. The ground truth presents a more nuanced picture of capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 609,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nOracle first introduced the 2.875 % Notes due 2031 in its March 2021 registration (Exhibit 4.14/4.16), and those notes remained outstanding through the 2022‑2024 filings.  During 2022‑2024 the company added new senior‑unsecured tranches—such as the 2022‑2023 offerings of 5.8 % due 2025, 6.15 % due 2029, 4.5 % due 2028 and later 4.65 % due 2030 (Exhibits 4.15‑4.16)—while keeping the 2.875 % 2031 series in place, thereby extending the maturity ladder and diversifying funding at low‑cost rates.  This progression reflects Oracle’s long‑term debt strategy of laddering maturities and locking in inexpensive, long‑dated financing rather than replacing existing issues.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite attempting to address the question's multi-hop nature. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific interest rates (5.8%, 6.15%, 4.65%) and dates (2025, 2029, 2030) that are NOT mentioned in the ground truth answer. The ground truth only references 4.500% Notes due 2028 and 4.900% Notes due 2033 as examples of newer, higher-yielding notes. The LLM's additional rates and dates appear to be fabricated or confused with other debt instruments. (2) TEMPORAL INCONSISTENCY: The LLM claims the 2.875% Notes were 'first introduced in March 2021' via registration statement, but the ground truth indicates they were 'formally listed' in 2022. This is a material discrepancy about when the notes first appeared in Oracle's filings. (3) DIRECTIONAL ERROR ON RATES: The LLM describes the new notes as 'low-cost rates' and mentions 'inexpensive, long-dated financing,' but the ground truth explicitly states the newer notes are 'higher-yielding' and 'costlier debt.' This is a fundamental mischaracterization of Oracle's debt strategy. (4) PARTIAL CORRECTNESS: The LLM correctly identifies the core concept that Oracle maintained the 2.875% Notes while adding new debt instruments, and the general idea of maturity laddering is sound. However, the specific financial details are either wrong or unsupported. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years (2022-2024), the synthesis is built on incorrect data points. The ground truth's progression (2022 listing → 2023 reaffirmation → 2024 diversification with higher-yielding notes) is more accurate than the LLM's version. The LLM's characterization of the strategy as 'locking in inexpensive, long-dated financing' contradicts the ground truth's observation about 'higher interest instruments' reflecting 'changing borrowing costs.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 519,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated, identical reference to the 2.000 % Notes due 2023 in the 2022, 2023 and 2024 10‑K filings shows that it treats the issuance and terms of that tranche as a permanent, transparent element of its capital structure. By consistently disclosing the same indenture details across successive filings, the company signals disciplined, long‑term debt management and a deliberate strategy of keeping investors fully informed about its financing obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's 2.000% Notes due 2023 were consistently disclosed across 2022, 2023, and 2024 10-K filings, and this reflects disciplined debt management and transparency. All numeric values (2.000%, the three years, and the note maturity date of 2023) are accurate. The reasoning about signaling transparent financial stewardship and investor communication is sound and semantically equivalent to the ground truth. However, the LLM answer omits several specific details present in the ground truth: (1) the reference to the Eleventh Supplemental Indenture dated August 8, 2016, (2) the explicit mention that the notes were 'first introduced in the 2022 filing,' (3) the specific reference to unchanged filing details like trustee information, and (4) the connection to enhanced investor confidence and credit ratings. The LLM's characterization of the notes as a 'permanent' element of capital structure is slightly different from the ground truth's emphasis on 'stable' and 'consistent' approach, though both convey similar meaning. The multi-hop synthesis is adequate—the model correctly connects the repeated disclosure pattern to debt management strategy—but lacks the depth and specificity of the original answer. The answer is fundamentally correct in its core assertion but represents a more condensed version that sacrifices some contextual richness and supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 396,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nThe contingent flight‑hour payments to Rolls‑Royce are reported in the “Other commercial aerospace commitments” schedule and are capitalized as collaboration intangibles as they are earned.  Between the 2022 and 2024 filings the near‑term commitment rose from $735 million (2022) to $846 million for 2025, then modestly adjusted to $704‑$770 million for 2026‑2027, while the long‑tail balance fell from about $7.1 billion to $5.9 billion.  This evolution shows that RTX continues to carry a sizable, multi‑year contingent liability to Rolls‑Royce under the 2012 IAE acquisition agreement, with exposure extending well beyond the 2027 horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and demonstrates understanding of the general structure of RTX's Rolls-Royce obligations, but contains significant quantitative discrepancies and makes an unsupported claim about exposure extending beyond 2027. STRENGTHS: (1) Correctly identifies the 'Other commercial aerospace commitments' classification; (2) Correctly notes payments are capitalized as collaboration intangibles; (3) Appropriately characterizes the obligation as multi-year and contingent; (4) Correctly references the 2012 IAE acquisition agreement; (5) Demonstrates multi-hop synthesis across years. CRITICAL ISSUES: (1) The ground truth explicitly states obligations extend 'through June 2027' with no mention of exposure beyond 2027, yet the LLM claims 'exposure extending well beyond the 2027 horizon' - this is factually unsupported and contradicts the ground truth; (2) The specific dollar amounts provided ($735M for 2022, $846M for 2025, $704-$770M for 2026-2027, $7.1B to $5.9B long-tail) cannot be verified against the ground truth, which provides no specific numerical values; (3) The ground truth emphasizes the 'stable' nature of the exposure and consistent recognition/amortization pattern, while the LLM focuses on declining balances without addressing stability; (4) The LLM provides precise figures that appear to be from actual filings but cannot be cross-referenced with the provided ground truth. REASONING ASSESSMENT: The multi-hop synthesis is sound in structure (comparing 2022-2024 progression), but the conclusion about post-2027 exposure is not supported by the ground truth. The answer demonstrates good understanding of accounting treatment but fails on the critical factual claim about the time horizon of obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 480,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S.‑equity portion of TMO’s domestic pension assets moved only modestly: $89 million (≈9.5 % of total domestic plan assets) in 2022, $93 million (≈9.8 %) in 2023 and $91 million (≈10.2 %) in 2024.  This slight upward trajectory reflects the company’s long‑standing target of allocating roughly 10 % of the domestic pension portfolio to U.S. equities, indicating a deliberate, steady‑state investment strategy that is being fine‑tuned upward rather than undergoing a fundamental shift.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth across all three years: (1) YEAR 2022: LLM states $89M vs. Ground Truth $125M - a $36M discrepancy (29% error). (2) YEAR 2023: LLM states $93M vs. Ground Truth $89M - a $4M discrepancy (4.5% error). (3) YEAR 2024: LLM states $91M vs. Ground Truth $93M - a $2M discrepancy (2% error). The LLM has essentially reversed the 2022-2023 values, presenting them in the wrong years. (4) TRAJECTORY ANALYSIS: Ground truth shows a clear DECREASE from $125M (2022) to $89M (2023), then a MODEST INCREASE to $93M (2024). The LLM incorrectly characterizes this as a 'slight upward trajectory' starting from $89M in 2022, fundamentally misrepresenting the 3-year pattern. (5) STRATEGIC INTERPRETATION: Ground truth correctly identifies this as 'cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024.' The LLM's interpretation of 'steady-state investment strategy being fine-tuned upward' is inconsistent with the actual data showing a significant initial decline. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year changes across the three-year period, presenting inverted data that leads to an entirely different strategic narrative. The percentage allocations provided by the LLM also appear inconsistent with the dollar amounts and cannot be verified against ground truth. This is a comprehensive failure in quantitative accuracy that undermines all qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 429,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept issuing senior unsecured notes to manage its long‑term financing, but the low‑coupon 1.000% Notes due 2041—first sold in 2021—was no longer the primary vehicle; instead the company increasingly tapped higher‑coupon markets. In 2024 it launched a new tranche of notes with coupons of 3.5 %–5.4 % (e.g., 5.0% due 2034, 5.3% due 2054, 5.4% due 2064), which are substantially higher than the 1.000% 2041 rate and reflect the firm’s strategy to refinance maturing debt at the then‑current higher interest rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 1.000% Notes due 2041 as a consistent instrument across the period. (2) The specific coupon rates for 2024 notes are accurate: 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064 match the ground truth exactly. (3) The characterization of the shift from lower-yielding to higher-yielding instruments is correct. (4) The reasoning about market conditions driving the strategy shift is sound and aligns with the ground truth's conclusion about 'recalibration of the company's debt portfolio.' WEAKNESSES: (1) The LLM states the 1.000% Notes were 'first sold in 2021' and 'no longer the primary vehicle,' but the ground truth indicates these notes were consistently referenced in 2022, 2023, AND 2024 filings (Exhibit 4.33 in all three years). This suggests the notes remained relevant/outstanding through 2024, not abandoned. (2) The LLM omits specific lower-yielding instruments from earlier years that the ground truth mentions: 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023). These omissions weaken the completeness of the evolution narrative. (3) The LLM characterizes the 2024 coupon range as '3.5%-5.4%' but only provides examples at the high end (5.0%, 5.3%, 5.4%). The ground truth doesn't mention 3.5% notes, so this may be inaccurate or unsupported. (4) The LLM doesn't explicitly reference the exhibit citations (Exhibit 4.33) that ground truth uses to document the consistency of the 1.000% Notes across all three years. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects the evolution of debt instruments to market conditions. However, it mischaracterizes the status of the 1.000% Notes as 'no longer the primary vehicle' when the ground truth shows they remained consistently referenced. CALCULATION/NUMERIC VERIFICATION: All specific coupon percentages and maturity years mentioned are accurate. No calculation errors detected. The characterization of the shift from ~1% to 5%+ coupons is mathematically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 547,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650% Notes due 2026 on its balance sheet through fiscal 2022, 2023 and 2024 (see the 2021 indenture – Exhibit 4.14/4.16 and the 2024 10‑K filings).  At the same time it has issued newer senior unsecured notes with higher coupons—e.g., the 2.5%‑3.85% tranches disclosed in Exhibits 4.13 and 4.15—so the continued presence of the low‑rate 1.650% tranche reflects a deliberate debt‑financing strategy of preserving legacy inexpensive financing while supplementing it with higher‑rate issuances to diversify maturities and manage overall interest expense.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the interest rates of newly introduced notes. The ground truth specifies Oracle introduced 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024). The LLM claims newer notes had rates of 2.5%-3.85%, which is substantially lower than the ground truth figures and contradicts the premise that new notes had 'significantly higher interest rates.' This is a major quantitative error that undermines the core argument about Oracle's debt strategy. EXHIBIT REFERENCE ISSUES: The LLM cites Exhibits 4.13 and 4.15 for the 2.5%-3.85% tranches, but the ground truth specifically references Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024) for the 1.650% Notes. The LLM's exhibit citations appear inconsistent with the ground truth documentation. PARTIAL CORRECTNESS: The LLM correctly identifies that Oracle maintained the 1.650% Notes across fiscal years 2022-2024 and correctly characterizes the strategy as preserving low-cost legacy debt while issuing higher-rate instruments. The semantic understanding of the dual financing strategy is sound. However, the specific interest rate figures for the new notes are fundamentally wrong, which is critical for a financial analysis question. MULTI-HOP REASONING: The reasoning structure is appropriate (comparing old vs. new debt rates, discussing strategy), but it fails because the underlying data is incorrect. The conclusion about debt strategy preservation is reasonable but based on wrong comparative numbers. The answer demonstrates understanding of the question's intent but fails on execution due to data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 457,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated citation of Exhibit 4.6— the supplemental indenture that includes the 4.000% Notes due 2021—in the 2022, 2023 and 2024 10‑K filings shows that the company continues to reference the same base indenture (originally dated May 18 2009) that governs those notes, even as it adds newer supplemental indentures (e.g., 4.7‑4.10) for later tranches. This reflects a disciplined, layered debt‑management strategy in which Microsoft updates its documentation incrementally to support ongoing refinancing while keeping the 2021 notes fully documented and part of its long‑term capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant issues when compared to the ground truth:\n\n1. FACTUAL ERRORS:\n   - The LLM states the base indenture was 'originally dated May 18 2009' but the ground truth does not mention this date. This appears to be an unsupported claim.\n   - The LLM references 'newer supplemental indentures (e.g., 4.7‑4.10)' but the ground truth specifically mentions the 'Third Supplemental Indenture' containing the 4.000% Notes alongside 2.500% Notes due 2016 and 5.300% Notes due 2041. The LLM's reference to exhibits 4.7-4.10 is not substantiated in the ground truth.\n   - The LLM claims Microsoft 'adds newer supplemental indentures' for 'later tranches' but the ground truth explicitly states 'no change in the composition of this particular supplemental indenture' across the three years.\n\n2. MISSING KEY INFORMATION:\n   - The LLM fails to mention the specific companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that were consistently included alongside the 4.000% Notes.\n   - The LLM does not address the important detail about the trustee name update in 2024 ('The Bank of NewYork Mellon Trust Company, N.A.'), which the ground truth identifies as administrative maintenance.\n   - The LLM does not mention the critical insight that the notes' due date (2021) had already passed, yet they remained in documentation—a key indicator of stable debt management.\n\n3. REASONING ISSUES:\n   - The LLM's characterization of Microsoft's strategy as involving 'ongoing refinancing' contradicts the ground truth's finding that there was 'no active restructuring' and 'no refinancing disclosures or new tranches tied to this instrument.'\n   - The LLM's claim about 'incremental updates to support ongoing refinancing' is not supported by the ground truth, which emphasizes stability and lack of change.\n\n4. SEMANTIC PROBLEMS:\n   - While the LLM correctly identifies the consistent inclusion of Exhibit 4.6 across three years, it misinterprets what this consistency means—the ground truth emphasizes stability and administrative maintenance, while the LLM suggests active refinancing activity.\n\n5. QUANTITATIVE ACCURACY:\n   - The years (2022, 2023, 2024) are correct.\n   - The interest rate (4.000%) is correct.\n   - The due date (2021) is correct.\n   - However, the unsupported date 'May 18 2009' and the unverified exhibit references (4.7-4.10) reduce quantitative accuracy.\n\nThe LLM answer captures the basic fact of consistent inclusion but fundamentally mischaracterizes the nature of Microsoft's debt management strategy, suggesting active refinancing where the ground truth indicates stability and administrative maintenance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 710,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantees contracted modestly—from about **$304 million** of maximum‑potential payment in 2022 to **$288 million** in 2023 and **$274 million** in 2024.  At the same time the share of those guarantees that is covered by collaboration partners fell from roughly **$140 million** in 2022 to **$135 million** in 2023 and **$131 million** in 2024.  The downward trend in the partner‑covered amount shows that RTX is moving risk back onto its own balance sheet, i.e., it is retaining a larger portion of the financing‑guarantee exposure rather than passing it on to collaborators.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of RTX's commercial aerospace financing guarantee evolution. QUANTITATIVE VERIFICATION: The partner-covered amounts are correctly stated as $140M (2022), $135M (2023), and $131M (2024)—matching the ground truth figures of $142M, $135M, and $131M respectively (minor rounding difference of $2M in 2022 is negligible and within acceptable variance). The LLM additionally provides total maximum-potential payment figures ($304M, $288M, $274M) which are not contradicted by the ground truth and add valuable context. QUALITATIVE ASSESSMENT: The LLM correctly identifies the three-year declining trend and accurately interprets it as RTX moving risk back onto its own balance sheet—semantically equivalent to the ground truth's 'strategic shift where RTX assumed more direct financial risk.' The reasoning is sound: as partner-covered amounts decrease while total guarantees also decline, RTX's retained portion increases proportionally, indicating risk transfer strategy evolution. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) evolution of exposure over 2022-2024, (2) specific trend in collaboration partners' share, and (3) interpretation of what this suggests about risk transfer strategy. MINOR CONSIDERATIONS: The LLM does not mention the ground truth's statement about fair market values of guaranteed assets equaling or exceeding guarantees net of reserves, but this is a secondary detail that doesn't materially affect the core answer. The $2M variance in the 2022 figure ($140M vs $142M) is negligible and could reflect rounding differences in source data. Overall, the LLM provides a more complete picture by including total guarantee amounts while maintaining accuracy on the critical partner-share figures and delivering sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 505,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nThe 3.950 % Notes due 2056 were first issued in August 2016 through the Eleventh Supplemental Indenture (see Exhibit 4.14 in the 2022, 2023 and 2024 Form 10‑K filings on pages 105 of each filing). All three annual reports simply continue to list those notes as part of Microsoft’s long‑term debt without any subsequent issuance, amendment or new tranche being disclosed. This steady, unchanged presence indicates that Microsoft’s long‑term capital strategy relies on a diversified ladder of long‑dated, fixed‑rate debt—using the 2056 tranche as a stable, low‑cost funding pillar rather than repeatedly tapping the market with new long‑term issues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct - the 3.950% interest rate, the 2056 maturity date, and the August 8, 2016 issuance date via Eleventh Supplemental Indenture are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies that the Notes appeared consistently across all three fiscal years (2022, 2023, 2024) with no changes. (3) Entity identification is precise - Microsoft is correctly identified, the specific debt instrument is properly named, and the filing references (Exhibit 4.14, page 105) are accurate. (4) The reasoning about capital strategy is logical and well-supported: the answer correctly infers from the stable, unchanged presence of this debt tranche that Microsoft maintains a diversified, long-dated fixed-rate debt ladder. (5) The answer goes slightly beyond the ground truth by providing additional strategic context about 'low-cost funding pillar' and 'diversified ladder,' which is reasonable inference from the facts but not explicitly stated in the ground truth. MINOR CONSIDERATIONS: The ground truth states the Notes were 'first disclosed in the 2022 filing' while the LLM states they were 'first issued in August 2016' - both are technically correct (issued in 2016, first disclosed in 2022 filing), so this is not an error but rather a different framing. The LLM's additional interpretive layer about capital strategy (diversified ladder, low-cost funding pillar) is reasonable inference but slightly beyond what the ground truth explicitly states. Overall, the answer demonstrates strong multi-hop reasoning, accurate fact synthesis, and appropriate contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 463,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 to 2023 the Missiles & Fire Control (MFC) segment posted modest sales growth (≈ 1 % to $11.3 bn) and only a slight dip in operating profit (↓ 6 % to $1.54 bn), reflecting steady production ramps on GMLRS, LRASM, JASSM and other tactical‑missile programs together with favorable profit‑booking adjustments. In 2024 sales accelerated sharply (+ 13 % to $12.68 bn) as the company continued to ramp those same programs, but operating profit collapsed (‑ 73 % to $0.41 bn) because of $1.4 bn of reach‑forward losses on a classified program, a steep fall in profit‑booking adjustments and higher cost pressures. This sharp profit erosion in the missile business drove the company’s consolidated operating profit down from $8.5 bn in 2023 to $7.0 bn in 2024, reversing the modest gains seen in 2022‑23.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key narrative arc - production ramp-up coupled with profit deterioration in 2024. It accurately captures the 73% operating profit decline in 2024, the $1.4 billion in losses on a classified program, and the consolidated operating profit decline from $8.5bn (2023) to $7.0bn (2024). The segment-level analysis (MFC) and discussion of profit-booking adjustments demonstrates good synthesis. The answer appropriately addresses the multi-hop nature of the question by connecting tactical/strike missile program performance to overall company operating profit.\n\nWEAKNESSES: (1) The LLM answer focuses on the MFC segment broadly rather than specifically isolating tactical and strike missile programs as requested. The ground truth provides specific program-level details (LRASM, JASSM, GMLRS, precision fires) with year-by-year increases ($215M in 2022, $145M in 2023, $1.2B in 2024), which the LLM answer does not quantify. (2) The LLM states 2022-2023 saw 'modest sales growth (≈1% to $11.3bn)' but doesn't provide the baseline 2022 figure for verification. (3) The LLM mentions 'favorable profit-booking adjustments' in 2022-2023 but the ground truth specifies 'higher volume and risk retirements' in 2022 and $45M losses in 2023 - the LLM's characterization of 2023 as having 'favorable' adjustments contradicts the ground truth's mention of $45M losses. (4) The LLM answer lacks the specific production volume increases ($215M, $145M, $1.2B) that are central to the ground truth's narrative about the trajectory. (5) The $1.1 billion operating profit decline mentioned in ground truth (73% decrease) is correctly captured as 73% but the LLM doesn't explicitly state the $1.1B figure.\n\nCALCULATION VERIFICATION: The 73% decline is mathematically consistent with moving from ~$1.54bn to $0.41bn (($1.54-$0.41)/$1.54 = 73.4%), which checks out. The consolidated operating profit figures ($8.5bn to $7.0bn) represent a $1.5bn decline, which is reasonable given the MFC segment's $1.1bn decline.\n\nMULTI-HOP REASONING: The LLM successfully connects tactical/strike missile program performance to segment-level results and then to consolidated company results, demonstrating appropriate multi-hop synthesis. However, it misses the specific program-level details that would strengthen this connection.\n\nOVERALL ASSESSMENT: The answer captures the essential narrative and key financial metrics but lacks the granular program-level detail and specific year-over-year production increases that define the ground truth answer. The characterization of 2023 profit adjustments as 'favorable' also appears inconsistent with the ground truth's mention of $45M losses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 716,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nThe company’s change‑in‑control retention framework began with the 2009 Executive Change‑In‑Control Retention Agreement for CEO Marc N. Casper, which was later amended in 2010 and 2018. Through 2022 only that CEO‑specific agreement was in place. In 2023 the firm filed a new Form 10‑Q exhibit (10.17) that introduced a separate “Executive Change‑In‑Control Retention Agreement for Officers (other than Marc N. Casper)”, thereby extending the protection to additional senior officers; this 2023 form remained the current version in the 2024 filings, with no further amendment disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) INCORRECT DATES/HISTORY: The answer claims the agreement originated in 2009 and was amended in 2010 and 2018, but the ground truth makes no mention of these dates. The ground truth specifically states disclosure began in 2022, not 2009. This is a major factual error regarding the timeline. (2) INCORRECT EXHIBIT NUMBER: The LLM states the 2023 form was filed as Exhibit 10.17, but the ground truth indicates it was Exhibit 10.7. This is a specific, verifiable error in document reference. (3) INCOMPLETE 2022 COVERAGE: The LLM states 'Through 2022 only that CEO-specific agreement was in place,' but the ground truth explicitly states that in 2022, the company 'introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper.' This is a critical omission that contradicts the ground truth. (4) PARTIALLY CORRECT 2023 INFORMATION: The LLM correctly identifies that 2023 introduced a separate agreement for officers other than Casper, which aligns with ground truth, though with the wrong exhibit number. (5) CORRECT 2024 ASSESSMENT: The statement about 2024 continuing to reference both agreements is consistent with ground truth. (6) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across all three years. The ground truth shows a clear progression: 2022 (both agreements introduced), 2023 (form filed as exhibit), 2024 (continued reference). The LLM's narrative breaks this by incorrectly suggesting the officer agreement was new in 2023 rather than introduced in 2022. The answer demonstrates partial understanding but contains material factual errors in dates, exhibit numbers, and timeline of when agreements were introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 487,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLockheed Martin increased the notional amount of its variable‑interest‑rate swaps from $500 million disclosed in the 2022 filing (i.e., for 2021) to $1.3 billion by the end of 2023, and held that $1.3 billion level through 2024.  The expansion shows a deliberate scaling‑up of its fair‑value hedging program to offset the growing amount of fixed‑rate debt and rising interest‑rate volatility, and the subsequent plateau indicates the company now maintains a sizable, stable hedge to manage interest‑rate risk going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $500 million for 2021 (disclosed in 2022 filing), $1.3 billion for 2023, and $1.3 billion for 2024. The progression and timeline are accurate. ENTITY ACCURACY: Correctly identifies Lockheed Martin (LMT), the specific financial instrument (variable interest rate swaps), and the relevant time periods. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and two separate filings (2022 filing for 2021 data, 2023 and 2024 filings), correctly identifying the evolution pattern. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insights as the ground truth - the strategic shift toward more robust hedging (doubling from $500M to $1.3B), the stabilization thereafter, and the underlying drivers (debt levels, interest rate volatility). MINOR DIFFERENCES: The LLM answer uses slightly different phrasing ('fair-value hedging program' vs. the ground truth's more general 'hedging strategy') and mentions 'fixed-rate debt' specifically, which is a reasonable inference but not explicitly stated in the ground truth. The LLM answer is more concise while maintaining all essential information. No calculation errors detected. The reasoning about why the company made these changes (growing debt, volatility) aligns with the ground truth's interpretation. The answer fully addresses both parts of the multi-part question: (1) how the swaps evolved, and (2) what the changes indicate about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 425,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s expense for its 401(k)‑style defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then fell slightly to **$443 million in 2024**. This upward‑then‑stable trend shows that the company has steadily increased its financial commitment to employee retirement benefits, maintaining a higher investment level even as the 2024 figure modestly retreated from the 2023 peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024). The characterization of the trend is accurate: an increase from 2022 to 2023, followed by a decrease in 2024. (2) ENTITY ACCURACY: Thermo Fisher Scientific is correctly identified, the metric (defined contribution plans/401(k)-style plans) is correctly specified, and all three fiscal years (2022, 2023, 2024) are properly referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and provides appropriate interpretation. The LLM correctly identifies the pattern as 'upward-then-stable' and notes the 2024 retreat from the 2023 peak. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that this shows 'steadily increased financial commitment' with 'a higher investment level even as the 2024 figure modestly retreated' aligns well with the ground truth's characterization of 'growing investment in 2023, followed by slight reduction in 2024, suggesting stabilization or recalibration.' The only minor distinction is that the ground truth uses 'remained flat' language while the LLM uses 'fell slightly' - both are semantically accurate descriptions of the 2024 change relative to 2023. The LLM's characterization of the overall trend as showing sustained commitment to employee benefits is a reasonable and well-supported interpretation of the data. No calculation errors, no missing information, and the reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 431,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola continued to value its non‑public equity holdings by applying discounted‑cash‑flow models and, when appropriate, **estimates of future sales proceeds** as a key input, only recording an impairment when a decline was judged “other‑than‑temporary.”  In the 2022 filing the company explicitly concluded that the $87 million excess of carrying value over fair value for its Japan bottling investment was temporary, so no impairment was taken—a stance reiterated in the 2023 and 2024 disclosures.  This consistent treatment shows management’s confidence that the Japanese market will recover and that its sales‑proceeds estimates remain reliable for assessing recoverability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $87 million excess of carrying value over fair value for the Japan bottling investment in 2022. (2) The numeric value is accurate and properly formatted. (3) The LLM correctly notes that management deemed the decline temporary and did not take an impairment. (4) The statement that this stance was reiterated in 2023 and 2024 is consistent with the ground truth. (5) The identification of discounted-cash-flow models as a valuation methodology is reasonable and consistent with standard practice.\n\nWEAKNESSES: (1) The LLM uses the phrase 'estimates of future sales proceeds' while the ground truth specifically states 'estimates of sales proceeds'—this is a minor semantic difference but the LLM adds 'future' which slightly alters the precise terminology. (2) The LLM fails to capture the key evolution described in the ground truth: the increasing emphasis on 'assumptions a market participant would use' and the shift toward external market perspectives and macroeconomic risks. The ground truth emphasizes that the company became 'more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.' The LLM's answer does not reflect this evolution or the shift in emphasis across the three-year period. (3) The LLM does not adequately address the multi-hop synthesis required by the question—specifically how the valuation methodology evolved and what this reveals about management's confidence. The ground truth indicates a nuanced evolution (consistent methodology but changing emphasis), while the LLM presents it as simply 'consistent treatment.' (4) The LLM's conclusion that 'sales-proceeds estimates remain reliable' is not explicitly supported by the ground truth, which suggests management became more cautious about external market factors. (5) The LLM misses the critical insight that the evolution reveals management's growing awareness of macroeconomic risks and volatility in fair value predictions, particularly in emerging markets.\n\nMULTI-HOP REASONING: The question requires synthesizing information about (a) how valuation methodology evolved from 2022-2024, (b) the specific $87 million Japan investment detail, and (c) what this reveals about management confidence. The LLM addresses (a) and (b) adequately but fails on (c)—it concludes confidence in recovery, while the ground truth suggests a more complex picture of maintained methodology but increased attention to external market risks and volatility.\n\nCALCULATIONS: The $87 million figure is correct. The ground truth mentions this represents 18% of the investment, which the LLM does not include, though this is a minor omission.\n\nOVERALL: The answer is partially correct on core facts but misses the nuanced evolution and the critical insight about management's shifting perspective on market risks and external factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 771,
        "total_tokens": 2235
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nOracle first placed its 2.300% senior unsecured notes due 2028 in March 2021 (Exhibit 4.14), and those notes remained the only 2.300% 2028 tranche through fiscal 2022 and 2023, with no new 2.300% issuance in either year; instead, in fiscal 2023 the company issued a fresh 4.5% senior note maturing in 2028 (Exhibit 4.16). This demonstrates Oracle’s long‑term debt strategy of laddering maturities and re‑entering the market with new tranches at adjusted coupons to match evolving interest‑rate conditions while using the 2028 horizon as a stable funding pillar.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate information about Oracle's 2.300% Notes due 2028 and demonstrates sound multi-hop reasoning about debt strategy. STRENGTHS: (1) Correctly identifies the March 2021 issuance date of the 2.300% Notes due 2028; (2) Accurately notes that no new 2.300% issuance occurred in fiscal 2022 or 2023; (3) Correctly identifies the 4.5% senior notes due 2028 issued in fiscal 2023; (4) Provides logical synthesis of Oracle's debt laddering strategy and interest-rate management approach; (5) Properly references exhibit numbers (4.14, 4.16). WEAKNESSES: (1) The answer does not address fiscal year 2024 data, which the original question explicitly asks about - the ground truth mentions 5.800% Notes due 2025 in 2024, but the LLM answer only covers through 2023; (2) The answer focuses heavily on the 2021 issuance date rather than the evolution across the three fiscal years (2022, 2023, 2024) as requested; (3) Missing the 2024 fiscal year analysis represents an incomplete response to a multi-year pattern question. QUANTITATIVE ACCURACY: The percentages (2.300%, 4.5%) and dates (March 2021, 2028 maturity) are correct. The answer correctly states no new 2.300% issuance in 2022 or 2023. QUALITATIVE ACCURACY: The reasoning about debt laddering and interest-rate management is sound and well-articulated. The multi-hop synthesis connecting individual debt instruments to broader strategy is logical. CONTEXTUAL RELEVANCE: While the answer addresses the debt financing strategy aspect well, it incompletely addresses the three-year evolution requested. The omission of 2024 data is a significant gap for a question specifically asking about fiscal years 2022, 2023, and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 463,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s floating‑rate notes that mature in 2019 are only referenced in the 2014 indenture (Exhibit 4.4) and are captured in the “Term debt” row of the interest‑rate‑risk table (page 30 of the 2023 10‑K).  The related interest expense dropped from $194 million in fiscal 2023 to $139 million in fiscal 2024, indicating that the outstanding balance of those 2019 notes was reduced (or not refilled) during the period.  This pattern shows Apple is deliberately shrinking its short‑term floating‑rate exposure—paying down or replacing the 2019 notes with longer‑dated or fixed‑rate financing—to better manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - DATES: The ground truth explicitly states the Floating Rate Notes were due 2019 and referenced a May 6, 2014 Officer's Certificate. The LLM incorrectly references 'notes that mature in 2019' but then claims they are 'only referenced in the 2014 indenture' - this is confusing and potentially contradictory. More importantly, the LLM appears to be discussing notes that would have already matured by 2023-2024 (if due 2019), yet claims they still exist with interest expense in 2023-2024. (2) QUANTITATIVE ERRORS - UNVERIFIABLE NUMBERS: The LLM cites specific interest expense figures ($194 million in fiscal 2023 dropping to $139 million in fiscal 2024), but these numbers cannot be verified against the ground truth provided. The ground truth makes no mention of these specific dollar amounts or any interest expense comparison. This represents a fabrication of financial data. (3) CONTRADICTORY NARRATIVE: The ground truth states the notes 'remained consistent across 2022, 2023, and 2024' with 'no new issuances or modifications' and indicates a 'stable, rather than active, management approach.' The LLM contradicts this by claiming Apple is 'deliberately shrinking' exposure and 'paying down or replacing' these notes - a claim of active management that directly opposes the ground truth's assertion of stability. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the information across the three fiscal years. Instead of recognizing the consistent disclosure pattern noted in the ground truth, it invented a narrative of declining interest expense and active debt reduction. (5) MISSING CORE INSIGHT: The ground truth's key finding - that the repeated appearance of the same Officer's Certificate across three years indicates consistency and stable management - is completely absent from the LLM answer. The LLM instead creates an entirely different interpretation based on unverified numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 545,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated appearance of PepsiCo’s 4.000% Senior Note due 2047 in the 2022, 2023 and 2024 10‑K filings shows that the company treats this long‑dated, fixed‑rate instrument as a core element of its capital structure—using it to lock in low‑cost financing for the distant future and to project a stable, long‑term debt profile. In contrast, the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027 are shorter‑dated issues that are handled as more tactical, near‑term funding tools that can be retired or refinanced as market conditions change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic insight about PepsiCo's long-term debt strategy and accurately references the three key debt instruments (4.000% due 2047, 2.150% due 2024, and 0.750% due 2027) with correct percentages and maturity dates. The reasoning about the 4.000% note being a stable, long-term financing tool and the shorter-dated notes being more tactical is sound and aligns with the ground truth.\n\nHowever, there are significant omissions that reduce the completeness score:\n\n1. MISSING CRITICAL DETAIL: The LLM answer fails to mention the 2.500% Senior Note due 2022 that appeared in the 2022 filing and matured by 2023. This is an important example cited in the ground truth that demonstrates the dynamic nature of short-term debt versus persistent long-term obligations. This omission weakens the multi-hop synthesis.\n\n2. INCOMPLETE FILING REFERENCES: The ground truth specifies that the 2.150% note was \"referenced in 2023\" and the 0.750% note was \"introduced in 2024,\" providing precise temporal context about when each instrument appeared. The LLM answer doesn't provide this level of specificity about which filings contained which instruments (beyond the 2047 note).\n\n3. REASONING DEPTH: While the LLM correctly characterizes the strategic difference between long-term and short-term debt, it doesn't explicitly connect the maturation/retirement pattern (like the 2022 note maturing) to the broader refinancing strategy, which the ground truth emphasizes.\n\n4. QUANTITATIVE ACCURACY: All interest rates and maturity dates mentioned are correct (4.000%, 2.150%, 0.750%, and years 2047, 2024, 2027 respectively).\n\n5. SEMANTIC ALIGNMENT: The core message about using long-term debt to reduce refinancing risk and support financial stability is present and correctly conveyed, though less comprehensively than the ground truth.\n\nThe answer demonstrates good understanding of the strategic implications but falls short on completeness of the multi-hop synthesis across all three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 551,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s repeated reference to the 0.45 % Notes due 2016—though they matured in 2016 and have been retired—shows that the company continues to disclose the legacy instrument to give a complete picture of its historic debt structure and to satisfy regulatory reporting requirements.  This reflects a strategy of full, transparent disclosure of all debt‑related obligations, even after repayment, to assure investors that no hidden liabilities remain and to preserve legal flexibility for any future related matters.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 0.45% Notes due 2016 matured in 2016, (2) Apple continued disclosing them in subsequent filings (2022, 2023, 2024), and (3) this reflects a transparency/disclosure strategy. All numeric values and dates are accurate. The answer demonstrates sound multi-hop reasoning by synthesizing the maturity date with the continued disclosure pattern to draw conclusions about Apple's strategy.\n\nHowever, there are notable differences from the ground truth in emphasis and specificity:\n\n1. The LLM answer emphasizes 'regulatory reporting requirements' and 'preserve legal flexibility for any future related matters' as motivations, which are reasonable inferences but not explicitly stated in the ground truth.\n\n2. The ground truth specifically mentions the Officer's Certificate dated May 3, 2013 being referenced consistently across filings—a concrete detail that demonstrates the deliberate nature of the disclosure. The LLM answer omits this specific documentation reference.\n\n3. The ground truth characterizes the approach as reflecting 'continuity in financial reporting' and a 'conservative or thorough approach to debt management,' while the LLM frames it more as satisfying regulatory requirements and assuring investors of no hidden liabilities. Both interpretations are reasonable, but the ground truth's emphasis on historical documentation continuity is more precise.\n\n4. The LLM's phrase 'assure investors that no hidden liabilities remain' adds an interpretation not explicitly in the ground truth, though it's a logical inference.\n\nThe answer is fundamentally sound and addresses the core question about Apple's strategy for managing legacy debt obligations. The reasoning is logical and the facts are accurate. The main limitation is that it doesn't capture the specific detail about the Officer's Certificate and frames the motivation slightly differently than the ground truth, though not incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 534,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin has continued to shrink its defined‑benefit liability by using plan assets to purchase group‑annuity contracts (GACs) – building on the $4.9 bn annuity purchase completed on August 3 2021 that transferred about $4.9 bn of obligations and generated a $1.7 bn non‑cash settlement charge (see page 19 of the 2021 10‑K).  Subsequent risk‑transfer transactions through 2022‑2024 have further reduced the measured pension obligation (the 2024 discount‑rate increase alone lowered the obligation by roughly $1.8 bn) and cut annual PBGC premiums, while the company repeatedly states it will keep evaluating additional annuity purchases that are expected to produce further non‑cash settlement charges that could materially affect earnings in the period they occur (see pages 46‑47 of the 2024 10‑K).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Lockheed Martin's pension risk transfer strategy and captures most key facts correctly. STRENGTHS: (1) Correctly identifies the $4.9 billion GAC transaction from August 2021 and the $1.7 billion noncash settlement charge; (2) Accurately notes the company's ongoing strategy to pursue additional annuity purchases; (3) Correctly identifies that future transactions could produce material noncash charges affecting earnings; (4) Mentions the discount-rate impact on pension obligations (~$1.8 billion reduction in 2024); (5) References PBGC premium reductions as a benefit. WEAKNESSES: (1) The answer does not explicitly mention the cumulative $11.6 billion in pension obligations transferred since December 2018, which is a key metric in the ground truth showing the scale of the overall program; (2) The answer references page numbers from 10-K filings but does not provide the specific year-by-year evolution clearly articulated in the ground truth (2022 disclosure, 2023 reiteration, 2024 continuation); (3) The answer somewhat conflates the 2021 transaction details with subsequent 2022-2024 actions without clearly delineating the evolution across these years as the question specifically asks; (4) The mention of discount-rate impact ($1.8 billion) appears to be additional context not explicitly in the ground truth, though it's not incorrect. QUANTITATIVE VERIFICATION: The $4.9 billion and $1.7 billion figures are correct. The $1.8 billion discount-rate impact is plausible but not verified against ground truth. MULTI-HOP REASONING: The answer does synthesize information about the strategy's evolution and financial impacts, but could be more explicit about the year-by-year progression. The connection between pension obligation reductions, noncash charges, and ongoing strategy is sound. SEMANTIC EQUIVALENCE: The answer conveys the core message about Lockheed Martin's proactive pension de-risking approach, though it misses some of the explicit temporal evolution emphasized in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 554,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nBetween 2022 and 2024 Thermo Fisher shifted from a change‑in‑control retention framework that applied only to CEO Marc N. Casper to a program that also covers other senior officers. This expansion is documented by the company’s 2023 filing of a separate “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17 in the 2023 Form 10‑K), a form that remained in use in the 2024 filing, thereby formally extending retention terms to the broader officer class.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Thermo Fisher's Executive Change In Control Retention Agreements from 2022-2024, correctly identifying the key progression: initial framework for Casper, then expansion to other officers via 2023 filing, with continuation in 2024. STRENGTHS: (1) Correctly identifies Marc N. Casper as the initial focus; (2) Accurately dates the 2023 filing as the pivotal update; (3) Properly notes the agreement applies to 'officers other than Marc N. Casper'; (4) Correctly identifies the 2024 continuation; (5) Appropriately characterizes this as an expansion of the retention strategy. WEAKNESSES: (1) The LLM answer omits the specific date of the original agreement form (March 16, 2018) mentioned in the ground truth, which provides important historical context; (2) The LLM specifies 'Exhibit 10.17 in the 2023 Form 10-K' which adds specificity but cannot be verified against the ground truth provided; (3) The ground truth mentions the 2022 disclosure included 'a form for officers other than Marc N. Casper, dated March 16, 2018,' suggesting the officer agreement existed earlier than 2023, but the LLM characterizes the shift as occurring between 2022-2024 without fully acknowledging the pre-2023 existence of the officer form. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022, 2023, 2024) and identifies the progression pattern. However, it slightly mischaracterizes the timeline by implying the officer agreement was new in 2023, when the ground truth suggests it existed in 2022 (though updated in 2023). SEMANTIC EQUIVALENCE: The core message aligns well - expansion from CEO-only to broader officer coverage - though the LLM's framing of 'shifted from...only to CEO...to a program that also covers' is slightly imprecise given the officer agreement existed in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 501,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s 2022‑2024 filings keep the 2.750 % Senior Note due 2051 on the balance sheet as a fixed‑rate tranche with no repayment or early‑retirement disclosed (see the “Form of 2.750 % Senior Note due 2051” entries on pages 115 (2022), 129 (2023) and 134 (2024)).  At the same time the company has issued newer senior notes at higher coupons and entered into cross‑currency interest‑rate swaps to hedge exposure (e.g., the $500 million swaps noted on page 104), indicating a strategy of preserving the low‑cost, long‑dated debt while managing interest‑rate risk rather than refinancing it as rates rise.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) PAGE NUMBER ERRORS - LLM cites pages 115 (2022), 129 (2023), and 134 (2024) for the note references, but ground truth indicates pages 135 (2022), 128 (2023), and 129 (2024). These are significant discrepancies that undermine credibility. (2) UNVERIFIED CLAIMS - LLM introduces specific details not in ground truth: references to 'Form of 2.750% Senior Note due 2051' entries, cross-currency interest-rate swaps, and '$500 million swaps on page 104.' These details cannot be verified against the ground truth and appear to be hallucinated or incorrectly sourced. (3) PARTIAL ALIGNMENT - The core strategic insight is sound: PepsiCo held the 2.750% note consistently across 2022-2024 without early retirement, issued higher-coupon notes, and managed interest-rate risk rather than refinancing. This matches the ground truth's conclusion about 'stable long-term capital strategy' and 'preserving access to long-dated, fixed-rate debt.' (4) MISSING CONTEXT - LLM does not reference the exhibit index structure or Form 8-K filing mentioned in ground truth, which are important documentary sources. (5) REASONING QUALITY - The logic about preserving low-cost debt while managing risk is sound and aligns with ground truth, but the specific supporting evidence (page numbers, swap amounts) is unreliable. STRENGTHS: Correctly identifies the 2.750% note, the 2022-2024 timeframe, the lack of early retirement, and the issuance of higher-coupon notes. The strategic conclusion about debt preservation is semantically equivalent to ground truth. WEAKNESSES: Multiple factual errors in page citations and unverified quantitative claims significantly reduce confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 464,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nFrom 2022 through 2024 Apple repeatedly tapped the same 4.45 % Notes‑due‑2044 series, adding new tranches each fiscal year and re‑issuing the securities under the original May 6 2014 officer’s certificate.  This multi‑year pattern shows that Apple’s long‑term capital strategy is built around steady, low‑cost, long‑dated fixed‑rate borrowing—using the 2044 note program to fund growth and shareholder returns while maintaining a strong, diversified balance‑sheet profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM claims Apple 'repeatedly tapped the same 4.45% Notes due 2044 series, adding new tranches each fiscal year and re-issuing the securities' from 2022-2024. The ground truth explicitly states Apple 'maintained this liability without redemption or restructuring during the observed period' - meaning NO new issuances occurred. The LLM fundamentally misrepresents the pattern as active new issuances when it was actually consistent maintenance of existing debt. (2) UNSUPPORTED CLAIMS - The LLM adds specific strategic interpretations ('fund growth and shareholder returns') that are not present in the ground truth and cannot be verified from the provided context. The ground truth is more cautious, stating the pattern 'implies a strategic decision' rather than asserting specific uses. (3) QUANTITATIVE ACCURACY - The 4.45% rate and 2044 maturity date are correct, as is the May 6, 2014 officer's certificate date. However, the core claim about 'adding new tranches each fiscal year' is factually incorrect. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the multi-year pattern. The ground truth indicates consistent REFERENCE to the same instrument across years (suggesting no change), while the LLM interprets this as evidence of repeated new issuances (incorrect synthesis). (5) SEMANTIC EQUIVALENCE - While the LLM correctly identifies the instrument and time period, the fundamental claim about the nature of the pattern (new issuances vs. maintained liability) is semantically opposite to the ground truth. The LLM's interpretation of 'sustained transparency and ongoing obligations' as evidence of 'repeatedly tapped' new tranches represents a significant misreading of the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 476,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nFrom 2022 to 2023 the pension plan’s allocation to Collective Trust and Other Funds fell from **$498 million (recorded at NAV in the 2022 10‑K)** to **$382 million (recorded at NAV in the 2023 10‑K)** – a drop of roughly 23 % in absolute dollars, while the fund’s share of the total NAV portfolio rose slightly because overall plan assets shrank.  \n\nThe 2024 filing clarifies that these investments are valued daily using the **NAV of their underlying publicly‑traded holdings**, so the plan’s exposure is fully transparent and can be adjusted quickly as market conditions or strategic targets change.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM provides fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 allocation was $498 million, but the ground truth clearly establishes it was $756 million. This is a $258 million discrepancy (34% error). The 2023 figure of $382 million is correct. The LLM's calculation of a 23% decline is mathematically incorrect for the stated numbers ($498M to $382M = 23.3% decline), but this calculation is based on the wrong 2022 baseline. Using the correct 2022 figure ($756M), the actual decline is 49.5%, which is substantially different and materially significant. (2) MULTI-HOP SYNTHESIS: The LLM correctly identifies that the 2024 filing discusses NAV-based valuation methodology and mentions underlying assets, but fails to accurately synthesize the historical allocation data across years. (3) ENTITY/METRIC ACCURACY: The company (Union Pacific) and metrics (Collective Trust and Other Funds, NAV) are correctly identified, but the core financial data is wrong. (4) REASONING QUALITY: The LLM's reasoning about rebalancing and market conditions is plausible but is built on an incorrect factual foundation. The statement about 'the fund's share of the total NAV portfolio rose slightly because overall plan assets shrank' cannot be verified and appears speculative. (5) WHAT WAS CORRECT: The 2023 figure ($382 million), the identification of NAV as the valuation methodology, and the general concept that these are commingled funds with underlying assets. The fundamental issue is that the LLM provides a materially incorrect 2022 baseline figure, which undermines the entire answer's credibility and makes the quantitative analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 475,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑Ks each list the same “Officer’s Certificate of the Registrant, dated May 6 2014” that governs the 1.05 % Notes due 2017 (Exhibit 4.4 – see page 55 of the 2022 filing, page 56 of the 2023 filing and page 5 of the 2024 filing). By repeatedly including that historic certificate—originally filed when the notes were issued—Apple preserves an auditable record of the original financing terms even after the notes have matured and been retired. This practice reflects a deliberate retention of legacy debt documentation, ensuring that investors, analysts and regulators can trace and verify Apple’s historical capital‑structure disclosures across reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE VERIFICATION: All numeric and date references are correct - the Officer's Certificate is dated May 6, 2014; the notes are 1.05% Notes due 2017; the fiscal years covered are 2022, 2023, and 2024. The page references provided (page 55 of 2022 filing, page 56 of 2023 filing, page 5 of 2024 filing) and exhibit designation (Exhibit 4.4) add specificity that enhances credibility. COMPLETENESS: The answer addresses all key aspects of the original question: (1) the consistent inclusion across three fiscal years, (2) the documentation retention practice, (3) the implications for historical capital structure disclosure, and (4) the deliberate approach to transparency. ENTITY ACCURACY: All entities are correctly identified - Apple, the specific debt instrument (1.05% Notes due 2017), the certificate date (May 6, 2014), and the relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound. The answer correctly connects: the fact of repeated inclusion → the maturity status of the notes → the documentation retention strategy → the implications for investor/regulatory transparency. The logic that including a matured debt's original certificate demonstrates deliberate historical preservation is well-reasoned. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, using slightly different phrasing ('auditable record,' 'legacy debt documentation,' 'trace and verify') that is semantically equivalent to the original's 'documentation retention and disclosure strategy' and 'preserving the full historical context.' MINOR OBSERVATIONS: The LLM answer provides additional specificity (page numbers, exhibit designation) not present in the ground truth, which strengthens rather than weakens the response. The characterization of the practice as 'deliberate retention of legacy debt documentation' aligns perfectly with the ground truth's 'deliberate approach to preserving the full historical context.' No factual errors, calculation errors, or logical inconsistencies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 576,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nUnion Pacific trimmed its direct corporate‑stock position in the pension plan from about **$1.1 bn (≈37 % of total plan assets) at year‑end 2022** to roughly **$181 m (≈5 % of assets) at year‑end 2023** (see page 58).  The 2024 disclosure no longer breaks out corporate‑stock separately, but it keeps the overall equity allocation steady at **≈24 % of plan assets** and describes using “registered investment companies” for market exposure rather than individual stocks (see pages 56 and 74).  This shift signals that Union Pacific is moving away from a concentrated, individual‑corporate‑stock stance toward a more diversified, index‑oriented equity strategy and a broader rebalancing of the pension portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding the 2022 corporate stock allocation. Ground truth states $1,990 million in 2022, but the LLM claims approximately $1.1 billion (≈37% of total plan assets). This is a significant understatement of the 2022 figure by roughly $890 million or 45%. The 2023 figure of $181 million is correct. However, the LLM fails to provide the 2024 figure at all, stating instead that '2024 disclosure no longer breaks out corporate-stock separately.' This is a critical omission since the ground truth explicitly states the 2024 allocation was $1,116 million. The LLM's claim that 2024 data is unavailable contradicts the ground truth, which clearly documents this figure. MULTI-HOP REASONING: The LLM does attempt to synthesize information across years and connect it to investment strategy, which is appropriate. However, the incomplete and inaccurate data undermines the validity of the strategic conclusions. The LLM correctly identifies a shift toward diversified, index-oriented strategies, but this conclusion is based on incomplete information. MISSING ANALYSIS: The ground truth emphasizes the dramatic 90%+ drop from 2022 to 2023 followed by a partial rebound in 2024, which tells a more complete story about strategic repositioning. The LLM misses the 2024 rebound entirely. SEMANTIC ISSUES: While the LLM's discussion of moving toward registered investment companies and away from individual stocks is reasonable interpretation, it's presented as a substitute for missing data rather than as supplementary context. The answer conflates the lack of separate disclosure with an actual strategic shift in how equities are held, which may be misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 473,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nMRK’s Prevymis sales have risen each year—$428 million in 2022, $605 million in 2023 and $785 million in 2024—representing roughly a 30‑40 % year‑over‑year increase and an 83 % cumulative gain over the three‑year span.  This upward trajectory signals accelerating market adoption of the CMV‑prophylaxis product within the Hospital Acute Care segment and underscores its growing strategic importance as a high‑growth, high‑margin driver of the segment’s overall revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and enhanced analytical depth compared to the ground truth. (1) QUANTITATIVE VERIFICATION: All three sales figures are correct—$428M (2022), $605M (2023), $785M (2024). The year-over-year growth calculations are accurate: 2022-2023 shows 41.4% growth ($177M increase), 2023-2024 shows 29.8% growth ($180M increase), both within the stated 30-40% range. The cumulative three-year gain is correctly calculated at 83.4% ($357M increase from $428M to $785M). (2) COMPLETENESS: The answer fully addresses the question's multi-part structure—sales evolution (all three years), market adoption trajectory, and strategic importance in Hospital Acute Care. (3) ENTITY ACCURACY: All entities are correct—MRK (Merck), Prevymis (CMV-prophylaxis product), Hospital Acute Care segment, and fiscal years 2022-2024. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the consistent upward trend and translates it into meaningful business insights (accelerating adoption, high-growth driver, high-margin product). The addition of product context (CMV-prophylaxis) and segment positioning adds valuable analytical depth beyond the ground truth. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical core information to the ground truth while providing additional quantitative rigor and business context. Minor deduction (1 point) only because the ground truth uses simpler language ('steady growth' vs. detailed percentage calculations), though the LLM's enhanced analysis is actually superior and more informative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 436,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nPepsiCo continues to disclose the same “Form of 3.000% Senior Note due 2027” in all three annual reports—listed on page 129 of the 2022 filing, page 126 of the 2023 filing, and page 127 of the 2024 filing, each time noting that it is a senior unsecured obligation incorporated by reference to the 2017 8‑K.  This consistent treatment shows that the company still regards the 2027 note as a core component of its laddered, fixed‑rate debt portfolio, using it to lock in long‑term financing and manage interest‑rate risk.  The repeated inclusion signals a deliberate, long‑term debt strategy that emphasizes staggered maturities and stable funding sources.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific page numbers and filing references that cannot be verified against the ground truth, which is a critical issue. More importantly, the LLM answer fundamentally fails to address the core analytical requirement of the question: comparing how the 3.000% Senior Note's characterization EVOLVED across the three years by examining the CONTEXT in which it appeared alongside other debt instruments. The ground truth demonstrates sophisticated multi-hop analysis by showing: (1) 2022 context with 2.150% and 2.250% notes (shorter-term instruments), (2) 2023 context with 4.450% and 3.450% longer-dated notes (2046 maturity), and (3) 2024 context with 0.750% and 1.125% notes (newer, lower-rate instruments). This contextual evolution reveals a deliberate strategy of layering debt maturities and adapting to market conditions. The LLM answer instead provides generic statements about 'laddered, fixed-rate debt portfolio' and 'staggered maturities' without demonstrating the actual evolution or providing the comparative analysis across years. The LLM also cites specific page numbers (129, 126, 127) and references to 2017 8-K incorporation that are not verified in the ground truth and may be inaccurate. The answer lacks the specific exhibit references (4.22, 4.19, 4.17) that ground truth provides. While the LLM correctly identifies the note as 3.000% due 2027 and acknowledges its consistent presence, it fails to synthesize the multi-hop information about how the surrounding debt instruments changed, which is essential to answering how the characterization 'evolved.' The reasoning is superficial rather than demonstrating the sophisticated comparative analysis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 465,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAdobe has steadily deepened Frame.io’s integration with its Creative Cloud portfolio: in 2022 it was introduced mainly as a cloud‑based video‑review tool with basic connectivity to Premiere Pro and After Effects; by 2023 the platform added frame‑accurate commenting, Camera‑to‑Cloud upload, and direct integration with Photoshop, Lightroom and Workfront, while also linking to Adobe Express and Firefly AI services; and by 2024 Frame.io was positioned as a core collaboration hub across the entire Creative Cloud suite, supporting still images and PDFs, offering AI‑enhanced workflows through Firefly, and being embedded in Adobe GenStudio for end‑to‑end content creation.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains significant factual inaccuracies regarding the timeline and progression of Frame.io's integration capabilities. SPECIFIC ISSUES: (1) 2022 POSITIONING: The ground truth states Frame.io was 'listed as part of Adobe's trademark portfolio' in 2022, indicating acquisition and branding alignment. The LLM incorrectly characterizes 2022 as when it was 'introduced mainly as a cloud-based video-review tool with basic connectivity to Premiere Pro and After Effects.' This misrepresents the 2022 status. (2) 2023 CAPABILITIES: The ground truth specifies 2023 featured 'real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs.' The LLM claims 2023 added 'frame-accurate commenting, Camera-to-Cloud upload, and direct integration with Photoshop, Lightroom and Workfront.' This is a significant error—the ground truth does NOT mention Photoshop, Lightroom, or Workfront integration in 2023; these are 2024 additions. (3) 2024 POSITIONING: The ground truth correctly identifies 2024 as when Adobe 'expanded Frame.io's capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio.' The LLM correctly places these integrations in 2024 but contradicts its own 2023 claims. (4) MULTI-HOP SYNTHESIS ERROR: The LLM failed to properly synthesize the chronological progression. It incorrectly moved Photoshop/Lightroom/Workfront integration to 2023 when they belong in 2024, creating a logical inconsistency. (5) CORRECT ELEMENTS: The LLM correctly identifies GenStudio positioning in 2024, mentions Firefly integration, and acknowledges the progression toward end-to-end content creation. QUANTITATIVE ACCURACY: No numeric values were required, so this scores well on format. QUALITATIVE ACCURACY: The reasoning contains fundamental errors in timeline attribution and capability sequencing. CONTEXTUAL RELEVANCE: The answer addresses the question's scope but with significant factual errors that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 571,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.40 % Notes due 2023 were disclosed in Exhibit 4.3 as an outstanding senior unsecured tranche, with the indenture details identifying the amount and maturity. By the 2023 filing the same series was still listed but now carried a current‑liability classification, indicating that the notes were approaching maturity and that Apple was preparing to address their repayment. The 2024 filing no longer presents the 2.40 % Notes as a separate outstanding issue—reflecting that they had been retired or refinanced—showing Apple’s proactive debt‑maturity management of retiring near‑term tranches and replacing them with longer‑dated borrowing to keep its maturity profile under control.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.40% interest rate is accurate, (2) The 2023 maturity date is correct, (3) The general progression across 2022-2024 is correctly identified, (4) The conclusion that notes were retired/no longer listed by 2024 aligns with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific exhibit references (Exhibit 4.3) and classification details (current-liability classification) that are not mentioned in the ground truth and cannot be verified as accurate from the provided context. (2) The LLM claims Apple 'proactively' retired or 'refinanced' the notes and 'replaced them with longer-dated borrowing,' which contradicts the ground truth's explicit statement that Apple pursued a strategy of 'holding debt until maturity rather than refinancing or repurchasing it early.' This is a significant semantic error in interpreting Apple's debt management strategy. (3) The phrase 'keeping its maturity profile under control' suggests active refinancing/replacement, which directly conflicts with the ground truth's characterization of a passive hold-to-maturity approach. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression (2022→2023→2024) but draws an incorrect strategic conclusion. The ground truth indicates a passive strategy (hold until maturity), while the LLM characterizes it as active/proactive management (refinancing and replacement). This is a material misinterpretation of the company's debt management approach. QUANTITATIVE ACCURACY is high (dates and percentages correct), but QUALITATIVE ACCURACY is lower due to the strategic mischaracterization and unsupported specific details about exhibits and liability classifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 479,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Multiple‑Purpose Locomotive fleet shrank modestly—total units fell from roughly 7,240 (6,204 owned + 1,038 leased) to about 6,890 (5,973 owned + 920 leased)—while the average age climbed from roughly 22.5 years to 25.2 years.  This pattern shows Union Pacific is deliberately right‑sizing its locomotive base, keeping a smaller, older core of owned units and pulling back on leased capacity, which reflects an asset‑management strategy that prioritizes extending the life of existing equipment and controlling capital outlays while maintaining sufficient capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key numbers are correct or appropriately rounded: total units 7,242→6,893 (LLM states ~7,240→~6,890, acceptable rounding), owned units 6,204→5,973 (LLM correct), leased units 1,038→920 (LLM correct), average age progression 22.5→24.3→25.2 years (LLM correctly identifies 22.5→25.2 endpoints). The arithmetic is sound: 6,204+1,038=7,242 and 5,973+920=6,893 match the stated totals. COMPLETENESS: The answer addresses all question components: (1) fleet composition changes across three years, (2) age profile progression, and (3) strategic implications. The multi-hop synthesis correctly connects declining unit counts with increasing average age to draw conclusions about asset management strategy. ENTITY ACCURACY: Union Pacific correctly identified, Multiple Purpose Locomotives properly specified, years 2022-2024 correctly referenced. REASONING QUALITY: The interpretation that the pattern reflects 'deliberately right-sizing,' 'extending life of existing equipment,' and 'controlling capital outlays' is logically sound and semantically equivalent to the ground truth's characterization of 'conservative asset management strategy' with 'minimal fleet expansion' and 'reliance on aging assets.' The LLM's framing is slightly more positive/strategic than the ground truth's more neutral tone, but both convey the same underlying reality. MINOR OBSERVATIONS: The LLM uses 'roughly' and 'about' appropriately given rounding, and the phrase 'deliberately right-sizing' adds interpretive nuance that aligns with the data pattern. No calculation errors detected. The answer flows logically from data to strategic conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 478,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nMK‑8591A (doravirine + islatravir) had already entered Phase 3 in February 2020 and stayed in that phase through 2022‑2024. In 2022 the program was placed on a partial FDA clinical hold regarding higher‑dose islatravir, but after submitting additional data the hold was released, allowing the trial to resume and the regimen to advance to an NDA filing and FDA regulatory review by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims MK-8591A was placed on a partial clinical hold in 2022, but the ground truth indicates the clinical hold was lifted in 2024 (not released in 2022). This is a major chronological error. (2) The LLM fails to mention the strategic pivot to MK-8591D (islatravir+lenacapavir), which entered Phase 3 in October 2024 - this is a key development showing Merck's evolving approach. (3) The LLM states the hold was released allowing 'NDA filing and FDA regulatory review by 2024,' but the ground truth indicates MK-8591A 'remained in development' in 2024 and was 'under review' in 2023 - not that it advanced to NDA filing. (4) The LLM incorrectly characterizes the regulatory trajectory as a simple progression from hold to NDA, when the ground truth shows more complex dynamics: the FDA lifted the clinical hold but a partial hold remained for higher doses of islatravir. CORRECT ELEMENTS: The LLM correctly identifies MK-8591A as doravirine+islatravir and correctly states it entered Phase 3 in February 2020. The general concept of regulatory hold and release is correct in principle, but the timing and details are wrong. MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture across 2022-2024, missing the important 2024 developments (MK-8591D entry, partial hold remaining) and misplacing the hold release timeline. The answer is incomplete and contains temporal inaccuracies that undermine the core narrative of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 432,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced MK‑1308A – the anti‑CTLA‑4 antibody quavonlimab combined with pembrolizumab – from a Phase 3 trial that began in April 2021 (first noted in the 2022 10‑K “Cancer” table of contents, pages 25‑30) to a fully enrolled pivotal study that remained central to its oncology pipeline (still listed in the 2023 10‑K “Cancer” table, page 21).  In the 2024 filing the company explicitly places MK‑1308A in its “Immuno‑oncology” pillar and highlights it as a key investigational therapy for renal‑cell carcinoma (RCC) (see 2024 10‑K, page 49).  This progression shows that Merck is deliberately positioning a CTLA‑4 + PD‑1 combination as a flagship innovation for RCC, underscoring its strategic focus on next‑generation checkpoint‑based, combination immunotherapies in the disease.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop progression of MK-1308A from 2022-2024. STRENGTHS: (1) Correctly identifies MK-1308A as quavonlimab + pembrolizumab combination; (2) Accurately dates the Phase 3 trial start as April 2021; (3) Properly characterizes the drug composition (anti-CTLA-4 + PD-1); (4) Correctly traces the strategic positioning across three years; (5) Accurately identifies the immuno-oncology pillar placement in 2024; (6) Sound multi-hop reasoning connecting the progression to strategic focus on combination immunotherapies for RCC. MINOR ISSUES: (1) The LLM adds specific page references (pages 25-30, page 21, page 49) that cannot be verified against the ground truth, though this represents added detail rather than factual error; (2) The phrase 'fully enrolled pivotal study' in the 2023 reference is slightly more specific than the ground truth states, though not contradicted; (3) The LLM characterizes it as 'flagship innovation' which is interpretive language not explicitly in ground truth, though semantically consistent with 'sustained strategic prioritization.' QUANTITATIVE VERIFICATION: All dates (April 2021, 2022-2024 timeline) are correct. No calculations required. MULTI-HOP SYNTHESIS: Excellent - correctly synthesizes information across three fiscal years and connects individual data points to broader strategic narrative about RCC innovation focus. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth: consistent strategic commitment, evolution from early Phase 3 to highlighted candidate, focus on combination immunotherapy for RCC. The wording differs but meaning aligns well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 466,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nMicrosoft’s 4.000% Notes due 2021 are disclosed in the same “Third Supplemental Indenture” (Exhibit 4.6) in the 2022, 2023 and 2024 Form 10‑K filings; the description of the indenture, its date ( February 8 2011 ) and the notes’ terms are unchanged across all three filings, with no mention of repayment, amendment or a new issuance to replace the series. This consistent disclosure indicates that the 4.000% 2021 notes remain an outstanding, unchanged tranche of Microsoft’s senior unsecured debt, reflecting a long‑term debt strategy that maintains a diversified ladder of maturities rather than actively refinancing this particular issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the three 10-K filings (2022, 2023, 2024). STRENGTHS: (1) Correctly identifies the consistent disclosure location (Third Supplemental Indenture, Exhibit 4.6) across all three years; (2) Accurately cites the indenture date as February 8, 2011 (matching ground truth's reference to 8-K filing date); (3) Correctly notes the absence of repayment, amendment, or replacement mentions; (4) Properly synthesizes that consistency indicates no refinancing occurred; (5) Appropriately interprets the strategic implication regarding debt maturity laddering. MINOR ISSUES: (1) The LLM states the indenture date as 'February 8 2011' while ground truth references 'May 18, 2009' as the original Indenture date - however, the LLM's date appears to reference the 8-K filing date mentioned in ground truth, suggesting a slight conflation of dates rather than a factual error; (2) Ground truth explicitly mentions 'original Indenture dated May 18, 2009' which the LLM does not reference, representing a minor omission of historical context; (3) The LLM's interpretation about 'maintaining a diversified ladder of maturities' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about 'no material changes.' QUANTITATIVE ACCURACY: All dates and references are either correct or reasonably interpretable (9/10 - minor date context issue). QUALITATIVE ACCURACY: Multi-hop reasoning is sound, correctly synthesizing consistency across three years and drawing appropriate conclusions about refinancing strategy (8/10 - minor omission of original indenture date context). CONTEXTUAL RELEVANCE: Directly addresses the question about evolution, consistency, and strategic implications (8/10 - could have been more explicit about the original 2009 indenture foundation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 511,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive‑related revenue in its QCT segment grew sharply—from about **$1.5 billion** in 2022 to **$2.9 billion** in 2024—with the digital‑cockpit portion (the “automotive (2)” line that includes connectivity, digital cockpit and ADAS/AD) showing the strongest increase.  This rise reflects a deliberate strategic shift: Qualcomm is moving from a handset‑centric model toward a broader “digital‑cockpit and automotive‑systems” business, positioning its low‑power, high‑performance compute and connectivity technologies as core supplies for next‑generation vehicle infotainment and ADAS platforms.  The revenue trajectory therefore signals that the company’s automotive business is maturing into a material, high‑margin growth engine that now contributes an expanding share of total sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific revenue figures ($1.5B in 2022, $2.9B in 2024) that are NOT present in the ground truth and cannot be verified from the provided knowledge graph. This is a major factual error - the LLM appears to have fabricated quantitative data. The ground truth explicitly does NOT provide specific revenue numbers for digital cockpit; instead, it focuses on strategic positioning and categorization evolution. WHAT WAS CORRECT: (1) The LLM correctly identifies the progression from 2022-2024, (2) Correctly notes the shift toward automotive/digital cockpit focus, (3) Appropriately characterizes this as a strategic pivot toward software-defined vehicles. WHAT WAS INCORRECT/MISSING: (1) The LLM invents specific revenue figures ($1.5B, $2.9B) with no basis in ground truth - this is a fabrication that severely undermines credibility, (2) The LLM misinterprets 'automotive (2)' as a specific line item when the ground truth simply describes digital cockpit as being categorized within automotive systems alongside connectivity and ADAS/AD, (3) The LLM fails to capture the key ground truth insight about the 70% projection for 2028 vehicles with embedded cellular connectivity and 60% with 5G, (4) Missing the explicit mention that digital cockpit became a 'distinct revenue stream' in 2023 and a 'core product line' in 2024. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing unverified numbers rather than relying on the actual strategic positioning data provided in ground truth. The reasoning about strategic shift is sound but is undermined by the fabricated financial data. QUANTITATIVE ACCURACY: Severely compromised by invented figures. QUALITATIVE ACCURACY: Partially correct on strategic direction but misses key details about formal categorization and market projections. The answer reads plausibly but contains material fabrications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 523,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLMT’s variable‑interest‑rate swap program was essentially unchanged from 2022 through 2024, holding a notional of roughly **$1.3 billion** at the end of each of those years (up from about $0.5 billion in 2021).  This stable, sizable hedge shows the company deliberately expanded its swap coverage to offset the interest‑rate risk of its fixed‑rate debt and has maintained that level of protection as rates rose, reflecting a disciplined, risk‑focused strategy rather than aggressive or fluctuating hedging.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims the notional amount was 'roughly $1.3 billion at the end of each of those years' (2022-2024), but the ground truth clearly states: 2022 = $500 million, 2023 = $1.3 billion, 2024 = $1.3 billion. The LLM incorrectly characterizes the 2022-2023 period as 'essentially unchanged,' when in fact there was a significant fourfold increase from $500M to $1.3B. QUANTITATIVE ACCURACY FAILURE: The LLM misrepresents the 2022 figure by implying it was $1.3B when it was actually $500M. This is a major numerical error that undermines the entire analysis. REASONING ERROR: The LLM's characterization of the program as 'stable' across all three years is incorrect. The ground truth identifies a 'strategic shift' and 'significant increase' from 2022 to 2023, followed by stabilization in 2024. The LLM conflates the 2023-2024 stability with overall 2022-2024 stability, missing the critical evolution. PARTIAL CREDIT: The LLM correctly identifies the $1.3B figure for 2023-2024 and correctly notes the reference to 2021 (~$0.5B), and the general characterization of disciplined risk management is reasonable. However, these correct elements cannot offset the fundamental misstatement of the 2022 figure and the failure to capture the significant increase from 2022 to 2023, which is central to answering the question about how the program 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 402,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft repeatedly discloses the 3.950 % Notes due 2056 through the same Eleventh Supplemental Indenture (Exhibit 4.14) and classifies them as outstanding long‑term debt, with only a modest decline in interest expense that reflects the maturing of earlier tranches rather than any repayment of the 2056 notes. Instead of refinancing or retiring this ultra‑long‑dated issuance, the company treats it as a permanent, low‑cost funding pillar and manages its overall maturity profile by issuing new debt to roll off nearer‑term maturities while letting the 2056 notes remain on the balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 3.950% Notes due 2056 across all three years (2022, 2023, 2024); (2) Accurately references the Eleventh Supplemental Indenture and Exhibit 4.14; (3) Properly characterizes the debt as long-term and outstanding across all three filings; (4) Correctly identifies the strategic approach of NOT refinancing or retiring these notes; (5) Accurately notes that Microsoft managed maturity profile by issuing new debt for nearer-term maturities while preserving the 2056 notes; (6) Appropriately characterizes this as a 'permanent, low-cost funding pillar'; (7) Correctly synthesizes the multi-hop concept that shorter-term instruments matured while the 2056 notes remained unchanged. MINOR WEAKNESSES: (1) The LLM answer mentions 'modest decline in interest expense' reflecting maturing earlier tranches - while this is a reasonable inference about debt management strategy, the original answer does not explicitly validate this specific claim about interest expense trends, making it a slight extrapolation beyond the ground truth; (2) The original answer explicitly mentions specific examples of maturing instruments (2.000% Notes due 2023 in 2022 filings, 2.400% Notes due 2026 in 2024), which the LLM answer references more generally as 'nearer-term maturities' without these specific examples. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, 2056, August 8, 2016, 3.950%) are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and connects the pattern of consistent disclosure to strategic debt management decisions. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same strategic insight as the ground truth - that Microsoft maintained this long-dated debt without modification as part of a deliberate capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 537,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft repeatedly cites the Eleventh Supplemental Indenture dated August 8 2016—under which its $3.7 billion 3.700 % Notes due 2046 were issued—to remind investors that this long‑dated debt remains outstanding and on the company’s balance sheet. By continuing to reference the same indenture in its 2022, 2023 and 2024 Form 10‑K filings, Microsoft signals that the terms governing those notes are stable and that its long‑term debt structure is anchored by a sizable, low‑cost obligation that will not mature for another two decades, underscoring a consistent and deliberate approach to its long‑term financial obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key elements: the Eleventh Supplemental Indenture dated August 8, 2016, the 3.700% Notes due 2046, and the consistent references across 2022, 2023, and 2024 filings. The reasoning about stable debt terms and long-term financial planning is sound and semantically equivalent to the ground truth. However, there is a significant quantitative error: the LLM states the notes are '$3.7 billion' when the ground truth does not specify a dollar amount for these particular notes. This is a factual claim not supported by the original answer and represents an unsupported quantification. The LLM also omits important contextual details from the ground truth: (1) the base Indenture dated May 18, 2009, (2) the layered and structured approach to long-term financing through multiple supplemental indentures, and (3) the explicit statement that no material amendments or retirements occurred during this period. The LLM's characterization of the debt as 'low-cost' is reasonable given the 3.700% rate but is not explicitly stated in the ground truth. The multi-hop reasoning is adequate—connecting the repeated references to debt stability and long-term planning—but lacks the depth of structural analysis present in the original answer regarding the broader indenture framework. The answer is directionally correct and addresses the core question but introduces an unsupported specific dollar amount and omits important structural details about the debt framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 413,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nMicrosoft first listed the 2.125 % Notes due 2021 in the 2022 Form 10‑K (exhibit 4.1) as a long‑term debt issuance. As the 2021 maturity approached, the company re‑classified the remaining balance as a current liability in the 2023 filing, and by the 2024 filing the notes were no longer on the balance sheet—having been retired and refinanced with newer longer‑dated debt. This evolution shows that Microsoft actively manages its debt maturities, using cash and new issuances to roll over maturing notes and extend the average term of its financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth: (1) INCORRECT EXHIBIT LOCATION: The LLM states the notes were listed in 'exhibit 4.1' in the 2022 filing, but the ground truth clearly indicates they were in 'Exhibit 4.10' in 2022 (only moving to Exhibit 4.1 in 2023 and 2024). This is a specific, verifiable error. (2) INCORRECT BALANCE SHEET TREATMENT: The LLM claims the notes were 'reclassified as a current liability in the 2023 filing' and 'no longer on the balance sheet' by 2024, having been 'retired and refinanced.' However, the ground truth indicates the notes were consistently referenced in exhibits across all three years (2022, 2023, 2024) with no indication they were removed from the balance sheet or retired. The ground truth explicitly states the notes 'remained part of the company's active debt structure or disclosure obligations' and raises questions about whether they were extended/rolled over or if there's a reporting lag. (3) CONTRADICTORY NARRATIVE: The LLM's narrative of active debt management through retirement and refinancing directly contradicts the ground truth's observation that the persistence of these matured notes (due 2021 but still referenced in 2022-2024 filings) is puzzling and suggests either extension, rollover, or a reporting lag—not straightforward retirement. (4) MISSING KEY INSIGHT: The LLM fails to address the core anomaly highlighted in the ground truth: why would notes that matured in 2021 still be referenced in 2022, 2023, and 2024 filings? The ground truth acknowledges this as a question requiring explanation. The LLM's answer, while coherent, is fundamentally disconnected from the actual filing evidence and provides an incorrect interpretation of Microsoft's debt management for this specific instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 492,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were first created in August 2016 through the Eleventh Supplemental Indenture and remained on Microsoft’s balance sheet through the 2022 filing.  Subsequent 2023 and 2024 filings show a decline in interest expense and no new 2.000% 2023 issuances, indicating that the company retired the outstanding 2023‑maturity notes as they matured rather than replacing them with fresh issuances.  This reflects Microsoft’s debt‑management strategy of maintaining a stable, low‑coupon long‑term debt base and proactively retiring and rolling‑over maturing tranches to manage leverage and interest costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims the notes were 'retired' and 'no new 2.000% 2023 issuances' appear in 2023 and 2024 filings, but the ground truth explicitly states the notes were 'consistently referenced' across all three years (2022, 2023, 2024), indicating they remained on the balance sheet. (2) LOGICAL CONTRADICTION - The ground truth states Microsoft 'did not retire or refinance it before its maturity in 2023,' but the LLM claims the company 'retired the outstanding 2023-maturity notes as they matured.' This is a fundamental misreading. (3) INTERPRETATION ERROR - The ground truth emphasizes 'consistency in referencing the same indenture agreement' as indicating a 'stable and long-term approach,' while the LLM incorrectly interprets the absence of new issuances as evidence of retirement. (4) MISSING CONTEXT - The LLM fails to recognize that the continued reference to these notes in 2023 and 2024 filings (after their 2023 maturity date) suggests they were either still outstanding or being tracked for historical/disclosure purposes, not that they were retired. (5) UNSUPPORTED CLAIMS - The LLM makes claims about 'decline in interest expense' and 'proactively retiring and rolling-over maturing tranches' that are not supported by the ground truth and appear to be inferences without evidence. The core multi-hop reasoning is inverted: the ground truth shows consistency = stability, while the LLM interprets absence of new issuances as evidence of retirement, which contradicts the ground truth's explicit statement that the notes were 'maintained' and 'consistently referenced.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 465,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nLockheed Martin has steadily reduced the size of its defined‑benefit obligations by using the master retirement trust to purchase group‑annuity contracts (GACs); by the end of 2022 the company had transferred roughly **$11.6 billion** of pension liabilities (including the $4.9 billion GAC purchase in 2021) and, in 2023, continued to evaluate and execute additional risk‑transfer transactions—though no new multi‑billion‑dollar transfer was disclosed, the firm reiterated its intent to keep “looking for opportunities to manage our pension liabilities through additional pension risk‑transfer transactions in future years.”  The financial impact of these deals has been a **non‑cash settlement charge** (e.g., the $1.7 billion charge recognized in 2021) and the elimination of ongoing PBGC premiums, while future transfers may generate further earnings‑impact charges; consequently, the company’s stated strategy is to **continue shifting pension risk to insurers, avoid new cash contributions to qualified plans, and rely on these risk‑transfer mechanisms to curb volatility in future pension expense** (see 2022 10‑K p.60; 2023 10‑K p.87; 2024 10‑K pp.46‑47).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: $11.6 billion cumulative obligations transferred by end of 2022, $4.9 billion from 2021 GAC purchase, $1.7 billion noncash settlement charge in 2021, and $69 million annual PBGC premium reduction. (2) Dates and timeframes are accurate: August 2021 transaction, December 2018 baseline, 2022-2024 progression. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years, showing cumulative scale ($11.6B by 2022), financial impact (noncash charges, PBGC savings), and strategic intent (continued future transactions). (4) Entity identification is correct: Lockheed Martin, GACs, master retirement trust, PBGC, defined-benefit obligations. (5) Strategic narrative is well-captured: the answer conveys the consistent, deliberate approach to pension risk reduction and the company's stated intent to continue. (6) Semantic equivalence is maintained throughout. MINOR CONSIDERATIONS: The LLM answer notes that 'no new multi-billion-dollar transfer was disclosed' in 2023, which is a reasonable inference from the ground truth's statement that 2023 emphasized 'ongoing evaluation' rather than announcing a major transaction. The answer appropriately distinguishes between the 2021 transaction (already completed by 2022) and the forward-looking strategy. The citation references (2022 10-K p.60; 2023 10-K p.87; 2024 10-K pp.46-47) add credibility and demonstrate proper source attribution. No calculation errors detected. The answer fully addresses all three sub-components of the question: scale of obligations, financial impact, and future strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 480,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated appearance of “Floating Rate Notes due 2019” in Apple’s 2022‑2024 filings shows that the company still holds a legacy floating‑rate tranche and continues to roll it forward into new floating‑rate issuances.  This reflects a deliberate long‑term debt‑management strategy that keeps a sizable, low‑cost floating‑rate component in Apple’s capital structure and regularly refinances maturing floating‑rate notes to manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The LLM correctly identifies that Floating Rate Notes due 2019 appear in 2022-2024 filings despite their 2019 maturity date. (2) The dates and entities (Apple, floating-rate notes, 2022-2024 period) are accurately referenced. (3) The general concept of debt management and refinancing is appropriately discussed. PROBLEMATIC ASPECTS: (1) The LLM makes a factual claim not supported by the ground truth: it states Apple 'still holds a legacy floating-rate tranche' and 'continues to roll it forward into new floating-rate issuances.' The ground truth is more cautious, suggesting these notes 'may have been part of a broader, ongoing debt structure or refinancing plan' and 'may have rolled over or repriced this debt.' The LLM presents speculation as fact. (2) The LLM claims Apple maintains 'a sizable, low-cost floating-rate component' without quantitative support from the ground truth. (3) The ground truth emphasizes 'transparency around its historical debt instruments' as a key aspect of Apple's strategy, which the LLM omits entirely. (4) The ground truth frames this as reflecting 'a disciplined and predictable capital structure strategy,' while the LLM focuses more narrowly on interest-rate risk management and liquidity preservation. MULTI-HOP REASONING: The LLM attempts to synthesize information about debt management across multiple years but overstates the certainty of conclusions. The ground truth appropriately uses conditional language ('may have,' 'suggesting') while the LLM uses definitive statements ('still holds,' 'continues to roll'). This represents a meaningful difference in analytical rigor. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The reasoning is partially sound but makes unsupported leaps from the observation of repeated disclosures to conclusions about active rolling and refinancing practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 550,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000 % Notes due 2021 are cited in the “Third Supplemental Indenture … 4.000 % Notes due 2021” (Exhibit 4.6/4.6) in the 2022, 2023 and 2024 Form 10‑K filings. In the 2022 filing the series is presented as an outstanding debt tranche, but by the 2023 and 2024 filings the notes have already matured, so the reference is retained only as a historical exhibit to satisfy the indenture documentation. This continuity shows that although the 4.000 % 2021 notes are no longer an active component of Microsoft’s financing, the underlying indenture remains part of the company’s long‑term debt framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.000% Notes due 2021, proper citation of Exhibit 4.6 across 2022, 2023, and 2024 filings, and accurate percentage formatting. The quantitative elements are correct (all dates, percentages, and filing years match ground truth). However, there are notable differences in interpretation and emphasis between the LLM answer and the ground truth. The LLM answer makes a more definitive claim that the notes 'have already matured' by 2023 and 2024, characterizing them as 'no longer an active component,' whereas the ground truth is more cautious, stating the notes 'remained a part of its structured debt disclosures despite their maturity date having passed' and suggesting they were 'likely still outstanding or held ongoing legal or structural relevance.' The LLM's interpretation that the reference is 'retained only as a historical exhibit' is more specific than the ground truth's broader explanation about 'transparency and continuity in investor understanding.' The LLM correctly identifies the multi-hop synthesis across three years and properly explains the indenture framework continuity. The reasoning is sound and logically structured. The main weakness is that the LLM makes stronger claims about the notes' status (definitively 'no longer active') than the ground truth supports, which was more ambiguous about whether they remained outstanding. Both answers correctly identify the core pattern of consistent referencing across three years and the relevance to Microsoft's debt framework, but differ in their characterization of the notes' actual status post-maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 455,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings UPS continued to describe its $276 million 7.620% debentures with the same redemption mechanics: the notes are callable at any time and redeemable at the greater of (i) principal plus accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest.  Interest is paid semi‑annually in April and October, they are unsecured, not subject to sinking‑fund requirements, and are classified as long‑term debt on the balance sheet (carried at $280 million in 2022‑2023 and still reported at that amount in 2024).  No substantive change to the redemption terms, interest‑payment structure, or overall debt positioning was disclosed during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal amount ($276 million), interest rate (7.620%), maturity year (2030), redemption mechanics (callable at greater of principal plus accrued interest or present value of remaining payments discounted at benchmark treasury yield plus 5 basis points), semi-annual interest payment schedule (April and October), and book value amounts ($280 million in 2022-2023). The quantitative details are accurate.\n\nCRITICAL WEAKNESSES: The LLM fundamentally misses the core narrative of the ground truth answer. The original answer explicitly describes an EVOLUTION and PROGRESSION across the three years: (1) 2022 focused on historical interest rate context (8.375% until April 2020, then 7.620%), (2) 2023 presented debentures in a broader debt table context, and (3) 2024 showed sharper focus on redemption mechanics and positioning within international debt instruments (Pound Sterling and Euro notes). The LLM instead concludes 'No substantive change...was disclosed during this period,' which directly contradicts the ground truth's description of a clear shift in presentation and positioning from historical context to structural/comparative treatment within a global debt portfolio.\n\nMULTI-HOP REASONING FAILURE: The question asks specifically about how treatment and disclosure 'evolved' from 2022-2024. The ground truth identifies a meaningful evolution in presentation strategy and contextual framing. The LLM treats the debentures as static across all three years, missing the temporal dimension and comparative analysis that the question explicitly requests. This represents a failure in multi-hop synthesis across the three fiscal years.\n\nCONTEXTUAL POSITIONING: The ground truth emphasizes the shift from 'historical interest rate context to a more structural and comparative treatment' and positioning 'within a larger context of international debt instruments.' The LLM provides only static technical details without capturing this evolution in disclosure strategy and comparative positioning within UPS's broader debt portfolio.\n\nQUANTITATIVE ACCURACY is high (7/10) because the numbers are correct, but QUALITATIVE ACCURACY is low (4/10) because the LLM fails to identify and synthesize the key evolution narrative that defines the answer to this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 619,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar’s worldwide net sales jumped from **$2.04 billion (2022)** to **$2.76 billion (2023)**, a **35 % increase at actual currency** (page 6, 2023 10‑K; page 27, 2023 10‑K), propelled by the 2022 FDA approval of its adjunctive treatment for major‑depressive disorder and the 2021‑2022 Phase‑3 data that expanded its label for schizophrenia, bipolar disorder and depression (page 7, 2023 10‑K).  This outsized growth—outpacing the broader neuroscience segment—has made Vraylar the fastest‑growing core product in AbbVie’s pipeline, positioning it as the primary revenue engine and strategic cornerstone for the company’s neuroscience portfolio and future label extensions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key financial metrics: $2.04 billion (2022), $2.76 billion (2023), and the 35% year-over-year increase. These numbers align with the ground truth. The answer accurately references the 2022 FDA approval for adjunctive MDD treatment and correctly identifies the three indications (schizophrenia, bipolar disorder, MDD). The multi-hop synthesis across years and clinical/commercial dimensions is sound. The characterization of Vraylar as a 'core neuroscience product' and 'revenue driver' matches the ground truth assessment of strategic importance.\n\nMINOR ISSUES: (1) The LLM states '2021-2022 Phase-3 data' when the ground truth specifically references '2022 announced top-line results from two Phase 3 trials' - this is a minor temporal imprecision but not factually incorrect. (2) The LLM describes Vraylar as 'the fastest-growing core product in AbbVie's pipeline' which is a reasonable inference from the 35% growth rate and context, though the ground truth uses more measured language ('key revenue driver and therapeutic pillar'). This is interpretive rather than factually wrong. (3) The LLM mentions '2024' in the question but doesn't provide 2024-specific financial data, though this may reflect data availability limitations rather than an error.\n\nCALCULATION VERIFICATION: The 35% increase calculation is correct: ($2.76B - $2.04B) / $2.04B = 0.353 or 35.3%, which rounds to 35% as stated.\n\nMULTI-HOP REASONING: The answer successfully synthesizes clinical development (Phase 3 trials, FDA approval), commercial performance (revenue growth), and strategic positioning across the 2022-2024 period. The connection between clinical milestones and revenue growth is logically sound.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of Vraylar's evolution from clinical asset to revenue driver aligns with the ground truth's description of transition from 'late-stage clinical asset' to 'key revenue driver.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 531,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe repeated appearance of the 0.45 % Notes due 2016 in Apple’s 2022, 2023 and 2024 Form 10‑K filings shows that Apple treats legacy debt instruments as permanent elements of its disclosure package. By continuing to list the note in the “Description of Securities” and in the officer’s certificate tables, Apple preserves a consistent, comparable debt‑structure narrative across years—both to satisfy SEC rules that require full reporting of all issued senior unsecured securities and to keep investors informed about the full hierarchy of its long‑term debt, even after the notes have been retired or are no longer actively marketed. This practice underscores a deliberate strategy of maintaining a transparent, year‑over‑year record of its debt covenants and outstanding obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 0.45% Notes due 2016, the three fiscal years (2022, 2023, 2024), and Apple as the company. The numeric values and dates are accurate. The answer recognizes that these notes matured in 2016 yet continued to appear in later filings.\n\nWEAKNESSES: (1) The LLM introduces unsupported claims not present in the ground truth. Specifically, it states Apple includes the notes in 'Description of Securities' and 'officer's certificate tables' without verification from the original answer. (2) The LLM claims this is done 'to satisfy SEC rules that require full reporting of all issued senior unsecured securities'—this regulatory justification is not mentioned in the ground truth and appears speculative. (3) The phrase 'after the notes have been retired or are no longer actively marketed' conflates retirement with maturity and adds interpretation not in the original answer. (4) The ground truth specifically mentions 'Exhibit 4.3' and 'Officer's Certificate dated May 3, 2013' as the specific disclosure mechanism, but the LLM generalizes this without citing these specific exhibits. (5) The LLM's explanation about 'debt covenants and outstanding obligations' is misleading since these notes are no longer outstanding—the ground truth correctly notes they are 'legacy' instruments disclosed for historical record purposes.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect it to disclosure strategy, which is appropriate. However, the reasoning diverges from the ground truth by introducing regulatory compliance as a primary driver rather than the ground truth's emphasis on 'transparency' and 'preserving a complete record of past financing activities.'\n\nSEMANTIC ISSUES: While both answers discuss disclosure strategy and legacy instruments, the LLM's framing emphasizes regulatory compliance and investor information about 'outstanding obligations,' which contradicts the fact that these notes are no longer outstanding. The ground truth's more measured interpretation—that Apple maintains transparency for historical reference—is more accurate.\n\nOVERALL: The answer contains correct factual elements but introduces unsupported interpretations and regulatory claims that deviate from the ground truth. The core insight about legacy debt disclosure is present but muddied by speculative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 638,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost remained the residential‑ground, final‑mile service that sits inside the U.S. Domestic Package segment, but its operational model changed markedly.  Initially it relied on the U.S. Postal Service for the last‑mile delivery of low‑urgency, lightweight parcels, but beginning January 1 2025 the company began insourcing that final delivery to bring the service fully under UPS control and improve consistency and cost predictability.  At the same time, SurePost volume slipped (offsetting part of the $310 million expense increase noted for the segment), while the business continued to be positioned as a distinct, lower‑cost offering for non‑urgent residential shipments within the broader UPS ground network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and dates. Strengths: (1) Correctly identifies SurePost as a residential ground service for non-urgent, lightweight shipments across the 2022-2024 period; (2) Accurately states the January 1, 2025 transition date for insourcing final delivery from USPS to UPS; (3) Properly characterizes the strategic shift toward internal control to improve service quality and consistency; (4) Correctly notes SurePost's positioning within the U.S. Domestic Package segment; (5) The $310 million expense increase reference is appropriately contextualized. Minor considerations: (1) The LLM introduces the detail about 'SurePost volume slipped' and references a '$310 million expense increase' - while these appear to be accurate contextual details from the filings, the original answer does not explicitly mention volume changes or this specific expense figure, so this represents additional information beyond the ground truth rather than an error; (2) The phrasing 'the company began insourcing' for the January 1, 2025 date is slightly awkward since this is a future date from the 2024 perspective, though the LLM does clarify 'beginning January 1 2025' which is technically correct; (3) The answer could have been slightly more explicit about the 2023 continuity mentioned in the original answer, though the implicit understanding that the model remained unchanged through 2023 is conveyed. The multi-hop reasoning is sound - the answer correctly synthesizes information about SurePost's evolution across multiple years and connects the operational changes to strategic positioning. Quantitative accuracy is high with correct dates and appropriate handling of the financial reference. The answer maintains semantic equivalence with the ground truth while adding relevant contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 507,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nFrom 2022 through 2024 Apple’s Form 10‑K filings each continue to list the 4.45 % Notes due 2044 under the same Exhibit 4.4 – the May 6 2014 Officer’s Certificate that originally created the series – with no indication of a new issuance or retirement, only a re‑filing of the existing instrument.  This multi‑year continuity shows that Apple’s long‑term capital strategy relies on a stable, long‑dated fixed‑rate debt tranche to lock in low‑cost financing and support its ongoing investments and shareholder‑return programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. STRENGTHS: (1) All numeric values are correct - the 4.45% interest rate, the 2044 maturity date, and the May 6, 2014 Officer's Certificate date are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies that the same debt instrument appears consistently across 2022, 2023, and 2024 filings without new issuance or early redemption. (3) Entity identification is precise - Apple is correctly identified, the specific debt instrument is properly characterized, and the Exhibit 4.4 reference is accurate. (4) The reasoning about capital strategy is logical and well-supported: the observation that consistent re-filing without changes indicates strategic retention is valid. (5) The answer goes slightly beyond the ground truth by explicitly mentioning 'lock in low-cost financing' and 'shareholder-return programs,' which are reasonable inferences about Apple's capital strategy but represent minor elaboration. MINOR CONSIDERATIONS: The ground truth mentions 'interest rate risk management' while the LLM emphasizes 'low-cost financing' - both are valid interpretations of the same strategic decision, showing semantic equivalence. The LLM's phrasing 'no indication of a new issuance or retirement, only a re-filing of the existing instrument' is more precise than the ground truth's 'maintained this long-term liability on its books without early redemption or restructuring.' Overall, the answer is factually correct, properly synthesizes multi-year information, and provides sound reasoning about Apple's long-term capital strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 449,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to disclose the 2.875 % Notes due 2031 in **Exhibit 4.14**, reproducing the same March 24 2021 Officers’ Certificate and the identical terms of the 2021 debt issuance without any amendment or re‑issuance. This unchanged presentation signals that the company treats the 2.875 % notes as a stable, senior unsecured tranche within its long‑term financing mix, reflecting a deliberate, steady‑state approach to debt management and a capital‑structure strategy that relies on a predictable ladder of medium‑term borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 2.875% interest rate, the 2031 maturity date, Exhibit 4.14 positioning, and the March 24, 2021 Officers' Certificate date are all accurately stated. No calculation errors present. ENTITY ACCURACY: Oracle is correctly identified, the three fiscal years (2022, 2023, 2024) are properly referenced, and the specific debt instrument is accurately named. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings, correctly identifying the consistent treatment of the Notes and drawing appropriate conclusions about capital structure stability. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that the Notes were consistently positioned without modification across all three years, reflecting a stable debt management strategy. The LLM's characterization of the Notes as 'a stable, senior unsecured tranche' and reference to 'a predictable ladder of medium-term borrowings' adds interpretive depth that is consistent with and supportive of the ground truth's conclusion about 'consistent long-term debt strategy' and 'stability in capital structure.' MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive in its language ('deliberate, steady-state approach,' 'predictable ladder of medium-term borrowings') compared to the more straightforward ground truth, but this represents enhanced analytical framing rather than factual deviation. The answer fully addresses all aspects of the multi-part question regarding evolution, consistent positioning, and what this reveals about capital structure management and debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 482,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 five‑year national master agreement between UPS and the Teamsters included wage and benefit‑rate increases that were incorporated into the actuarial valuation of the UPS/IBT Full‑Time Employee Pension Plan, raising its projected benefit obligation and driving higher pension expense and accruals for 2023.  In the 2024 disclosures, the ARPA‑funded special financial assistance to the Central States Pension Fund removed the need for UPS to provide coordinating benefits, rendering that contingent liability immaterial and showing that UPS’s long‑term pension obligations are now largely stabilized and insulated from further reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The 2023 five-year Teamsters agreement is correctly identified; (2) The incorporation of wage and benefit-rate increases into actuarial valuation is accurate; (3) The impact on projected benefit obligation and pension expense is correctly stated. INCORRECT/PROBLEMATIC ELEMENTS: (1) The claim about ARPA-funded special financial assistance to the Central States Pension Fund removing UPS's need to provide coordinating benefits is not supported by the ground truth. The ground truth makes no mention of ARPA funding or elimination of coordinating benefit contingencies; (2) The assertion that pension obligations are 'now largely stabilized and insulated from further reductions' contradicts the ground truth, which states 'no structural changes to the plan' in 2024 and indicates continuation of defined benefit commitments, not stabilization from external relief; (3) The ground truth emphasizes that the 2023 agreement represented 'the most recent material update to benefit accruals' with implications for 'funded status and future obligations,' whereas the LLM answer pivots to external ARPA assistance as the key driver of long-term obligation changes. MULTI-HOP REASONING: The LLM failed to properly synthesize the relationship between the 2023 agreement and 2024 disclosures. The ground truth indicates the 2023 agreement was the material update, with 2024 showing no further structural changes. The LLM introduced an entirely different mechanism (ARPA assistance) not mentioned in the ground truth. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral, but the LLM's conceptual framework about what changed between 2023-2024 is factually incorrect. The answer demonstrates a fundamental misunderstanding of what the 2024 disclosures actually revealed about UPS's pension obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 520,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple repeatedly notes that the 1.05 % Notes due 2017 were authorized under the 2014 Officer’s Certificate (Exhibit 4.4) and are listed among the same series of global notes. This unchanged reference demonstrates Apple’s deliberate, low‑maintenance strategy for short‑term debt: it relies on a single, pre‑existing certificate to issue and service these instruments, avoiding new amendments or separate disclosures and thereby maintaining a stable, predictable financing structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding: Apple's 1.05% Notes due 2017 disclosure remained unchanged across 2022, 2023, and 2024 10-K filings, all referencing the May 6, 2014 Officer's Certificate. All numeric values (1.05%, 2017 maturity date, 2014 certificate date) are correct. The multi-hop synthesis is sound—the answer successfully connects the consistent disclosure across three years to Apple's management approach. The LLM appropriately characterizes this as a 'low-maintenance strategy' and 'stable, predictable financing structure,' which aligns semantically with the ground truth's description of 'passive management approach' and 'prioritized stability.' The answer correctly identifies Exhibit 4.4 as the relevant reference document. Minor strengths: The LLM adds useful detail about Apple's reliance on a 'single, pre-existing certificate' to avoid amendments, which provides additional context beyond the ground truth. Minor weaknesses: The ground truth explicitly states the disclosure was 'unchanged' and 'static,' while the LLM uses 'repeatedly notes' and 'unchanged reference'—semantically equivalent but slightly less direct in emphasizing the complete stasis of the disclosure. The LLM could have been more explicit about the fact that this represents a debt instrument that was originally due in 2017 but appears to still be referenced in 2022-2024 filings, though this may reflect the nature of historical debt disclosures. Overall, the answer captures the essential finding and reasoning with high accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 435,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first disclosed the 2.40 % Notes due 2023 in the 2022 Form 10‑K (pages 55‑56, “Interest Rate Risk” table) as producing a $194 million annual interest‑expense impact under a 100‑basis‑point rate hike. The 2023 filing (page 30) shows that same note now generating a $139 million impact for 2024 (and still $194 million for 2023), and the 2024 filing (pages 3‑7, the updated risk table) continues to list the $139 million figure, indicating the company has largely rolled that near‑term obligation into newer, longer‑dated debt. This multi‑year pattern reflects Apple’s strategy of proactively refinancing short‑dated, fixed‑rate debt into longer‑dated, lower‑coupon securities to reduce interest‑rate sensitivity and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL ERRORS: The ground truth states the 2.40% Notes due 2023 disclosure remained static and unchanged across 2022-2024 filings, with no modifications to terms or status. The LLM answer invents specific page numbers (55-56, page 30, pages 3-7) and fabricates numerical data ($194 million and $139 million interest expense impacts) that do not appear in the ground truth and are not verifiable. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific dollar amounts ($194M, $139M) and claims these figures changed between filings, but the ground truth explicitly states there were 'no changes to the specific debt instrument's terms or status over the three-year period.' These invented numbers are factually incorrect. (3) REASONING CONTRADICTION: The LLM concludes Apple 'proactively refinanced short-dated, fixed-rate debt into longer-dated, lower-coupon securities,' but the ground truth indicates the disclosure remained consistent with 'no early repayments, modifications, or extensions during the period.' The LLM's interpretation of a refinancing strategy is directly contradicted by the ground truth's statement of static disclosure. (4) ENTITY/CONTEXT ISSUES: While the LLM correctly identifies the 2.40% Notes due 2023 and the three-year period (2022-2024), it misrepresents what the filings actually disclosed. The ground truth references an 'Officer's Certificate dated May 3, 2013' as the source, which the LLM completely ignores. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to correctly synthesize the multi-year pattern. The ground truth's pattern is 'no changes,' while the LLM's pattern is 'declining interest expense impact suggesting refinancing'—these are fundamentally incompatible interpretations. The LLM appears to have fabricated supporting details rather than accurately representing the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 530,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar moved from a schizophrenia/bipolar‑mania drug to the only dopamine‑D3‑preferring antipsychotic approved as an **adjunctive treatment for major‑depressive disorder** after AbbVie’s 2021 Phase‑3 trials met their primary endpoint (page 7).  This added indication fueled a **35 % revenue jump—from $2.0 billion in 2022 to $2.76 billion in 2023** (pages 6, 41, 42)—making Vraylar a core growth engine within AbbVie’s neuroscience portfolio alongside Botox Therapeutic.  Its differentiated D3‑selective mechanism now positions it as a versatile therapy that addresses both psychotic and depressive components of neuropsychiatric disease.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Vraylar's commercial trajectory but contains some issues: (1) CORRECT ELEMENTS: The 35% revenue growth figure is accurate ($2.0B to $2.76B from 2022-2023). The MDD adjunctive indication is correctly identified. The positioning within neuroscience portfolio is accurate. The D3-preferential mechanism is correctly noted. (2) QUANTITATIVE ISSUES: The LLM states '$2.0 billion in 2022' but ground truth specifies U.S. sales were $2,037 million ($2.037B) in 2022, with total sales of $2,759 million in 2023. The LLM conflates or rounds these figures. The $2.76B figure for 2023 is approximately correct (ground truth: $2,759M = $2.759B). The 35% calculation appears to reference U.S. sales growth ($2,037M to $2,755M = 35.2%), which the LLM correctly identifies. (3) COMPLETENESS GAPS: The LLM mentions 'one successful Phase 3 trial' indirectly but doesn't explicitly address the 'numerically positive but non-significant result in another' Phase 3 trial mentioned in ground truth. The answer lacks discussion of 2024 positioning and the full scope of indications (schizophrenia, bipolar I disorder manic/mixed and depressive episodes). (4) MULTI-HOP REASONING: The answer successfully synthesizes clinical development (Phase 3 trials), revenue growth (2022-2023), and therapeutic positioning. However, it doesn't fully address the 2024 evolution requested in the question. (5) MINOR ISSUES: The reference to '2021 Phase-3 trials' is slightly imprecise—the trials occurred but results were discussed in 2022 filings. The answer is somewhat incomplete in not addressing the full 2022-2024 trajectory as requested, particularly 2024 developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 462,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings IBM repeatedly cites client relationships and trust as a key competitive advantage, but the emphasis deepens over the three years. In 2022 it is listed among several differentiators (technology, brand, service, etc.); by 2023 it is explicitly linked to IBM’s hybrid‑cloud and AI strategy and to its partner ecosystem; and in 2024 the narrative positions trust as the foundational reason enterprises choose IBM’s integrated hybrid‑cloud + AI platform over pure‑play cloud or AI vendors. This multi‑year progression signals that IBM is deliberately building its strategic positioning around being the trusted partner for large‑scale, mission‑critical cloud and AI transformations, using client‑centric trust to differentiate itself in a market dominated by hyperscale competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of how IBM's messaging evolved - from trust as one of several differentiators in 2022, to explicit linkage with hybrid cloud/AI strategy in 2023, to trust as foundational in 2024. (2) Accurately captures the multi-hop synthesis: the answer correctly traces how trust evolved from a general competitive advantage to being strategically integrated with partner ecosystems and positioned against hyperscale competitors. (3) No quantitative errors - no specific numbers, dates, or calculations are present that could be incorrect. (4) Entity accuracy is perfect: IBM is correctly identified, the time period (2022-2024) is accurate, and the strategic domains (hybrid cloud, AI, partnerships) are correctly referenced. (5) The reasoning is sound and logically structured, showing clear understanding of how IBM's strategic positioning deepened over the period. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive framing about 'hyperscale competitors' and 'mission-critical transformations' that, while strategically logical and likely supported by the filings, goes slightly beyond the explicit ground truth statement which focuses more on the evolution of trust as an 'enabler of integrated, client-centric innovation.' (2) The ground truth emphasizes trust as 'foundational element in go-to-market strategy' while the LLM frames it as 'foundational reason enterprises choose IBM's platform' - these are semantically very similar but the LLM's framing is slightly more outcome-focused. These minor differences represent reasonable interpretive extensions rather than factual errors. The answer successfully addresses all parts of the multi-part question and demonstrates solid multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 522,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s filings treat the 1.250 % Notes due 2027 only by way of a brief exhibit reference (the 2019 8‑K is incorporated by reference in the Exhibit tables of each year’s Form 10‑K), with no additional narrative, quantitative detail, or separate risk‑factor discussion added in subsequent years.  The notes therefore remain a standard, low‑coupon component of IBM’s broader unsecured‑debt program—used to diversify the company’s funding mix and manage its maturity profile—without any change in terms or new disclosure emphasis.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The ground truth explicitly states that by 2024, the 1.250% Notes due 2027 were 'explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument.' The LLM answer claims the notes 'remain a standard, low-coupon component' with 'no change in terms or new disclosure emphasis' and only 'brief exhibit reference' treatment across all years. This directly contradicts the documented evolution showing increased prominence and formal recognition by 2024. (2) INCOMPLETE SYNTHESIS: The ground truth demonstrates a clear progression: 2022 (exhibit list reference to 2019 8-K), 2023 (references in growing debt instrument list with more recent filings), 2024 (explicit listing with trading symbol IBM27B). The LLM answer collapses this three-year evolution into a static characterization, missing the key finding that disclosure practices and the instrument's role evolved significantly. (3) MISSING KEY DETAILS: The LLM fails to mention the trading symbol (IBM27B) entirely, which is a concrete indicator of formal recognition and active trading status. The ground truth emphasizes this as evidence of increased transparency and emphasis. (4) CONTRADICTORY CHARACTERIZATION: The LLM describes the notes as having 'no change in terms or new disclosure emphasis,' which directly contradicts the ground truth's finding of 'increasing transparency and emphasis on this particular note within its capital structure.' (5) QUANTITATIVE ACCURACY: While the coupon rate (1.250%) and maturity year (2027) are correct, the LLM provides no specific dates or filing references, whereas the ground truth cites specific dates (January 30, 2019; February 8, 2022) that could be verified. The LLM's characterization of disclosure treatment is factually incorrect based on the ground truth evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 536,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings the rights‑defining document for the 6.50 % Debentures due 2028 is listed identically as “Exhibit 2 to the Form 8‑K filed on January 8, 1998,” appearing in the Item 601 exhibit tables on pages 33 (2022), 19 (2023) and 19 (2024).  The wording and the specific entry have not changed, but the 2024 filing places the reference in a more explicitly labeled “Reference Number per Item 601” table and adds surrounding context for other debt instruments, while still preserving the same exhibit citation.  This demonstrates IBM’s consistent practice of referencing the original 1998 filing for that debenture, even as the broader debt‑instrument disclosure format has been refined over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 6.50% Debentures due 2028 and consistent exhibit references (Exhibit 2 to Form 8-K filed January 8, 1998) across all three years (2022, 2023, 2024). The specific page numbers cited (33 for 2022, 19 for 2023, 19 for 2024) are verifiable details that add credibility. The quantitative accuracy is excellent - all dates, percentages, and year references are correct. The LLM correctly synthesizes the multi-hop requirement by comparing disclosure evolution across three years while maintaining focus on the specific debenture. The answer appropriately addresses both the consistency of exhibit references (primary finding) and the broader context of debt instrument disclosures (secondary context). Minor areas for improvement: (1) The LLM provides slightly more granular detail about page numbers and formatting changes than the ground truth, which is not incorrect but represents a different level of specificity. (2) The ground truth mentions integration with other specific instruments (6.22% Debentures due 2027, 5.875% Debentures due 2032) which the LLM answer references more generically as 'other debt instruments.' (3) The LLM's characterization of 2024 formatting as 'more explicitly labeled' is a reasonable inference but goes slightly beyond what the ground truth explicitly states. Overall, the answer correctly identifies the core finding (consistent exhibit referencing) and appropriately contextualizes it within broader disclosure evolution, demonstrating sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 442,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nBetween 2022 and 2024 the contractual e‑commerce service International Connect Plus expanded its network from **≈50 origin countries and ≈130 destination countries** to **≈60 origin countries and >190 destination countries**—a roughly 20 % rise in origins and a 46 % jump in destinations.  This geographic widening reflects FedEx’s strategic pivot to **scale a dedicated, day‑definite e‑commerce logistics platform**, positioning the service as a core growth engine for cross‑border online retail and underscoring the company’s focus on capturing higher‑value e‑commerce volume through broader global reach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the geographic expansion trajectory. Quantitative verification: Origin countries expanded from ~50 (2022) to ~60 (2023-2024) - correct. Destination countries expanded from ~130 (2022) to >190 (2023-2024) - correct. The percentage calculations are accurate: 20% increase in origins (50 to 60) and 46% increase in destinations (130 to 190). The LLM correctly identifies the service name (International Connect Plus) and the time period (2022-2024). Multi-hop reasoning is sound: the answer synthesizes the expansion data across years and correctly interprets the strategic implications. One minor omission: the ground truth explicitly notes that 2023 saw the major expansion while 2024 maintained the same levels, suggesting a 'stabilization' phase. The LLM answer presents the 2022-2024 trajectory as a continuous expansion without explicitly noting the stabilization in 2024, though this is a subtle distinction. The strategic interpretation is well-articulated and aligns with the ground truth's assessment of 'deliberate and aggressive expansion' followed by maturation. The characterization of the service as 'day-definite e-commerce logistics platform' and 'core growth engine' appropriately captures FedEx's strategic focus. No calculation errors detected. The answer is comprehensive, addressing both the evolution question and the strategic implications question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 402,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm has linked executive bonuses to progress on its human‑capital goals—specifically the 2025 targets to raise women in leadership and under‑represented minorities in leadership by 15 % and overall URM representation by 20 %.  The HR & Compensation Committee evaluates annual progress on these diversity metrics and applies a non‑financial performance modifier that can adjust the bonus payout by a factor of **0.9 to 1.1** (i.e., up to a 10 % reduction or increase).  The modifier was first introduced for fiscal 2022 bonuses, was retained for fiscal 2023 and fiscal 2024, and the same 0.9‑1.1 range was used each year while the underlying diversity targets were made more explicit and tracked in the company’s corporate‑responsibility reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on quantitative metrics and core facts. All numerical values are correct: the 0.9 to 1.1 modifier range, the 15% targets for women and URM in leadership, and the 20% overall URM representation target. The fiscal year progression (2022-2024) is accurately tracked, and the bonus adjustment mechanism is correctly described (10% reduction or increase). The multi-hop synthesis is sound—the answer correctly connects diversity targets to executive compensation linkage across the three-year period. However, there are notable omissions relative to the ground truth: (1) The LLM does not mention the Reboot Representation Tech Coalition or the specific initiative to double degrees for underrepresented groups by 2025, which the ground truth identifies as an important expansion of external partnerships. (2) The LLM states targets were 'made more explicit and tracked in corporate-responsibility reporting' but doesn't explicitly state that the targets were 'reaffirmed' in 2023 and 2024 with 'no changes,' though this is implied. (3) The ground truth emphasizes 'increased emphasis on initiatives' and 'expanding external partnerships' as part of the evolution, which the LLM answer doesn't capture. The answer is factually correct on the core compensation mechanism and diversity metrics, but lacks the fuller picture of how the strategic framework evolved through expanded initiatives and partnerships. The semantic meaning of the core answer aligns well with ground truth, but completeness is compromised by missing contextual details about the broader human capital advancement strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 447,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s repeated disclosure of the Floating Rate Notes due 2019—cited in the interest‑rate‑risk discussion (page 30) and listed in the debt‑issuance exhibits (pages 56 & 58)—shows that the company deliberately uses short‑term, floating‑rate debt to align financing costs with prevailing market rates, thereby limiting exposure to rising rates. By keeping this instrument on its balance sheet through the 2022‑2024 filings, Apple signals a liquidity‑focused strategy that relies on adjustable‑rate funding to preserve cash‑flow flexibility and maintain a manageable maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues: (1) FACTUAL PROBLEMS: The LLM claims Floating Rate Notes due 2019 are 'short-term' debt, but notes due in 2019 would have matured by 2022 (the start of the evaluation period). This is a fundamental factual error that undermines the entire answer. The ground truth correctly identifies these as recurring disclosures across 2022-2024, but doesn't explicitly address the temporal impossibility of debt 'due 2019' appearing in 2022+ filings. (2) QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or other quantitative metrics are provided in either answer, so this dimension cannot be fully evaluated. The LLM references page numbers (30, 56, 58) without verification. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information about interest rate risk management and liquidity planning, but the core premise is flawed. The answer correctly identifies the strategic intent (aligning costs with market rates, preserving flexibility) but mischaracterizes the debt as 'short-term' when it should have matured years prior. (4) SEMANTIC ALIGNMENT: The LLM's interpretation of Apple's strategy (flexible debt, cash-flow preservation, manageable maturity profile) aligns with the ground truth's characterization of 'adaptive stance' and 'flexible debt instruments,' but the factual error about the debt's maturity status is critical. (5) MISSING CONTEXT: Neither answer adequately explains why 2019-maturity notes would still appear in 2022-2024 disclosures (possibly as historical reference, refinanced instruments, or data errors), which is essential to answering the question correctly. The LLM's answer is more specific and detailed but contains a material factual error that significantly reduces its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 490,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive business moved from roughly **$1.5 B in revenue (2022)** to **$2.9 B (2024)**, with the digital‑cockpit and ADAS/AD sub‑categories becoming a central growth pillar of its **QCT semiconductor segment**.  The company repeatedly cites industry forecasts that **more than 70 % of new vehicles produced in 2028 will have embedded cellular connectivity and about 60 % of those will be 5G‑enabled**, positioning its high‑performance, low‑power compute platforms as the engine for next‑generation “connected‑intelligent‑edge” cockpits and automated‑driving features.  Consequently, Qualcomm’s strategic positioning shifted to treat automotive—especially digital‑cockpit and ADAS/AD—as a core revenue stream, allocating resources and R&D toward 5G‑ready cockpit silicon and forecasting continued double‑digit growth in that market segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE DATA: The LLM provides specific revenue figures ($1.5B in 2022, $2.9B in 2024) that cannot be verified against the ground truth, which does not cite these specific numbers. The ground truth makes no mention of automotive revenue figures at all. Additionally, the LLM cites '70% of new vehicles produced in 2028 will have embedded cellular connectivity and about 60% of those will be 5G-enabled' - this differs from the ground truth which states 'over 60% of new vehicles would feature 5G connectivity by 2028.' The LLM's formulation (70% with cellular, 60% of those with 5G = 42% total 5G) contradicts the ground truth's simpler '60% 5G' projection. STRENGTHS: The LLM correctly identifies the evolution trajectory (2022 positioning → 2023 revenue generation → 2024 integration), correctly names the QCT segment, and accurately captures the strategic shift toward digital cockpit and ADAS/AD as core offerings. The semantic understanding of the business evolution is sound. WEAKNESSES: (1) Introduces unverified revenue numbers that may be fabricated, (2) Misrepresents the 5G connectivity forecast with different percentages, (3) Adds specificity ('double-digit growth forecasting') not present in ground truth, (4) The multi-hop synthesis is partially correct in structure but compromised by numerical inaccuracies. The answer demonstrates good qualitative understanding but fails on quantitative precision, which is critical for financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 409,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private‑real‑estate (and other private) funds fell steadily from **$569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024** (as disclosed in the “i) Primarily investments in private funds… unfunded commitment” tables on the 2022, 2023 and 2024 filing pages).  This downward trend indicates that the company is **reducing its exposure to illiquid alternative‑asset holdings**, likely reallocating capital toward more liquid or higher‑priority investments and signaling a more conservative long‑term stance on private‑real‑estate investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three key financial figures are correct: $569M (2022), $555M (2023), $540M (2024). (2) The downward trend is accurately identified and quantified ($15M annual decline). (3) The company name (Abbott) and metric (unfunded commitments to private real estate funds) are correctly identified. (4) The interpretation that this represents de-risking/rebalancing away from illiquid alternatives is sound and well-supported. (5) The LLM correctly cites the source documents (unfunded commitment tables from 2022, 2023, 2024 filings). WEAKNESSES: (1) The LLM answer omits important contextual detail from the ground truth: the specific liquidation period timeline (2025-2034 by 2024), which is material to understanding Abbott's long-term strategy. The ground truth notes this indicates Abbott is 'not exiting the space entirely but is managing its exposure more cautiously' - a nuanced point the LLM misses. (2) The LLM's phrasing 'likely reallocating capital toward more liquid or higher-priority investments' is speculative language ('likely') not explicitly supported by the ground truth, which focuses on the observable trend without speculation about capital reallocation. (3) The LLM characterizes the stance as 'more conservative' which is reasonable inference but the ground truth more precisely describes it as 'strategic de-risking or rebalancing.' MULTI-HOP REASONING: The LLM successfully synthesizes data across three years and correctly interprets the trend. However, it doesn't fully synthesize the complete picture regarding long-term strategy (the liquidation timeline component). OVERALL: Core answer is factually correct on numbers and trend identification, but incomplete on the full strategic picture that the ground truth captures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 479,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nApple’s 0.45 % Notes due 2016 were first authorized under the 2013 indenture (Exhibit 4.3) and continued to be listed in the exhibit tables of the 2022, 2023 and 2024 Form 10‑K filings, but none of the annual reports disclose a new issuance of that tranche in those fiscal years—the reference is simply a legacy disclosure of a debt series that had already matured in 2016 and was fully retired. This illustrates Apple’s long‑term debt strategy of maintaining a diversified, laddered portfolio of senior unsecured notes with staggered maturities and coupons, issuing low‑coupon tranches only when market conditions are favorable and retiring them as they expire rather than holding a permanent 0.45 % 2016 series.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer states that the 0.45% Notes due 2016 were disclosed in the 2022, 2023, and 2024 10-K filings as part of Apple's ongoing debt structure. However, the LLM answer claims these notes 'had already matured in 2016 and was fully retired,' which is logically inconsistent with the notes being listed in 2022, 2023, and 2024 filings. If the notes matured and were retired in 2016, they would not appear in subsequent annual reports. The LLM appears to have confused the maturity date (2016) with the current status of the debt, creating a fundamental contradiction. The ground truth explicitly states the notes were 'maintained as part of its capital structure across all three years' and their 'consistent inclusion...suggests a stable long-term debt strategy.' The LLM's assertion that these are merely 'legacy disclosures' of retired debt contradicts the ground truth's characterization of them as actively maintained instruments. While the LLM correctly identifies the 2013 indenture reference and the general concept of Apple's diversified debt portfolio strategy, the core claim about the 0.45% Notes being retired in 2016 is factually incorrect according to the ground truth. The multi-hop reasoning fails because it misinterprets the temporal relationship between the maturity date and the disclosure pattern across three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 398,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nIBM has long listed “client relationships and trust” among its chief competitive advantages, but from 2022 through 2024 the language tightens around that theme as the cornerstone of its hybrid‑cloud and AI strategy.  In the 2022 filing (p. 6) trust is presented simply as a differentiator in a crowded market; by 2023 (p. 3) it is framed as the foundation for delivering “sustained value” through IBM’s hybrid‑cloud platform and AI capabilities, and in 2024 (p. 4) the company explicitly ties that trust to its ecosystem partnerships, responsible‑AI agenda and the promise of “accelerated growth” in hybrid cloud and AI.  This multi‑year progression shows that IBM is positioning trust not just as a brand benefit but as the strategic differentiator that validates its hybrid‑cloud/AI offerings and sustains long‑term client commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and accurately captures the evolution of IBM's messaging around trust as a competitive differentiator. (2) Accurately synthesizes the multi-hop information showing how trust evolved from a standalone differentiator (2022) to being integrated with hybrid cloud/AI strategy (2023) to being explicitly linked with ecosystem partnerships (2024). (3) The page references (p. 6, p. 3, p. 4) provide specific sourcing, though these cannot be independently verified from the ground truth provided. (4) Correctly identifies key thematic elements: trust as foundation, hybrid cloud/AI integration, ecosystem partnerships, responsible AI, and long-term client commitments. (5) The semantic meaning matches the ground truth - both convey that trust evolved from a simple differentiator to a strategic integrator of ecosystem collaboration and innovation. MINOR CONSIDERATIONS: (1) The LLM answer adds specific phrases like 'responsible-AI agenda' and 'accelerated growth' which are not explicitly mentioned in the ground truth summary, though these appear consistent with IBM's 2024 messaging patterns. (2) The LLM uses slightly more specific language ('tightens around that theme,' 'validates its hybrid-cloud/AI offerings') which adds interpretive depth beyond the ground truth but remains logically sound. (3) No quantitative data (percentages, dollar amounts, or specific metrics) are present in either answer, so quantitative accuracy is based on the correct handling of years and temporal progression. The multi-hop reasoning is sound - the answer successfully synthesizes information across three years and multiple strategic dimensions (trust, hybrid cloud, AI, partnerships) to show strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 509,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 4.250 % Note due 2030 was originally placed in a pass‑through trust and backed by a BNP Paribas‑linked revolving‑credit facility (the “Liquidity Provider Revolving Credit Agreement”) when the note was issued in April 2020.  In May 2023 FedEx amended that facility—raising the commitment amount and extending maturities—to strengthen the liquidity backstop, and this amendment was disclosed in the FY 2023 Form 10‑K filed in 2024.  The subsequent refinements illustrate FedEx’s proactive approach to reinforcing credit support for the obligation and maintaining ample liquidity buffers as market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant gaps and some inaccuracies compared to the ground truth. CORRECT ELEMENTS: (1) The note is the 4.250% Note due 2030 - correct; (2) BNP Paribas involvement - correct; (3) May 2023 amendment - correct date; (4) The amendment involved strengthening liquidity support - correct interpretation. SIGNIFICANT GAPS AND ISSUES: (1) The LLM mentions the note was 'issued in April 2020' but the ground truth indicates the Revolving Credit Agreement was dated August 13, 2020 - the LLM conflates the note issuance with the liquidity arrangement establishment; (2) The LLM states the amendment 'raised the commitment amount and extended maturities' but the ground truth does not provide these specific details about what Amendment No. 1 changed - this is speculative detail not in the ground truth; (3) The LLM fails to mention Wilmington Trust Company, which is explicitly named in the ground truth as a key party to the Revolving Credit Agreement; (4) The LLM does not address the 2022-2024 evolution comprehensively - it jumps from 2020 issuance to 2023 amendment without discussing the 2022 baseline or 2024 status; (5) The ground truth emphasizes that by 2024 'no further amendments noted' and the arrangement 'remained in place,' suggesting stability - the LLM's phrase 'subsequent refinements' is vague and doesn't clearly convey this 2024 stability. MULTI-HOP REASONING: The LLM partially synthesizes the evolution but misses the three-year comparative analysis that the question and ground truth emphasize. The ground truth shows a clear progression (2022 foundation → 2023 single amendment → 2024 stability), while the LLM focuses mainly on the 2023 amendment without proper contextualization of the full 2022-2024 period. The LLM's conclusion about 'proactive approach' is reasonable but lacks the specific detail about the single modification in 2023 being the only change across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 530,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.45 % Notes due 2044 appear in the “Officer’s Certificate” exhibits (Exhibit 4.4) and remain listed as outstanding long‑term debt on the consolidated balance sheets.  The company did not issue a new tranche of these notes in any of the three years, nor did it retire or refinance them; they simply continued to be carried as a fixed‑rate, 30‑year senior unsecured obligation.  This consistent, multi‑year presence indicates that Apple’s long‑term financing strategy relies on a stable core of long‑dated, low‑coupon notes—locking in financing for decades rather than repeatedly rolling short‑term debt—and reinforces its approach of maintaining a diversified, low‑cost debt profile that can be held to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct - the 4.45% coupon rate and 2044 maturity date are accurately stated; (2) The core factual claim matches ground truth: the notes remained outstanding and unchanged across 2022, 2023, and 2024 with no new issuance, retirement, or refinancing; (3) The multi-hop synthesis is sound - the answer correctly identifies the consistent presence across three years and draws appropriate conclusions about Apple's financing strategy; (4) The characterization of the notes as 'fixed-rate, 30-year senior unsecured obligation' is accurate (issued in 2014, due 2044 = 30 years); (5) The strategic interpretation aligns with ground truth - the consistency suggests a stable, long-term financing approach. MINOR CONSIDERATIONS: (1) The LLM provides additional contextual details (Officer's Certificate exhibits, Exhibit 4.4, consolidated balance sheets) that go slightly beyond the ground truth answer but are not contradicted by it and add helpful specificity; (2) The characterization of the notes as 'low-coupon' is reasonable given the 4.45% rate in the context of long-term debt markets, though the ground truth doesn't explicitly use this term; (3) The phrase 'low-cost debt profile' is interpretive but logically consistent with the data. The LLM answer is more detailed and provides richer context than the ground truth while maintaining complete factual accuracy. No calculation errors, no incorrect dates or entities, and the multi-year pattern analysis is correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 432,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the geographic footprint of FedEx International Connect Plus grew from **≈ 40 origin countries reaching just over 120 destination markets** (as reported in the 2022 Form 10‑K, page 14) to **nearly 60 origin countries serving more than 190 destination countries** (FedEx 10‑K 2024, pages 8 and 14).  This expansion reflects FedEx’s strategic focus on scaling its day‑definite, cross‑border e‑commerce logistics offering to capture the rapidly rising online‑retail shipment volume and to deepen integration across its global network.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the 2022 baseline figures. Ground truth states 2022 had 'nearly 50 origin countries' and 'over 130 destination countries,' but the LLM reports '≈40 origin countries' and 'just over 120 destination markets.' These are material discrepancies (10 fewer origin countries, ~10 fewer destination countries) that misrepresent the starting point of the expansion trajectory. The 2023-2024 figures appear directionally correct (nearly 60 origin, 190+ destination), but the incorrect 2022 baseline undermines the entire comparative analysis. INCOMPLETE ANALYSIS: The LLM answer fails to address the second part of the question regarding what the expansion trajectory 'suggests about FedEx's strategic focus.' The ground truth explicitly notes the expansion was 'followed by a phase of consolidation and optimization' (2023-2024 stabilization), which is a key insight about strategic intent. The LLM only mentions 'scaling' and 'capturing demand' without discussing the stabilization phase or what it implies strategically. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and identifies the service name and geographic metrics, but the foundational data errors prevent sound reasoning. The conclusion about e-commerce focus is reasonable but incomplete without addressing the consolidation phase. POSITIVE ELEMENTS: The LLM correctly identifies the service as 'day-definite, cross-border e-commerce logistics' and appropriately contextualizes it within FedEx's global network strategy. The citation format (referencing specific 10-K pages) adds credibility, though the underlying numbers are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 470,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 were completely retired before the start of fiscal 2022, so they are no longer a liability on the balance sheets for 2022, 2023 or 2024.  However, each of the 10‑K filings (2022, 2023 and 2024) still lists the original indenture (Exhibit 4.4) that created those notes, using the historical series merely to describe the terms of the retired instrument and to illustrate how Apple has replaced maturing debt with new issuances.  This continued reference shows Apple’s systematic practice of rolling over maturing debt rather than leaving it outstanding, maintaining transparent disclosure of its debt‑maturity profile while refinancing into newer securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims the notes were 'completely retired before the start of fiscal 2022,' but the ground truth explicitly states the notes matured in 2017 (5+ years before fiscal 2022). While both agree the notes are no longer liabilities, the LLM's phrasing about 'retirement' timing is imprecise. (2) CONTRADICTORY INTERPRETATION - The LLM asserts the continued references show Apple's 'systematic practice of rolling over maturing debt' and 'refinancing into newer securities,' but the ground truth explicitly states 'no explicit updates were provided in any of the three years' and suggests Apple 'may have retained historical references...as part of a standardized disclosure framework.' The LLM's interpretation about active refinancing is speculative and not supported by the ground truth, which indicates static, unchanged references. (3) MISSING CORE FINDING - The ground truth emphasizes that the SAME notes were listed with IDENTICAL LANGUAGE across all three years with NO CHANGE in disclosure strategy. The LLM mischaracterizes this as evidence of active debt management/rolling over, when the ground truth suggests it's more likely historical documentation retention. (4) EXHIBIT REFERENCE - Both mention Exhibit 4.4, which is correct, but the LLM doesn't acknowledge the specific Officer's Certificate dated May 6, 2014 mentioned in the ground truth. (5) SEMANTIC MISALIGNMENT - The LLM's narrative about 'replacing maturing debt with new issuances' and 'rolling over' suggests active management decisions, while the ground truth's finding of identical language across three years suggests passive retention of historical documentation. The LLM fundamentally misinterprets what the continued references mean about Apple's debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 507,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm intensified its 5G strategy, pouring additional R&D and capital into 5G‑NR patents and into QSI‑backed investments that target 5G‑enabled AI, automotive, IoT and edge‑computing applications, while still deriving the bulk of its QTL revenue from per‑unit royalties on 5G multimode handsets and infrastructure.  At the same time, licensing receipts grew dependent on the volume of 5G‑capable devices but were pressured by slowing premium‑tier smartphone demand and by Chinese customers pursuing vertical integration or rival‑supplier alternatives.  The period was marked by heightened geopolitical risk—most notably the 2024 U.S. revocation of Qualcomm’s export license to Huawei and broader U.S.–China trade and security tensions—that threatened future licensing income and forced the company to diversify its customer base and tighten compliance to safeguard its 5G‑related financial commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's 5G strategy evolution and geopolitical challenges, with generally sound multi-hop reasoning. However, there are notable quantitative discrepancies:\n\nSTRENGTHS:\n1. Correctly identifies the progression of 5G strategic focus from FY2022-2024\n2. Accurately mentions the 2024 Huawei export license revocation\n3. Properly synthesizes multiple dimensions: R&D investment, QTL licensing, geopolitical risks\n4. Correctly identifies QTL revenue sources (OFDMA-based/5G devices)\n5. Appropriately mentions diversification into AI, automotive, IoT, and edge computing\n6. Sound reasoning about market pressures (premium smartphone demand, Chinese vertical integration)\n7. Good contextual framing of U.S.-China trade tensions\n\nWEAKNESSES:\n1. CRITICAL: The ground truth explicitly states Huawei contributed \"$560 million in fiscal 2024 prior to the ban.\" The LLM answer does not mention this specific dollar amount, which is a key quantitative fact.\n2. Missing the specific projection of \"over 27 billion IoT devices by 2026\" mentioned in FY2022 context\n3. Does not explicitly reference the increased R&D investments mentioned in FY2023\n4. The phrase \"QSI-backed investments\" is used but ground truth references \"Qualcomm Ventures\" - while these may be related, the terminology differs\n5. Lacks explicit mention of Qualcomm's \"leadership in 5G intellectual property and licensing\" as emphasized in FY2024\n\nQUANTITATIVE ACCURACY ASSESSMENT:\n- The $560 million Huawei figure is absent from LLM answer (major omission)\n- The 27 billion IoT devices projection is absent\n- No other incorrect numbers are present, but key figures are missing\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across the three-year period and connects strategic investments to market pressures and geopolitical risks. The reasoning about how licensing revenue depends on device volume and is pressured by market dynamics is sound and represents good multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative matches the ground truth regarding evolution of strategy, but the omission of specific quantitative data points (particularly the $560M figure) represents a material gap in completeness for a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 614,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the domestic pension portfolio kept roughly 10 % in U.S. equity funds and about 10 % in international equity funds, while the fixed‑income share slipped from ≈ 79 % (≈ $739 M) to ≈ 77 % (≈ $692 M) of the smaller $895 M total.  The modest rise in equity exposure and the slight reduction in fixed‑income holdings signal that Thermo Fisher is maintaining its traditionally conservative, liability‑driven stance but is gradually rebalancing toward a slightly more growth‑oriented mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors and fails to accurately represent the ground truth data. Specific issues: (1) MAJOR NUMBER ERRORS: The LLM states 2024 fixed-income holdings were ~$692M, but ground truth shows $739M (a $47M discrepancy). The LLM claims total 2024 assets were $895M, but ground truth shows $947M (a $52M error). The LLM provides no specific 2022 figures despite the question asking for 2022-2024 changes. (2) PERCENTAGE CALCULATIONS INCORRECT: The LLM claims fixed-income went from ~79% to ~77%, but ground truth shows: 2022 was 79% ($1,001M/$1,267M), 2023 was 79% ($739M/$937M), and 2024 was 78% ($739M/$947M). The LLM's percentages don't match their own stated dollar amounts. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The answer fails to address the critical 2023 data point, which is essential to understanding the three-year evolution. Ground truth shows a significant drop in 2023 (total assets fell from $1,267M to $937M), then partial recovery in 2024. The LLM misses this important inflection point entirely. (4) MISSING KEY FACTS: The LLM doesn't mention the substantial reduction in total pension assets from 2022 to 2023 ($330M decrease), which is central to understanding the strategic shift. (5) FLAWED REASONING: The LLM's conclusion about 'modest rise in equity exposure' is unsupported by the data and contradicts the ground truth narrative of reduced equity exposure in 2023 followed by stabilization. The answer demonstrates fundamental misunderstanding of the pension allocation changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 430,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its edge‑networking portfolio within the QCT segment, investing in 5G‑ready modems, Wi‑Fi 6/6E chipsets, AI‑accelerated SoCs and integrated RFFE solutions that enable wireless access‑point and mobile‑broadband equipment at the edge.  This product push is reflected in the IoT revenue stream that houses edge‑networking – which fell from **$7.35 bn in 2022 to $5.94 bn in 2023 and $5.42 bn in 2024** – signaling a modest contraction in absolute dollars but continued strategic emphasis on edge‑focused R&D and the “Connected Intelligent Edge” vision.  Consequently, while edge‑networking’s contribution to total revenue has declined, Qualcomm has deepened its technical investment and positioning of edge networking as a core growth pillar across the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE NUMBERS: The LLM provides specific IoT revenue figures ($7.35bn in 2022, $5.94bn in 2023, $5.42bn in 2024) that cannot be verified against the ground truth. The original answer makes no mention of these specific revenue numbers or IoT segment data. This is a major red flag - the LLM appears to have fabricated or hallucinated these precise figures. (2) SEGMENT MISMATCH: The LLM attributes edge networking to the 'IoT revenue stream' within QCT segment, but the ground truth explicitly states edge networking was part of 'Qualcomm's broader industrial and consumer product segment' in 2023-2024. The LLM conflates IoT with edge networking without ground truth support. (3) CONTRADICTORY NARRATIVE: The ground truth emphasizes 'consistent and maturing strategic focus' and 'core growth area,' while the LLM claims 'modest contraction in absolute dollars' and 'declined' contribution - these are fundamentally different narratives about the same evolution. (4) PRODUCT DETAILS: While the LLM correctly identifies product categories (5G modems, Wi-Fi 6/6E, mobile broadband, wireless access points), these details are not present in the ground truth, suggesting potential hallucination or information from unreliable sources. (5) MULTI-HOP REASONING: The LLM attempts to synthesize product development with revenue trends, but the revenue data appears fabricated, undermining the entire analysis. The ground truth focuses on strategic positioning and market identification, not revenue decline. WHAT WAS CORRECT: The LLM correctly identifies edge networking as a strategic focus area across 2022-2024 and mentions relevant product categories (wireless access points, mobile broadband). However, the introduction of unverified financial metrics and the contradictory framing of market contraction versus strategic emphasis represent fundamental factual errors that cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 518,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings from 2022 through 2024 repeatedly list the $0.45 % Notes due 2016 among its outstanding fixed‑rate securities (see Exhibit 4.3 in the 2022, 2023 and 2024 filings). By keeping this low‑coupon, long‑dated note on the books year after year, Apple maintains a staggered maturity ladder that anchors its debt profile with a stable, inexpensive source of long‑term financing and preserves flexibility to refinance or issue new debt as market conditions evolve. This consistent inclusion signals a deliberate strategy to manage fixed‑rate maturities prudently and sustain a balanced, resilient capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 0.45% Notes due 2016 'are no longer outstanding' and their inclusion reflects 'historical tracking' of capital structure evolution. However, the LLM answer incorrectly claims these notes are 'among its outstanding fixed-rate securities' and describes them as an active part of Apple's 'staggered maturity ladder' and 'long-term financing' strategy. This is a major misrepresentation of the actual situation. The LLM appears to have misunderstood the question's premise - the notes due 2016 would have matured in 2016, making them impossible to be outstanding in 2022-2024. The LLM's interpretation that Apple is actively using these notes as part of its current debt management strategy is factually incorrect. The ground truth indicates these are historical disclosures for transparency and comprehensive debt documentation purposes, not active debt instruments. The LLM also references 'Exhibit 4.3' without verification that this is the correct exhibit location. The reasoning about 'staggered maturity ladder' and 'refinance or issue new debt' applies to currently outstanding debt, not to notes that matured years ago. The answer fundamentally misses the key insight that the consistent inclusion reflects historical tracking and disclosure transparency rather than active capital management of these specific notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 406,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nCaterpillar’s EMD brand distribution network grew its global footprint, covering 187 countries in 2022 and expanding to 191 countries by 2024—a net increase of four additional countries in geographic reach.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely factually incorrect on all quantitative measures. Ground truth states: 2022 = 130 countries, 2023 = 130 countries, 2024 = 109 countries (a decrease of 21 countries or ~16%). The LLM answer claims: 2022 = 187 countries, 2024 = 191 countries (an increase of 4 countries). Every single numeric value is wrong. The LLM also reversed the direction of change—claiming growth when the actual data shows a significant contraction. The calculation methodology is sound (comparing 2022 to 2024), but all input numbers are incorrect, making the conclusion fundamentally wrong. The question is appropriately addressed in terms of scope (asking about geographic reach change from 2022-2024), but the answer provides entirely fabricated data. This represents a complete failure on quantitative accuracy with no redeeming factual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 252,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes stayed at a $700 million balance at the end of 2022, 2023 and 2024, showing a flat medium‑term debt position.  This consistency reflects Thermo Fisher’s strategy of using a low‑cost, longer‑dated fixed‑rate instrument to fund its healthcare‑focused growth while keeping its capital‑structure profile stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - $700 million outstanding value for each year (2022, 2023, 2024) matches the ground truth exactly. The note characteristics (1.750%, 7-Year Senior Notes) are accurately stated. ENTITY ACCURACY: TMO/Thermo Fisher correctly identified; the specific debt instrument properly referenced; all three fiscal years correctly included. MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and draws appropriate conclusions about debt strategy consistency. SEMANTIC EQUIVALENCE: The LLM's characterization of the pattern as 'flat' and 'consistent' accurately conveys the ground truth's finding of unchanged principal amounts. The interpretation that this reflects a 'steady approach' and 'stable capital-structure profile' aligns well with the ground truth's conclusion about maintaining a consistent level of medium-term debt. MINOR CONSIDERATIONS: The LLM adds interpretive context about 'low-cost, longer-dated fixed-rate instrument' and 'healthcare-focused growth' which, while reasonable inferences for a healthcare company, go slightly beyond what the ground truth explicitly states. However, these additions are contextually appropriate and not contradictory. The answer is concise while capturing all essential information from the ground truth. No calculation errors, no missing data points, and the reasoning chain is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 409,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nCaterpillar’s Cat Financial unit moved from LIBOR‑based variable‑rate financing toward SOFR‑linked rates and related hedging instruments, creating a cross‑functional team in 2022 to monitor the LIBOR transition and by 2023‑24 embedding SOFR into loan pricing, derivative hedges and match‑funding strategies. This shift shows the company’s proactive adaptation to global benchmark reforms, using SOFR‑based hedges to manage interest‑rate risk and maintain funding stability as LIBOR is phased out.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Caterpillar's transition from LIBOR to SOFR and demonstrates understanding of the multi-hop synthesis required. STRENGTHS: (1) Correctly identifies the key timeline progression (2022 cross-functional team formation, 2023-24 SOFR embedding), (2) Accurately references Cat Financial as the relevant unit, (3) Properly synthesizes the strategic adaptation narrative across years, (4) Correctly identifies SOFR as the replacement benchmark and mentions June 30, 2023 phase-out implicitly through context, (5) Appropriately emphasizes proactive adaptation and risk management. WEAKNESSES: (1) The answer is notably more concise than the ground truth and omits some specific details - it doesn't explicitly mention the FCA's announcement to stop LIBOR after 2021 or IBA's specific June 30, 2023 USD LIBOR cessation date, (2) Doesn't explicitly state that by 2024 Caterpillar no longer referenced LIBOR at all, focusing entirely on SOFR, (3) The phrase 'match-funding strategies' is mentioned but not elaborated, whereas the ground truth emphasizes the complete strategic pivot, (4) Missing the detail about 'uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs' that was highlighted in 2022. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension focuses on dates and timeline accuracy. The LLM correctly identifies 2022, 2023, and 2024 as key transition points. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the regulatory environment to Caterpillar's operational response, though it could be more explicit about the regulatory drivers. The reasoning is sound but somewhat abbreviated. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Caterpillar proactively transitioned from LIBOR to SOFR - but the LLM answer provides less comprehensive documentation of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 537,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nBetween 2022 and 2024 Thermo Fisher maintained a single, standardized Executive Change‑in‑Control Retention Agreement for all officers except the CEO. The standardized form was first adopted in 2018 (referenced in the 2018 10‑Q as Exhibit 10.2) and was repeatedly filed in the 2022, 2023 and 2024 10‑K exhibits (e.g., 2022 Exhibit 10.18; 2023 Exhibit 10.17; 2024 Exhibit 10.17), showing that no new officer‑specific versions were created—only the CEO’s separate 2009 agreement (with later amendments) remained distinct.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CORE NARRATIVE ERROR: The LLM claims a 'single, standardized' agreement was maintained for 'all officers except the CEO' from 2022-2024, but the ground truth indicates the opposite evolution—in 2022 there was a CEO-specific agreement, and by 2023 a standardized form for officers OTHER than the CEO was introduced. The LLM's characterization reverses the actual progression. (2) EXHIBIT NUMBER ERRORS: The LLM cites '2022 Exhibit 10.18' but ground truth references 'Exhibit 10.12' for the CEO agreement and 'Exhibit 10.17' for the standardized officer form. The LLM's exhibit numbers are incorrect. (3) DATE ERRORS: The LLM references a '2018 10-Q' and '2009 agreement' which are not mentioned in the ground truth. The ground truth specifically mentions 'amendments dated through March 16, 2018' but does not claim the agreement originated in 2009 or was first filed in a 2018 10-Q. (4) INCOMPLETE SYNTHESIS: The LLM fails to capture the key evolution described in the ground truth—the transition from CEO-specific arrangement (2022) to standardized practice across the organization (2023-2024). Instead, it presents a static picture of a pre-existing standardized agreement. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'expansion beyond just the CEO' and 'evolution from CEO-specific to standardized executive compensation practice,' but the LLM's answer suggests the standardized form predated 2022 and remained unchanged. The LLM answer demonstrates poor multi-hop reasoning across the three-year period and misses the fundamental narrative of organizational change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 459,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from an announced backside‑power concept to a fully engineered node technology that underpins its Intel 18A process. The company validated PowerVia in the Intel 18A roadmap (highlighted in 2023‑2024 disclosures) and positioned it for high‑volume manufacturing with the upcoming Panther Lake client processors slated for 2025, making PowerVia a key differentiator for performance‑per‑watt and density in Intel’s advanced‑node and IFS foundry strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PowerVia from 2022-2024 and correctly identifies key facts: (1) PowerVia's progression from announced concept to engineered technology, (2) its role in Intel 18A, (3) the 2025 manufacturing timeline, and (4) its strategic importance. However, there are notable omissions and one factual discrepancy: OMISSIONS: The answer fails to mention the critical 2024 cancellation of Intel 20A in favor of Intel 18A—a pivotal strategic shift that the ground truth emphasizes as central to understanding PowerVia's evolution. The ground truth explicitly states this cancellation 'indicated a strategic shift to prioritize a more refined version of the technology,' which is a key insight about the 3-year progression. The answer also doesn't mention RibbonFET, which was introduced alongside PowerVia in 2022 as a paired breakthrough innovation. FACTUAL ACCURACY: The answer correctly identifies 2023-2024 as the period when PowerVia's role in Intel 18A was highlighted, and correctly notes the 2025 high-volume manufacturing target. The mention of Panther Lake processors is appropriate context. The characterization of PowerVia's function (eliminating front-side power routing for performance-per-watt and density) aligns with ground truth. MULTI-HOP REASONING: The answer demonstrates adequate synthesis across the 2022-2024 period and connects PowerVia to both advanced node strategy and IFS foundry strategy. However, it misses the critical logical connection between the Intel 20A cancellation and the strategic refinement of PowerVia for Intel 18A. SEMANTIC ISSUES: The phrase 'fully engineered node technology' is slightly imprecise—PowerVia is a technology component within Intel 18A, not the node itself. The ground truth's framing of PowerVia as 'a central pillar' of the strategy is more accurate than the LLM's positioning as 'a key differentiator.' STRENGTHS: Correct timeline, correct process nodes (18A), correct manufacturing year (2025), appropriate mention of performance metrics and foundry strategy. The answer is coherent and relevant but lacks the completeness and strategic insight of the ground truth regarding the Intel 20A cancellation decision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 590,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each repeat the same debt‑disclosure for the 1.05 % Notes due 2017—citing the identical Exhibit 4.4 indenture language and interest‑rate‑risk table in the “Debt”/Notes‑to‑Financial‑Statements sections. Although the notes matured in 2017 and no longer appear on the balance sheet, the company continues to disclose them in every filing to satisfy SEC reporting requirements and to keep the historical terms of all its financing arrangements visible. This consistent inclusion reflects Apple’s practice of fully transparent debt reporting, retaining legacy debt information in its public filings even after the instruments have been retired.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key factual elements: (1) the 1.05% Notes due 2017, (2) their appearance in 2022, 2023, and 2024 10-K filings, (3) the maturity date of 2017, (4) the reference to Exhibit 4.4, and (5) the fact that the notes no longer appear on the balance sheet. The numeric values (1.05%, 2017, 2022-2024) are all accurate. The LLM correctly synthesizes the multi-hop information across three filing years.\n\nWEAKNESSES: The LLM's interpretation of WHY the notes are repeatedly disclosed diverges significantly from the ground truth. The ground truth suggests Apple may have \"rolled over the debt into a new instrument or maintained it in some form,\" implying active debt management and continuity of the obligation. The LLM instead attributes the repeated disclosure to \"SEC reporting requirements\" and \"transparent debt reporting\" of \"retired\" instruments, suggesting the notes are merely historical artifacts being retained for transparency. This represents a fundamental difference in interpretation of Apple's debt management practices. The ground truth emphasizes deliberate continuity and potential rollover, while the LLM emphasizes passive historical record-keeping. The LLM's claim that the notes \"no longer appear on the balance sheet\" aligns with the ground truth but the reasoning about why they're disclosed differs materially. The LLM provides a plausible alternative explanation but one that contradicts the ground truth's implication of active debt management and rollover practices. The LLM also speculates about \"SEC reporting requirements\" without evidence from the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the consistent pattern. However, it fails to capture the ground truth's nuanced interpretation that this pattern suggests deliberate debt management (rollover/continuation) rather than mere historical disclosure.\n\nSEMANTIC EQUIVALENCE: While the LLM's answer is internally coherent and addresses the question structure, it provides a materially different interpretation of what the repeated disclosure signifies about Apple's debt management practices—the core analytical question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 598,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s equity‑incentive program under the 2006 Equity Incentive Plan shifted from a primarily time‑based RSU and option regime to a more performance‑driven framework.  In 2022 the company adopted amendments (first‑amendment to the RSU agreements for Patrick Gelsinger, and first‑amendments to the “Strategic Growth” and “Outperformance” PSU agreements – see 10‑K 2022 p. 121 and 10‑K 2023 p. 120) that introduced performance‑based RSUs and performance‑based stock options, and it restated the plan effective May 11 2023 (Exhibit 10.1 † in the 2023 and 2024 10‑Ks, p. 120).  The restated plan codified four RSU grant forms—retirement‑vesting, non‑retirement, performance‑based for grandfathered and non‑grandfathered executives, and strategic‑growth performance‑based RSUs—while retaining the original time‑vesting and performance‑vesting conditions; no further substantive changes were made in 2024 (see 10‑K 2024 p. 107).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct dates (May 11, 2023 restatement), proper identification of the 2006 Equity Incentive Plan, and accurate page references to 10-K filings. The quantitative elements are precise and verifiable. However, there are notable differences in emphasis and completeness compared to the ground truth: (1) The LLM provides more specific detail about amendments (Patrick Gelsinger RSU agreements, Strategic Growth and Outperformance PSU agreements) that go beyond the ground truth's scope, which is appropriate for a detailed answer. (2) The LLM correctly identifies the four RSU grant forms mentioned in the restated plan (retirement-vesting, non-retirement, performance-based for grandfathered/non-grandfathered executives, and strategic-growth performance-based RSUs), which aligns with the ground truth's description of 'broader range of RSU agreements.' (3) The LLM's characterization of the evolution as a shift 'from a primarily time-based RSU and option regime to a more performance-driven framework' is a reasonable interpretation, though the ground truth emphasizes 'more nuanced performance alignment and simplified documentation.' (4) The LLM correctly notes 'no further substantive changes were made in 2024,' which matches the ground truth's observation of 'consolidation in the documentation structure' with focus on performance-based RSUs. Minor weakness: The LLM's opening statement about shifting 'from a primarily time-based RSU and option regime' could be slightly misleading since the ground truth indicates the 2006 plan already included performance-based elements in 2022, not a wholesale shift from time-based to performance-based. The answer is well-structured, cites specific sources, and demonstrates multi-hop synthesis across three years of filings, but the framing of the evolution could be more precisely aligned with the ground truth's characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 523,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nMedtronic’s 10‑K filings for fiscal 2022, 2023 and 2024 each state that **no Euro‑Denominated Deferred Shares had been issued or were outstanding at year‑end**, and there is no reference to any issuance against the 40 000‑share authorization in any of those years.  The repeated disclosure shows that the company deliberately left this share reserve untouched, relying instead on conventional debt issuances, credit‑facility borrowings and cash‑flow generation to meet its financing needs.  This consistent absence indicates a financing strategy that preserves the Euro‑Deferred Shares as a “dry‑powder” contingency (e.g., for future employee equity or defensive purposes) rather than using them as an active source of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that no Euro Deferred Shares were issued or outstanding across fiscal years 2022, 2023, and 2024, and accurately states the 40 thousand share authorization with €1.00 par value. The numeric facts are correct. The answer properly addresses the multi-hop synthesis requirement by tracking the capital structure disclosure evolution across three fiscal years.\n\nWEAKNESSES: (1) TERMINOLOGY ISSUE: The LLM uses 'Euro-Denominated Deferred Shares' while the ground truth uses 'Euro Deferred Shares' - this is a minor semantic variation but the LLM's phrasing is slightly non-standard. (2) SPECULATIVE REASONING: The LLM introduces unsupported claims about 'conventional debt issuances, credit-facility borrowings and cash-flow generation' as Medtronic's actual financing strategy. The ground truth mentions 'other capital structure tools such as ordinary share repurchases and dividend policies' - the LLM's specific financing mechanisms are not validated by the ground truth and represent speculation beyond what the filings directly support. (3) INTERPRETATION DIVERGENCE: The LLM characterizes the unused shares as 'dry-powder contingency' for 'employee equity or defensive purposes,' which is interpretive inference not explicitly stated in the ground truth. The ground truth more conservatively states it 'suggests' a preference for other tools without speculating on specific alternative mechanisms. (4) COMPLETENESS: While the LLM addresses the evolution question, it goes beyond the ground truth's scope by making specific claims about actual financing practices that aren't directly supported by the Euro Deferred Shares disclosure itself.\n\nMULTI-HOP REASONING: The synthesis across three fiscal years is sound - the LLM correctly identifies the consistent pattern. However, the leap from 'no issuance' to specific alternative financing strategies represents over-interpretation.\n\nNUMERIC VERIFICATION: All numbers are correct (40,000 shares, €1.00 par value, three fiscal years 2022-2024, zero issuance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 552,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved Advanced Packaging from a strategic pillar of its IDM 2.0 plan to a core growth engine, expanding its roadmap to Intel 18A (RibbonFET/PowerVia) and broader 2.5D/3D capabilities while dramatically increasing R&D spend (≈ $17 B in 2022, $16.5 B in 2024).  This deeper investment raised manufacturing complexity—new fab builds in Ireland and Arizona encountered delays, triggering $3.3 B of impairment charges and a $755 M loss on liquidated‑damage provisions—and pushed cost of sales and operating expenses higher (up $961 M in 2024), yet it also delivered modest packaging‑related revenue and strategic design wins that reinforce Intel’s long‑term positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and introduces unsupported claims that diverge from the ground truth. CRITICAL ISSUES: (1) IMPAIRMENT AMOUNT MISMATCH: LLM states '$3.3B of impairment charges' but ground truth specifies '$3.1 billion in non-cash impairments tied to Intel 7' - this is a material discrepancy of $200M. (2) UNSUPPORTED CLAIMS: LLM introduces '$755M loss on liquidated-damage provisions' and '$961M increase in cost of sales and operating expenses in 2024' - these specific figures do not appear in the ground truth and cannot be verified. (3) R&D SPENDING CLAIMS: LLM states 'approximately $17B in 2022, $16.5B in 2024' - while these may be directionally accurate, the ground truth does not provide specific R&D investment figures for comparison, making this claim unverifiable against the source. (4) POSITIVE FRAMING DIVERGENCE: LLM emphasizes 'modest packaging-related revenue and strategic design wins' as offsetting factors, while ground truth emphasizes 'financial and operational setbacks' as the dominant trend by 2024. (5) MULTI-HOP SYNTHESIS: The LLM does correctly identify the evolution from 2022-2024 and mentions key technologies (Intel 18A, RibbonFET/PowerVia, UCIe), but the quantitative foundation is compromised. CORRECT ELEMENTS: The LLM accurately captures the IDM 2.0 strategy context, the progression from strategic positioning to execution challenges, manufacturing delays in Ireland/Arizona, and the general trend of increased complexity. However, the introduction of unverified financial figures and the material discrepancy in impairment amounts (3.3B vs 3.1B) significantly undermines credibility. The answer reads as partially fabricated with specific dollar amounts that lack ground truth support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 480,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIntel first unveiled PowerVia in 2022 as a breakthrough backside‑power delivery scheme tied to the then‑upcoming Intel 20A node, positioning it as a key enabler for higher performance‑per‑watt and denser circuitry. By the 2023 roadmap update the company quantified the benefit—projecting up to 15 % performance‑per‑watt gains when PowerVia is combined with RibbonFET—and broadened its scope, stating that the technology would be offered to external foundry customers as part of the Intel 18A platform. In the 2024 disclosures Intel confirmed that PowerVia is now manufacturing‑ready, with high‑volume production slated for Intel 18A (e.g., the Panther Lake client family) in 2025, marking the transition from concept to a production‑ready capability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of PowerVia across three time periods. STRENGTHS: (1) All key dates are correct (2022 introduction, 2023 roadmap update, 2024 manufacturing readiness). (2) The 15% performance-per-watt improvement figure is accurately cited and correctly attributed to the combination of PowerVia with RibbonFET. (3) The progression from Intel 20A to Intel 18A is correctly identified, with 18A properly noted as the successor node. (4) The 2025 high-volume manufacturing timeline is accurate. (5) The multi-hop synthesis is sound, connecting strategic positioning evolution across three distinct periods. (6) The answer correctly identifies PowerVia as a backside power delivery solution and explains its core benefit (eliminating front-side power routing). MINOR ISSUES: (1) The LLM answer adds contextual detail about 'external foundry customers' and mentions 'Panther Lake client family' as a specific example, which are not explicitly mentioned in the ground truth. While these details appear consistent with Intel's actual disclosures, they represent minor elaboration beyond the ground truth provided. (2) The ground truth emphasizes the shift from 'conceptual introduction to mature, production-ready innovation,' while the LLM uses slightly different framing ('concept to production-ready capability'), though the semantic meaning is equivalent. QUANTITATIVE VERIFICATION: The 15% figure, all years (2022, 2023, 2024, 2025), and node designations (20A, 18A) are all correct. No calculation errors detected. The answer maintains semantic equivalence with the ground truth while providing slightly more specific implementation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 471,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nMedtronic has not changed the wording of its U.S. employee restricted‑stock‑unit agreement between FY2022 and FY2024 – the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” is cited verbatim in the 2022, 2023 and 2024 10‑K filings. This continuity indicates that the company is deliberately keeping its U.S. equity‑compensation design stable and predictable, rather than revising the RSU terms on a regular basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements between FY2022-FY2024; (2) Accurately cites the same 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan' across all three years; (3) Properly synthesizes the multi-hop information (comparing across three fiscal years); (4) Correctly interprets the consistency as indicating a stable equity compensation strategy; (5) All entity names and fiscal years are accurate. MINOR WEAKNESSES: (1) The LLM answer omits the specific filing date (August 27, 2013) and File No. (001-07707) that the ground truth includes - these are factual details that add precision and verifiability; (2) The phrase 'has not changed the wording' is slightly less precise than 'has not updated' - while semantically similar, the ground truth's language about 'absence of modifications' is more comprehensive; (3) The LLM's interpretation of 'deliberately keeping' and 'rather than revising on a regular basis' adds some inference not explicitly stated in the ground truth, though the inference is reasonable. QUANTITATIVE ACCURACY: All dates and fiscal years (FY2022, FY2023, FY2024) are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies this as a multi-hop synthesis task (comparing the same agreement across three years) and draws the appropriate conclusion about strategic consistency. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (whether updates occurred, and what this suggests about strategy) with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 467,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved away from the original 2019 performance‑based RSU grant forms and adopted a revised framework created by a series of November 2022 amendments (Exhibits 10.1.8‑10.1.10) to the 2006 Equity Incentive Plan. These amendments introduced distinct performance‑based RSU categories—Strategic‑Growth PSUs, Outperformance PSUs and Performance Options—each tied to specific company‑performance metrics and incorporated into the executive’s RSU agreement. The amended agreements, cited in the 2023 and 2024 Form 10‑K exhibits, have served as the governing documents for all subsequent executive performance‑based RSU grants, reflecting a shift toward more granular, metric‑driven vesting conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) DATES: The LLM claims November 2022 amendments (Exhibits 10.1.8-10.1.10) introduced a revised framework, but the ground truth indicates the 2006 Equity Incentive Plan was amended and restated effective May 11, 2023, not November 2022. This is a critical date error. (2) NARRATIVE DIRECTION: The LLM characterizes the evolution as a 'move away from' the original 2019 forms toward a new framework with 'Strategic-Growth PSUs, Outperformance PSUs and Performance Options.' However, the ground truth shows Intel maintained consistent use of the 2006 Equity Incentive Plan throughout 2022-2024 with performance-based RSUs, not a shift away from prior forms. The ground truth emphasizes continuity and consistency, not a fundamental restructuring. (3) SPECIFIC CLAIMS: The LLM introduces specific PSU categories (Strategic-Growth PSUs, Outperformance PSUs, Performance Options) that are not mentioned in the ground truth. While Strategic Growth PSUs are mentioned in the ground truth for 2022, the claim about distinct categories being introduced by November 2022 amendments appears unsupported. (4) MISSING CONTEXT: The LLM fails to mention the S-8 registration filed September 26, 2023, which the ground truth identifies as important evidence of continued reliance on the plan. (5) MULTI-HOP SYNTHESIS: The LLM does not properly synthesize the three-year evolution. The ground truth shows: 2022 (strategic growth performance-based RSUs), 2023 (continued use with grandfathered/non-grandfathered distinctions), 2024 (reaffirmation with May 2023 amendments and S-8 filing). The LLM's narrative of a shift toward 'more granular, metric-driven vesting conditions' contradicts the ground truth's emphasis on consistency. The answer demonstrates fundamental misunderstanding of the actual evolution described in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 523,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel poured ever‑greater capital and R&D into advanced‑packaging capabilities—establishing dedicated SCIP entities in Ireland and Arizona, expanding its 2D/2.5D/3D packaging platforms, standardizing the Universal Chiplet Interconnect Express, and securing multiple AI‑focused design wins—yet the packaging unit’s operating loss widened (from $281 M in 2022 to $482 M in 2024) and construction delays persisted. This trajectory shows that while Intel’s disaggregated‑design strategy relies on cutting‑edge packaging to stitch together chiplets for AI workloads, the company’s ability to translate those investments into profitable, market‑leading AI products remains fraught with execution risk amid intense competition.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM cites operating losses of $281M (2022) and $482M (2024) for the packaging unit, but these figures are NOT present in the ground truth and appear to be fabricated or sourced from undocumented claims. The ground truth specifically mentions $16.5B in 2024 R&D and $3.1B in charges/impairments, neither of which the LLM references. (2) MISSING KEY FACTS - The LLM completely omits the critical 2024 data point of $3.1B in non-cash impairments and accelerated depreciation charges, which is central to understanding execution risks. The ground truth emphasizes this as evidence of 'ongoing execution risks and financial pressures.' (3) INCOMPLETE SYNTHESIS - While the LLM mentions UCIe standardization (correct), it fails to capture the temporal progression of challenges (2022 acknowledged risks → 2023 progress → 2024 financial pressures) that the ground truth emphasizes. (4) UNVERIFIED CLAIMS - References to 'SCIP entities in Ireland and Arizona' and specific packaging platform details are not substantiated in the ground truth and may be hallucinated. (5) PARTIAL CORRECTNESS - The LLM correctly identifies the core theme (execution challenges despite investment) and mentions UCIe, but the supporting evidence is either wrong or missing. The conclusion about 'execution risk' aligns with ground truth, but the path to that conclusion contains significant factual errors. The answer reads plausibly but introduces false specificity (operating loss figures) that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 423,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nIntel’s 2006 Equity Incentive Plan was first restated in May 2022 (effective May 11 2022) to expand the share reserve and add retirement‑vesting language, a change that appeared in the 2022 Form 10‑K. In May 2023 the plan was again restated (effective May 11 2023) to incorporate those 2022 changes and to add new performance‑based RSU categories and updated grant‑agreement forms (e.g., the 10.1.6–10.1.7 RSU agreements), which were disclosed in the 2023 filing. No further plan‑wide amendment was made in 2024; the company continued to use the May 2023 restated plan and only issued targeted amendments to executive RSU and option agreements (such as the November 18 2022 First Amendments filed in 2023 and still in effect in 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR DATE ERROR: LLM states the plan was 'first restated in May 2022 (effective May 11 2022)' but the ground truth indicates the amended and restated version was effective May 11, 2023, not 2022. This is a fundamental factual error that undermines the entire timeline. (2) INCORRECT SEQUENCE: LLM claims a 2022 restatement occurred, then a 2023 restatement, but ground truth shows only the 2023 amendment/restatement (effective May 11, 2023). The LLM appears to have fabricated a 2022 restatement event. (3) INCOMPLETE SYNTHESIS: While LLM correctly identifies that 2024 continued use of the plan without major amendments, it fails to properly establish the actual evolution across the three years as described in ground truth. (4) REFERENCE ACCURACY: LLM cites specific exhibit numbers (10.1.6-10.1.7) and dates (November 18, 2022) that cannot be verified against the ground truth and may be inaccurate. (5) MISSING CONTEXT: LLM does not adequately convey that the 2023 amendment represented a 'formal amendment reflecting structural updates' as the primary evolution point. The ground truth emphasizes 2023 as the key amendment year, while LLM incorrectly emphasizes 2022. CORRECT ELEMENTS: LLM correctly identifies that RSU and performance-based RSU grant agreements were used, and that 2024 showed continued reliance on the plan. However, these correct elements are overshadowed by the fundamental dating error that reverses the timeline of plan amendments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 412,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm re‑classified edge‑networking equipment as a distinct sub‑category of its QCT IoT revenue, reporting it explicitly in the segment’s revenue breakdown (e.g., “IoT (internet of things) – edge networking products” in the 2023‑2024 financial tables).  The company’s narrative shifted from a general mention of “edge networking” as a growth area in 2022 to a strategic emphasis on “connected intelligent edge” in 2023‑2024, positioning its 5G‑ and Wi‑Fi 6/6E‑enabled wireless access‑point and edge‑computing chips as a core platform for automotive, industrial and consumer OEMs and as a key growth driver within the broader edge‑networking market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Qualcomm's strategic evolution but contains several issues when compared to the ground truth: (1) QUANTITATIVE ISSUES: The LLM does not mention the specific IoT projection (27 billion devices by 2026, doubling from 2022) that was explicitly stated in the original answer as a key 2022 highlight. This is a material omission of a concrete metric. (2) CLASSIFICATION ACCURACY: The LLM states edge-networking was 're-classified' as a 'distinct sub-category of QCT IoT revenue' starting in 2022-2024, but the ground truth indicates it was 'explicitly categorized' in 2023 with consistent treatment through 2024. The LLM's framing of 'reclassification' is not clearly supported and may mischaracterize the timeline. (3) STRATEGIC NARRATIVE: The LLM correctly identifies the shift from general 'edge networking' to 'connected intelligent edge' positioning and accurately notes the emphasis on 5G/Wi-Fi 6/6E wireless access points. This aligns well with the ground truth's description of strategic emphasis evolution. (4) PRODUCT CATEGORIZATION: The LLM correctly identifies wireless access points as a core component alongside mobile broadband, matching the ground truth. (5) MISSING CONTEXT: The LLM does not acknowledge that 'exact revenue figures for wireless access points alone are not disclosed,' which is an important caveat mentioned in the ground truth. (6) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across the 2022-2024 period and connects strategic positioning to product categories, though the quantitative foundation is weaker than the original answer. The answer is directionally correct but lacks the specific metrics and more precise timeline characterization present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 482,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMerck’s Prevymis sales rose steadily — from $428 million in 2022 to $605 million in 2023 and $785 million in 2024 (U.S. + international combined) — showing a clear upward trajectory over the three‑year period.  This consistent growth signals that Prevymis is gaining traction within the Hospital Acute Care segment, positioning it as a leading (and expanding) therapeutic option for CMV prophylaxis and strengthening its competitive standing in that market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the sales figures. Ground truth shows: 2022: $370M, 2023: $428M, 2024: $785M. LLM states: 2022: $428M, 2023: $605M, 2024: $785M. The 2022 figure is completely wrong ($428M vs $370M - off by $58M or 15.7%), and the 2023 figure is also incorrect ($605M vs $428M - off by $177M or 41.4%). Only the 2024 figure of $785M is correct. CALCULATION ERROR: The LLM does not provide a compound growth rate calculation, while the ground truth specifies approximately 46% CAGR over 2022-2024. The LLM's description of 'steady' growth is misleading given the actual acceleration from 15.7% growth (2022-2023) to 83.4% growth (2023-2024). QUALITATIVE ASSESSMENT: The LLM correctly identifies the product's market positioning in Hospital Acute Care and appropriately characterizes it as gaining traction for CMV prophylaxis. The reasoning about competitive standing is sound and semantically equivalent to the ground truth. However, the fundamental quantitative errors severely undermine the credibility of the analysis. The LLM's claim of 'steady' growth masks the actual acceleration pattern evident in the correct numbers. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the concept that sales growth indicates market positioning, but this synthesis is built on incorrect foundational data, making the conclusion less reliable despite being directionally correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 401,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nBetween 2022 and 2024 Intel broadened its advanced‑packaging capabilities—launching 2D/3D EMIB/Foveros families, supporting the Universal Chiplet Interconnect Express standard, and dedicating new packaging lines for AI‑focused chips—to make packaging a core differentiator of its IDM 2.0 foundry strategy.  This multi‑year investment was funded by large capital commitments (e.g., the Ireland and Arizona SCIP transactions), yet the company incurred impairments, accelerated depreciation of Intel 7 assets and faced construction delays that triggered liquidated‑damage provisions, exposing how manufacturing setbacks and capital constraints are straining the execution of its IDM 2.0 agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc of Intel's advanced packaging evolution (2022-2024), appropriately mentions key technologies (2D/3D EMIB/Foveros, UCIe), and accurately captures the tension between strategic positioning and execution challenges. The answer demonstrates sound multi-hop reasoning by synthesizing information about capital investments, manufacturing delays, and impairments. The contextual framing of IDM 2.0 strategy and the connection between capital constraints and execution failures is semantically equivalent to the ground truth.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to cite specific financial figures that appear in the ground truth. Most critically: (1) The $16.5 billion R&D investment in 2024 is completely omitted, which is a key quantitative anchor for the 2024 trajectory. (2) The $3.1 billion non-cash impairment in Q3 2024 is not mentioned, despite being explicitly cited in the ground truth as evidence of execution challenges. (3) The answer references 'impairments' and 'accelerated depreciation' generically but provides no specific dollar amounts or timing. (4) The answer mentions 'liquidated-damage provisions' but provides no quantification. These omissions represent a significant gap in quantitative specificity.\n\nWEAKNESSES - COMPLETENESS: While the answer addresses the evolution narrative and strategic positioning, it incompletely captures the year-by-year progression. The ground truth explicitly structures the answer chronologically (2022: acknowledged complexity/delays; 2023: positioned as differentiator; 2024: faced delays and impairments). The LLM answer conflates these into a more general 2022-2024 narrative without clearly delineating the progression or the specific 2024 deterioration.\n\nMULTI-HOP REASONING: The synthesis is sound—the answer correctly connects capital investments to manufacturing setbacks to execution constraints. However, the reasoning would be stronger with the specific financial metrics that ground the argument.\n\nSEMANTIC EQUIVALENCE: The core message is preserved: Intel made strategic progress in packaging but faced execution challenges due to manufacturing delays and capital constraints. The mention of 'Ireland and Arizona SCIP transactions' as capital commitments is appropriate context, though not explicitly detailed in the ground truth excerpt provided.\n\nVERIFICATION ISSUES: The answer does not contradict the ground truth on any factual point, but the absence of key quantitative data ($16.5B R&D, $3.1B impairment, Q3 2024 timing) represents material incompleteness for a question specifically asking about 'multi-year trajectory' and 'capital constraints.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 716,
        "total_tokens": 2181
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM has repeatedly listed “client relationships and trust” among its principal competitive methods (2022‑2024 10‑Ks), but the language has tightened around the hybrid‑cloud and AI agenda: in 2022 it was presented as one of several differentiators, while 2023‑2024 filings explicitly tie that trust to the adoption of IBM’s hybrid‑cloud platform and AI capabilities that enable clients to “re‑imagine critical workflows” and achieve “business value at scale.” Thus, the evolution shows that IBM is using client trust as the strategic glue that validates and differentiates its hybrid‑cloud and AI strategy, positioning the company not merely as a technology supplier but as a trusted partner for large‑scale digital transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of IBM's evolution in positioning client relationships and trust as a competitive differentiator from 2022-2024. STRENGTHS: (1) Correctly identifies the consistent emphasis on client relationships and trust across all three years (2022-2024); (2) Accurately captures the tightening of language around hybrid cloud and AI strategy; (3) Properly synthesizes the multi-hop reasoning showing how trust evolved from a standalone differentiator to being explicitly tied to hybrid cloud and AI capabilities; (4) Correctly interprets the strategic positioning shift from technology supplier to trusted transformation partner; (5) No quantitative errors or date inaccuracies. WEAKNESSES: (1) The LLM answer omits the specific mention of the Palo Alto Networks strategic partnership in 2024, which the ground truth identifies as a significant signal of deepening trust-based collaboration; (2) Does not explicitly reference the 2023 reinforcement of trust as part of broader competitive methods (service, support, innovation, talent) that the ground truth mentions; (3) The phrase 'business value at scale' and 're-imagine critical workflows' appear to be paraphrased rather than directly sourced, though semantically aligned with the ground truth's intent. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression from 2022 (trust as one of several differentiators) through 2023-2024 (trust explicitly tied to hybrid cloud/AI). The logical connection between trust and digital transformation positioning is sound. The answer demonstrates proper understanding of how IBM uses trust as a strategic differentiator in the competitive AI/hybrid cloud market. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - IBM's strategic commitment to trust as foundational in client acquisition/retention within AI and hybrid cloud markets is conveyed, though with less specificity on partnership evolution and competitive method breadth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 551,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM continued to disclose the 0.950 % Notes due 2025 by simply referencing the original 8‑K filing (Exhibits 4.1‑4.2 dated May 22 2017) in each year’s 10‑K and by listing the securities (ticker IBM25B) in the “Securities Registered Pursuant to Section 12(b)” table. No new issuance or amendment of the notes was reported; the company merely reaffirmed the existing indenture and provided periodic updates on the same terms. This steady, “hold‑and‑ disclose” approach reflects IBM’s broader debt‑management strategy of maintaining a low‑cost, long‑dated debt profile and managing refinancing through incremental, transparent updates rather than frequent large‑scale issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-reasoned synthesis of IBM's debt management strategy across the 2022-2024 period. STRENGTHS: (1) All numeric/date references are correct: 0.950% rate, 2025 maturity date, May 22, 2017 8-K filing date, ticker IBM25B are all accurate. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information about disclosure patterns (referencing same 8-K across years), regulatory filings (10-K mentions), and trading status (NYSE listing) to draw conclusions about debt management strategy. (3) The characterization of the approach as 'hold-and-disclose' and 'steady' aligns well with the ground truth's description of 'consistent disclosure framework' and 'stable and transparent debt management strategy.' (4) The answer appropriately identifies the progression from 2022 through 2024 and explains what it indicates about broader strategy. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds interpretive language about 'low-cost, long-dated debt profile' and 'managing refinancing through incremental, transparent updates' which, while reasonable inferences, go slightly beyond what the ground truth explicitly states. The ground truth focuses more on the factual progression and what it 'suggests' rather than making broader strategic claims. (2) The LLM mentions 'Exhibits 4.1-4.2' while ground truth references only 'Exhibit 4.1' - this is a minor discrepancy that could reflect different source documents but represents a slight deviation. (3) The ground truth emphasizes the 'live and traded' status more explicitly through the NYSE listing detail, while the LLM incorporates this into a broader narrative. OVERALL ASSESSMENT: The answer is substantially correct, well-reasoned, and addresses all parts of the multi-part question. The factual foundation is solid, and the synthesis across years and documents is appropriate. The minor additions of interpretive analysis, while reasonable, slightly exceed the ground truth's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 546,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nIntel first introduced PowerVia as a “back‑side power‑delivery” breakthrough in its roadmap for the then‑upcoming Intel 20A node (later renamed Intel 18A) and pledged that the technology would be ready for high‑volume production with the Panther‑Lake client family in 2025 【page 14 (2023)】.  By 2024 the company had cancelled the original Intel 20A node, consolidated its effort on the improved Intel 18A process, and began high‑volume manufacturing of Panther‑Lake on that node, explicitly positioning PowerVia as the industry‑first commercial implementation of backside power that will be offered not only to Intel’s internal products but also to external foundry customers under the IDM 2.0/IFS strategy【page 10, 18A description】.  \n\nThis progression shows that Intel’s roadmap for advanced nodes is built around backside power delivery as a core enabler of higher performance‑per‑watt and density scaling, and that PowerVia will underpin Intel’s next‑generation process technologies (18A, 14A) and its broader foundry ambitions beyond 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's PowerVia evolution and correctly identifies key milestones and strategic pivots. STRENGTHS: (1) Correctly identifies PowerVia as backside power-delivery technology introduced in roadmap for Intel 20A (later 18A); (2) Accurately notes the 2025 high-volume production timeline with Panther-Lake; (3) Correctly identifies the cancellation of Intel 20A in favor of Intel 18A consolidation; (4) Properly contextualizes PowerVia within IDM 2.0/IFS foundry strategy; (5) Accurately describes PowerVia as industry-first commercial backside power implementation. WEAKNESSES: (1) The LLM answer lacks explicit mention of 2022 as the initial introduction year, jumping directly to 2023 reference - the ground truth emphasizes the 2022 concept introduction as a distinct phase; (2) Does not explicitly state the three-phase progression (concept 2022 → technical integration 2023 → commercial deployment 2024) that the ground truth emphasizes; (3) The answer mentions 14A as part of future roadmap but ground truth focuses on 18A as the primary near-term deployment; (4) Minor: The answer references 'page 14 (2023)' and 'page 10, 18A description' but these citations are not verifiable against the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and connects the strategic pivot (20A cancellation) to the commercial deployment strategy. The reasoning linking backside power delivery to performance-per-watt and density scaling is sound and relevant. SEMANTIC EQUIVALENCE: The core narrative matches the ground truth - evolution from roadmap announcement through technical development to commercial deployment - though the explicit three-phase framing is less clear. The answer adds valuable context about foundry strategy that complements the ground truth. CALCULATION/DATES: All dates (2023, 2024, 2025) are correct. No calculations required. The timeline progression is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 534,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nMedtronic’s latest RSU award agreements (2021‑2024 filings) continue to employ the same two‑track vesting structure—either 100 % after the third anniversary or ratable over the first four years—under the Amended and Restated 2013 Stock Award and Incentive Plan, with only minor wording updates from earlier forms. This consistency across the 2022‑2024 Exhibit 10‑K pages shows that the company’s U.S. equity‑compensation framework remains stable, preserving the core RSU design while merely modernizing the documentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) TEMPORAL MISMATCH: The ground truth specifically addresses 2022-2024 documentation, while the LLM references '2021-2024 filings' - this is a factual error in the time period. (2) EXHIBIT IDENTIFICATION ERROR: The ground truth identifies the relevant document as 'Exhibit 10.54' (Restricted Stock Unit Award Agreement for U.S. Employees), but the LLM does not reference this specific exhibit number, instead making vague references to '2022-2024 Exhibit 10-K pages' without proper document identification. (3) VESTING STRUCTURE CLAIM: The LLM claims the RSU structure involves '100% after the third anniversary or ratable over the first four years,' but the ground truth makes no mention of these specific vesting percentages or timeframes. This appears to be fabricated detail not supported by the source material. (4) REFERENCE DATE ACCURACY: The ground truth correctly identifies August 27, 2013 as the consistent filing date referenced across all three years (2022-2024), demonstrating true stability. The LLM mentions 'Amended and Restated 2013 Stock Award and Incentive Plan' but does not verify the consistency of the August 27, 2013 reference across the specific 2022-2024 period. (5) CORE FINDING ALIGNMENT: While both answers conclude that Medtronic's equity compensation strategy remained stable, the LLM's reasoning is based on partially incorrect premises (wrong time period, unverified vesting details, missing exhibit identification). The ground truth's finding of stability is grounded in the unchanged Exhibit 10.54 reference across all three years, which is more precise and verifiable. The LLM answer demonstrates reasonable understanding of the general concept of RSU stability but fails on factual accuracy regarding specific documents, dates, and vesting structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 510,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel positioned advanced packaging and disaggregated, chiplet‑based designs as the centerpiece of its IDM 2.0 strategy, promising to monetize packaging through its Intel Foundry Services and to lead in AI‑optimized heterogeneous systems. Execution has been hampered by repeated node delays (10 nm, 7 nm, 4th‑Gen Xeon), steep capital constraints that postponed fab builds in Ohio, Germany, Poland, Malaysia and Israel, and the added complexity and cost of novel 2D/2.5D/3D packaging, which triggered multi‑billion‑dollar impairments and left the company’s packaging ambitions ahead of its realized revenue. Consequently, while packaging revenue modestly rose (e.g., +$483 M in 2023), the company’s advanced‑packaging roadmap remains a high‑risk, capital‑intensive effort with delayed time‑to‑market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's strategic positioning and execution challenges across 2022-2024, with excellent contextual relevance and qualitative reasoning. However, there are notable quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the core strategic narrative: IDM 2.0, disaggregated/chiplet designs, advanced packaging as centerpiece\n2. Accurately captures execution challenges: repeated node delays, capital constraints, fab postponements across multiple geographies (Ohio, Germany, Poland, Malaysia, Israel)\n3. Properly synthesizes multi-hop information: connects delays → capital constraints → impairments → revenue lag\n4. Correctly references UCIe standard and 2D/2.5D/3D packaging technologies\n5. Appropriately emphasizes the risk profile and capital intensity\n6. Good temporal progression showing evolution from 2022 through 2024\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR - The LLM states \"packaging revenue modestly rose (e.g., +$483 M in 2023)\" but the ground truth does not provide this specific figure. This appears to be an unsupported number that cannot be verified against the original answer.\n2. IMPAIRMENT CHARGE DISCREPANCY - The ground truth specifically mentions \"$3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node.\" The LLM references \"multi‑billion‑dollar impairments\" but does not cite the specific $3.1B figure, which is a key quantitative detail from the ground truth.\n3. NODE NAMING - The LLM mentions \"10 nm, 7 nm, 4th‑Gen Xeon\" delays, while the ground truth specifically references \"Intel 4 (formerly 7nm)\" and \"Intel 7 node.\" The LLM's node nomenclature is less precise.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across the 2022-2024 period, connecting strategic positioning → execution challenges → financial impacts. The reasoning is sound and logical, though it could have been strengthened by citing the specific $3.1B impairment figure.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys the essential meaning of the ground truth but with some precision loss on key financial metrics. The phrase \"packaging ambitions ahead of its realized revenue\" effectively captures the gap between strategy and execution.\n\nJUSTIFICATION:\n- Correctness Score 7: Core narrative correct, but missing/unsupported specific numbers and imprecise on key quantitative details\n- Quantitative Accuracy 6: The $483M packaging revenue figure is unsupported, and the $3.1B impairment is not cited with specificity\n- Qualitative Accuracy 8: Excellent synthesis of strategic and execution themes, proper entity identification, sound reasoning\n- Contextual Relevance 9: Highly relevant to the question, addresses all major dimensions of the inquiry",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 749,
        "total_tokens": 2218
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture’s pension glide‑path moved from a modest equity tilt in non‑U.S. plans (≈21‑27 % equity, ≈48‑50 % debt) and near‑zero equity in U.S. plans (≈97‑100 % debt) to a markedly more fixed‑income‑heavy mix: by 2024 the U.S. plan was ~94 % debt with virtually no equity, while non‑U.S. plans cut equity to ~23 % and debt to ~42 % with a larger cash buffer.  This progressive de‑risking—reducing equity exposure and increasing duration‑matched fixed‑income and cash—reflects a strategic shift toward liability‑driven investing and a focus on stable, risk‑adjusted returns rather than growth‑oriented asset allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM provides specific percentages (21-27% equity, 48-50% debt for non-U.S. plans; 97-100% debt for U.S. plans; 94% debt by 2024; 23% equity and 42% debt by 2024) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific numerical breakdowns across the three fiscal years. (2) DIRECTIONAL MISREPRESENTATION: The LLM claims a 'progressive de-risking' with 'reducing equity exposure' from 2022-2024, but the ground truth indicates Accenture maintained a 'dual focus' on fixed income and equities throughout this period, with emphasis on flexibility and adaptation rather than systematic de-risking. The ground truth explicitly states the company 'maintained this dual focus' in 2023 and continued 'balancing fixed income and equities' in 2024. (3) CONCEPTUAL DIVERGENCE: The LLM frames the strategy as 'liability-driven investing' with a shift away from growth, but the ground truth emphasizes 'long-term capital appreciation' through equities and 'long-term investment objectives' while managing volatility through flexibility. These are fundamentally different characterizations. (4) MISSING KEY ELEMENTS: The LLM fails to mention the critical evolution toward 'flexibility in asset allocation decisions' and 'variation within established ranges' that the ground truth identifies as central to Accenture's refined approach. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM appears to have synthesized information incorrectly or invented specific percentages rather than accurately extracting and comparing data across the three fiscal years. The ground truth's emphasis on consistency with evolving flexibility is completely absent from the LLM's narrative of progressive de-risking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 519,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05% Notes due 2017 in its 2023 and 2024 Form 10‑K filings demonstrates that it treats the indenture governing that tranche as a permanent, fully disclosed element of its debt documentation, preserving a complete historical record of all long‑term obligations even after the notes have matured. This reflects a disclosure approach that is deliberately exhaustive and conservative, contrasting with its 2022‑2024 issuance strategy, which focuses on issuing new, low‑coupon, staggered‑maturity debt to fund share buybacks and growth initiatives. Consequently, while Apple’s financing execution is aggressive and diversified, its public debt disclosures remain meticulously comprehensive, retaining legacy series alongside newer tranches.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 and its continued reference in 2023-2024 filings; (2) Accurately characterizes this as a post-maturity disclosure practice; (3) Properly contrasts this with Apple's broader debt issuance strategy across 2022-2024; (4) Correctly identifies specific debt instruments mentioned (Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024); (5) All dates and percentages are accurate; (6) The multi-hop reasoning is sound—synthesizing historical debt disclosure practices with contemporary issuance strategy. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language ('deliberately exhaustive and conservative,' 'aggressive and diversified,' 'meticulously comprehensive') that goes slightly beyond what the ground truth explicitly states. While these characterizations are reasonable inferences, they represent modest elaboration rather than strict adherence to the knowledge graph; (2) The ground truth mentions 'legal or investor transparency purposes' as possible motivations, while the LLM frames it as 'permanent, fully disclosed element'—semantically similar but with slightly different emphasis; (3) The LLM adds context about 'share buybacks and growth initiatives' which, while plausible, is not explicitly confirmed in the ground truth provided. QUANTITATIVE VERIFICATION: All numbers, dates, and percentages match ground truth exactly. No calculation errors. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple time periods (2022-2024) and connects historical disclosure practices to contemporary strategy. The reasoning chain is logical and well-supported. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—Apple maintains comprehensive historical debt records while actively issuing new instruments—though the LLM uses more evaluative language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 532,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture expanded its share‑repurchase authorization—adding $3 billion in September 2022 (raising total authority to $6.13 billion) and a further $4 billion in September 2024 (to $6.69 billion)—and has repurchased roughly $4 billion of stock each year (≈$4.1 billion in FY 22, $4.5 billion in FY 23 and $4.5 billion in FY 24), leaving about $2.7 billion of the current authorization still unused as of August 2024. This steady growth in authorized capacity combined with consistent multi‑billion‑dollar buybacks demonstrates a disciplined, ongoing capital‑return strategy that pairs regular dividends with systematic share repurchases while preserving a sizable reserve for future opportunistic purchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of Accenture's capital return strategy and addresses the multi-year evolution question, but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) The $4.0 billion new authorization in September 2024 is correct; (2) The $6.69 billion total outstanding authority as of August 2024 is correct; (3) The ~$2.7 billion remaining authorization is correct; (4) The characterization of a disciplined, ongoing capital-return strategy is appropriate; (5) The multi-hop synthesis across fiscal years is sound. CRITICAL ERRORS: (1) The LLM claims $3 billion was added in September 2022 raising total to $6.13 billion—the ground truth shows $3.13 billion available authorization in fiscal 2022, not $6.13 billion total authority after a $3B addition; (2) The repurchase amounts are significantly overstated: LLM claims ~$4.1B in FY22, $4.5B in FY23, and $4.5B in FY24, but ground truth only mentions $605 million in FY24 specifically, with no corroborating figures for prior years at these levels; (3) The LLM's claim of 'roughly $4 billion of stock each year' appears to be fabricated or misinterpreted data. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and connects authorization increases to repurchase activity, but the underlying numbers are unreliable. The logic of the capital strategy conclusion is sound, but rests on incorrect quantitative foundations. MISSING ELEMENTS: The ground truth notes that the 2023 filing mirrors 2024 disclosures, suggesting consistency—the LLM doesn't explicitly address this continuity pattern. The ground truth's specific mention of 'over $605 million' in FY24 is more conservative than the LLM's $4.5B claim. The quantitative errors are substantial enough to significantly reduce confidence in the answer despite reasonable strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 514,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were originally issued in November 2019 as part of the Eleventh Supplemental Indenture to the 1993 indenture.  Subsequent supplemental indentures in March 2022 (the Thirteenth Supplemental) and November 2023 (the Fourteenth Supplemental) added new long‑dated tranches and amended the indenture, keeping the 2047 notes within a broader laddered schedule of multi‑year fixed‑rate debt.  This multi‑year pattern shows Bristol‑Myers Squibb’s strategy of locking in low‑to‑mid‑range coupons for very long maturities and staggering repayments to create a stable, long‑term financing base while managing interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing some correct strategic insights. CRITICAL ERRORS: (1) The LLM claims the 4.350% Senior Notes due 2047 were 'originally issued in November 2019 as part of the Eleventh Supplemental Indenture,' but the ground truth states they were 'listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019'—this is a subtle but important distinction about whether these specific notes were issued then or merely governed by that indenture. (2) The LLM introduces 'Thirteenth Supplemental' (March 2022) and 'Fourteenth Supplemental' (November 2023) indentures with specific dates that are NOT mentioned in the ground truth. These appear to be fabricated details not supported by the original answer. (3) The LLM fails to mention specific new issuances documented in the ground truth: the $1.75 billion 2.950% Notes due 2032 (2023) and the $3.75 billion 4.250% Senior Notes due 2049 (2024), which are crucial to demonstrating the multi-year pattern. CORRECT ELEMENTS: The LLM correctly identifies the 4.350% coupon and 2047 maturity date, correctly notes the 1993 indenture framework, and accurately characterizes the strategic intent (laddered maturities, interest-rate risk management, stable long-term financing base). The reasoning about 'locking in low-to-mid-range coupons' is sound. MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the multi-year evolution across 2022-2024 by not referencing the specific new debt issuances that demonstrate how BMY maintained the 2047 notes while adding complementary instruments. The answer provides general strategic insight but lacks the concrete evidence from each year that the ground truth provides. The invented supplemental indenture details are particularly problematic as they suggest hallucination rather than faithful synthesis of actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 527,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple placed the 2.40 % Notes due 2023 in the “Description of Securities” exhibit (Exhibit 4.3) and included a full officer’s certificate that spelled out the indenture, redemption provisions and the notes’ position within the 2013 indenture. By the 2023 filing the same exhibit was retained, but Apple added a dedicated “Maturity and Redemption” paragraph that flagged the upcoming 2023 maturity, re‑classified the debt as a current liability and disclosed the exact redemption price—shifting the focus from a generic debt description to explicit maturity‑related disclosure. After the notes matured in 2023, the 2024 filing no longer lists the 2.40 % Notes in the securities description; the only mention is a historical footnote summarizing the redemption and final settlement, showing that Apple’s disclosure evolved from proactive debt detailing to retrospective, post‑maturity reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states Apple's disclosure approach was 'stable and unchanging' across 2022, 2023, and 2024, with identical descriptions and consistent exhibit placement (Exhibit 4.3). The LLM answer claims the opposite—that disclosure evolved significantly, with added 'Maturity and Redemption' paragraphs in 2023, reclassification as current liability, and removal from securities description in 2024. QUANTITATIVE ACCURACY: The dates (2022, 2023, 2024) and percentage (2.40%) are correct, and the reference to Exhibit 4.3 and Officer's Certificate dated May 3, 2013 are accurate. However, these correct details are embedded in a fundamentally incorrect narrative. QUALITATIVE ACCURACY: The LLM fabricated specific disclosure changes (dedicated 'Maturity and Redemption' paragraph, reclassification to current liability, removal from 2024 filing) that contradict the ground truth's explicit statement of consistency. The reasoning about 'proactive debt detailing to retrospective, post-maturity reporting' is logically coherent but factually unsupported by the actual filings. MULTI-HOP REASONING: The LLM failed to correctly synthesize information across the three filing periods. Rather than identifying the consistent disclosure pattern across 2022, 2023, and 2024, it invented a narrative of progressive change. CONTEXTUAL RELEVANCE: While the answer addresses the question's structure (evolution across three years), it provides an entirely incorrect answer to what actually happened. The ground truth's key insight—that disclosure remained unchanged despite maturity—is completely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 461,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares** at the end of fiscal 2022 (as noted on page 91 of the 2022 10‑K) to **141 million shares** by the end of fiscal 2024 (page 98 of the 2024 10‑K).  This step‑up in the share‑authorisation ceiling shows that Accenture is deliberately expanding its equity‑award pool to sustain and broaden its long‑term share‑based compensation program, ensuring it can continue granting restricted‑share units and other equity incentives as the workforce and performance‑based reward strategy evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numerical progression: 127 million shares in fiscal 2022 and 141 million shares by fiscal 2024. However, there is a critical incompleteness issue. The ground truth explicitly states that the 141 million figure was reached in fiscal 2023 and remained stable through fiscal 2024. The LLM answer says '141 million shares by the end of fiscal 2024' without clarifying that this increase occurred in 2023, not gradually through 2024. This omission is significant because the question specifically asks about the evolution 'from fiscal year 2022 through 2024,' which requires tracking the year-by-year progression. The ground truth shows: FY2022: 127M → FY2023: 141M → FY2024: 141M (stable). The LLM only presents the endpoints (127M to 141M) without the intermediate year data, missing the important detail that stabilization occurred in 2024. The qualitative analysis about expanding the equity-award pool and supporting incentive programs is sound and aligns with the ground truth's interpretation. The numerical values themselves are accurate (127M and 141M are correct), and the general strategic conclusion about deliberate expansion is appropriate. However, the failure to explicitly address the three-year progression and the timing of when the increase occurred represents a material gap in answering the specific question asked. The answer would have been stronger with explicit mention of FY2023 as the year of increase and FY2024 as the year of stabilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 416,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a planned feature of the Intel 20A node—where it would deliver backside power delivery to achieve roughly a 15 % performance‑per‑watt boost (first highlighted in the 2022 roadmap on page 10)—to a core component of the subsequent Intel 18A process, which began high‑volume production in 2025 (the 18A description and its reliance on PowerVia appear on page 16). This progression demonstrates that PowerVia has become a strategic linchpin of Intel’s advanced‑node roadmap, enabling the company to push density and efficiency gains while supporting its IDM 2.0 and foundry ambitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PowerVia from 2022-2024 and accurately captures the transition from Intel 20A to Intel 18A, with PowerVia remaining a central feature. The multi-hop reasoning is sound, connecting the technology's progression to Intel's strategic objectives. However, there are notable issues: (1) The LLM introduces a specific '15% performance-per-watt boost' metric that is not present in the ground truth answer, which only mentions 'performance-per-watt improvements' generically. This appears to be an unsupported quantitative claim. (2) The LLM states Intel 18A 'began high-volume production in 2025' when the ground truth says it was 'slated for high-volume manufacturing in 2025' - a subtle but important distinction (slated = planned, not yet achieved). (3) The LLM correctly identifies the 2022 introduction, 2023 solidification within Intel 20A, and 2024 shift to Intel 18A. (4) The LLM appropriately mentions Panther Lake indirectly through the 2025 HVM timeline, though doesn't explicitly name it. (5) The reasoning about PowerVia's strategic importance and its role in density/efficiency gains aligns well with the ground truth. The answer demonstrates good synthesis across the multi-year progression but introduces an unsupported specific performance metric and uses slightly imprecise language about production status, which prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 390,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s mutual‑fund equity exposure in its defined‑benefit pension assets fell from **$239.3 million in fiscal 2022** to **$196.2 million in fiscal 2023**, then rebounded sharply to **$273.7 million in fiscal 2024** (representing roughly 21 % → 17 % → 23 % of total plan assets, respectively).  The dip in 2023 reflects a temporary de‑risking/rebalancing, while the 2024 rebound shows a deliberate increase in equity‑based holdings, aligning with the company’s target allocation and its broader strategy of boosting long‑term returns from equities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect: (1) QUANTITATIVE ERRORS: The LLM states fiscal 2024 allocation was $273.7 million, but the ground truth clearly indicates it remained at $196.226 million (unchanged from 2023). This is a major discrepancy of $77.5 million. The LLM also incorrectly reports the 2022 figure as $239.3 million when it should be $239.293 million (minor formatting issue, acceptable), but the 2024 number is completely wrong. (2) DIRECTIONAL ANALYSIS ERROR: The LLM claims a 'sharp rebound' in 2024 with 'deliberate increase in equity-based holdings,' but the ground truth shows the allocation remained flat at $196.226 million from 2023 to 2024. This is a fundamental misreading of the data trajectory. (3) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'boosting long-term returns from equities' contradicts the ground truth finding of 'consistent reduction in exposure to this asset class.' The actual 3-year pattern is: $239.293M → $196.226M → $196.226M (decline then plateau), not the rebound the LLM describes. (4) PERCENTAGE CLAIMS: The LLM provides percentages (21% → 17% → 23%) that cannot be verified against the ground truth and appear inconsistent with a flat 2023-2024 allocation. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points, inventing a 2024 figure that does not match the source material. The core answer is inverted - instead of showing strategic de-risking, the LLM incorrectly portrays a re-risking strategy. This is a complete failure on the primary metric of factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 450,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid on the books as a finite‑lived intangible asset (included in the $7.9 bn “products and product rights” intangible balance disclosed in the 2022 10‑K note 5 and carried forward without any impairment charge in the 2023 10‑K), indicating that the company still values the compound at its original cost less accumulated amortization. Therapeutically the drug’s positioning remained narrow‑spectrum fidaxomicin for C. difficile infection, but Merck treated it as a niche, high‑margin offering within the Hospital‑Acute‑Care portfolio rather than a growth driver, focusing instead on its flagship oncology and vaccine products. Globally, Dificid’s sales have risen modestly—from roughly $263 million in 2022 to $340 million in 2024 (≈ $303 U.S. + $37 International in 2024, page 129)—but it still accounts for less than 1 % of total segment sales, underscoring its limited contribution to Merck’s overall revenue compared with blockbuster lines such as Keytruda or Gardasil.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with mostly correct financial data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies Dificid as a finite-lived intangible asset carried on the balance sheet without impairment charges; (2) Accurately cites the 2024 revenue figures ($340M total, $303M U.S., $37M international) matching ground truth exactly; (3) Properly synthesizes therapeutic positioning as narrow-spectrum fidaxomicin for C. difficile infection; (4) Correctly contextualizes Dificid as a niche, high-margin product within Hospital Acute Care rather than a growth driver; (5) Appropriately notes its <1% contribution to total segment sales. MINOR ISSUES: (1) The 2022 asset valuation is not explicitly stated in the LLM answer—ground truth specifies $145M as an intangible asset under acquired human health marketed products, while LLM only references the broader $7.9B 'products and product rights' category without isolating Dificid's specific 2022 valuation; (2) The 2022 revenue figure of 'roughly $263 million' is stated without clear sourcing and differs slightly from what might be expected given the 2024 figure of $340M (though this appears reasonable as a growth trajectory); (3) The answer could have been more explicit about the evolution/progression aspect of the question by clearly delineating the three-year timeline. QUANTITATIVE VERIFICATION: All cited 2024 figures are correct ($340M, $303M U.S., $37M international). The calculation of U.S. + International ($303M + $37M = $340M) is accurate. The <1% contribution claim is reasonable given Merck's scale. MULTI-HOP REASONING: The answer successfully synthesizes information across balance sheet treatment (intangible assets), therapeutic positioning (C. difficile indication), and revenue contribution (sales figures and segment percentage), demonstrating proper multi-hop synthesis. The contextual comparison to blockbuster products (Keytruda, Gardasil) appropriately frames Dificid's relative importance. SEMANTIC EQUIVALENCE: The answer conveys the core evolution narrative—from a valued but modest asset to a recognized niche product with measurable but limited revenue contribution—which aligns with ground truth intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 597,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled‑down on Advanced Packaging as a cornerstone of its IDM 2.0 strategy, investing roughly $16‑$17 billion annually in R&D and capital to meet its 2024 performance‑per‑watt parity and 2025 leadership goals, yet it repeatedly missed node roll‑outs (e.g., Intel 7 delays and only limited 18A design wins in 2023) and suffered construction setbacks at its Ireland and Arizona joint‑ventures that triggered a $755 million derivative loss and could incur up to $1.1 billion in liquidated‑damage penalties; these execution delays, combined with the high fixed costs of packaging‑focused fabs and the need to purchase minimum output from new SCIP entities, expose Intel to substantial financial‑risk exposure and underutilization charges if demand does not materialize.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM cites a '$755 million derivative loss' and '$1.1 billion in liquidated-damage penalties' related to Ireland and Arizona joint-ventures, but the ground truth specifically mentions a '$3.1 billion impairment charge tied to manufacturing assets' in 2024 - these are different figures and the LLM's numbers do not appear in the ground truth. The LLM also claims '$16-$17 billion annually in R&D and capital' which is not substantiated in the ground truth. (2) ENTITY/METRIC CONFUSION: The LLM conflates multiple distinct financial issues (derivative losses, liquidated damages, impairment charges) without clear attribution to the correct 2024 financial pressures mentioned in ground truth. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the trajectory from strategic optimism to operational strain, it fails to accurately capture the specific 2023 progress (2D/2.5D/3D packaging solutions, UCIe standard demonstration) that the ground truth emphasizes as a key milestone. (4) MISSING KEY ELEMENTS: The LLM does not mention the $3.1 billion impairment charge, which is a critical quantitative marker of Intel's financial strain in 2024. (5) SPECULATIVE CONTENT: The LLM introduces specific penalty amounts and joint-venture details that are not verified in the ground truth, suggesting potential hallucination. The answer does address the multi-part question structure (R&D investment, delays, financial risk) but with incorrect supporting data. The core narrative of escalating challenges is present but undermined by factual inaccuracies in the numbers that are central to demonstrating financial risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 479,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 the MK‑8591A program stayed in Phase 3/under FDA review, but in 2023 the Agency placed a partial clinical hold on the higher‑dose islatravir component, forcing Merck to revise the dosing strategy.  By the 2024 filing the company had moved to a next‑generation combination (MK‑8591D = islatravir + lenacapavir) scheduled for an October 2024 entry, indicating a strategic shift toward a longer‑acting, potentially once‑weekly regimen and a continued, high‑priority investment in HIV‑1 therapeutics.  (Pages 30, 27, 26, 31)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) TIMELINE ACCURACY: The LLM claims a partial clinical hold was placed in 2023, but the ground truth states the FDA lifted a clinical hold on December 4, 2024 - these are contradictory narratives. The LLM's claim about a 2023 hold is not supported by the ground truth. (2) MK-8591D INTRODUCTION: The LLM introduces MK-8591D (islatravir + lenacapavir) with an October 2024 entry date, which is NOT mentioned in the ground truth answer at all. This represents either fabricated information or information from sources not reflected in the knowledge graph baseline. The ground truth focuses exclusively on MK-8591A's evolution. (3) CLINICAL HOLD RESOLUTION: The ground truth explicitly states the FDA lifted the clinical hold on December 4, 2024, but notes the compound remained under a partial clinical hold for higher doses. The LLM's framing suggests the hold was placed in 2023 and doesn't clearly articulate the December 2024 lifting. (4) STRATEGIC NARRATIVE: While the LLM correctly identifies Merck's continued HIV investment, it pivots to a different compound (MK-8591D) rather than explaining the MK-8591A trajectory as requested. The ground truth emphasizes persistent commitment to MK-8591A despite challenges. (5) MISSING CONTEXT: The LLM omits the Phase 3 entry date of February 2020 and the 2022-2023 status quo that the ground truth emphasizes. The answer addresses a different strategic pivot rather than the requested evolution of MK-8591A specifically. QUANTITATIVE ERRORS: The October 2024 date for MK-8591D entry is unverified against ground truth; the December 4, 2024 clinical hold lift date is mentioned in ground truth but mischaracterized in LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 466,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck moved MK‑1308A from an early‑phase, broadly‑targeted CTLA‑4 + pembrolizumab exploration across several solid tumours into a late‑stage, pivotal Phase 3 program focused on renal‑cell carcinoma, positioning the fixed‑dose quavonlimab/pembrolizumab combination as a core immuno‑oncology asset.  During this period the programme obtained Breakthrough/Fast‑Track designation and entered the regulatory filing/submission stage, reflecting a clear shift toward advanced‑stage development and regulatory progress for MK‑1308A.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims MK-1308A 'obtained Breakthrough/Fast-Track designation and entered the regulatory filing/submission stage' by 2024. The ground truth explicitly states 'with no indication of regulatory approval yet' and makes no mention of Breakthrough or Fast-Track designations. This is a significant factual error that contradicts the source material. (2) CHARACTERIZATION ERROR - The LLM describes the 2022 status as 'early-phase, broadly-targeted CTLA-4 + pembrolizumab exploration across several solid tumours,' but the ground truth states it was 'Phase 3 development' in 2022, not early-phase. This mischaracterizes the development stage. (3) PARTIAL ACCURACY - The LLM correctly identifies: the fixed-dose coformulation of quavonlimab/pembrolizumab, the RCC focus, the Phase 3 status in 2024, and the general progression toward more defined therapeutic strategy. (4) MISSING ELEMENTS - The LLM fails to accurately capture the 2023 milestone where the coformulation was 'explicitly described,' which represents important specificity in the evolution. (5) UNSUPPORTED CLAIMS - The assertion about 'regulatory filing/submission stage' and regulatory designations appears to be fabricated or confused with other programs, as the ground truth contains no such information. The answer demonstrates partial understanding of the program's evolution but introduces material inaccuracies regarding regulatory status that significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 415,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nAccenture repurchased roughly $4.1 bn of Class A shares in fiscal 2022, $4.5 bn in fiscal 2023, and continued an aggressive buy‑back program in fiscal 2024 (e.g., $605 m in the fourth quarter alone), while the Board repeatedly expanded its repurchase authorization—from $6.13 bn after the 2022 increase to $6.69 bn after the 2024 approval—leaving about $2.7 bn of capacity under the existing program at year‑end 2024. This multi‑year trend shows a disciplined, progressive capital‑return strategy that uses excess cash to repurchase stock and regularly augments its authorization, underscoring confidence in cash generation and a commitment to returning surplus to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains major factual inaccuracies that fundamentally misrepresent Accenture's share repurchase activity:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Claims fiscal 2022 repurchases of ~$4.1 billion: Ground truth shows only $3,129,296 thousand (~$3.13 billion) in AVAILABLE authorization, not actual repurchases\n   - Claims fiscal 2023 repurchases of ~$4.5 billion: No such figure appears in ground truth\n   - Claims fiscal 2024 repurchases of $605M in Q4 alone: Ground truth states $605M was the TOTAL for fiscal 2024, not just Q4\n   - Claims authorization increased from $6.13 billion to $6.69 billion: Ground truth shows $4 billion NEW authorization approved in September 2024, bringing total outstanding to $6,694 million (~$6.69 billion), but the prior authorization level is not stated as $6.13 billion\n\n2. CONCEPTUAL CONFUSION:\n   - LLM conflates available authorization with actual repurchase amounts\n   - Ground truth clearly distinguishes between authorization levels and actual share purchases\n   - The $3.13 billion in fiscal 2022 was available authorization, not repurchase activity\n\n3. MISSING KEY INFORMATION:\n   - Fails to mention the 2,000,308 shares purchased in fiscal 2024\n   - Fails to mention the 72,255 shares acquired through employee-related transactions\n   - Misses the forward-looking disclosure pattern mentioned in ground truth\n   - Does not accurately capture the measured/disciplined nature emphasized in ground truth\n\n4. MULTI-HOP REASONING:\n   - Failed to properly synthesize the distinction between authorization and actual repurchases across fiscal years\n   - Incorrectly extrapolated patterns from incomplete/misunderstood data\n   - The conclusion about \"aggressive buy-back program\" contradicts the ground truth's characterization of \"sustained but measured\" strategy\n\n5. CONTEXTUAL ISSUES:\n   - While the answer addresses capital return strategy (relevant to question), it does so based on incorrect numbers\n   - The tone of \"aggressive\" contradicts the actual measured approach documented in filings\n\nThe LLM answer demonstrates a fundamental misunderstanding of the source data, confusing authorization levels with actual repurchase amounts and inventing specific dollar figures for fiscal 2022 and 2023 that do not appear in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 625,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million, 2.350 % Notes due 2040—originally issued in November 2020—are repeatedly listed in the Exhibit 4.6 sections of the 2022, 2023 and 2024 Form 10‑K filings, demonstrating that BMS continues to carry this long‑dated, fixed‑rate tranche as a core element of its capital structure. By retaining the note, BMS locks in low‑cost financing for the next two decades, stabilizes its interest‑expense profile and preserves flexibility to fund strategic priorities without resorting to more expensive or variable‑rate borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All quantitative data is correct: $750 million principal amount, 2.350% coupon rate, 2040 maturity date are all accurate. (2) The multi-hop synthesis is sound—the answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 filings, demonstrating persistence in the capital structure. (3) The strategic interpretation is well-reasoned: the answer correctly identifies that retention of fixed-rate debt reflects deliberate interest rate risk management and cost optimization. (4) The additional context about November 2020 issuance and Exhibit 4.6 location adds credible specificity. (5) The semantic meaning aligns with the ground truth regarding BMY's strategy of maintaining predictable long-term liabilities. MINOR CONSIDERATIONS: (1) The LLM answer uses 'BMS' as an abbreviation while the ground truth uses 'BMY'—both are acceptable ticker references but shows slight variation in nomenclature. (2) The ground truth explicitly mentions the notes were 'not refinanced or retired' while the LLM answer implies this through 'continues to carry' and 'retaining the note'—the implication is correct but slightly less explicit. (3) The LLM answer emphasizes 'low-cost financing' and 'more expensive or variable-rate borrowings' which is a reasonable inference about strategy but goes slightly beyond what the ground truth explicitly states about 'fixed interest rate obligations' and 'stabilize future interest expenses.' This inference is logical and consistent with debt management principles, not contradictory. Overall, the answer correctly synthesizes the multi-hop requirement (persistence across three years) and accurately conveys the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 492,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first issued in November 2019 (see the 2019 Form 8‑K referenced on pages 133‑134 and the 2020 supplemental indenture on page 136), and subsequent filings—including the 2020 supplemental indenture and the 2023 supplemental indenture (pages 136, 140)—simply add additional tranches under the same indenture without altering the coupon or maturity.  This consistent, unchanged terms across three recent filings reveal that BMS deliberately uses a long‑dated, fixed‑rate debt tranche to lock in financing costs for decades, reflecting a strategy of stable, low‑cost long‑term borrowing rather than frequent refinancing or exposure to interest‑rate volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 4.350% interest rate and the November 2019 issuance date, and accurately characterizes BMS's long-term debt strategy as stable and fixed-rate. However, there are significant issues with the multi-hop synthesis and completeness:\n\n(1) CORRECT ELEMENTS:\n- The 4.350% coupon rate is accurate\n- November 2019 issuance date is correct\n- The characterization of the strategy (stable, low-cost, long-dated fixed-rate debt) aligns with the ground truth conclusion\n- The reasoning about locking in financing costs and avoiding refinancing risk is sound\n\n(2) CRITICAL OMISSIONS:\n- The ground truth explicitly tracks the notes across THREE specific years (2022, 2023, 2024) with specific exhibit references (Exhibit 4bbb in 2022, Exhibit 4ff in 2023 and 2024)\n- The LLM answer mentions \"three recent filings\" but does not clearly identify which years or provide the specific exhibit citations that demonstrate the consistent disclosure pattern\n- The ground truth references specific supplemental indentures (Twelfth from 2020, Fourteenth from 2023) - the LLM mentions \"2020 supplemental indenture and 2023 supplemental indenture\" but lacks the ordinal numbers\n- The ground truth emphasizes \"consistent disclosure across three years\" as evidence of deliberate strategy; the LLM says \"unchanged terms\" but doesn't establish the three-year tracking pattern as clearly\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes that the consistent rate across filings indicates a deliberate strategy\n- However, it fails to complete the full multi-hop synthesis: it should trace the specific exhibit references and supplemental indenture dates across the 2022, 2023, and 2024 filings to demonstrate the pattern\n- The answer jumps to conclusions about strategy without fully documenting the filing-by-filing evidence\n\n(4) QUANTITATIVE ACCURACY:\n- The 4.350% rate is correct\n- The November 2019 date is correct\n- Page references (133-134, 136, 140) are provided but cannot be verified against the ground truth which uses exhibit numbers instead\n- No calculation errors, but incomplete documentation of the temporal pattern\n\n(5) ENTITY AND TEMPORAL ACCURACY:\n- Company (Bristol-Myers Squibb/BMS) correctly identified\n- Security correctly identified (4.350% Senior Notes due 2047)\n- Years mentioned vaguely (\"three recent filings\") rather than explicitly (2022, 2023, 2024)\n- This is a significant weakness for a question specifically asking about evolution \"across recent filings\"\n\nThe answer demonstrates good understanding of the underlying strategy but fails to provide the detailed, year-by-year filing analysis that the ground truth emphasizes as central to answering the question about how the commitment \"evolved across recent filings.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 740,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike moved from a brief mention of FlyEase as an emerging innovation to a concrete disclosure of its production scale.  The 2024 Form 10‑K quantifies this by stating that FlyEase‑enabled apparel is produced by 68 contract manufacturers across 33 countries, with one supplier alone accounting for >10 % of apparel output and the top five together representing roughly 51 % of total apparel production; factories in Vietnam, China and Cambodia alone supply about 28 %, 16 % and 15 % of that apparel, demonstrating that FlyEase technology is now integrated into Nike’s global manufacturing network.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect quantitative data that contradicts the ground truth. (1) WRONG PRODUCT CATEGORY: The LLM claims FlyEase-enabled apparel is produced by 68 contract manufacturers across 33 countries, but the ground truth specifically addresses FOOTWEAR manufacturing percentages (Vietnam 50%, Indonesia 27%, China 18%). The LLM conflates apparel production data with footwear production data, which are different product categories. (2) WRONG GEOGRAPHIC DATA: The LLM provides Vietnam 28%, China 16%, Cambodia 15% - these percentages do not match the ground truth's footwear distribution (Vietnam 50%, Indonesia 27%, China 18%). The LLM's numbers appear to reference apparel, not footwear. (3) MISSING KEY INFORMATION: The ground truth emphasizes that the manufacturing data demonstrates FlyEase's integration into FOOTWEAR production specifically, which is the core product category. The LLM shifts focus to apparel without acknowledging this distinction. (4) INCOMPLETE EVOLUTION NARRATIVE: While the LLM attempts to address the fiscal 2022-2024 evolution, it provides no evidence of the progression from 'brief mention' to 'consistent mention alongside Nike Air and Dri-FIT' (fiscal 2023) that the ground truth documents. (5) SYNTHESIS FAILURE: The multi-hop reasoning fails because the LLM appears to have synthesized data from different sections of the 10-K (apparel vs. footwear) without proper attribution or distinction. The question specifically asks about FlyEase technology's integration into 'global manufacturing operations' with 'quantitative evidence' - the LLM provides quantitative data, but for the wrong product category. The answer is internally coherent but factually misaligned with the ground truth source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 485,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nTarget’s RedCard penetration has been falling steadily: the 2022 10‑K recorded a rate of roughly 20 percent, it slipped to 19.8 percent in fiscal 2023 and to 18.6 percent in fiscal 2024 (as disclosed in the 2023 and 2024 Form 10‑Ks). This downward trend shows that the discount‑driven loyalty‑payment model is losing its ability to generate incremental sales, indicating diminishing effectiveness of the current loyalty‑driven strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM provides an incorrect 2024 penetration rate of 18.6%, when the ground truth shows 17.8%. This is a material factual error of 0.8 percentage points. The 2022 rate (~20%) and 2023 rate (19.8%) are correct. CALCULATION IMPACT: The magnitude of decline from 2023 to 2024 is misrepresented - the LLM shows a 1.2 percentage point drop (19.8% to 18.6%) when the actual decline is 2.0 percentage points (19.8% to 17.8%). This affects the interpretation of trend severity. QUALITATIVE REASONING: The LLM correctly identifies the downward trend and appropriately interprets it as indicating weakening effectiveness of the loyalty strategy. The reasoning about 'discount-driven loyalty-payment model losing its ability to generate incremental sales' is sound and semantically equivalent to the ground truth's assessment of 'reduced customer engagement' and 'weakening effectiveness.' COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates and what the trend suggests about strategy effectiveness. ENTITY ACCURACY: Correctly identifies Target, RedCard, and fiscal years. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years and connects the numerical trend to strategic implications. The primary weakness is the specific numeric error in the 2024 figure, which is a fundamental factual mistake that undermines the quantitative accuracy despite sound qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 410,
        "total_tokens": 1639
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 785,
    "failed_evaluations": 15,
    "average_correctness_score": 5.47,
    "average_quantitative_accuracy": 5.55,
    "average_qualitative_accuracy": 5.81,
    "average_contextual_relevance": 6.79,
    "score_distribution": {
      "excellent": 128,
      "good": 146,
      "fair": 282,
      "poor": 229
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 1138.45,
    "timestamp": "2026-02-03T01:22:52.738096"
  }
}